<SEC-DOCUMENT>0000885725-22-000023.txt : 20220804
<SEC-HEADER>0000885725-22-000023.hdr.sgml : 20220804
<ACCEPTANCE-DATETIME>20220804161638
ACCESSION NUMBER:		0000885725-22-000023
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		69
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		221136796

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bsx-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:202f2156-2eff-48c6-8020-e675b6a04e60,g:66d98efe-f6bb-4852-90b5-5e203e0b5e35,d:81ec8629b9df431d9ba97fad2f676991--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:bsx="http://www.bostonscientific.com/20220630" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY18zLTEtMS0xLTk5NzA2_90db6a9c-601d-4460-8be2-1819ff862a90">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY180LTEtMS0xLTk5NzA2_5bae4dcb-af62-4358-83eb-ddbf9d996dbe">12/31</ix:nonNumeric><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY181LTEtMS0xLTk5NzA2_1b75a1ec-7a57-47bd-9e93-4c2d0f354c4e">2022</ix:nonNumeric><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY182LTEtMS0xLTk5NzA2_7a1417aa-51f1-4f7a-a315-c6b8a93a5911">Q2</ix:nonNumeric><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY183LTEtMS0xLTk5NzA2_cb1874c5-510a-490c-b98a-7777999a62f3">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3470063d13da4b78885156191cea35c6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i92528d124d4e47d4a4ecea47db134aa8_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia14da29940934c628d805300ec2c17c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d88de9252574e38a75e71a25f421c17_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c57ac41bacb4c959c5a7c938d5fe29b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic39344112e4b495b9d151b1e92eaac82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic195e04f558f4180bdfa85d54ab847eb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1083b51b32f84f9ca03bffc92e5faa00_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc86164a6a43461a9651ec61b88f32e6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id535101847a6481a96023d3bc410b6bd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd0efc03c9fd497083ef2469237d078f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2696e3eb89444f7e9d4aa930e613f0b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideceab173cc44867a7c0a083004446ae_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifee4f63199724a10854016dabc453a58_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id049216887f0461ebc0924dd96909b7f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8f7a0da6f194f4f924ff1168b96527d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id45c80183e4a4f64b08b6a4853ef9f4c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815c23c139b84522831b294d59dd7d1e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1accaba913b4d1fbcb2c28cac07c0b0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie90c9ee4716140dd8fae0ab1d0950fed_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9391520b32e640fe97bcc36c1e5962f2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ff7c22212045f6b95c0a15cfeed14a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf5905737675481fb710c2ba0f468446_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fd9a0d26fab4332b61d8fad802ce5c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if15cc720f87a460abc0eb4e4e59fe876_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d680683b1e14d29be1a910573f28e70_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f97f1273c1442381613e9edae599b9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c84bc9bc635449b990165995bfde9a2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd771fc7d304e65a737b060eb018b8f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3466963199fd4fa3ade9bfff3a977e9f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84240be430054940bd414a4c7f52641a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25f858a6d47415ba74ad94fa706aa56_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6833d10fdee44d23b00e6ef571848119_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6ff8621f654a959cb451ed414f77d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e2b757294d44982a169d202719a992a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia346d18d384c42c7a6e99a584fdc97ce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a9e610d324a45d1a062c68adfb90b1f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74f91cea543f4d33980254e8da67f9f5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic48e2fdfe8f64c8b8bae824c8b0d223a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be8a81ffb4f47a6b727c3d0e0043401_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04889bdcfd104454b1ef3794d7f8830a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if43d66985bfd4da1b42f8e3e134778a6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c7ff30c0e34b678886a170580868c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44a04e2556f74b76bb8d693c12f82912_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a98c3dc779644d6b41945be1f5e75ed_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ebba7d42bf4a138a7fea99714df893_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id47b2514859f4f27848ade4cccce2be8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ffda331fdc249b9afd399366fe2269a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c66b638de3480c9eb8a388b49f2860_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7781cde9f4be4c6f8a6068f01de92fb5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9303b7f6c9604c1a9623997b119bcbcd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4588728b1b54b1598ce091e28f075b5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530a24628ff94bd8b6ecf768eb616100_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f2c362bdaec4d7c93ae599a3400d63c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a6e58ba7314b24a600982bbb84d5a8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd1a4c6e5ac4665bd79ed3e6e017085_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i685d9eb49f444cc59ed839c5b206c9d5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe2dc1f9b004e68839d9b76d40729f1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53edfe4ecc4f46be8baf73fc46188f98_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb6d5756a23e440086572a008869074f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34144dea661c452383c3d71bbf39f3ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reportablesegments"><xbrli:measure>bsx:reportablesegments</xbrli:measure></xbrli:unit><xbrli:unit id="business"><xbrli:measure>bsx:business</xbrli:measure></xbrli:unit><xbrli:context id="iee11fc6752204977a88f533ae4110495_I20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MITechCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i901ac63f75eb49639a4b506d76c7ec85_D20220615-20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MITechCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="krw"><xbrli:measure>iso4217:KRW</xbrli:measure></xbrli:unit><xbrli:context id="i5d7ad645f9b848e1960b6c1e9e613c6d_D20220214-20220214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-14</xbrli:startDate><xbrli:endDate>2022-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6d6608abc97401680adb8a26144b089_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6ac896dcc134060bdfc576d15c1f097_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d9b36d9b8943b68833ea0d071ed7d7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d861b96bd57474b92fcd29da39816fd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8031cd75b7814af29c4289dc1effe3ab_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib50cd8c4907244fa92f0e05706dcb767_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4462bc60133842ae953e65f20c772978_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifabaa3915ef144c09350675944f975ab_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6400d3c1fc24ca7bc85488919500c81_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b875ad2ff61444eb8f91d7e24664368_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75537fd4e06e411da653741c44074044_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if74b152ba6674c9da5871cb3bbed2af5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia306834040fd4493904c3d80050dfd07_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0038b38441f64cd1b1acadca2f9bdaf0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e1b80835cd3429dbe3445e36fc51f36_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id81e42a730db41b38addf624d55f0162_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="units"><xbrli:measure>bsx:units</xbrli:measure></xbrli:unit><xbrli:context id="ib0f0a63946614b93a706e459effcd822_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a007c4c42ba48c5af6af1adc620a5fe_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f07b1cab36340b2ac0e5013fe615164_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49748441876b428ca5de05c44d5f8499_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i989b56a183c946599da9be6a40044f0d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i424661b18ce84471819c51a4428349f4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a66fba061d3493aadeb2bf2117d4954_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i375d15b254054889b41fe012dea6ffd6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03013c27a6841b7b47d775cd8a4af8f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="id1d47dac14094180bc21b9214c11f723_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468740812f144020bed248757e33716f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02c663df999f43dba49c3e3fbdf4fd2a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5061cce88844571861e47c227eaa358_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d1877eb16ab4005bd5a1107e8dbe1aa_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf43344805b748ac8599d034b8fce38c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2155113815f245cb9e7caf23337d1848_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a865e40488d4b68a9fc599365b502d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fc7373cbc44f879acb93c09335f462_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77cb4812b8444881a8d1c6f3fe5f74ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b5c735c1eb4e9d95ed6be4cff64301_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i719d462654114eafa29963ace1f8a603_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91b81d90dcbd47d4994136811e97c5d2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e8c43d7f5314418961e8542ec180403_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d7a66e4fc364008a329768490327166_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1c1d0d7e6944bec9f3db53ad92fa034_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bb3e27fa63747a6b668bebab370867c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe82f860e15b483eaa3f27e40e7892cb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8474860170d474cbdbaf74e8fca9837_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i54cc7fcec9c242049c00578499ae8d13_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i997580c2ac9449cd9e09cac79cf4ac38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivative_instrument"><xbrli:measure>bsx:derivative_instrument</xbrli:measure></xbrli:unit><xbrli:context id="i1344f19ab092477889926fa8d06bba45_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if739a2c2f671402cb916170e3525437c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9d19a6bc3646338057525a9924ed42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id543b8483478491ab47eae96f17a2688_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18555e5fe782424da673f442fb298b06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c2e1aa2b5844bed9e3e6cae8d1958cd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id86e5cefc372494fb57cf5b9fb285236_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i721e9eac5b5c48a6aed4014b232cb438_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b807c0a08b94dddbe4f5e93f8fa811f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie84824453888409a909a24869be1cb1e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19171c2bd8484559af6db37d1aef1e11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f84dd2e1f24639a171ca54b2bba99a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082a9a99169e4067bb5133812e745527_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761665691f614dc391144cd928de4ff7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6605492210c74a4d9c31d30486122af1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9915524281c147b9b413b8c968c0375a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f1313d335714e77935281b63801f86d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e1669b9c2046b8aca9b105f46ecef9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5d2dfee4ee42909a9a420320563b9f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i894ed00d9114436795ac77d2513cb0d7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ad80cea173e459d9cffda4c1fb19c1d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i213187d28dcc430e8a47b7ba1ff645fe_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85f496eaa364904b720459ed2c8ae50_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06eeef8c3a2458a80d5fbb8e8971e2f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i283c9b3d2d864286a042216f0f64a9d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f79da42a51e4c689131977628edf127_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a8a481fded45df857975789968d39d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2075fa6d454b41ae2afcc3adfef0cc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70cc74c177124666847f665ef6dcce62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie23236f5602843f6a6cbba70fbcd25a3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522dd4a58a4841a5963ab9f73b804c01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e040f387ddc4ec38df96824cb9d67e4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd0b6009b67642718139f8490ac1a838_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i395049b051f7434bbf8dc1b8a8366602_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20de2ae88de4431b9b32645d028faae9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903aa99cb11d474c86e447953994f505_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1390af8c345c4263bf87707c4ef576e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85c78ca58b04142a6350664eedf1e72_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab5d2a58a3649bfb781ee50c6b74f2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4db18d7065c43ef83b29c8496790e86_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98c61e122e2347a5aa71be7a5df24cec_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b623df0e8c34375b46c759975f64119_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5f68cddd5ad42158036f7073b369a6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa3999e4bde44be99a76ff42c4163037_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27f146899c2744beaee1eff239630ac4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5055ee5be0c54a1498e064e638e3fc43_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad29e7417ab84660bbf5561c20e93d02_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf9c2c8c325e4eafb24af39665b6c948_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3b1e53f8964f6589f2176f191c0f08_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21815a7af6e34709a5951ddbb9f495fc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ce1e2f30ce34162a65a41a860c47fb7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ff32150be744fab5239abe91331844_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e7fbf9ea5d43a2b38aa9bad667e187_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bce25b2bb6a42e1a1077eeec7d3b9bc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80e70f9bdc9a4a9f829773dd8d40f1a2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd5038c2fb0e4b95b80671df1615c58e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73db81a84992414f90cb1a67fc97fb24_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10527d633af14853a3d6a28a3b84ea28_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e95c9c3ca2647bebeb689903f4662b6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8c1c7c026a4812bc680c9687955ea5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i771f92b343bb4886afe00f44b7d62b4d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85ee741df5d4ac693e71a7c46cb1f5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ee2942cb1e94674ab49ef190a069073_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48210b087009430d87d3ee09bbd7480b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id937d257d4a3403f8db692c5b41aa9ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fcf8358875242f7af0e421a76768692_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6669b1014a64e8189357320d104615a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b9b62e05a72418aa23a2c8539d02f68_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5293e3f0677c486fa8ef0b0311b62005_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fa9924b99f54b9bba102c4cbf10aca9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea96d4ea7d04a2daa8f980b999df830_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05aa77d5eb404436ad25e54997dd9780_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a0674ef27014518a6dd75ea87e28933_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id715136c1f6f43e190b1b7cb7b6a75e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib286dd30c58f4a679933177bb048f7b4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice55734ff9694ebb8bba28051710baa2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd222b4f248248c38837a4b7e751501d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7b3863114dd40908e490c5e045b081d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacacfc94ceb24a648193a04798d1e6dc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id86681f9c3b6492daaf4162fa8970450_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie950b3741f1d4e158b9ee15c4b4ed9a2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68de0d9b3a8e49ceafd696fc5709bd12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4b1f8f175024c6bbb7edb59c01d0d1c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i416ba9b4dd0d46c889e4493851b6db3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae315c0e1554dacaae58b7af1c8736f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i784b8e2bd7b74fe1b05c54c5962c8c64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie68f0f5b7ac54919bae4f7f9efc554d2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff06f923ba6c43cc86c4783c3efd3131_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08584e30dcf848aba71c8d5f57625e6f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4aea0c204194bf984d537214fddfde2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24581130201d4bb6bb06505b8f5af435_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i138c7c7c86e847c989a9ffb258cc207b_I20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c00dff781d2413cbbf1f18bed5d6e0f_D20210510-20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-10</xbrli:startDate><xbrli:endDate>2021-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia309b17ea78345ba80fb7b052728c043_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69088951be3f4fdeba3d3644b3c3b6f5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449d136159f049a5985130241fa62d0c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b4c437272d480aa75455fc20ccedd2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3ac65cbf784533b5620e4ff1832c2c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca81ce52f414e53a0e5cc4d51005e69_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f6851db735d4b949b672cef2153d2d0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d1ff42f2c334bd38528daf462dad7f6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea70986a88704b33aeb401629439ceee_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950105374ecc4d5681ba3458a73eadc0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie27b0338c0a34e858b0b2dccd5137bb4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i327d423409a741438941c3983d47e655_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a8923e44054f43b4d6eed3d687f722_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39de90268a7a4225b6941c9ff3a19fab_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingAggregatePrincipalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2038d40094f64de1965e4f053aeab53d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb6722339b944352b0b56bcac0aadaaf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i649407080a3b4a2a8dbe0062791430e0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if742f92ece7547768b16200d191f5b16_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic314a6b5f97d44198af151b25dbf609c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f1129cfb5e4c6bb359d217903f8368_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95b3c6ed9730476381312a30a5c8bcbd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e345c3e41bc48a8bc324b8f8375b600_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7bfd166b4841ad94b29f8f0775f55f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i646d9a6e9da946f785beb189d5511265_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f2e5182166b4e258ce14bd1c6bc2462_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2579a67e9154ae9bdb34bfdbaff7852_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32519afb04824cab904e19b493da014d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00ae8b0ca7d84dedb85b5fdbfbb37484_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i877957e5afdf40429ed18f3f84b993f7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaac3357a9aaa450e8357d06a28faf82a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claims"><xbrli:measure>bsx:claims</xbrli:measure></xbrli:unit><xbrli:context id="i0e48a7919ffd4f7981e1a7533395f383_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if145ba28e56b4a3e8ebaaade117334db_D20220805-20220805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-05</xbrli:startDate><xbrli:endDate>2022-08-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i762a71d1a5314a20b775461852e10332_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6b779abd6047358a4ff3e1753f9f78_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45237c280a543b788d2d06d99616c10_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bacdd63be81431e93233ee3874cc618_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b8a09505de24098ace745ffd92c8c9b_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07e0936bffa54f1fa93786399e12f047_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f9725f39b04b94a04843a31af9469d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7da2c1103ea4f908aac0cd8da683037_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie962472004ed49bb91bf3bb5bc90460e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ea4cb7460f44638f76c93ae1fe62a6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48c6b2ef29f5412b953d8ca8ea8e10f2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6276dfcd8f548909ad2b95aec63305f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f6c85fe355c406693e3fc90a6900617_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf7fdde677424e58ac261d8de70f896f_I20201214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb3f873e631440948432841109248bb6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida343bc176194f5883adbf14b2db3add_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaed936efbefb4d6883a1c81638adf58d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b181944f869422eaf28616562fd7a82_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35b65bf8163846418605a1c7c4224987_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6a468432bf4452ae37008655365bb9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i525a2094c6934a6485d6adda3f6a9b3a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cfee3824c314f15a3cc0a778059755c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i029f075c73314285a73d6046fc56ace1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic71339696da74c3c8be300118987e2a8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51540ac012634339a60c076ab917ca1b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06aeb53ebd2a4b1e99e14da58b780ce5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff0c73d214b4802aa383f6e6d6fb43a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01387391808f459ca10145d370775508_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a26c50603134586aeac79e838ea999a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbab2482ba9049fa8035d7fda68e3e46_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ff4cf4706044822b1d8fdff41caeeef_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab3d8ec398548efb4eb940722d1321b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24181bede48642979bf2659f8d3aca26_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i097b7bc5ad3e49d090a6fd4a3a2eac38_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99a609ec70434875bcd818a22223603c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad37ab5761724dd0bbe10d6aae7e351f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2acd2e07b1e341d4826054cff9f227ae_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib74ccd408f0b4969918ea713b800279e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08dfea82b704fd2833f1be5b210aca1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62067935217749dda69756e659e18d90_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9aaa5a5ca5f4e1f9301c01ec21b59e4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife3a11266e3d4321956fbc6d063b8a10_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1bf87505d2e4df7a780b78429497619_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie096244a71f845ca9eb0386aa8bcb3df_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b76bd80819b4615aeb5e962c486399a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ad59d435c194a23bb052a2504b3a319_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i415f872bf2c24ddfb98d985defe44440_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56bd4269832542bbba47c90663ce137a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47af1619791b4510b83d7d9ec10d1f42_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11f711ef34d649a2b44fa21f66871d34_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie14c2530827644ac893d5a38b3b01e88_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9768fb32a294fe1a98e46c54fb002fc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cd92fc770d74050ae6bc234223e19d9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie89fa19fb7d0473489935cee03e984eb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67775ec6a0934c30bf8aad1e7f6a0b6e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd09fe7de65f43ac93174dff385f04f6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb15f66e0dd4ad0898c5b50246fc5c7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc56c808748d4532afd8021abe0fbcba_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c8f3f10502c4f71ba2b31433a377b1e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36124ada3c8c43858ecb9286e86c2606_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fcfa3282cb148bbb748113d9528f7d4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761eb0a00d5444d5bf6bd2da5be27e90_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7433a0c7505464f961708a119d005b0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cdfe346e87b4744ae0e10651fe6a828_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabb00784efe74f8eba9e037108ad5aed_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2165365374154b58bb3c0a37d075e600_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9984e82eade4f2da3d2886469fb33b5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81be0345e72e40c38e9b1ec204739080_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifddfedd7174745d6aa132760e4e7d5f7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99797b8a0ac14a2683275123479db9e2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if17b5b0c3eef43dbb88f6d84614f82fc_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66ff310abb0c46ea842c1b5f2e101e06_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec55fa860e274f43bd665e1c527396ce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97f0fc8326c54d22b47c92fcf1404dac_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bcbe244161b44d08e2fb019d7190d8f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e17753aeed403cb6eb068b78c4172e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i162fa62a834d4024853d19c92f7d6803_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibefe540c865646ed9b0550380e6694dd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c88d81fbc054204b7dcb69d35b1ef8b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id67f6d5f8c204080bdcf3a8e11fae3eb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee0862174ab84b5880a7a5c5cf80931d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1d0fb3e4bf949b28e24977c79ce55f1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib647bd82c32d48dcab841641a70e3f4e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d47bcaff1842cb93b282563df9bd3d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f4d52a894b84bd585ff1aaee9ca68ed_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i717d79b707704b4a980799d216fbe641_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4179fffe78ef47a98f15ff8bc5762603_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0850efa38229479ea51013e0c6bd5ea4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82bb612d582148409a856cd8d6ce1da9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68f1e5b68bbf468ba366d5f07ad381b3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a332d62f2234fb896c3d81a7d7067ae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59461725015b4ab0a58f6b01f477955e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i042f5fcfd216400fb83d5b60c989ea25_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e9c75133f8543928b4807ac698a3f26_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia26a0d345a5a449683f9b0d89f1bb0a2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb908941b01946c392c481a9232193d7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i270e1d01244f4fd1b70234c80e9c0a94_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0abd801e946448e39c75bab8c1af730a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9bd5d80ec5b456092ac8652192da3ec_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e48cde1c09741fbbba8a76eba96c309_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i027ec43cabba41aaaaef1e9bb6739bbb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b6db5791ed44ccb0478df69ce8783d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifded57350dbc45cd90ffe08f24872546_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cfbf4ba247a4bd986d605da59f36b2a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cf55369f4514daa8887c854a382c1e1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99703b37b0ba48548c020a30c6b767e1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b2e0b3398bd4e9089a8388936799f46_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b6f04a66de74745848be0c25b2101eb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c9374eeb03f4c75a38fbf4295d7ffce_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc10c58865a4ff49ce0aa5218fd4974_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bdb29df4e854a19ae8ac360d53a3ea3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4da71fc4bd38481295e9d4de2b991770_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c8a6d03a20a4949b1bf505a8eedd6e7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief4415458b8949d9b372a41950b1d1c3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68d0be2afe1f471a8619be6368d23738_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ece9f53176241d1bddc8b97e5dcef4e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e38e69dadc14904ae3f0b4e977669e6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic077b66564b344bebb50e1be764ab9f0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i376c6e7abe2e42cabecb0d501e815677_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2643d6f56a40465881ef187eb4469dcd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8750752709c49678ab5476ee86964b1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d74776bb9b34e2cb0202a6760a54d00_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e873293fe6f418abbda4c5513c16be8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd5db3e942a74cbbaecb06454183c1eb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia531b4492dd040f3a0690a15663e829e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8df47fefeb74301add15e147b70ea9e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i641e5a7630d44a29abf0929b9ecbef09_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6269d280022f444da4365044dfebd1d0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cb6cd854f654144ad897e7e04aeb62b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a9d62ca9859478bbe137b00bb8bb81c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e27a21a2c6948ca8b4f0ed8a4c7ef45_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6a9247c0e4f45168242ed303b39c984_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bf11f4ecaa9458bab1012646612725f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e5f14f850024bdebc7d74e786cc46f5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95d03048f54a432b95f83d107f210120_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia045a31057fb468287b2baf2b245589a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11d9db0e99274141bc4e13555d17f9cb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb18f5e6c0e247a1b6a690cad0c427ef_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b165acafefe40209f5b6aabf02a3eba_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58a24ee4843a4c589a865ad63ca56d2a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1af6c9e0567f4219812341c9ab0f8940_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i983f6a62e8b44a20bd0879dcc23a0b33_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad62834ae44945f2a01034ea56d06a2e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica8940d222b9412497da6820d116c5db_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id893e6f844384001b614fa60554e39a0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2e80e247a6c4d63b59a373ccd6a4547_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d23ca3116f74ae08667619cf99610b1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31a87cc275df4c02827aeae66b3db474_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc114ba40df543a494974546b8688cda_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i996ce945e0ea47dc9b384cfd1a7cbb4d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee4a0405fcc46768dd9df2f2ee25d9a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i576cdae0729b4f15904cf440be39a5dc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad2ffb4bccd6473cbf1edf6b51561e8b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16fa28ceec55463fb802e656bce05d72_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50b995e2611d498b87e589132f982b29_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb96738c2284048800a1132782bf2bb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dcfd0caac50408a9d88c51b81a20b7c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id80b1eedfabd457080936ffd53512c5f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6c5221cbb284081a999df868d95ab10_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c19828588024500887d5d62d92864cd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icea6a8cb2f274f1cae8b176f73989975_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac6b29cb0bd643ea830c23024f6f122c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c0a9db1c8e4014b2df4e46dd5de46d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71761ebafaa4d329453f22bab510d1a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i353a9c38bf404c4b8bc5520b92a5b9c8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i251b6cd8103d489a9a3ad606f5d9de1e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie11f0a8ff4d240c69c1c5b12228bb893_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic50fcbfa6940498f8cf9056629ab9c88_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad83b783c274c09bcf887c0897c360a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica1a058ee7ff4842a9dd996eaadeab8f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d14bc6cd205427587873034553c97bf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c7a5b47c514f479f5321f0ab2663f4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib077df6e7685413397c816d1f7399061_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c63c604879341609359afebf06b84fb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e4f0985ad1740deba3b810eecdeeafe_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d6871b5efa47e089e55373103fc46a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56409fbd56bf4a44914cd2c8465f7903_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a20447358346669ee315fe67d484ef_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44122c777f7d4e659c894fab8bfe0463_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b571919e0954c0998434728e8377c58_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d01db59981d45bab53856f63a5438ae_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88b175c8d6f949ae9aa8ce0c709a1945_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i804e2fb842734bbbb84a1af373c0f50b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c70b969bbd496a8d242a26de3a03b1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10cf842a669546239f5adb70a68f5d12_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96c8adaf4f394f7bbe3dbe88b56bf82f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8ad17ca3dd24c48ad06fb834dcfe750_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9cd2c0e0d24475aa93ac3069d5a1401_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fb7facade49428fb1d9af329e51a7cc_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i981f627a420a466797e7c582e56d78d7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637a3831852e44fc9d35643a000aa777_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b5433550a40439c899d6f89ee694767_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41aab6c00bda4f86820878b7c6774c9e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie16d4e79dbaa470fbcb924d46c0c79ad_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide5536294b9c422399ae5dc27f304dc9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ccea46e8c094031bc29d50afc2fb0a7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d9437b6a921439292845559c4c462b2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402fc673d13248f590527d5a9df8dd9c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0185ce7757d248cfb6fbd1ea52edba1c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id46a54a0a24f40f988a953734d9ef437_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80e3da031c9b4d6e944876c1bf4edd3c_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i81ec8629b9df431d9ba97fad2f676991_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA0_105299fa-842a-42b6-8d65-166633997dcd">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MjYyOWE4YmRiMGM2NDQ3M2E5YjZiYTczYjQwMzljZDUvdGFibGVyYW5nZToyNjI5YThiZGIwYzY0NDczYTliNmJhNzNiNDAzOWNkNV8wLTAtMS0xLTk5NzA2_0016e561-7a1c-472e-a829-99675cb9f9dd">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8xMjA_0f57a8d9-3ea8-4a4e-bf81-941cdbbdd97c">June&#160;30, 2022</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6ZGUyZDVmMWJmYzkyNDkxNmJjMDJkMTU3Yzk4MTIxZTcvdGFibGVyYW5nZTpkZTJkNWYxYmZjOTI0OTE2YmMwMmQxNTdjOTgxMjFlN18wLTAtMS0xLTk5NzA2_51c9aede-5474-43e9-9428-7db11fa56fca">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA1_6cfb5d0f-7faf-4652-8b26-682c32706cb6">1-11083</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDEy_cd0dc1fb-e833-4430-b1ce-3a9ac03f8d55">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6NjY3ZTQ3MGYxN2ZmNGU0OGFhNmExZmU2N2NiZWQ0ODkvdGFibGVyYW5nZTo2NjdlNDcwZjE3ZmY0ZTQ4YWE2YTFmZTY3Y2JlZDQ4OV8wLTAtMS0xLTk5NzA2_b0ebba4c-13d2-42f6-805d-e9a199adb7a5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6NjY3ZTQ3MGYxN2ZmNGU0OGFhNmExZmU2N2NiZWQ0ODkvdGFibGVyYW5nZTo2NjdlNDcwZjE3ZmY0ZTQ4YWE2YTFmZTY3Y2JlZDQ4OV8wLTItMS0xLTk5NzA2_f8033f40-9871-4f67-83db-14ddbd44764c">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDEz_b7f8b46b-a5e5-40cd-b7e5-b0be678a821c">300 Boston Scientific Way</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDAx_2f0e3d7e-6237-4d55-a7c8-b4dc91c6441e">Marlborough</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA2_13f884d8-6093-4d64-b43e-7267469957ee">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA5_fb63f353-ee42-4cb4-be1a-bcb186826b01">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA3_9b279eb7-916e-47f9-82fd-6156682b6bf2">508</ix:nonNumeric> <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDAy_2377b80c-fa2e-4446-8302-23d7e495ea7a">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8xLTAtMS0xLTk5NzA2_8f150117-3a45-4f8f-a222-1ed1b7f2b3b6">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8xLTItMS0xLTk5NzA2_ee82689d-530d-4cac-bf2b-6afca9aeaff5">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8xLTQtMS0xLTk5NzA2_42b9e375-dcd0-4b77-92ef-02537449235e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8yLTAtMS0xLTk5NzA2_fd3a8dd1-a9a4-4ebb-aa5f-dd63b496a495">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8yLTItMS0xLTk5NzA2_a099dc3b-61e9-4f2f-98d4-08df98cc9b61">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8yLTQtMS0xLTk5NzA2_88e4682a-897e-45fa-b448-bc1be5c2e164">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8zLTAtMS0xLTk5NzA2_964db46f-2279-446c-9936-8fdf4b58830f">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8zLTItMS0xLTk5NzA2_f1d6c87f-2adb-4bf4-9770-3fb3de988569">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8zLTQtMS0xLTk5NzA2_18d123aa-b589-456e-9770-e564b34299e6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDEw_c919c16b-c24c-45c5-8d87-d3308d89bc60">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA4_ae541b7e-3a2e-4f74-8382-6b6cae7161c6">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MzhhYTYwM2Y4MWIwNDZmNDg3MzMyMDMwZTJmOWMxZTAvdGFibGVyYW5nZTozOGFhNjAzZjgxYjA0NmY0ODczMzIwMzBlMmY5YzFlMF8wLTAtMS0xLTk5NzA2_cc5f2174-7197-404e-904a-a4c4727051b8">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MzhhYTYwM2Y4MWIwNDZmNDg3MzMyMDMwZTJmOWMxZTAvdGFibGVyYW5nZTozOGFhNjAzZjgxYjA0NmY0ODczMzIwMzBlMmY5YzFlMF8xLTMtMS0xLTk5NzA2_b9150b03-03db-4a89-a69e-bf0c701f3f1a">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MzhhYTYwM2Y4MWIwNDZmNDg3MzMyMDMwZTJmOWMxZTAvdGFibGVyYW5nZTozOGFhNjAzZjgxYjA0NmY0ODczMzIwMzBlMmY5YzFlMF8yLTMtMS0xLTk5NzA2_a0e0d460-05ac-422a-81a6-46e930ac5c10">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDAz_272f03fe-a151-4ea1-a8cc-0fd091da350b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of Common Stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="2" name="dei:EntityListingParValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8xOTYy_4dc5dfc9-d277-4183-9707-aaa6d0d8ab1e">0.01</ix:nonFraction> par value per share, as of July&#160;29, 2022 was <ix:nonFraction unitRef="shares" contextRef="i92528d124d4e47d4a4ecea47db134aa8_I20220729" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8xOTk5_44fa4ec9-2d83-41f0-8aff-ff9bb1222367">1,431,614,313</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_16">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_16">Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_19">Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_22">Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_22">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_25">Consolidated Balance Sheets (Unaudited as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_25">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_25"> 2022)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_25">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_28">Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_31">Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_34">Notes to the Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_34">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_130">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_130">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_130">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_157">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_157">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_157">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_160">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_160">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_160">58</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_163">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_163">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_163">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_166">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_166">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_166">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_169">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_169">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_169">59</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_175">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_175">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_175">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_178">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_178">61</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy0xLTEtMS05OTcwNg_3064f86c-696f-48bf-9ee1-03c338e62f2c">3,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy0zLTEtMS05OTcwNg_f1b03ede-2b5e-4cda-89c9-42f1cbca0db6">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy01LTEtMS05OTcwNg_3bec9cc5-62a5-43c1-a7ec-1dec59500293">6,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy03LTEtMS05OTcwNg_00e172d6-241f-45c6-8438-d0ae36b9227f">5,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC0xLTEtMS05OTcwNg_0d4c780c-3bc3-4fe1-b734-9e809bb7e1e1">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC0zLTEtMS05OTcwNg_f2a0f215-3c2c-4c1a-ad09-492f8f9e43e5">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC01LTEtMS05OTcwNg_ac75fdc2-8532-4da2-8d35-a2b2ee97afb5">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC03LTEtMS05OTcwNg_29db05ca-58e9-42a2-ac6b-b2f8a2c2edbe">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS0xLTEtMS05OTcwNg_54f02f1f-27a4-4358-8e44-dbeeb99d7490">2,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS0zLTEtMS05OTcwNg_3cd14e24-babb-4d51-a178-e41f9b5bb4b2">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS01LTEtMS05OTcwNg_3ac5f2d0-07db-4057-8ffe-40fd5f791c9d">4,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS03LTEtMS05OTcwNg_9ae832c8-be91-4b99-9884-99a925f9a73f">3,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC0xLTEtMS05OTcwNg_cae93069-548c-41fd-8f39-9bf93cdb3a0b">1,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC0zLTEtMS05OTcwNg_20192c51-81c7-414c-a7c0-9588ef84d840">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC01LTEtMS05OTcwNg_911da315-1b81-409d-a115-1161ba72141e">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC03LTEtMS05OTcwNg_34b5a4ab-781c-4c2f-ab6e-7c3db890aa32">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS0xLTEtMS05OTcwNg_ca2bdbee-faaf-4ab6-8b19-4996ac3b66d7">335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS0zLTEtMS05OTcwNg_230d226b-455c-4866-ab43-e65f92d9e1d5">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS01LTEtMS05OTcwNg_a66fd62a-8345-4368-80eb-d6ce7fa15f3a">654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS03LTEtMS05OTcwNg_bc4b69fb-6001-4d03-9f2d-1cd48e93fcc3">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtMS0xLTEtOTk3MDY_aa146415-a7d1-46b0-a10f-2306b69ebd04">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtMy0xLTEtOTk3MDY_64fde8f4-be5a-4f32-9401-bcf627d7101b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtNS0xLTEtOTk3MDY_9670db1a-6973-4ebb-95e4-a1a12fca07d0">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtNy0xLTEtOTk3MDY_b4faa2ef-2b4a-4ceb-b212-86c716b61ca4">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtMS0xLTEtOTk3MDY_cfb24182-02be-4723-bdb9-3cd5631ff339">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtMy0xLTEtOTk3MDY_e6de3861-027f-45d1-bf2e-64ea91a676ad">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtNS0xLTEtOTk3MDY_36060347-fe1f-4625-98eb-441e29aa27a0">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtNy0xLTEtOTk3MDY_d2f4c921-279c-4a2f-a482-aeb8cf8c51df">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtMS0xLTEtOTk3MDY_81858954-451b-4d7b-9e35-00dac7c04e89">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtMy0xLTEtOTk3MDY_e7e69599-45ef-4ba9-bf27-1f466def7b11">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtNS0xLTEtOTk3MDY_128bb775-0427-43af-8b57-581f91cac18c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtNy0xLTEtOTk3MDY_61977263-342d-445d-b6ad-6eb27e05c8d7">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtMS0xLTEtOTk3MDY_24ecc462-8639-4ebe-a6ee-a15a2a079dbf">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtMy0xLTEtOTk3MDY_69f261b3-64eb-45bc-9aa0-9f3a5be37a27">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtNS0xLTEtOTk3MDY_c340f5b7-db1f-4427-a17a-adec8016a84e">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtNy0xLTEtOTk3MDY_5bd604ef-3ad1-4186-ac35-2a64d7b594cc">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtMS0xLTEtOTk3MDY_40fc4422-0d7b-44dd-bbb4-7e2b14534c6b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtMy0xLTEtOTk3MDY_48064561-e2da-4e3f-8cee-6f774edf4179">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtNS0xLTEtOTk3MDY_a0cb3111-93a5-4329-9f61-be47c1cdd5b3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtNy0xLTEtOTk3MDY_d222df37-831f-4304-9a80-8d0bcf129cef">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtMS0xLTEtOTk3MDY_bd6cf8c7-efe9-48d6-971d-6faa048d0f40">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtMy0xLTEtOTk3MDY_5c2e2723-5cef-42c5-be76-d157f8c204fd">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtNS0xLTEtOTk3MDY_2908a82e-3a0d-47cd-849f-4d8e64233bdd">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtNy0xLTEtOTk3MDY_59970653-dfc6-47d7-ae00-772cc3e0fc82">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of businesses and assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctMS0xLTEtOTk3MDY_e04c36bc-491d-4b1c-8c7b-30f239b0f9fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctMy0xLTEtOTk3MDY_8ac6baa7-e9bb-4594-89a1-0c76e5ef8f2c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctNS0xLTEtOTk3MDY_bb89823d-bc1a-42d5-8e75-42453519f31d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctNy0xLTEtOTk3MDY_116f2c94-f3a1-41ae-956a-865167667e70">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtMS0xLTEtOTk3MDY_417a1931-5c01-4f09-9eee-81cd293f470d">1,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtMy0xLTEtOTk3MDY_26ad99cb-3eef-4b4a-9697-6f9b1a87ab2f">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtNS0xLTEtOTk3MDY_0e4accdc-386c-4d20-b279-fd04c4b36289">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtNy0xLTEtOTk3MDY_3a450427-7b0c-4a72-88aa-7599fd8f9a3b">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktMS0xLTEtOTk3MDY_85b7cc32-2cb9-4404-8114-de2bbff9fc4c">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktMy0xLTEtOTk3MDY_753d0a6d-4486-4ec2-b68d-63e79962b6cc">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktNS0xLTEtOTk3MDY_6eeb09f7-3816-41a1-8123-07a0e9a4ceef">889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktNy0xLTEtOTk3MDY_26c49af3-1111-4e50-a3cd-8539dc2d9927">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItMS0xLTEtOTk3MDY_3f6015a6-fddc-4632-9f3c-19fab42df367">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItMy0xLTEtOTk3MDY_1c2a0ad3-35e8-4a50-b8e5-89f3a3b61bc1">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItNS0xLTEtOTk3MDY_4a15e538-1614-4221-a582-bd5ec3eb5c2a">343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItNy0xLTEtOTk3MDY_cae00af4-fcd8-4b2f-b99b-59f0fa28ef93">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtMS0xLTEtOTk3MDY_76b39457-1468-4797-bb6f-b45a82fe5bc8">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtMy0xLTEtOTk3MDY_5de2cbf4-1ef2-4089-a03a-dfeccd3c7cfc">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtNS0xLTEtOTk3MDY_ec4f2a45-c98d-416b-ac13-f00887590c5d">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtNy0xLTEtOTk3MDY_35d4e560-df48-4eba-acef-a1c1c4bd7824">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss)&#160;before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtMS0xLTEtOTk3MDY_768f52fd-7f94-4194-b5f4-e32589d22ee7">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtMy0xLTEtOTk3MDY_9460b936-1070-48d1-b7d9-566ae63603cf">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtNS0xLTEtOTk3MDY_496c6316-080b-4011-b2e1-40de635f7156">501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtNy0xLTEtOTk3MDY_18f83db7-6cf9-41c9-b097-4b90cd91d774">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtMS0xLTEtOTk3MDY_f0d95b43-2ee8-4012-aea0-7ece51e0843a">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtMy0xLTEtOTk3MDY_5c7aacf2-a62b-48de-8452-473af63e2c85">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtNS0xLTEtOTk3MDY_9ec83d5d-cd7e-4bbc-99b8-25c6464fd2e8">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtNy0xLTEtOTk3MDY_3c3eb097-c92b-487f-8e31-feb4f5c7d669">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtMS0xLTEtOTk3MDY_aa2eb9e2-e8ba-402d-87d6-4e57d28fd56f">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtMy0xLTEtOTk3MDY_ea96b581-071c-464d-a25a-d95cf6c4e241">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtNS0xLTEtOTk3MDY_2a34eec2-b845-4ec9-ab36-0b3b1e0a15cf">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtNy0xLTEtOTk3MDY_a663faa1-7294-4ac7-a53c-e04bee28dc1f">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctMS0xLTEtOTk3MDY_9ab27cea-10a7-4047-9ced-5035b690661b">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctMy0xLTEtOTk3MDY_75075f28-55cb-4a60-a8dd-bc38dbb088e6">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctNS0xLTEtOTk3MDY_e10d3034-32f2-4082-a4a0-9e301573eddb">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctNy0xLTEtOTk3MDY_ee9a07e6-8665-48a5-af1f-0e70bbbb26dd">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtMS0xLTEtOTk3MDY_3bb33874-b23b-4159-bf29-dbe01b003dba">246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtMy0xLTEtOTk3MDY_336e59b5-f4fb-4efb-88e7-1a47361bfb31">172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtNS0xLTEtOTk3MDY_bbc6ba4e-9183-4d43-8f11-096087432939">342</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtNy0xLTEtOTk3MDY_b7f128e4-51b1-48bd-a600-a995f131208d">500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtMS0xLTEtOTk3MDY_5ee60d7f-a318-4a38-8d7c-b485878f42f1">0.17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtMy0xLTEtOTk3MDY_cc905311-cef2-4863-ae77-ea10e96474c1">0.12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtNS0xLTEtOTk3MDY_7b7f4296-a731-497a-8956-6185276c4162">0.24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtNy0xLTEtOTk3MDY_af1a24c7-d734-4b0d-942b-c9ce6ffe1d34">0.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtMS0xLTEtOTk3MDY_af25de8d-1b51-4539-80d3-312499792d49">0.17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtMy0xLTEtOTk3MDY_cce39595-ae60-4553-83e9-f21db2bc3142">0.12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtNS0xLTEtOTk3MDY_57f9afba-48b2-488a-b5c8-b9edc2524a4f">0.24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtNy0xLTEtOTk3MDY_133599bf-7d9a-4a2c-9658-4f35330fe75d">0.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtMS0xLTEtOTk3MDY_a6ad48f8-d6f1-4a1b-ad36-69918414db24">1,429.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtMy0xLTEtOTk3MDY_5cf196fb-19dc-40e9-8cc2-ac1d47c790c1">1,421.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtNS0xLTEtOTk3MDY_dcc848d2-e7d7-4b75-82a8-d28fdaefea27">1,428.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtNy0xLTEtOTk3MDY_4e5af27f-3b69-4f7a-9410-cebfe6a09cc1">1,420.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtMS0xLTEtOTk3MDY_9dde85db-439d-47b6-8186-ed898e8ccd40">1,437.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtMy0xLTEtOTk3MDY_01284266-9ec6-4eb4-803b-fd9d6dacc564">1,432.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtNS0xLTEtOTk3MDY_e36fcda7-379a-4ffc-80e0-b77786217625">1,438.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtNy0xLTEtOTk3MDY_4286218b-0099-4ea1-ba30-5fd11ea6b6ec">1,431.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi0xLTEtMS05OTcwNg_aa2eb9e2-e8ba-402d-87d6-4e57d28fd56f">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi0zLTEtMS05OTcwNg_ea96b581-071c-464d-a25a-d95cf6c4e241">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi01LTEtMS05OTcwNg_2a34eec2-b845-4ec9-ab36-0b3b1e0a15cf">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi03LTEtMS05OTcwNg_a663faa1-7294-4ac7-a53c-e04bee28dc1f">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC0xLTEtMS05OTcwNg_a92cf1e2-967f-4243-b8f0-43a3edb012b7">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC0zLTEtMS05OTcwNg_b0e7c677-9f3b-4a26-a3c6-90ccd50bdfba">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC01LTEtMS05OTcwNg_39b5031c-9ba6-4e7b-9482-da9a8ba23f29">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC03LTEtMS05OTcwNg_b1ccbf69-20bb-4bd4-bb53-5ba00be93e2f">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS0xLTEtMS05OTcwNg_6853966d-7fa8-4be6-bbaa-2b5c9700cfcf">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS0zLTEtMS05OTcwNg_306982a9-6a73-4873-83a3-08dfc40cca9f">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS01LTEtMS05OTcwNg_7ef5633e-f901-4deb-b224-6b2e1b6e37cf">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS03LTEtMS05OTcwNg_11edfa7c-f582-4055-bed4-2979dabc98a2">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy0xLTEtMS05OTcwNg_6d07c133-5027-4891-8f18-d3bf848def10">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy0zLTEtMS05OTcwNg_48815552-ee76-4dab-878c-0876160d21c9">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy01LTEtMS05OTcwNg_d928b1c2-80cb-42ee-adc8-d86c9fff015f">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy03LTEtMS05OTcwNg_f6e75e07-e8bf-437e-87d1-21d6366cd381">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC0xLTEtMS05OTcwNg_dda9c008-9995-48be-bc5f-25848b5f33fa">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC0zLTEtMS05OTcwNg_7cde796a-48fd-472f-840d-3e151d0d7d3a">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC01LTEtMS05OTcwNg_5fbfe208-7c05-43cb-85af-efb2f023061d">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC03LTEtMS05OTcwNg_81bcc1cc-9a72-4652-86ad-9bcd5e90c375">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS0xLTEtMS05OTcwNg_e806cb77-8069-4620-a191-d2e2179664d9">471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS0zLTEtMS05OTcwNg_c651057f-8315-46a2-a2e0-6d6450677643">170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS01LTEtMS05OTcwNg_f6906af6-c2ee-4aae-a27a-2c6a9bc2897d">540</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS03LTEtMS05OTcwNg_c70b61d1-be2d-473a-a306-58ed5f572c14">558</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNC0xLTEtMS05OTcwNg_cbcd390e-d40b-4452-8871-55975e5de404">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNC0zLTEtMS05OTcwNg_9a271f24-b0ac-450c-8c9f-1a7e17413122">1,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNS0xLTEtMS05OTcwNg_93ba2f4b-5e59-4e9f-bebf-fe33dce4cb42">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNS0zLTEtMS05OTcwNg_35742f6c-fc76-485e-9ddc-3d00c359fbb9">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNi0xLTEtMS05OTcwNg_34b67d7d-db15-4899-8f9e-a9ededa7537f">1,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNi0zLTEtMS05OTcwNg_a5385f3f-497b-45f7-8156-78b8af0b6961">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNy0xLTEtMS05OTcwNg_2302098d-dcfe-4647-8a4d-cfd2a13f61c5">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNy0zLTEtMS05OTcwNg_a5776c32-7e46-4400-93b8-ea1754f499be">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfOS0xLTEtMS05OTcwNg_c686c2bb-a9d6-46b9-8f51-ad800ac5f611">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfOS0zLTEtMS05OTcwNg_77cf7f00-c9ef-46d3-916e-ed4f329e6fd6">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTAtMS0xLTEtOTk3MDY_1889e51c-2aa4-4b35-b9bc-b3b0c3c61dbf">5,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTAtMy0xLTEtOTk3MDY_17aad0a1-c84b-41a8-bc19-df036e31e825">6,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTEtMS0xLTEtOTk3MDY_bfa3dd0e-4fbb-4731-93e6-2358afcdb8f5">2,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTEtMy0xLTEtOTk3MDY_532cc894-6f1c-4bf6-be0e-c2f3fe2bb599">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTItMS0xLTEtOTk3MDY_917ef038-7d97-4c9d-9193-f0dfa8dc095e">12,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTItMy0xLTEtOTk3MDY_ea071e4c-b7cc-4999-90a7-4146ba728022">11,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTMtMS0xLTEtOTk3MDY_29bec04a-41cd-418a-99af-e199b96453e2">6,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTMtMy0xLTEtOTk3MDY_c5bc5e29-8406-4937-b70b-5ae4f0b8081e">6,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTQtMS0xLTEtOTk3MDY_3d6a8740-fe38-45fc-82ac-f2d22f37ad4e">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTQtMy0xLTEtOTk3MDY_4c1969bf-0b0a-4207-8de1-6fd6fb060f1a">4,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTUtMS0xLTEtOTk3MDY_090a39ae-2f9f-41b5-b8f5-38a6b2c0fe95">1,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTUtMy0xLTEtOTk3MDY_b8703b0a-a73d-4a92-8621-27aa1c98caf0">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTYtMS0xLTEtOTk3MDY_edd9ad9e-b034-42ce-8acd-5262c06785ca">32,189</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTYtMy0xLTEtOTk3MDY_24e3ccbc-b410-4a42-b230-fba439160d31">32,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjAtMS0xLTEtOTk3MDY_398bda20-c4b9-4c5c-97d6-086bd38cd320">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjAtMy0xLTEtOTk3MDY_28b8a4b7-dcda-4bf6-bafd-83de4eb1a638">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjEtMS0xLTEtOTk3MDY_1b2b0f70-728d-49e5-bbb2-177bba865637">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjEtMy0xLTEtOTk3MDY_94d455e8-511f-42b7-b5ae-1fc383e00ac1">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjItMS0xLTEtOTk3MDY_d689f569-9a34-473e-a0e5-758099790257">2,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjItMy0xLTEtOTk3MDY_63074078-38b4-4b6c-8529-b481964a704e">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjMtMS0xLTEtOTk3MDY_c4b77f3e-21ac-4a7d-b42b-0489db688bf9">784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjMtMy0xLTEtOTk3MDY_3f1440b6-fd9b-4818-a1d2-68f9340dfa3c">783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjQtMS0xLTEtOTk3MDY_9bf1183a-68ae-4974-8225-c3b6253cf1c6">3,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjQtMy0xLTEtOTk3MDY_34929bcb-2659-413d-85d6-ad5f1e729373">4,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjUtMS0xLTEtOTk3MDY_3bc095a1-4ea6-4dee-afab-5b85429ef84b">8,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjUtMy0xLTEtOTk3MDY_b1e5b2d1-465a-43d7-bd14-927ad3d2440f">8,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjYtMS0xLTEtOTk3MDY_2defd55a-a866-4124-940f-a03967871992">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjYtMy0xLTEtOTk3MDY_7703edd0-7e4b-4a26-a43b-ac86bb67758e">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjctMS0xLTEtOTk3MDY_f03d0901-eef1-4a9e-a076-5989161018d4">1,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjctMy0xLTEtOTk3MDY_bf5108a7-3066-4097-8dcc-879b5dfdbe2b">2,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjktMS0xLTEtOTk3MDY_38be2476-9a2d-45c0-b1c0-9db18634e6b4"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjktMy0xLTEtOTk3MDY_02d2d15d-df08-438e-a840-636564403cc0"></ix:nonFraction></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF8yMQ_08dad1b0-d991-45cc-9a9c-c5b4d5102f26"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF8yMQ_f63486e4-5bb7-484e-9b39-b26a7b15d193">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF80Nw_58e96556-36f0-4ebc-ba19-c28129963a10"><ix:nonFraction unitRef="shares" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF80Nw_be7def8b-e617-47aa-a1ab-afda30a5458a">50,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF82Ng_4601f0ce-c727-4c8c-b700-734b414ba74a"><ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF82Ng_882e0b3d-5107-4905-a1aa-7c2717a9631c">10,062,500</ix:nonFraction></ix:nonFraction> shares as of June 30, 2022 and December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMS0xLTEtOTk3MDY_d15c8a2f-dd0d-4fba-9d4c-cc6f15b617ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMy0xLTEtOTk3MDY_14c63bd7-a0af-4d75-9e04-d80c3172f4d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl8xOA_66dddde7-27bc-401b-a0c6-d79dcd2b41dc"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl8xOA_867f75c3-aebe-404e-a0a5-1c6937a39fe7">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl80NA_6d4a57fd-6390-43f5-a00f-27e3166a2991"><ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl80NA_76b08837-c502-41ee-9b5f-056c32450463">2,000,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl8yMTk5MDIzMjU1NzAx_fe600fad-389e-4956-b2fc-9d6599acb8aa">1,693,192,785</ix:nonFraction> shares as of June 30, 2022 and <ix:nonFraction unitRef="shares" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl85OA_39b7f132-95e6-4b5b-a589-f4c16a0a8ef3">1,688,810,052</ix:nonFraction> shares as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMS0xLTEtOTk3MDY_0c0155f4-1190-4bf7-ae4e-deb8cc576700">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMy0xLTEtOTk3MDY_0979d476-20c0-4ab9-8103-058fce9b5be2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoyMWMzNjE0ODk4N2E0MDNjOTZjYmRkMTkxODg5MjljMF8zMA_2fadc4dd-771a-4f13-b2c7-27ecf4d4ba08"><ix:nonFraction unitRef="shares" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="0" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoyMWMzNjE0ODk4N2E0MDNjOTZjYmRkMTkxODg5MjljMF8zMA_d35abd52-f450-4cae-83c8-9299f2cd146f">263,289,848</ix:nonFraction></ix:nonFraction> shares as of June 30, 2022 and December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMS0xLTEtOTk3MDY_d339349c-77a9-4f51-bf84-c7aba6578242">2,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMy0xLTEtOTk3MDY_c3727aef-fee1-45b0-aed2-6fae5c9ede2d">2,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzUtMS0xLTEtOTk3MDY_29bb394b-a952-4398-8159-f51da0d05e66">20,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzUtMy0xLTEtOTk3MDY_e4c741ed-b35d-4eb2-8878-935057c567b2">19,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzYtMS0xLTEtOTk3MDY_2f86aad2-f844-4d8f-9137-d49ca62e332c">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzYtMy0xLTEtOTk3MDY_cbf766ae-e7e8-416f-9809-fd5e5b39e9db">1,392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzctMS0xLTEtOTk3MDY_56c1df11-8fc0-4199-a357-72bf0803bb59">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzctMy0xLTEtOTk3MDY_da65c186-a08e-4f80-bbf7-c57dd047ba6c">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzgtMS0xLTEtOTk3MDY_0e0e4ff3-b3c8-4a99-8f8c-6b296083c193">17,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzgtMy0xLTEtOTk3MDY_343da57e-80a3-411f-bfec-7a5473aae498">16,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzktMS0xLTEtOTk3MDY_2cf48776-a8fd-4cce-85b6-3fbde9bde637">32,189</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzktMy0xLTEtOTk3MDY_14c42f90-0944-4b9e-b2c2-1d9a8a0214eb">32,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred stock shares issued</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d88de9252574e38a75e71a25f421c17_I20220331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy0xLTEtMS05OTcwNg_8b0c87d0-3608-4227-82d3-99694ff693ad">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c57ac41bacb4c959c5a7c938d5fe29b_I20210331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy0zLTEtMS05OTcwNg_f04a2e27-12de-4eac-bfb3-46240d322c4d">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic39344112e4b495b9d151b1e92eaac82_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy01LTEtMS05OTcwNg_fc2700e6-07d0-406c-b19f-05fbb6967aa8">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy03LTEtMS05OTcwNg_7cc90b09-4a65-40ef-b999-229c370dc9c1">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS0xLTEtMS05OTcwNg_4b36496a-44ff-4f9d-9a44-1c6e81ca0f34">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS0zLTEtMS05OTcwNg_704a0741-9c73-4541-b462-9fda55a8f399">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS01LTEtMS05OTcwNg_b3dcfaeb-93f1-48be-8c61-ac7447a6a3b2">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS03LTEtMS05OTcwNg_2f2a5fe7-25a2-4642-8437-681528d94a72">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock shares issued</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc86164a6a43461a9651ec61b88f32e6_I20220331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy0xLTEtMS05OTcwNg_88ff7246-2d89-4ee4-a25a-d9ab12408f4c">1,692,828,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id535101847a6481a96023d3bc410b6bd_I20210331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy0zLTEtMS05OTcwNg_1b27f0dd-e0ae-4cdb-97c4-3ef8621bac5b">1,683,861,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifd0efc03c9fd497083ef2469237d078f_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy01LTEtMS05OTcwNg_d2395c1c-e69d-4523-a44f-1eb73bc6e7c6">1,688,810,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2696e3eb89444f7e9d4aa930e613f0b7_I20201231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy03LTEtMS05OTcwNg_318127f7-d5a1-4c8b-92b0-8042ebe2e315">1,679,911,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS0xLTEtMS05OTcwNg_c232da99-0bd3-4bb5-9f31-b10862551858">363,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS0zLTEtMS05OTcwNg_7f4bd71d-fea1-471e-ab50-7d6cc5845dfa">1,145,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideceab173cc44867a7c0a083004446ae_D20220101-20220630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS01LTEtMS05OTcwNg_72d05e75-7ae8-4d49-8671-1a2bc4f0c574">4,382,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS03LTEtMS05OTcwNg_6747ba5a-a3e1-406c-a36b-eafca54200de">5,094,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtMS0xLTEtOTk3MDY_fd8ea75e-f9d4-4bc7-bdc4-b9ef457ba622">1,693,192,785</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtMy0xLTEtOTk3MDY_3259945b-c704-4955-9e61-e19f5e56f718">1,685,006,608</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtNS0xLTEtOTk3MDY_5e15a39c-ce2a-4a4e-9929-53b5b636bfc5">1,693,192,785</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtNy0xLTEtOTk3MDY_4ec5bc50-9737-4950-92d6-7901559845cb">1,685,006,608</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d88de9252574e38a75e71a25f421c17_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtMS0xLTEtOTk3MDY_9f2adde8-9ff0-4f0b-a881-00ad3bf6bf33">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c57ac41bacb4c959c5a7c938d5fe29b_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtMy0xLTEtOTk3MDY_f727fa70-bc11-437a-adef-dd9a6184a38b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic39344112e4b495b9d151b1e92eaac82_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtNS0xLTEtOTk3MDY_17db9218-76a2-41db-aea2-41466d1bc173">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtNy0xLTEtOTk3MDY_e2c3c9e6-aaab-4c0b-87f4-c9fe685a4cfa">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id049216887f0461ebc0924dd96909b7f_D20220401-20220630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtMS0xLTEtOTk3MDY_14f2a2be-7fed-4dc2-a535-51d5bb2933c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8f7a0da6f194f4f924ff1168b96527d_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtMy0xLTEtOTk3MDY_815a770d-64a2-4f16-b785-6c052e102f17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45c80183e4a4f64b08b6a4853ef9f4c_D20220101-20220630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtNS0xLTEtMTA1Nzk5_ef4f1387-5bdf-4ef1-97bd-3611cfa6235f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815c23c139b84522831b294d59dd7d1e_D20210101-20210630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtNy0xLTEtOTk3MDY_f0185a3e-0406-405e-b034-0aacc438659d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtMS0xLTEtOTk3MDY_e0af17b7-9e89-4f7b-baca-d4a5f6d94a26">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtMy0xLTEtOTk3MDY_00d325aa-0f24-4637-86b1-52ec8e647ff3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtNS0xLTEtOTk3MDY_91190ee6-5abc-45de-a30e-30000c41d4b5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtNy0xLTEtOTk3MDY_313cacc9-1b9a-459d-a4cf-8cb44f7a4f0f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc86164a6a43461a9651ec61b88f32e6_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctMS0xLTEtOTk3MDY_48ce829b-b719-4c75-9e84-7287aeb5e8f5">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id535101847a6481a96023d3bc410b6bd_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctMy0xLTEtOTk3MDY_ad9972de-f62d-4a79-a91a-b6cddca3cb9b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0efc03c9fd497083ef2469237d078f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctNS0xLTEtOTk3MDY_1ead39ac-c32f-4ed6-8f81-907a55c38348">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2696e3eb89444f7e9d4aa930e613f0b7_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctNy0xLTEtOTk3MDY_e79303ab-f707-497c-9ec2-832882992317">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtMS0xLTEtOTk3MDY_7ad82480-3996-436f-8929-3bca8c14c855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtMy0xLTEtOTk3MDY_b33b7b97-5973-491a-89a8-e51a196dc4a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideceab173cc44867a7c0a083004446ae_D20220101-20220630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtNS0xLTEtMTA1ODQ1_bcd73ad2-ef00-41fd-87c6-76c75412d790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtNy0xLTEtOTk3MDY_d3316cb3-4804-4384-89c0-f76abf1580ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktMS0xLTEtOTk3MDY_ec72f37a-4eda-432b-8ff3-4a12584cc438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktMy0xLTEtOTk3MDY_18afd878-82bd-4d61-bbac-788845bb4164">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideceab173cc44867a7c0a083004446ae_D20220101-20220630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktNS0xLTEtMTA1ODQ1_818790fe-217e-49b0-a65b-117541db6658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktNy0xLTEtMTA1ODU1_bfd9ec51-5ec9-4e99-bbf5-9721e7a051e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1accaba913b4d1fbcb2c28cac07c0b0_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtMS0xLTEtOTk3MDY_f008b5ee-3941-4173-a7aa-9ddd565961b7">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90c9ee4716140dd8fae0ab1d0950fed_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtMy0xLTEtOTk3MDY_25a6b397-b275-43e4-b14d-38df03713e07">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1accaba913b4d1fbcb2c28cac07c0b0_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtNS0xLTEtOTk3MDY_3308a368-316b-4ea2-84dd-6eecd1901592">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90c9ee4716140dd8fae0ab1d0950fed_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtNy0xLTEtOTk3MDY_697fe73c-8d68-4f40-bb1e-d87656a0d0b1">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9391520b32e640fe97bcc36c1e5962f2_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItMS0xLTEtOTk3MDY_fdd8f7bc-211e-4b7f-b9b4-31acd87bfe92">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ff7c22212045f6b95c0a15cfeed14a_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItMy0xLTEtOTk3MDY_4b59cd75-8494-46f8-ae0b-0935652c119c">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5905737675481fb710c2ba0f468446_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItNS0xLTEtOTk3MDY_b6641bf0-f060-4be9-8995-3a5265ea69d6">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fd9a0d26fab4332b61d8fad802ce5c8_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItNy0xLTEtOTk3MDY_f75b5806-31fb-4aa6-b1be-9d0693372a2f">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if15cc720f87a460abc0eb4e4e59fe876_D20220401-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtMS0xLTEtOTk3MDY_feda8cc2-8148-41bd-a1ae-41f4b5b07829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d680683b1e14d29be1a910573f28e70_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtMy0xLTEtOTk3MDY_54f773ea-59b5-4f4c-beb5-03fe87f07b1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f97f1273c1442381613e9edae599b9_D20220101-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtNS0xLTEtOTk3MDY_cec58fae-186c-4be8-8fac-a76e17eaa2fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c84bc9bc635449b990165995bfde9a2_D20210101-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtNy0xLTEtOTk3MDY_93b4700d-e19d-4295-a349-287eb666b6e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd771fc7d304e65a737b060eb018b8f_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtMS0xLTEtOTk3MDY_8df8385c-ab69-4bd9-8b45-284328ef2d04">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3466963199fd4fa3ade9bfff3a977e9f_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtMy0xLTEtOTk3MDY_32fb438d-17f3-4f35-a1f9-c491ee6d5915">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd771fc7d304e65a737b060eb018b8f_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtNS0xLTEtOTk3MDY_f7a4b670-aef8-4f78-8a01-2f7a1e819fd8">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3466963199fd4fa3ade9bfff3a977e9f_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtNy0xLTEtOTk3MDY_a856cdfd-adbc-49c0-959d-4bcc7f3e9151">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84240be430054940bd414a4c7f52641a_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtMS0xLTEtOTk3MDY_9e94aa6c-88ec-4918-9187-0bad0e422b25">20,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25f858a6d47415ba74ad94fa706aa56_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtMy0xLTEtOTk3MDY_09bc2509-da74-4b7e-b23e-a6b35dc3dd30">19,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6833d10fdee44d23b00e6ef571848119_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtNS0xLTEtOTk3MDY_7228f45e-1432-49b8-91c4-dce1a361fe12">19,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b6ff8621f654a959cb451ed414f77d0_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtNy0xLTEtOTk3MDY_b726a02f-d140-4aa1-a830-87ec648d0b6c">19,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2b757294d44982a169d202719a992a_D20220401-20220630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktMS0xLTEtOTk3MDY_59b6d5c3-acb6-4306-9ade-49a0ec55ac27">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia346d18d384c42c7a6e99a584fdc97ce_D20210401-20210630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktMy0xLTEtOTk3MDY_4b281db0-3f7e-4c0a-858a-d504135fe0c4">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a9e610d324a45d1a062c68adfb90b1f_D20220101-20220630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktNS0xLTEtOTk3MDY_9e162d5c-7df7-415f-abab-70f51bcff9a0">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f91cea543f4d33980254e8da67f9f5_D20210101-20210630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktNy0xLTEtOTk3MDY_05f62bca-8d7d-4b9c-a756-6145f7fa9567">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48e2fdfe8f64c8b8bae824c8b0d223a_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtMS0xLTEtOTk3MDY_a6f474ea-f43e-4326-9c31-93d939c27ca7">20,103</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be8a81ffb4f47a6b727c3d0e0043401_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtMy0xLTEtOTk3MDY_afa6f3b4-e01a-4a98-b436-61355591b194">19,817</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48e2fdfe8f64c8b8bae824c8b0d223a_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtNS0xLTEtOTk3MDY_88447205-32ff-48bb-8989-febefac281c6">20,103</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be8a81ffb4f47a6b727c3d0e0043401_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtNy0xLTEtOTk3MDY_4ba89a64-c6fb-4b0e-ba00-6a7c6bded4fb">19,817</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04889bdcfd104454b1ef3794d7f8830a_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItMS0xLTEtOTk3MDY_fa2f5202-d8d2-43a0-bad9-1342a5ec23cd">1,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if43d66985bfd4da1b42f8e3e134778a6_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItMy0xLTEtOTk3MDY_153b7e6c-3879-4418-9f24-a10a452b4d61">2,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2c7ff30c0e34b678886a170580868c5_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItNS0xLTEtOTk3MDY_e45bc252-6994-40aa-b2f4-a146aab4b1b6">1,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a04e2556f74b76bb8d693c12f82912_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItNy0xLTEtOTk3MDY_30a9ff1c-9052-4372-a474-d5ee28c92a44">2,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a98c3dc779644d6b41945be1f5e75ed_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtMS0xLTEtOTk3MDY_b269cf1c-bb66-476a-b497-4da870b5dbab">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ebba7d42bf4a138a7fea99714df893_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtMy0xLTEtOTk3MDY_026cd79e-3715-4972-80dc-57d027e64e2e">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47b2514859f4f27848ade4cccce2be8_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtNS0xLTEtOTk3MDY_f91ba87b-922e-490f-b8e4-a780a313df9d">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ffda331fdc249b9afd399366fe2269a_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtNy0xLTEtOTk3MDY_50c95ae3-1641-4118-9672-534afca4e178">527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a98c3dc779644d6b41945be1f5e75ed_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtMS0xLTEtOTk3MDY_3b3fc547-5b79-47eb-a0a3-1801dc6a8173">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62ebba7d42bf4a138a7fea99714df893_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtMy0xLTEtOTk3MDY_4b7793cd-1b11-478e-935b-ae97a47a54cb">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47b2514859f4f27848ade4cccce2be8_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtNS0xLTEtOTk3MDY_35559636-4bb9-4eeb-9f61-aea899e793ed">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ffda331fdc249b9afd399366fe2269a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtNy0xLTEtOTk3MDY_c6ae439d-9650-4bd2-9507-b2b8f10cf410">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c66b638de3480c9eb8a388b49f2860_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtMS0xLTEtOTk3MDY_ddd3c692-59b7-4a7a-ad38-251ef3702c57">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7781cde9f4be4c6f8a6068f01de92fb5_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtMy0xLTEtOTk3MDY_c07868a8-9e11-44cd-9733-6f69c6f4ee60">1,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c66b638de3480c9eb8a388b49f2860_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtNS0xLTEtOTk3MDY_6126de1f-3412-464c-96a5-884293192271">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7781cde9f4be4c6f8a6068f01de92fb5_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtNy0xLTEtOTk3MDY_5d20fb92-994d-429e-892b-3844baf732d7">1,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss), Net of Tax </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9303b7f6c9604c1a9623997b119bcbcd_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctMS0xLTEtOTk3MDY_5a4144ed-f6da-4f2a-a569-9e1acc171ad6">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4588728b1b54b1598ce091e28f075b5_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctMy0xLTEtOTk3MDY_17a79b28-e808-4981-8db6-6da3be1de954">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530a24628ff94bd8b6ecf768eb616100_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctNS0xLTEtOTk3MDY_1bfc2bf3-a9ad-4dc5-bf1d-42c37503f81d">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f2c362bdaec4d7c93ae599a3400d63c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctNy0xLTEtOTk3MDY_7634d2c1-72e7-4d0d-b887-90b66954b7b9">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a6e58ba7314b24a600982bbb84d5a8_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtMS0xLTEtOTk3MDY_4f680fd0-7f96-4803-a135-08eb3435669c">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbd1a4c6e5ac4665bd79ed3e6e017085_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtMy0xLTEtOTk3MDY_173a4a5a-bc9f-40a6-8bc5-d3dc7346202e">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685d9eb49f444cc59ed839c5b206c9d5_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtNS0xLTEtOTk3MDY_204b9326-16e8-4f46-8940-3cc75a548857">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe2dc1f9b004e68839d9b76d40729f1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtNy0xLTEtOTk3MDY_7488de78-6796-447d-9b46-c6e685282e94">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53edfe4ecc4f46be8baf73fc46188f98_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktMS0xLTEtOTk3MDY_e6a80ac0-d3f2-4c64-b1ed-f797a0491261">433</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6d5756a23e440086572a008869074f_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktMy0xLTEtOTk3MDY_d82b3137-7067-439d-a747-7186b21fad9c">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53edfe4ecc4f46be8baf73fc46188f98_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktNS0xLTEtOTk3MDY_213ec8f2-7f41-4d5e-aaa3-9618376110ab">433</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6d5756a23e440086572a008869074f_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktNy0xLTEtOTk3MDY_09e99bdc-4fc4-46f1-b86c-2ac853cf0f62">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtMS0xLTEtOTk3MDY_d80fa2f2-16c5-4078-bad6-58d08568fdde">17,251</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtMy0xLTEtOTk3MDY_35516750-d453-431a-9b22-6d8a8dfa9659">15,942</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtNS0xLTEtOTk3MDY_6120819b-02fd-46ec-9766-b6525ef05eac">17,251</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtNy0xLTEtOTk3MDY_e82dc396-2cae-4de5-8469-a73d4b2f6237">15,942</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMi0xLTEtMS05OTcwNg_303487f8-b86e-4f84-a954-640b49d446ce">370</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMi0zLTEtMS05OTcwNg_8a5f2f89-632d-4a41-a8e6-2be15236bd58">527</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on disposal of businesses and assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNC0xLTEtMS05OTcwNg_04f18f5d-4e9f-4443-8610-e6df7da404ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNC0zLTEtMS05OTcwNg_c705ff58-5368-41cd-b41f-696003a0eca2">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNS0xLTEtMS05OTcwNg_70440e32-b509-4c58-bff2-99cee82cdcab">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNS0zLTEtMS05OTcwNg_dd265ac8-35dd-4190-8185-71b1808046e6">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred and prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNi0xLTEtMS05OTcwNg_190e94ca-3ff0-48e1-b939-a88de4be682b">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNi0zLTEtMS05OTcwNg_c49a5fd2-6176-4668-8676-8209208aba66">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNy0xLTEtMS05OTcwNg_bf29c9a9-1264-47b9-82d3-ea030502f923">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNy0zLTEtMS05OTcwNg_feadc28a-c920-4378-b39c-b7cd1250773a">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOC0xLTEtMS05OTcwNg_6a6d038e-f55f-4bf4-aecd-9c4d21dd7c35">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOC0zLTEtMS05OTcwNg_4c422bbf-0243-4f6c-8c9e-c769fa149058">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss (gain) on investments and notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOS0xLTEtMS05OTcwNg_e7adf0aa-94a7-4c40-839e-cd35b832f78f">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOS0zLTEtMS05OTcwNg_cdc6f2a7-334f-49aa-8123-ec9761412784">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTAtMS0xLTEtOTk3MDY_15ad8c78-213a-44c7-b1e4-1d6c93cef73e">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTAtMy0xLTEtOTk3MDY_199b553a-5108-47b1-b687-2285543ed057">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTEtMS0xLTEtOTk3MDY_92174bae-b5fa-42bf-827b-ae6a738ca10d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTEtMy0xLTEtOTk3MDY_544e600d-02e8-41fa-a9c7-aa3eaa0e4bda">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTMtMS0xLTEtOTk3MDY_cf537eb8-e0f4-4b50-9d6c-1561a511d00a">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTMtMy0xLTEtOTk3MDY_dd0201a1-fb80-4bec-b3bb-22971129a464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTQtMS0xLTEtOTk3MDY_34be411e-a3f7-43e4-a6bf-fb426a2a40ba">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTQtMy0xLTEtOTk3MDY_955657a5-3f1e-4bae-ac4d-14e745c2ea90">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTYtMS0xLTEtOTk3MDY_bab4c919-6992-4a4f-a7db-9840027a4529">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTYtMy0xLTEtOTk3MDY_4c60abaa-6fd5-447f-8f3e-4e722eb04318">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTctMS0xLTEtOTk3MDY_452944f9-4752-42a9-88f6-98d32e52a5b0">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTctMy0xLTEtOTk3MDY_6d79d408-f1f8-4162-a5a0-3cb702fe4f6d">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTgtMS0xLTEtOTk3MDY_ffec70b5-3c9f-4d35-b246-198f4c347abe">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTgtMy0xLTEtOTk3MDY_16e26d4f-3824-4d56-9164-8eaabbd23838">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTktMS0xLTEtOTk3MDY_2f717716-9184-4c97-91c8-0826ee92e369">449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTktMy0xLTEtOTk3MDY_7b831c50-521f-421f-8228-5f766c6a834f">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjEtMS0xLTEtOTk3MDY_7cc28fd8-7939-4694-a967-a407c28ea16e">249</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjEtMy0xLTEtOTk3MDY_b91f6fb0-27a7-46e1-978e-a1342ae0c4b0">927</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment and internal use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjQtMS0xLTEtOTk3MDY_28ab59f8-181c-438f-8446-1cf379ebd06f">226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjQtMy0xLTEtOTk3MDY_41670ebe-15d8-41c7-9546-9d134346f7af">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjUtMS0xLTEtOTk3MDY_14f4a0db-bd18-45d9-aeef-75c5c7dbdb6e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjUtMy0xLTEtOTk3MDY_cccd0dac-9624-4d11-b112-f70d6cc9b8d2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for acquisitions of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjYtMS0xLTEtOTk3MDY_3b7b455a-14c6-4ab8-bc56-ab7e4f241c6d">1,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjYtMy0xLTEtOTk3MDY_210212dc-f029-4198-8b3f-0b72da118416">706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from (payments for) investments and acquisitions of certain technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMS0xLTEtMTEzNjY0_b3684c80-cdb3-41b5-88a2-95f75dcfbe61">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMy0xLTEtMTEzNjY0_d7a4f106-cde4-4e7c-8576-f983ba632fb6">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from disposal of certain businesses and assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMS0xLTEtOTk3MDY_44075010-0e6a-4ae8-917d-110cbb0b3633">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMy0xLTEtOTk3MDY_cd77572d-0e31-4e57-b64b-7f1995482035">801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjgtMS0xLTEtOTk3MDY_1164df4c-a071-42dd-b63d-09c4114ecbb8">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjgtMy0xLTEtOTk3MDY_eb382acd-2eab-47cc-9fb4-be46fc12ff70">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from settlements of hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjktMS0xLTEtOTk3MDY_4310ad94-1781-43b0-bb17-27fc178548a7">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjktMy0xLTEtOTk3MDY_9c382391-105c-42cf-a12b-b64d31e2b96b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzEtMS0xLTEtOTk3MDY_7e6c9573-8cc5-49b9-bee5-af00726b27bd">1,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzEtMy0xLTEtOTk3MDY_eb052721-e0cf-450f-b5c1-aa71d45951bd">71</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent consideration previously established in purchase accounting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzQtMS0xLTEtOTk3MDY_d641e84e-6b4c-4dd6-8aba-c9f4d1928467">283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzQtMy0xLTEtOTk3MDY_3cf1e980-0ee8-4b94-91be-cba2abc13109">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzUtMS0xLTEtOTk3MDY_d9eac270-6ae9-4406-a4b8-74ff350976c5">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzUtMy0xLTEtOTk3MDY_39b8f5d1-d681-4cc9-81cc-a5a9cf5fce16">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzYtMS0xLTEtOTk3MDY_a5b287d8-a0d4-4ee4-ab41-37edfa89f17c">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzYtMy0xLTEtOTk3MDY_6ae41c2a-533d-4c42-a8b5-8b7d5a0895e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzgtMS0xLTEtOTk3MDY_01f52342-ccf2-4a3b-81e8-581b9e4f37c7">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzgtMy0xLTEtOTk3MDY_99310b56-11a4-43fa-87e7-d92f403c39d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on long-term borrowings and debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDEtMS0xLTEtOTk3MDY_02881c23-818b-4560-a42a-52a6f69c5043">3,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDEtMy0xLTEtOTk3MDY_4e08cdb4-fd58-4154-981f-dc38b1c1ecb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDItMS0xLTEtOTk3MDY_f7ea552d-e4b0-4c76-8c17-33e94c5ee754">3,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDItMy0xLTEtOTk3MDY_a7dbe8fd-413d-4624-ab21-0cb8d838446a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDMtMS0xLTEtOTk3MDY_274995c9-13fb-4944-87d5-9e40967acf87">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDMtMy0xLTEtOTk3MDY_f45dd8c3-50d6-49e5-b5d7-4be683a1b4eb">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash used to net share settle employee equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDYtMS0xLTEtOTk3MDY_52ec9f1e-e2e0-4ab3-8d67-90d2c3c8fcfa">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDYtMy0xLTEtOTk3MDY_4ff6ebf6-7891-4fe9-98d2-766153b308dc">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDctMS0xLTEtOTk3MDY_7416000b-fedc-40cb-bb91-46f681a075c1">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDctMy0xLTEtOTk3MDY_5225b534-1860-4473-bed8-3c88b96d8254">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDgtMS0xLTEtOTk3MDY_6c13cd59-6ad4-42ba-8471-f27baf46dbda">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDgtMy0xLTEtOTk3MDY_3e4b6b67-e147-46a6-9399-b6775c991bfb">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTAtMS0xLTEtOTk3MDY_799b69bc-4135-4241-ab53-de7da4af9c4e">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTAtMy0xLTEtOTk3MDY_23b7d75a-ab94-4ddf-aeaa-5d3726ae92fe">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTItMS0xLTEtOTk3MDY_393a53d0-f925-435a-b426-f12d83907530">1,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTItMy0xLTEtOTk3MDY_5b900032-088f-4e5f-8253-899d9dff9862">903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTMtMS0xLTEtOTk3MDY_b9703027-1acb-4129-972f-3af6b516241b">2,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTMtMy0xLTEtOTk3MDY_bba3a935-128e-4966-89b3-da61f887ff2d">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTQtMS0xLTEtOTk3MDY_f9ae6eea-07ac-4530-9872-2ecbc223af30">458</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTQtMy0xLTEtOTk3MDY_c71f1537-96a5-4780-9857-8a15db0af9b1">2,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(SUPPLEMENTAL INFORMATION)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Supplemental Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfMy0xLTEtMS05OTcwNg_0c29de98-f1b8-4e24-a8cb-6720c7481eaf">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfMy0zLTEtMS05OTcwNg_fc13ea05-155a-4198-bf11-fc409ddd09e8">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of contingent consideration recorded in purchase accounting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNC0xLTEtMS05OTcwNg_2fd445cf-2b52-4b34-8e54-b8189e709d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNC0zLTEtMS05OTcwNg_1224e16e-011d-4c2c-82b0-a87265441cc8">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNS0xLTEtMS05OTcwNg_b1780d2c-36d2-40a1-aaac-8de39ec01355">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNS0zLTEtMS05OTcwNg_b200f513-a63c-4ad2-990d-4c1f5807fe82">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Reconciliation to amounts within the unaudited consolidated balance sheets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMi0xLTEtMS05OTcwNg_cbcd390e-d40b-4452-8871-55975e5de404">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMi0zLTEtMS05OTcwNg_d50eb00c-d5d3-43fb-971e-b44df21e7fb7">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMy0xLTEtMS05OTcwNg_50faef4d-b4c7-4fe1-a463-dde0cd43820c">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMy0zLTEtMS05OTcwNg_ea05493c-7708-4cfd-9743-fff7a3631bc0">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNC0xLTEtMS05OTcwNg_c00bb88d-aa28-4fa3-be6b-67d9391b33b3">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNC0zLTEtMS05OTcwNg_d6839788-2aa3-4592-9db3-175d6f618e00">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNS0xLTEtMS05OTcwNg_c45459da-4f6d-4a56-a880-fc068977e99d"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNS0xLTEtMS05OTcwNg_eda1495c-888d-412b-a3e3-6fdfb999ec65">458</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNS0zLTEtMS05OTcwNg_66bb076b-8029-4741-a16f-d604d3820ca0">2,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_37"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zNy9mcmFnOjE4ZjA2MjMyNzBkOTRmZmRiYjY0YmY2NzdmMjFlMWQzL3RleHRyZWdpb246MThmMDYyMzI3MGQ5NGZmZGJiNjRiZjY3N2YyMWUxZDNfMTkzMg_9527003a-2137-4490-b33a-846f7fde122e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into <ix:nonFraction unitRef="reportablesegments" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="0" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zNy9mcmFnOjE4ZjA2MjMyNzBkOTRmZmRiYjY0YmY2NzdmMjFlMWQzL3RleHRyZWdpb246MThmMDYyMzI3MGQ5NGZmZGJiNjRiZjY3N2YyMWUxZDNfMTAzMA_981bdca8-b775-4672-9b72-735470fa455a">two</ix:nonFraction> reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zNy9mcmFnOjE4ZjA2MjMyNzBkOTRmZmRiYjY0YmY2NzdmMjFlMWQzL3RleHRyZWdpb246MThmMDYyMzI3MGQ5NGZmZGJiNjRiZjY3N2YyMWUxZDNfMTkzNw_a62182b8-12a5-4387-b4b7-37d08c85d6a0" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_43"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc2MQ_ccc1229c-4e71-485e-b7fc-2115e947924a" continuedAt="iefc5b643785543dab3e16a6fe6ceed38" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed <ix:nonFraction unitRef="business" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTM3_74d2accf-8bb0-435c-b2cc-5773cd7ba305">one</ix:nonFraction> acquisition in the first six months of 2022, and <ix:nonFraction unitRef="business" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTcw_7e5dc777-5308-438e-a7e9-4d43cc028af1">one</ix:nonFraction> acquisition and <ix:nonFraction unitRef="business" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="0" name="bsx:NumberOfBusinessesDivested" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTg5_44235c84-756a-4133-b0cd-2115dd922d79">one</ix:nonFraction> divestiture in the first six months of 2021. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2022, we announced our entry into a definitive agreement with Synergy Innovation Co, Ltd, to purchase its majority stake of M.I. Tech Co., Ltd., (M.I. Tech), a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. The agreement, whereby we will purchase approximately <ix:nonFraction unitRef="number" contextRef="iee11fc6752204977a88f533ae4110495_I20220615" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI3MDc5Mg_81ac4711-3e69-4957-875d-9ecfe0daff1d">64</ix:nonFraction> percent of the outstanding shares of M.I. Tech, consists of a purchase price of KRW <ix:nonFraction unitRef="krw" contextRef="i901ac63f75eb49639a4b506d76c7ec85_D20220615-20220615" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzcwNw_02fe78f4-b1e5-4858-a45c-0a485eacb06f">291.2</ix:nonFraction> billion or approximately $<ix:nonFraction unitRef="usd" contextRef="i901ac63f75eb49639a4b506d76c7ec85_D20220615-20220615" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzY4OA_a7b845d9-e1a9-4ca9-9a5d-d0fd73bee032">230</ix:nonFraction> million, subject to closing adjustments. The acquisition is expected to close during the second half of 2022, subject to customary closing conditions. The M.I. Tech stent portfolio complements our existing Endoscopy portfolio which will give physicians more treatment options to meet specific patient needs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which has developed the radiofrequency (RF) NRG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and VersaCross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which expands our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i5d7ad645f9b848e1960b6c1e9e613c6d_D20220214-20220214" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfOTQ1_ff9b3d45-f814-42d0-8f37-5f573feef011">1.471</ix:nonFraction> billion, net of cash acquired, subject to closing adjustments. We are integrating the Baylis Medical business into our Cardiology division.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="iefc5b643785543dab3e16a6fe6ceed38" continuedAt="i958ec2b8072b494095fbf761c188368f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price was comprised of the amounts presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. <ix:nonNumeric contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc0Ng_5f6df518-967f-45bc-878f-197476cc88d6" continuedAt="i3cb083c16c7d426091665ae04dfbca7e" escape="true">The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, </ix:nonNumeric></span><ix:continuation id="i3cb083c16c7d426091665ae04dfbca7e" continuedAt="i36ed586d9dc4404babd09efae3dbeea0"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 805).</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i36ed586d9dc4404babd09efae3dbeea0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjI2NjhhNmMyZGY4MTRhOWI5MTU4OGMyOTMyN2I3Y2IyL3RhYmxlcmFuZ2U6MjY2OGE2YzJkZjgxNGE5YjkxNTg4YzI5MzI3YjdjYjJfMS0xLTEtMS05OTcwNg_7bb0dc99-3259-410f-ae0f-83bd0c65354c">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjI2NjhhNmMyZGY4MTRhOWI5MTU4OGMyOTMyN2I3Y2IyL3RhYmxlcmFuZ2U6MjY2OGE2YzJkZjgxNGE5YjkxNTg4YzI5MzI3YjdjYjJfNC0xLTEtMS05OTcwNg_12de2054-d9c1-4226-be96-9caaa69a18c4">1,471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjczNg_117e5383-b66f-4314-aec6-f40067daf201" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.082%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfMS0xLTEtMS05OTcwNg_04c7a467-02fc-458a-9b28-a592336bc18b">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfMi0xLTEtMS05OTcwNg_df3fef75-f6da-4219-bf11-a731bdcdeece">657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfNC0xLTEtMS05OTcwNg_bcc4ed15-ddf2-4eea-a526-6fc623daa929">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfNi0xLTEtMS05OTcwNg_c9650ea7-3046-454d-bd2d-dfbb92899e5e">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfNy0xLTEtMS05OTcwNg_e53ab9da-bf35-4786-a263-62f1e650ed43">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfOC0xLTEtMS05OTcwNg_880bce74-25b2-4134-b0ed-c68201178458">1,471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcxNg_f19edbfd-a482-44b9-852c-7f0ff87fff6b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6d6608abc97401680adb8a26144b089_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfMy0xLTEtMS05OTcwNg_78b3dc47-cdcd-445b-89d2-525970a5c04c">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6ac896dcc134060bdfc576d15c1f097_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfMy0zLTEtMS05OTcwNg_55478902-fd96-43ae-955c-e4e86c9cc3d3">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28d9b36d9b8943b68833ea0d071ed7d7_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfMy01LTEtMS05OTcwNg_a72675bb-260b-4902-a80a-219fa3de2494">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d861b96bd57474b92fcd29da39816fd_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfNC0xLTEtMS05OTcwNg_4bc2a8a3-41ef-4924-a38f-cea7550f3c30">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8031cd75b7814af29c4289dc1effe3ab_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfNC0zLTEtMS05OTcwNg_ecc7566e-bc94-49ff-9872-2c916cf81093">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib50cd8c4907244fa92f0e05706dcb767_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfNC01LTEtMS05OTcwNg_d5a8b488-8b8b-482a-a267-dfe19063c6a5">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfOC0xLTEtMS05OTcwNg_24b64a54-0beb-474c-bba5-13a361b5fa43">657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the acquisition of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjM3OQ_5b09e2f8-ab72-4b6e-b43f-f68088fb7a95">925</ix:nonFraction> million and up to an additional $<ix:nonFraction unitRef="usd" contextRef="i4462bc60133842ae953e65f20c772978_I20210301" decimals="-6" name="bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjQwNg_05bac815-6ff9-4701-b2da-6a24d90e814a">300</ix:nonFraction> million in a potential commercial milestone payment. We had been an investor in Preventice since 2015 and held an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="i4462bc60133842ae953e65f20c772978_I20210301" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjU0NQ_0c655db5-1cfe-4c11-bfc2-8794b481ef4c">22</ix:nonFraction> percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $<ix:nonFraction unitRef="usd" contextRef="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjc2Mw_591c99ce-cd4d-4109-b6eb-7289fd634910">195</ix:nonFraction> million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first quarter of 2021. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjkwMA_607eb4d8-5e56-4e7b-8306-292ceebe25fc">706</ix:nonFraction> million, net of cash acquired, and an additional revenue-based milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i4462bc60133842ae953e65f20c772978_I20210301" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzkzNg_7bc5460b-520b-4851-a958-3cbb03d1da47">216</ix:nonFraction> million made during the second quarter of 2022. The Preventice business is being managed by our Cardiology division. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i958ec2b8072b494095fbf761c188368f" continuedAt="i62c11a1ea55a407e80a781fd385a639b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of Preventice as a business combination, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. <ix:nonNumeric contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc1OQ_cfd06565-8f97-49c6-ab63-0c4d5681af76" continuedAt="i830d7b8ef4f542b58ce111f8302ade06" escape="true">The final purchase price was comprised of the following components:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i830d7b8ef4f542b58ce111f8302ade06"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfMS0xLTEtMS05OTcwNg_de2124a9-c47e-4ff9-8fdf-935490feee46">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfMi0xLTEtMS05OTcwNg_b0434498-a618-48ac-a53a-0c368e0c4e62">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfMy0xLTEtMS05OTcwNg_e7fefc31-3a0c-4197-8df9-0f6bea83288d">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfNC0xLTEtMS05OTcwNg_f5c9e954-320a-48f8-9d01-dd7ab417cb84">1,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcwMQ_f15bc4b5-488c-4390-8d32-6b9cba3ff121" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfMS0xLTEtMS05OTcwNg_f910ca97-3db6-49d7-8453-c189d106bc15">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfMi0xLTEtMS05OTcwNg_70a1246a-6004-4171-b762-bf381aaa4b00">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfNC0xLTEtMS05OTcwNg_3fc0a5cd-52e8-4821-a274-c2e511afe826">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfNi0xLTEtMS05OTcwNg_11cbf3b7-bff1-414e-9e91-b65d605a37c2">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfOC0xLTEtMS05OTcwNg_104cd2b4-52ba-4dff-96be-f8d0d8e58738">1,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc1NA_520affe8-219c-4726-a0aa-c50bbef3aad8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6400d3c1fc24ca7bc85488919500c81_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfMi0xLTEtMS05OTcwNg_1c4bb8fc-f928-4a05-885b-51c65de80563">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b875ad2ff61444eb8f91d7e24664368_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfMi0zLTEtMy05OTcwNg_443efc24-6ec9-4370-8812-8430afa1f195">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75537fd4e06e411da653741c44074044_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfMi03LTEtMy05OTcwNg_aa75d98a-ba5f-48b2-af6d-bda37f38e643">10</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74b152ba6674c9da5871cb3bbed2af5_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNC0xLTEtMS05OTcwNg_33f41435-df31-496b-91fb-bc3c64ac2066">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia306834040fd4493904c3d80050dfd07_D20220101-20220630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNC0zLTEtMS05OTcwNg_c5e0495b-1604-4a7d-a5c7-a0fe7f97ef00">8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0038b38441f64cd1b1acadca2f9bdaf0_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNC03LTEtMS05OTcwNg_e417efd4-c448-4998-bb7d-e5ad3f7bc84e">10</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabaa3915ef144c09350675944f975ab_I20220630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNy0xLTEtMS05OTcwNg_061b2418-325c-4c70-b192-41a51c5c0dbe">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022 we recorded certain measurement period adjustments related to our prior year acquisition of the surgical business of Lumenis, LTD. (Lumenis). We recorded an accrued income tax liability within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other non-current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets of $<ix:nonFraction unitRef="usd" contextRef="i4e1b80835cd3429dbe3445e36fc51f36_I20220630" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTA5OTUxMTYzOTA3Ng_8537caad-e2e7-4a22-a360-6fee619716ca">177</ix:nonFraction> million related to uncertain tax positions assumed in connection with the acquisition. We were indemnified by the sellers for the majority of such tax obligations and recognized a corresponding indemnification asset of $<ix:nonFraction unitRef="usd" contextRef="id81e42a730db41b38addf624d55f0162_I20210930" decimals="-6" name="us-gaap:BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2OTk0OQ_61670e2d-77fa-44da-82b2-8e7291fe7020">172</ix:nonFraction> million at the acquisition date within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Subsequent to the acquisition date, interest and penalties accrued on the tax liability are being recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and corresponding adjustments to the indemnification asset are being recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations. The outcome of these matters is subject to uncertainty and ultimately, the amount of tax due and the related indemnification reimbursement we receive will be dependent on the outcome of tax return examinations by relevant authorities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details regarding our indemnification asset.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDA0MA_9d27ca91-b166-4e36-85fc-b9575b13d0b7">800</ix:nonFraction> million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of <ix:nonFraction unitRef="units" contextRef="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301" decimals="0" name="bsx:DivestitureAgreementTransferOfFacilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDE3Mg_5ab65dc8-e193-4c78-955c-07486418d564">five</ix:nonFraction> facilities and approximately <ix:nonFraction unitRef="units" contextRef="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301" decimals="0" name="bsx:DivestitureAgreementTransferOfGlobalEmployees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDIwNA_2f2e0f56-7618-4fde-9aa1-892e44c9c8bc">280</ix:nonFraction> employees globally. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter and first six months of 2021, we recognized a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain on disposal of businesses and assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the transaction of $<ix:nonFraction unitRef="usd" contextRef="ib0f0a63946614b93a706e459effcd822_D20210401-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzczMg_62f77cd6-a440-41cd-a018-d4c4bd5bff1a">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1a007c4c42ba48c5af6af1adc620a5fe_D20210101-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2Mzc0MA_a7fa327d-44ac-4090-a46c-7595b6ed60f5">9</ix:nonFraction> million, respectively, within our accompanying unaudited consolidated statements of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i62c11a1ea55a407e80a781fd385a639b" continuedAt="ib5d9755f9e044506926816780633e25c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcxNA_0dfb25bf-6376-4704-8950-ba2a1b62e94c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability during the first six months of 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfMS0xLTEtMS05OTcwNg_bb6655cb-1006-4312-9652-2a9c6eb584d0">486</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfNC0xLTEtMS05OTcwNg_02065c57-9d51-435c-a02e-42a2d412f6bb">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfNS0xLTEtMS05OTcwNg_05b02ed0-8b9a-418c-a12e-00cbf136809b">314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfNi0xLTEtMS05OTcwNg_19a79684-c0b4-4228-a1fb-e0d5e8c33617">219</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was $<ix:nonFraction unitRef="usd" contextRef="i9f07b1cab36340b2ac0e5013fe615164_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDgwMg_7b727c37-f170-4267-930f-9e750923960f">544</ix:nonFraction> million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc2NA_77dd0974-565e-458c-a981-014ae4fe961e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i49748441876b428ca5de05c44d5f8499_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS0xLTEtMS05OTcwNg_8cfd2f27-daf0-400b-8d42-f8e52d2e23cb">107</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i989b56a183c946599da9be6a40044f0d_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS00LTEtMS05OTcwNg_63984c3b-c460-4ab8-b31c-817629aa32ea">1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i424661b18ce84471819c51a4428349f4_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS02LTEtMS05OTcwNg_8944c4fd-e398-4592-babd-6e7700806165">2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a66fba061d3493aadeb2bf2117d4954_I20220630" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS03LTEtMS05OTcwNg_542d4474-87ea-4090-83df-a793b4112fcc">1</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i989b56a183c946599da9be6a40044f0d_I20220630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMi00LTEtMS05OTcwNg_cf12b4f1-66bd-4baf-9c2a-ded2f493e1ca">80</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i424661b18ce84471819c51a4428349f4_I20220630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMi02LTEtMS05OTcwNg_2b29ba39-3eff-4e50-b41a-935ff09cb485">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a66fba061d3493aadeb2bf2117d4954_I20220630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMi03LTEtMS05OTcwNg_70c9df4a-5a5b-45fe-ad79-1e1841c90c67">90</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i375d15b254054889b41fe012dea6ffd6_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC0xLTEtMS05OTcwNg_02dadfd3-4d84-49c1-bf7d-0926b396c4ee">112</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="ie03013c27a6841b7b47d775cd8a4af8f_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC00LTEtMS05OTcwNg_704ed1c1-b205-420a-9389-afae3f86af30">6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1d47dac14094180bc21b9214c11f723_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC02LTEtMS05OTcwNg_11c2669e-5b15-4894-9f38-2480ef52aee6">14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i468740812f144020bed248757e33716f_I20220630" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC03LTEtMS05OTcwNg_b843a8a1-b3b9-4ba8-b731-e0be08fa5844">7</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i375d15b254054889b41fe012dea6ffd6_I20220630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNS00LTEtMS05OTcwNg_54778535-6c9d-42f4-bc52-a0b9c3530f3f">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i468740812f144020bed248757e33716f_I20220630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNS03LTEtMS05OTcwNg_deaa6e64-3202-403d-a0fc-0ab8cfd1c761">100</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to research and development (R&amp;D), regulatory and commercialization-based milestones and revenue-based payments are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of June&#160;30, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcyMw_50d2e6e5-8635-4f5e-be5a-018c88d97248" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMi0xLTEtMS05OTcwNg_fb83292e-f641-48fe-aec3-5c2a5621c42f">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMi0zLTEtMS05OTcwNg_e4eb8148-fb9a-47a3-8982-5da006b92e0f">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMy0xLTEtMS05OTcwNg_de20eaa1-049a-46df-ab83-3d2fcc94c886">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMy0zLTEtMS05OTcwNg_1501edf4-15ca-4b05-8b85-a8bbaf4ea293">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNC0xLTEtMS05OTcwNg_7bc290ca-318b-4567-b0f0-308835984718">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNC0zLTEtMS05OTcwNg_fd43a857-3567-45cc-8571-cdaf3fc7a75a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNS0xLTEtMS05OTcwNg_69f8e4d1-1a4b-4a4c-8547-5263cc5d732b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNS0zLTEtMS05OTcwNg_6d6762b0-0859-4256-b207-f2aaee5608e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNi0xLTEtMS05OTcwNg_3a011a3a-a671-42e4-b8e1-ba1067fe96ea">384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNi0zLTEtMS05OTcwNg_644abf9f-2ea0-4988-98e3-ff852cf440fc">412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Publicly-held securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="ib5d9755f9e044506926816780633e25c" continuedAt="i5e8cabe315b74e74ac1eba5fe60f91ab"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5e8cabe315b74e74ac1eba5fe60f91ab">As of June&#160;30, 2022, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjU1OQ_2ddd848d-9ec0-4d33-9ad1-26a2d9c34565">233</ix:nonFraction> million, which represents amortizable intangible assets, in-process research and development (IPR&amp;D), goodwill and deferred tax liabilities.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_49"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfODUw_7e5a2d1e-f236-4769-9526-7ac34c4fa291" continuedAt="i354af898b393416ab3db80d1a327bc7e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfODQ0_8fca9949-c02e-4047-9988-f8d474d358a6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02c663df999f43dba49c3e3fbdf4fd2a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi0xLTEtMS05OTcwNg_fb8bd4f8-51ea-4459-822b-75c8d284c487">12,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02c663df999f43dba49c3e3fbdf4fd2a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi0zLTEtMS05OTcwNg_c314712d-822b-4ad7-a0e0-63bc4cd94daf">7,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5061cce88844571861e47c227eaa358_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi01LTEtMS05OTcwNg_1b5777f9-b486-41bd-9a88-626fc5855072">11,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5061cce88844571861e47c227eaa358_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi03LTEtMS05OTcwNg_67ba86e2-09dc-4d36-812b-9621c7501ce1">6,754</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1877eb16ab4005bd5a1107e8dbe1aa_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy0xLTEtMS05OTcwNg_89155cd9-ea8c-4bd3-872a-56bec37fa6f6">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d1877eb16ab4005bd5a1107e8dbe1aa_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy0zLTEtMS05OTcwNg_8db80e99-00e7-4cb3-ae7c-a33b9a51fde3">392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf43344805b748ac8599d034b8fce38c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy01LTEtMS05OTcwNg_d374d78c-e41c-4c9e-9805-169bee24a140">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf43344805b748ac8599d034b8fce38c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy03LTEtMS05OTcwNg_92302779-81e1-4cac-a904-a7776779eaf8">398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2155113815f245cb9e7caf23337d1848_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC0xLTEtMS05OTcwNg_d1eef8d2-10e0-40d5-af16-96d1b3249769">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2155113815f245cb9e7caf23337d1848_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC0zLTEtMS05OTcwNg_f9abfd9c-2dee-4c78-b956-3bc6c3e80f21">1,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a865e40488d4b68a9fc599365b502d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC01LTEtMS05OTcwNg_a4b109b2-c7ea-429f-b1d3-abdf656fe430">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a865e40488d4b68a9fc599365b502d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC03LTEtMS05OTcwNg_98f9c663-2a7f-4602-8e98-319842637453">1,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS0xLTEtMS05OTcwNg_2c4077da-6d6b-4c62-adef-d7e0f2ac591a">14,955</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS0zLTEtMS05OTcwNg_33149de0-22a4-4c54-ac86-4bf693c98863">8,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS01LTEtMS05OTcwNg_1d876f09-0f20-456c-9c1a-ae1c08045bc4">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS03LTEtMS05OTcwNg_5f24b9d0-b246-4ee9-88ff-74dbd33a6d2c">8,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87fc7373cbc44f879acb93c09335f462_I20220630" decimals="-6" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy0xLTEtMS05OTcwNg_8a7370e9-aa48-437c-b314-77c7087d8926">22,783</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87fc7373cbc44f879acb93c09335f462_I20220630" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy0zLTEtMS05OTcwNg_fedd8310-2182-4fb8-85cc-e148555f00cf">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77cb4812b8444881a8d1c6f3fe5f74ca_I20211231" decimals="-6" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy01LTEtMS05OTcwNg_6a770bae-e09a-42ab-84b8-af2dc813b271">21,888</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77cb4812b8444881a8d1c6f3fe5f74ca_I20211231" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy03LTEtMS05OTcwNg_eecebd24-02b5-49bd-8a45-1d54c74900f2">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b5c735c1eb4e9d95ed6be4cff64301_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfOS0xLTEtMS05OTcwNg_e6ca9f83-a325-4dd5-aa2f-e06cf9db3c07">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i719d462654114eafa29963ace1f8a603_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfOS01LTEtMS05OTcwNg_9e862f46-722d-4600-b8ae-922724b77a5a">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b81d90dcbd47d4994136811e97c5d2_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTAtMS0xLTEtOTk3MDY_92c3a5bc-130e-49ba-b693-ff3d62afab53">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e8c43d7f5314418961e8542ec180403_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTAtNS0xLTEtOTk3MDY_a861e8d6-c6c5-4ca7-b875-9acbea7f7e07">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTEtMS0xLTEtOTk3MDY_69757fed-6968-4c66-8bd2-300e30179a4d">232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTEtNS0xLTEtOTk3MDY_ac3edd7b-869f-4450-951f-8ae2706d0295">246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in our balance of goodwill and amortizable intangible assets is primarily related to our acquisition of Baylis Medical completed in the first quarter of 2022. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfODcz_6ab1c7d8-7183-43c6-9152-7d7351a7bdff" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d7a66e4fc364008a329768490327166_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfMS0xLTEtMS05OTcwNg_56b9b690-8855-45c8-a2f9-253350c29321">4,246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1c1d0d7e6944bec9f3db53ad92fa034_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfMS0zLTEtMS05OTcwNg_7ac24066-2214-4c39-acbb-6657205a8e18">7,741</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfMS03LTEtMS05OTcwNg_9c9526ab-6aaa-4be9-9e4c-d35a75f21359">11,988</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNC0xLTEtMS05OTcwNg_906fb927-54b2-47af-9637-c39f359e0991">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNC0zLTEtMS05OTcwNg_8d002feb-407e-4281-8baa-484a0d18c13f">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNC03LTEtMS05OTcwNg_43401246-07ba-4384-9968-42722333d3cd">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNS0xLTEtMS05OTcwNg_515c1685-ab82-4d70-9516-dfffe2f5d795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNS0zLTEtMS05OTcwNg_ce14d0e8-d597-4b78-b159-e132cb4cb86d">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNS03LTEtMS05OTcwNg_032604f5-5069-42d2-8894-f55ce86b43e3">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb3e27fa63747a6b668bebab370867c_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNy0xLTEtMS05OTcwNg_f813930c-7f57-4ab3-9587-aeb4c545be8e">4,241</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe82f860e15b483eaa3f27e40e7892cb_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNy0zLTEtMS05OTcwNg_878bfc4e-e7ff-41c2-9de1-b68af321cbc9">8,642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNy03LTEtMS05OTcwNg_9c3107ca-eddf-46f2-8bc8-12a435d6252f">12,883</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into <ix:nonFraction unitRef="reportablesegments" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="0" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfNDYx_981bdca8-b775-4672-9b72-735470fa455a">two</ix:nonFraction> reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Asset Impairments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the first six months of 2022 or 2021. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. Following the reorganization of our operational structure in the first quarter of 2022, we identified the following reporting units for purposes of our annual goodwill impairment test: Interventional Cardiology, Rhythm Management, Peripheral Interventions, Endoscopy, Urology and Pelvic Health and Neuromodulation. Based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 350), we aggregated the Interventional Cardiology Therapies and Watchman components of our Cardiology operating segment into a </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i354af898b393416ab3db80d1a327bc7e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">single Interventional Cardiology reporting unit, and aggregated the Cardiac Rhythm Management and Electrophysiology components into a single Rhythm Management reporting unit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, we performed our annual goodwill impairment test utilizing both the qualitative and quantitative approach described in FASB ASC Topic 350. The qualitative approach was used for testing reporting units where fair value has historically exceeded carrying value by greater than 100 percent, and all other reporting units were tested using the quantitative approach. For those tested using the qualitative approach, after assessing the totality of events, it was determined that it was not more likely than not that the fair value of the reporting units was less than their carrying value, and it was not deemed necessary to proceed to the quantitative test. For all reporting units tested using the quantitative approach, we determined that the fair value of each reporting unit exceeded their carrying value and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfMjE5OTAyMzI3MTgzNQ_81858954-451b-4d7b-9e35-00dac7c04e89">7</ix:nonFraction> million in the second quarter and first six months of 2022, and $<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfMjE5OTAyMzI1ODcwNw_99b02b6d-957f-4dbc-8921-6daee6fd6a28">45</ix:nonFraction> million in the second quarter and first six months of 2021. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. During the second quarter of 2021, we determined it was more likely than not that one of our indefinite-lived intangible assets was impaired based on our qualitative assessment of impairment indicators. We tested the intangible asset for recoverability and recorded an impairment charge associated with incremental time and cost to complete the associated in-process research and development (IPR&amp;D) project.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_55"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNDE_45f7fc27-4f97-4e21-a49d-ada75366f409" continuedAt="ie41672558d7844d08b827569824f1010" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, British pound sterling, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of June&#160;30, 2022 and December&#160;31, 2021, we designated as a net investment hedge a portion of our &#8364;<ix:nonFraction unitRef="eur" contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMjUyOQ_189b6809-855f-462e-b3d5-01028fc81311">900</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMjU2NQ_3374ac14-22f3-4bea-8541-e0bd32616a89">0.625</ix:nonFraction>% euro-denominated senior notes issued in November 2019 and due in 2027 (2027 Notes). For these nonderivative instruments, we defer recognition of the </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ie41672558d7844d08b827569824f1010" continuedAt="i48f3c213e9ba4105a7af5eec95cc5891"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency remeasurement gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than <ix:nonNumeric contextRef="i54cc7fcec9c242049c00578499ae8d13_D20220101-20220630" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMzQ1Nw_f812a465-556c-4a9d-b5fe-c46c5ec388c4">one year</ix:nonNumeric>, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="derivative_instrument" contextRef="i997580c2ac9449cd9e09cac79cf4ac38_I20211231" decimals="0" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNDIwOA_2237ebb6-653e-4fe8-85f0-10eb44a13f8c"><ix:nonFraction unitRef="derivative_instrument" contextRef="i1344f19ab092477889926fa8d06bba45_I20220630" decimals="0" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNDIwOA_d20a46fb-9159-46d2-9916-dee25cf713b3">no</ix:nonFraction></ix:nonFraction> interest rate derivative instruments designated as cash flow hedges outstanding as of June&#160;30, 2022 or December&#160;31, 2021. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $<ix:nonFraction unitRef="usd" contextRef="if739a2c2f671402cb916170e3525437c_I20220630" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTIxMg_5724e9b0-2541-45ae-9647-f346a3c2e078">9</ix:nonFraction> million loss as of June&#160;30, 2022</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a $<ix:nonFraction unitRef="usd" contextRef="idb9d19a6bc3646338057525a9924ed42_I20211231" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTIzNQ_223100ac-7448-46e9-bf93-d6095c3176d9">24</ix:nonFraction> million loss as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyOTM_f2258f90-be54-425f-b17d-07bd19151de0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.430%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id543b8483478491ab47eae96f17a2688_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMi00LTEtMS05OTcwNg_1b64129b-ca0b-4444-beac-c58e22bd2cb2">3,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18555e5fe782424da673f442fb298b06_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMi02LTEtMS05OTcwNg_94f00b8e-ac24-4140-817d-b9a001cebee9">3,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2e1aa2b5844bed9e3e6cae8d1958cd_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMy00LTEtMS05OTcwNg_89cabcb7-9a21-49f0-a77c-25d0263c8cea">365</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86e5cefc372494fb57cf5b9fb285236_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMy02LTEtMS05OTcwNg_28eb2133-2720-4df9-a666-57c5625918be">493</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i721e9eac5b5c48a6aed4014b232cb438_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNC00LTEtMS05OTcwNg_29e3eb5d-d4f1-4b6c-a0f3-54434fb93086">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b807c0a08b94dddbe4f5e93f8fa811f_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNC02LTEtMS05OTcwNg_74e92346-ce8b-44cd-a89a-fc7ad9a218f9">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84824453888409a909a24869be1cb1e_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNS00LTEtMS05OTcwNg_d20d840c-b88b-4bc7-903f-bfb32df7698a">3,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19171c2bd8484559af6db37d1aef1e11_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNS02LTEtMS05OTcwNg_16ad4128-5569-45c9-ba97-45300e12a001">3,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNy00LTEtMS05OTcwNg_5f09fd95-0da7-4188-ad2b-c51e61b7d802">7,917</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNy02LTEtMS05OTcwNg_1bcb4812-5406-4837-bf21-eedd33a9201e">9,378</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;<ix:nonFraction unitRef="eur" contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTQxMg_189b6809-855f-462e-b3d5-01028fc81311">900</ix:nonFraction> million debt principal associated with our 2027 Notes designated as a net investment hedge.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of June&#160;30, 2022 is within <ix:nonFraction unitRef="units" contextRef="i47f84dd2e1f24639a171ca54b2bba99a_I20220630" decimals="INF" name="bsx:ForwardCurrencyContractsTimetoMaturity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTU1MA_33e25010-0a71-4771-bb8b-8828b52b13fe">60</ix:nonFraction>&#160;months for all forward currency contracts designated as cash flow hedges and generally less than <ix:nonNumeric contextRef="i54cc7fcec9c242049c00578499ae8d13_D20220101-20220630" name="us-gaap:DerivativeRemainingMaturity1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTY1MA_7a777750-5de9-4d46-97e8-6019c03fb767">one year</ix:nonNumeric> for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature between one and three years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i48f3c213e9ba4105a7af5eec95cc5891" continuedAt="iea37d03e18ca410ab07dc3f159f8e7e7"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTc_e3eb2aa0-d666-4038-a3e1-84a788848c46" continuedAt="ifdc06180c4194d62aec3fd8a39d2c9a3" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0xLTEtMS05OTcwNg_6689dc11-0363-4d36-ba11-97b60b80a0d7">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0yLTEtMS05OTcwNg_2449addf-43a2-4710-8da6-76387ffca32e">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0zLTEtMS05OTcwNg_7e0cc0ce-65ea-4698-ba53-d86c5480d40c">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS02LTEtMS05OTcwNg_61262d28-70f5-45e8-9805-783134a6ec2e">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS04LTEtMS05OTcwNg_b093355c-5336-4450-ae40-669a37040cd6">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS05LTEtMS05OTcwNg_9b379f16-08d3-489c-85f3-9b0c8c66d933">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0xMC0xLTEtOTk3MDY_605d019c-b91e-4896-8420-4f4f00b897d3">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0xLTEtMS05OTcwNg_09048397-4983-4f66-9130-a6b02c399383">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0yLTEtMS05OTcwNg_6f4df3c1-809b-47ee-8da7-d53d15ec6200">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0zLTEtMS05OTcwNg_0dd4fbc1-fe16-47c6-a14e-1278d19d830b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi02LTEtMS05OTcwNg_62ecff6b-bbc6-4ba2-998c-dad3797496b7">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi04LTEtMS05OTcwNg_25b6d96f-cf50-4b6d-bdc2-fd5f6d5274c9">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi05LTEtMS05OTcwNg_416e6064-9afd-41ff-a58e-1be2b2d5680c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0xMC0xLTEtOTk3MDY_01b5af1b-ab93-48a7-85cd-a07e611284ad">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0xLTEtMS05OTcwNg_e480da05-1e18-4089-af35-5e82bb7d71f2">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0yLTEtMS05OTcwNg_a9583ffd-3201-4fe9-9898-9e3a67d29f6a">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0zLTEtMS05OTcwNg_eb93b567-d0e3-4c7a-a097-8e2c473e83d5">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC02LTEtMS05OTcwNg_3c422c8e-661f-4fc7-b36c-a106cb93f82a">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC04LTEtMS05OTcwNg_b60805da-3912-48ef-8da2-ed2a432541d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC05LTEtMS05OTcwNg_67d9a64d-1f15-40da-b5fe-198368b3ea3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0xMC0xLTEtOTk3MDY_460f560a-dbef-4285-ac12-b7ed9c580393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMS0xLTEtOTk3MDY_befbaa3d-5b93-4a03-84dc-5f944a68a6bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMi0xLTEtOTk3MDY_696f4216-4191-4b5a-b602-f1accd514fa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMy0xLTEtOTk3MDY_ef251b63-b925-459f-ac05-a616463c8498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtNi0xLTEtOTk3MDY_62ecff6b-bbc6-4ba2-998c-dad3797496b7">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtOC0xLTEtOTk3MDY_51422984-59b9-45c7-8406-0cbe7e557934">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtOS0xLTEtOTk3MDY_252e3a29-5552-427c-8ed0-d5393cd0b7cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMTAtMS0xLTk5NzA2_aad9e35c-e9d2-4352-b743-7bdf0ae55864">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0xLTEtMS05OTcwNg_31d63fb0-7157-4e06-8756-4b899e278ccd">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0yLTEtMS05OTcwNg_b40359ff-ecb0-4f92-a3e5-7f4eb442c9b2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0zLTEtMS05OTcwNg_7ff27aec-2100-41f7-aa44-2081ead7c59f">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS02LTEtMS05OTcwNg_b3ddad65-7013-4994-944b-ea286643915c">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS04LTEtMS05OTcwNg_3ed101cd-58dc-4868-bd7f-c3c96408ddd3">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS05LTEtMS05OTcwNg_f9509678-9409-4011-ac0a-41e0e0235080">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0xMC0xLTEtOTk3MDY_713edae8-f50e-450e-bda9-8e59042abb1f">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0xLTEtMS05OTcwNg_fa3f09fc-d91c-4926-8228-8e42e40f22c2">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0yLTEtMS05OTcwNg_3499100c-7779-4968-b15b-84cb45bb1c6b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0zLTEtMS05OTcwNg_8fcdd897-d8b5-436a-ad3e-eb569cef6585">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi02LTEtMS05OTcwNg_0b5c8ff4-c73f-48be-95e0-bbbf9322e7c8">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi04LTEtMS05OTcwNg_f49eccd4-8b22-4fe9-a771-917010c4655f">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi05LTEtMS05OTcwNg_19ed0be9-97f4-4cbd-8e9c-aca8ab6173fc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0xMC0xLTEtOTk3MDY_b28a87e1-9a29-4aca-8733-d6f75007b7cb">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0xLTEtMS05OTcwNg_438a4cf7-9399-42b7-836b-fddd14b0b534">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0yLTEtMS05OTcwNg_8e21d91a-7d31-4619-8ce7-91be783149be">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0zLTEtMS05OTcwNg_ab407ce7-1088-430e-91be-4d2d718be4ff">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC02LTEtMS05OTcwNg_0f15649e-e1da-4e76-9bd6-efc0b64a727d">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC04LTEtMS05OTcwNg_1f17aa48-709c-4219-9900-69f7d64302a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC05LTEtMS05OTcwNg_d75c1d5f-7411-484e-b4bf-93d4f67c13d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0xMC0xLTEtOTk3MDY_0469c637-7751-424f-958c-9e289f6d468c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMS0xLTEtOTk3MDY_05c74cb1-b14d-4987-b158-c85525540636">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMi0xLTEtOTk3MDY_5d9aa093-7a6c-4b5d-84bb-c0aa1b1f1800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMy0xLTEtOTk3MDY_6b978d63-a570-4ab5-b8d8-7615af611cf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtNi0xLTEtOTk3MDY_0b5c8ff4-c73f-48be-95e0-bbbf9322e7c8">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtOC0xLTEtOTk3MDY_18e771eb-578d-4ccd-83e5-dbdbef574434">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtOS0xLTEtOTk3MDY_18df53a4-f113-4be2-baa7-dd9ac50bf0c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMTAtMS0xLTk5NzA2_c6bc806d-b42f-4f80-a1e0-d7b00dd60fa6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0xLTEtMS0xMDQ5MDU_8d6d1ffe-ee5f-4a29-a7e0-05887202a5d0">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0yLTEtMS0xMDQ5MDU_136578d2-4837-4fd5-b44f-2263946e1b9b">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0zLTEtMS0xMDQ5MDU_e03b6ecc-9222-4f4b-a79c-3ff0a4421879">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS02LTEtMS0xMDQ5MDU_31dedd71-d3ba-4ca4-9d65-96305ea6f518">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS04LTEtMS0xMDQ5MDU_2b8283b5-1a07-4d71-a6ab-94f5482a2c09">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS05LTEtMS0xMDQ5MDU_64035633-1e14-4d71-ad51-17fb97710993">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0xMC0xLTEtMTA0OTA1_0c91ad41-0f45-49cc-88f1-f72c3ced1402">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0xLTEtMS0xMDQ5MDU_ae14ed42-33e0-468a-9cf5-561c19314d9f">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0yLTEtMS0xMDQ5MDU_c8fff9c6-1586-4250-a864-8d1da0d30cf5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0zLTEtMS0xMDQ5MDU_43c1caa6-c1f9-422e-8b65-aca60cf16dad">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi02LTEtMS0xMDQ5MDU_3a0d204f-bcbc-4a27-8554-9dbd969f863e">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi04LTEtMS0xMDQ5MDU_d953a5e5-79c3-4b26-b4af-27a8fe4c3045">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi05LTEtMS0xMDQ5MDU_ada6a1d0-e236-4517-948d-a75c90118ede">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0xMC0xLTEtMTA0OTA1_2505b45f-5b11-412f-a010-130d86b89dff">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0xLTEtMS0xMDQ5MDU_b6f59640-65cd-47cf-8be2-610b4d78a53f">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0yLTEtMS0xMDQ5MDU_125389db-ef5b-48e7-80fe-fa448cc283ee">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0zLTEtMS0xMDQ5MDU_4180f603-13bf-4214-acf4-345f0698527f">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC02LTEtMS0xMDQ5MDU_0e53826f-640b-4df4-9a65-e6dae7cfc820">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC04LTEtMS0xMDQ5MDU_d3b5e6b5-30d8-46e3-821c-20642d08af03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC05LTEtMS0xMDQ5MDU_9ace64ea-aeaf-4d10-a59d-026b814d6e8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0xMC0xLTEtMTA0OTA1_7ad6e31e-496f-4e45-8386-13ae6260e230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMS0xLTEtMTA0OTA1_038d44d8-2e7e-43b6-8ef0-f9611af92a89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMi0xLTEtMTA0OTA1_22368630-cea8-4b6b-897b-f72acb2035d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMy0xLTEtMTA0OTA1_365e5246-008d-465f-b74c-42b002678919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtNi0xLTEtMTA0OTA1_3a0d204f-bcbc-4a27-8554-9dbd969f863e">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtOC0xLTEtMTA0OTA1_d3f32690-666f-4607-bcf8-55048a1cfdb2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtOS0xLTEtMTA0OTA1_8e4a021c-0a70-47cb-bb30-d090b258ae86">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMTAtMS0xLTEwNDkwNQ_50206cda-2079-4248-a0ff-5a4f86bd1c80">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="iea37d03e18ca410ab07dc3f159f8e7e7" continuedAt="i28a93c89d0524e9fbcd975e47026a8fc"><ix:continuation id="ifdc06180c4194d62aec3fd8a39d2c9a3"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0xLTEtMS0xMDQ5MDA_a080582a-2d66-4c2b-8ed4-d69761c98278">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0yLTEtMS0xMDQ5MDA_9dd47c15-82f3-4c6a-b737-fbbb46d576b7">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0zLTEtMS0xMDQ5MDA_e4f2e3d4-8f30-442c-ac38-abf0954129a0">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS02LTEtMS0xMDQ5MDA_d97bd9b4-6d53-48cf-83cd-00af10556a78">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS04LTEtMS0xMDQ5MDA_38e2387b-0ec7-4fbe-84a0-31ad95cb4b3b">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS05LTEtMS0xMDQ5MDA_a31bdd6d-00e6-466a-813d-4ad0a571db3a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0xMC0xLTEtMTA0OTAw_808e10bb-da39-4dbc-9120-051299e92ead">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0xLTEtMS0xMDQ5MDA_316aa748-ccd4-4cc0-921a-11c7121c0de9">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0yLTEtMS0xMDQ5MDA_d1bec0c1-6543-4790-9f6d-839e87a8b621">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0zLTEtMS0xMDQ5MDA_6c68e2ff-7de1-429f-b89c-460f28d85609">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi02LTEtMS0xMDQ5MDA_6c764caa-e86a-4a7a-83d9-999594110fa4">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi04LTEtMS0xMDQ5MDA_e9e26dfe-c4e8-4fc2-b084-72ad39f3fc84">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi05LTEtMS0xMDQ5MDA_a3fa3995-fa18-4070-badc-9125c9e08aec">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0xMC0xLTEtMTA0OTAw_383a2d53-c2fe-49ea-adcc-3ed2c1e54756">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0xLTEtMS0xMDQ5MDA_8c7ad306-8f51-4dfb-8c01-3a34799ca845">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0yLTEtMS0xMDQ5MDA_5c950100-a8fd-4a0a-a761-1fc66ff5edb7">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0zLTEtMS0xMDQ5MDA_a40b4f42-6e6e-485c-a72d-1079095fdf33">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC02LTEtMS0xMDQ5MDA_a3bf6b77-9f6c-4653-8d63-16fdde81f853">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC04LTEtMS0xMDQ5MDA_deb17fe5-0cc6-4ad9-83d0-f6e41ac6a9da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC05LTEtMS0xMDQ5MDA_f04496d8-b9cc-4f0b-aec6-f817f941e3b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0xMC0xLTEtMTA0OTAw_01ac9df4-3d3b-40d2-a968-437816ea5927">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMS0xLTEtMTA0OTAw_9c657193-1146-45b7-b329-9e6018c05d98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMi0xLTEtMTA0OTAw_31c9e57e-165a-4f06-9879-074fe65d740b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMy0xLTEtMTA0OTAw_06b7e516-331c-4bcc-8a50-7fc633f2cf8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtNi0xLTEtMTA0OTAw_6c764caa-e86a-4a7a-83d9-999594110fa4">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtOC0xLTEtMTA0OTAw_a7a58875-5a8a-4cb9-85e4-55e057cd0ae7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtOS0xLTEtMTA0OTAw_6fdcb0d4-4521-4e62-9b74-208de22eb173">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMTAtMS0xLTEwNDkwMA_b9943122-40cf-49cd-83dd-7805d1e1dc74">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. <ix:nonFraction unitRef="usd" contextRef="i7f1313d335714e77935281b63801f86d_D20220401-20220630" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_028d7c1a-3f75-4095-981d-f2e5d98e7f10"><ix:nonFraction unitRef="usd" contextRef="i94e1669b9c2046b8aca9b105f46ecef9_D20220101-20220630" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_5e6f940c-d456-472b-b475-11a42580ab6a"><ix:nonFraction unitRef="usd" contextRef="idc5d2dfee4ee42909a9a420320563b9f_D20210101-20210630" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_ad8b0d20-c2cc-48c3-a948-dfc5df3a0418"><ix:nonFraction unitRef="usd" contextRef="i894ed00d9114436795ac77d2513cb0d7_D20210401-20210630" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_f8b7287a-25b5-42c8-b78c-0275d0604dd8">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTg_eaf7b020-a5e5-4cf9-95e5-9ef437fceec3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:28.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad80cea173e459d9cffda4c1fb19c1d_I20220630" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmI1ZTE0NjJlZmU4OTQ1NGZhM2RhNjhmYmQwZmY1ZTRmL3RhYmxlcmFuZ2U6YjVlMTQ2MmVmZTg5NDU0ZmEzZGE2OGZiZDBmZjVlNGZfMS02LTEtMS05OTcwNg_ae6edaeb-ade4-4075-bc76-8bd73d8b771c">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213187d28dcc430e8a47b7ba1ff645fe_I20220630" decimals="-6" name="bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmI1ZTE0NjJlZmU4OTQ1NGZhM2RhNjhmYmQwZmY1ZTRmL3RhYmxlcmFuZ2U6YjVlMTQ2MmVmZTg5NDU0ZmEzZGE2OGZiZDBmZjVlNGZfMi02LTEtMS05OTcwNg_ab34f90a-a8b0-4586-ace4-db5c195310f8">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if85f496eaa364904b720459ed2c8ae50_I20220630" decimals="-6" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmI1ZTE0NjJlZmU4OTQ1NGZhM2RhNjhmYmQwZmY1ZTRmL3RhYmxlcmFuZ2U6YjVlMTQ2MmVmZTg5NDU0ZmEzZGE2OGZiZDBmZjVlNGZfMy02LTEtMS05OTcwNg_9a3f77f7-ed52-4eba-a996-14b6cdac2226">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTk_6c55dec9-d1e1-44ef-8868-6a54c0ca5147" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.117%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi00LTEtMS05OTcwNg_95489d50-dfab-4939-a694-f2f961866831">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi02LTEtMS05OTcwNg_f6bedcc0-335b-4e7f-9bc4-6a85fbaf614e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi04LTEtMS05OTcwNg_d57d1e9e-d63f-4b28-b058-f50f75f2dea4">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi0xMC0xLTEtOTk3MDY_d848ecf0-e66d-485d-bec6-b29e4ec9aa72">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy00LTEtMS05OTcwNg_76cd347b-263f-4287-85b6-f4cdcafe2a2f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy02LTEtMS05OTcwNg_d7c3da43-1b04-4d60-b8e1-40f5f488c766">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy04LTEtMS05OTcwNg_36f6193e-3087-4d8f-a6a9-a816aa20cf33">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy0xMC0xLTEtOTk3MDY_8baf6b21-6505-4703-846c-5acb54b89872">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630" decimals="-6" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC00LTEtMS05OTcwNg_ce1570e9-b138-465b-b042-e90b2107b8ec">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC02LTEtMS05OTcwNg_ca5f3701-5f1c-471b-85b6-da5e60cac427">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC04LTEtMS05OTcwNg_944235ea-84ba-40c4-aa97-e59c1c3fef0f">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC0xMC0xLTEtOTk3MDY_87bdf913-b00b-466a-8458-b61b4a8aaf9c">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTM_e651f46c-93d4-40b6-9eaf-98e09abe338c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i28a93c89d0524e9fbcd975e47026a8fc" continuedAt="i4162247bc37f4025baba2f446d0caf4c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyODk_5be4fbad-1074-4ff0-8ac6-7c8b733eca19" continuedAt="i56184b46f33341c6be0e185fc56891c6" escape="true">The following are the balances of our derivative and nonderivative assets and liabilities:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i56184b46f33341c6be0e185fc56891c6"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.911%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie06eeef8c3a2458a80d5fbb8e8971e2f_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNC00LTEtMS05OTcwNg_47b26fa0-09b9-4655-b503-cb7e8d898aef">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i283c9b3d2d864286a042216f0f64a9d8_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNC02LTEtMS05OTcwNg_826fba67-6486-4ab9-944d-4a0bb7cf15ef">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f79da42a51e4c689131977628edf127_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNS00LTEtMS05OTcwNg_2f62d093-e94f-463e-9d6c-34930a49b408">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a8a481fded45df857975789968d39d_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNS02LTEtMS05OTcwNg_8a88b694-7ef9-4edd-a883-c23e53fa6591">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2075fa6d454b41ae2afcc3adfef0cc_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNi00LTEtMS05OTcwNg_6de85c30-f19b-4202-889b-5c5ffff7c2d9">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cc74c177124666847f665ef6dcce62_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNi02LTEtMS05OTcwNg_fc39af01-6612-44f4-9e59-270dc37e2515">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23236f5602843f6a6cbba70fbcd25a3_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfOC00LTEtMS05OTcwNg_da0ef93e-075d-4e2b-8350-b935d8b08cf1">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i522dd4a58a4841a5963ab9f73b804c01_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfOC02LTEtMS05OTcwNg_e0e96ec3-c08d-4bc2-a95d-1d450d9ab781">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTAtNC0xLTEtOTk3MDY_d47cadf0-501e-4348-a8e2-e16cf2e00c99">538</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTAtNi0xLTEtOTk3MDY_3ba2de8f-0bd1-4257-807e-0994168aaae0">394</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e040f387ddc4ec38df96824cb9d67e4_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTQtNC0xLTEtOTk3MDY_a1db5bfb-4c2d-44f4-99a6-81fd02f8960a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0b6009b67642718139f8490ac1a838_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTQtNi0xLTEtOTk3MDY_080f3a09-d166-4a21-a366-e2508fd9cbf3">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i395049b051f7434bbf8dc1b8a8366602_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTUtNC0xLTEtOTk3MDY_78df4b5d-163d-414e-a7bd-16e03d1ab251">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20de2ae88de4431b9b32645d028faae9_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTUtNi0xLTEtOTk3MDY_ae7cf0d9-6f75-4cc0-853b-8c27ef0c4a09">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903aa99cb11d474c86e447953994f505_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTYtNC0xLTEtOTk3MDY_189eb092-11f4-48a5-8013-e3398ab33ee7">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1390af8c345c4263bf87707c4ef576e7_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTYtNi0xLTEtOTk3MDY_034783f3-c72d-485e-806b-87263ab43188">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2075fa6d454b41ae2afcc3adfef0cc_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTgtNC0xLTEtOTk3MDY_ccd643b5-7ed3-429c-959b-726f6af5b7cf">938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cc74c177124666847f665ef6dcce62_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTgtNi0xLTEtOTk3MDY_97113913-bb24-4b09-a58b-8472380e8160">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id85c78ca58b04142a6350664eedf1e72_I20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjAtNC0xLTEtOTk3MDY_e333996f-32c0-4e16-920c-f95a51a7f987">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab5d2a58a3649bfb781ee50c6b74f2c_I20211231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjAtNi0xLTEtOTk3MDY_9663620e-9ef6-428f-9beb-4e5dbd0dc5cc">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjEtNC0xLTEtOTk3MDY_a914d35e-ee57-4540-82e2-eed8bfd6027c">966</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjEtNi0xLTEtOTk3MDY_ce3cae9e-3ac9-4d71-9bd7-523b2fcb8715">1,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;<ix:nonFraction unitRef="eur" contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfOTAxNA_189b6809-855f-462e-b3d5-01028fc81311">900</ix:nonFraction> million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i4162247bc37f4025baba2f446d0caf4c" continuedAt="i38c8e69c9fe44222b09b90719563a25a"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyOTg_799c373e-405b-4cb6-8795-227f73e0d689" continuedAt="ie55a7d573cf948ef8d8b7f10a8cea9b7" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xLTEtMS05OTcwNg_77f72b14-bc04-46a0-9dcc-427af8434d7a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0zLTEtMS05OTcwNg_09dfc005-22a1-4b66-9558-257a4d130284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC01LTEtMS05OTcwNg_763eb908-4e19-4b49-a835-eeea9829b5e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC03LTEtMS05OTcwNg_a558cdd9-b5fb-47b5-a0c8-c8fe93153ff1">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC05LTEtMS05OTcwNg_268337e9-d0fb-41e4-a5ec-b5f2206b8696">1,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xMS0xLTEtOTk3MDY_0cce398d-7d64-415d-95d6-55dcc38b3324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xMy0xLTEtOTk3MDY_64598c40-9fed-418c-a86f-7a07d561b1b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xNS0xLTEtOTk3MDY_c0e91a10-02a6-44d7-8cce-c135ce96df2e">1,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xLTEtMS05OTcwNg_47c7051a-e677-400e-9aa1-5f6da60f3e48">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0zLTEtMS05OTcwNg_0ac45c0d-c14a-4543-a608-8772f18a6a8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS01LTEtMS05OTcwNg_083590b7-5220-4846-b87a-8b51963a1e59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS03LTEtMS05OTcwNg_98756ee6-f3da-431f-a0be-f46edbb45529">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS05LTEtMS05OTcwNg_1661a078-e4c7-46d4-b8c0-0ca61228c34e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xMS0xLTEtOTk3MDY_295b1815-59ab-4249-9a7a-c935ea0a72ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xMy0xLTEtOTk3MDY_530c2af0-f08e-4b78-ab53-70cffed1fa3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xNS0xLTEtOTk3MDY_f14ee84c-e2dc-4e97-b89f-6da5c17ee477">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xLTEtMS05OTcwNg_6e2dc587-ca00-4ac3-b9b2-3506a8c3f73a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0zLTEtMS05OTcwNg_2f7330c5-4fd2-4497-817e-5e0a1f8e2342">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi01LTEtMS05OTcwNg_ee413e0d-db64-4ecf-8a2a-377a319f1814">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi03LTEtMS05OTcwNg_16f7378e-7f4e-46e1-90ca-757101f24b5c">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi05LTEtMS05OTcwNg_1d0c07c9-3233-4dd4-82df-b8b7df75aefb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xMS0xLTEtOTk3MDY_bfd9528c-6343-4f20-9340-4a9b9f148d1c">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xMy0xLTEtOTk3MDY_00f4f5f6-7730-4403-b6e7-a24dfb5e83a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xNS0xLTEtOTk3MDY_432de13e-252d-4981-a4b1-ab30f227dccf">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xLTEtMS05OTcwNg_b7a2a551-9157-400d-97d0-d325ec16c190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0zLTEtMS05OTcwNg_de0dfc1c-bafd-4384-88f3-33ab0ec9553b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy01LTEtMS05OTcwNg_34c7cec2-305f-418c-9e3f-0535d1e8400f">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy03LTEtMS05OTcwNg_d6c800e3-e951-4843-a60f-c4fb995934a9">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy05LTEtMS05OTcwNg_3ec3717d-f362-4752-bcfd-dd4d6231d167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xMS0xLTEtOTk3MDY_57b6f2db-b2a5-4827-986f-eba36d27aec1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xMy0xLTEtOTk3MDY_6075cfbb-616a-40ee-8fbf-01004717552e">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xNS0xLTEtOTk3MDY_18c7e494-82fc-4bdc-a7f1-de18c29c6923">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xLTEtMS05OTcwNg_97008c09-678d-4e95-b2d5-0632fb20d553">40</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0zLTEtMS05OTcwNg_ff4bc4b6-83a6-4ed4-a2e8-5a76840cd2e2">538</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC01LTEtMS05OTcwNg_413901c6-389f-4c1a-b26a-005a39d85414">182</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC03LTEtMS05OTcwNg_750f2198-29a7-42cd-9fa8-8ad3d4bf788a">760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC05LTEtMS05OTcwNg_caefb011-f0f1-426e-bdd1-b202adcb0162">1,642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xMS0xLTEtOTk3MDY_9aeed273-c85d-4c40-bab5-99fed9c3f558">394</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xMy0xLTEtOTk3MDY_9d7ccab1-bba1-4086-acb2-0e4d872b36cd">246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xNS0xLTEtOTk3MDY_f4ca9fbb-29a1-467e-957a-b4b764bcd834">2,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMS0xLTEtOTk3MDY_2c7466ad-079d-42b4-a7d2-0c85648f58eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMy0xLTEtOTk3MDY_8e315270-83a2-41c1-91c5-d4ea4e8f05f7">966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtNS0xLTEtOTk3MDY_9eae475a-1eec-4aba-900b-2ce0edcb4a15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtNy0xLTEtOTk3MDY_71171945-02e5-4abb-bac4-6132e7b6cab9">966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtOS0xLTEtOTk3MDY_dbe302a5-a78d-4444-a347-24a79aad8587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMTEtMS0xLTk5NzA2_93023bf8-68be-4de3-b8a1-e6d8918d246b">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMTMtMS0xLTk5NzA2_90116f2e-cb3c-432e-aaab-5880bdd18e31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMTUtMS0xLTk5NzA2_73d69cc0-d922-4aef-a392-d882b895b8ed">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMS0xLTEtOTk3MDY_430cf038-d3fd-4ebc-a911-117e56091cc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMy0xLTEtOTk3MDY_ff10208c-d79b-43d3-9474-1b681263b485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtNS0xLTEtOTk3MDY_18813898-a66c-4d9c-bfb0-feef41f6f907">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtNy0xLTEtOTk3MDY_0ab04501-4fd7-416b-847a-3d2c66650ba5">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtOS0xLTEtOTk3MDY_c91763ae-c7d6-460f-b3e0-9b3f4e9ce580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMTEtMS0xLTk5NzA2_74a32824-95b8-4cb7-8d17-a717fb9d42ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMTMtMS0xLTk5NzA2_a4da112a-aff3-44bc-80b5-1dc8655e15a0">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMTUtMS0xLTk5NzA2_2702f509-301b-45df-a975-76e427855cb0">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMS0xLTEtOTk3MDY_31c8b24c-01d5-4a2b-885b-2740c3033c1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMy0xLTEtOTk3MDY_440346f9-ed0b-459f-912b-e2cbca1d9453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItNS0xLTEtOTk3MDY_e5fd7aea-95ca-47bf-86b0-ea70dd62ac39">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItNy0xLTEtOTk3MDY_3bea93bc-262d-4dd3-86a7-32dc4bdddcdf">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItOS0xLTEtOTk3MDY_01f7d87d-bde1-404c-8aa9-810f004c018a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMTEtMS0xLTk5NzA2_27e66605-27de-4be1-a338-c738d1d68b9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMTMtMS0xLTk5NzA2_156d1144-af48-4eae-88a7-5e6de6e7fc62">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMTUtMS0xLTk5NzA2_c2f55b1d-e2eb-4333-aa9f-235111a7ebd7">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMS0xLTEtOTk3MDY_3c2e35b6-5d09-408a-a0da-9c5656655b36">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMy0xLTEtOTk3MDY_46c78cb8-d199-4420-82a8-ab8f818939f3">966</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtNS0xLTEtOTk3MDY_b430e6dd-2895-4e27-ad40-a450514f79bc">434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtNy0xLTEtOTk3MDY_00cb068b-567c-43c9-9223-b4aee4ea8604">1,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtOS0xLTEtOTk3MDY_8e6c811a-7536-4518-bcf2-030b972cb60e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMTEtMS0xLTk5NzA2_b954991e-f61d-4968-beb8-73087372fdbf">1,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMTMtMS0xLTk5NzA2_62c556e3-e26b-407f-8cc2-5d8434b2b59e">767</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMTUtMS0xLTk5NzA2_0b35752e-5944-4f50-b908-6ea56f9af925">1,838</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $<ix:nonFraction unitRef="usd" contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA3MTU_77f72b14-bc04-46a0-9dcc-427af8434d7a">36</ix:nonFraction> million invested in money market funds and time deposits as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA3ODA_268337e9-d0fb-41e4-a5ec-b5f2206b8696">1.632</ix:nonFraction> billion as of December&#160;31, 2021, we held $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA4MDE_7170eb4a-1391-4e52-81ea-3cf3d76e57c0">240</ix:nonFraction> million in interest-bearing and non-interest-bearing bank accounts as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA4NzY_ef1d8767-1d07-4590-a806-60235ab797ab">293</ix:nonFraction> million as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We maintain a financial asset and associated liability for our licensing arrangements measured at fair value in our accompanying unaudited consolidated balance sheets in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie55a7d573cf948ef8d8b7f10a8cea9b7" continuedAt="i0afa123f1abc4dbdabdce01a15cb16b1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2022 include the following significant unobservable inputs:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i27f146899c2744beaee1eff239630ac4_I20220630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfMS0xLTEtMS05OTcwNg_7c81fd6a-a86a-4c1a-9dfe-63c3d9393098">182</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5055ee5be0c54a1498e064e638e3fc43_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfMS00LTEtMS05OTcwNg_42c2180a-605c-4c43-93e2-1f080299e256">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad29e7417ab84660bbf5561c20e93d02_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfMS03LTEtMS05OTcwNg_4dc8ce23-0e34-43c9-970d-56b572316b98">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i27f146899c2744beaee1eff239630ac4_I20220630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC0xLTEtMS05OTcwNg_d62a1e35-3342-436a-8eb5-21e2ae500a6f">215</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf9c2c8c325e4eafb24af39665b6c948_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC00LTEtMS05OTcwNg_ea4e4be0-e2a3-4431-b429-39f84f64207d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb3b1e53f8964f6589f2176f191c0f08_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC02LTEtMS05OTcwNg_70bf2a1c-9596-4763-9f66-a213a8966fc8">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21815a7af6e34709a5951ddbb9f495fc_I20220630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC03LTEtMS05OTcwNg_e1c4c8d8-f88f-4598-9f7e-19ca449c1558">13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i38c8e69c9fe44222b09b90719563a25a"><ix:continuation id="i0afa123f1abc4dbdabdce01a15cb16b1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfMS0xLTEtMS05OTcwNg_1b56e603-c6b0-443e-a831-1e8c8578998c">246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ce1e2f30ce34162a65a41a860c47fb7_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfMi0xLTEtMS05OTcwNg_b277c847-d30f-4aa3-be57-ce1139b5dc32">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce1e2f30ce34162a65a41a860c47fb7_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfMy0xLTEtMS05OTcwNg_c9d7ba1d-28b4-497a-8a39-15d19392038a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfNC0xLTEtMS05OTcwNg_0e8d2ddf-0f8b-449e-8757-c2b1d3a8d7aa">182</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfMS0xLTEtMS05OTcwNg_eaef6e46-a613-4706-b95c-ad67aab57444">281</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ff32150be744fab5239abe91331844_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsForRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfMi0xLTEtMS05OTcwNg_03c7d9d0-bd30-4834-8811-0e6746fc4dea">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ff32150be744fab5239abe91331844_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfMy0xLTEtMS05OTcwNg_76710436-3a9e-4077-a3a9-a14b9007fb1a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b623df0e8c34375b46c759975f64119_I20220630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfNC0xLTEtMS05OTcwNg_c4023d6b-6d15-4e4d-887b-1cc954f67a50">215</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTI5MTA_0a9aad3e-bfec-4843-a752-36fed96dfe56">8.517</ix:nonFraction> billion as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTI5MjY_87364ff8-1601-4a0b-b720-6e6aac3457b5">10.196</ix:nonFraction> billion as of December&#160;31, 2021. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfODA_45abc0ed-964c-4cf8-8e10-20a4810931e1">8.971</ix:nonFraction> billion as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfOTY_14dbe076-3e3c-4f9c-a4d1-cf01a89f536e">9.065</ix:nonFraction> billion as of December&#160;31, 2021, with current maturities of $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTM2_c1c213fc-c212-43ea-b2e0-3e6b7c498540">170</ix:nonFraction> million as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTUy_a1b481cc-c304-4da7-bfac-447db88eddbf">261</ix:nonFraction> million as of December&#160;31, 2021. <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk2NA_f27dc17f-120b-4ba8-b791-f1e4427d1c5d" continuedAt="i795ba1725031475b8799da0557884a5e" escape="true"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfODAxNQ_c78f5d1a-0c93-4c21-b020-88c566f140cc" continuedAt="ie64152337b8e4f19aa96fac4b1380da9" escape="true">The debt maturity schedule for our long-term debt obligations is presented below: </ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i795ba1725031475b8799da0557884a5e" continuedAt="i70a60b25379246bfbb105f53054aa6b0"><ix:continuation id="ie64152337b8e4f19aa96fac4b1380da9"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e7fbf9ea5d43a2b38aa9bad667e187_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMy02LTEtMS05OTcwNg_4c71dc9a-7fdf-44fc-93da-8862062c27f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bce25b2bb6a42e1a1077eeec7d3b9bc_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMy04LTEtMS05OTcwNg_8387e33f-0623-4a5b-b947-e17d96d5a535">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50e7fbf9ea5d43a2b38aa9bad667e187_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMy0xMC0xLTEtOTk3MDY_956ec493-e05b-4e8e-9853-0eaef3cb3dd8">4.125</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e70f9bdc9a4a9f829773dd8d40f1a2_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNC02LTEtMS05OTcwNg_7073eefe-8d47-4767-bf77-50a9673cefc3">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5038c2fb0e4b95b80671df1615c58e_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNC04LTEtMS05OTcwNg_4b9dc93c-21c8-4d93-bad0-d0a93daadb6f">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80e70f9bdc9a4a9f829773dd8d40f1a2_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNC0xMC0xLTEtOTk3MDY_62673670-0a46-4939-8bb3-7a7f027d83da">3.450</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNS02LTEtMS05OTcwNg_df8b22fc-67fd-4bd1-9d86-3a44d2bcb119">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10527d633af14853a3d6a28a3b84ea28_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNS04LTEtMS05OTcwNg_5156e240-b05b-4694-b67d-e383ee02378e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNS0xMC0xLTEtOTk3MDY_8d9051f7-8c51-44de-a97b-6deee951f2a6">0.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e95c9c3ca2647bebeb689903f4662b6_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNi02LTEtMS05OTcwNg_d64a82db-af73-4ffb-b804-1e58ac951218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8c1c7c026a4812bc680c9687955ea5_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNi04LTEtMS05OTcwNg_0f98c707-9f03-4d44-a772-29e5c2067e99">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e95c9c3ca2647bebeb689903f4662b6_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNi0xMC0xLTEtOTk3MDY_4bb74ee7-cc3e-4645-90f9-19a1281c44ff">3.850</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i771f92b343bb4886afe00f44b7d62b4d_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNy02LTEtMS05OTcwNg_1b8174cc-939e-499f-88fa-46395533e9bc">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85ee741df5d4ac693e71a7c46cb1f5a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNy04LTEtMS05OTcwNg_20b5ca9d-d3f3-424b-bf3e-9c753c70cbf9">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i771f92b343bb4886afe00f44b7d62b4d_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNy0xMC0xLTEtOTk3MDY_26dc06f0-7597-49f6-abcf-bb90643c979c">1.900</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee2942cb1e94674ab49ef190a069073_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOC02LTEtMS05OTcwNg_45916eee-d778-4917-9978-ca7a1bcd5fad">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48210b087009430d87d3ee09bbd7480b_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOC04LTEtMS05OTcwNg_0e3d4773-e6c4-4471-a1c6-ac39ede874fb">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ee2942cb1e94674ab49ef190a069073_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOC0xMC0xLTEtOTk3MDY_13ade501-42ef-4f16-988a-a7e047be5dad">3.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOS02LTEtMS05OTcwNg_bdda24cf-ff01-40cb-9cea-66b76cc7fc68">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id937d257d4a3403f8db692c5b41aa9ab_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOS04LTEtMS05OTcwNg_6e216725-e74b-4428-be6b-7b830a6e1a73">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOS0xMC0xLTEtOTk3MDY_620e7d26-9fbf-4313-98cb-58803221e2e8">0.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTAtNi0xLTEtOTk3MDY_25431cbf-bf55-4665-a9d3-c2a9054f4d97">779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fcf8358875242f7af0e421a76768692_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTAtOC0xLTEtOTk3MDY_9a71df1d-8468-4252-980a-5a8c7287cce5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTAtMTAtMS0xLTk5NzA2_ad5e5a6a-bd83-40d3-acfc-eb2f93e29026">1.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6669b1014a64e8189357320d104615a_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTEtNi0xLTEtOTk3MDY_e5d60142-d01f-4c1a-8b53-1c784e3e4157">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b9b62e05a72418aa23a2c8539d02f68_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTEtOC0xLTEtOTk3MDY_e8cfafcf-b6ab-4519-9f80-2a8cde7e3e3c">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6669b1014a64e8189357320d104615a_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTEtMTAtMS0xLTk5NzA2_ac162341-c4df-4893-8395-d90c899496d8">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5293e3f0677c486fa8ef0b0311b62005_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTItNi0xLTEtOTk3MDY_ffb3dc0e-11c5-481d-a94d-75c5515de0c3">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa9924b99f54b9bba102c4cbf10aca9_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTItOC0xLTEtOTk3MDY_dcbad1bf-1a9c-4dca-9815-52c96da42b8a">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5293e3f0677c486fa8ef0b0311b62005_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTItMTAtMS0xLTk5NzA2_4120ba2d-efbc-4cb5-ae53-3d7b7d322348">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea96d4ea7d04a2daa8f980b999df830_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTMtNi0xLTEtOTk3MDY_cba071d1-58ed-49c5-a8cf-6a3236fc635f">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05aa77d5eb404436ad25e54997dd9780_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTMtOC0xLTEtOTk3MDY_07798eba-5481-4497-b8d1-5b4d91a1c16f">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ea96d4ea7d04a2daa8f980b999df830_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTMtMTAtMS0xLTk5NzA2_3a54d0f5-c186-4e2e-9a3b-f56a5ae2caec">2.650</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTQtNi0xLTEtOTk3MDY_bde8a3cc-a7cb-44c9-82f3-dcd2dbbc6bcc">779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id715136c1f6f43e190b1b7cb7b6a75e1_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTQtOC0xLTEtOTk3MDY_25765343-26e1-4094-821a-23fdc56d9c79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTQtMTAtMS0xLTk5NzA2_5b0e458c-8b62-4ef2-bd48-e2690cc0977f">1.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTUtNi0xLTEtOTk3MDY_07318b7f-041f-4ac8-93d5-c3cf017dd222">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice55734ff9694ebb8bba28051710baa2_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTUtOC0xLTEtOTk3MDY_510bd8b9-9e0e-41dd-af11-f069ebd55a85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTUtMTAtMS0xLTk5NzA2_adfbd7e6-16f6-46ea-a1d8-14bb334110ab">1.875</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd222b4f248248c38837a4b7e751501d_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTYtNi0xLTEtOTk3MDY_a223243f-fb8f-48e3-8a14-ff5444080c2a">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7b3863114dd40908e490c5e045b081d_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTYtOC0xLTEtOTk3MDY_1a5fce28-af84-422d-9454-d448b2f5c667">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd222b4f248248c38837a4b7e751501d_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTYtMTAtMS0xLTk5NzA2_e58817d8-9531-4ef6-8834-7bebb2c82e4c">6.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacacfc94ceb24a648193a04798d1e6dc_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTctNi0xLTEtOTk3MDY_5120a23a-069c-4e7d-99f1-ff6b05ea1389">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86681f9c3b6492daaf4162fa8970450_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTctOC0xLTEtOTk3MDY_9aa9592c-8d4e-4734-b7dd-1fc2852c0655">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacacfc94ceb24a648193a04798d1e6dc_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTctMTAtMS0xLTk5NzA2_5ce34057-a4ac-4a9b-8894-5981a99d14c9">4.550</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie950b3741f1d4e158b9ee15c4b4ed9a2_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTgtNi0xLTEtOTk3MDY_fd836938-3322-4074-9694-eb6a8aab828e">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68de0d9b3a8e49ceafd696fc5709bd12_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTgtOC0xLTEtOTk3MDY_e13c4d38-2a37-4928-82e4-0629717d0b70">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie950b3741f1d4e158b9ee15c4b4ed9a2_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTgtMTAtMS0xLTk5NzA2_5597dba5-8653-489c-8eba-9f6a9cfd5eca">7.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b1f8f175024c6bbb7edb59c01d0d1c_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTktNi0xLTEtOTk3MDY_84cf8eb4-bd94-44d9-8b17-fef90a0c5377">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i416ba9b4dd0d46c889e4493851b6db3c_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTktOC0xLTEtOTk3MDY_40b0f52f-d9d9-4d4c-b7d7-7896220d48cc">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4b1f8f175024c6bbb7edb59c01d0d1c_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTktMTAtMS0xLTk5NzA2_3f61e570-85fa-4055-aa16-e8512257856b">4.700</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ae315c0e1554dacaae58b7af1c8736f_I20220630" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjAtNi0xLTEtOTk3MDY_4d333efe-2ae2-4fd5-9812-c292312882e4">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i784b8e2bd7b74fe1b05c54c5962c8c64_I20211231" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjAtOC0xLTEtOTk3MDY_f6b38ecb-893c-4036-b6d9-e4a0e16388bb">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68f0f5b7ac54919bae4f7f9efc554d2_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjEtNi0xLTEtOTk3MDY_74db69a8-feb3-442b-9dee-3db6af3ce70d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff06f923ba6c43cc86c4783c3efd3131_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjEtOC0xLTEtOTk3MDY_d6cb5a1a-c7b1-4804-9b3f-4d6353967c14">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08584e30dcf848aba71c8d5f57625e6f_I20220630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjItNi0xLTEtOTk3MDY_b02fe154-56a7-4216-8893-adbfc2b3c875">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4aea0c204194bf984d537214fddfde2_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjItOC0xLTEtOTk3MDY_6c978cb7-0f1a-4307-bd14-94a1f15748fd">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjMtNi0xLTEtOTk3MDY_4f9e79fd-57a2-430f-8cd2-3dec6456338f">8,802</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjMtOC0xLTEtOTk3MDY_fcb1a89a-ca2e-4f05-9c8f-a87a8ca3d733">8,804</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December 31, 2021, respectively.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below. In addition, in the first quarter of 2022, we repaid $<ix:nonFraction unitRef="usd" contextRef="i24581130201d4bb6bb06505b8f5af435_I20220630" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTI0Mg_549c123c-9fd2-4e0c-b84f-de2867ec0d43">250</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i24581130201d4bb6bb06505b8f5af435_I20220630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTI0OA_b3f10527-87ff-4ba7-8653-7f34016cadc3">3.375</ix:nonFraction>% May 2022 Senior Notes classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated balance sheets as of December 31, 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021, we entered into a new $<ix:nonFraction unitRef="usd" contextRef="i138c7c7c86e847c989a9ffb258cc207b_I20210510" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTQyOQ_62102ba1-9235-4529-88bc-dfcce3c89a9d">2.750</ix:nonFraction> billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with <ix:nonNumeric contextRef="i1c00dff781d2413cbbf1f18bed5d6e0f_D20210510-20210510" name="bsx:DebtInstrumentExtensionOptionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk5Ng_8342e1ef-8535-4013-8eeb-0fb1efcb77bd">one-year</ix:nonNumeric> extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were <ix:nonFraction unitRef="usd" contextRef="ia309b17ea78345ba80fb7b052728c043_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTg3Mg_a63a34db-22e0-40a4-bf6b-69c9a8efe6a3"><ix:nonFraction unitRef="usd" contextRef="i69088951be3f4fdeba3d3644b3c3b6f5_I20220630" decimals="0" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTg3Mg_ea76cdc4-cc12-4b89-bb8e-3c5afabadf5e">no</ix:nonFraction></ix:nonFraction> amounts outstanding under the 2021 Revolving Credit Facility as of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i70a60b25379246bfbb105f53054aa6b0" continuedAt="ib93f577251f2459c881108c4315b8ebc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022 or December&#160;31, 2021; however, outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfODAwNQ_f16b54c6-7ff0-45bc-b66d-0bbbcbec4672" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility.</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:32.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i449d136159f049a5985130241fa62d0c_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOmJiYWFiNjlhZTNjZjRjODhhNjJhOWNlYTc0MGY3ZDE2L3RhYmxlcmFuZ2U6YmJhYWI2OWFlM2NmNGM4OGE2MmE5Y2VhNzQwZjdkMTZfMi0yLTEtMS05OTcwNg_60999985-f62e-4644-ac55-8928dd679792">3.75</ix:nonFraction> times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29b4c437272d480aa75455fc20ccedd2_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOmJiYWFiNjlhZTNjZjRjODhhNjJhOWNlYTc0MGY3ZDE2L3RhYmxlcmFuZ2U6YmJhYWI2OWFlM2NmNGM4OGE2MmE5Y2VhNzQwZjdkMTZfMi00LTEtMS05OTcwNg_eb855d09-ac55-424e-8568-37f15b3e1ed9">2.61</ix:nonFraction> times</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of <ix:nonFraction unitRef="number" contextRef="i7e3ac65cbf784533b5620e4ff1832c2c_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjMyMg_b05bb4e6-8a88-46c1-9960-27faed15d084">3.75</ix:nonFraction> times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="bsx:QualifiedAcquisitionConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjUwMg_2c51eb0f-dd9f-4cbe-9572-e9cd8cd580dd">1.000</ix:nonFraction> billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is <ix:nonFraction unitRef="number" contextRef="i0ca81ce52f414e53a0e5cc4d51005e69_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjY5NA_04c547aa-fd49-4c1a-8ee4-c750a1c90f32">4.75</ix:nonFraction> times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to <ix:nonFraction unitRef="number" contextRef="i1f6851db735d4b949b672cef2153d2d0_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjc5Mw_57c81886-bdaa-42b9-a472-acddba1600af">4.50</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="i7d1ff42f2c334bd38528daf462dad7f6_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjc5Nw_b65eac20-956b-4d29-87de-72ac87366545">4.25</ix:nonFraction> times and <ix:nonFraction unitRef="number" contextRef="iea70986a88704b33aeb401629439ceee_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjgwNA_bc64f23e-17a7-4d13-88a1-2a9262270390">4.00</ix:nonFraction> times, respectively. Thereafter, a maximum leverage ratio of <ix:nonFraction unitRef="number" contextRef="i950105374ecc4d5681ba3458a73eadc0_I20220630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjg2Mg_18bb03e2-e480-4769-88e3-2b1a4b012dde">3.75</ix:nonFraction> times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for the recently completed qualified acquisitions due to the funding using cash on hand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreement, through maturity, of any non-cash charges and up to $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:ExclusionFromEbitdaForRestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzI4OQ_814d1515-2765-4915-be53-94f0be3c0fa8">500</ix:nonFraction> million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzQyMw_06ab03d5-47b7-4291-b334-3331afefdb44">311</ix:nonFraction> million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:LitigationAndDebtExclusionFromEbitda" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzc1NQ_fafaffcf-c16b-44c2-9a4c-45d62d6e55f9">1.455</ix:nonFraction> billion in the aggregate. As of June&#160;30, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzc5Mw_3e7601e2-2e4d-45dd-b464-625031dc176d">1.080</ix:nonFraction> billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the 2021 Revolving Credit Facility. <ix:nonNumeric contextRef="ie27b0338c0a34e858b0b2dccd5137bb4_D20220101-20220630" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk4Ng_fbd68a34-917b-4dba-aeee-4283f2e5a315" continuedAt="i7df7a48fa36941a1938e7d100de2d3cb" escape="true">We had $<ix:nonFraction unitRef="usd" contextRef="i327d423409a741438941c3983d47e655_I20220630" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNDc1OQ_b09fd8e8-a747-4850-a217-d50ad3eb20c4">155</ix:nonFraction> million of commercial paper outstanding as of June&#160;30, 2022 and none as of December&#160;31, 2021. </ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><ix:continuation id="i7df7a48fa36941a1938e7d100de2d3cb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327d423409a741438941c3983d47e655_I20220630" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMi0xLTEtMS05OTcwNg_b09fd8e8-a747-4850-a217-d50ad3eb20c4">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMi0zLTEtMS05OTcwNg_65f6236b-e511-4173-bc11-08a09b9e20ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327d423409a741438941c3983d47e655_I20220630" decimals="-6" name="bsx:MaximumCommercialPaperOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMy0xLTEtMS05OTcwNg_a696990a-b83e-455c-b045-2df1165f2d46">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231" decimals="-6" name="bsx:MaximumCommercialPaperOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMy0zLTEtMS05OTcwNg_a74f5e49-f03b-4a11-ae6c-698eb36b0856">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327d423409a741438941c3983d47e655_I20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNC0xLTEtMS05OTcwNg_9d3af117-ce08-4352-a8c2-98c7fb034c2d">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNC0zLTEtMS05OTcwNg_c42d6ce6-ccf6-4b91-9dff-59607a1c1c18">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 days</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 days</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i327d423409a741438941c3983d47e655_I20220630" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNi0xLTEtMS05OTcwNg_5707db86-d364-400c-b082-b3f7565f7648">1.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNi0zLTEtMS05OTcwNg_ee27b589-0e8d-4f35-96d7-e1f9c3b86486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ib93f577251f2459c881108c4315b8ebc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $<ix:nonFraction unitRef="usd" contextRef="i8ae315c0e1554dacaae58b7af1c8736f_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNDg3Ng_1fef6ea6-d090-4c97-8210-7882477f7820">8.878</ix:nonFraction> billion as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i784b8e2bd7b74fe1b05c54c5962c8c64_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNDg5Mg_5db52ce7-b951-456a-9bd5-6b58bf8db407">9.121</ix:nonFraction> billion as of December&#160;31, 2021. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, American Medical Systems Europe B.V. (AMS Europe), an indirect, wholly owned subsidiary of Boston Scientific, completed a registered public offering (the Offering) of &#8364;<ix:nonFraction unitRef="eur" contextRef="i39de90268a7a4225b6941c9ff3a19fab_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTQyMw_cdc1b066-2745-4cc7-aaad-95d7cf0ab634">3.000</ix:nonFraction> billion in aggregate principal amount of euro-dominated senior notes comprised of &#8364;<ix:nonFraction unitRef="eur" contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUwMA_853cb91d-0a6c-4d4b-812a-51632265fe97">1.000</ix:nonFraction> billion of <ix:nonFraction unitRef="rate" contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUwNg_4e741662-45ba-4a47-b6bf-b0a5cb7d6492">0.750</ix:nonFraction>% Senior Notes due 2025, &#8364;<ix:nonFraction unitRef="eur" contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUzMg_e4203ede-30d5-4092-b7c1-2c75375c51e6">750</ix:nonFraction> million of <ix:nonFraction unitRef="rate" contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUzOA_1aa38425-593d-4830-9bd2-1fdce116148a">1.375</ix:nonFraction>% Senior Notes due 2028, &#8364;<ix:nonFraction unitRef="eur" contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTU2NA_aa8a5d83-c28a-4ec6-b2b5-cc03d42a9cbd">750</ix:nonFraction> million of <ix:nonFraction unitRef="rate" contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTU3MA_8ca65bb2-2e31-4f23-80a7-cc1ac098de31">1.625</ix:nonFraction>% Senior Notes due 2031 and &#8364;<ix:nonFraction unitRef="eur" contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTU5OQ_631f12ad-803c-4d23-9925-b0944c11f7ae">500</ix:nonFraction> million of <ix:nonFraction unitRef="rate" contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTYwNQ_55a616a2-a57f-455b-b7be-c484299afb80">1.875</ix:nonFraction>% Senior Notes due 2034 (collectively, the Eurobonds). Boston Scientific has fully and unconditionally guaranteed all of AMS Europe's obligations under the Eurobonds, and no other subsidiary of Boston Scientific will guarantee these obligations. AMS Europe is a &#8220;finance subsidiary&#8221; as defined in Rule 13-01(a)(4)(vi) of Regulation S-X. The financial condition, results of operations and cash flows of AMS Europe are consolidated in the financial statements of Boston Scientific. The Offering resulted in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjE5OTAyMzI2MzYzMg_3967d841-4c5b-4396-8230-f49180be6334">3.270</ix:nonFraction> billion, net of investor discounts and issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i2038d40094f64de1965e4f053aeab53d_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNjMxMA_d100c873-686d-4a17-8758-d97cb104c289">3.275</ix:nonFraction>&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. We recorded associated debt extinguishment charges of $<ix:nonFraction unitRef="usd" contextRef="ieb6722339b944352b0b56bcac0aadaaf_D20220101-20220331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjE5OTAyMzI2MzU3NA_b478c2b4-f696-4c6c-80c4-f6142e5293de">194</ix:nonFraction> million in the first quarter of 2022 presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk5MA_71c2faed-9af0-414b-bc82-cc9294e2d170" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.912%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i649407080a3b4a2a8dbe0062791430e0_I20220630" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi0xLTEtMS05OTcwNg_7c2e395b-0245-4be0-88e1-9c14b7d68e1e">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if742f92ece7547768b16200d191f5b16_D20220101-20220630" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi0zLTEtMS05OTcwNg_27af423f-da5c-4915-9d67-64834d5dcc24">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic314a6b5f97d44198af151b25dbf609c_I20211231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi01LTEtMS05OTcwNg_7b1e57b5-4e07-4089-bc44-820369eb599d">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02f1129cfb5e4c6bb359d217903f8368_D20220101-20220331" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi03LTEtMS05OTcwNg_10a4d975-e079-483a-8fa6-91881526ddd5">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b3c6ed9730476381312a30a5c8bcbd_I20220630" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy0xLTEtMS05OTcwNg_27067bb8-2153-4817-851f-d059abde59f5">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e345c3e41bc48a8bc324b8f8375b600_D20220101-20220630" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy0zLTEtMS05OTcwNg_0b8e7714-6027-49f6-b43e-60ef6dc321a9">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7bfd166b4841ad94b29f8f0775f55f_I20211231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy01LTEtMS05OTcwNg_aef7d875-be3e-4881-b12b-2111468b39db">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i646d9a6e9da946f785beb189d5511265_D20220101-20220331" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy03LTEtMS05OTcwNg_fa3d7619-8b06-4f45-8781-7f27ac08b0e1">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f2e5182166b4e258ce14bd1c6bc2462_I20220630" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC0xLTEtMS05OTcwNg_f5a70ccb-f95d-436f-aa14-163d6c2346fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia2579a67e9154ae9bdb34bfdbaff7852_D20220101-20220630" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC0zLTEtMS05OTcwNg_3399c34f-c96e-4d52-975f-913154c76701">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32519afb04824cab904e19b493da014d_I20211231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC01LTEtMS05OTcwNg_a049b9a7-84bf-4427-9cc9-5e7858abaa6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00ae8b0ca7d84dedb85b5fdbfbb37484_D20220101-20220331" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC03LTEtMS05OTcwNg_ce8d7f7f-84e7-4360-915d-08d495deaae1">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzM1Nw_d55f1818-20e5-4b4e-aa99-4c81b4603b15">128</ix:nonFraction> million as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzM3Mw_7e20ed39-a551-46b8-b1df-2c9aded65325">134</ix:nonFraction> million as of December&#160;31, 2021, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of June&#160;30, 2022 and December&#160;31, 2021 we had not recognized a related liability for any outstanding letters of credit within our accompanying unaudited consolidated balance sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE0NA_eb35c046-140d-475e-8fc2-1a4419b6d7eb" continuedAt="i42f5faad398342a2b240684f3187b5fd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions within our accompanying unaudited consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE4NA_ac97f20d-42b2-4f98-a2d5-f79b87c51201" continuedAt="i2ccb4c656abc4a1fb3832a7a65a12344" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.861%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMi0xLTEtMS05OTcwNg_01455f45-fbc6-4549-8e35-a19e4088e8e7">2,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMi0zLTEtMS05OTcwNg_60ecc6d3-b650-450e-b503-c6ac831b57fd">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMy0xLTEtMS05OTcwNg_58cf5b75-e07f-42b7-9c1a-9d2328757132">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMy0zLTEtMS05OTcwNg_e74a1999-9e6f-4fef-9c78-2f8d1750dfb5">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfNC0xLTEtMS05OTcwNg_8393d8d5-e35a-47bb-8ad8-09fe7442fbd0">1,917</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfNC0zLTEtMS05OTcwNg_7927c2ea-8109-4d39-8a0f-ddeaa5756f6f">1,778</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:continuation id="i2ccb4c656abc4a1fb3832a7a65a12344"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi0xLTEtMS05OTcwNg_b1a4621a-d8d6-4d6b-9c8a-cb8963a63c81">113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi0zLTEtMS05OTcwNg_c91d2302-b2ef-4cfe-9d45-c72acf0538c0">101</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi01LTEtMS05OTcwNg_3ccc3b85-4261-484b-8229-e3af6b91e7b2">108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi03LTEtMS05OTcwNg_d1380692-e06c-44dd-aece-0148d1dc6275">105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy0xLTEtMS05OTcwNg_93684002-ba48-4f60-83e8-16bde05eba06">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy0zLTEtMS05OTcwNg_86b4f81f-a077-44d0-b0c0-74c88e73cd4b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy01LTEtMS05OTcwNg_2d2eb235-7dc4-4499-aa68-3b4f59c72435">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy03LTEtMS05OTcwNg_75dfef5d-fc19-40ff-b169-505ecf7d1dc7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC0xLTEtMS05OTcwNg_8c60e388-ca5a-4ea5-8ca9-e312b4c1026c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC0zLTEtMS05OTcwNg_c5fb8576-7a43-4aab-9179-a3dd3d6b8bf5">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC01LTEtMS05OTcwNg_563fca51-4984-4de7-99a5-cd571f475ccf">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC03LTEtMS05OTcwNg_712da490-485a-493e-974a-f2cf689eb115">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS0xLTEtMS05OTcwNg_2ac81dab-d8e6-452d-a9c9-b153ed0985c7">117</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS0zLTEtMS05OTcwNg_d4bc9abb-4877-4d27-914d-7978eaee316c">107</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS01LTEtMS05OTcwNg_ad5d3dc9-3e26-4b0e-b7c6-018c8e1ba08e">117</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS03LTEtMS05OTcwNg_b3def719-dca0-48b0-adc5-020c20da57be">107</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 326), we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic and geopolitical conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other entities, and, in southern Europe, relative to those in other countries. More recently, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjIwOQ_a4fdfc12-26fc-4c69-a995-27a9ef0b12d1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMi0xLTEtMS05OTcwNg_44dd6bfd-d6ed-4ba2-bcd2-6c112422950a">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMi0zLTEtMS05OTcwNg_e61c88db-4df8-4a4a-8e5e-a741a2dfcbfe">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMy0xLTEtMS05OTcwNg_c69cd4ea-719c-4534-b8ff-4af5727099bc">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMy0zLTEtMS05OTcwNg_e42d7e88-fa4b-422c-a36c-480309fc3384">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNC0xLTEtMS05OTcwNg_84611782-c886-4a3d-a0b6-cbd793c100c4">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNC0zLTEtMS05OTcwNg_973c5adc-7487-4968-9da5-e374b76f6a83">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNS0xLTEtMS05OTcwNg_d2fb3c6a-989e-442a-9eaa-74bc828d7a30">1,752</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNS0zLTEtMS05OTcwNg_f077b25a-df75-49b6-8e8f-7a35bfde3fac">1,610</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i42f5faad398342a2b240684f3187b5fd" continuedAt="i656b4a28cbe644298f3bc8c97b55cd6f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE0Mw_2fe23f6e-b1e0-4838-96eb-bcaf75c4e7d9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMi0xLTEtMS05OTcwNg_65b75a72-8108-4dce-bd2c-ef708b863bff">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMi0zLTEtMS05OTcwNg_91c14bb3-7336-4da4-8cb3-19697df3bc7c">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMy0xLTEtMS05OTcwNg_debe725e-c6b6-48ff-ad2d-411d3897e5df">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMy0zLTEtMS05OTcwNg_b596803c-75ec-4620-9b30-2f1fed08d5d1">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNC0xLTEtMS05OTcwNg_d183636d-5dce-41f0-b660-8e59ddf50da8">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNC0zLTEtMS05OTcwNg_9a36d7a2-eb82-4da2-aa86-ddb94dda9621">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNS0xLTEtMS05OTcwNg_add8e8fe-7d55-429c-bdc7-1eea2a8a2d04">362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNS0zLTEtMS05OTcwNg_dc104216-9f0d-4434-ad0a-0d64773bc65a">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNi0xLTEtMS05OTcwNg_49984658-4016-4ead-9f3d-978577572c79">874</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNi0zLTEtMS05OTcwNg_13773935-3e5e-4700-8e91-b0c6d93c6a95">799</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE5Ng_3516bb22-c4b0-4816-90bb-eae95f1e2a57" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMi0xLTEtMS05OTcwNg_6e89472f-c3fd-4478-a9f4-b131abf231c0">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMi0zLTEtMS05OTcwNg_a2bc75a8-55c8-43ca-bd64-11de93f3f470">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMy0xLTEtMS05OTcwNg_e4dd54be-d063-43ce-aee2-01f059d30092">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMy0zLTEtMS05OTcwNg_a4ca77e1-e548-4e6b-859c-159f2bf6a502">1,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:EquipmentFurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNC0xLTEtMS05OTcwNg_cf84298d-352c-4ba3-8768-9701640c66b1">3,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="bsx:EquipmentFurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNC0zLTEtMS05OTcwNg_b23e2609-0f18-4adc-8717-3b44d8a9ce2f">3,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNS0xLTEtMS05OTcwNg_98c51c7b-437c-4c2b-adf5-2c389aac5d0b">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNS0zLTEtMS05OTcwNg_1ca91181-a9b6-48e3-939c-b033d121d6c2">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNi0xLTEtMS05OTcwNg_3ccda21a-cab7-419d-989e-85146cfa588e">5,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNi0zLTEtMS05OTcwNg_f986ff5d-a5d5-472a-a34d-790223a5575f">5,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNy0xLTEtMS05OTcwNg_d115c039-4e3a-4c5e-8260-d368e7209937">3,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNy0zLTEtMS05OTcwNg_2fcfcb2f-1d15-4eb8-9d3d-cb1ffaa853e4">3,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfOC0xLTEtMS05OTcwNg_b2763040-12fb-4e34-92b7-5108fb783d74">2,246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfOC0zLTEtMS05OTcwNg_6f438ab8-bf3b-4af5-af3a-fa7b5cc1cbb4">2,252</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMTk3NQ_11b0c5b6-47fc-4f73-ab91-010c2931a5bb">80</ix:nonFraction> million&#160;for the second quarter of 2022, $<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjAwNw_647c22df-a012-4d8e-8bb6-8961d2959fae">83</ix:nonFraction> million for the second quarter of 2021, $<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE5OTAyMzI1ODg3Mw_29a846df-0858-4e67-bee4-99aae2f0d917">156</ix:nonFraction> million for the first six months of 2022, and $<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE5OTAyMzI1ODg3OQ_00979875-d12e-4866-a63e-c144589fc164">166</ix:nonFraction> million for the first six months of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE4Nw_02820310-fb61-4406-993b-60a58d00c7b6" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMi0xLTEtMS05OTcwNg_21dec8bc-27c9-42c7-9242-53a327b47ec7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMi0zLTEtMS05OTcwNg_601761ec-c8d1-4c64-805f-44bc5c8c0743">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMy0xLTEtMS05OTcwNg_0ea18ba0-7618-4942-8e0b-475a23ed4eb9">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMy0zLTEtMS05OTcwNg_e4b3ae14-2b8b-40d5-ae30-2db2a8051d8c">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNC0xLTEtMS05OTcwNg_32e4970f-3eca-4ca8-94db-31e042076a91">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNC0zLTEtMS05OTcwNg_1784d612-eda9-4a57-b251-09d6cb16734f">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNS0xLTEtMS05OTcwNg_3df2c74b-0a9c-48bf-a3e2-919ed16982e9">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNS0zLTEtMS05OTcwNg_e2418082-92b3-45b8-8330-d222a51fbbc4">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNi0xLTEtMS05OTcwNg_14d4133a-9d66-4133-9304-2d4bcbaa7f37">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNi0zLTEtMS05OTcwNg_942ba794-90a7-4a79-ad3b-9a8ff7091b02">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:IndemnificationAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0xLTEtMS0xMDg5NjY_e5a51336-6c97-4ea7-b537-581d0119fadd">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="bsx:IndemnificationAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0zLTEtMS0xMDg5NjY_ceab2210-60a5-40b9-9dba-696809b88474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0xLTEtMS05OTcwNg_a877a975-41cb-44ba-901a-d26bb92fcefe">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0zLTEtMS05OTcwNg_e6e1de79-f9bd-49b1-918e-ba1adfbfe297">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfOC0xLTEtMS05OTcwNg_a13f0459-8bad-4699-b04d-faf5f74966ab">1,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfOC0zLTEtMS05OTcwNg_7305cd31-b3e9-43c1-903b-6e0d2a1c2294">1,410</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjIxMA_783c03f5-f14a-4ad9-83f8-5b362f12ed93" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMi0xLTEtMS05OTcwNg_71cd0a1b-cced-4b6b-991a-2700c57955af">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMi0zLTEtMS05OTcwNg_eee37110-228f-4d34-bd73-ca0629336f9c">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMy0xLTEtMS05OTcwNg_1cbe798a-49ac-47c1-a0e4-3b991ab3bdbe">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMy0zLTEtMS05OTcwNg_cdf60232-d2e8-4fa1-bb14-f97e9dbf1b9b">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNC0xLTEtMS05OTcwNg_323bde46-ca03-48a0-8ae9-cd2bf0f54a26">335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNC0zLTEtMS05OTcwNg_68a45ce8-0133-4fa5-9858-a932c830e098">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNS0xLTEtMS05OTcwNg_a20e6fa7-abd3-4c08-9c17-49d3c1b73a71">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNS0zLTEtMS05OTcwNg_422f1092-6053-4628-8f01-fcb346107c52">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNi0xLTEtMS05OTcwNg_b377156d-a5fa-495a-91a2-2c2dee341510">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNi0zLTEtMS05OTcwNg_0b33b435-caaf-4a55-9665-ca67f814591c">686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNy0xLTEtMS05OTcwNg_5ba3cab2-6552-44cf-b195-c5566fc3de93">2,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNy0zLTEtMS05OTcwNg_4b46b5e4-60de-4328-93e3-d731a11b33d3">2,436</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i656b4a28cbe644298f3bc8c97b55cd6f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE4Mw_84b53d9d-4970-41ae-be06-e67a108bb2d2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMi0xLTEtMS05OTcwNg_ff74d3ec-858b-4d37-ac8d-b802d09eb545">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMi0zLTEtMS05OTcwNg_3099ab37-c354-45fd-8334-3db9db5e1a99">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMy0xLTEtMS05OTcwNg_1ad8c6ce-af67-48db-ba6a-465c06f2acd6">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMy0zLTEtMS05OTcwNg_88681a59-cee3-4ad1-ac4d-51f9fcc2ff14">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNC0xLTEtMS05OTcwNg_c496df90-c4a9-4ace-b367-e5432d17cdca">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNC0zLTEtMS05OTcwNg_46763595-2e1c-4dba-8eb9-92319d3c97bb">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNi0xLTEtMS05OTcwNg_01422a7c-ff1b-4562-8159-7eef41596002">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNi0zLTEtMS05OTcwNg_7dbd9519-714d-4bde-bcb3-0da54dd33a48">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNy0xLTEtMS05OTcwNg_1d386598-534f-463d-b3a2-b7675b7ef1ac">784</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNy0zLTEtMS05OTcwNg_67c04b4d-703f-4cef-a9c7-70ba33f5f12e">783</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE3Nw_a4958157-c64f-4611-aed1-2f20025d85dd" escape="true"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMi0xLTEtMS05OTcwNg_ecfd1bbc-183a-40e4-a4a4-ff2945862877">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMi0zLTEtMS05OTcwNg_b69ce687-c277-4277-89a4-c450ba8297c4">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMy0xLTEtMS05OTcwNg_6dc0b8fe-109e-4346-912b-80adac4d19d1">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMy0zLTEtMS05OTcwNg_9faf17ca-5049-4854-9348-62eb6c7d06c8">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNC0xLTEtMS05OTcwNg_50197452-4018-48fe-9e59-b9bfb0ed76c1">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNC0zLTEtMS05OTcwNg_57118695-13cb-46af-a227-a58b0442adf3">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNS0xLTEtMS05OTcwNg_6d45a1a6-b7c8-4b6c-b90f-73a329e8125c">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNS0zLTEtMS05OTcwNg_ea27d997-732d-4bdd-a2e9-c3cff762883b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNi0xLTEtMS05OTcwNg_e2843b77-b58c-4072-99ca-aeb4b8806df9">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNi0zLTEtMS05OTcwNg_bcc86349-e135-4f25-9e92-2474cea214dd">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNy0xLTEtMS05OTcwNg_c8dd4e80-bec8-4876-ba54-b8e9ddaa30ab">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNy0zLTEtMS05OTcwNg_fee0fa18-9689-4263-9c7a-9fa1f01d0c02">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOC0xLTEtMS05OTcwNg_6ede37f6-ef8a-48a7-af20-639964034e16">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOC0zLTEtMS05OTcwNg_686ee307-9a82-451a-abde-d24cf462287d">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOS0xLTEtMS05OTcwNg_e788080b-cff2-4ff7-bc07-df18da88250a">1,988</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOS0zLTEtMS05OTcwNg_f246f991-d9fa-4e25-84a6-50b4b30f3a49">2,220</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our 2019 acquisition of BTG plc. (BTG), we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom employees. During the second quarter of 2022, we transferred the benefit obligation and associated assets of the pension plan to third party insurers, and as a result, were relieved from primary responsibility of the benefit obligation and the related plan assets. The transaction did not have a material impact on our financial position or results of operations.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_85"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfMTE5MQ_b13cbc8d-5949-422b-8e0d-82f1d0555738" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfMTE5OQ_05865a1f-abd2-424c-bc67-874456ababdb" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi0xLTEtMS05OTcwNg_5d0db1d4-dfe7-4c6c-9d25-37abf39fdb63">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi0zLTEtMS05OTcwNg_232fb046-849f-428d-b9a8-a97346c75330">24.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi01LTEtMS05OTcwNg_123d7ad6-b3b6-4f98-a1c6-27417af39484">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi03LTEtMS05OTcwNg_fea894bc-b61a-42b6-895e-27b76707c199">11.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our reported tax rates for the second quarter and first six months of 2022, as compared to the same periods in 2021, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include acquisition/divestiture-related charges and receipts, charges and receipts on investment portfolio net losses (gains), litigation-related net charges, as well as certain discrete tax items primarily related to changes in tax laws, unrecognized tax benefits, changes in valuation allowance and foreign return-to-provision adjustments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNTYx_92a6dde3-5259-4ac0-aab1-988c3215aa62">411</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNjE1_d7ff37ad-382a-404b-a2a9-3595dfff5d58">333</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNjg4_a5de764e-d7b9-4597-934c-1bb17c7c2a9a">255</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNzQy_4b86a720-f586-4d92-b805-6a1206cc56f2">177</ix:nonFraction> million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfMTE4OA_2da0d015-16d9-4aff-b1c9-480e38ef3c89">55</ix:nonFraction> million.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTIxNTM_741d8961-d109-4ef9-8dfb-be286da52507" continuedAt="i41736efa0f1144819b0b6b63b94b6964" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity. For additional information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTIxNjM_5ed0ce8d-4394-4f90-81ea-0de328137c8f" continuedAt="i11038253a9ad4120946d4bca01e36bfe" escape="true">FASB ASC Topic 450, </ix:nonNumeric></span><ix:continuation id="i11038253a9ad4120946d4bca01e36bfe" continuedAt="i30b6593216124896b8c0a0a2d2b09226"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i30b6593216124896b8c0a0a2d2b09226">Our accrual for legal matters that are probable and estimable was</ix:continuation> $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjU0NQ_c8588df4-3425-4929-8f1a-00fe08402442">514</ix:nonFraction> million as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjU2MQ_29e246e5-3c04-42f9-a003-45d29d1f917e">548</ix:nonFraction> million as of December&#160;31, 2021 and includes certain estimated costs of settlement, damages and defense primarily related to product liability cases or claims related to our transvaginal surgical mesh products. A portion of this accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjkzNw_50faef4d-b4c7-4fe1-a463-dde0cd43820c">132</ix:nonFraction> million as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjk1Mw_a6d674b5-0576-4095-8542-d50689a22785">188</ix:nonFraction> million as of December&#160;31, 2021. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjE5OTAyMzI2Nzg0Mg_2908a82e-3a0d-47cd-849f-4d8e64233bdd">42</ix:nonFraction> million during the second quarter and first six months of 2022, $<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMzA4OQ_5c2e2723-5cef-42c5-be76-d157f8c204fd">298</ix:nonFraction> million during the second quarter of 2021 and $<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjE5OTAyMzI4MzMxNA_59970653-dfc6-47d7-ae00-772cc3e0fc82">302</ix:nonFraction> million during the first six months of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against four then-asserted patents, which resulted in the court staying the case until 2020. All IPRs concluded and confirmed the validity of certain claims of each challenged patent. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in February 2023. The Company has also asserted patents against Cook in Germany and the United Kingdom. In January 2022, the D&#252;sseldorf Regional Court, Patent Litigation Chamber ruled that Cook&#8217;s Instinct Endoscopic Clip technology infringes the Company&#8217;s patent, EP 3 023 061. The D&#252;sseldorf Court granted an ex parte preliminary injunction giving the Company the right to enjoin Cook (Cook Medical EUDC GmbH, Germany, Cook </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i41736efa0f1144819b0b6b63b94b6964" continuedAt="i5323342b1e944942995915c477b5a489"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutschland GmbH, Germany and Cook Medical Europe Ltd., Ireland) from offering and selling Instinct Endoscopic Clips in Germany.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, in the United States, approximately <ix:nonFraction unitRef="claims" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfNjkxOA_72b95e24-4b92-4160-9f92-208f2a9cd11f">55,000</ix:nonFraction> product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. Outside the United States, approximately <ix:nonFraction unitRef="claims" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfNzE0Ng_c318fc2d-02ec-46fd-874d-56839831f2d6">2,700</ix:nonFraction> cases or claims have been asserted, predominantly in Canada, the United Kingdom, Ireland and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately <ix:nonFraction unitRef="claims" contextRef="i0e48a7919ffd4f7981e1a7533395f383_I20220630" decimals="0" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfNzc1OQ_445d296d-1fb3-4bb7-b1f0-ec072e661512">53,000</ix:nonFraction> cases and claims in the United States, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately <ix:nonFraction unitRef="claims" contextRef="i0e48a7919ffd4f7981e1a7533395f383_I20220630" decimals="0" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODE0OA_445d296d-1fb3-4bb7-b1f0-ec072e661512">53,000</ix:nonFraction> cases and claims, approximately <ix:nonFraction unitRef="claims" contextRef="i0e48a7919ffd4f7981e1a7533395f383_I20220630" decimals="0" name="bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODE4Mw_7e4d344b-5094-4b76-a31c-15404afbee0b">52,000</ix:nonFraction> have met the conditions of the settlement and are final. In Canada, we have settled approximately <ix:nonFraction unitRef="claims" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="INF" name="bsx:CanadaSettledClaims" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODI4NA_f3ccd4cb-8c0b-4e53-b00e-8ff8d18f135c">300</ix:nonFraction> claims. In Australia, the Company has reached a settlement, subject to court approval, that resolves the approximately <ix:nonFraction unitRef="units" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:CertifiedClassActionsInAustraliaMesh" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODQwNg_2f3a93b5-c61e-46d4-8193-032539ca2be3">2,300</ix:nonFraction> claims asserted in the consolidated class action filed against the Company in the first quarter of 2021. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the company is facing fewer than <ix:nonFraction unitRef="claims" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODY5Mg_e55d4dff-39bc-42c5-b037-6c1e44b1a83e">90</ix:nonFraction> cases and claims in the United Kingdom and Canada.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In February 2021, the Multi-District Litigation (MDL) established in February 2012 by the United States Federal Courts was closed after all pending cases were dismissed or remanded to courts of primary jurisdiction.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle, and expect that more cases will go to trial through 2023. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in <ix:nonFraction unitRef="claims" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTA3NzU_9f1b6e42-ff90-4af5-b578-663e9ea38352">127</ix:nonFraction> filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and actively selling in the fourth quarter of 2018. The plaintiffs assert they are entitled to monetary damages related to alleged injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of approximately <ix:nonFraction unitRef="claims" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTEyNjQ_884a2969-d2ae-479f-9947-db32c81a281a">325</ix:nonFraction> claims, none of which have been filed. As of June&#160;30, 2022, we have entered into master settlement agreements with certain plaintiffs' counsel to resolve approximately <ix:nonFraction unitRef="units" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTE0NzY_14126a2a-f43f-4231-b160-3b7657f07fe8">225</ix:nonFraction> cases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i5323342b1e944942995915c477b5a489"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#8217;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. Subsequently, on March 30, 2022, the Federal Prosecutor&#8217;s office issued a non-binding recommendation that is contrary to the Attorney General&#8217;s recommendation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full Commission is considering both of these recommendations but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#8217;s decision.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam. The Company is cooperating with government agencies while investigating these allegations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments were due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents. Labcoat sought monetary damages related to an earn-out provision. On March 25, 2022, the parties agreed to a confidential settlement which resolves the dispute. The settlement did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro Corp. (Nevro) in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro's Senza&#8482; Spinal Cord Stimulation (SCS) System. The company sought lost profits, a reasonable royalty and a permanent injunction. At a trial held in October and November 2021 regarding six of Boston Scientific's originally asserted patent claims, a jury granted Boston Scientific a monetary award, finding that each asserted claim was valid, that four of the six claims were infringed by Nevro, and that two of the claims were willfully infringed by Nevro. On July 29, 2022, the parties reached a confidential settlement agreement, pursuant to which the Company agreed to make a payment to Nevro of $<ix:nonFraction unitRef="usd" contextRef="if145ba28e56b4a3e8ebaaade117334db_D20220805-20220805" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTI2NDQzODM3NDc3Mjc_de2136ba-f83c-4277-bd19-a3e7fcb588f3">85</ix:nonFraction> million to resolve all pending litigation between the parties, including this matter and the 18-cv-664 and 21-cv-258 matters described below. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation were infringed by Nevro&#8217;s Senza&#8482; I and Senza&#8482; II SCS Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our SCS systems infringed five Nevro patents. Nevro sought lost profits, a reasonable royalty and a permanent injunction. On July 29, 2022, the parties agreed to a confidential settlement, described above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, Nevro filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#8217;s spinal cord stimulation systems. Nevro sought lost profits, a reasonable royalty and a permanent injunction. On July 29, 2022, the parties agreed to a confidential settlement, described above.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_97"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfMTcwMg_853c94c4-350f-433e-ad6f-1e1693e691e9" continuedAt="icac90c4da1f74871a5db4c9cd8c7b9f5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNTI_fd84e8da-aa5e-44e7-b775-2c5199c323f3">50</ix:nonFraction> million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="i762a71d1a5314a20b775461852e10332_I20200527" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNDY4_b28a7dbb-c3c0-4d52-b277-362cf2ff9769">10,062,500</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNDgx_1c8f6e2e-2c2b-4c42-bcd8-6cdd4fecc943">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i762a71d1a5314a20b775461852e10332_I20200527" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNTky_dcffd0ec-c6c9-4d9a-b973-57b12daf80da">100</ix:nonFraction> per share. The net proceeds from the MCPS offering were </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="icac90c4da1f74871a5db4c9cd8c7b9f5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximately $<ix:nonFraction unitRef="usd" contextRef="i6b6b779abd6047358a4ff3e1753f9f78_D20200527-20200527" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNjYz_b7e2354e-310f-46d9-a773-958adc0a9e31">975</ix:nonFraction>&#160;million after deducting underwriting discounts and commissions and offering expenses. As of June&#160;30, 2022, our MCPS had an aggregate liquidation preference of $<ix:nonFraction unitRef="usd" contextRef="ia45237c280a543b788d2d06d99616c10_I20220630" decimals="-6" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfODA0_a54fed95-edaa-43b8-86b0-94460f5a39a0">1.006</ix:nonFraction>&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared, and we paid, a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5bacdd63be81431e93233ee3874cc618_D20220401-20220630" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfMTAxNg_532b70c8-d4cc-4cc2-9c34-fa60fd7a8010">1.375</ix:nonFraction> per MCPS share to holders of our MCPS as of May 15, 2022, representing a dividend period from March 2022 through May 2022. On July 25, 2022 the Committee declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4b8a09505de24098ace745ffd92c8c9b_D20220725-20220725" decimals="4" name="us-gaap:PreferredStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfMTIxMw_9d892080-bdac-4411-b71f-94941814d7c5">1.375</ix:nonFraction> per MCPS share to holders of our MCPS as of August 15, 2022, representing a dividend period from June through August 2022. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheet as of June&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.</span></div></ix:continuation><div id="i81ec8629b9df431d9ba97fad2f676991_100"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE5OTY_ad047533-b2aa-464b-9253-8647e0d78180" escape="true"><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE5OTM_32f5b7b7-f34b-439e-b453-004c80446c2d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItMS0xLTEtOTk3MDY_a6ad48f8-d6f1-4a1b-ad36-69918414db24">1,429.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItMy0xLTEtOTk3MDY_5cf196fb-19dc-40e9-8cc2-ac1d47c790c1">1,421.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItNS0xLTEtOTk3MDY_dcc848d2-e7d7-4b75-82a8-d28fdaefea27">1,428.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItNy0xLTEtOTk3MDY_4e5af27f-3b69-4f7a-9410-cebfe6a09cc1">1,420.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtMS0xLTEtOTk3MDY_4ea9cb73-2edf-4298-b8a3-4bfafb550177">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtMy0xLTEtOTk3MDY_e15e94ea-1467-4072-a5a5-2827015792b5">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtNS0xLTEtOTk3MDY_7b0d1bb9-9252-4ecd-ac32-a21793c17d42">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtNy0xLTEtOTk3MDY_04451443-8e3d-4a9a-a5f7-18f6fc96b851">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtMS0xLTEtOTk3MDY_9dde85db-439d-47b6-8186-ed898e8ccd40">1,437.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtMy0xLTEtOTk3MDY_01284266-9ec6-4eb4-803b-fd9d6dacc564">1,432.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtNS0xLTEtOTk3MDY_e36fcda7-379a-4ffc-80e0-b77786217625">1,438.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtNy0xLTEtOTk3MDY_4286218b-0099-4ea1-ba30-5fd11ea6b6ec">1,431.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE5ODg_29377cfd-6694-4988-bfaa-9148e260f84c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07e0936bffa54f1fa93786399e12f047_D20220401-20220630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItMS0xLTEtOTk3MDY_62b3d332-5fea-460b-823e-8189eefe64a5">7</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48f9725f39b04b94a04843a31af9469d_D20210401-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItMy0xLTEtOTk3MDY_8f44da49-38bb-4a12-800d-d96bd3bfcddf">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7da2c1103ea4f908aac0cd8da683037_D20220101-20220630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItNS0xLTEtOTk3MDY_f5fd72af-a99f-4774-a47f-580b896b7457">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie962472004ed49bb91bf3bb5bc90460e_D20210101-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItNy0xLTEtOTk3MDY_552616cb-30b0-406f-846d-f55fbd6e09e2">6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3ea4cb7460f44638f76c93ae1fe62a6_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtMS0xLTEtOTk3MDY_9c56bb08-cfed-4f4e-bc4f-992fc4b7cba1">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48c6b2ef29f5412b953d8ca8ea8e10f2_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtMy0xLTEtOTk3MDY_ff52a448-f10e-45de-b076-124ff4d49fdf">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6276dfcd8f548909ad2b95aec63305f_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtNS0xLTEtOTk3MDY_81aa0e54-9834-49b5-bd5d-07bd318a84fb">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f6c85fe355c406693e3fc90a6900617_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtNy0xLTEtOTk3MDY_cc0c7012-b851-4362-9628-df6cdbea72c6">24</ix:nonFraction></span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the second quarter and first six months of 2022 and 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented within our accompanying unaudited consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued less than <ix:nonFraction unitRef="shares" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzIxOTkwMjMyNTg2Mjg_51b8ba55-fc44-4ede-a258-6f895a442d63">one million</ix:nonFraction> shares of our common stock in the second quarter of 2022, approximately <ix:nonFraction unitRef="shares" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzEwOTk1MTE2MzAxNDY_e335033c-61df-4bc2-9088-dcedbee2d838">four million</ix:nonFraction> shares in the first six months of 2022, approximately <ix:nonFraction unitRef="shares" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzEwOTk1MTE2MzA1MzY_b0a9b292-e094-497e-a9df-28a375c73e3a">one million</ix:nonFraction> shares in the second quarter of 2021, and approximately <ix:nonFraction unitRef="shares" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzEwOTk1MTE2MzA1ODQ_398f1c34-090c-49e1-ab53-b58b2a9eae9b">five million</ix:nonFraction> shares in the first six months of 2021, following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first six months of 2022 or 2021. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="icf7fdde677424e58ac261d8de70f896f_I20201214" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE4ODM_d26a71e5-009b-4a0a-b73d-2ca0f61955c1">1.000</ix:nonFraction> billion of our common stock. As of June&#160;30, 2022, we had the full amount remaining available under the authorization.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90ZXh0cmVnaW9uOjMzZTY0ZjhkZTY2ZDRhZjQ5YTRjOGM3NjNkMTc5MjA0XzE4NzM_3215095a-f5c1-4907-8d22-4cd15330ab1a" continuedAt="i20d91a4d70c2421f96ff886a438e3668" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into <ix:nonFraction unitRef="reportablesegments" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="0" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90ZXh0cmVnaW9uOjMzZTY0ZjhkZTY2ZDRhZjQ5YTRjOGM3NjNkMTc5MjA0XzI3OA_981bdca8-b775-4672-9b72-735470fa455a">two</ix:nonFraction> reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. There was no impact to the reporting units identified for purposes of our annual goodwill impairment testing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and evaluate our reportable segments based on their respective net sales, operating income, excluding intersegment profits, and operating income as a percentage of net sales, all excluding the impact of foreign currency. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations and are included in the reconciliation below. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for net sales by reportable segment presented in accordance with U.S. GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90ZXh0cmVnaW9uOjMzZTY0ZjhkZTY2ZDRhZjQ5YTRjOGM3NjNkMTc5MjA0XzE4NzE_57835c39-0bab-4a63-af4b-771e71a45fef" continuedAt="i4f3370c37d3b465f978bdcaa4daf2640" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages). We have revised prior periods to conform to the current year presentation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtMS0xLTEtOTk3MDY_852ca4bc-2930-4734-b0a9-89e375ce652c">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtMy0xLTEtOTk3MDY_5d705bd1-dff0-4150-8046-609f2b81bec4">1,185</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtNS0xLTEtOTk3MDY_eda7d4ad-e577-48f8-ad0f-65176f6774b2">2,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtNy0xLTEtOTk3MDY_afdbbc18-8c6a-4cb4-ad78-eb2924997360">2,233</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktMS0xLTEtOTk3MDY_af54c506-fbec-4b1e-ac06-f16c523b94c2">2,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktMy0xLTEtOTk3MDY_f130b32d-656c-4f36-803b-b44a72309c7b">1,865</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktNS0xLTEtOTk3MDY_9608e7e5-9311-499b-b504-848212c67af4">3,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktNy0xLTEtOTk3MDY_4a628de0-ad81-4c93-98fb-5d4f3a04fb65">3,526</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed936efbefb4d6883a1c81638adf58d_D20220401-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTEtMS0xLTk5NzA2_f5735ffc-ac77-4eb6-a7cb-459221cf8c43">3,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b181944f869422eaf28616562fd7a82_D20210401-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTMtMS0xLTk5NzA2_36a45c8f-842d-44d6-b035-4c98d7362f07">3,050</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b65bf8163846418605a1c7c4224987_D20220101-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTUtMS0xLTk5NzA2_b82349de-44dc-476f-b6f2-6180e6428f17">6,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6a468432bf4452ae37008655365bb9_D20210101-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTctMS0xLTk5NzA2_b47bfb98-1b90-4651-b87b-99d5d0769c3f">5,758</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525a2094c6934a6485d6adda3f6a9b3a_D20220401-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTEtMS0xLTk5NzA2_54d93221-dfee-4a5e-9eae-551991c33b66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cfee3824c314f15a3cc0a778059755c_D20210401-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTMtMS0xLTk5NzA2_168ac8f7-f44a-47b9-bf79-d55aab95c8dd">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029f075c73314285a73d6046fc56ace1_D20220101-20220630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTUtMS0xLTk5NzA2_eb7192ac-825f-483c-b2ad-23a47a51b3a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71339696da74c3c8be300118987e2a8_D20210101-20210630" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTctMS0xLTk5NzA2_23837b06-3a32-4e05-89ee-20f4a3b1aa35">13</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" sign="-" name="bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTEtMS0xLTk5NzA2_9904c4cb-1aa6-4d34-bf83-a65f30633912">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTMtMS0xLTk5NzA2_db5f5f33-58af-4509-beaf-9af4b3ce2e77">27</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTUtMS0xLTk5NzA2_12ef8b9d-2e92-479d-9c05-d18cfc47d871">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTctMS0xLTk5NzA2_466a6b92-2f13-44c6-a41a-ffd184a8939f">58</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTEtMS0xLTk5NzA2_ce9c8899-ef4a-4d6b-b547-b59dbecfb039">3,244</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTMtMS0xLTk5NzA2_d5cc3f5b-3917-41f8-bdcb-e9384651b15e">3,077</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTUtMS0xLTk5NzA2_cad737e2-f5d0-4ccb-84b3-2cc133b53d95">6,270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTctMS0xLTk5NzA2_ee16ceff-90f4-4631-89aa-cb58ef6307c8">5,829</ix:nonFraction></span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItMS0xLTEtOTk3MDY_3c65e80a-8904-405c-b8c4-9dc33b6f6429">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItMy0xLTEtOTk3MDY_3fdb1315-2304-4848-85a2-0f58c6f06df4">403</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItNS0xLTEtOTk3MDY_c30eaf3a-b102-43b4-81ee-40286335a8a4">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItNy0xLTEtOTk3MDY_e15f2c2e-47e8-44a6-9bf8-da247648a835">748</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtMS0xLTEtOTk3MDY_fa61d55c-8c5e-46cc-a695-d56052aa01a0">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtMy0xLTEtOTk3MDY_4f23d573-694f-4416-b150-7294f698184d">529</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtNS0xLTEtOTk3MDY_4e70298c-4c32-4e83-8db3-a832ac7b5df7">1,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtNy0xLTEtOTk3MDY_dcb0d83e-96f8-443a-be11-239935f95504">989</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51540ac012634339a60c076ab917ca1b_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtMS0xLTEtOTk3MDY_1655f509-a3be-4ded-9035-2754a15517fc">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06aeb53ebd2a4b1e99e14da58b780ce5_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtMy0xLTEtOTk3MDY_e0d59f23-0a90-425a-80c2-143984d5c239">932</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff0c73d214b4802aa383f6e6d6fb43a_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtNS0xLTEtOTk3MDY_ea01c355-7758-4df8-8122-bf0a90d7f5ad">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01387391808f459ca10145d370775508_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtNy0xLTEtOTk3MDY_334ecb21-ab66-4c73-ab03-43fa3e59e064">1,736</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a26c50603134586aeac79e838ea999a_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtMS0xLTEtOTk3MDY_b8862eeb-c69b-4352-85d9-697b1b4dc050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbab2482ba9049fa8035d7fda68e3e46_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtMy0xLTEtOTk3MDY_6a9125e9-4d10-49b3-9958-9be775d70886">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ff4cf4706044822b1d8fdff41caeeef_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtNS0xLTEtOTk3MDY_796e761f-3c5f-47bd-9eab-3c55e814add7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab3d8ec398548efb4eb940722d1321b_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtNy0xLTEtOTk3MDY_d3410dff-9f2e-48fd-8eec-ce294564d351">4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24181bede48642979bf2659f8d3aca26_D20220401-20220630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctMS0xLTEtOTk3MDY_445fcd54-d598-4318-8c98-ea93524e343c">123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i097b7bc5ad3e49d090a6fd4a3a2eac38_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctMy0xLTEtOTk3MDY_1b7fda40-f988-4602-8566-d2b878f45b4c">159</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a609ec70434875bcd818a22223603c_D20220101-20220630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctNS0xLTEtOTk3MDY_349baa08-b6e6-4424-b70e-b43342c32aba">189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad37ab5761724dd0bbe10d6aae7e351f_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctNy0xLTEtOTk3MDY_2eb1c6da-cc4a-4ea7-8943-403a6288a879">298</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2acd2e07b1e341d4826054cff9f227ae_D20220401-20220630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtMS0xLTEtOTk3MDY_e7f209e8-7bf7-48c7-8c46-1bab01995124">192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib74ccd408f0b4969918ea713b800279e_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtMy0xLTEtOTk3MDY_170807d9-9702-455f-9177-e71af716bdb0">331</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08dfea82b704fd2833f1be5b210aca1_D20220101-20220630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtNS0xLTEtOTk3MDY_6447706a-053f-485d-8e1b-a0cee877244e">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62067935217749dda69756e659e18d90_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtNy0xLTEtOTk3MDY_ff114074-8aa2-40cb-835f-2c059774e3ec">445</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktMS0xLTEtOTk3MDY_20adc693-cc40-4fd4-8bd8-ad7e3111ffca">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktMy0xLTEtOTk3MDY_f9ed7cb4-76cb-492c-82df-e9df3198cea2">180</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktNS0xLTEtOTk3MDY_082d5c01-01fd-401c-bb24-91b6ac170c31">402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktNy0xLTEtOTk3MDY_b010d41a-a5e9-4ed9-ae8c-ee20cf265ddf">365</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTEtMS0xLTk5NzA2_21db0166-a8bb-4b7b-98e9-7ee6c110dde4">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTMtMS0xLTk5NzA2_4d103d36-351a-447c-954e-555f681d9177">262</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTUtMS0xLTk5NzA2_04e0d3c6-aedf-4fd5-9b42-d3d5abe33206">889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTctMS0xLTk5NzA2_2aa03a86-2644-4d33-963f-d992fc2925a5">632</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTEtMS0xLTk5NzA2_e425340d-3819-42bb-b497-341af0793e82">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTMtMS0xLTk5NzA2_738250e9-7a6f-4210-8d9a-7fe1688a1120">113</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTUtMS0xLTk5NzA2_efb9619a-23ef-4fdc-a1e7-d85cf46c5532">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTctMS0xLTk5NzA2_8f59bf07-35d7-45cf-b15a-71d3f3e6bef3">157</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTEtMS0xLTk5NzA2_144dbcaf-b990-482d-8743-b4c1397bf382">345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTMtMS0xLTk5NzA2_5ffd20ef-2a5b-4b39-b8fa-62d4be57b852">149</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTUtMS0xLTEwMTQzNQ_fca182b6-5f21-4051-9f98-084403303615">501</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTctMS0xLTEwMTQzNQ_14b9b43c-7323-4fce-b686-3d3f8b5e4b3c">474</ix:nonFraction></span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Prior to the divestiture, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.</span></div></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><ix:continuation id="i20d91a4d70c2421f96ff886a438e3668"><ix:continuation id="i4f3370c37d3b465f978bdcaa4daf2640"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItMS0xLTEtOTk3MDY_348a8a87-53e2-40cb-be0a-b515236ee973">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItMy0xLTEtOTk3MDY_58c37614-19c5-4ed7-ac2d-0237f067b5f3">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItNS0xLTEtMTAxNTMy_9adceee8-86d6-4c9c-808d-df9ff8131570">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItNy0xLTEtMTAxNTMy_28b942c9-6d76-4b14-a487-32d8808906cb">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtMS0xLTEtOTk3MDY_8823ed3a-7e0b-42ba-a75a-b552eb667dfd">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtMy0xLTEtOTk3MDY_9679077f-d43f-4b38-a0c8-532948c2d089">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtNS0xLTEtMTAxNTMy_5b21a91f-ff2a-4234-8187-6afdfb0be12a">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtNy0xLTEtMTAxNTMy_2c26b29a-dfd9-4f49-8899-6a18d090dce1">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></ix:continuation></div><div id="i81ec8629b9df431d9ba97fad2f676991_112"></div><div><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzI2MTc_ee14508f-bca7-4f89-8b47-ab5df9aef459" continuedAt="i81b5ef274a0a455c8d0c1de429486d32" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes within our accompanying unaudited consolidated statements of operations. In the first quarter of 2022, we reorganized our business structure into <ix:nonFraction unitRef="business" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:NumberOfBusinesses" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzIwOQ_28c1fdae-0588-4711-89fe-00940d9d6e20">five</ix:nonFraction> operating segments and on March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction. <ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzI2MTM_d4efd308-88b6-41ea-8559-13be89994059" continuedAt="i6bfa0f0a694e4fa0bdebc19dab91e7b8" escape="true">The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We have revised prior periods to conform to current year presentation:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i6bfa0f0a694e4fa0bdebc19dab91e7b8" continuedAt="i8d1bc9a279ae40e4b77c6ea4ed40889d"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9aaa5a5ca5f4e1f9301c01ec21b59e4_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtMS0xLTEtOTk3MDY_6a56db24-32b9-43cd-83e9-aa279b600b27">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife3a11266e3d4321956fbc6d063b8a10_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtMy0xLTEtOTk3MDY_d6cf63f3-816b-4313-8d3d-272afd51824c">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bf87505d2e4df7a780b78429497619_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtNS0xLTEtOTk3MDY_3f6c6b73-cbd6-484f-93ca-84572adff279">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie096244a71f845ca9eb0386aa8bcb3df_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtNy0xLTEtOTk3MDY_b3ba71d4-0f0e-474a-b71a-5b08a79436f1">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b76bd80819b4615aeb5e962c486399a_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtOS0xLTEtOTk3MDY_bd19fd15-7d6d-4772-9a98-72ed39cc181b">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad59d435c194a23bb052a2504b3a319_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtMTEtMS0xLTk5NzA2_b3630799-2e78-45af-9b99-8718c8343cce">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415f872bf2c24ddfb98d985defe44440_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtMS0xLTEtOTk3MDY_0128ee9c-b5b7-4883-9317-f550c9d1c46f">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56bd4269832542bbba47c90663ce137a_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtMy0xLTEtOTk3MDY_36fbb44c-03b7-491f-9bb1-e1000e41fdfb">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47af1619791b4510b83d7d9ec10d1f42_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtNS0xLTEtOTk3MDY_fffc2274-11f1-4b6a-b744-cc948f5e25df">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11f711ef34d649a2b44fa21f66871d34_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtNy0xLTEtOTk3MDY_bbcc940d-a4ef-4e84-823a-2df0bf5e7802">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14c2530827644ac893d5a38b3b01e88_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtOS0xLTEtOTk3MDY_a9ae0e66-c6b5-4d39-b467-9640261b5793">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9768fb32a294fe1a98e46c54fb002fc_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtMTEtMS0xLTk5NzA2_7d0cfdfa-b7fd-427f-8740-6adb7f31eae2">397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd92fc770d74050ae6bc234223e19d9_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtMS0xLTEtOTk3MDY_b26aab10-8b28-43e9-88d1-7aaf46758bc0">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89fa19fb7d0473489935cee03e984eb_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtMy0xLTEtOTk3MDY_f9f5818b-f3bd-4bf3-96ab-44bb400e887b">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67775ec6a0934c30bf8aad1e7f6a0b6e_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtNS0xLTEtOTk3MDY_76edc111-4165-4d9b-bcfe-7e435a3d8908">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd09fe7de65f43ac93174dff385f04f6_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtNy0xLTEtOTk3MDY_44ce2e5d-b3e7-4504-85cc-36ddf5449b70">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb15f66e0dd4ad0898c5b50246fc5c7_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtOS0xLTEtOTk3MDY_af72aeb6-d08f-42d4-be97-d9acc328134d">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc56c808748d4532afd8021abe0fbcba_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtMTEtMS0xLTk5NzA2_709f3970-332a-449a-827a-dae150fbe629">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c8f3f10502c4f71ba2b31433a377b1e_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtMS0xLTEtOTk3MDY_c6b59b94-3788-4a26-8a13-172a640ea2df">844</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36124ada3c8c43858ecb9286e86c2606_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtMy0xLTEtOTk3MDY_a24fab8e-fb1f-441e-8339-39db7ebfd325">404</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtNS0xLTEtOTk3MDY_df10db0f-ef07-438a-9982-1b334d6def6b">1,248</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fcfa3282cb148bbb748113d9528f7d4_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtNy0xLTEtOTk3MDY_db7b590c-eabc-4340-8be3-84d683eb2fdd">794</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761eb0a00d5444d5bf6bd2da5be27e90_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtOS0xLTEtOTk3MDY_6c6d5d82-6c46-4838-9c1a-c562af03c63c">400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtMTEtMS0xLTk5NzA2_1018c68b-69e4-425d-a150-439e936ef7ff">1,195</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7433a0c7505464f961708a119d005b0_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctMS0xLTEtOTk3MDY_ddc6e296-7318-4afd-89eb-e364ab547d92">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cdfe346e87b4744ae0e10651fe6a828_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctMy0xLTEtOTk3MDY_66e5744f-70b9-43b1-a1bf-97c2ff72c4df">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabb00784efe74f8eba9e037108ad5aed_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctNS0xLTEtOTk3MDY_a5a647c9-b9d4-4d0b-8148-bd339ff94291">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2165365374154b58bb3c0a37d075e600_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctNy0xLTEtOTk3MDY_e5296d59-38ea-47c8-b79c-b15a1f775de5">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9984e82eade4f2da3d2886469fb33b5_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctOS0xLTEtOTk3MDY_54ab7928-7843-481c-bec3-8293d5af1f1c">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81be0345e72e40c38e9b1ec204739080_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctMTEtMS0xLTk5NzA2_6b7fe090-80b4-4a0c-aa03-9e3195829331">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifddfedd7174745d6aa132760e4e7d5f7_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtMS0xLTEtOTk3MDY_e99565c2-f4ae-4a54-9976-74fa93e02b72">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99797b8a0ac14a2683275123479db9e2_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtMy0xLTEtOTk3MDY_81ffaba7-4567-43c3-adf2-d15a57bf673b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17b5b0c3eef43dbb88f6d84614f82fc_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtNS0xLTEtOTk3MDY_7b7777c3-0a5f-4ea8-87c2-180279f4603c">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ff310abb0c46ea842c1b5f2e101e06_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtNy0xLTEtOTk3MDY_3620117f-2e20-4412-bc9b-f120769260af">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec55fa860e274f43bd665e1c527396ce_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtOS0xLTEtOTk3MDY_818f7732-f83a-4f87-aa77-bc981312392a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f0fc8326c54d22b47c92fcf1404dac_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtMTEtMS0xLTk5NzA2_ed10f03d-51a9-4e6d-bc67-4907c2cdebcb">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcbe244161b44d08e2fb019d7190d8f_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktMS0xLTEtOTk3MDY_c9cb7807-f43b-414d-b931-570243107e4e">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e17753aeed403cb6eb068b78c4172e_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktMy0xLTEtOTk3MDY_030c4baf-89ed-4842-8670-6f1130de226e">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162fa62a834d4024853d19c92f7d6803_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktNS0xLTEtOTk3MDY_2de9059a-fb68-4126-9314-2068c9742d95">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibefe540c865646ed9b0550380e6694dd_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktNy0xLTEtOTk3MDY_c1eda30b-f97a-4d53-a1f1-d246cf1b35c4">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c88d81fbc054204b7dcb69d35b1ef8b_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktOS0xLTEtOTk3MDY_b69cdaff-57bf-4672-b7e9-78056bcdca89">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67f6d5f8c204080bdcf3a8e11fae3eb_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktMTEtMS0xLTk5NzA2_a20029de-18f5-409b-a725-3b08d7beef25">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0862174ab84b5880a7a5c5cf80931d_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTEtMS0xLTk5NzA2_8fe6feb0-c08b-4cdd-9ffb-797a98eda551">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d0fb3e4bf949b28e24977c79ce55f1_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTMtMS0xLTk5NzA2_cf88eec0-9e1e-4d9f-87f2-09165cd87296">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib647bd82c32d48dcab841641a70e3f4e_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTUtMS0xLTk5NzA2_af371bc9-7991-4d9d-93b5-c4280e4d311d">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0d47bcaff1842cb93b282563df9bd3d_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTctMS0xLTk5NzA2_1325efbb-6670-42e7-b962-9e184837d4fa">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4d52a894b84bd585ff1aaee9ca68ed_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTktMS0xLTk5NzA2_6cb16e49-fee8-4af1-8af1-9df7db1539ad">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717d79b707704b4a980799d216fbe641_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTExLTEtMS05OTcwNg_34ffb493-0a12-4cb4-a3f5-8ee8f50338c2">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4179fffe78ef47a98f15ff8bc5762603_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTEtMS0xLTk5NzA2_9af0ed03-e18e-41ce-8259-773fe3f0c9d9">832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0850efa38229479ea51013e0c6bd5ea4_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTMtMS0xLTk5NzA2_7083dca1-a321-45d1-a9cc-77d39203c4ea">685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82bb612d582148409a856cd8d6ce1da9_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTUtMS0xLTk5NzA2_06bc1ca7-e964-4a94-98f3-634ec76d49bc">1,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68f1e5b68bbf468ba366d5f07ad381b3_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTctMS0xLTk5NzA2_12531966-b01b-4d6c-ad98-9b3658dc233b">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a332d62f2234fb896c3d81a7d7067ae_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTktMS0xLTk5NzA2_9326db45-c216-47da-bf45-aff37f8f931a">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59461725015b4ab0a58f6b01f477955e_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTExLTEtMS05OTcwNg_eeae9d57-7b59-4094-a3a4-b9c3762451f1">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i042f5fcfd216400fb83d5b60c989ea25_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTEtMS0xLTk5NzA2_890b2085-facb-4406-bfff-1375c1a5760c">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9c75133f8543928b4807ac698a3f26_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTMtMS0xLTk5NzA2_aad3c2d8-86d6-45dc-877a-28ec4a174694">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia26a0d345a5a449683f9b0d89f1bb0a2_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTUtMS0xLTk5NzA2_c540339c-7685-4626-ad44-6179980560c8">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb908941b01946c392c481a9232193d7_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTctMS0xLTk5NzA2_074e3bef-19b1-49d2-afc1-326e963a5e0c">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i270e1d01244f4fd1b70234c80e9c0a94_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTktMS0xLTk5NzA2_b0db61ef-357e-4ecc-8b59-1481ec27d74b">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abd801e946448e39c75bab8c1af730a_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTExLTEtMS05OTcwNg_0db30992-c61e-45bf-b9c0-408108e7f5e5">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9bd5d80ec5b456092ac8652192da3ec_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTEtMS0xLTk5NzA2_9b22cf30-2da6-437d-8cb8-405be169cd5c">1,089</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e48cde1c09741fbbba8a76eba96c309_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTMtMS0xLTk5NzA2_03f769b3-47da-4345-a8ff-11775e556e86">906</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTUtMS0xLTk5NzA2_7f883539-ce1c-4e00-9b48-a3f37c336405">1,996</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ec43cabba41aaaaef1e9bb6739bbb_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTctMS0xLTk5NzA2_93c60f2d-4468-4901-bd63-2fd1aa7db9db">1,005</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b6db5791ed44ccb0478df69ce8783d_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTktMS0xLTk5NzA2_5479f024-9e65-4f58-a6eb-5d9241a0d6ed">877</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTExLTEtMS05OTcwNg_f9adb63b-32cc-4945-888e-92f4bab9d150">1,883</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifded57350dbc45cd90ffe08f24872546_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTEtMS0xLTk5NzA2_bc6c4a95-e211-465e-ae00-6ef2b356e2e8">1,933</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfbf4ba247a4bd986d605da59f36b2a_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTMtMS0xLTk5NzA2_26a55461-a581-4d0e-9419-1fccb3062a83">1,311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTUtMS0xLTk5NzA2_4ab8d7f6-79dc-4f36-94db-cb12b549c105">3,244</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf55369f4514daa8887c854a382c1e1_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTctMS0xLTk5NzA2_b835d235-fc6e-4ea2-8394-35caf4d6ad03">1,800</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99703b37b0ba48548c020a30c6b767e1_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTktMS0xLTk5NzA2_664acec5-d7d1-45de-9732-675fbef79804">1,277</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTExLTEtMS05OTcwNg_efdd5f43-e93a-41e5-9bd6-c5346d5dc6a0">3,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2e0b3398bd4e9089a8388936799f46_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtMS0xLTEtMTAxMTQ5_b279ecb2-603e-4646-8cb1-ecfc57d5a4de">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6f04a66de74745848be0c25b2101eb_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtMy0xLTEtMTAxMTQ5_a6832ee0-6268-4771-8fb0-e0abec912527">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9374eeb03f4c75a38fbf4295d7ffce_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtNS0xLTEtMTAxMTQ5_ef51314a-d14b-438f-a2f6-c9c7ca9698ba">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc10c58865a4ff49ce0aa5218fd4974_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtNy0xLTEtMTAxMTQ5_86dfe72d-580a-47bf-a3a2-5deb8f9b6dbe">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdb29df4e854a19ae8ac360d53a3ea3_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtOS0xLTEtMTAxMTQ5_7791c4c0-ed93-43a6-87d0-0fdb1f2ef1c9">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da71fc4bd38481295e9d4de2b991770_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtMTEtMS0xLTEwMTE0OQ_ea16d1a1-ce20-43e9-889b-966ccd3b2173">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8a6d03a20a4949b1bf505a8eedd6e7_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtMS0xLTEtMTAxMTQ5_5a205b03-c0e3-4cdf-987f-90592fea2ad9">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4415458b8949d9b372a41950b1d1c3_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtMy0xLTEtMTAxMTQ5_7d9db31c-7148-4a4a-a35d-966ccd4fca49">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d0be2afe1f471a8619be6368d23738_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtNS0xLTEtMTAxMTQ5_46602c08-1224-4199-8f1e-c5da63e356a0">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ece9f53176241d1bddc8b97e5dcef4e_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtNy0xLTEtMTAxMTQ5_ce87a051-4df8-4d2c-a0d0-95e0e75a7b41">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e38e69dadc14904ae3f0b4e977669e6_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtOS0xLTEtMTAxMTQ5_908e9315-568b-4fc9-86c0-59be32ea5472">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic077b66564b344bebb50e1be764ab9f0_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtMTEtMS0xLTEwMTE0OQ_dbbf8402-fa85-44c3-ab66-14a5a533f898">758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376c6e7abe2e42cabecb0d501e815677_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtMS0xLTEtMTAxMTQ5_14f87661-eb3a-4946-8d89-e629d35636bb">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2643d6f56a40465881ef187eb4469dcd_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtMy0xLTEtMTAxMTQ5_faf4db86-569b-4f93-84c7-49ef467fd752">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8750752709c49678ab5476ee86964b1_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtNS0xLTEtMTAxMTQ5_b90598f3-ccaf-4573-9953-296541067690">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d74776bb9b34e2cb0202a6760a54d00_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtNy0xLTEtMTAxMTQ5_96ded638-ebdd-48c9-961c-6b3e18787534">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e873293fe6f418abbda4c5513c16be8_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtOS0xLTEtMTAxMTQ5_7c5f4bce-184f-47f4-8e6a-ccdd064a773c">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5db3e942a74cbbaecb06454183c1eb_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtMTEtMS0xLTEwMTE0OQ_377af248-65fe-4c58-883b-bfb70dbdddd0">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia531b4492dd040f3a0690a15663e829e_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMS0xLTEtMTAxNjk5_f98cc6ff-c43d-414e-865f-0ad203dcd776">1,602</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8df47fefeb74301add15e147b70ea9e_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMy0xLTEtMTAxNzIw_4c650c8a-0169-432c-b23a-b77c3b8247f5">799</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNS0xLTEtMTAxOTY3_5e5de6d3-d957-4b31-89a0-e8a3bf44f18d">2,402</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i641e5a7630d44a29abf0929b9ecbef09_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNy0xLTEtMTAxNjc2_923505c9-1588-4998-8a5c-f291a7ccd86f">1,483</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6269d280022f444da4365044dfebd1d0_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtOS0xLTEtMTAxNzI3_584301ec-823f-4512-90cd-323b218a001f">769</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMTEtMS0xLTEwMTk2NA_a3934b9a-e7c9-4fc1-b85b-0b6fa2a3225c">2,252</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb6cd854f654144ad897e7e04aeb62b_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMS0xLTEtMTAxMTQ5_02e086fa-2155-43a6-a1fb-f045238ffb3b">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9d62ca9859478bbe137b00bb8bb81c_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMy0xLTEtMTAxMTQ5_29d80dcc-72ba-4f14-bef9-9e4d03e8b499">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e27a21a2c6948ca8b4f0ed8a4c7ef45_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNS0xLTEtMTAxMTQ5_425d92d8-89e3-4066-8f51-f31538497930">1,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a9247c0e4f45168242ed303b39c984_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNy0xLTEtMTAxMTQ5_6bfddac6-7878-4747-8199-df35db266781">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf11f4ecaa9458bab1012646612725f_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtOS0xLTEtMTAxMTQ5_e4fc41b5-e3c3-4506-91bb-095721f6c694">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5f14f850024bdebc7d74e786cc46f5_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMTEtMS0xLTEwMTE0OQ_725e56fb-2436-49f6-9f82-f58915535ab4">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d03048f54a432b95f83d107f210120_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctMS0xLTEtMTAxMTQ5_7df3bfc4-94c8-4e54-8586-4205a14dc371">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia045a31057fb468287b2baf2b245589a_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctMy0xLTEtMTAxMTQ5_e25513e0-8951-466e-8ae5-9477b26db0a5">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d9db0e99274141bc4e13555d17f9cb_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctNS0xLTEtMTAxMTQ5_1f14c296-4886-4c69-9c98-f8c40383bf3c">476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb18f5e6c0e247a1b6a690cad0c427ef_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctNy0xLTEtMTAxMTQ5_e3fe9fcf-ebe6-45e7-b9c0-f00dadf46249">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b165acafefe40209f5b6aabf02a3eba_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctOS0xLTEtMTAxMTQ5_e3260152-8b9e-4c09-911e-a40f70b9ad56">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58a24ee4843a4c589a865ad63ca56d2a_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctMTEtMS0xLTEwMTE0OQ_e8e6a226-31e2-4ac8-a9de-9f501e59afa4">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af6c9e0567f4219812341c9ab0f8940_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtMS0xLTEtMTAxMTQ5_d5136167-c4a5-42f1-ae13-46c73e1c5c7c">667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983f6a62e8b44a20bd0879dcc23a0b33_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtMy0xLTEtMTAxMTQ5_ef831455-f612-4937-b954-57c29dd1b66a">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad62834ae44945f2a01034ea56d06a2e_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtNS0xLTEtMTAxMTQ5_9abbf399-c3e7-48f2-81b0-4542f8de9ec1">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8940d222b9412497da6820d116c5db_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtNy0xLTEtMTAxMTQ5_f6a909b2-df3e-4f49-8c11-ba944650cb26">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id893e6f844384001b614fa60554e39a0_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtOS0xLTEtMTAxMTQ5_567b764f-c930-43ae-9d73-d98cd13effb4">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2e80e247a6c4d63b59a373ccd6a4547_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtMTEtMS0xLTEwMTE0OQ_23f67407-decc-4947-8dfb-0a5fa098261a">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d23ca3116f74ae08667619cf99610b1_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktMS0xLTEtMTAxMTQ5_8246cdc4-62e7-490f-8d86-0066422b6210">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31a87cc275df4c02827aeae66b3db474_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktMy0xLTEtMTAxMTQ5_324e30de-2d0d-4a4e-bd54-494ada31e512">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc114ba40df543a494974546b8688cda_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktNS0xLTEtMTAxMTQ5_540eed21-3cc6-4b69-9410-6bfe364928cf">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996ce945e0ea47dc9b384cfd1a7cbb4d_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktNy0xLTEtMTAxMTQ5_d0652386-59a0-4610-8a02-259e431c9e51">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee4a0405fcc46768dd9df2f2ee25d9a_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktOS0xLTEtMTAxMTQ5_dd4972e9-66ac-402e-a7ec-854f497c2f33">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576cdae0729b4f15904cf440be39a5dc_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktMTEtMS0xLTEwMTE0OQ_2fe2e24c-e24e-40e8-bf38-7966276891ed">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2ffb4bccd6473cbf1edf6b51561e8b_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTEtMS0xLTEwMTE0OQ_b84fa568-9622-4718-bdc0-e36ce3e4e754">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16fa28ceec55463fb802e656bce05d72_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTMtMS0xLTEwMTE0OQ_3dbb51ab-70f0-4f1a-896a-6214e4622052">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b995e2611d498b87e589132f982b29_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTUtMS0xLTEwMTE0OQ_0a36678b-be07-4467-9696-21d0fdd6b629">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb96738c2284048800a1132782bf2bb_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTctMS0xLTEwMTE0OQ_2c3c4aac-ee10-4b21-a134-3d123a188640">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dcfd0caac50408a9d88c51b81a20b7c_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTktMS0xLTEwMTE0OQ_2a600ad1-5170-4fb5-9684-0d2f07ba7521">1,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80b1eedfabd457080936ffd53512c5f_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTExLTEtMS0xMDExNDk_4467702d-719e-443d-8917-9149efa6fde5">2,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6c5221cbb284081a999df868d95ab10_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTEtMS0xLTEwMTE0OQ_6ab28e86-a0d0-45a0-ba50-ee9784ce64d8">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c19828588024500887d5d62d92864cd_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTMtMS0xLTEwMTE0OQ_50eb02ff-0d58-43e3-a7b8-31d2d08e5c07">430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea6a8cb2f274f1cae8b176f73989975_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTUtMS0xLTEwMTE0OQ_2e815571-52ca-4b4c-8f1f-f77a1128ae7f">944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac6b29cb0bd643ea830c23024f6f122c_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTctMS0xLTEwMTE0OQ_ce97125f-9423-43ab-b482-bbf01eeb2aed">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c0a9db1c8e4014b2df4e46dd5de46d_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTktMS0xLTEwMTE0OQ_ba47bb4a-41d2-4e64-a5da-98ff4e05fac4">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71761ebafaa4d329453f22bab510d1a_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTExLTEtMS0xMDExNDk_ba722a52-ee1e-4175-adc3-6d90ba20080e">906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353a9c38bf404c4b8bc5520b92a5b9c8_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTEtMS0xLTEwMTY5MA_487c594e-fc95-49e4-a252-4e0ba1dd2788">2,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251b6cd8103d489a9a3ad606f5d9de1e_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTMtMS0xLTEwMTcxMw_cc96bc5c-2b90-4130-88b5-ceb02e90c53a">1,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTUtMS0xLTEwMTk3MA_3882166a-f444-4ced-815a-ffb6b42ab170">3,868</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11f0a8ff4d240c69c1c5b12228bb893_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTctMS0xLTEwMTY2OA_6e028354-4e1d-4a56-9bb1-72d98424f013">1,893</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic50fcbfa6940498f8cf9056629ab9c88_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTktMS0xLTEwMTcwNg_4716ff85-9fa2-4328-a742-a0ddce4b57cc">1,670</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTExLTEtMS0xMDE5NTE_c75476db-ca18-4074-956d-51d5c4d96fd6">3,564</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ad83b783c274c09bcf887c0897c360a_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTEtMS0xLTEwMTg4NA_a6365e73-ad22-49d1-82b6-da43367e5733">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1a058ee7ff4842a9dd996eaadeab8f_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTMtMS0xLTEwMTg4Nw_70a2d1ef-bea9-4399-afc9-eb0af9888e6b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029f075c73314285a73d6046fc56ace1_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTUtMS0xLTEwMTg5MA_b82e90c8-2257-428a-9633-2d1604b721c0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d14bc6cd205427587873034553c97bf_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTctMS0xLTEwMTg1MQ_12874974-242b-4a9d-a9ee-d8ceb91501a5">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c7a5b47c514f479f5321f0ab2663f4_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTktMS0xLTEwMTg2MA_cf7888e7-0f43-4c2d-b9d1-c88795bd97ba">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71339696da74c3c8be300118987e2a8_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTExLTEtMS0xMDE4NzM_e0e42cd1-63a1-41df-a114-36943802ec31">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib077df6e7685413397c816d1f7399061_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTEtMS0xLTEwMTMwNg_77d4a1db-9659-47c5-acff-1a496144378a">3,711</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c63c604879341609359afebf06b84fb_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTMtMS0xLTEwMTMwNg_3182c3d7-a5be-44ed-9b96-4f83284c1dc1">2,559</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTUtMS0xLTEwMTMwNg_c25c9035-12f4-4a0e-bbae-4ab18522c5f5">6,270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4f0985ad1740deba3b810eecdeeafe_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTctMS0xLTEwMTMwNg_5f69f77a-d855-47af-bbba-655540bc931f">3,386</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d6871b5efa47e089e55373103fc46a_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTktMS0xLTEwMTMwNg_aaf9381d-cb36-4dc6-95c6-d6bd730ef23e">2,443</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTExLTEtMS0xMDEzMDY_a09cb318-e7ec-4c6c-9474-a6db909a0ce1">5,829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note K- Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for information on our reportable segments.</span></div></ix:continuation></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i81b5ef274a0a455c8d0c1de429486d32" continuedAt="i59355054c88e4db380598f216f29d146"><ix:continuation id="i8d1bc9a279ae40e4b77c6ea4ed40889d"><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56409fbd56bf4a44914cd2c8465f7903_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItMS0xLTEtOTk3MDY_975df327-b110-4359-bc88-efa1c0b6993f">1,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a20447358346669ee315fe67d484ef_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItMy0xLTEtOTk3MDY_a4e8101f-178c-443b-8eb5-969583cd6af2">1,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44122c777f7d4e659c894fab8bfe0463_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItNS0xLTEtOTk3MDY_6f87a953-1061-48cc-b0d2-dd95fb1f2905">3,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b571919e0954c0998434728e8377c58_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItNy0xLTEtOTk3MDY_881bb0c8-9117-41b2-89de-373670122508">3,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d01db59981d45bab53856f63a5438ae_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtMS0xLTEtOTk3MDY_f653b016-64f2-4fa5-964b-d28bca6e37a6">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b175c8d6f949ae9aa8ce0c709a1945_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtMy0xLTEtOTk3MDY_a4f1e18c-d6e2-4c4d-8244-cd8a4f66c0d9">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804e2fb842734bbbb84a1af373c0f50b_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtNS0xLTEtOTk3MDY_49006b76-18ba-4602-a295-027c61112e96">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c70b969bbd496a8d242a26de3a03b1_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtNy0xLTEtOTk3MDY_ae59f29f-2092-4f1a-b60b-89d10bc3c688">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10cf842a669546239f5adb70a68f5d12_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtMS0xLTEtOTk3MDY_14bdcb80-76d1-4908-a048-1ead3f17b50b">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96c8adaf4f394f7bbe3dbe88b56bf82f_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtMy0xLTEtOTk3MDY_78e77be2-d763-48d4-a22e-6acc36a46f11">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ad17ca3dd24c48ad06fb834dcfe750_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtNS0xLTEtOTk3MDY_c42181ac-6cce-449d-8e7e-cd7470f92f70">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cd2c0e0d24475aa93ac3069d5a1401_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtNy0xLTEtOTk3MDY_1a91ef44-febc-4e0d-8a6e-de477799ccc4">994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb7facade49428fb1d9af329e51a7cc_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtMS0xLTEtOTk3MDY_b32c9807-d48e-4dbe-b0af-3e5776992c6a">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i981f627a420a466797e7c582e56d78d7_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtMy0xLTEtOTk3MDY_65cf4db8-96bd-4f25-bb58-4a9def42a70c">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i637a3831852e44fc9d35643a000aa777_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtNS0xLTEtOTk3MDY_2e904e30-53ad-4406-8d19-15b9b93cfee4">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5433550a40439c899d6f89ee694767_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtNy0xLTEtOTk3MDY_cf5e18d8-7c82-47d3-88cd-a296a9597664">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed936efbefb4d6883a1c81638adf58d_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtMS0xLTEtOTk3MDY_4c9b46fc-4b74-4ac0-8728-96d9a714ab92">3,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b181944f869422eaf28616562fd7a82_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtMy0xLTEtOTk3MDY_ed24c651-000f-44e5-8f3f-b04cdeb8e9dc">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b65bf8163846418605a1c7c4224987_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtNS0xLTEtMTAxMjY5_77889dbc-06e8-47ff-91af-80273daae48b">6,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6a468432bf4452ae37008655365bb9_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtNy0xLTEtMTAxMjYy_821fecde-5c62-4ddf-b8e8-0c73eb112772">5,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41aab6c00bda4f86820878b7c6774c9e_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctMS0xLTEtOTk3MDY_b4c74bd1-4c60-4beb-9062-a5d361e8dd27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie16d4e79dbaa470fbcb924d46c0c79ad_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctMy0xLTEtOTk3MDY_2728146d-a395-435f-acd6-0ea3702938a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ad83b783c274c09bcf887c0897c360a_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctNS0xLTEtOTk3MDY_a6365e73-ad22-49d1-82b6-da43367e5733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d14bc6cd205427587873034553c97bf_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctNy0xLTEtOTk3MDY_12874974-242b-4a9d-a9ee-d8ceb91501a5">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5536294b9c422399ae5dc27f304dc9_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtMS0xLTEtOTk3MDY_6e1c9673-362b-47fd-b3b6-a71e1b8e2040">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccea46e8c094031bc29d50afc2fb0a7_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtMy0xLTEtOTk3MDY_50023029-0bb3-4181-894c-5359ff6993c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1a058ee7ff4842a9dd996eaadeab8f_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtNS0xLTEtOTk3MDY_70a2d1ef-bea9-4399-afc9-eb0af9888e6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c7a5b47c514f479f5321f0ab2663f4_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtNy0xLTEtOTk3MDY_cf7888e7-0f43-4c2d-b9d1-c88795bd97ba">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525a2094c6934a6485d6adda3f6a9b3a_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktMS0xLTEtOTk3MDY_d88562e4-6709-489c-a3b0-9b4c17a27799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cfee3824c314f15a3cc0a778059755c_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktMy0xLTEtOTk3MDY_598a9a4a-9f59-43ff-92d0-df6dfa04491c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029f075c73314285a73d6046fc56ace1_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktNS0xLTEtOTk3MDY_ca5b20be-67e9-4a56-9882-8a25c6e50a1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71339696da74c3c8be300118987e2a8_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktNy0xLTEtOTk3MDY_e0e42cd1-63a1-41df-a114-36943802ec31">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTEtMS0xLTk5NzA2_4ab8d7f6-79dc-4f36-94db-cb12b549c105">3,244</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTMtMS0xLTk5NzA2_0bc6d3b7-e7a6-4259-b4b0-f47255190ed1">3,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTUtMS0xLTk5NzA2_88584c53-564d-46d3-9ffb-a39effcd993e">6,270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTctMS0xLTk5NzA2_72e7e1ab-8155-40da-b334-b447453e36e1"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTctMS0xLTk5NzA2_82a03f9e-d154-404f-a2a8-ebc216bd9622">5,829</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d9437b6a921439292845559c4c462b2_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTEtMS0xLTk5NzA2_23f80323-d99e-4358-bd2a-4b1cc40d4282">427</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402fc673d13248f590527d5a9df8dd9c_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTMtMS0xLTk5NzA2_2c42deb1-6891-41f6-8bc8-9686bf693ad5">359</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0185ce7757d248cfb6fbd1ea52edba1c_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTUtMS0xLTk5NzA2_7f26942d-d447-4c29-b831-aa0385d560b4">817</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id46a54a0a24f40f988a953734d9ef437_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTctMS0xLTk5NzA2_a0421694-ea31-4101-b860-b26fcc0d2262">676</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We define Emerging Markets as the <ix:nonFraction unitRef="units" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="0" name="bsx:EmergingMarketstotalnumberofcountries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1Xzc3MQ_1a3f5f9a-bc32-47b1-8117-7b6d67c80a51">20</ix:nonFraction> countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, which currently includes the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzE0MTA_7fac1dab-7ade-4514-8d44-cb291f71726a">501</ix:nonFraction> million as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzE0MjY_44764f33-ba87-4866-8f17-4b0a0e3ac90d">484</ix:nonFraction> million as of December&#160;31, 2021. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiology business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our Cardiology business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzE5ODE_1372ac46-e099-44cb-9459-0a2a337164d3">35</ix:nonFraction> million in the second quarter and $<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzIwMDE_3cb3108e-3962-429b-b0fc-4e2a4c6b4d8b">76</ix:nonFraction> million in the first six months of 2022 that was included in the above contract liability balance as of December&#160;31, 2021. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i59355054c88e4db380598f216f29d146"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on variable consideration, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_118"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90ZXh0cmVnaW9uOjhkMWIxNzk4YjRlZjQxZTBhM2ZlNmJhOTg4YWU1ODI5XzMzMg_c2fef65a-1dc5-48c5-b1e1-1fe38eaf7409" continuedAt="id31e6b427d2d412a87de55addeb68b53" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90ZXh0cmVnaW9uOjhkMWIxNzk4YjRlZjQxZTBhM2ZlNmJhOTg4YWU1ODI5XzIxOTkwMjMyNTcxOTM_db78c2df-336b-4efe-b9b2-2a1f0f6122a9" continuedAt="ie43ed91618ae4ddcbbaefb443b807d45" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtMS0xLTEtOTk3MDY_0bb1acfe-d3df-4d47-a2ef-bcaa3d31b7bb">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtMy0xLTEtOTk3MDY_36c2a9e4-4b51-441b-bbd4-24336c3f07cc">229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtNy0xLTEtOTk3MDY_de8bd72f-55b2-4f8a-8db1-8b13f94accf2">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtOS0xLTEtOTk3MDY_bf8abfb2-9547-4ca3-b679-dca39fbfd78f">222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItMS0xLTEtOTk3MDY_75c1edc0-4461-44e4-8c6f-5bf0edbf66ad">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItMy0xLTEtOTk3MDY_118a5b42-c989-4dac-89ca-c4177d7f101e">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItNy0xLTEtOTk3MDY_1de0e276-cb57-4623-91bb-cdea49868b2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItOS0xLTEtOTk3MDY_b57e3221-47ee-41e0-a113-4733394728eb">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtMS0xLTEtOTk3MDY_44da265d-461a-493f-bc08-4247ae6978e6">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtMy0xLTEtOTk3MDY_2f941350-9f72-477e-95df-1b869334a57d">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtNy0xLTEtOTk3MDY_3cfb73e7-02dc-489f-96a7-28f741f54f63">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtOS0xLTEtOTk3MDY_ea134898-c61b-4888-8107-c80411c0c810">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtMS0xLTEtOTk3MDY_095e8ba1-27ad-4f06-84bc-00da67b07cac">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtMy0xLTEtOTk3MDY_d17b1f46-bbc6-4efa-b10c-4b87df549262">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtNy0xLTEtOTk3MDY_24cf8d91-7323-4f79-a65c-121875869e17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtOS0xLTEtOTk3MDY_c1a1e0d8-24dc-4cb1-b7fa-dc5d5f8f7644">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtMS0xLTEtOTk3MDY_6e262042-d8d4-4b03-932f-f4980ffd6f3e">106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtMy0xLTEtOTk3MDY_9ec14e6d-f85e-47fa-973b-13d6cc889c16">363</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtNy0xLTEtOTk3MDY_b09aca56-96dd-41de-bbfe-6af4422bbbf6">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtOS0xLTEtOTk3MDY_c9d0f2c6-fbd2-4c31-ae01-67ce18de6542">433</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="id31e6b427d2d412a87de55addeb68b53"><ix:continuation id="ie43ed91618ae4ddcbbaefb443b807d45"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtMS0xLTEtOTk3MDY_5e3125b2-6f9c-41ea-b8f3-30bec1630be9">134</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtMy0xLTEtOTk3MDY_d444c5f0-bb35-4eab-8048-a24d98d4dc0b">165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtNy0xLTEtOTk3MDY_29f4fc21-4608-42a1-9a10-f933266693c2">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtOS0xLTEtOTk3MDY_924c48dc-00f9-4dc1-ac28-c4cfb7601144">254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItMS0xLTEtOTk3MDY_6d04dc1d-407c-4c1f-af06-842c1690959d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItMy0xLTEtOTk3MDY_f2b05190-178a-4f38-8e10-8aff6ade7e4b">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItNy0xLTEtOTk3MDY_c7f74c17-ae54-4ccd-9d24-e6f9e56a6c16">0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItOS0xLTEtOTk3MDY_cceabe13-fb23-406c-84d0-defcf99dcce5">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtMS0xLTEtOTk3MDY_7c315c65-b698-4d17-b581-d93d87f5f34a">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtMy0xLTEtOTk3MDY_bd6b3693-9b0c-4185-a86e-158c0fdd0508">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtNy0xLTEtOTk3MDY_b5166be0-5fba-4236-a900-7a6657cb363b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtOS0xLTEtOTk3MDY_c891ad3f-0a8e-4361-9caf-0b5760ce286b">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtMS0xLTEtOTk3MDY_b3d67db4-e970-445f-8e7f-49cc202f0dec">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtMy0xLTEtOTk3MDY_388c04c4-ccb4-40ec-b83e-79529afbd854">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtNy0xLTEtOTk3MDY_4d4ed03a-553c-4b5a-aa18-10704e396963">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtOS0xLTEtOTk3MDY_7a0b63df-ab96-4a3b-99e1-4b3054d8a4ee">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtMS0xLTEtOTk3MDY_3feef6c6-a18a-4f0c-8f19-50ad026557bf">136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtMy0xLTEtOTk3MDY_e9a6ce90-7ae2-488c-a8cd-1565fd71680e">146</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtNy0xLTEtOTk3MDY_ae76afb5-d01d-451c-b665-b4d1d92ff9cd">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtOS0xLTEtOTk3MDY_86c7db56-a2e6-41b9-8be2-d31ea2dd472d">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtMS0xLTEtMTAxMDU2_c99c8135-04db-4554-bdb5-5a4a92f934e9">93</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtMy0xLTEtMTAxMDU2_ab9b4375-f26f-47a2-beef-505a43e371d6">206</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtNy0xLTEtMTAxMDU2_fb847c71-4e66-40f2-883d-6a73a5f5b1dd">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da29940934c628d805300ec2c17c2_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtOS0xLTEtMTAxMDU2_3fe94ae0-80bc-4011-871e-4caf9e5feced">263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItMS0xLTEtMTAxMDU2_31c5561d-50e1-4f8e-8e40-4fe7505a0a73">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItMy0xLTEtMTAxMDU2_11917c6a-2862-46b9-a2b9-ee2a6f127069">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItNy0xLTEtMTAxMDU2_99822c3a-4764-41e9-9433-9b780e863a68">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItOS0xLTEtMTAxMDU2_ae2d9736-73fe-4be5-afee-e3012f12ad99">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtMS0xLTEtMTAxMDU2_17363baf-2fef-409e-ae5d-6e598a6aeb21">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtMy0xLTEtMTAxMDU2_8535ffec-bcfb-4f60-a995-467f74c89d73">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtNy0xLTEtMTAxMDU2_770ff1d3-8cf8-49d5-ad46-a8952c63e7a6">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtOS0xLTEtMTAxMDU2_210dfd2f-f081-4c60-ac4e-e3961b78493a">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtMS0xLTEtMTAxMDU2_1b9ded55-e7cc-4c1f-8b2f-c24037c0849b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtMy0xLTEtMTAxMDU2_cf2e7430-de29-426e-8ade-27cbe1313331">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtNy0xLTEtMTAxMDU2_afdb9262-3240-48dd-8a46-0e363ee05d8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtOS0xLTEtMTAxMDU2_c650c1d1-4c66-484a-acf2-d3aca0f4a1ab">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtMS0xLTEtMTAxMDU2_f90dbe1c-c5ee-46dc-a0e6-deeae26308e2">106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtMy0xLTEtMTAxMDU2_40993b2e-1032-4d65-b324-6e9524b13271">363</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtNy0xLTEtMTAxMDU2_37c9c272-abd0-4640-8d4f-580510897461">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtOS0xLTEtMTAxMDU2_4b0ebf1e-4ee2-4599-9ca5-978e015ce6ba">433</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtMS0xLTEtMTAxMDU5_5defe265-2e82-4f90-b1e8-ef4f19a8c29e">218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtMy0xLTEtMTAxMDU5_88ebb95c-8462-47c0-bf27-5034c6b22bd2">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtNy0xLTEtMTAxMDU5_c87f485a-bc79-4ee8-b99e-962e09e3358f">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtOS0xLTEtMTAxMDU5_b326d513-51aa-4d7c-8134-9b9e1aaa68c0">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItMS0xLTEtMTAxMDU5_9ea5edeb-38ff-452c-87fe-dd99741b098b">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItMy0xLTEtMTAxMDU5_7b8eb03d-3c80-469b-b34a-57f321b35fc6">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItNy0xLTEtMTAxMDU5_1726bd4d-cc36-424a-9454-d2aee6fa4493">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItOS0xLTEtMTAxMDU5_34135d92-8067-4de3-9657-3a48130d745b">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtMS0xLTEtMTAxMDU5_ad35c2d9-6721-40e8-acfa-244fc16c0934">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtMy0xLTEtMTAxMDU5_b2868b22-eb45-4eae-85df-d15f666866a7">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtNy0xLTEtMTAxMDU5_04db5e0d-84ca-432f-95eb-68219688952f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtOS0xLTEtMTAxMDU5_f9cfe8e9-ef3e-43a2-a9cd-f2d66868476e">144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtMS0xLTEtMTAxMDU5_c64053e2-ade2-451c-bcbc-d2877189e13d">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtMy0xLTEtMTAxMDU5_6f545ae3-c9d4-4f86-a2a8-6f62af165fe2">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtNy0xLTEtMTAxMDU5_8f3e396e-0ec4-4478-9b5b-d80c461ea68d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtOS0xLTEtMTAxMDU5_35ec348f-7269-4ed3-82da-08b06020ecaf">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtMS0xLTEtMTAxMDU5_ba39ebf8-5b4e-4450-95ad-fb5eb33e8191">136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtMy0xLTEtMTAxMDU5_e17acc49-806c-48f3-8b39-db14fd743806">146</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtNy0xLTEtMTAxMDU5_204d8575-3abe-4d2b-b875-cb8d8e8cd1ba">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee4f63199724a10854016dabc453a58_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtOS0xLTEtMTAxMDU5_670ece4c-a909-402d-af53-8bd2e008142f">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $<ix:nonFraction unitRef="usd" contextRef="i80e3da031c9b4d6e944876c1bf4edd3c_D20210301-20210301" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzYtMC0xLTEtMTAxMDIxL3RleHRyZWdpb246MTgyMjBiYzYxM2FmNDBhM2I3NGQzODFiNGFhN2M2NDZfMTQ1_6653f643-85db-407e-9117-a6a2922fbb73">127</ix:nonFraction> million of cumulative translation adjustments associated with the disposed business from Accumulated other comprehensive income (loss), net of tax.</span></div></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_124"></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:NewAccountingPronouncementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzMzODM_70ead8c3-327b-4c1d-8a8e-5c7123e469f4" continuedAt="i218226d464144472bb2d48a4e0601faa" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first six months of 2022, we implemented the following standards, which did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzM0MTk_be77736a-f72a-490d-a627-0a2485abab59" continuedAt="i67a666095fa94de6a186a68c1d44716f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i218226d464144472bb2d48a4e0601faa"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i67a666095fa94de6a186a68c1d44716f">classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We adopted Update No. 2021-05 in the first quarter of 2022 on a prospective basis.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzMzODc_f4662545-a9af-42b0-8fc1-12a98bebfbd7" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASC Update No. 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods. Update No. 2022-01 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the corresponding period. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzMzODg_7caee6fa-b060-4b39-b9a6-a6e6707994ff" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASC Update No. 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments- Credit Losses (Topic 326: Troubled Debt Restructurings and Vintage Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-02 makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13. Update No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Update No. 2022-02 should be applied prospectively, with the option of modified retrospective adoption for the recognition and measurement of troubled debt restructurings. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2016-13. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzEwOTk1MTE2Mzc5NTM_5c9e73f7-9b30-41cc-9f42-3b20797cb6ba" escape="true"><ix:nonNumeric contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630" name="bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzEwOTk1MTE2Mzc5NTc_836713e3-e826-4fbd-931c-8832b8a02925" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASC Update No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance and the amendments in this update should be applied prospectively. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></ix:nonNumeric></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:49.5pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.36pt">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for more than 40 years, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions and improve patients&#8217; quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. Our net sales have increased substantially since our formation, fueled in part by strategic acquisitions designed to improve our ability to take advantage of growth opportunities in the medical device industry and to build diversified portfolios within our core businesses. We advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared COVID-19, including all additional variations and strains thereof, a global pandemic (COVID-19 pandemic). Procedural delays from the further resurgence of COVID-19 infections and the emergence of new, more contagious variant strains of COVID-19, as well as staffing shortages within healthcare facilities, have and may continue to negatively impact demand for our products, net sales, gross profit margin and operating expenses as a percentage of net sales. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we expect the COVID-19 pandemic and related impacts will continue to negatively impact our performance to an extent, we continue to believe our long-term fundamentals remain strong and we intend to manage through these challenges with strategic focus and the winning spirit of our global team. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic Trends</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic conditions created in part by the COVID-19 pandemic, have had, and are expected to continue to have, a negative impact on our business. We face and expect to continue to face, increases in the cost and limited availability of raw materials, components, and other inputs necessary to manufacture and distribute our products due to constraints and inflation within the global supply chain, as well as increases in the cost and time to distribute our products. Further, other macroeconomic factors have led to a challenging labor market in which we compete, which impacts in some cases, our ability to retain and attract new talent as well as put inflationary pressure on certain operational costs due to wage increases. Uncertainty around inflationary pressures, rising interest rates and monetary policy, could potentially cause new, or exacerbate existing, economic challenges that we may face. These conditions could worsen, or others could arise, if the U.S. and global economies were to enter recessionary periods, triggered or exacerbated by monetary policy designed to curb inflation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Sustainability </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sustainable environmental, social and governance practices underpin all aspects of our global business. Our approach is aligned with the United Nations Sustainable Development Goals and our material topics and practices are informed by a broad range of internal and external stakeholders &#8211; locally, nationally and globally. Our employees around the world work with suppliers and other organizations that share our commitment to these practices that help address issues related to health inequity, economic disparity, climate change and environmental protection. These efforts are supported by our cross-functional Corporate Social Responsibility Steering Committee, our Corporate Social Responsibility Council, our Environmental Health and Safety teams and policies, our Global Council for Inclusion, as well as our local, regional and national employee and community engagement programs. In addition, our 2021 annual bonus plan included performance measured against environmental targets, employee engagement goals and human capital metrics targets, including global gender and U.S. (inclusive of Puerto Rico) multicultural goals. In 2022 we were named to the Forbes 2022 list of America's Best Employers for Diversity, as well as ranked number one among Health Care Equipment companies on renewable energy use by JUST Capital. We were also ranked on the list of 100 best Corporate Citizens of 2022 by 3BL Media. For additional information on our sustainability efforts, as well as our Diversity, Equity and Inclusion (DE&amp;I) initiatives, refer to our most recent Annual Report on Form 10-K. For additional information on our annual bonus plan, refer to our Proxy Statement for the 2022 Annual Meeting of Shareholders. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended June 30, 2022</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the second quarter of 2022 were $3.244 billion, as compared to $3.077 billion for the second quarter of 2021. This increase of $167 million, or 5.4 percent, included operational</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net sales growth of 9.6 percent and the negative impact of 420 basis points from foreign currency fluctuations. The increase in our net sales was primarily driven by recent acquisitions as well as the strength and diversity of our product portfolio coupled with growth in the underlying markets in which we compete and strong commercial execution. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our net sales by global business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders for the second quarter of 2022 was $246 million, or $0.17 per diluted share. Our reported results for the second quarter of 2022 included certain charges and/or credits totaling $389 million (after-tax), or $0.27 per diluted share. Excluding these items, adjusted net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $635 million, or $0.44 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders for the second quarter of 2021 was $172 million, or $0.12 per diluted share. Our reported results for the second quarter of 2021 included certain charges and/or credits totaling $405 million (after-tax), or $0.28 per diluted share. Excluding these items, adjusted net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $577 million, or $0.40 per diluted share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational net sales growth rates, which exclude the impact of foreign currency fluctuations, and other adjusted measures, which exclude certain items required by generally accepted accounting principles in the United States (U.S. GAAP) are not prepared in accordance with U.S. GAAP and should not be considered in isolation from, or as a replacement for, the most directly comparable GAAP measure. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for a discussion of management&#8217;s use of these non-GAAP financial measures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of these reconciling items:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.506%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.00)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">744</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">649</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">665</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">577</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> For the second quarter and first six months of 2022 and 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited consolidated statements of operations, for purposes of calculating GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Six Months Ended June 30, 2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the first six months of 2022 were $6.270 billion, as compared to $5.829 billion for the first six months of 2021. This increase of $441 million, or 7.6 percent, included operational</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net sales growth of 11.1 percent and the negative impact of 350 basis points from foreign currency fluctuations. The increase in our net sales was primarily driven by recent acquisitions as well as the strength and diversity of our product portfolio coupled with growth in the underlying markets in which we compete and strong commercial execution. Refer to Quarterly Results and Business Overview for a discussion of our net sales by global business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders for the first six months of 2022 was $342 million, or $0.24 per diluted share. Our reported results for the first six months of 2022 included certain charges and/or credits totaling $854 million (after-tax), or $0.59 per diluted share. Excluding these items, adjusted net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first six months of 2022 was $1.197 billion, or $0.83 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders for the first six months of 2021 was $500 million, or $0.35 per diluted share. Our reported results for the first six months of 2021 included certain charges and/or credits totaling $602&#160;million (after-tax), or $0.42 per diluted share. Excluding these items, adjusted net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first six months of 2021 was $1.102&#160;billion, or $0.77 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of these reconciling items:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">501</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">370</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,416</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,224</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">474</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">527</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,129</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Results and Business Overview </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reorganized our operational structure and have aggregated our core businesses, each of which generate revenues from the sale of medical devices (Medical Devices), into two reportable segments: MedSurg and Cardiovascular. Within the Cardiovascular segment, the newly formed Cardiology division represents the combined former Rhythm Management and Interventional Cardiology divisions. We have revised prior periods to conform to the current year presentation. The following section describes our net sales and results of operations by reportable segment and business unit. For additional information on our businesses and product offerings, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase/(Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.4%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.4%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase/(Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,402</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,868</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,564</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100.0)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less-invasive technologies. Our net sales of Endoscopy products were $560 million for the second quarter and $1.091 billion for the first six months of 2022, and represented 17 percent of our consolidated net sales in both periods. Our Endoscopy net sales increased $9 million, or 1.6 percent, in the second quarter and increased $41 million, or 3.9 percent, in the first six months of 2022, compared to the prior year periods. In the second quarter of 2022, this increase included operational net sales growth of 5.8 percent and a negative impact of 430 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2022, this increase included operational net sales growth of 7.3 percent and a negative impact of 340 basis points from foreign currency fluctuations, compared to the prior year period. This growth was primarily driven by our single-use imaging franchise led by our EXALT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> D Single-use Duodenoscope and our biliary franchise led by our AXIOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stent and Delivery System, as well as our hemostasis and infection prevention franchises.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology and Pelvic Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies. Our net sales of Urology and Pelvic Health products were $450 million for the second quarter and $863 million for the first six months of 2022, representing 14 percent of our consolidated net sales in both periods. Our Urology and Pelvic Health net sales increased $53 million, or 13.4 percent, in the second quarter and increased $105 million, or 13.9 percent, in the first six months of 2022, compared to the prior year periods. In the second quarter of 2022, this increase included operational net sales growth of 16.2 percent and a negative impact of 280 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2022, this increase included operational net sales growth of 16.1 percent and a negative impact of 220 basis points from foreign currency fluctuations, compared to the prior year period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales growth included organic net sales growth of 7.0 percent in the second quarter of 2022 and 7.0 percent in the first six months of 2022, and the positive impact of 920 basis points in both periods, from our acquisition of the surgical business of Lumenis, LTD. (Lumenis) in the third quarter of 2021. Organic net sales growth was driven by strong performance across our key products, including our LithoVue&#8482; Single-Use Digital Flexible Ureteroscopes and SpaceOAR&#8482; Hydrogel Systems, as well as continued focus on globalization. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Our net sales of Neuromodulation products were $239 million for the second quarter and $448 million for the first six months of 2022, representing 7 percent of our consolidated net sales in both periods. Our Neuromodulation net sales decreased $8 million, or 3.4 percent in the second quarter and increased $3 million, or 0.7 percent in the first six months of 2022, compared to the prior year periods. In the second quarter of 2022, this decrease included an operational net sales decline of 1.0 percent and a negative impact of 240 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2022, this increase included operational net sales growth of 2.8 percent and a negative impact of 210 basis points from foreign currency fluctuations, compared to the prior year period. Operational net sales declines for the second quarter of 2022 were primarily due to very strong procedural volumes in the second quarter of 2021 associated with sharp recovery from the COVID-19 pandemic as well as the U.S. launch of our WaveWriter Alpha&#8482; SCS and Vercise Genus&#8482; DBS systems. Operational net sales growth for the first six months of 2022 was primarily driven by the first quarter performance of our spinal cord stimulation (SCS) systems.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiology business develops and manufactures devices and medical technologies for diagnosing and treating a variety of diseases and abnormalities of the heart. Our net sales of Cardiology products were $1.517 billion for the second quarter and $2.925 billion for the first six months of 2022, representing 47 percent of our consolidated net sales in both periods. Our Cardiology net sales increased $108 million, or 7.6 percent, in the second quarter and $266 million, or 10.0 percent in the first six months of 2022, compared to the prior year periods. In the second quarter of 2022, this increase included operational net sales growth of 12.5 percent and a negative impact of 480 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2022, this increase included operational net sales growth of 14.1 percent and a negative impact of 410 basis points from foreign currency fluctuations, compared to the prior year period. Operational net sales growth included organic net sales growth of 8.5 percent in the second quarter of 2022 and 9.7 percent for the first six months of 2022, and the positive impact of 400 and 440 basis points, respectively, from our acquisitions of Preventice Solutions, Inc. (Preventice), Farapulse, Inc. and Baylis Medical in the first and third quarter of 2021 and the first quarter of 2022, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organic net sales growth was primarily driven by continued market expansion of Left Atrial Appendage Closure (LAAC) procedures with our WATCHMAN&#8482; FLX LAAC Device, as well as performance of our percutaneous coronary intervention guidance and subcutaneous implantable cardiac defibrillator (S-ICD) franchises. Organic net sales growth was also driven by our diagnostics franchise, led by our LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, as well as our wearable ambulatory electrocardiograph portfolio. In addition, sales growth in the first six months of 2022 was driven by our structural heart valve franchise led by our ACURATE neo2&#8482; Aortic Valve Systems.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. Our net sales of Peripheral Interventions products were $478 million for the second quarter and $944 million for the first six months of 2022, representing 15 percent of our consolidated net sales in both periods. Our Peripheral Interventions net sales increased $6 million, or 1.2 percent, in the second quarter and increased $38 million, or 4.2 percent, in the first six months of 2022, compared to the prior year periods. In the second quarter of 2022, this increase included operational net sales growth of 5.7 percent and a negative impact of 450 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2022, this increase included operational net sales growth of 7.8 percent and a negative impact of 360 basis points from foreign currency fluctuations, compared to the prior year period. Operational net sales growth was primarily driven by our drug eluting franchise led by our Ranger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Drug-Coated Balloon and Eluvia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Drug-Eluting Stent System within our arterial portfolio as well as our interventional oncology franchise led by our TheraSphere&#8482; Y-90 Radioactive Glass Microspheres.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Pharmaceuticals </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business for a purchase price of approximately $800 million. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic imperative to drive global expansion, we are seeking to grow net sales and market share by expanding our global presence, including in Emerging Markets. We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, which currently includes the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. Our Emerging Markets net sales represented 13 percent of our consolidated net sales in the second quarter and first six months of 2022, and 12 percent in the second quarter and first six months of 2021. In the second quarter of 2022, our Emerging Markets net sales grew 18.9 percent on a reported basis, which included operational net sales growth of 26.0 percent and a negative impact of 710 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2022, our Emerging Markets net sales grew 20.8 percent on a reported basis, which included operational net sales growth of 27.3 percent and a negative impact of 650 basis points from foreign currency fluctuations, compared to the prior year period. The increase in the second quarter of 2022 compared to the prior year period was driven primarily by growth in India and Brazil as we continue to focus on globalization </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our products. We experienced sequentially lower growth in China in the second quarter of 2022 due to decreased procedural volumes related to the recent increase of COVID-19 cases and associated public health measures implemented. The increase in the first six months of 2022 compared to the prior year period was driven primarily by growth in China, India and Brazil. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_139"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $2.233 billion for the second quarter of 2022, $2.132 billion for the second quarter of 2021, $4.304 billion first six months of 2022 and $3.990 billion first six months of 2021. As a percentage of net sales, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased to 68.8 percent in the second quarter of 2022, as compared to 69.3 percent in the second quarter of 2021 and increased to 68.6 percent in the first six months of 2022, as compared to 68.4 percent in the first six months of 2021. The following is a reconciliation of our gross profit margin and a description of the drivers of the changes from period to period:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.4%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing, volume and mix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other period expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.6%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary factors contributing to the decrease in our gross profit margin in the second quarter of 2022, as compared to the same period in the prior year, were the impacts of inflation on costs of certain raw materials, direct labor and freight, as well as inefficiencies in our manufacturing plants due to constraints in material availability, which were partially offset by the favorable impact of foreign currency fluctuations and the realization of standard cost improvements. As expected, these macro-economic factors have negatively impacted our gross profit margin, and we expect continued negative impact throughout 2022 while these factors persist. Despite the challenging macro-economic environment, we experienced an overall increase in our gross profit margin in first six months of 2022, as compared to the same period in the prior year, due to increased sales of higher-margin products and the favorable impact of foreign currency fluctuations, which offset the macro-economic factors that became more pronounced in the second quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our operating expenses:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A Expenses)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $45 million, or 4 percent, as compared to the prior year period and were 50 basis points lower as a percentage of net sales. In the first six months of 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $86 million, or 4 percent, as compared to the prior year period and were 120 basis points lower as a percentage of net sales. The increases in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were primarily due to higher selling costs driven by higher global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D Expenses)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to advancing medical technologies and investing in meaningful R&amp;D projects across our businesses. In the second quarter of 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $36 million, or 12 percent, as compared to the prior year period and were 60 basis points higher as a percentage of net sales. In the first six months of 2022, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $79 million, or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 percent, as compared to the prior year period, and were 60 basis points higher as a percentage of net sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased in both the second quarter and first six months of 2022 as a result of investments across our businesses in order to maintain a pipeline of new products that we believe will contribute to profitable sales growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our other operating expenses, which are excluded by management for purposes of evaluating operating performance. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further description of certain operating expenses:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of businesses and assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $24 million, or 13 percent, compared to the prior year period. In the first six months of 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $37 million, or 10 percent, as compared to first six months of 2021. The increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in both the second quarter and first six months of 2022 was driven by the addition of amortizable intangible assets associated with our recent acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Asset Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $7 million in the second quarter and first six months of 2022, and $45 million in the second quarter and first six months of 2021. The impairment charges recorded in 2021 were primarily attributable to incremental time and cost to complete an acquired in-process research and development (IPR&amp;D) project. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item&#160;7 of our most recent Annual Report on Form 10-K for additional details and a discussion of key assumptions used in our goodwill and intangible asset impairment testing and future events that could have a negative impact on the recoverability of our goodwill and intangible assets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Net Expense (Benefit)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To recognize changes in the fair value of our contingent consideration liability, we recorded net charges of $36 million and $48 million in the second quarter and first six months of 2022, respectively, and net benefits of $85 million and $91 million in the in the second quarter and first six months of 2021, respectively. The net charges recorded in the first six months of 2022 related to an increase in expected payments for achievement of commercialization-based milestones and revenue-based payments as a result of over-performance. In addition, we made payments of $314 million associated with prior acquisitions during the first six months of 2022, following the achievement of revenue and/or regulatory milestones. The net benefits recorded in the first six months of 2021 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or, in the case of nVision, for milestones that would not be achieved due to management's discontinuation of the R&amp;D program. In addition, we made payments of $14 million associated with prior acquisitions during the first six months of 2021, following the achievement of a revenue-based milestone. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for additional details related to our contingent consideration arrangements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges (Credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, our Board of Directors approved, and we committed to, a new global restructuring program (the 2019 Restructuring Plan). In addition, on February 22, 2022, our Board of Directors approved increased cost estimates to complete </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional activities identified under the program, which are expected to result in total pre-tax charges of approximately $450 million to $500 million, and approximately $375 million to $425 million of these charges are expected to result in cash outlays. We expect the majority of activity associated with our 2019 Restructuring Plan to be substantially complete by the end of 2022. A substantial portion of the savings are being reinvested in strategic growth initiatives. Pursuant to this program, restructuring charges were $11 million in the second quarter of 2022, $3 million in the second quarter of 2021, $14 million in the first six months of 2022 and $6 million in the first six months of 2021. Restructuring-related charges were $24 million in the second quarter of 2022, $35 million in the second quarter of 2021, $49 million in the first six months of 2022 and $64 million in the first six months of 2021, and were recorded primarily in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Aortic Valve System and our decision to retire the entire LOTUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valve platform. We recorded $2 million of restructuring charges and $16 million of restructuring-related charges associated with the product discontinuation in the first six months of 2021. The restructuring activities were completed in 2021 and resulted in total pre-tax restructuring and restructuring-related net charges of approximately $80 million.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $42 million during the second quarter and first six months of 2022. We recorded litigation-related net charges of $298 million during the second quarter and $302 million during first six months of 2021, primarily related to transvaginal surgical mesh products. We increased the accrual associated with this matter to account for increased, post-COVID-19 settlement and litigation activity related to the remaining cases and claims the Company faces, our revision of the per-case settlement amount for these cases is based on recent settlement and litigation activity and changes to our expectations regarding the rate of incoming cases and claims. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;within our accompanying unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation, and therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with the financial covenant required by our credit arrangements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for discussion of our material legal proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and average borrowing rate:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average borrowing rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our average borrowing rate decreased in the second quarter of 2022 compared to the prior year period, due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the issuance of euro-denominated bonds in the first quarter of 2022, which carry lower interest rates than our prior period debt portfolio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our average borrowing rate increased in the first six months of 2022 compared to the prior year period due to $194&#160;million of charges associated with the early extinguishment of $3.275&#160;billion of certain of our senior notes, including payment of tender premiums and the acceleration of unamortized debt issuance costs. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for information regarding our debt obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other, net </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign currency gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Preventice in the first quarter of 2021, we remeasured the fair value of our previously-held equity interest, which resulted in a $195 million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first six months of 2021. In the second quarter and first six months of 2021, we also recorded losses of $8 million and $154 million, respectively, on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the partial disposition of our ownership and remeasurement of our remaining investment to fair value based on observable market prices. The Preventice gain is included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition/divestiture-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the Pulmonx loss is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment portfolio net losses (gains)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to Financial Summary for the reconciliation and Additional Information for a discussion of management's use of non-GAAP financial measures.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_142"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rate</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our reported tax rates for the second quarter and first six months of 2022, as compared to the same periods in 2021, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include acquisition/divestiture-related charges and receipts, charges and receipts on investment portfolio net losses (gains), litigation-related net charges, as well as certain discrete tax items primarily related to changes in tax laws, unrecognized tax benefits, changes in valuation allowance and foreign return-to-provision adjustments.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results are affected by the selection and application of accounting policies and methods. In the second quarter and first six months of 2022, there were no material changes to the application of critical accounting policies previously disclosed in our most recent Annual Report on Form 10-K. </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_151"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current business plan, we believe our existing balance of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, future cash generated from operations, access to capital markets and existing credit facilities will be sufficient to fund our operations, invest in our infrastructure, pay our legal-related liabilities, pay taxes due, service and repay our existing debt and fund possible acquisitions for the next 12 months and for the foreseeable future. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we had $276 million of unrestricted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on hand, comprised of $36 million invested in money market funds and time deposits and $240 million in interest bearing and non-interest-bearing bank accounts. We invest excess cash on hand in short-term financial instruments that earn at market interest rates while mitigating principal risk through instrument and counterparty diversification, as well as what we believe to be prudent instrument selection. We limit our direct exposure to securities in any one industry or issuer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. As of&#160;June&#160;30, 2022, we had $155 million of commercial paper debt outstanding, resulting in an additional $2.595 billion of available liquidity under the 2021 Revolving Credit Facility.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional details related to our debt obligations, including our financial covenant requirement, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a summary and description of our net cash inflows (outflows):</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of 2022, cash provided by operating activities decreased $678 million as compared to the prior year period primarily due to changes in working capital partially offset by comparatively higher net sales and operating income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of 2022, cash used for investing activities included a net cash payment of $1.471 billion for the acquisition of Baylis Medical. In the first six months of 2021, cash provided by investing activities included proceeds of $801 million from the divestiture of the Specialty Pharmaceuticals business and $92 million of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">proceeds from (payments for) investments and acquisitions of certain technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, partially offset by a net cash payment of $706 million for the acquisition of Preventice. For more information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q. In addition, we made </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">purchases of property, plant and equipment and internal use software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $226 million in the first six months of 2022 and $181 million in the first six months of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of 2022, we completed a public offering (the Offering) of &#8364;3.000 billion in aggregate principal amount of euro-dominated senior notes. The Offering resulted in cash proceeds of $3.270&#160;billion, net of investor discounts and issuance costs. We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $3.275&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. Cash used for financing activities in the first six months of 2022 also included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">payments on short-term borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $250 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">payment of contingent consideration previously established in purchase accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $283 million and an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">increase (decrease) in commercial paper </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $154 million. For more information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item 1 of this Quarterly Report on Form 10-Q. In the first six months of 2022 and 2021, cash used for financing activities also included cash payments associated with the settlement of employee equity awards and payments for royalty rights associated with the Zytiga&#8482; Drug.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility described below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of 3.75 times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisition occurs, the maximum permitted leverage ratio is 4.75 times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for the recently completed qualified acquisitions due to the funding using cash on hand. We believe that we have the ability to comply with the financial covenant for the next 12 months. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreement, through maturity, of any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2022, we had $311 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $1.455 billion in the aggregate. As of June&#160;30, 2022, we had $1.080 billion of the litigation exclusion remaining.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our acquisitions involve the payment of contingent consideration. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for further details regarding the estimated potential amount of future contingent consideration we could be required to pay associated with our acquisitions. There have been no other material changes to our contractual obligations and commitments as of June&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received $58 million in the first six months of 2022 and $38 million in the first six months of 2021 in proceeds from stock issuances related to our stock option and employee stock purchase plans. Proceeds from the exercise of employee stock options and employee stock purchases vary from period to period based upon, among other factors, fluctuations in the trading price of our common stock and in the exercise and stock purchase patterns of our employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock in the second quarter or first six months of 2022 or 2021. On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of June&#160;30, 2022, we had the full amount remaining available under the authorization. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our material legal proceedings refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements implemented since December&#160;31, 2021 and new accounting pronouncements to be implemented is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note N &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established controls and procedures to escalate enterprise level issues, including cybersecurity matters, to the appropriate management levels within our organization and our Board of Directors, or members or committees thereof, as appropriate. Under our framework, cybersecurity issues are analyzed by subject matter experts and a crisis committee for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to the Company&#8217;s financial results, operations, and/or reputation are immediately reported by management to the Board of Directors, or individual members or committees thereof, as appropriate, in accordance with our escalation framework. In addition, we have established procedures to ensure that management responsible for overseeing the effectiveness of disclosure controls is informed in a timely manner of known cybersecurity risks and incidents that may materially impact our operations and that timely public disclosure is made or updated, as appropriate.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conflict between Russia and Ukraine raises cybersecurity risks on a global basis. While there is significant uncertainty around implications of cybersecurity attacks resulting from the conflict, we have taken steps to better understand our readiness, including the resilience of our critical business functions, with the goal of reducing the impact if such an event were to occur.</span></div><div style="margin-bottom:10pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Trading Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors and executive officers are subject to our Stock Trading Policy, which is designed to facilitate compliance with insider trading laws and governs transactions in our common stock and related derivative securities. Our policy designates certain regular periods, dictated by release of financial results, in which trading is restricted for individuals in information-sensitive positions, including directors and executive officers. In addition, additional periods of trading restriction may be imposed as determined by the President and Chief Executive Officer, General Counsel, or Chief Financial Officer in light of material pending developments. Further, during permitted windows, individuals in information-sensitive positions are required to seek pre-clearance for trades from the General Counsel, who assesses whether there are any important pending developments, including cybersecurity matters, which need to be made public before the individual may participate in the market.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, certain of our executive officers adopt written stock trading plans in accordance with Rule 10b5-1 under the Exchange Act and our own Stock Trading Policy. A Rule 10b5-1 Trading Plan is a written document that pre-establishes the amount, prices and dates (or formulas for determining the amounts, prices and dates) of future purchases or sales of our stock, including shares issued upon exercise of stock options or vesting of deferred stock units. These plans are entered into at a time when the person is not in possession of material non-public information about the Company. We disclose details regarding individual Rule 10b5-1 Trading Plans on the Investor Relations section of our website.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share (EPS) that exclude certain charges (credits); operational net sales, which exclude the impact of foreign currency fluctuations; and organic net sales, which exclude the impact of foreign currency fluctuations as well as the impact of certain acquisitions and divestitures with less than a full period of comparable net sales. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To calculate adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share we exclude certain charges (credits), which include amortization expense, goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), investment portfolio gains and losses, restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits), EU MDR implementation costs, debt extinguishment charges, deferred tax expenses (benefits) and discrete tax items. Amounts are presented after-tax at our effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 740-270-30, "General Methodology and Use of Estimated Annual Effective Tax Rate." Please refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in our most recent Annual Report filed on Form 10-K filed with the Securities and Exchange Commission for an explanation of each of these adjustments and the reasons for excluding each item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) available to common stockholders and GAAP net income (loss) per common share - assuming dilution, respectively.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. To calculate organic net sales growth rates, we also remove the impact of acquisitions and divestitures with less than a full period of comparable net sales. The GAAP financial measure most directly comparable to operational net sales and organic net sales is net sales on a GAAP basis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the relevant sections of this Quarterly Report.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance. </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) available to common stockholders, adjusted net income (loss) per share, operational net sales and organic net sales growth rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safe Harbor for Forward-Looking Statements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we may make from time to time, including statements contained in this Quarterly Report on Form 10-Q and information incorporated by reference herein, constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221;, &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;aim,&#8221; "goal," "target," "continue," "hope" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Quarterly Report on Form 10-Q are based on certain risks and uncertainties, including the risk factors described in Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K and the specific risk factors discussed herein and in connection with forward-looking statements throughout this Quarterly Report on Form 10-Q, which could cause actual results to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this Quarterly Report on Form 10-Q.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Risks and uncertainties that may cause such differences include, among other things: the impact of the ongoing COVID-19 pandemic on our operations and financial results; the impact of foreign currency fluctuations; future U.S. and global economic, political, competitive, reimbursement and regulatory conditions, including as a result of the ongoing conflict between Russia and Ukraine; manufacturing, distribution and supply chain disruptions and cost increases; disruptions caused by cybersecurity events; disruptions caused by extreme weather or other climate change-related events; labor shortages and increases in labor costs; new product introductions and the market acceptance of those products; markets for our products; expected pricing environment; expected procedural volumes; the closing and integration of acquisitions; clinical trial results; demographic trends; intellectual property rights; litigation; financial market conditions; the execution and effect of our restructuring program; the execution and effect of our business strategy, including our cost-savings and growth initiatives; our ability to achieve environmental, social and governance goals and commitments; and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic.&#160;All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, refer to Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K filed with the SEC, which we may update in Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in subsequent Quarterly Reports on Form 10-Q that we will file hereafter.&#160;We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.&#160;This cautionary statement is applicable to all forward-looking statements contained in this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some of the important risk factors that could cause our actual results to differ materially from our expectations in any forward-looking statements. For further discussion of these and other risk factors, refer to Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Businesses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on the worldwide economy and financial markets, and developments related to the disease,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on our global manufacturing and distribution system, including disruption in the manufacture or supply of certain components, materials or products, or the failure to secure in a timely manner alternative manufacturing or additional or replacement components, materials or products,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Labor shortages and the impact of inflation on the cost of raw materials and direct labor, including as a result of the economic effects of the COVID-19 pandemic,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic upon the scheduling of elective and semi-emergent procedures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of natural disasters, climate change, additional future public health crises and other catastrophic events on our ability to manufacture, distribute and sell our products,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive offerings and related declines in average selling prices for our products,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ongoing impact on our business of physician alignment to hospitals, governmental investigations and audits of hospitals and other market and economic conditions on the overall number of procedures performed,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The performance of, and physician and patient confidence in, our products and technologies or those of our competitors,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact and outcome of ongoing and future clinical trials and market studies undertaken by us, our competitors or other third parties or perceived product performance of our or our competitors' products,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variations in clinical results, reliability or product performance of our and our competitors' products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to acquire or develop, launch and supply new or next-generation products and technologies worldwide and in line with our commercialization strategies in a timely and successful manner and with respect to our recent acquisitions,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of consolidation and competition in the markets in which we do business or plan to do business,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as some of our products are more profitable than others,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to attract and retain talent, including key personnel associated with recent acquisitions, and to maintain our robust corporate culture,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The inability of certain of our employees to return to work full-time due to impacts of the COVID-19 pandemic, or our inability to recruit personnel into direct labor roles for the duration of the pandemic,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain and maintain regulatory approval in the U.S. and around the world, including EU MDR and the associated timing and cost of product approval, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased pressure on the availability and rate of third-party reimbursement for our products and procedures in the U.S. and around the world, including with respect to the timing and costs of creating and expanding markets for new products and technologies, </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The issuance of new or revised accounting standards by the Financial Accounting Standards Board or the Securities and Exchange Commission, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of potential goodwill and intangible asset impairment charges on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Compliance, Litigation and Data Protection</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of healthcare policy changes and legislative or regulatory efforts in the U.S., the EU and around the world to modify product approval or reimbursement processes, including a trend toward demonstrating clinical outcomes, comparative effectiveness and cost efficiency, as well as the impact of other healthcare reform legislation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with our regulatory compliance and quality systems and activities in the U.S., the EU and around the world, including meeting regulatory standards applicable to manufacturing and quality processes,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of global legal, regulatory or market responses to climate change, including increased compliance burdens and costs to meet regulatory obligations,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to minimize or avoid future field actions or FDA warning letters relating to our products and processes and the ongoing inherent risk of potential physician advisories related to our or our competitors' products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased scrutiny of and heightened global regulatory enforcement facing the medical device industry arising from political and regulatory changes, economic pressures or otherwise, including under U.S. Anti-Kickback </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statute, U.S. False Claims Act and similar laws in other jurisdictions, U.S. Foreign Corrupt Practices Act (FCPA) and similar laws in other jurisdictions, and U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs and risks associated with current and future asserted litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of our litigation and risk management practices, including self-insurance and compliance activities on our loss contingencies, legal provisions and cash flows,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of, diversion of management attention as a result of, and costs to cooperate with, litigate and/or resolve governmental investigations and our class action, product liability, contract and other legal proceedings,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of failure to protect our intellectual property rights and the outcome of patent litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to operate properly our information systems that support our business operations and protect our data integrity and products from a cyber-attack or other breach that has a material adverse effect on our business, reputation or results of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including increased risks as an indirect result of the ongoing conflict between Russia and Ukraine, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact to internal control over financial reporting relating to potential restrictions to access to consigned inventory at customer locations for our inventory count procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovation and Certain Growth Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing, size and nature of our strategic growth initiatives and market opportunities, including with respect to our internal research and development platforms and externally available research and development platforms and technologies and the ultimate cost and success of those initiatives and opportunities,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to complete planned clinical trials successfully, obtain regulatory approvals and launch new and next generation products in a timely manner consistent with cost estimates, including the successful completion of projects from in-process research and development,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to identify and prioritize our internal research and development project portfolio and our external investment portfolio on profitable net sales growth opportunities as well as to maintain the estimated timing and costs of such projects and expected revenue levels for the resulting products and technologies,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop, manufacture and market new products and technologies successfully and in a timely manner and the ability of our competitors and other third parties to develop products or technologies that render our products or technologies noncompetitive or obsolete, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute appropriate decisions to discontinue, write-down or reduce the funding of any of our research and development projects, including projects from in-process research and development from our acquisitions, in our growth adjacencies or otherwise,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on acquisitions, alliances or investments to introduce new products or technologies and to enter new or adjacent growth markets and our ability to fund them or to fund contingent payments with respect to those acquisitions, alliances and investments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential failure to successfully integrate and realize the expected benefits, including cost synergies, from the strategic acquisitions, alliances and investments we have consummated or may consummate in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependency on international net sales to achieve growth, including in emerging markets,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing and collectability of customer payments, as well as our ability to continue factoring customer receivables where we have factoring arrangements, or to enter new factoring arrangements with favorable terms,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact on pricing due to national and regional tenders,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geopolitical and economic conditions, including civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the Russia/Ukraine conflict,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and related, downstream effects thereof, including the impact of sanctions on U.S. manufacturers doing business in these regions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Protection of our intellectual property, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including FCPA, EU MDR and similar laws in other jurisdictions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in reimbursement practices and policies,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of significant developments or uncertainties stemming from changes in the U.S. government following presidential and congressional elections, including changes in U.S. trade policies, tariffs and the reaction of other countries thereto, particularly China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to maintain or expand our worldwide market positions in the various markets in which we compete or seek to compete, including through investments in product diversification and emerging markets such as Brazil, Russia, India and China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute and realize anticipated benefits from our investments in emerging markets, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, expenses and resulting margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to generate sufficient cash flow to fund operations, capital expenditures, global expansion initiatives, any litigation settlements and judgments, share repurchases and strategic investments and acquisitions as well as maintaining our investment grade ratings and managing our debt levels and financial covenant compliance,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to access the public and private capital markets when desired and to issue debt or equity securities on terms reasonably acceptable to us,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open tax matters, exposure to additional tax liabilities and the impact of changes in U.S. and international tax laws,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open litigation matters, exposure to additional loss contingencies and legal provisions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of examinations and assessments by domestic and international taxing authorities on our tax provisions, financial condition or results of operations,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of counterparty default on our derivative financial instruments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to collect outstanding and future receivables and/or sell receivables under our factoring programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Reduction and Optimization Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with changes made or expected to be made to our organizational and operational structure, pursuant to our restructuring plans as well as any further restructuring or optimization plans we may undertake in the future and our ability to recognize benefits and cost reductions from such programs and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Business disruption and employee distraction as we execute our global compliance program, restructuring and optimization plans and divestitures of assets or businesses and implement our other strategic and cost reduction initiatives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell medical devices globally and our earnings and cash flows are exposed to market risk from changes in currency exchange rates and interest rates. We address these risks through a risk management program that includes the use of derivative financial instruments. We operate the program pursuant to documented corporate risk management policies. We do not enter derivative transactions for speculative purposes. Gains and losses on derivative financial instruments substantially offset losses and gains on underlying hedged exposures. Furthermore, we manage our exposure to counterparty risk on derivative instruments by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our currency risk consists primarily of foreign currency denominated firm commitments, forecasted foreign currency denominated intercompany and third-party transactions and net investments in certain subsidiaries. We use both nonderivative (primarily European manufacturing operations) and derivative instruments to manage our earnings and cash flow exposure to changes in currency exchange rates. We had currency derivative instruments outstanding in the contract amount of $6.920 billion as of June&#160;30, 2022 and $8.381 billion as of December&#160;31, 2021. A ten percent appreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would increase the derivative instruments&#8217; fair value by $264 million as of June&#160;30, 2022 as compared to $298 million as of December&#160;31, 2021. A ten percent depreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would decrease the derivative instruments&#8217; fair value by $323 million as of June&#160;30, 2022 as compared to $364 million as of December&#160;31, 2021. Any increase or decrease in the fair value of our currency exchange rate sensitive derivative instruments would be substantially offset by a corresponding decrease or increase in the fair value of the hedged underlying asset, liability or forecasted transaction, resulting in minimal impacts on our unaudited consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We have historically used interest rate derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. We had no interest rate derivative instruments outstanding as of June&#160;30, 2022 and December&#160;31, 2021. As of June&#160;30, 2022, $8.878 billion in aggregate principal amount of our outstanding debt obligations was at fixed interest rates, representing approximately 98 percent of our total debt, on an amortized cost basis. As of June&#160;30, 2022, our outstanding debt obligations at fixed interest rates were comprised of senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for further information regarding our derivative financial instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (CEO) and our Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of June&#160;30, 2022 pursuant to Rule&#160;13a-15(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Disclosure controls and procedures are designed to ensure that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such material information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, our CEO and CFO concluded that, as of June&#160;30, 2022, our disclosure controls and procedures were effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting in the second quarter or first six months of 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A multi-year implementation of a new global enterprise resource planning (ERP) system is in progress and will replace our existing ERP system. The implementation is expected to occur in phases over the next several years. As the phased implementation occurs, it will result in changes to our processes and procedures which will include changes to our internal controls over financial reporting. As such changes occur, we will evaluate quarterly whether they materially affect our internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note G &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to other information contained elsewhere in this report, you should carefully consider the factors discussed in Part&#160;I, Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report filed on Form 10-K, which could materially affect our business, financial condition or future results.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i81ec8629b9df431d9ba97fad2f676991_175"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (* documents filed or furnished with this report)</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.749%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000885725/000110465922031615/tm228612d1_ex4-1.htm">Indenture dated as of March 8, 2022, among American Medical Systems Europe B.V., Boston Scientific Corporation and U.S. Bank Trust Company, National Association, as Trustee (incorporated by reference to Exhibit 4.1, Current Report on Form 8-K dated March 8, 2022, File No. 1-11083)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000885725/000110465922031615/tm228612d1_ex4-2.htm">0.750% Senior Notes due March 8, 2025 (incorporated herein by reference to Exhibit 4.2, Current Report on Form 8-K dated March 8, 2022, File No. 1-11083)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000885725/000110465922031615/tm228612d1_ex4-3.htm">1.375% Senior Notes due March 8, 2028 (incorporated herein by reference to Exhibit 4.3, Current Report on Form 8-K dated March 8, 2022, File No. 1-11083)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000885725/000110465922031615/tm228612d1_ex4-4.htm">1.625% Senior Notes due March 8, 2031 (incorporated herein by reference to Exhibit 4.4, Current Report on Form 8-K dated March 8, 2022, File No. 1-11083)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000885725/000110465922031615/tm228612d1_ex4-5.htm">1.875% Senior Notes due March 8, 2034 ((incorporated herein by reference to Exhibit 4.5, Current Report on Form 8-K dated March 8, 2022, File No. 1-11083)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465922057017/tm2214421d1_ex10-1.htm">Form of EC Non-CEO Change in Control Agreement (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated May 6, 2022, File No. 1-11083)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465922057017/tm2214421d1_ex10-2.htm">Boston Scientific Corporation Employee Stock Purchase Plan, Amended and Restated Effective as of July 1, 2022 (incorporated by reference herein to Exhibit 10.2, Current Report on Form 8-K dated May 6, 2022, File No. 1-11083)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit22-subsidiaryissuer.htm">Subsidiary Issuer of Guaranteed Securities</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-ceo302q22022.htm">Certification of the Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-cfo302q22022.htm">Certification of the Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-ceo906q22022.htm">Certification of the Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-cfo906q22022.htm">Certification of the Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.749%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 73pt;text-align:left;text-indent:-72pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i81ec8629b9df431d9ba97fad2f676991_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i81ec8629b9df431d9ba97fad2f676991_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August&#160;4, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and<br/>Chief Financial Officer&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-ceo302q22022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2cb11b7febbc4a4da617a97d4cdc3303_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael F. Mahoney, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-cfo302q22022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i99b70b08a78949038c59830e09b725f0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel J. Brennan, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.542%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-ceo906q22022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia314153d4ee345078e034cbe344b8cbe_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322-cfo906q22022.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9af82a8c3fd54c75b13c3eb4b2f8f9d1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:4.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>6
<FILENAME>exhibit22-subsidiaryissuer.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i527e534dc0ce428d8eea296236d9cdab_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 22</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiary Issuer of Guaranteed Securities</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Boston Scientific (the &#8220;Registrant&#8221;) is the guarantor of the senior unsecured registered notes listed below issued by American Medical Systems Europe B.V., a wholly-owned finance subsidiary of the Registrant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">American Medical Systems Europe B.V.&#58; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0.750% Senior Notes due 2025</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.375% Senior Notes due 2028</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.625% Senior Notes due 2031</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> 1.875% Senior Notes due 2034&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>bsx-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:202f2156-2eff-48c6-8020-e675b6a04e60,g:66d98efe-f6bb-4852-90b5-5e203e0b5e35-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0001001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1001002 - Statement - Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1004005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>1005006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsSupplementalDisclosure" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.bostonscientific.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationBasisofPresentationPolicies" roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetails" roleURI="http://www.bostonscientific.com/role/BasisofPresentationDetails">
        <link:definition>2403401 - Disclosure - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandStrategicInvestments" roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments">
        <link:definition>2104102 - Disclosure - Acquisitions, Divestitures and Strategic Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandStrategicInvestmentsTables" roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables">
        <link:definition>2305301 - Disclosure - Acquisitions, Divestitures and Strategic Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresDetails" roleURI="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails">
        <link:definition>2406402 - Disclosure - Acquisitions and Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationDetails" roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails">
        <link:definition>2407403 - Disclosure - Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails">
        <link:definition>2408404 - Disclosure - Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2109103 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillTables" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables">
        <link:definition>2310302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails">
        <link:definition>2411405 - Disclosure - Goodwill and Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurements" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements">
        <link:definition>2112104 - Disclosure - Hedging Activities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies">
        <link:definition>2213202 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsTables" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables">
        <link:definition>2314303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsDetails" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails">
        <link:definition>2415406 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitments" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments">
        <link:definition>2116105 - Disclosure - Contractual Obligations and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsTables" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables">
        <link:definition>2317304 - Disclosure - Contractual Obligations and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsDetails" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails">
        <link:definition>2418407 - Disclosure - Contractual Obligations and Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation">
        <link:definition>2119106 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>2320305 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationDetails" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails">
        <link:definition>2421408 - Disclosure - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bostonscientific.com/role/IncomeTaxes">
        <link:definition>2122107 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables">
        <link:definition>2323306 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails">
        <link:definition>2424409 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies">
        <link:definition>2125108 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesCommitmentsandContingenciesPolicies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies">
        <link:definition>2226203 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2427410 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.bostonscientific.com/role/StockholdersEquity">
        <link:definition>2128109 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails">
        <link:definition>2429411 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstanding" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding">
        <link:definition>2130110 - Disclosure - Weighted Average Shares Outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingTables" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables">
        <link:definition>2331307 - Disclosure - Weighted Average Shares Outstanding (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingDetails" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails">
        <link:definition>2432412 - Disclosure - Weighted Average Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.bostonscientific.com/role/SegmentReporting">
        <link:definition>2133111 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.bostonscientific.com/role/SegmentReportingTables">
        <link:definition>2334308 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails">
        <link:definition>2435413 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.bostonscientific.com/role/Revenue">
        <link:definition>2136112 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.bostonscientific.com/role/RevenueTables">
        <link:definition>2337309 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.bostonscientific.com/role/RevenueDetails">
        <link:definition>2438414 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncome" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome">
        <link:definition>2139113 - Disclosure - Changes in Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies">
        <link:definition>2240204 - Disclosure - Changes in Other Comprehensive Income Changes in Other Comprehensive Income (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeTables" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables">
        <link:definition>2341310 - Disclosure - Changes in Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeDetails" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails">
        <link:definition>2442415 - Disclosure - Changes in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements">
        <link:definition>2143114 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2244205 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_AccruedRebatesCurrent" abstract="false" name="AccruedRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RevenueBasedPaymentsMember" abstract="true" name="RevenueBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LatinAmericaandCanadaMember" abstract="true" name="LatinAmericaandCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ExclusionFromEbitdaForRestructuringCharges" abstract="false" name="ExclusionFromEbitdaForRestructuringCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherOtherLongtermAssets" abstract="false" name="OtherOtherLongtermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OperatingIncomeUnallocatedToSegment" abstract="false" name="OperatingIncomeUnallocatedToSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OperatingIncomeAllocatedToReportableSegments" abstract="false" name="OperatingIncomeAllocatedToReportableSegments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DivestitureAgreementTransferOfGlobalEmployees" abstract="false" name="DivestitureAgreementTransferOfGlobalEmployees" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" abstract="false" name="DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalUrologyandPelvicHealthReportingUnitMember" abstract="true" name="GlobalUrologyandPelvicHealthReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LicensingarrangementassetsMember" abstract="true" name="LicensingarrangementassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_June2025NotesMember" abstract="true" name="June2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalCardiologyReportingUnitMember" abstract="true" name="GlobalCardiologyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SpecialtyPharmaceuticalsMember" abstract="true" name="SpecialtyPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_StatementAxis" abstract="true" name="StatementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_March2031NotesMember" abstract="true" name="March2031NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CovenantAxis" abstract="true" name="CovenantAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" abstract="true" name="CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_March2028SeniorNotesMember" abstract="true" name="March2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_EmergingMarketstotalnumberofcountries" abstract="false" name="EmergingMarketstotalnumberofcountries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_May2025NotesMember" abstract="true" name="May2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalEndoscopyEndoReportingUnitMember" abstract="true" name="GlobalEndoscopyEndoReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_InventoryStepUpAmortization" abstract="false" name="InventoryStepUpAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_December2027NotesMember" abstract="true" name="December2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_YenDenominatedFactoringArrangementsMember" abstract="true" name="YenDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ElectrophysiologyEPMember" abstract="true" name="ElectrophysiologyEPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_The2018FacilityDomain" abstract="true" name="The2018FacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_NewAccountingPronouncementsPolicyTextBlock" abstract="false" name="NewAccountingPronouncementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_SpecialChargesMember" abstract="true" name="SpecialChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" abstract="false" name="ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_RDRegulatoryandCommercializationbasedMilestoneMember" abstract="true" name="RDRegulatoryandCommercializationbasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSixthQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2026NotesMember" abstract="true" name="March2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2029NotesMember" abstract="true" name="March2029NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_PreventiceSolutionsIncMember" abstract="true" name="PreventiceSolutionsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_NumberOfBusinesses" abstract="false" name="NumberOfBusinesses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_Segmentoperatingincomeaspercentageofnetsales" abstract="false" name="Segmentoperatingincomeaspercentageofnetsales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_MaximumLeverageRatio" abstract="false" name="MaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_TotalAllocatedToReportableSegmentsMember" abstract="true" name="TotalAllocatedToReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_MaximumCommercialPaperOutstanding" abstract="false" name="MaximumCommercialPaperOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" abstract="false" name="ImpactOfForeignCurrencyFluctuationsOnNetSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" abstract="true" name="CondensedConsolidatedBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" abstract="true" name="TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_November2035NotesMember" abstract="true" name="November2035NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_MITechCoLtdMember" abstract="true" name="MITechCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" abstract="false" name="ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_EntityAbstract" abstract="true" name="EntityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_BaylisMedicalMember" abstract="true" name="BaylisMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_OtherNet" abstract="false" name="OtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CertifiedClassActionsInAustraliaMesh" abstract="false" name="CertifiedClassActionsInAustraliaMesh" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_AllBusinessAcquisitionsMember" abstract="true" name="AllBusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DebtInstrumentExtensionOptionTerm" abstract="false" name="DebtInstrumentExtensionOptionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_March2034NotesMember" abstract="true" name="March2034NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" abstract="true" name="CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CardiovascularMember" abstract="true" name="CardiovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_EuroDenominatedFactoringArrangementsMember" abstract="true" name="EuroDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ContingentConsiderationLiabilityProbabilityOfPayment" abstract="false" name="ContingentConsiderationLiabilityProbabilityOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_DiscountRateFairValueInput" abstract="false" name="DiscountRateFairValueInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_ForeigncurrencydenominatedindebtMember" abstract="true" name="ForeigncurrencydenominatedindebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CorporateExpensesincludinghedgingactivitiesMember" abstract="true" name="CorporateExpensesincludinghedgingactivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_DivestitureAgreementTransferOfFacilities" abstract="false" name="DivestitureAgreementTransferOfFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_Licensingarrangements" abstract="false" name="Licensingarrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Paymenttonetsharesettleemployeeequityawards" abstract="false" name="Paymenttonetsharesettleemployeeequityawards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_BSXReportableSegmentsMember" abstract="true" name="BSXReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" abstract="false" name="SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" abstract="false" name="CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_March2025NotesMember" abstract="true" name="March2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" abstract="false" name="CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_March2039NotesMember" abstract="true" name="March2039NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_StatementDomain" abstract="true" name="StatementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RenminbiDenominatedFactoringArrangementsMember" abstract="true" name="RenminbiDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfifthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CovenantDomain" abstract="true" name="CovenantDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_Netcurrencyexchangegainloss" abstract="false" name="Netcurrencyexchangegainloss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationLineItems" abstract="true" name="ScheduleofIncomeTaxRateReconciliationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_OtherCurrentAssetsAbstract" abstract="true" name="OtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_March2049NotesMember" abstract="true" name="March2049NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LitigationAndDebtExclusionFromEbitda" abstract="false" name="LitigationAndDebtExclusionFromEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" abstract="false" name="TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ActualCovenantMember" abstract="true" name="ActualCovenantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_IntangibleAssetsandGoodwillLineItems" abstract="true" name="IntangibleAssetsandGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_TheOfferingAggregatePrincipalAmountMember" abstract="true" name="TheOfferingAggregatePrincipalAmountMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalPeripheralInterventionsPiReportingUnitMember" abstract="true" name="GlobalPeripheralInterventionsPiReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" abstract="false" name="ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_January2040NotesMember" abstract="true" name="January2040NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" abstract="false" name="ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CardiacRhythmManagementMember" abstract="true" name="CardiacRhythmManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" abstract="false" name="ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" abstract="false" name="DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_GlobalNeuromodulationNmReportingUnitMember" abstract="true" name="GlobalNeuromodulationNmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_NumberOfBusinessesDivested" abstract="false" name="NumberOfBusinessesDivested" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationTextualsAbstract" abstract="true" name="SupplementalBalanceSheetInformationTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_LumenisMember" abstract="true" name="LumenisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" abstract="false" name="RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_June2030NotesMember" abstract="true" name="June2030NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_WatchmanMember" abstract="true" name="WatchmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" abstract="false" name="Productliabilitycasesorclaimsrelatedtomeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" abstract="true" name="RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ForwardCurrencyContractsTimetoMaturity" abstract="false" name="ForwardCurrencyContractsTimetoMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_MedsurgMember" abstract="true" name="MedsurgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_IndemnificationAsset" abstract="false" name="IndemnificationAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LicensingarrangementliabilitiesMember" abstract="true" name="LicensingarrangementliabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_InterventionalCardiologyTherapiesMember" abstract="true" name="InterventionalCardiologyTherapiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_Noncashimpactoftransferredroyaltyrights" abstract="false" name="Noncashimpactoftransferredroyaltyrights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" abstract="false" name="ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_Licensingarrangementsliability" abstract="false" name="Licensingarrangementsliability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_May2022NotesMember" abstract="true" name="May2022NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_QualifiedAcquisitionConsideration" abstract="false" name="QualifiedAcquisitionConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductCanada" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_October2023NotesMember" abstract="true" name="October2023NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CurrentRequirementMember" abstract="true" name="CurrentRequirementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RevolvingCreditFacility2021Member" abstract="true" name="RevolvingCreditFacility2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationAbstract" abstract="true" name="SupplementalBalanceSheetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_EquipmentFurnitureAndFixturesGross" abstract="false" name="EquipmentFurnitureAndFixturesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Licensingarrangementsasset" abstract="false" name="Licensingarrangementsasset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" abstract="true" name="RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationTable" abstract="true" name="ScheduleofIncomeTaxRateReconciliationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_March2024NotesMember" abstract="true" name="March2024NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" abstract="false" name="ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" abstract="false" name="ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_PaymentsForRoyaltyRights" abstract="false" name="PaymentsForRoyaltyRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CanadaSettledClaims" abstract="false" name="CanadaSettledClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_March2028NotesMember" abstract="true" name="March2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>bsx-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:202f2156-2eff-48c6-8020-e675b6a04e60,g:66d98efe-f6bb-4852-90b5-5e203e0b5e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_832ee698-dc3b-46db-8299-dfd7a77536b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_359b2cdb-473c-4818-b593-9a16e2e7a82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_832ee698-dc3b-46db-8299-dfd7a77536b8" xlink:to="loc_us-gaap_OperatingIncomeLoss_359b2cdb-473c-4818-b593-9a16e2e7a82b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_90c184cb-97b1-48f5-a72b-762b93bc44c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_832ee698-dc3b-46db-8299-dfd7a77536b8" xlink:to="loc_us-gaap_InterestExpense_90c184cb-97b1-48f5-a72b-762b93bc44c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9962ab18-6419-4031-b4d8-caef2911cc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_832ee698-dc3b-46db-8299-dfd7a77536b8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9962ab18-6419-4031-b4d8-caef2911cc7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8469d8a6-b2f2-4d50-847e-b07b4884ed8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9570c4bf-db9f-4dda-808e-752be3cf56fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8469d8a6-b2f2-4d50-847e-b07b4884ed8b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9570c4bf-db9f-4dda-808e-752be3cf56fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8d6aead8-b392-40c6-a191-bbc884ed5b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8469d8a6-b2f2-4d50-847e-b07b4884ed8b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8d6aead8-b392-40c6-a191-bbc884ed5b2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_6e7ab4ae-49cc-4aba-94b9-6c9171b2e166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_RoyaltyExpense_6e7ab4ae-49cc-4aba-94b9-6c9171b2e166" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_6ed22971-6773-42b7-85fc-ea4ffad32b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_6ed22971-6773-42b7-85fc-ea4ffad32b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_97a26f4e-87d9-4ec2-8b0d-e68e31dc310d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_97a26f4e-87d9-4ec2-8b0d-e68e31dc310d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_f5901a5f-600a-4bf8-bb87-0d1662b6130c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_f5901a5f-600a-4bf8-bb87-0d1662b6130c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2bda4059-f412-4876-8ddc-13310d031c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2bda4059-f412-4876-8ddc-13310d031c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_746ce581-6d6e-4013-bbcf-336abadf6f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_LitigationSettlementExpense_746ce581-6d6e-4013-bbcf-336abadf6f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_59154e81-390e-42bb-a9fc-a90a70629a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_RestructuringCharges_59154e81-390e-42bb-a9fc-a90a70629a53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_7f73740f-62d0-4518-b732-095825555dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_7f73740f-62d0-4518-b732-095825555dec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0d9c8755-303f-458f-9c50-9d9d84a623d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4bda18fd-32a3-4467-b598-f4cc21a0bf75" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0d9c8755-303f-458f-9c50-9d9d84a623d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1eefbc2a-3e37-4671-b051-8c4c5f4a95ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_86b09455-6089-4cfc-8027-209e45beac63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1eefbc2a-3e37-4671-b051-8c4c5f4a95ce" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_86b09455-6089-4cfc-8027-209e45beac63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac1beb37-f11e-4e51-90b6-0002e88884b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1eefbc2a-3e37-4671-b051-8c4c5f4a95ce" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac1beb37-f11e-4e51-90b6-0002e88884b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1fe99875-f728-4cef-b87d-c640c0264b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_32e94a92-d7d9-4cd9-bb1d-3fe0510328eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1fe99875-f728-4cef-b87d-c640c0264b68" xlink:to="loc_us-gaap_DividendsPreferredStockStock_32e94a92-d7d9-4cd9-bb1d-3fe0510328eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d7764f5a-ee2c-4aa7-bd2c-a0048a7bbb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1fe99875-f728-4cef-b87d-c640c0264b68" xlink:to="loc_us-gaap_ProfitLoss_d7764f5a-ee2c-4aa7-bd2c-a0048a7bbb4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_191321fd-ae19-4511-81d0-1906aee7c6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_07e1be58-03d1-4ce4-850b-b412994e05f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_191321fd-ae19-4511-81d0-1906aee7c6a7" xlink:to="loc_us-gaap_GrossProfit_07e1be58-03d1-4ce4-850b-b412994e05f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_cc09dc47-dc72-40e8-84eb-5abd7e6501ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_191321fd-ae19-4511-81d0-1906aee7c6a7" xlink:to="loc_us-gaap_OperatingExpenses_cc09dc47-dc72-40e8-84eb-5abd7e6501ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_525d2836-a860-4540-a752-3b8111852879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9368e960-0db8-448c-a567-27f7c5ae6f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_525d2836-a860-4540-a752-3b8111852879" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9368e960-0db8-448c-a567-27f7c5ae6f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_6b550550-8e36-4139-bb1b-ca124cfbf6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_525d2836-a860-4540-a752-3b8111852879" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_6b550550-8e36-4139-bb1b-ca124cfbf6c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7a178424-e882-4649-9c58-d6394e62151f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_525d2836-a860-4540-a752-3b8111852879" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7a178424-e882-4649-9c58-d6394e62151f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_449d056d-f015-42fa-bd04-ac8c00d3dfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eba64aa5-0d90-47c3-a20f-065c61ee19d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_449d056d-f015-42fa-bd04-ac8c00d3dfdb" xlink:to="loc_us-gaap_ProfitLoss_eba64aa5-0d90-47c3-a20f-065c61ee19d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4f5aee56-3d6c-4e82-adba-9b786bc76b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_449d056d-f015-42fa-bd04-ac8c00d3dfdb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4f5aee56-3d6c-4e82-adba-9b786bc76b4d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1b4db7ff-1571-47b8-9e60-dce357dc9700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2f7399c7-e85e-4842-9eb5-77b2ac011e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1b4db7ff-1571-47b8-9e60-dce357dc9700" xlink:to="loc_us-gaap_DebtCurrent_2f7399c7-e85e-4842-9eb5-77b2ac011e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6a672258-fdc4-482f-a3d5-f26136783314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1b4db7ff-1571-47b8-9e60-dce357dc9700" xlink:to="loc_us-gaap_AccountsPayableCurrent_6a672258-fdc4-482f-a3d5-f26136783314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_643d337f-1de2-4922-910e-4832588a41a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1b4db7ff-1571-47b8-9e60-dce357dc9700" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_643d337f-1de2-4922-910e-4832588a41a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_acb26943-0831-4997-984b-b57183146b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1b4db7ff-1571-47b8-9e60-dce357dc9700" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_acb26943-0831-4997-984b-b57183146b35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bd62291a-faa7-412f-a65d-ef939fe00d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_50bfcfa9-a5de-4546-a724-cadeca96949c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bd62291a-faa7-412f-a65d-ef939fe00d43" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_50bfcfa9-a5de-4546-a724-cadeca96949c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_43bc9e75-3844-4d5c-a750-598c3f719f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bd62291a-faa7-412f-a65d-ef939fe00d43" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_43bc9e75-3844-4d5c-a750-598c3f719f4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_ac685b8c-98cd-4d81-abe7-eacf121f6f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bd62291a-faa7-412f-a65d-ef939fe00d43" xlink:to="loc_us-gaap_PrepaidTaxes_ac685b8c-98cd-4d81-abe7-eacf121f6f47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cb5132c0-eead-4b16-841b-d099300c6ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bd62291a-faa7-412f-a65d-ef939fe00d43" xlink:to="loc_us-gaap_InventoryNet_cb5132c0-eead-4b16-841b-d099300c6ea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a0cd921a-a7b0-43a8-97e2-87a00c32cfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bd62291a-faa7-412f-a65d-ef939fe00d43" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a0cd921a-a7b0-43a8-97e2-87a00c32cfb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dadb594d-f21a-46e8-905f-404aceab9b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_761314b8-d36d-4fa8-be26-c40c4b90b8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dadb594d-f21a-46e8-905f-404aceab9b83" xlink:to="loc_us-gaap_TreasuryStockValue_761314b8-d36d-4fa8-be26-c40c4b90b8c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c1501937-a482-496e-9a9e-4bbb2c6080d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dadb594d-f21a-46e8-905f-404aceab9b83" xlink:to="loc_us-gaap_CommonStockValue_c1501937-a482-496e-9a9e-4bbb2c6080d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a8d98440-386a-4b17-a0c8-d52336415f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dadb594d-f21a-46e8-905f-404aceab9b83" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a8d98440-386a-4b17-a0c8-d52336415f4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0ce4f7cf-2d5d-49c2-9d68-e14b87a1df92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dadb594d-f21a-46e8-905f-404aceab9b83" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0ce4f7cf-2d5d-49c2-9d68-e14b87a1df92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5bcc3f78-0a93-4262-aa6e-fc1d79868838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dadb594d-f21a-46e8-905f-404aceab9b83" xlink:to="loc_us-gaap_PreferredStockValue_5bcc3f78-0a93-4262-aa6e-fc1d79868838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0fb3e328-777c-4f38-9b01-60a3c11f438c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dadb594d-f21a-46e8-905f-404aceab9b83" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0fb3e328-777c-4f38-9b01-60a3c11f438c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a33143be-84a7-40e5-8791-a3315f28e2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c3774510-0285-45cf-8dbe-0019d52c9886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a33143be-84a7-40e5-8791-a3315f28e2dd" xlink:to="loc_us-gaap_LiabilitiesCurrent_c3774510-0285-45cf-8dbe-0019d52c9886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2c49e3a3-2fe1-4941-a53d-5d294204b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a33143be-84a7-40e5-8791-a3315f28e2dd" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2c49e3a3-2fe1-4941-a53d-5d294204b1f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1d0d0081-2867-4433-96ed-c2c7a11b8c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a33143be-84a7-40e5-8791-a3315f28e2dd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1d0d0081-2867-4433-96ed-c2c7a11b8c4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6aaa4209-4d09-4380-a962-ebb37b512ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a33143be-84a7-40e5-8791-a3315f28e2dd" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6aaa4209-4d09-4380-a962-ebb37b512ae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_75e43c73-14c2-42f5-ad30-74dacb01f0be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a33143be-84a7-40e5-8791-a3315f28e2dd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_75e43c73-14c2-42f5-ad30-74dacb01f0be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_02176b55-c290-4e10-bde9-99ea46239e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a33143be-84a7-40e5-8791-a3315f28e2dd" xlink:to="loc_us-gaap_CommitmentsAndContingencies_02176b55-c290-4e10-bde9-99ea46239e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dca32af0-7b92-46d5-9de1-7d080111c20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d8f493ff-65be-4fd1-b576-2215aa85deb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dca32af0-7b92-46d5-9de1-7d080111c20a" xlink:to="loc_us-gaap_AssetsCurrent_d8f493ff-65be-4fd1-b576-2215aa85deb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6c62db97-071d-4a42-8203-a59efadb417b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dca32af0-7b92-46d5-9de1-7d080111c20a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6c62db97-071d-4a42-8203-a59efadb417b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3be58b8d-ae34-4de8-8c85-af9561cc5416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dca32af0-7b92-46d5-9de1-7d080111c20a" xlink:to="loc_us-gaap_Goodwill_3be58b8d-ae34-4de8-8c85-af9561cc5416" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_43c08015-d9da-456f-aa5f-0dbec8aa1aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dca32af0-7b92-46d5-9de1-7d080111c20a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_43c08015-d9da-456f-aa5f-0dbec8aa1aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fa586697-5f8e-44fa-96e0-30c762f774e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dca32af0-7b92-46d5-9de1-7d080111c20a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fa586697-5f8e-44fa-96e0-30c762f774e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_43549c06-fa66-4758-b992-1ad44a5eb13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dca32af0-7b92-46d5-9de1-7d080111c20a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_43549c06-fa66-4758-b992-1ad44a5eb13f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6f44b162-d525-422a-81de-f2be84df0e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6f44b162-d525-422a-81de-f2be84df0e92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_433bde66-fb70-48d7-8594-ed39bcebfcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_433bde66-fb70-48d7-8594-ed39bcebfcc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_cc61748e-df9d-49d6-adf0-d8b088fb1bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_cc61748e-df9d-49d6-adf0-d8b088fb1bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_679bd678-d716-4ad4-9cea-f559a9eca81a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_679bd678-d716-4ad4-9cea-f559a9eca81a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_67fc36d3-450f-4179-a629-6384f479ea57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_67fc36d3-450f-4179-a629-6384f479ea57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_843e1e03-7eba-4383-8dcb-cbb0210686e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_843e1e03-7eba-4383-8dcb-cbb0210686e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_0bea3b91-7288-47e1-9fa1-1c12b35a6862" xlink:href="bsx-20220630.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55fbb850-da4a-45c4-b512-ddf2e04f789f" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_0bea3b91-7288-47e1-9fa1-1c12b35a6862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5851dcad-98fb-46a7-8b3c-c1aed6a7c4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f02046b-9f29-4813-a0b3-d34c5159c19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5851dcad-98fb-46a7-8b3c-c1aed6a7c4f6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f02046b-9f29-4813-a0b3-d34c5159c19f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d519ffd-aa0e-465c-99db-9bfe2f442099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5851dcad-98fb-46a7-8b3c-c1aed6a7c4f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d519ffd-aa0e-465c-99db-9bfe2f442099" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d26dd350-586f-40bf-8296-0ad3537459ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5851dcad-98fb-46a7-8b3c-c1aed6a7c4f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d26dd350-586f-40bf-8296-0ad3537459ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d370f8a9-c49f-4d25-9092-acdaacb9b668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5851dcad-98fb-46a7-8b3c-c1aed6a7c4f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d370f8a9-c49f-4d25-9092-acdaacb9b668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_95c154d2-1298-45b9-bd6a-2c3abc0243f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_95c154d2-1298-45b9-bd6a-2c3abc0243f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_35fc4f02-8d67-414e-b86e-52bb5481ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_35fc4f02-8d67-414e-b86e-52bb5481ac22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_09beffb7-0e4f-4c52-9065-fada05e510b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_GainLossOnInvestments_09beffb7-0e4f-4c52-9065-fada05e510b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8c15fa28-20a7-490f-8039-0f4028bc722c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_ShareBasedCompensation_8c15fa28-20a7-490f-8039-0f4028bc722c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c9137c83-1457-4c39-ae1f-276086af7b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c9137c83-1457-4c39-ae1f-276086af7b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_37cf45ab-d26f-4801-a668-376a21094a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_37cf45ab-d26f-4801-a668-376a21094a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_eaf677c4-53d9-43a7-a627-3c83be13cb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_eaf677c4-53d9-43a7-a627-3c83be13cb3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_08ef73c6-fa38-45a2-9a49-b43f2412ffb7" xlink:href="bsx-20220630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_bsx_InventoryStepUpAmortization_08ef73c6-fa38-45a2-9a49-b43f2412ffb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_8909ba23-d23b-446c-b717-ad24a30b4d51" xlink:href="bsx-20220630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_8909ba23-d23b-446c-b717-ad24a30b4d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_df0641c8-e36b-4b7c-8d77-fe51ef83f5c2" xlink:href="bsx-20220630.xsd#bsx_OtherNet"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_bsx_OtherNet_df0641c8-e36b-4b7c-8d77-fe51ef83f5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2f9af6ed-0f95-4966-a890-c8452c3656f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_ProfitLoss_2f9af6ed-0f95-4966-a890-c8452c3656f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a0d4e8c0-af75-497c-9f02-7ad4d58873b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a0d4e8c0-af75-497c-9f02-7ad4d58873b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efab752a-6cfc-4ffa-b36b-6f015a01812f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efab752a-6cfc-4ffa-b36b-6f015a01812f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f7fe6e73-e1d5-475f-aecc-c90c3a2047b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f7fe6e73-e1d5-475f-aecc-c90c3a2047b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_45504cd4-d8f2-4512-b6bc-ea39b3e182cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fef1e83c-ed66-4316-afe1-5a7c3e749029" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_45504cd4-d8f2-4512-b6bc-ea39b3e182cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4bfa8130-b176-4d24-be06-e415e671409c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4bfa8130-b176-4d24-be06-e415e671409c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_99a2fff2-9546-4375-841e-8a8f2d658b78" xlink:href="bsx-20220630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_bsx_PaymentsForRoyaltyRights_99a2fff2-9546-4375-841e-8a8f2d658b78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_67adf1ab-df32-4454-b87b-60f5523ff924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_67adf1ab-df32-4454-b87b-60f5523ff924" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_a724040d-89be-4925-86b9-a2b2c12291b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_a724040d-89be-4925-86b9-a2b2c12291b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_1605eff7-e2e7-4b3d-840e-c53d01731072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_1605eff7-e2e7-4b3d-840e-c53d01731072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_6d3de6e8-4ef5-4e0c-acaa-2c627174cd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_6d3de6e8-4ef5-4e0c-acaa-2c627174cd12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_42a97019-45ff-4133-82f9-8de0a02e32ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_PaymentsOfDividends_42a97019-45ff-4133-82f9-8de0a02e32ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_c391b26b-327f-4c9e-bd78-24b130295831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_c391b26b-327f-4c9e-bd78-24b130295831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_4dd07bde-f777-4882-9b29-57c339c6f473" xlink:href="bsx-20220630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_4dd07bde-f777-4882-9b29-57c339c6f473" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_2070434a-f2dd-4bdb-b3d7-38cffe7ec3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2eae345-0645-4407-b153-b01bcba8cdfb" xlink:to="loc_us-gaap_ProceedsFromStockPlans_2070434a-f2dd-4bdb-b3d7-38cffe7ec3f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_caceb3b7-bd33-43b6-a2b1-a9e13715b10e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_86c4fa5c-253a-4961-8179-4509bd365bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_caceb3b7-bd33-43b6-a2b1-a9e13715b10e" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_86c4fa5c-253a-4961-8179-4509bd365bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_872c2791-c7cf-4444-8da2-84020faf10c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_caceb3b7-bd33-43b6-a2b1-a9e13715b10e" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_872c2791-c7cf-4444-8da2-84020faf10c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_d8ac500e-ae44-45e0-934e-96823fedd304" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_caceb3b7-bd33-43b6-a2b1-a9e13715b10e" xlink:to="loc_bsx_Licensingarrangements_d8ac500e-ae44-45e0-934e-96823fedd304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_faaf15bb-aae2-448f-9042-f640c8db2569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_caceb3b7-bd33-43b6-a2b1-a9e13715b10e" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_faaf15bb-aae2-448f-9042-f640c8db2569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5a7ec206-97c7-4523-9790-ecf0c7647f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_06d798ff-e071-418f-9d23-c2c6f850de03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5a7ec206-97c7-4523-9790-ecf0c7647f77" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_06d798ff-e071-418f-9d23-c2c6f850de03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_25df1882-87bd-4ac2-a3a6-ae7c317e5d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5a7ec206-97c7-4523-9790-ecf0c7647f77" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_25df1882-87bd-4ac2-a3a6-ae7c317e5d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ba3ecab3-c52c-4b26-bf73-eeb9f762ce55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ba3ecab3-c52c-4b26-bf73-eeb9f762ce55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_521628bd-d036-4498-b755-a98bdfb77fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_521628bd-d036-4498-b755-a98bdfb77fd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0326e58e-7952-439b-afcb-51816d5a8327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0326e58e-7952-439b-afcb-51816d5a8327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_ad946fb0-0a21-4ca3-a486-88789eb21435" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsliability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:to="loc_bsx_Licensingarrangementsliability_ad946fb0-0a21-4ca3-a486-88789eb21435" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2b518e72-bf86-4da5-aa7b-6104b8e68d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2b518e72-bf86-4da5-aa7b-6104b8e68d60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_31580f68-650a-4524-ba0a-41acc9668a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:to="loc_us-gaap_DeferredRevenue_31580f68-650a-4524-ba0a-41acc9668a42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a6768003-9e3f-4853-bef5-35cb0ab8d983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_75d6255f-7500-4a40-a536-a6cb7c5ba797" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a6768003-9e3f-4853-bef5-35cb0ab8d983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e849504a-6fff-4034-befc-b1def414cee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_6ada04c7-d4db-41db-bdcb-37a11e773586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e849504a-6fff-4034-befc-b1def414cee0" xlink:to="loc_us-gaap_TaxesPayableCurrent_6ada04c7-d4db-41db-bdcb-37a11e773586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_a6463ee6-0e37-4750-8662-f4c02887d92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e849504a-6fff-4034-befc-b1def414cee0" xlink:to="loc_us-gaap_DeferredRevenueCurrent_a6463ee6-0e37-4750-8662-f4c02887d92e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_24526882-de53-4763-a536-56a7e65e76a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e849504a-6fff-4034-befc-b1def414cee0" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_24526882-de53-4763-a536-56a7e65e76a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_e5e578a1-9191-497e-ae39-459928808dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e849504a-6fff-4034-befc-b1def414cee0" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_e5e578a1-9191-497e-ae39-459928808dd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_45dc263b-f6d8-4f46-8a21-aad9710a3663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_e3f76674-95f5-4833-9874-fae7ebd7e2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_45dc263b-f6d8-4f46-8a21-aad9710a3663" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_e3f76674-95f5-4833-9874-fae7ebd7e2b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_4ccaf009-8326-449e-941d-7b490ea6f8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_45dc263b-f6d8-4f46-8a21-aad9710a3663" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_4ccaf009-8326-449e-941d-7b490ea6f8ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_6cea64e3-86da-4aed-8e90-147e121221e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_6cea64e3-86da-4aed-8e90-147e121221e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_68ff7e67-d694-4309-9d9e-5f79e42efd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_68ff7e67-d694-4309-9d9e-5f79e42efd2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_a3af19f4-34c5-4240-8a45-918dc0810035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:to="loc_us-gaap_DerivativeAssets_a3af19f4-34c5-4240-8a45-918dc0810035" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_5dfc7c14-0120-4d4e-ae29-ebbd766b7a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:to="loc_us-gaap_Investments_5dfc7c14-0120-4d4e-ae29-ebbd766b7a98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_9cd82425-8b9f-4d3f-a465-2f129566d70c" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsasset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:to="loc_bsx_Licensingarrangementsasset_9cd82425-8b9f-4d3f-a465-2f129566d70c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IndemnificationAsset_f459049e-3fa9-4219-9a93-fe9ce0b53c57" xlink:href="bsx-20220630.xsd#bsx_IndemnificationAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:to="loc_bsx_IndemnificationAsset_f459049e-3fa9-4219-9a93-fe9ce0b53c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_e1447867-4e29-4e6b-afdd-c8e034a0bff3" xlink:href="bsx-20220630.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_60a22c40-d3b8-4966-9916-2e7c85b63517" xlink:to="loc_bsx_OtherOtherLongtermAssets_e1447867-4e29-4e6b-afdd-c8e034a0bff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c6a5bd4e-bb7a-4c3f-987c-2f3a52960ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d4df3e3b-9a41-435b-ab48-93a193ea83bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c6a5bd4e-bb7a-4c3f-987c-2f3a52960ffb" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d4df3e3b-9a41-435b-ab48-93a193ea83bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9366d1b4-db15-42ad-a5a4-bb54f3d0a837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c6a5bd4e-bb7a-4c3f-987c-2f3a52960ffb" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9366d1b4-db15-42ad-a5a4-bb54f3d0a837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7ff1aac8-19b0-46af-99e4-f1bd1030669d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c6a5bd4e-bb7a-4c3f-987c-2f3a52960ffb" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7ff1aac8-19b0-46af-99e4-f1bd1030669d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9a873c5c-c43a-4f85-a604-e17300ffe030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_bcac6ae5-f585-4592-a1a3-9cdb73ff7a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9a873c5c-c43a-4f85-a604-e17300ffe030" xlink:to="loc_us-gaap_LitigationReserveCurrent_bcac6ae5-f585-4592-a1a3-9cdb73ff7a76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c6cb8cdb-d1d4-4628-8ccb-bf56b1c4ac77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9a873c5c-c43a-4f85-a604-e17300ffe030" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c6cb8cdb-d1d4-4628-8ccb-bf56b1c4ac77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_57545912-2e38-4d37-8ad4-751910bd9ba3" xlink:href="bsx-20220630.xsd#bsx_AccruedRebatesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9a873c5c-c43a-4f85-a604-e17300ffe030" xlink:to="loc_bsx_AccruedRebatesCurrent_57545912-2e38-4d37-8ad4-751910bd9ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_26f46fec-578a-418f-ad3a-1d7f56497218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9a873c5c-c43a-4f85-a604-e17300ffe030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_26f46fec-578a-418f-ad3a-1d7f56497218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c043c4db-ead0-4879-a529-b26d1550947b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9a873c5c-c43a-4f85-a604-e17300ffe030" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c043c4db-ead0-4879-a529-b26d1550947b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_947ec48f-a04b-4513-afcf-d67d091195c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_719eb4ac-4fca-41ae-ad38-b4db00d07489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_947ec48f-a04b-4513-afcf-d67d091195c4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_719eb4ac-4fca-41ae-ad38-b4db00d07489" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_6004c725-f6a8-4e27-aa38-d74bb1f4d683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_947ec48f-a04b-4513-afcf-d67d091195c4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_6004c725-f6a8-4e27-aa38-d74bb1f4d683" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e969232a-7307-4280-838e-99bd5d3b8151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7d849abc-cc98-494f-99ba-48429805693f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e969232a-7307-4280-838e-99bd5d3b8151" xlink:to="loc_us-gaap_OperatingIncomeLoss_7d849abc-cc98-494f-99ba-48429805693f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_140d6d66-eb29-4717-b29c-f16a03d9587a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e969232a-7307-4280-838e-99bd5d3b8151" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_140d6d66-eb29-4717-b29c-f16a03d9587a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_046aa0d6-5aa2-4777-90ca-2b292f858e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_21c86a32-39f0-4ef4-979f-cfc740a01fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_046aa0d6-5aa2-4777-90ca-2b292f858e04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_21c86a32-39f0-4ef4-979f-cfc740a01fc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_25e58b0a-2fa5-41c2-aff0-850237404d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_046aa0d6-5aa2-4777-90ca-2b292f858e04" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_25e58b0a-2fa5-41c2-aff0-850237404d7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_59335a25-b1ad-4cf1-b447-5e0c4a206814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8fea45be-ac1f-4fbc-ac7e-2602aeeb78d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_59335a25-b1ad-4cf1-b447-5e0c4a206814" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8fea45be-ac1f-4fbc-ac7e-2602aeeb78d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_8bbf5a21-94ba-41be-a4db-fe08b9b69471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_59335a25-b1ad-4cf1-b447-5e0c4a206814" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_8bbf5a21-94ba-41be-a4db-fe08b9b69471" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3dd3460f-a351-4c0a-9132-2f074981732f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_4bd3c284-edb9-4e3b-8223-1a0c01ca897d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3dd3460f-a351-4c0a-9132-2f074981732f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_4bd3c284-edb9-4e3b-8223-1a0c01ca897d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_97b62e39-c94e-40f5-aaa5-8a18c75e863c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3dd3460f-a351-4c0a-9132-2f074981732f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_97b62e39-c94e-40f5-aaa5-8a18c75e863c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_79d41943-df61-4e4f-bf3c-5689f770e298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3d0eedf0-a075-416c-86da-6b4c34b5bd54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_79d41943-df61-4e4f-bf3c-5689f770e298" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3d0eedf0-a075-416c-86da-6b4c34b5bd54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1651ef85-78b9-4510-98a7-d54e4883398c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_79d41943-df61-4e4f-bf3c-5689f770e298" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1651ef85-78b9-4510-98a7-d54e4883398c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>bsx-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:202f2156-2eff-48c6-8020-e675b6a04e60,g:66d98efe-f6bb-4852-90b5-5e203e0b5e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20220630.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended" id="i430223dfc89046bdbac01045ba2e2ece_CoverDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d5e0c651-6804-4d36-a3dc-9984e5a6f7f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentType_d5e0c651-6804-4d36-a3dc-9984e5a6f7f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9bdee5f3-c1a8-4cec-9a4a-65f746b03e14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentQuarterlyReport_9bdee5f3-c1a8-4cec-9a4a-65f746b03e14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_81e7d436-278c-462e-964e-3e3519b5ea64" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentPeriodEndDate_81e7d436-278c-462e-964e-3e3519b5ea64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_37a8e593-b47f-4f34-ab19-7e3981fa9a18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentTransitionReport_37a8e593-b47f-4f34-ab19-7e3981fa9a18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7dfd4fdc-a935-496a-bf3a-228c5ff4cf3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityFileNumber_7dfd4fdc-a935-496a-bf3a-228c5ff4cf3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8f429674-f8c4-438e-bf9f-33970037958e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityRegistrantName_8f429674-f8c4-438e-bf9f-33970037958e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8e8f52c8-3681-4f3e-a094-98b4768245f2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8e8f52c8-3681-4f3e-a094-98b4768245f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f6cc1ecb-74a2-4a1c-a0b0-1b934b5c959e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityTaxIdentificationNumber_f6cc1ecb-74a2-4a1c-a0b0-1b934b5c959e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a4b6f633-b5d3-42a7-8eb2-2b3c4deefb5e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressAddressLine1_a4b6f633-b5d3-42a7-8eb2-2b3c4deefb5e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_be388b45-341c-4ace-83d3-c22ca0b44ba9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressCityOrTown_be388b45-341c-4ace-83d3-c22ca0b44ba9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_922983d7-11a4-477d-88d7-8117a0e1c824" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressStateOrProvince_922983d7-11a4-477d-88d7-8117a0e1c824" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c0c8874c-0fa4-42cf-9d44-db0fb1afc896" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressPostalZipCode_c0c8874c-0fa4-42cf-9d44-db0fb1afc896" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ac1e37ce-7ffe-4284-9595-f2d8ee4a727e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_CityAreaCode_ac1e37ce-7ffe-4284-9595-f2d8ee4a727e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a5488d2a-88cf-465a-adf6-dca033bb9947" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_LocalPhoneNumber_a5488d2a-88cf-465a-adf6-dca033bb9947" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a60e0880-da90-4edf-ba9b-24c266f7a2cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_Security12bTitle_a60e0880-da90-4edf-ba9b-24c266f7a2cd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_891d5f56-dcf5-43e5-8b4c-d268774594e4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_TradingSymbol_891d5f56-dcf5-43e5-8b4c-d268774594e4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_23050701-34f9-47f3-b24f-e873d9897b1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_SecurityExchangeName_23050701-34f9-47f3-b24f-e873d9897b1c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b0b0d7b0-2297-425a-a974-ec658cb220e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityCurrentReportingStatus_b0b0d7b0-2297-425a-a974-ec658cb220e5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e6e5dfd2-7b58-4c78-8ca6-465833b65bf9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityInteractiveDataCurrent_e6e5dfd2-7b58-4c78-8ca6-465833b65bf9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a31cadaf-eeff-458c-a11d-7969ff839616" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityFilerCategory_a31cadaf-eeff-458c-a11d-7969ff839616" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_fdf55d69-25bb-4aef-8140-e885be4d5db5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntitySmallBusiness_fdf55d69-25bb-4aef-8140-e885be4d5db5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d4235403-2365-4947-9c7f-3d49849d5d2c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityEmergingGrowthCompany_d4235403-2365-4947-9c7f-3d49849d5d2c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_868e9e42-18c3-4cca-810c-d98df3cb4f37" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityShellCompany_868e9e42-18c3-4cca-810c-d98df3cb4f37" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_128e28ac-08ee-4413-85e9-d21eac4c7bfc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityListingParValuePerShare_128e28ac-08ee-4413-85e9-d21eac4c7bfc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_28ab9a85-dbeb-46e6-89cc-5268c9feab08" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_28ab9a85-dbeb-46e6-89cc-5268c9feab08" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8e21d623-445d-49e0-9dc8-4c3909eb4036" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityCentralIndexKey_8e21d623-445d-49e0-9dc8-4c3909eb4036" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_caac9f29-22e7-402a-a282-c400a5f0b74e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_CurrentFiscalYearEndDate_caac9f29-22e7-402a-a282-c400a5f0b74e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b759f7f2-59d4-48a4-a2a6-0c63c179ce4a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentFiscalYearFocus_b759f7f2-59d4-48a4-a2a6-0c63c179ce4a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_45da61b3-f808-423c-ac51-f5f8e2c5e221" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_45da61b3-f808-423c-ac51-f5f8e2c5e221" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9d2f2974-3fb1-4ee3-ac9c-cd1cbcac6af8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_AmendmentFlag_9d2f2974-3fb1-4ee3-ac9c-cd1cbcac6af8" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_e6a64cea-8e19-4882-8d14-40916b5c7a53" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntitiesTable_e6a64cea-8e19-4882-8d14-40916b5c7a53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_418358bb-e1e0-4466-aeb9-3adea07b2b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_e6a64cea-8e19-4882-8d14-40916b5c7a53" xlink:to="loc_us-gaap_StatementClassOfStockAxis_418358bb-e1e0-4466-aeb9-3adea07b2b60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_418358bb-e1e0-4466-aeb9-3adea07b2b60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_418358bb-e1e0-4466-aeb9-3adea07b2b60" xlink:to="loc_us-gaap_ClassOfStockDomain_418358bb-e1e0-4466-aeb9-3adea07b2b60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_418358bb-e1e0-4466-aeb9-3adea07b2b60" xlink:to="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_146db0ed-022b-4033-95d4-466304ea0bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:to="loc_us-gaap_CommonStockMember_146db0ed-022b-4033-95d4-466304ea0bd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_02dbf16b-0010-467e-a6ec-b9cd0e7c0441" xlink:href="bsx-20220630.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:to="loc_bsx_SeniorNotedue2027Member_02dbf16b-0010-467e-a6ec-b9cd0e7c0441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_4838c029-bae7-409e-94a4-160b3e5f1e7b" xlink:href="bsx-20220630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:to="loc_bsx_A550MCPSSeriesAMember_4838c029-bae7-409e-94a4-160b3e5f1e7b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i822935a0c3fe4c9f9312e2e124c7160a_ConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b0e4338-b8dd-498f-bb31-fbd514836c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b0e4338-b8dd-498f-bb31-fbd514836c17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bdd48bfc-8216-4886-b46a-584f0bdb16df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bdd48bfc-8216-4886-b46a-584f0bdb16df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_376485b0-ea1d-40fe-8206-5f9508f53b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_GrossProfit_376485b0-ea1d-40fe-8206-5f9508f53b4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8205f0ac-2305-457e-a0f7-48d734d26ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8205f0ac-2305-457e-a0f7-48d734d26ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9a130b24-aaaa-42e6-bfba-e5bb36ce0d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9a130b24-aaaa-42e6-bfba-e5bb36ce0d9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_03719fbc-7e04-4721-aba7-d0604725d241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_RoyaltyExpense_03719fbc-7e04-4721-aba7-d0604725d241" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e67da025-d2f4-4bc5-8e0f-d26477905adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e67da025-d2f4-4bc5-8e0f-d26477905adc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c841180d-da40-4348-bc3c-ccb9869f7e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c841180d-da40-4348-bc3c-ccb9869f7e67" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d557c0a-2a00-4960-aeaf-aa049de41505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d557c0a-2a00-4960-aeaf-aa049de41505" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_034b5cd2-e96f-4894-8c1e-b2c2470ff9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_RestructuringCharges_034b5cd2-e96f-4894-8c1e-b2c2470ff9ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_d37e3546-2bf8-4e1d-a4a9-2df21e235b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_LitigationSettlementExpense_d37e3546-2bf8-4e1d-a4a9-2df21e235b02" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_636a5db3-78eb-415d-9aaa-efc142353a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_636a5db3-78eb-415d-9aaa-efc142353a1d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9e374da2-f6a5-4896-82fb-582a43814faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_OperatingExpenses_9e374da2-f6a5-4896-82fb-582a43814faa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ddbfa705-18e4-42b6-947f-80307606c126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_OperatingIncomeLoss_ddbfa705-18e4-42b6-947f-80307606c126" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3879538e-5af2-4f8b-8008-9319b932b4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:to="loc_us-gaap_InterestExpense_3879538e-5af2-4f8b-8008-9319b932b4b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1e788205-2b30-45c0-8a82-c2c7387ef95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1e788205-2b30-45c0-8a82-c2c7387ef95f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98766e36-92e3-4136-9dee-a344e6270308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98766e36-92e3-4136-9dee-a344e6270308" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_84f30efe-0188-4210-afd2-6b5ae34e1623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_84f30efe-0188-4210-afd2-6b5ae34e1623" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_856a6043-2372-417c-a4cb-0ada52584bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_ProfitLoss_856a6043-2372-417c-a4cb-0ada52584bb3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_740c1848-e382-43e0-933f-c3c2813212a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_DividendsPreferredStockStock_740c1848-e382-43e0-933f-c3c2813212a3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_535e6f66-eee6-44d5-b079-0706b1047c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_535e6f66-eee6-44d5-b079-0706b1047c86" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e03272a3-81d7-4ae5-8c63-355e20e5dac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_EarningsPerShareBasic_e03272a3-81d7-4ae5-8c63-355e20e5dac1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5fd334ce-f38d-47fa-9ee9-b5b9bc524739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5fd334ce-f38d-47fa-9ee9-b5b9bc524739" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e1b323f-892b-49ed-a5e6-e3a3e8b64162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e1b323f-892b-49ed-a5e6-e3a3e8b64162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3be7d8fd-2f39-4b17-9229-16570abd4e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3be7d8fd-2f39-4b17-9229-16570abd4e5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c8c86595-54a0-4b80-a199-d7948aae29a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_StatementTable_c8c86595-54a0-4b80-a199-d7948aae29a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f925c4ee-68b4-42fe-936f-cf6d00323682" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c8c86595-54a0-4b80-a199-d7948aae29a3" xlink:to="loc_srt_StatementScenarioAxis_f925c4ee-68b4-42fe-936f-cf6d00323682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f925c4ee-68b4-42fe-936f-cf6d00323682_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f925c4ee-68b4-42fe-936f-cf6d00323682" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f925c4ee-68b4-42fe-936f-cf6d00323682_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3891edd5-5fb7-4560-8aa2-279f70ef7585" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f925c4ee-68b4-42fe-936f-cf6d00323682" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3891edd5-5fb7-4560-8aa2-279f70ef7585" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="icf5a579bd07a4eeeb09ba475a3402a20_ConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_faa8521c-ade9-4f09-930c-cb6fa2b001d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:to="loc_us-gaap_ProfitLoss_faa8521c-ade9-4f09-930c-cb6fa2b001d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aec3f50-1e67-4abf-95ef-b253ef58a07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aec3f50-1e67-4abf-95ef-b253ef58a07d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2b64e1b8-029e-4e18-a36c-473d86b16388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2b64e1b8-029e-4e18-a36c-473d86b16388" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9d549c66-a7d3-437b-a468-740b4e1e3101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9d549c66-a7d3-437b-a468-740b4e1e3101" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fb5a27a5-c887-4406-a93b-cf02b6c871f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fb5a27a5-c887-4406-a93b-cf02b6c871f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1a71cdd-e3e3-4264-bbcf-6b1994af1c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1a71cdd-e3e3-4264-bbcf-6b1994af1c54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_952cac60-6fdd-4bb0-9694-6ec821c1a396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:to="loc_us-gaap_StatementTable_952cac60-6fdd-4bb0-9694-6ec821c1a396" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4b3a2424-1837-4d35-a57b-b48969acd419" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_952cac60-6fdd-4bb0-9694-6ec821c1a396" xlink:to="loc_srt_StatementScenarioAxis_4b3a2424-1837-4d35-a57b-b48969acd419" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4b3a2424-1837-4d35-a57b-b48969acd419_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_4b3a2424-1837-4d35-a57b-b48969acd419" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4b3a2424-1837-4d35-a57b-b48969acd419_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b750f066-0227-4c9c-b00a-dcb5fc067c06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_4b3a2424-1837-4d35-a57b-b48969acd419" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b750f066-0227-4c9c-b00a-dcb5fc067c06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="i58e490d815084627a64f121253faa2a3_ConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:to="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9e7a3bf-9962-4fb0-af00-034522d23667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9e7a3bf-9962-4fb0-af00-034522d23667" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_3598b6f5-d513-4ad6-9546-82c53e3653f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_3598b6f5-d513-4ad6-9546-82c53e3653f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4cf672f6-9c6e-4435-be66-26442de69985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_InventoryNet_4cf672f6-9c6e-4435-be66-26442de69985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_0f960ce5-9166-4c1c-9b12-c856710c910f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_PrepaidTaxes_0f960ce5-9166-4c1c-9b12-c856710c910f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_98852570-df46-4c5f-9cde-eb4c4e1620b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_98852570-df46-4c5f-9cde-eb4c4e1620b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_04c74bb0-3e14-488b-a001-850370455502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_AssetsCurrent_04c74bb0-3e14-488b-a001-850370455502" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_11ba1f77-2221-48fc-8cc8-b0e9f1a8d126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_11ba1f77-2221-48fc-8cc8-b0e9f1a8d126" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_79b18ce9-6065-44ac-b34e-91fba89d9a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_Goodwill_79b18ce9-6065-44ac-b34e-91fba89d9a64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67c0f339-c0c1-4d2f-b7d3-a35760ccc7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67c0f339-c0c1-4d2f-b7d3-a35760ccc7a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7a949add-ec05-4d24-be3b-cce523c78b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7a949add-ec05-4d24-be3b-cce523c78b0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5ecac811-13d8-4987-9a00-39bc1de9c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5ecac811-13d8-4987-9a00-39bc1de9c65e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6d849615-b15b-40d0-9b00-1e1784184a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_Assets_6d849615-b15b-40d0-9b00-1e1784184a4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2b14e9f5-20fb-428a-bf87-7900eb51a480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_DebtCurrent_2b14e9f5-20fb-428a-bf87-7900eb51a480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a82bc68e-61de-4148-bd6e-60d41406be97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_AccountsPayableCurrent_a82bc68e-61de-4148-bd6e-60d41406be97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4140201a-d9f5-4901-bd9e-e62251dd2e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4140201a-d9f5-4901-bd9e-e62251dd2e85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_dd8d7be4-3e89-4868-9744-e2372968848c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_dd8d7be4-3e89-4868-9744-e2372968848c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d66f1145-3b92-4e11-953b-fc109381916f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_LiabilitiesCurrent_d66f1145-3b92-4e11-953b-fc109381916f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b62cfb57-20f8-4d74-a893-c7296ee9dfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b62cfb57-20f8-4d74-a893-c7296ee9dfcd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b1a58f1f-1af5-4c71-ae77-920e2f3509c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b1a58f1f-1af5-4c71-ae77-920e2f3509c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_181eb274-322d-47d0-a030-cbe1f9f8e652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_181eb274-322d-47d0-a030-cbe1f9f8e652" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a6c2f99b-c2ae-4773-b07d-cdfcbe93e54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a6c2f99b-c2ae-4773-b07d-cdfcbe93e54d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3d24392a-bfd9-4e13-a976-dc84c0f4521a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_PreferredStockValue_3d24392a-bfd9-4e13-a976-dc84c0f4521a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a15af368-a6f6-43a2-8999-8b1f158f6671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_CommonStockValue_a15af368-a6f6-43a2-8999-8b1f158f6671" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f11b0eca-dc16-412b-84da-b408cf9d9e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_TreasuryStockValue_f11b0eca-dc16-412b-84da-b408cf9d9e68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_039152de-61ee-4ea4-8002-81b669537bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_039152de-61ee-4ea4-8002-81b669537bdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01651cfc-57d7-4c78-abb8-7e499f758216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01651cfc-57d7-4c78-abb8-7e499f758216" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_39381923-fedf-4438-8fa7-90266cb6b620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_39381923-fedf-4438-8fa7-90266cb6b620" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59fc985b-701d-440d-a45e-26609489e24b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59fc985b-701d-440d-a45e-26609489e24b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c5d3822-35c5-4cfe-b8ee-040097ad3971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c5d3822-35c5-4cfe-b8ee-040097ad3971" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:to="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_acb9daf5-bede-4c06-8b86-0045890fbf9e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:to="loc_srt_StatementScenarioAxis_acb9daf5-bede-4c06-8b86-0045890fbf9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_acb9daf5-bede-4c06-8b86-0045890fbf9e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_acb9daf5-bede-4c06-8b86-0045890fbf9e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_acb9daf5-bede-4c06-8b86-0045890fbf9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5fd5713e-c130-4fb8-b7b8-a65f49d90ede" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_acb9daf5-bede-4c06-8b86-0045890fbf9e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5fd5713e-c130-4fb8-b7b8-a65f49d90ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_36f0a764-618a-4358-9cea-72ee118b5dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:to="loc_us-gaap_StatementClassOfStockAxis_36f0a764-618a-4358-9cea-72ee118b5dd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_36f0a764-618a-4358-9cea-72ee118b5dd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36f0a764-618a-4358-9cea-72ee118b5dd8" xlink:to="loc_us-gaap_ClassOfStockDomain_36f0a764-618a-4358-9cea-72ee118b5dd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9884c12a-4597-4f07-b74e-189fd658b0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36f0a764-618a-4358-9cea-72ee118b5dd8" xlink:to="loc_us-gaap_ClassOfStockDomain_9884c12a-4597-4f07-b74e-189fd658b0a8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended" id="i7d0cdfddd5724ac680d3bc3e5de6a9ea_ConsolidatedStatementsofStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_1517a114-419e-4033-8f52-21a7af022e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_SharesIssued_1517a114-419e-4033-8f52-21a7af022e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_45593228-b5f3-4dd8-96cf-b488b4e0204c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_45593228-b5f3-4dd8-96cf-b488b4e0204c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d7cf3626-0da0-4904-b29a-e52f9e5bf571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d7cf3626-0da0-4904-b29a-e52f9e5bf571" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_c846704d-7bef-4b5f-9b30-3117bce1a599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_c846704d-7bef-4b5f-9b30-3117bce1a599" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_166143df-5c23-40d2-9e46-c514f250e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_166143df-5c23-40d2-9e46-c514f250e84f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_293627b3-a254-476c-a852-fce15468e44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_CommonStockSharesIssued_293627b3-a254-476c-a852-fce15468e44a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_f410ea0f-9463-4a77-9f38-857d27b493dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_f410ea0f-9463-4a77-9f38-857d27b493dd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ad2bca87-272c-4219-8ed9-9397257e2174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32f166cd-f9db-4a63-96cb-d539b645cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b6ec389f-0bdf-49c7-ac88-add6e81edadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_ProfitLoss_b6ec389f-0bdf-49c7-ac88-add6e81edadd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_42f263da-b033-4267-97ab-b9986ddf6d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_DividendsPreferredStockCash_42f263da-b033-4267-97ab-b9986ddf6d6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc6ebb85-ff45-4509-b3ac-a61a825f9330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc6ebb85-ff45-4509-b3ac-a61a825f9330" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_888872f6-c10c-46bb-8cd3-d3d6900366c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_StatementTable_888872f6-c10c-46bb-8cd3-d3d6900366c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4c16b912-915a-4be8-8e71-285119e306e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_888872f6-c10c-46bb-8cd3-d3d6900366c1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4c16b912-915a-4be8-8e71-285119e306e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4c16b912-915a-4be8-8e71-285119e306e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4c16b912-915a-4be8-8e71-285119e306e8" xlink:to="loc_us-gaap_EquityComponentDomain_4c16b912-915a-4be8-8e71-285119e306e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4c16b912-915a-4be8-8e71-285119e306e8" xlink:to="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_c6273c39-6418-488d-b63e-5187fb240fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_PreferredStockMember_c6273c39-6418-488d-b63e-5187fb240fc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8002b958-bcf7-4a91-a215-a79b37ff4ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_CommonStockMember_8002b958-bcf7-4a91-a215-a79b37ff4ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_3b24deb8-a8fe-46c8-bd46-01647a2cf527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_TreasuryStockMember_3b24deb8-a8fe-46c8-bd46-01647a2cf527" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_96d3f3b8-5135-411f-829a-ffb304fcabc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_96d3f3b8-5135-411f-829a-ffb304fcabc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7b070ccc-4a30-4e91-b406-e890bbb1eb44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_RetainedEarningsMember_7b070ccc-4a30-4e91-b406-e890bbb1eb44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_667507aa-c2a7-4690-b4a1-95d188b4536b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_667507aa-c2a7-4690-b4a1-95d188b4536b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="ie049042ee0494019b409840866368a38_ConsolidatedStatementsofCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a4fa62ca-a507-4155-9409-62e19a4a2595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_ProfitLoss_a4fa62ca-a507-4155-9409-62e19a4a2595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6c0677a6-e009-48b3-89ef-dc5b3289bbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6c0677a6-e009-48b3-89ef-dc5b3289bbeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_75d7c280-416f-4bec-acd7-4868803738c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_75d7c280-416f-4bec-acd7-4868803738c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_64942931-f399-441b-91a2-624cf5fe602b" xlink:href="bsx-20220630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_64942931-f399-441b-91a2-624cf5fe602b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4eea6812-667e-40fa-823c-40aea0c2e18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_ShareBasedCompensation_4eea6812-667e-40fa-823c-40aea0c2e18e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7092778c-84b9-487b-800e-b299dfa3a488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7092778c-84b9-487b-800e-b299dfa3a488" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_56632b2b-14f6-4bec-becc-465a5fbfdf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_GainLossOnInvestments_56632b2b-14f6-4bec-becc-465a5fbfdf0b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f8a51616-2d44-4227-baa4-8fa3b33a38f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f8a51616-2d44-4227-baa4-8fa3b33a38f1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_653aad5f-f621-4175-b3f6-6ba499eed16e" xlink:href="bsx-20220630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_bsx_InventoryStepUpAmortization_653aad5f-f621-4175-b3f6-6ba499eed16e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1e1c91e5-febb-4133-a7bf-0bd5f2334b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1e1c91e5-febb-4133-a7bf-0bd5f2334b9e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_e9971997-2733-4ec7-9f4a-19e2b3798315" xlink:href="bsx-20220630.xsd#bsx_OtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_bsx_OtherNet_e9971997-2733-4ec7-9f4a-19e2b3798315" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_59ed0315-e287-4cbd-93e3-205de204ef53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_59ed0315-e287-4cbd-93e3-205de204ef53" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2c383a96-dec7-4ca3-997c-ad3cf744b417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2c383a96-dec7-4ca3-997c-ad3cf744b417" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_94ebb28c-ddc6-470e-b63b-64c42b92eef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_94ebb28c-ddc6-470e-b63b-64c42b92eef6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e2da3f4b-d84c-49dc-be50-af65e62034e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e2da3f4b-d84c-49dc-be50-af65e62034e7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73a4dd16-b80d-4c24-bb36-add57d1b567f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73a4dd16-b80d-4c24-bb36-add57d1b567f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_710688f0-52a7-4e70-a791-1d6646dcb225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_710688f0-52a7-4e70-a791-1d6646dcb225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_5ac3d8f7-3aeb-46fb-907c-f88096d70187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_5ac3d8f7-3aeb-46fb-907c-f88096d70187" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ef70a2c7-0916-43fb-aa2b-a4ec8e776f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ef70a2c7-0916-43fb-aa2b-a4ec8e776f84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129b1fea-dc7e-4c63-810a-732351db0003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129b1fea-dc7e-4c63-810a-732351db0003" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f37f772f-7796-4eee-ab9d-e1db6e7f782b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f37f772f-7796-4eee-ab9d-e1db6e7f782b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ae330340-bffc-47e9-94fb-345f96bf7170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ae330340-bffc-47e9-94fb-345f96bf7170" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_6c8388ce-0a44-40f7-aa94-8651774371ab" xlink:href="bsx-20220630.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_6c8388ce-0a44-40f7-aa94-8651774371ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8d9f7152-8e47-4782-b200-d04010b1a8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8d9f7152-8e47-4782-b200-d04010b1a8b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b274f1f8-6070-4857-843f-3ea1ce39073d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b274f1f8-6070-4857-843f-3ea1ce39073d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_7c27199a-448c-4d79-b345-690a754d8551" xlink:href="bsx-20220630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_bsx_PaymentsForRoyaltyRights_7c27199a-448c-4d79-b345-690a754d8551" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_dadda752-9b2d-43a2-879e-fa7f6c445b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_dadda752-9b2d-43a2-879e-fa7f6c445b3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_882ca6f4-874f-4e8a-b78e-f40a40adeae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_882ca6f4-874f-4e8a-b78e-f40a40adeae4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_a67ccbe7-1cc8-461a-8b12-8df0133d16f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_a67ccbe7-1cc8-461a-8b12-8df0133d16f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d411ac1d-6c7f-4290-a6b7-72b4124c92bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d411ac1d-6c7f-4290-a6b7-72b4124c92bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_c50a00a6-7cbc-4cc0-bc77-3135582f625c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_PaymentsOfDividends_c50a00a6-7cbc-4cc0-bc77-3135582f625c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_f28bd74a-0e0a-4c64-ace4-d46ba4ab6234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_f28bd74a-0e0a-4c64-ace4-d46ba4ab6234" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_de360e9d-5b8b-4d37-9090-503a425f0e67" xlink:href="bsx-20220630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_de360e9d-5b8b-4d37-9090-503a425f0e67" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_c1d144fa-20f1-4b55-9d77-a2c81b465755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromStockPlans_c1d144fa-20f1-4b55-9d77-a2c81b465755" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73d5ba59-07de-4f32-b937-306d3c672e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73d5ba59-07de-4f32-b937-306d3c672e53" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc07ae76-ba5b-4e9a-b23f-c1a4524911a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc07ae76-ba5b-4e9a-b23f-c1a4524911a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f11c0294-ef12-4e97-8d2d-a86c05425323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f11c0294-ef12-4e97-8d2d-a86c05425323" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87803ae6-89f1-4813-a39a-f1c7f09d39f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87803ae6-89f1-4813-a39a-f1c7f09d39f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d076c3d-3a86-4921-8381-2205a7549ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7a9d1986-984c-4f8d-a952-a605b826491d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_2e6c8582-e356-4f86-8a48-14cb3f516b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_2e6c8582-e356-4f86-8a48-14cb3f516b98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_6ca5ae5c-f4ec-40ab-9bf8-3f30c461c0d1" xlink:href="bsx-20220630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_6ca5ae5c-f4ec-40ab-9bf8-3f30c461c0d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6dbdf00d-15d5-4803-9715-391ec1e721b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_StatementTable_6dbdf00d-15d5-4803-9715-391ec1e721b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_138d9c37-d254-44a2-808d-3d84125a95dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6dbdf00d-15d5-4803-9715-391ec1e721b2" xlink:to="loc_srt_StatementScenarioAxis_138d9c37-d254-44a2-808d-3d84125a95dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_138d9c37-d254-44a2-808d-3d84125a95dd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_138d9c37-d254-44a2-808d-3d84125a95dd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_138d9c37-d254-44a2-808d-3d84125a95dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9fd4612c-a53b-4f1b-b385-b2ef7460eae3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_138d9c37-d254-44a2-808d-3d84125a95dd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9fd4612c-a53b-4f1b-b385-b2ef7460eae3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofCashFlowsSupplementalDisclosure"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="extended" id="i11d47a70db754390a68214c4dfb86613_ConsolidatedStatementsofCashFlowsSupplementalDisclosure">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ebf06d5-0dcc-4b1c-bd96-0383330e54a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ebf06d5-0dcc-4b1c-bd96-0383330e54a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ce55c340-04cf-4d76-8fdf-eb26047f78e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ce55c340-04cf-4d76-8fdf-eb26047f78e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_d237b813-c07f-4e4c-babc-a140b49e8ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_d237b813-c07f-4e4c-babc-a140b49e8ab5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45f6ceb7-13aa-4235-b158-558988fef059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45f6ceb7-13aa-4235-b158-558988fef059" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_30ba55fa-03b9-4948-b2b5-b349d25849f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_StatementTable_30ba55fa-03b9-4948-b2b5-b349d25849f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_b1b3411f-6c59-4a17-a694-c90dd66cb836" xlink:href="bsx-20220630.xsd#bsx_StatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_30ba55fa-03b9-4948-b2b5-b349d25849f7" xlink:to="loc_bsx_StatementAxis_b1b3411f-6c59-4a17-a694-c90dd66cb836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_b1b3411f-6c59-4a17-a694-c90dd66cb836_default" xlink:href="bsx-20220630.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementAxis_b1b3411f-6c59-4a17-a694-c90dd66cb836" xlink:to="loc_bsx_StatementDomain_b1b3411f-6c59-4a17-a694-c90dd66cb836_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_1d4a1242-9995-4466-9714-041e201bb000" xlink:href="bsx-20220630.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementAxis_b1b3411f-6c59-4a17-a694-c90dd66cb836" xlink:to="loc_bsx_StatementDomain_1d4a1242-9995-4466-9714-041e201bb000" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#AcquisitionsDivestituresandStrategicInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="extended" id="i7ab2e5e227cb4a9da0dfd9cc64a95d31_AcquisitionsDivestituresandStrategicInvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_d22d25f4-4da0-42b2-9c31-24e1701de4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_d22d25f4-4da0-42b2-9c31-24e1701de4d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7f0d2349-ca27-401e-a5bf-64e22714ebf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7f0d2349-ca27-401e-a5bf-64e22714ebf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2d8aafa2-3a50-43d6-91b0-6e1d7a849971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2d8aafa2-3a50-43d6-91b0-6e1d7a849971" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9705d0f1-8739-4255-bce2-415d09ca1f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9705d0f1-8739-4255-bce2-415d09ca1f3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_8dde68cc-155c-409f-81f1-65fb98c1fdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_8dde68cc-155c-409f-81f1-65fb98c1fdfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_1996d1d8-2b20-4727-bb53-1b165372dd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_1996d1d8-2b20-4727-bb53-1b165372dd4b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab7d380d-9831-41d6-b283-7036665a14a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab7d380d-9831-41d6-b283-7036665a14a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab7d380d-9831-41d6-b283-7036665a14a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab7d380d-9831-41d6-b283-7036665a14a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab7d380d-9831-41d6-b283-7036665a14a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab7d380d-9831-41d6-b283-7036665a14a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_77cd83c1-f2f6-4681-a2bc-180b3bc8e285" xlink:href="bsx-20220630.xsd#bsx_BaylisMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:to="loc_bsx_BaylisMedicalMember_77cd83c1-f2f6-4681-a2bc-180b3bc8e285" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_9ec2ff55-4ca5-4803-927d-a911e95ff9fc" xlink:href="bsx-20220630.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:to="loc_bsx_PreventiceSolutionsIncMember_9ec2ff55-4ca5-4803-927d-a911e95ff9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_20bbd248-7e84-4bb7-a78f-01574ee00abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_20bbd248-7e84-4bb7-a78f-01574ee00abd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_20bbd248-7e84-4bb7-a78f-01574ee00abd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_20bbd248-7e84-4bb7-a78f-01574ee00abd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_20bbd248-7e84-4bb7-a78f-01574ee00abd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ab0285df-aca8-416c-bf4b-9e833ed347ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_20bbd248-7e84-4bb7-a78f-01574ee00abd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ab0285df-aca8-416c-bf4b-9e833ed347ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_930b96f7-24ff-4046-8bfe-384d1432d1a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_srt_OwnershipAxis_930b96f7-24ff-4046-8bfe-384d1432d1a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_930b96f7-24ff-4046-8bfe-384d1432d1a1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_930b96f7-24ff-4046-8bfe-384d1432d1a1" xlink:to="loc_srt_OwnershipDomain_930b96f7-24ff-4046-8bfe-384d1432d1a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c7b201f1-ed74-4bd6-b044-bfab72e99a3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_930b96f7-24ff-4046-8bfe-384d1432d1a1" xlink:to="loc_srt_OwnershipDomain_c7b201f1-ed74-4bd6-b044-bfab72e99a3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0302483a-e55d-49b5-83f6-467b03a3c66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0302483a-e55d-49b5-83f6-467b03a3c66f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0302483a-e55d-49b5-83f6-467b03a3c66f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0302483a-e55d-49b5-83f6-467b03a3c66f" xlink:to="loc_us-gaap_ClassOfStockDomain_0302483a-e55d-49b5-83f6-467b03a3c66f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5032bdb1-da47-4c1b-94d4-0fd8c029d423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0302483a-e55d-49b5-83f6-467b03a3c66f" xlink:to="loc_us-gaap_ClassOfStockDomain_5032bdb1-da47-4c1b-94d4-0fd8c029d423" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#AcquisitionsandDivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="extended" id="ia8b0df60c0d74526b0c58870adf320c1_AcquisitionsandDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_b3d647e6-20ac-4d9d-ad2a-ccd29a95ed37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_b3d647e6-20ac-4d9d-ad2a-ccd29a95ed37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinessesDivested_560307c7-479d-4741-b98b-89793fbe0e5e" xlink:href="bsx-20220630.xsd#bsx_NumberOfBusinessesDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_NumberOfBusinessesDivested_560307c7-479d-4741-b98b-89793fbe0e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_989ec04f-128a-4da4-9008-e13b19be3186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_989ec04f-128a-4da4-9008-e13b19be3186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_e7268b18-8f4a-4e84-b1bf-12f3f8b605e8" xlink:href="bsx-20220630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_e7268b18-8f4a-4e84-b1bf-12f3f8b605e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_20080df4-e7fe-4bc0-8a08-6d68a1bf5b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_20080df4-e7fe-4bc0-8a08-6d68a1bf5b62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d34a46f6-25e3-46b4-9925-4a234cc90d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d34a46f6-25e3-46b4-9925-4a234cc90d05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5fa313f9-6361-476f-bbf8-5cc6bfdcc6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5fa313f9-6361-476f-bbf8-5cc6bfdcc6f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_18e748e4-c6df-41af-b131-822ba6f56548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_18e748e4-c6df-41af-b131-822ba6f56548" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6dc22ea9-7c6f-4fe8-823d-76d9cda19870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6dc22ea9-7c6f-4fe8-823d-76d9cda19870" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_64da5295-59d2-4b1e-9b9e-d7d9a8bd5214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_64da5295-59d2-4b1e-9b9e-d7d9a8bd5214" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4401d709-a86d-473c-ba5d-fb8d16dd8f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4401d709-a86d-473c-ba5d-fb8d16dd8f37" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4cc27850-6829-4378-b1c9-0cc43951d86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_Goodwill_4cc27850-6829-4378-b1c9-0cc43951d86f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a469aa73-0eb4-41fe-bcde-3a7d7a1c0fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a469aa73-0eb4-41fe-bcde-3a7d7a1c0fd5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0a4b4837-5dd5-478e-9800-2259ec48ae65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0a4b4837-5dd5-478e-9800-2259ec48ae65" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_fe58765c-851e-454b-9273-3c387e763582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_fe58765c-851e-454b-9273-3c387e763582" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_456de02c-ddeb-4d93-a967-89a17004c22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_456de02c-ddeb-4d93-a967-89a17004c22b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7db54e2b-dbaa-47f6-a2ba-cdf435cb0933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7db54e2b-dbaa-47f6-a2ba-cdf435cb0933" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_58629517-6fe8-40e3-a8bb-bcff0a509bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_58629517-6fe8-40e3-a8bb-bcff0a509bc1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_884cc636-8a55-4660-9bd9-f7534a318e9e" xlink:href="bsx-20220630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_DiscountRateFairValueInput_884cc636-8a55-4660-9bd9-f7534a318e9e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4555f593-d9f0-406c-af77-6cdd5b26550f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4555f593-d9f0-406c-af77-6cdd5b26550f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities_07497a47-0899-46e0-af31-125e628a0afc" xlink:href="bsx-20220630.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_DivestitureAgreementTransferOfFacilities_07497a47-0899-46e0-af31-125e628a0afc" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_a86de83d-3073-4ea2-8be6-c2fc6c212b8f" xlink:href="bsx-20220630.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_a86de83d-3073-4ea2-8be6-c2fc6c212b8f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f0c23799-fc4d-4e6f-adc3-eee61c9e770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f0c23799-fc4d-4e6f-adc3-eee61c9e770c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_d66fd05e-b280-4afd-81b9-b069dd97184b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_d66fd05e-b280-4afd-81b9-b069dd97184b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cf1b4840-81e7-4227-990e-8a301dad8e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cf1b4840-81e7-4227-990e-8a301dad8e20" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_190f37a4-bc78-44cf-9376-6626af002ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_190f37a4-bc78-44cf-9376-6626af002ebf" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_670c8f4f-997a-4ca0-bbd0-f2875269f8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_670c8f4f-997a-4ca0-bbd0-f2875269f8e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_670c8f4f-997a-4ca0-bbd0-f2875269f8e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_670c8f4f-997a-4ca0-bbd0-f2875269f8e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_670c8f4f-997a-4ca0-bbd0-f2875269f8e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_670c8f4f-997a-4ca0-bbd0-f2875269f8e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_979df8e7-c19a-4350-b6e1-93ced2bbef0f" xlink:href="bsx-20220630.xsd#bsx_BaylisMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_BaylisMedicalMember_979df8e7-c19a-4350-b6e1-93ced2bbef0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_11c0cc70-7c70-404c-94d6-3690f0d84c8a" xlink:href="bsx-20220630.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_PreventiceSolutionsIncMember_11c0cc70-7c70-404c-94d6-3690f0d84c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisMember_90c500f8-821b-4e7e-b6be-ff681be67c2a" xlink:href="bsx-20220630.xsd#bsx_LumenisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_LumenisMember_90c500f8-821b-4e7e-b6be-ff681be67c2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MITechCoLtdMember_25498e60-7ab6-43ef-a3da-13330c3f4c30" xlink:href="bsx-20220630.xsd#bsx_MITechCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_MITechCoLtdMember_25498e60-7ab6-43ef-a3da-13330c3f4c30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f07bdbd0-a900-40cf-9c19-6064e8667eb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_srt_RangeAxis_f07bdbd0-a900-40cf-9c19-6064e8667eb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f07bdbd0-a900-40cf-9c19-6064e8667eb7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f07bdbd0-a900-40cf-9c19-6064e8667eb7" xlink:to="loc_srt_RangeMember_f07bdbd0-a900-40cf-9c19-6064e8667eb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f07bdbd0-a900-40cf-9c19-6064e8667eb7" xlink:to="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1f74a3ec-1bf8-48b5-82f8-6945da687f6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:to="loc_srt_MinimumMember_1f74a3ec-1bf8-48b5-82f8-6945da687f6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0053b578-88ca-447f-b063-aebf472ae464" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:to="loc_srt_MaximumMember_0053b578-88ca-447f-b063-aebf472ae464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_036726e7-e544-4209-9e03-b776e970647e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:to="loc_srt_WeightedAverageMember_036726e7-e544-4209-9e03-b776e970647e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_75672f24-42bc-4e89-9b50-f0d6a5302e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_75672f24-42bc-4e89-9b50-f0d6a5302e9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a8ff94f0-47a3-44fc-987c-6ee26d6d08a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a8ff94f0-47a3-44fc-987c-6ee26d6d08a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8ec0c376-50c4-46cd-bc43-609099588cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8ec0c376-50c4-46cd-bc43-609099588cdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8ec0c376-50c4-46cd-bc43-609099588cdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8ec0c376-50c4-46cd-bc43-609099588cdf" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8ec0c376-50c4-46cd-bc43-609099588cdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8ec0c376-50c4-46cd-bc43-609099588cdf" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d7af4ce7-907a-4a40-9b48-427d64b5a6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d7af4ce7-907a-4a40-9b48-427d64b5a6af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9e58d14e-0694-4b65-8f47-01f4a4c7794a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9e58d14e-0694-4b65-8f47-01f4a4c7794a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b42f871a-8971-42b2-ac29-2382eca3da42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b42f871a-8971-42b2-ac29-2382eca3da42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b42f871a-8971-42b2-ac29-2382eca3da42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b42f871a-8971-42b2-ac29-2382eca3da42" xlink:to="loc_us-gaap_SegmentDomain_b42f871a-8971-42b2-ac29-2382eca3da42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b14e3af-046e-4f1e-9307-a30f38e6fab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b42f871a-8971-42b2-ac29-2382eca3da42" xlink:to="loc_us-gaap_SegmentDomain_1b14e3af-046e-4f1e-9307-a30f38e6fab0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f6d71d6d-0e48-4f21-9cf9-50fd38974156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f6d71d6d-0e48-4f21-9cf9-50fd38974156" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f6d71d6d-0e48-4f21-9cf9-50fd38974156_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f6d71d6d-0e48-4f21-9cf9-50fd38974156" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f6d71d6d-0e48-4f21-9cf9-50fd38974156_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_230cf4f8-c14d-4da4-8ab5-c9cfc4a1c039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f6d71d6d-0e48-4f21-9cf9-50fd38974156" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_230cf4f8-c14d-4da4-8ab5-c9cfc4a1c039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_189463bf-1f7c-49e1-8679-9300d1c70cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_230cf4f8-c14d-4da4-8ab5-c9cfc4a1c039" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_189463bf-1f7c-49e1-8679-9300d1c70cc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd818675-4cb6-423c-9b40-7eebf292c405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd818675-4cb6-423c-9b40-7eebf292c405" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd818675-4cb6-423c-9b40-7eebf292c405_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd818675-4cb6-423c-9b40-7eebf292c405" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd818675-4cb6-423c-9b40-7eebf292c405_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2449b65-cab5-4332-95a2-78ad41d53a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd818675-4cb6-423c-9b40-7eebf292c405" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2449b65-cab5-4332-95a2-78ad41d53a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_ecf1a14c-6a53-4ba9-85d3-f2f1da0aca70" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2449b65-cab5-4332-95a2-78ad41d53a86" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_ecf1a14c-6a53-4ba9-85d3-f2f1da0aca70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6d5f9c81-f889-44b8-aeb9-7c66d7f85298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6d5f9c81-f889-44b8-aeb9-7c66d7f85298" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6d5f9c81-f889-44b8-aeb9-7c66d7f85298_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6d5f9c81-f889-44b8-aeb9-7c66d7f85298" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6d5f9c81-f889-44b8-aeb9-7c66d7f85298_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_de36c655-1add-42b3-bc93-db81a909f1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6d5f9c81-f889-44b8-aeb9-7c66d7f85298" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_de36c655-1add-42b3-bc93-db81a909f1b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_23bcc849-cf2f-4427-99f3-5bba9dad6819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_de36c655-1add-42b3-bc93-db81a909f1b5" xlink:to="loc_us-gaap_SubsequentEventMember_23bcc849-cf2f-4427-99f3-5bba9dad6819" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#ContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended" id="icfcb2df7f2c6465b974cf7ec4deb0b5e_ContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2b901711-7d01-4bce-bbd6-b166ff815133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2b901711-7d01-4bce-bbd6-b166ff815133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5f7add71-593d-4950-8b13-f68c8ddf9782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5f7add71-593d-4950-8b13-f68c8ddf9782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f200dd58-5453-43cc-8efd-37646d90cf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f200dd58-5453-43cc-8efd-37646d90cf7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_949db7d3-9eac-4de9-ae87-e522a3ff7328" xlink:href="bsx-20220630.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_bsx_PaymentOfContingentConsideration_949db7d3-9eac-4de9-ae87-e522a3ff7328" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9d97ffe5-5757-49ac-b097-bccdcf702213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b6eda605-466d-4258-a68a-0777952334a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b6eda605-466d-4258-a68a-0777952334a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5ca2537c-c922-4f92-9eb1-e50ce0eaae6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_2216c5e9-3df7-45c7-83fe-eda0bf3511d3" xlink:href="bsx-20220630.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_2216c5e9-3df7-45c7-83fe-eda0bf3511d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_7aa11ce4-b50a-4592-8c8e-18152e8f9de3" xlink:href="bsx-20220630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:to="loc_bsx_DiscountRateFairValueInput_7aa11ce4-b50a-4592-8c8e-18152e8f9de3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f9f73e4c-10df-48b0-b45b-5ee7c6c99ca2" xlink:href="bsx-20220630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f9f73e4c-10df-48b0-b45b-5ee7c6c99ca2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9b762bfd-811b-471b-a05a-b2c459e5997d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_srt_RangeAxis_9b762bfd-811b-471b-a05a-b2c459e5997d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b762bfd-811b-471b-a05a-b2c459e5997d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9b762bfd-811b-471b-a05a-b2c459e5997d" xlink:to="loc_srt_RangeMember_9b762bfd-811b-471b-a05a-b2c459e5997d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9b762bfd-811b-471b-a05a-b2c459e5997d" xlink:to="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f4561d08-37f3-4972-9f3d-63b8ad6cff0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:to="loc_srt_MinimumMember_f4561d08-37f3-4972-9f3d-63b8ad6cff0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_56fb195d-524b-42c3-9214-5d17c7b609fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:to="loc_srt_MaximumMember_56fb195d-524b-42c3-9214-5d17c7b609fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_a8882a5c-6778-4fd8-899e-1227d6e7ac00" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:to="loc_srt_WeightedAverageMember_a8882a5c-6778-4fd8-899e-1227d6e7ac00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_c274035e-ed93-4be5-a9e9-b2a15fda21b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_ValuationTechniqueAxis_c274035e-ed93-4be5-a9e9-b2a15fda21b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_c274035e-ed93-4be5-a9e9-b2a15fda21b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c274035e-ed93-4be5-a9e9-b2a15fda21b4" xlink:to="loc_us-gaap_ValuationTechniqueDomain_c274035e-ed93-4be5-a9e9-b2a15fda21b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_d14cbdcb-e4f5-47b8-b167-43c64e841947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c274035e-ed93-4be5-a9e9-b2a15fda21b4" xlink:to="loc_us-gaap_ValuationTechniqueDomain_d14cbdcb-e4f5-47b8-b167-43c64e841947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_51edab90-bd58-49a5-8360-ed06416e53ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d14cbdcb-e4f5-47b8-b167-43c64e841947" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_51edab90-bd58-49a5-8360-ed06416e53ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9dd80e40-9bae-46ed-94e0-778881b8d237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9dd80e40-9bae-46ed-94e0-778881b8d237" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9dd80e40-9bae-46ed-94e0-778881b8d237_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9dd80e40-9bae-46ed-94e0-778881b8d237" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9dd80e40-9bae-46ed-94e0-778881b8d237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ab2b0f7-46a5-4de3-9856-26e30bb1c513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9dd80e40-9bae-46ed-94e0-778881b8d237" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ab2b0f7-46a5-4de3-9856-26e30bb1c513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllBusinessAcquisitionsMember_13c916d1-0cea-4ca8-a5b8-4dd796a62a85" xlink:href="bsx-20220630.xsd#bsx_AllBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ab2b0f7-46a5-4de3-9856-26e30bb1c513" xlink:to="loc_bsx_AllBusinessAcquisitionsMember_13c916d1-0cea-4ca8-a5b8-4dd796a62a85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_4a7148a6-c010-4639-a559-70dcb787616d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_4a7148a6-c010-4639-a559-70dcb787616d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_4a7148a6-c010-4639-a559-70dcb787616d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4a7148a6-c010-4639-a559-70dcb787616d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_4a7148a6-c010-4639-a559-70dcb787616d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4a7148a6-c010-4639-a559-70dcb787616d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_414bfc9f-497e-4d39-82c6-d105d4197a70" xlink:href="bsx-20220630.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_414bfc9f-497e-4d39-82c6-d105d4197a70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_a8daed79-1f1c-4106-aca1-120d5f4431e1" xlink:href="bsx-20220630.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:to="loc_bsx_RevenueBasedPaymentsMember_a8daed79-1f1c-4106-aca1-120d5f4431e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2e9a14e5-6352-4240-8965-c36b9ec87eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2e9a14e5-6352-4240-8965-c36b9ec87eb3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2e9a14e5-6352-4240-8965-c36b9ec87eb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e9a14e5-6352-4240-8965-c36b9ec87eb3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2e9a14e5-6352-4240-8965-c36b9ec87eb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7e799e59-67fe-4a09-8a5d-81c2c92a8a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e9a14e5-6352-4240-8965-c36b9ec87eb3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7e799e59-67fe-4a09-8a5d-81c2c92a8a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_773bc235-4b5b-4a90-8b5b-79be63bf8e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7e799e59-67fe-4a09-8a5d-81c2c92a8a66" xlink:to="loc_us-gaap_SubsequentEventMember_773bc235-4b5b-4a90-8b5b-79be63bf8e48" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#StrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended" id="i813ce9587fdb490287088717949c0c8f_StrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b58f5869-e315-4224-b980-9abc96098a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquityMethodInvestments_b58f5869-e315-4224-b980-9abc96098a22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d3eaf57a-d250-4aa3-b08d-52f795fe7197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d3eaf57a-d250-4aa3-b08d-52f795fe7197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ee40551a-7774-431a-9ddc-826d9b617cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ee40551a-7774-431a-9ddc-826d9b617cf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6796a9f2-d5a2-42e5-8c34-ad80da0a586d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6796a9f2-d5a2-42e5-8c34-ad80da0a586d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_dc42cb27-2d28-494c-86f4-2cdd3a65f46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_Investments_dc42cb27-2d28-494c-86f4-2cdd3a65f46a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_035c854c-3c6e-42ef-8251-87050350cc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_035c854c-3c6e-42ef-8251-87050350cc9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1c236f32-b357-451b-b112-ced1c1b8b175" xlink:href="bsx-20220630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1c236f32-b357-451b-b112-ced1c1b8b175" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_80474eab-a4b7-43c4-bc99-52654f2c25ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_80474eab-a4b7-43c4-bc99-52654f2c25ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f5039486-34eb-4dc9-b77c-b5df41fc9bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f5039486-34eb-4dc9-b77c-b5df41fc9bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f5039486-34eb-4dc9-b77c-b5df41fc9bce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f5039486-34eb-4dc9-b77c-b5df41fc9bce" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f5039486-34eb-4dc9-b77c-b5df41fc9bce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ea52d40f-df2c-4f53-a859-dd3a7b33c39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f5039486-34eb-4dc9-b77c-b5df41fc9bce" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ea52d40f-df2c-4f53-a859-dd3a7b33c39d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_acae0f23-6ccc-4869-bc73-78163589c9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ea52d40f-df2c-4f53-a859-dd3a7b33c39d" xlink:to="loc_us-gaap_SubsequentEventMember_acae0f23-6ccc-4869-bc73-78163589c9c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_31075f16-3884-44f6-832f-119bb10f4ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_31075f16-3884-44f6-832f-119bb10f4ae1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31075f16-3884-44f6-832f-119bb10f4ae1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_31075f16-3884-44f6-832f-119bb10f4ae1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31075f16-3884-44f6-832f-119bb10f4ae1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b490ca05-7333-4db9-b854-cf6cde336769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_31075f16-3884-44f6-832f-119bb10f4ae1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b490ca05-7333-4db9-b854-cf6cde336769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_8c787805-8336-4f36-a41f-546666faff84" xlink:href="bsx-20220630.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b490ca05-7333-4db9-b854-cf6cde336769" xlink:to="loc_bsx_PreventiceSolutionsIncMember_8c787805-8336-4f36-a41f-546666faff84" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="ic04c32f0bcae4c67afc54f9845089418_GoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:href="bsx-20220630.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_322d86c4-df3f-468c-9c91-e884062ff8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_322d86c4-df3f-468c-9c91-e884062ff8b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2697b3c1-59c6-4b9e-8059-c8ace9731f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2697b3c1-59c6-4b9e-8059-c8ace9731f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_76323445-fcf5-49f1-9e3f-f971341fd30c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_GoodwillGross_76323445-fcf5-49f1-9e3f-f971341fd30c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_078c4d46-820c-478a-b5f9-782359b65dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_078c4d46-820c-478a-b5f9-782359b65dbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae387bb1-59c9-41c2-9998-0abc01fb83bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae387bb1-59c9-41c2-9998-0abc01fb83bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2227b169-d950-487e-9561-c5a33f11aeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2227b169-d950-487e-9561-c5a33f11aeef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e1f935fc-cd7c-4c28-b43b-04851466e485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:to="loc_us-gaap_Goodwill_e1f935fc-cd7c-4c28-b43b-04851466e485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7ca311d9-487e-4814-aa1d-96a2f6413e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7ca311d9-487e-4814-aa1d-96a2f6413e7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_418ea8a6-cde4-4e74-823c-54509c267a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_418ea8a6-cde4-4e74-823c-54509c267a2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7cb2cdd1-a14c-4513-8905-b9ba21187130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_0ad798e9-a024-4f5f-9c68-90a490ee75cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_NumberOfReportableSegments_0ad798e9-a024-4f5f-9c68-90a490ee75cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb63ed08-daae-489f-831b-af128c187d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb63ed08-daae-489f-831b-af128c187d50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fb63ed08-daae-489f-831b-af128c187d50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb63ed08-daae-489f-831b-af128c187d50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fb63ed08-daae-489f-831b-af128c187d50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb63ed08-daae-489f-831b-af128c187d50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00aab881-8938-4a60-aecd-b61aab4b2347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00aab881-8938-4a60-aecd-b61aab4b2347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_2f5d20f5-39ec-40a8-9de1-a49e72a6f261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:to="loc_us-gaap_PatentsMember_2f5d20f5-39ec-40a8-9de1-a49e72a6f261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a930fca7-5d9b-4f84-9e75-414a6f507584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a930fca7-5d9b-4f84-9e75-414a6f507584" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dcfda880-5a96-4b9a-b962-0f3b50fb81b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dcfda880-5a96-4b9a-b962-0f3b50fb81b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_dcfda880-5a96-4b9a-b962-0f3b50fb81b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dcfda880-5a96-4b9a-b962-0f3b50fb81b7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_dcfda880-5a96-4b9a-b962-0f3b50fb81b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dcfda880-5a96-4b9a-b962-0f3b50fb81b7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_b2df8654-99df-4b25-a066-44896309c8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:to="loc_us-gaap_GoodwillMember_b2df8654-99df-4b25-a066-44896309c8ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d3ef402b-ade0-4219-8a64-20675381ed77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d3ef402b-ade0-4219-8a64-20675381ed77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f8336dd7-c669-413c-a44c-053f17148fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f8336dd7-c669-413c-a44c-053f17148fe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a75a733a-2ec8-4cb9-af22-174078e15a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a75a733a-2ec8-4cb9-af22-174078e15a05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a75a733a-2ec8-4cb9-af22-174078e15a05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a75a733a-2ec8-4cb9-af22-174078e15a05" xlink:to="loc_us-gaap_SegmentDomain_a75a733a-2ec8-4cb9-af22-174078e15a05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a75a733a-2ec8-4cb9-af22-174078e15a05" xlink:to="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_fd44832f-b68e-47b8-9a08-a0e561ea388f" xlink:href="bsx-20220630.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:to="loc_bsx_MedsurgMember_fd44832f-b68e-47b8-9a08-a0e561ea388f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_cc664006-3d04-4016-80ce-0f09166bf344" xlink:href="bsx-20220630.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:to="loc_bsx_CardiovascularMember_cc664006-3d04-4016-80ce-0f09166bf344" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended" id="i4676d683f4714f348ccadae527905146_HedgingActivitiesandFairValueMeasurementsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_f50df68b-7f7e-47b0-a5b6-524a50884931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_f50df68b-7f7e-47b0-a5b6-524a50884931" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e46416ea-4241-4289-8125-1a8a38f1fcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e46416ea-4241-4289-8125-1a8a38f1fcd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_aa317fee-4acd-4eb2-a652-b0261adad1cb" xlink:href="bsx-20220630.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_aa317fee-4acd-4eb2-a652-b0261adad1cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_22798faf-28dd-42db-9917-236f2f2bb42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_22798faf-28dd-42db-9917-236f2f2bb42d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_ce92cc75-260d-43e2-9ba2-063502166192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_ce92cc75-260d-43e2-9ba2-063502166192" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_10bf22a1-e40d-4873-8a5a-48ca05aeb3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_DerivativeTable_10bf22a1-e40d-4873-8a5a-48ca05aeb3de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d14b2556-bfed-454a-a5f3-b532d1c2adc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_10bf22a1-e40d-4873-8a5a-48ca05aeb3de" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d14b2556-bfed-454a-a5f3-b532d1c2adc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d14b2556-bfed-454a-a5f3-b532d1c2adc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d14b2556-bfed-454a-a5f3-b532d1c2adc2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d14b2556-bfed-454a-a5f3-b532d1c2adc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4607ab05-5597-4837-a945-baa824ea602f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d14b2556-bfed-454a-a5f3-b532d1c2adc2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4607ab05-5597-4837-a945-baa824ea602f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_659e5500-18af-4f83-9c1a-d902dbc5bf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_50e243de-1d7e-4d70-9235-f4aa64537229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_659e5500-18af-4f83-9c1a-d902dbc5bf96" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_50e243de-1d7e-4d70-9235-f4aa64537229" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_659e5500-18af-4f83-9c1a-d902dbc5bf96" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fd978629-06a2-40de-adf6-fe94103d5275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fd978629-06a2-40de-adf6-fe94103d5275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fd978629-06a2-40de-adf6-fe94103d5275_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fd978629-06a2-40de-adf6-fe94103d5275" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fd978629-06a2-40de-adf6-fe94103d5275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_eae58c7d-670e-4dbd-b0d8-28ba30f0f0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fd978629-06a2-40de-adf6-fe94103d5275" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_eae58c7d-670e-4dbd-b0d8-28ba30f0f0d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c3179b4-9bdb-45bf-ad21-331b2804002e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c3179b4-9bdb-45bf-ad21-331b2804002e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended" id="id1ab3197a0b542e6b3682692b376143a_HedgingActivitiesandFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_00f88642-fca5-4f3f-aca4-c39af5750f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_LongTermDebt_00f88642-fca5-4f3f-aca4-c39af5750f14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b037bd5b-0543-4036-a5ba-aceaa99f37f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b037bd5b-0543-4036-a5ba-aceaa99f37f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_e2ecdb05-c6a8-4e3f-8e5b-1dddb691787d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeTermOfContract_e2ecdb05-c6a8-4e3f-8e5b-1dddb691787d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_b71d45e3-1123-483e-a420-30aef0d34d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_b71d45e3-1123-483e-a420-30aef0d34d99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_0e6ca2c9-90fc-4dd0-a714-b4e5a2a5fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_0e6ca2c9-90fc-4dd0-a714-b4e5a2a5fba4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_843843b1-44d6-4e26-92c3-8fe84238bbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeNotionalAmount_843843b1-44d6-4e26-92c3-8fe84238bbdb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_871f0b3e-2a01-467f-b08f-ce518571c484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_871f0b3e-2a01-467f-b08f-ce518571c484" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_dd8dd4ac-c500-46ce-a95a-5133f4f02259" xlink:href="bsx-20220630.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_dd8dd4ac-c500-46ce-a95a-5133f4f02259" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_87dd1149-c0ae-40e6-83eb-26ffea295ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_87dd1149-c0ae-40e6-83eb-26ffea295ba6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c33a28a3-49eb-4cf6-89e8-1ef693e8c6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c33a28a3-49eb-4cf6-89e8-1ef693e8c6b2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_0e820a9f-ebfa-4b4f-9c2c-e7fab8706f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_0e820a9f-ebfa-4b4f-9c2c-e7fab8706f85" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_56650400-8204-4ad8-8f0e-d31872e12ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_56650400-8204-4ad8-8f0e-d31872e12ee1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_95e0a329-af32-4342-a3f9-98b06b035c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_95e0a329-af32-4342-a3f9-98b06b035c09" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3523be97-a05a-4823-841e-286747e422bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3523be97-a05a-4823-841e-286747e422bb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_3f6daf23-0166-4e7b-a136-78fb1fe4be09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_3f6daf23-0166-4e7b-a136-78fb1fe4be09" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2f85e4dc-f37c-4786-88d4-b48567f8d60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2f85e4dc-f37c-4786-88d4-b48567f8d60d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9aba3fa6-ecee-4704-a6fe-9f1c3922dc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9aba3fa6-ecee-4704-a6fe-9f1c3922dc0f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0672bd6-6097-4d93-9f02-3d4b80041402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0672bd6-6097-4d93-9f02-3d4b80041402" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_52beee63-d606-4065-be4a-d618e88168e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_52beee63-d606-4065-be4a-d618e88168e0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1b44f74b-8382-49b6-b5ac-4585d7e73747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_InterestExpense_1b44f74b-8382-49b6-b5ac-4585d7e73747" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_72359c66-4325-4f70-8f99-541d53629553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_72359c66-4325-4f70-8f99-541d53629553" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_63189602-cd7e-4ded-bd1f-ae1d7d77163f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_63189602-cd7e-4ded-bd1f-ae1d7d77163f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_1a42252e-8f5d-474b-bcd3-ffc0c2ab3755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_1a42252e-8f5d-474b-bcd3-ffc0c2ab3755" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_0368e32b-0a80-43fc-8014-ed227cc96590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_0368e32b-0a80-43fc-8014-ed227cc96590" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5a395d82-87cf-44e7-9790-c5177ca0a0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5a395d82-87cf-44e7-9790-c5177ca0a0e6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_63a571ac-6fd7-4c14-9dd7-0b43eaec57ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_63a571ac-6fd7-4c14-9dd7-0b43eaec57ff" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_142f1a1a-a12b-4894-b1c5-c06d5ac3ae15" xlink:href="bsx-20220630.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_142f1a1a-a12b-4894-b1c5-c06d5ac3ae15" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fbdb9c50-0d42-440b-9ecc-8562d9f5570f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fbdb9c50-0d42-440b-9ecc-8562d9f5570f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_409e1734-086a-4a02-9ca0-9946d217bcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_409e1734-086a-4a02-9ca0-9946d217bcf3" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_5d5ee7ab-b667-4e46-9af3-d9b150a33263" xlink:href="bsx-20220630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_bsx_Netcurrencyexchangegainloss_5d5ee7ab-b667-4e46-9af3-d9b150a33263" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_61b0d26d-6eec-4dfc-b1b2-f7a75b927dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_61b0d26d-6eec-4dfc-b1b2-f7a75b927dba" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_bb66e748-c0d3-498a-929f-f3d941ac9fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_bb66e748-c0d3-498a-929f-f3d941ac9fcd" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c01ff0c6-a471-44f3-83b0-ee535438b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c01ff0c6-a471-44f3-83b0-ee535438b87d" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b20043b9-a543-4d39-ae5c-7d2ab093e75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b20043b9-a543-4d39-ae5c-7d2ab093e75c" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_db99b908-6be9-4d8c-92cb-804871dd3e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_db99b908-6be9-4d8c-92cb-804871dd3e77" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42558274-ff7e-46fb-a019-e551a8775cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42558274-ff7e-46fb-a019-e551a8775cda" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_91f346af-ec98-4cdc-87fb-d6432a5ed305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_91f346af-ec98-4cdc-87fb-d6432a5ed305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_91f346af-ec98-4cdc-87fb-d6432a5ed305_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_91f346af-ec98-4cdc-87fb-d6432a5ed305" xlink:to="loc_us-gaap_HedgingRelationshipDomain_91f346af-ec98-4cdc-87fb-d6432a5ed305_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_91f346af-ec98-4cdc-87fb-d6432a5ed305" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2250acbf-d33b-417e-8a5c-3c4029d44d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:to="loc_us-gaap_CashFlowHedgingMember_2250acbf-d33b-417e-8a5c-3c4029d44d5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9d76a661-f2c0-45bf-acfe-4652f87df536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9d76a661-f2c0-45bf-acfe-4652f87df536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_40088d6d-63e8-4988-b006-2c6963c80019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_HedgingDesignationAxis_40088d6d-63e8-4988-b006-2c6963c80019" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_40088d6d-63e8-4988-b006-2c6963c80019_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_40088d6d-63e8-4988-b006-2c6963c80019" xlink:to="loc_us-gaap_HedgingDesignationDomain_40088d6d-63e8-4988-b006-2c6963c80019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_40088d6d-63e8-4988-b006-2c6963c80019" xlink:to="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9859460e-06a2-4c60-a7a6-37e5eb788413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9859460e-06a2-4c60-a7a6-37e5eb788413" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a85e79de-d58d-4857-91c8-4c7161b8fa54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:to="loc_us-gaap_NondesignatedMember_a85e79de-d58d-4857-91c8-4c7161b8fa54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_38df7f68-338c-4a17-b315-6da05eeecbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_38df7f68-338c-4a17-b315-6da05eeecbb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_38df7f68-338c-4a17-b315-6da05eeecbb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38df7f68-338c-4a17-b315-6da05eeecbb5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_38df7f68-338c-4a17-b315-6da05eeecbb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38df7f68-338c-4a17-b315-6da05eeecbb5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c6205103-b6a7-4377-9ba3-8f866eddfcae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c6205103-b6a7-4377-9ba3-8f866eddfcae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0d9e31fe-abdb-4dc8-8aef-f6e3f7334765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0d9e31fe-abdb-4dc8-8aef-f6e3f7334765" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_9cc251e4-e93c-4780-b5a1-4a690cbb7ea0" xlink:href="bsx-20220630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_9cc251e4-e93c-4780-b5a1-4a690cbb7ea0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_476b8e59-8095-4d95-8ee7-c7fe08032e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_InterestRateContractMember_476b8e59-8095-4d95-8ee7-c7fe08032e82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e444fed3-bbe7-4a12-a83e-d2d080150dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e444fed3-bbe7-4a12-a83e-d2d080150dbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c659c154-06e6-4ff2-8d41-90b31dc37219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c659c154-06e6-4ff2-8d41-90b31dc37219" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c659c154-06e6-4ff2-8d41-90b31dc37219_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c659c154-06e6-4ff2-8d41-90b31dc37219" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c659c154-06e6-4ff2-8d41-90b31dc37219_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c659c154-06e6-4ff2-8d41-90b31dc37219" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_527cbbd9-acec-4bb9-b95f-2296d87190b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_527cbbd9-acec-4bb9-b95f-2296d87190b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_90219db0-e61b-47cf-8304-ec23b46e5403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_90219db0-e61b-47cf-8304-ec23b46e5403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a270649a-7677-43ae-aab7-52a43317fd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a270649a-7677-43ae-aab7-52a43317fd37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f01dcdcf-f02e-479a-bffb-e22495a9bb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f01dcdcf-f02e-479a-bffb-e22495a9bb43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2b51af03-5d59-4353-b171-825169d9a315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2b51af03-5d59-4353-b171-825169d9a315" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2b51af03-5d59-4353-b171-825169d9a315_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2b51af03-5d59-4353-b171-825169d9a315" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2b51af03-5d59-4353-b171-825169d9a315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2b51af03-5d59-4353-b171-825169d9a315" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9093369f-0bf4-4468-be4f-676802756932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:to="loc_us-gaap_CostOfSalesMember_9093369f-0bf4-4468-be4f-676802756932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_95c293df-1cbb-47b4-aa0e-f9ce15f1aaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:to="loc_us-gaap_InterestExpenseMember_95c293df-1cbb-47b4-aa0e-f9ce15f1aaaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b49a55ec-4ca2-460f-9e15-e20f13dfe257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b49a55ec-4ca2-460f-9e15-e20f13dfe257" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_95a7c94e-e3ce-47ae-a895-2f5deeca1023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_95a7c94e-e3ce-47ae-a895-2f5deeca1023" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95a7c94e-e3ce-47ae-a895-2f5deeca1023_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95a7c94e-e3ce-47ae-a895-2f5deeca1023" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95a7c94e-e3ce-47ae-a895-2f5deeca1023_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7e38988d-bb65-4754-b4c4-327273ea4eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95a7c94e-e3ce-47ae-a895-2f5deeca1023" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7e38988d-bb65-4754-b4c4-327273ea4eb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_5e3b09b9-61cf-45a3-abf3-34e3087c92bd" xlink:href="bsx-20220630.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e38988d-bb65-4754-b4c4-327273ea4eb6" xlink:to="loc_bsx_December2027NotesMember_5e3b09b9-61cf-45a3-abf3-34e3087c92bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0" xlink:to="loc_us-gaap_EquityComponentDomain_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_494016f2-8cdb-4efc-8c18-1bcff594d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0" xlink:to="loc_us-gaap_EquityComponentDomain_494016f2-8cdb-4efc-8c18-1bcff594d47d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_474da03a-6d0d-43de-81b2-41805d38b51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_494016f2-8cdb-4efc-8c18-1bcff594d47d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_474da03a-6d0d-43de-81b2-41805d38b51a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_8f16fba1-7ab9-4d99-ad7e-66d73e5985b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_8f16fba1-7ab9-4d99-ad7e-66d73e5985b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cf23d1d2-65d7-4a28-9eb6-5ecb47f7c900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cf23d1d2-65d7-4a28-9eb6-5ecb47f7c900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d6a9fef1-405f-4f61-832b-e1a795199ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_DerivativeAssets_d6a9fef1-405f-4f61-832b-e1a795199ca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_1a1cf4d1-7c23-4f37-98a1-6568ebbd256b" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsasset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_Licensingarrangementsasset_1a1cf4d1-7c23-4f37-98a1-6568ebbd256b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_fdbc61de-b4af-46e3-b658-54e5f3a54ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_fdbc61de-b4af-46e3-b658-54e5f3a54ab6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_c285a24a-6d93-4f9b-9b80-008f4f5decc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_DerivativeLiabilities_c285a24a-6d93-4f9b-9b80-008f4f5decc6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b3ce075f-f9c6-41a6-9b31-377b967f183a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b3ce075f-f9c6-41a6-9b31-377b967f183a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_a7c80f6d-f62f-4409-bb15-de18d7f4ab5b" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsliability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_Licensingarrangementsliability_a7c80f6d-f62f-4409-bb15-de18d7f4ab5b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_38a1a0f9-5021-47a6-a19b-a66bf76345b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_PaymentsForRoyalties_38a1a0f9-5021-47a6-a19b-a66bf76345b6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8db7cdab-371e-4a1b-a851-9ef11418edfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8db7cdab-371e-4a1b-a851-9ef11418edfc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_7b0913ea-b027-4ac2-94db-2d0d877f6637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_Cash_7b0913ea-b027-4ac2-94db-2d0d877f6637" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_0233c58b-79c7-4ed4-9cec-0059b9dd1b1a" xlink:href="bsx-20220630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_DiscountRateFairValueInput_0233c58b-79c7-4ed4-9cec-0059b9dd1b1a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_e6ec5cd8-ba39-4ded-bd95-78706529b0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_e6ec5cd8-ba39-4ded-bd95-78706529b0e1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_5d387ec9-3500-45e6-908b-dd8cbd2e3051" xlink:href="bsx-20220630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_5d387ec9-3500-45e6-908b-dd8cbd2e3051" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_9c713528-1cc3-485d-9a2f-842c1b97877c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_9c713528-1cc3-485d-9a2f-842c1b97877c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_3428dcf4-fe88-45b8-9512-5b715e1d876c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_3428dcf4-fe88-45b8-9512-5b715e1d876c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_359edc71-d6e3-42eb-9592-9a01529dc85e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_srt_RangeAxis_359edc71-d6e3-42eb-9592-9a01529dc85e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_359edc71-d6e3-42eb-9592-9a01529dc85e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_359edc71-d6e3-42eb-9592-9a01529dc85e" xlink:to="loc_srt_RangeMember_359edc71-d6e3-42eb-9592-9a01529dc85e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_359edc71-d6e3-42eb-9592-9a01529dc85e" xlink:to="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_b0f76f9c-add5-485f-bc83-654563bc712e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:to="loc_srt_WeightedAverageMember_b0f76f9c-add5-485f-bc83-654563bc712e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cfecc3e4-ea5d-48d5-981d-c1c903e93eee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:to="loc_srt_MinimumMember_cfecc3e4-ea5d-48d5-981d-c1c903e93eee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d9386ad8-6750-47d8-96de-cda02e75d3ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:to="loc_srt_MaximumMember_d9386ad8-6750-47d8-96de-cda02e75d3ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_746c134e-c121-4854-88bd-cafdd16a2b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_746c134e-c121-4854-88bd-cafdd16a2b0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_746c134e-c121-4854-88bd-cafdd16a2b0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_746c134e-c121-4854-88bd-cafdd16a2b0e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_746c134e-c121-4854-88bd-cafdd16a2b0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_466741c4-ce10-4145-8fdd-6eb4e7346c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_746c134e-c121-4854-88bd-cafdd16a2b0e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_466741c4-ce10-4145-8fdd-6eb4e7346c49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6c497352-3b9a-4b4d-af8f-8680a1189228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_466741c4-ce10-4145-8fdd-6eb4e7346c49" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6c497352-3b9a-4b4d-af8f-8680a1189228" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b68518b0-8bd6-4897-87ed-66e9710cb62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b68518b0-8bd6-4897-87ed-66e9710cb62b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b68518b0-8bd6-4897-87ed-66e9710cb62b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b68518b0-8bd6-4897-87ed-66e9710cb62b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b68518b0-8bd6-4897-87ed-66e9710cb62b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b68518b0-8bd6-4897-87ed-66e9710cb62b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1faad1ba-d15f-48dd-8ac2-3916efb88a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1faad1ba-d15f-48dd-8ac2-3916efb88a17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1d66f379-325b-427e-a795-aaef19a2db91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1d66f379-325b-427e-a795-aaef19a2db91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d5d341ad-e98e-4bb6-b847-5bc9eebc6351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d5d341ad-e98e-4bb6-b847-5bc9eebc6351" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_51dbea48-0c6b-48af-a6da-57e2954ef722" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:to="loc_bsx_LicensingarrangementassetsMember_51dbea48-0c6b-48af-a6da-57e2954ef722" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_732919b6-c8c7-4a3c-8eb8-94c6f475bbe2" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_732919b6-c8c7-4a3c-8eb8-94c6f475bbe2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended" id="i774d43cd8dd1448ca1679dd4b4a2a963_ContractualObligationsandCommitmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_d10df047-fdda-45f8-bd7f-9113ffc9315f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_427fe555-c8cd-4297-aa7e-53dcfff60068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d10df047-fdda-45f8-bd7f-9113ffc9315f" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_427fe555-c8cd-4297-aa7e-53dcfff60068" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d10df047-fdda-45f8-bd7f-9113ffc9315f" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ea9101cb-1508-4bef-80cc-6799828b5678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ea9101cb-1508-4bef-80cc-6799828b5678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_64992191-90d5-4106-ab2b-feccd6571fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ea9101cb-1508-4bef-80cc-6799828b5678" xlink:to="loc_us-gaap_CommercialPaperMember_64992191-90d5-4106-ab2b-feccd6571fc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1bf24019-4317-4533-a26b-f16e8d941a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:to="loc_us-gaap_DebtInstrumentAxis_1bf24019-4317-4533-a26b-f16e8d941a01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1bf24019-4317-4533-a26b-f16e8d941a01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1bf24019-4317-4533-a26b-f16e8d941a01" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1bf24019-4317-4533-a26b-f16e8d941a01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_28454c50-3eeb-4447-ba27-cdd9188e7bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1bf24019-4317-4533-a26b-f16e8d941a01" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_28454c50-3eeb-4447-ba27-cdd9188e7bfa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended" id="i2ba09591a0df451dba9c14692fe1d42b_ContractualObligationsandCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_e3dd1aad-3082-40e0-8590-076c510d7cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_e3dd1aad-3082-40e0-8590-076c510d7cfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3ba40b8f-675b-4c08-8f52-24888575f55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtCurrent_3ba40b8f-675b-4c08-8f52-24888575f55e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0a32fcda-592a-42ac-a709-414e86c5ea36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LongTermDebt_0a32fcda-592a-42ac-a709-414e86c5ea36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_064bf55c-f44a-46bf-984b-f9f80bb21cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_064bf55c-f44a-46bf-984b-f9f80bb21cf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_188e4d10-cb2f-49e0-803a-a84db741260d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_188e4d10-cb2f-49e0-803a-a84db741260d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1fe728ac-ea6f-406a-b311-7fc9d98faeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1fe728ac-ea6f-406a-b311-7fc9d98faeb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_982a54eb-5b31-41dc-9081-2263a6a41cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_982a54eb-5b31-41dc-9081-2263a6a41cef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm_5aaf2096-ac3e-4e69-b4d2-162fbce940d0" xlink:href="bsx-20220630.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_DebtInstrumentExtensionOptionTerm_5aaf2096-ac3e-4e69-b4d2-162fbce940d0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_4a0f8df3-0173-4b8d-be2a-69aa0d8ecb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_4a0f8df3-0173-4b8d-be2a-69aa0d8ecb5f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_3925b501-de34-4627-ba9f-b56c87ffdbd1" xlink:href="bsx-20220630.xsd#bsx_MaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_MaximumLeverageRatio_3925b501-de34-4627-ba9f-b56c87ffdbd1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_e276cbf0-6102-450b-a6fa-1cb915e25a88" xlink:href="bsx-20220630.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_e276cbf0-6102-450b-a6fa-1cb915e25a88" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_e188075f-90fe-4d0e-8a9c-ad9deaf7b3d8" xlink:href="bsx-20220630.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_e188075f-90fe-4d0e-8a9c-ad9deaf7b3d8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_966c5d94-c128-4b7e-ba5d-a2c98310e1ca" xlink:href="bsx-20220630.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_966c5d94-c128-4b7e-ba5d-a2c98310e1ca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_89e1276e-7d67-45ea-aa36-2cd4b71e6246" xlink:href="bsx-20220630.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_89e1276e-7d67-45ea-aa36-2cd4b71e6246" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_1aed30f3-a1bd-4951-b6d6-efbc2db43c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_1aed30f3-a1bd-4951-b6d6-efbc2db43c6a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_c366bd53-9b3f-42f3-9f41-72e0268ee837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_c366bd53-9b3f-42f3-9f41-72e0268ee837" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_a440dcdf-57df-4bd0-8cab-1cd897b5d1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_a440dcdf-57df-4bd0-8cab-1cd897b5d1f8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration_9425993b-3b3d-41a8-82d2-8381dbb83da1" xlink:href="bsx-20220630.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_QualifiedAcquisitionConsideration_9425993b-3b3d-41a8-82d2-8381dbb83da1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding_18be069a-142a-4a23-8a32-011b728384ab" xlink:href="bsx-20220630.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_MaximumCommercialPaperOutstanding_18be069a-142a-4a23-8a32-011b728384ab" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f4ed7bd4-771c-465b-a082-a26662bcb77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f4ed7bd4-771c-465b-a082-a26662bcb77c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_b11df23c-2889-4d03-bf52-485056f608fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_b11df23c-2889-4d03-bf52-485056f608fe" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_641e33de-52d5-4b34-be07-947cc22d22da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_CommercialPaper_641e33de-52d5-4b34-be07-947cc22d22da" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ed42d9ff-93d6-4372-8dce-358a1e737300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ShortTermBorrowings_ed42d9ff-93d6-4372-8dce-358a1e737300" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_de0b7098-2178-43f0-abf8-54d28a90404e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_de0b7098-2178-43f0-abf8-54d28a90404e" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_576d211b-ac0b-4af6-9c04-7fe352b16680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_576d211b-ac0b-4af6-9c04-7fe352b16680" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_c382cefb-5817-42b2-9402-ad9b56bee1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_PaymentsForRoyalties_c382cefb-5817-42b2-9402-ad9b56bee1e5" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_9317fb6a-661c-455a-91e8-cf109b68c658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_9317fb6a-661c-455a-91e8-cf109b68c658" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c5784bbe-b378-4806-aef8-eed6eb866e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_DebtInstrumentAxis_c5784bbe-b378-4806-aef8-eed6eb866e6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c5784bbe-b378-4806-aef8-eed6eb866e6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5784bbe-b378-4806-aef8-eed6eb866e6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c5784bbe-b378-4806-aef8-eed6eb866e6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5784bbe-b378-4806-aef8-eed6eb866e6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member_07c11144-df10-45b4-a664-194057412ef8" xlink:href="bsx-20220630.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_RevolvingCreditFacility2021Member_07c11144-df10-45b4-a664-194057412ef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_0b64ca7a-3692-464c-b400-ca56a93f6d5d" xlink:href="bsx-20220630.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_0b64ca7a-3692-464c-b400-ca56a93f6d5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_e8eb97ec-06fa-4b33-94ca-32f92e039829" xlink:href="bsx-20220630.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_e8eb97ec-06fa-4b33-94ca-32f92e039829" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_2a2ed82b-9988-433e-9b1d-0fe5ee1a4c47" xlink:href="bsx-20220630.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_2a2ed82b-9988-433e-9b1d-0fe5ee1a4c47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ab12ad4-e2d1-4df0-b11e-968a202f99d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ab12ad4-e2d1-4df0-b11e-968a202f99d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ab12ad4-e2d1-4df0-b11e-968a202f99d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ab12ad4-e2d1-4df0-b11e-968a202f99d1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ab12ad4-e2d1-4df0-b11e-968a202f99d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ab12ad4-e2d1-4df0-b11e-968a202f99d1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_20dab163-dc67-48a6-9ed6-feabdd503d0f" xlink:href="bsx-20220630.xsd#bsx_May2022NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_May2022NotesMember_20dab163-dc67-48a6-9ed6-feabdd503d0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_33034baf-1acd-46a9-a0df-c9c2ca7ebd1f" xlink:href="bsx-20220630.xsd#bsx_October2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_October2023NotesMember_33034baf-1acd-46a9-a0df-c9c2ca7ebd1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_d7e7ab94-fa4b-4f5b-99b0-82b956945dac" xlink:href="bsx-20220630.xsd#bsx_March2024NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2024NotesMember_d7e7ab94-fa4b-4f5b-99b0-82b956945dac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_3ec344f6-330b-4319-8b0b-69e1550ecac1" xlink:href="bsx-20220630.xsd#bsx_May2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_May2025NotesMember_3ec344f6-330b-4319-8b0b-69e1550ecac1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_e3526741-c1d0-4d33-892f-eb8bd53c7714" xlink:href="bsx-20220630.xsd#bsx_June2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_June2025NotesMember_e3526741-c1d0-4d33-892f-eb8bd53c7714" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_bfae3c78-c7ca-49b2-b784-c585656e7f6d" xlink:href="bsx-20220630.xsd#bsx_March2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2026NotesMember_bfae3c78-c7ca-49b2-b784-c585656e7f6d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_0b4902e0-32be-4f04-8461-de269a915cac" xlink:href="bsx-20220630.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_December2027NotesMember_0b4902e0-32be-4f04-8461-de269a915cac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_3222fc6d-9b97-412f-b774-d2c2a0729829" xlink:href="bsx-20220630.xsd#bsx_March2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2028NotesMember_3222fc6d-9b97-412f-b774-d2c2a0729829" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_b1e42f79-6483-4b74-9a7f-81f18a71c734" xlink:href="bsx-20220630.xsd#bsx_March2029NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2029NotesMember_b1e42f79-6483-4b74-9a7f-81f18a71c734" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_c35784c8-aee5-40d4-8753-2727f50a2ace" xlink:href="bsx-20220630.xsd#bsx_June2030NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_June2030NotesMember_c35784c8-aee5-40d4-8753-2727f50a2ace" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_4f5be227-1f7c-42e6-b3c2-2c765d0f2e6f" xlink:href="bsx-20220630.xsd#bsx_November2035NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_November2035NotesMember_4f5be227-1f7c-42e6-b3c2-2c765d0f2e6f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_0302b811-5800-4194-b40a-44a702f1c3c6" xlink:href="bsx-20220630.xsd#bsx_March2039NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2039NotesMember_0302b811-5800-4194-b40a-44a702f1c3c6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_59b4a131-f53c-4b55-934f-3bb116b9ade9" xlink:href="bsx-20220630.xsd#bsx_January2040NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_January2040NotesMember_59b4a131-f53c-4b55-934f-3bb116b9ade9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_5d4c0621-a724-41d6-bb96-585070f09288" xlink:href="bsx-20220630.xsd#bsx_March2049NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2049NotesMember_5d4c0621-a724-41d6-bb96-585070f09288" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_a7bf6515-57e5-4090-8ddf-8d9dbad4bebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_SeniorNotesMember_a7bf6515-57e5-4090-8ddf-8d9dbad4bebf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b0ca76d5-d5d7-4757-9f58-8470ebe4668f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_InterestRateSwapMember_b0ca76d5-d5d7-4757-9f58-8470ebe4668f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_0c1975d7-c253-47c7-a50a-fd55b55806bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_0c1975d7-c253-47c7-a50a-fd55b55806bf" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9e9e6006-882f-400a-8e49-02ded408caa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_LineOfCreditMember_9e9e6006-882f-400a-8e49-02ded408caa4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2025NotesMember_b5182086-d840-4ac9-8d2d-bdca96a740ec" xlink:href="bsx-20220630.xsd#bsx_March2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2025NotesMember_b5182086-d840-4ac9-8d2d-bdca96a740ec" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028SeniorNotesMember_aff0244e-4bdc-438e-b1a9-47be44d96635" xlink:href="bsx-20220630.xsd#bsx_March2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2028SeniorNotesMember_aff0244e-4bdc-438e-b1a9-47be44d96635" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2031NotesMember_5c06019f-e3c1-4f2b-bdb1-8873738add18" xlink:href="bsx-20220630.xsd#bsx_March2031NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2031NotesMember_5c06019f-e3c1-4f2b-bdb1-8873738add18" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2034NotesMember_ba8350ee-260a-4649-aac6-08982e97f691" xlink:href="bsx-20220630.xsd#bsx_March2034NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2034NotesMember_ba8350ee-260a-4649-aac6-08982e97f691" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingAggregatePrincipalAmountMember_1da82900-3a4d-4348-9d48-a4b77860ad12" xlink:href="bsx-20220630.xsd#bsx_TheOfferingAggregatePrincipalAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_TheOfferingAggregatePrincipalAmountMember_1da82900-3a4d-4348-9d48-a4b77860ad12" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_870765e9-42b7-47cc-b77a-69bfc007f9a1" xlink:href="bsx-20220630.xsd#bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_870765e9-42b7-47cc-b77a-69bfc007f9a1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_af97f9e8-5cd8-4470-afdd-390f12454e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_af97f9e8-5cd8-4470-afdd-390f12454e31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_af97f9e8-5cd8-4470-afdd-390f12454e31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_af97f9e8-5cd8-4470-afdd-390f12454e31" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_af97f9e8-5cd8-4470-afdd-390f12454e31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_423e5659-c72b-4c3a-a486-4b5b0899eb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_af97f9e8-5cd8-4470-afdd-390f12454e31" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_423e5659-c72b-4c3a-a486-4b5b0899eb7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_6032ab7f-380d-438e-9750-60eff9ea422b" xlink:href="bsx-20220630.xsd#bsx_The2018FacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_423e5659-c72b-4c3a-a486-4b5b0899eb7a" xlink:to="loc_bsx_The2018FacilityDomain_6032ab7f-380d-438e-9750-60eff9ea422b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1d2170ed-9910-495c-8e1c-ab1f9084480a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_CreditFacilityAxis_1d2170ed-9910-495c-8e1c-ab1f9084480a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1d2170ed-9910-495c-8e1c-ab1f9084480a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1d2170ed-9910-495c-8e1c-ab1f9084480a" xlink:to="loc_us-gaap_CreditFacilityDomain_1d2170ed-9910-495c-8e1c-ab1f9084480a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cccc2e7c-a821-4a86-bc47-4a2aa9ccfc25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1d2170ed-9910-495c-8e1c-ab1f9084480a" xlink:to="loc_us-gaap_CreditFacilityDomain_cccc2e7c-a821-4a86-bc47-4a2aa9ccfc25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5e95926a-c2b4-4a16-920b-cfa3b51c0070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cccc2e7c-a821-4a86-bc47-4a2aa9ccfc25" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5e95926a-c2b4-4a16-920b-cfa3b51c0070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_b83a8035-1524-4a5e-abe0-4ab760630acb" xlink:href="bsx-20220630.xsd#bsx_CovenantAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_bsx_CovenantAxis_b83a8035-1524-4a5e-abe0-4ab760630acb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_b83a8035-1524-4a5e-abe0-4ab760630acb_default" xlink:href="bsx-20220630.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_CovenantAxis_b83a8035-1524-4a5e-abe0-4ab760630acb" xlink:to="loc_bsx_CovenantDomain_b83a8035-1524-4a5e-abe0-4ab760630acb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:href="bsx-20220630.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_CovenantAxis_b83a8035-1524-4a5e-abe0-4ab760630acb" xlink:to="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_eb502928-b431-4389-90e8-8d4a8d5aee09" xlink:href="bsx-20220630.xsd#bsx_CurrentRequirementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_CurrentRequirementMember_eb502928-b431-4389-90e8-8d4a8d5aee09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_621f8277-0817-457c-878d-54993ee0dee6" xlink:href="bsx-20220630.xsd#bsx_ActualCovenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_ActualCovenantMember_621f8277-0817-457c-878d-54993ee0dee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_e2ab5531-64c1-45a4-9842-bc4502a2a823" xlink:href="bsx-20220630.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_e2ab5531-64c1-45a4-9842-bc4502a2a823" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_ef0d45e8-075e-445f-b9a0-43d2816f1ced" xlink:href="bsx-20220630.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_ef0d45e8-075e-445f-b9a0-43d2816f1ced" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_0b391dd9-9647-408d-add2-f0cfaefe3e22" xlink:href="bsx-20220630.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_0b391dd9-9647-408d-add2-f0cfaefe3e22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_374d63c3-46e4-417f-a274-dd133526ca4f" xlink:href="bsx-20220630.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_374d63c3-46e4-417f-a274-dd133526ca4f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_50b3a7ea-8124-4fca-a6e1-d966ef429761" xlink:href="bsx-20220630.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_50b3a7ea-8124-4fca-a6e1-d966ef429761" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_736b8cc9-3348-4aff-90fd-dcf95332463c" xlink:href="bsx-20220630.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_736b8cc9-3348-4aff-90fd-dcf95332463c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1066abae-e2f1-475e-826e-8f54ba6f53e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1066abae-e2f1-475e-826e-8f54ba6f53e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1066abae-e2f1-475e-826e-8f54ba6f53e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1066abae-e2f1-475e-826e-8f54ba6f53e4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1066abae-e2f1-475e-826e-8f54ba6f53e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1066abae-e2f1-475e-826e-8f54ba6f53e4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d99251f0-0f81-4ea2-99f8-ba8486c3678a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:to="loc_us-gaap_CommercialPaperMember_d99251f0-0f81-4ea2-99f8-ba8486c3678a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_4a93c5ab-3db8-46f4-b54f-30ac1338bd6e" xlink:href="bsx-20220630.xsd#bsx_May2022NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:to="loc_bsx_May2022NotesMember_4a93c5ab-3db8-46f4-b54f-30ac1338bd6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a5d88009-d81c-4b98-b89d-2226122fc31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a5d88009-d81c-4b98-b89d-2226122fc31f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5d88009-d81c-4b98-b89d-2226122fc31f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5d88009-d81c-4b98-b89d-2226122fc31f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5d88009-d81c-4b98-b89d-2226122fc31f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5d88009-d81c-4b98-b89d-2226122fc31f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_3e84ccc5-3e1d-4f55-95fe-82a43492dc79" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:to="loc_bsx_LicensingarrangementassetsMember_3e84ccc5-3e1d-4f55-95fe-82a43492dc79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_ee18b9df-f4f4-477e-9e78-50c2165575ec" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_ee18b9df-f4f4-477e-9e78-50c2165575ec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended" id="id0e7c7cc7ebc46b4bc82ec06747bc976_SupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:href="bsx-20220630.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cfc71445-fd97-4599-8e6a-b57522025036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cfc71445-fd97-4599-8e6a-b57522025036" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6c9aa703-66f3-4eac-8de2-a0a8b018fc79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6c9aa703-66f3-4eac-8de2-a0a8b018fc79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_c7537a11-eefb-408f-a895-258c23d52b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_c7537a11-eefb-408f-a895-258c23d52b5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_14f7ae0c-596c-4c7e-be88-246261775621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_14f7ae0c-596c-4c7e-be88-246261775621" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_11c1a814-f189-4d1d-bacf-14e54eb3b037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_Depreciation_11c1a814-f189-4d1d-bacf-14e54eb3b037" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cbd0e13b-6bd4-4bd1-bff6-3a96b4c85d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cbd0e13b-6bd4-4bd1-bff6-3a96b4c85d39" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3a373eb4-d8cc-4ced-919d-1ea3650759f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3a373eb4-d8cc-4ced-919d-1ea3650759f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a373eb4-d8cc-4ced-919d-1ea3650759f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3a373eb4-d8cc-4ced-919d-1ea3650759f2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a373eb4-d8cc-4ced-919d-1ea3650759f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74d4939b-5ad0-4312-bcf9-a557253bd8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3a373eb4-d8cc-4ced-919d-1ea3650759f2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74d4939b-5ad0-4312-bcf9-a557253bd8d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_753e0074-6b55-46fb-9b5e-e87b28db1934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_753e0074-6b55-46fb-9b5e-e87b28db1934" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_753e0074-6b55-46fb-9b5e-e87b28db1934_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_753e0074-6b55-46fb-9b5e-e87b28db1934" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_753e0074-6b55-46fb-9b5e-e87b28db1934_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5dd2d980-665b-4284-8312-e2be222c357f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_753e0074-6b55-46fb-9b5e-e87b28db1934" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5dd2d980-665b-4284-8312-e2be222c357f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended" id="idd8fc687a1564860bcf57721b9f9b5cf_IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_862c22b4-247d-4fe7-8820-385d64d9a69b" xlink:href="bsx-20220630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d6543cab-3b7b-4819-b520-6f9b07f8934f" xlink:href="bsx-20220630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_862c22b4-247d-4fe7-8820-385d64d9a69b" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d6543cab-3b7b-4819-b520-6f9b07f8934f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_70548cf0-087e-4bc7-b741-db3a5e5c8bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d6543cab-3b7b-4819-b520-6f9b07f8934f" xlink:to="loc_us-gaap_VariableRateAxis_70548cf0-087e-4bc7-b741-db3a5e5c8bd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_70548cf0-087e-4bc7-b741-db3a5e5c8bd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_70548cf0-087e-4bc7-b741-db3a5e5c8bd4" xlink:to="loc_us-gaap_VariableRateDomain_70548cf0-087e-4bc7-b741-db3a5e5c8bd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b6213e50-45d5-459d-a69a-20f954c5b06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_70548cf0-087e-4bc7-b741-db3a5e5c8bd4" xlink:to="loc_us-gaap_VariableRateDomain_b6213e50-45d5-459d-a69a-20f954c5b06a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i539b8fed8c3a4ebbb5c4bed6e7edb3df_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_61cc77d0-1954-4306-96e8-531827255556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_61cc77d0-1954-4306-96e8-531827255556" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_77a469e7-2b9e-4a5e-a3f8-fd884ab4b3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_77a469e7-2b9e-4a5e-a3f8-fd884ab4b3e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_da03ecb6-9553-439d-9fe7-d97bb62b0bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_LitigationSettlementExpense_da03ecb6-9553-439d-9fe7-d97bb62b0bbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_aaf30735-1af0-4a6e-a9ec-ea0260c2bd13" xlink:href="bsx-20220630.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_aaf30735-1af0-4a6e-a9ec-ea0260c2bd13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_cc4efa24-35a7-44ef-bfc9-fd2e1997f8de" xlink:href="bsx-20220630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_cc4efa24-35a7-44ef-bfc9-fd2e1997f8de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_efbd9c37-083d-4a16-a396-3c9c607770ec" xlink:href="bsx-20220630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_efbd9c37-083d-4a16-a396-3c9c607770ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_3f4f9c41-7549-4a52-ac3c-e5136c870bf8" xlink:href="bsx-20220630.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_3f4f9c41-7549-4a52-ac3c-e5136c870bf8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh_56641a0a-bf68-4e48-b8f6-504617497aa1" xlink:href="bsx-20220630.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_CertifiedClassActionsInAustraliaMesh_56641a0a-bf68-4e48-b8f6-504617497aa1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_3738e48d-3359-4bb2-b842-db8980b296b8" xlink:href="bsx-20220630.xsd#bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_3738e48d-3359-4bb2-b842-db8980b296b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_e4873e8d-c097-4a0d-adba-19f03c8b01c2" xlink:href="bsx-20220630.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_e4873e8d-c097-4a0d-adba-19f03c8b01c2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_bb931bf8-4295-4252-a685-5a72f7fe1442" xlink:href="bsx-20220630.xsd#bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_bb931bf8-4295-4252-a685-5a72f7fe1442" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CanadaSettledClaims_5f412a15-4696-417c-a0ed-4f5dcb663a7f" xlink:href="bsx-20220630.xsd#bsx_CanadaSettledClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_CanadaSettledClaims_5f412a15-4696-417c-a0ed-4f5dcb663a7f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16a66cdb-9003-4601-a344-c23ab03b3256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16a66cdb-9003-4601-a344-c23ab03b3256" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf2edd36-8621-493e-86f2-c84e88e1b2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf2edd36-8621-493e-86f2-c84e88e1b2d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8b70fa59-cf2a-4406-b280-32f5994e9d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:to="loc_us-gaap_LitigationStatusAxis_8b70fa59-cf2a-4406-b280-32f5994e9d10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8b70fa59-cf2a-4406-b280-32f5994e9d10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_8b70fa59-cf2a-4406-b280-32f5994e9d10" xlink:to="loc_us-gaap_LitigationStatusDomain_8b70fa59-cf2a-4406-b280-32f5994e9d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9f2c1034-1289-4733-93ab-d6c819310b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_8b70fa59-cf2a-4406-b280-32f5994e9d10" xlink:to="loc_us-gaap_LitigationStatusDomain_9f2c1034-1289-4733-93ab-d6c819310b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b6d03ca9-cdb1-49c2-bf72-75d77622406b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_9f2c1034-1289-4733-93ab-d6c819310b7a" xlink:to="loc_us-gaap_SettledLitigationMember_b6d03ca9-cdb1-49c2-bf72-75d77622406b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4491e126-a0b2-4653-b9fa-72ce5e823868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4491e126-a0b2-4653-b9fa-72ce5e823868" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4491e126-a0b2-4653-b9fa-72ce5e823868_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4491e126-a0b2-4653-b9fa-72ce5e823868" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4491e126-a0b2-4653-b9fa-72ce5e823868_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1ff365c5-965a-4ea3-8ead-2074fb2f5646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4491e126-a0b2-4653-b9fa-72ce5e823868" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1ff365c5-965a-4ea3-8ead-2074fb2f5646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_577910a0-c26e-467c-9cec-b75e48093373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1ff365c5-965a-4ea3-8ead-2074fb2f5646" xlink:to="loc_us-gaap_SubsequentEventMember_577910a0-c26e-467c-9cec-b75e48093373" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended" id="i290a0318b356479a8925bc503d1cd9db_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b441d4e5-dc55-43c4-ba99-cbafe199983b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b441d4e5-dc55-43c4-ba99-cbafe199983b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_cd4ac4ac-38d1-464a-9d85-8492de53acb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockSharesIssued_cd4ac4ac-38d1-464a-9d85-8492de53acb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_09309003-6f98-4dc8-809f-e330c9cf5de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_09309003-6f98-4dc8-809f-e330c9cf5de3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_6b99d31a-6146-47cc-8b34-21fe742b2cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_6b99d31a-6146-47cc-8b34-21fe742b2cde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_eeeca20e-65c6-4a83-8f8e-2daadf2d83ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_eeeca20e-65c6-4a83-8f8e-2daadf2d83ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_f66e7e48-7cec-442c-97d2-bc98bd27c6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_f66e7e48-7cec-442c-97d2-bc98bd27c6cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_3f52a3da-41b5-41d9-84ae-8727c431d7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_3f52a3da-41b5-41d9-84ae-8727c431d7c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_69415f38-ff92-4fa1-a162-9f8bbdb51487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PaymentsOfDividends_69415f38-ff92-4fa1-a162-9f8bbdb51487" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_f5e18934-ebde-4ae1-aca4-07b1be936278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_f5e18934-ebde-4ae1-aca4-07b1be936278" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_89927cfb-daba-49ac-82fb-3ffff171046c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_89927cfb-daba-49ac-82fb-3ffff171046c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8e788d4d-e496-4a7a-be35-9a0c48de6356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8e788d4d-e496-4a7a-be35-9a0c48de6356" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a6383baa-2619-447f-8397-334eb0fe38ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a6383baa-2619-447f-8397-334eb0fe38ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a6383baa-2619-447f-8397-334eb0fe38ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a6383baa-2619-447f-8397-334eb0fe38ac" xlink:to="loc_us-gaap_ClassOfStockDomain_a6383baa-2619-447f-8397-334eb0fe38ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a6383baa-2619-447f-8397-334eb0fe38ac" xlink:to="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_ec7a5a51-55e2-4716-8ec1-5a2163071640" xlink:href="bsx-20220630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:to="loc_bsx_A550MCPSSeriesAMember_ec7a5a51-55e2-4716-8ec1-5a2163071640" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4e1653d3-a6a8-4152-817a-4631f1396838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:to="loc_us-gaap_CommonStockMember_4e1653d3-a6a8-4152-817a-4631f1396838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_d14e41d6-91a0-4481-a228-59d4d30cd71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:to="loc_us-gaap_PreferredStockMember_d14e41d6-91a0-4481-a228-59d4d30cd71c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_080c8125-42ac-446c-921b-f53e5a292633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_080c8125-42ac-446c-921b-f53e5a292633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_622c6448-b0bb-4a0b-a9ae-2c198a3d53a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_080c8125-42ac-446c-921b-f53e5a292633" xlink:to="loc_us-gaap_SubsequentEventMember_622c6448-b0bb-4a0b-a9ae-2c198a3d53a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44c81dbc-1b09-4eb3-9f9d-171172408cc6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:to="loc_srt_RangeAxis_44c81dbc-1b09-4eb3-9f9d-171172408cc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44c81dbc-1b09-4eb3-9f9d-171172408cc6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_44c81dbc-1b09-4eb3-9f9d-171172408cc6" xlink:to="loc_srt_RangeMember_44c81dbc-1b09-4eb3-9f9d-171172408cc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_44c81dbc-1b09-4eb3-9f9d-171172408cc6" xlink:to="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_582628b7-7fb0-4e72-8d69-d73b82bcd5a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:to="loc_srt_MinimumMember_582628b7-7fb0-4e72-8d69-d73b82bcd5a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_abafcf34-7ea6-4c1f-b7a8-109b968d379b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:to="loc_srt_MaximumMember_abafcf34-7ea6-4c1f-b7a8-109b968d379b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended" id="icdc71d1dbc5442d9be21aa5aea8bcb38_WeightedAverageSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a48050a4-4b2b-4c5e-a66a-b4f286dfc3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a48050a4-4b2b-4c5e-a66a-b4f286dfc3d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44011a7d-75e6-4cd2-8bcb-01a4b131a477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44011a7d-75e6-4cd2-8bcb-01a4b131a477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b9c005bf-f48f-449e-b72c-8d8fa5890edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b9c005bf-f48f-449e-b72c-8d8fa5890edd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c0ba35b6-68cf-4712-ba4e-19cb895b3cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c0ba35b6-68cf-4712-ba4e-19cb895b3cdd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_73c03bc9-549d-41ab-90bb-6a039065e852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_73c03bc9-549d-41ab-90bb-6a039065e852" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0c0203d2-5065-4ff9-a34a-aad679c442b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0c0203d2-5065-4ff9-a34a-aad679c442b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea6cf02e-348d-465b-aba0-51306226f596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea6cf02e-348d-465b-aba0-51306226f596" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea0c7e33-5d7d-41d5-b7c3-66125128a16d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea6cf02e-348d-465b-aba0-51306226f596" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea0c7e33-5d7d-41d5-b7c3-66125128a16d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ea0c7e33-5d7d-41d5-b7c3-66125128a16d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea0c7e33-5d7d-41d5-b7c3-66125128a16d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ea0c7e33-5d7d-41d5-b7c3-66125128a16d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea0c7e33-5d7d-41d5-b7c3-66125128a16d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b08dbbd5-5064-4f0b-9ea1-701f0b723d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b08dbbd5-5064-4f0b-9ea1-701f0b723d14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_8ceda80b-cb28-44fd-87e5-5bc055fe105e" xlink:href="bsx-20220630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:to="loc_bsx_A550MCPSSeriesAMember_8ceda80b-cb28-44fd-87e5-5bc055fe105e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended" id="i8755211f9a5c4de080cee18a6c9d5684_SegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_2d22cd4b-43f5-45c0-ab5d-613fb60e94a3" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_2d22cd4b-43f5-45c0-ab5d-613fb60e94a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_639f6fda-0d55-4577-a128-0f28afabd7c2" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_a6cef591-9ea7-4424-b911-f6646e86128f" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_a6cef591-9ea7-4424-b911-f6646e86128f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4726e1e7-a7f3-4ca9-81ca-aa206b764113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4726e1e7-a7f3-4ca9-81ca-aa206b764113" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_17956952-d954-4912-b31f-0ef5a6fa2a40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_OperatingIncomeLoss_17956952-d954-4912-b31f-0ef5a6fa2a40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3cec154e-a727-4a1f-a3a3-937ecff81382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3cec154e-a727-4a1f-a3a3-937ecff81382" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be2db2f5-5ed6-4a26-bf97-103cdb1a09ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be2db2f5-5ed6-4a26-bf97-103cdb1a09ea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_1468186e-f1da-4288-b6ef-59c384c91487" xlink:href="bsx-20220630.xsd#bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_1468186e-f1da-4288-b6ef-59c384c91487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_ad2ae7bf-628f-46e0-ac10-02660152fc53" xlink:href="bsx-20220630.xsd#bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_ad2ae7bf-628f-46e0-ac10-02660152fc53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_d023af37-d09a-435b-a32a-ec9b3b0a7fc6" xlink:href="bsx-20220630.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_d023af37-d09a-435b-a32a-ec9b3b0a7fc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_94c0fade-2713-4b33-9a46-fb1a30af5b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_94c0fade-2713-4b33-9a46-fb1a30af5b8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_79142888-cc75-40c6-9087-bd3625e69e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_79142888-cc75-40c6-9087-bd3625e69e92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_79142888-cc75-40c6-9087-bd3625e69e92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_79142888-cc75-40c6-9087-bd3625e69e92" xlink:to="loc_us-gaap_SegmentDomain_79142888-cc75-40c6-9087-bd3625e69e92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_79142888-cc75-40c6-9087-bd3625e69e92" xlink:to="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_7b44d937-7b63-4e56-a3e1-769ca91ae61f" xlink:href="bsx-20220630.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_MedsurgMember_7b44d937-7b63-4e56-a3e1-769ca91ae61f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_a4265164-b1dc-4a46-81ee-d24d183dc5bb" xlink:href="bsx-20220630.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_CardiovascularMember_a4265164-b1dc-4a46-81ee-d24d183dc5bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_00b3eb24-8cfd-4192-bb63-5797bd606a84" xlink:href="bsx-20220630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_BSXReportableSegmentsMember_00b3eb24-8cfd-4192-bb63-5797bd606a84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_9c554439-ff8e-463f-a51e-607632b26bb3" xlink:href="bsx-20220630.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_9c554439-ff8e-463f-a51e-607632b26bb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_29aab033-0c76-499e-9bbc-c3163092e5e6" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_29aab033-0c76-499e-9bbc-c3163092e5e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_d238354c-dc9c-4fe8-8c3e-a5df5c2a0a56" xlink:href="bsx-20220630.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_d238354c-dc9c-4fe8-8c3e-a5df5c2a0a56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_95176a22-66c3-47cf-91fe-0579ae100914" xlink:href="bsx-20220630.xsd#bsx_SpecialChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_SpecialChargesMember_95176a22-66c3-47cf-91fe-0579ae100914" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:to="loc_srt_ProductOrServiceAxis_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73" xlink:to="loc_srt_ProductsAndServicesDomain_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73" xlink:to="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_91485c70-9cc2-4c79-ac5c-d12d430e4d9f" xlink:href="bsx-20220630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_91485c70-9cc2-4c79-ac5c-d12d430e4d9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_e0e14c50-2556-42b5-9c37-a6072aaaec19" xlink:href="bsx-20220630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_e0e14c50-2556-42b5-9c37-a6072aaaec19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_eb2695ab-59dd-4b0a-bf8d-d4f5be98081f" xlink:href="bsx-20220630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_eb2695ab-59dd-4b0a-bf8d-d4f5be98081f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember_6ac53463-d2df-48a6-80c6-9187ae862206" xlink:href="bsx-20220630.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_InterventionalCardiologyTherapiesMember_6ac53463-d2df-48a6-80c6-9187ae862206" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember_8c783f15-3094-470a-a488-b91c3cb3bb7a" xlink:href="bsx-20220630.xsd#bsx_WatchmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_WatchmanMember_8c783f15-3094-470a-a488-b91c3cb3bb7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember_3a2220b2-8a05-476a-9475-0b29e012ee1f" xlink:href="bsx-20220630.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_CardiacRhythmManagementMember_3a2220b2-8a05-476a-9475-0b29e012ee1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember_feef869b-4491-48c0-96a2-003e158189a6" xlink:href="bsx-20220630.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_ElectrophysiologyEPMember_feef869b-4491-48c0-96a2-003e158189a6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember_d2e818a6-98ae-4909-bbca-5a47a2deef27" xlink:href="bsx-20220630.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalCardiologyReportingUnitMember_d2e818a6-98ae-4909-bbca-5a47a2deef27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_11f355bf-73f4-4737-8def-69b6f8e3cb3c" xlink:href="bsx-20220630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_11f355bf-73f4-4737-8def-69b6f8e3cb3c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_c4e7d16e-edb5-427d-8d05-0c1a581ebdf1" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_c4e7d16e-edb5-427d-8d05-0c1a581ebdf1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_028cadd3-9ff5-4cf1-8649-b73fe295ffc6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:to="loc_srt_StatementGeographicalAxis_028cadd3-9ff5-4cf1-8649-b73fe295ffc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_028cadd3-9ff5-4cf1-8649-b73fe295ffc6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_028cadd3-9ff5-4cf1-8649-b73fe295ffc6" xlink:to="loc_srt_SegmentGeographicalDomain_028cadd3-9ff5-4cf1-8649-b73fe295ffc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_028cadd3-9ff5-4cf1-8649-b73fe295ffc6" xlink:to="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f05e19bc-4df8-4d0a-abe8-14daf8232c95" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:to="loc_country_US_f05e19bc-4df8-4d0a-abe8-14daf8232c95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d634d940-498d-4bbe-be61-51dc3f3d148e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:to="loc_us-gaap_NonUsMember_d634d940-498d-4bbe-be61-51dc3f3d148e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended" id="i275db8b32efd4657b0718f9f0cb8a4ee_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23e3a2ae-2b7b-47d2-a5b2-7b302ad8f2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23e3a2ae-2b7b-47d2-a5b2-7b302ad8f2b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries_accb7e0d-e86a-4041-84f2-c82e9d922e3d" xlink:href="bsx-20220630.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:to="loc_bsx_EmergingMarketstotalnumberofcountries_accb7e0d-e86a-4041-84f2-c82e9d922e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ba272f1-1a96-4056-a65a-95614e7743d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_aad0ff04-12d2-488e-a154-fae15a0b08b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_aad0ff04-12d2-488e-a154-fae15a0b08b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aad0ff04-12d2-488e-a154-fae15a0b08b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aad0ff04-12d2-488e-a154-fae15a0b08b2" xlink:to="loc_us-gaap_SegmentDomain_aad0ff04-12d2-488e-a154-fae15a0b08b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aad0ff04-12d2-488e-a154-fae15a0b08b2" xlink:to="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_12dfab96-e4d9-4e63-91ad-1c388185f303" xlink:href="bsx-20220630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:to="loc_bsx_BSXReportableSegmentsMember_12dfab96-e4d9-4e63-91ad-1c388185f303" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_828ea25d-b955-4e9b-83f9-dc49f5b16686" xlink:href="bsx-20220630.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:to="loc_bsx_MedsurgMember_828ea25d-b955-4e9b-83f9-dc49f5b16686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_2ba97176-130a-41c7-b58f-4c05db36d130" xlink:href="bsx-20220630.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:to="loc_bsx_CardiovascularMember_2ba97176-130a-41c7-b58f-4c05db36d130" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e0ec29be-b656-4efe-946a-c8d01a8da57d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:to="loc_srt_ProductOrServiceAxis_e0ec29be-b656-4efe-946a-c8d01a8da57d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e0ec29be-b656-4efe-946a-c8d01a8da57d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e0ec29be-b656-4efe-946a-c8d01a8da57d" xlink:to="loc_srt_ProductsAndServicesDomain_e0ec29be-b656-4efe-946a-c8d01a8da57d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e0ec29be-b656-4efe-946a-c8d01a8da57d" xlink:to="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_bd6d7c28-9271-4f6b-8078-b60be7ab2d0c" xlink:href="bsx-20220630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_bd6d7c28-9271-4f6b-8078-b60be7ab2d0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_85ca67e4-04bd-4360-b74c-bc26376debbc" xlink:href="bsx-20220630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_85ca67e4-04bd-4360-b74c-bc26376debbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_54be635e-4874-4b25-8ee7-ff3080af97e2" xlink:href="bsx-20220630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_54be635e-4874-4b25-8ee7-ff3080af97e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember_9258011a-801a-42f9-bda7-89c47695ad22" xlink:href="bsx-20220630.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_InterventionalCardiologyTherapiesMember_9258011a-801a-42f9-bda7-89c47695ad22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember_3f3c2c00-ba93-4676-8714-a5b8a1d8fde0" xlink:href="bsx-20220630.xsd#bsx_WatchmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_WatchmanMember_3f3c2c00-ba93-4676-8714-a5b8a1d8fde0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember_cf6a50bb-96fa-491e-8bd5-a1f8805235cb" xlink:href="bsx-20220630.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_CardiacRhythmManagementMember_cf6a50bb-96fa-491e-8bd5-a1f8805235cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember_c5500310-2fb7-4cf1-9cec-a2bcd1fa6605" xlink:href="bsx-20220630.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_ElectrophysiologyEPMember_c5500310-2fb7-4cf1-9cec-a2bcd1fa6605" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember_8566c779-7a9c-467f-a811-02fec629e86d" xlink:href="bsx-20220630.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalCardiologyReportingUnitMember_8566c779-7a9c-467f-a811-02fec629e86d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_148395b6-4bc5-4768-8266-a90bc95f936d" xlink:href="bsx-20220630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_148395b6-4bc5-4768-8266-a90bc95f936d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_5b733443-6f92-40fe-b8f2-b91ecd4d1e89" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_5b733443-6f92-40fe-b8f2-b91ecd4d1e89" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:to="loc_srt_StatementGeographicalAxis_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9" xlink:to="loc_srt_SegmentGeographicalDomain_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9" xlink:to="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d542f975-61b7-437e-b37e-314a53d21a10" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_country_US_d542f975-61b7-437e-b37e-314a53d21a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_144fade5-65c8-479f-b224-18509f2dfecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_us-gaap_NonUsMember_144fade5-65c8-479f-b224-18509f2dfecb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_86d69cf7-676a-493d-ae35-74fde42f8632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_us-gaap_EMEAMember_86d69cf7-676a-493d-ae35-74fde42f8632" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_d6f49acc-4880-4404-b6c9-9d2908b2dda7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_srt_AsiaPacificMember_d6f49acc-4880-4404-b6c9-9d2908b2dda7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_9e7a2cea-b14c-46b8-99a7-7b243cc1ec87" xlink:href="bsx-20220630.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_bsx_LatinAmericaandCanadaMember_9e7a2cea-b14c-46b8-99a7-7b243cc1ec87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_1c9d3fc5-af1b-452d-8804-38f809101863" xlink:href="bsx-20220630.xsd#bsx_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_bsx_EmergingMarketsMember_1c9d3fc5-af1b-452d-8804-38f809101863" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended" id="icaecd86446b443afaaed83b22da0c585_ChangesinOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78ed280d-acd3-48b7-b22e-2c2b66b1a7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78ed280d-acd3-48b7-b22e-2c2b66b1a7cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_59d4cc17-2df5-42ee-9b6f-5a1d62134fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_59d4cc17-2df5-42ee-9b6f-5a1d62134fa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dea35748-623a-4a4e-8942-4e43ccf0510c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dea35748-623a-4a4e-8942-4e43ccf0510c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e7b663e7-48ba-470e-813e-a760b8ac248a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e7b663e7-48ba-470e-813e-a760b8ac248a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_04d3d080-e589-4781-a9e7-fac39bbec331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_04d3d080-e589-4781-a9e7-fac39bbec331" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_fc3a5a41-df2c-4635-9787-16ebf9c3fe71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_fc3a5a41-df2c-4635-9787-16ebf9c3fe71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d7911639-041b-4802-b13a-243732a96abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d7911639-041b-4802-b13a-243732a96abd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d97f41c7-bba8-43e9-80fb-61e25a797fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d97f41c7-bba8-43e9-80fb-61e25a797fa9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c22e70ab-4c83-4581-b007-533b13174bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c22e70ab-4c83-4581-b007-533b13174bd3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_aede8f75-e4b3-46b8-82cc-45238ea52c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_aede8f75-e4b3-46b8-82cc-45238ea52c4b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ce612c33-8889-4e2e-ab4d-a0c393f7dc18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ce612c33-8889-4e2e-ab4d-a0c393f7dc18" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_029f520f-40a9-4373-adcb-21a7e33fab10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_029f520f-40a9-4373-adcb-21a7e33fab10" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1bf68234-18d4-43ac-ae9f-7fec1f3db6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1bf68234-18d4-43ac-ae9f-7fec1f3db6ab" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_65d35c78-c012-4fdb-90b3-beadbd92b065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_65d35c78-c012-4fdb-90b3-beadbd92b065" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_05601045-3cac-44d0-b9d2-a4ae574004d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_05601045-3cac-44d0-b9d2-a4ae574004d5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820f12b3-1ba1-4e21-aa5e-b0b2f4347fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820f12b3-1ba1-4e21-aa5e-b0b2f4347fc9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_32c13c08-2899-4c97-89a9-7c8cf382a51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_32c13c08-2899-4c97-89a9-7c8cf382a51d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_32c13c08-2899-4c97-89a9-7c8cf382a51d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_32c13c08-2899-4c97-89a9-7c8cf382a51d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_32c13c08-2899-4c97-89a9-7c8cf382a51d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fdcbc34e-8512-4dae-8eeb-7f77aa71ef52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_32c13c08-2899-4c97-89a9-7c8cf382a51d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fdcbc34e-8512-4dae-8eeb-7f77aa71ef52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_3e6ae473-f139-47e9-90aa-f5d7e746ed72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fdcbc34e-8512-4dae-8eeb-7f77aa71ef52" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_3e6ae473-f139-47e9-90aa-f5d7e746ed72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab9d096f-791d-42c1-962e-4d8ed5432b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab9d096f-791d-42c1-962e-4d8ed5432b7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ab9d096f-791d-42c1-962e-4d8ed5432b7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab9d096f-791d-42c1-962e-4d8ed5432b7a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ab9d096f-791d-42c1-962e-4d8ed5432b7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5e3d8a2-d5d3-45e3-8f32-7c6a27e46a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab9d096f-791d-42c1-962e-4d8ed5432b7a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5e3d8a2-d5d3-45e3-8f32-7c6a27e46a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_a7527621-7710-4652-bb1f-f4dcc3f7567d" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5e3d8a2-d5d3-45e3-8f32-7c6a27e46a6e" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_a7527621-7710-4652-bb1f-f4dcc3f7567d" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>bsx-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:202f2156-2eff-48c6-8020-e675b6a04e60,g:66d98efe-f6bb-4852-90b5-5e203e0b5e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_dc82111d-2565-4c06-af29-5b0b4f341420_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_f7b3a050-a37b-419f-ad9c-457850e45c73_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_aa8b3485-c2ca-481c-98fb-e3fb15dd932d_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dacdb14-9543-4cfc-a0a4-0a76d018bc7e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2765e6b5-c224-4132-8a59-f91a760561dc_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_174f56db-963f-4a2b-8e26-293185727cc2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2b90e131-c758-447e-bc2a-74a6704a5f2e_terseLabel_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20220630.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_adda4d67-f059-48c8-9559-3d05cb44ea44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_91e9be3a-bf4b-4b89-a114-cfc2d17c214d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_cc39a99f-80cb-4a46-a2f8-4de53e43439e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_11fa7112-abf0-47a4-a946-ea18453c20ab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2ca73ee3-6175-4e2c-ad10-c38a2eee9dc9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cbdec014-786f-47de-84e5-b27f7f6fdb81_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8ab66504-74ba-4cdc-a252-400579d9afe3_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheOfferingAggregatePrincipalAmountMember_bbb2fed0-25ed-4dcf-b924-15fa368f19f0_terseLabel_en-US" xlink:label="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering</link:label>
    <link:label id="lab_bsx_TheOfferingAggregatePrincipalAmountMember_label_en-US" xlink:label="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - aggregate principal amount [Member]</link:label>
    <link:label id="lab_bsx_TheOfferingAggregatePrincipalAmountMember_documentation_en-US" xlink:label="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - aggregate principal amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:href="bsx-20220630.xsd#bsx_TheOfferingAggregatePrincipalAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:to="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_b23c738c-6885-4fc5-bb9b-dc146f4b3ff1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_55093576-afe8-4d43-ab0b-c57dc2ad8e7f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_WatchmanMember_8bcbf260-31fe-4e7b-a2de-3f87873cda28_terseLabel_en-US" xlink:label="lab_bsx_WatchmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watchman</link:label>
    <link:label id="lab_bsx_WatchmanMember_label_en-US" xlink:label="lab_bsx_WatchmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watchman [Member]</link:label>
    <link:label id="lab_bsx_WatchmanMember_documentation_en-US" xlink:label="lab_bsx_WatchmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watchman</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember" xlink:href="bsx-20220630.xsd#bsx_WatchmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_WatchmanMember" xlink:to="lab_bsx_WatchmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4e6f6316-effe-445e-8506-2c275decc08a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_03d47a46-ea48-417e-80ae-dcb461dc999b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_de3b83f0-8998-40cf-b825-809a9d7e061a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_32bb085e-aa6d-4e1f-a212-e8cfe48f7db9_verboseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_edf900d1-50a9-47f6-83b8-1c747b87b2ff_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4a80011e-1282-43c1-865d-a80da9fa446d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_56115251-e573-4fb1-ae06-184e849e42d8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_7d1dd8c0-e354-4ded-b794-c35481861e44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration previously established in purchase accounting</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_75a549d4-80b7-4204-9043-b1f18c82a78b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_74016567-b7ed-4fca-966d-45682c5081d3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_84549c5f-82f1-4b5a-bfbe-c285b8d49a93_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d18d5981-de9d-4ca1-b0b8-23f8272d3235_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_d1b11444-5254-49a6-bbdc-649a732ddd52_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_044e33f6-7952-4816-932e-5856edbc9eea_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_05eafb16-f182-4b65-abce-f9bf047edb2e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_e9349d57-bc19-4830-b0fb-57e4dc401576_verboseLabel_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_label_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_documentation_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:href="bsx-20220630.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:to="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_70d1e6f5-ec9a-4a90-aec2-b136015a6110_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d4e8a89f-5d50-4091-b7d8-78ee95cc4aac_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_3ad9dc9d-499e-4f6b-b4aa-ccddb59a5987_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_56adb3e8-f85b-497c-9154-c018597bb4d9_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_41a9d9f4-1d82-444b-a1cf-0392da32eeea_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2368b2cf-b287-4b17-b727-7268789f9ffe_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_The2018FacilityDomain_2224cdd9-d425-4943-bec2-0b11e9dc0bc2_terseLabel_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Member]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_label_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_documentation_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain" xlink:href="bsx-20220630.xsd#bsx_The2018FacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_The2018FacilityDomain" xlink:to="lab_bsx_The2018FacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_dc4f60ef-a838-4636-8c2e-09d90a2f9b4a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_b2c8626c-39cc-40ad-9889-58459ae15b88_terseLabel_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_label_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_documentation_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:href="bsx-20220630.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:to="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4fc220b2-bc04-47bc-a716-ad59a72a0f35_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_2068fc33-d697-41fb-8942-2722270c72ea_terseLabel_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract" xlink:href="bsx-20220630.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCurrentAssetsAbstract" xlink:to="lab_bsx_OtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_fbf31da4-bb19-4c14-90f1-eb2c7e49b0ba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ca8d5a14-65d1-4671-b073-fb992c1a0d3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0b84788-2e0f-43f2-99f9-22ddd755348d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_18768390-21d1-41c5-935d-34a20d5bbee8_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_a9fe3237-94d6-4346-b0d3-aa9dcfcc1a8f_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0002e4b0-291d-4c8e-ba89-1ea3bd2f534c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_146ada72-0884-412a-9b9f-f86c6ee0a7b3_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_339f1ba5-296a-47ee-9bc7-802120e7f440_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ae5460eb-cc43-4a3d-91e1-2e99a221d706_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_482aab24-a776-4d67-9cb1-e92574bcc6b5_terseLabel_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_label_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_documentation_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration" xlink:href="bsx-20220630.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_QualifiedAcquisitionConsideration" xlink:to="lab_bsx_QualifiedAcquisitionConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_b4496bd6-455a-439e-9d02-1023a5851f28_negatedLabel_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration" xlink:href="bsx-20220630.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentOfContingentConsideration" xlink:to="lab_bsx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed1b251d-ba31-4b40-b70e-a381ac47d2f7_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_b2765e01-ed76-4974-a5d6-9c476e0d87be_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_98123151-d323-409e-8301-7bb279092832_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_a7afd896-3b9e-43f3-a1bb-cfbc8374673a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_14e510a4-ceec-422c-a8e3-24fba58fa182_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3856aba8-4cec-42ad-a310-ef293bf2ce0f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7039a99d-ff1b-4678-a07e-629f11331984_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ActualCovenantMember_45217413-cb27-4550-b704-3b902f8b40e4_terseLabel_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_label_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_documentation_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember" xlink:href="bsx-20220630.xsd#bsx_ActualCovenantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ActualCovenantMember" xlink:to="lab_bsx_ActualCovenantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_1103b8e0-a5bf-44be-82b6-a870dbb36203_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:href="bsx-20220630.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:to="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7feb3f29-70bf-4c9f-986a-e72604e7e13d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_2e6da9d4-038c-494e-b177-6713f4269506_terseLabel_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolving Credit Facility</link:label>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_label_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility 2021 [Member]</link:label>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_documentation_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member" xlink:href="bsx-20220630.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevolvingCreditFacility2021Member" xlink:to="lab_bsx_RevolvingCreditFacility2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MedsurgMember_afb4a417-7195-4e5a-a9cd-dc45d1d6e88b_terseLabel_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_label_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_documentation_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember" xlink:href="bsx-20220630.xsd#bsx_MedsurgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MedsurgMember" xlink:to="lab_bsx_MedsurgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NumberOfBusinessesDivested_1f0bdeb5-7534-4022-90a0-165020b5fa82_terseLabel_en-US" xlink:label="lab_bsx_NumberOfBusinessesDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses Divested</link:label>
    <link:label id="lab_bsx_NumberOfBusinessesDivested_label_en-US" xlink:label="lab_bsx_NumberOfBusinessesDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses Divested</link:label>
    <link:label id="lab_bsx_NumberOfBusinessesDivested_documentation_en-US" xlink:label="lab_bsx_NumberOfBusinessesDivested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinessesDivested" xlink:href="bsx-20220630.xsd#bsx_NumberOfBusinessesDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NumberOfBusinessesDivested" xlink:to="lab_bsx_NumberOfBusinessesDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_34e1aa06-ad18-4b23-af5c-251dc892db3e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_9c60f79e-6ac7-44cd-bfc5-16d58efa393d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_697cd776-5271-4f40-a4bf-a35c6c0565f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_7170c46d-d20b-43c5-a7cd-d57e1aadf2e7_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20220630.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_eeeef731-cfa2-476d-8efd-e34c31a97a1d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_cf25d6b5-2eb1-4326-b8f2-83dd50b67882_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9f0abeb-da60-463b-909c-29635027d06b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3e792897-6838-4876-a485-6d9b91fc6379_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_5eeba22e-f743-4fbd-8bc0-f264e8aa866e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_848903e2-b6a7-4bdf-8cdf-e41a53e54af5_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_6d902bc4-6594-44b9-816d-08b066309b6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_c0687173-7976-4d0a-8e88-b139fbffe5ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangements_53a49aac-c368-41e6-a294-6bedb51e3fc4_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_label_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_documentation_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangements" xlink:to="lab_bsx_Licensingarrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_34e82461-de9a-4290-a8d3-620c935872c9_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_b3ead513-0d1d-4ab2-b899-51507acdce58_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_cb09cd63-a1e6-444e-aa47-6d218250eabd_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_5c5ece17-e12d-4b9b-b6fa-362215121f7b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of June 30, 2022 and December 31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiovascularMember_7d2f8bc2-8ead-461b-8b8d-32bc3dd40cae_terseLabel_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_label_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_documentation_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember" xlink:href="bsx-20220630.xsd#bsx_CardiovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiovascularMember" xlink:to="lab_bsx_CardiovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_5809936b-4ddd-4774-a1f1-36078c22328c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_1d73a982-1731-4ebc-90e8-e1238328724b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4a67e715-a921-4546-95df-9a1e53a9000b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_1f51c5ef-564b-4eb6-860b-c672915bf7b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_67041e3c-f472-4247-9718-16a5dd8b5595_terseLabel_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_label_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_documentation_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:href="bsx-20220630.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:to="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a6d27370-bc8a-49d0-9f22-7732882b971e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_4727c1de-9df0-48ea-9b5f-67a97f3a24b1_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:href="bsx-20220630.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_11ad2192-91ef-4683-aba3-2a3a9f5bbcc0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_590e78f4-ae72-4f17-90f2-4d0e807f42f0_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a5726828-be02-4063-aa78-2e055a278d77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_d9c19af4-1202-4fab-b985-f148a310336e_terseLabel_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Pelvic Health [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:href="bsx-20220630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:to="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_920b85e8-5bf3-456d-93d6-8028babdb959_terseLabel_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Interventions [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:href="bsx-20220630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:to="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_da89fdb6-82f7-4d50-a72a-2d3547f8f605_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_79d5ef1c-09bd-4dcc-90d6-faedcaa2be10_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0bdd4b70-ed44-4946-ba92-4afff2e4b52e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_553ee472-22e4-40ef-95ff-0ee1c499e0a3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_6bd5dc9b-3ef9-4173-ab14-ae6eedc75654_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_ef28227b-7f5f-46ab-9ab8-97541f9eb300_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2db137c6-fde5-4db8-8c3b-71a7b44b1e0e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_8235f282-9588-4970-87f6-5d9294d3ef69_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_18334fa5-4b97-4698-a8a8-b7db931a4c4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_af39327e-c626-4b2d-9469-c0795043e9f6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b33227cc-f3f4-47fb-8ee0-55211edd7030_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_5700d971-1a2d-4315-ac0b-0d7ac47a8731_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8ed731ab-a968-4048-b813-0416ea505d2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a6b329c0-a505-4bdc-bc0f-dbb8e228a9ef_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_e4de1efa-c78c-4b20-bfec-3b9304902e0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of businesses and assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantAxis_ca037280-5728-4d96-9edd-5a51ab1eedfb_terseLabel_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_label_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_documentation_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis" xlink:href="bsx-20220630.xsd#bsx_CovenantAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantAxis" xlink:to="lab_bsx_CovenantAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_720c30da-a441-4180-84ca-17fb9c271d66_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4a1bd815-c3f3-41ee-a194-19e536dc1d64_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1d41789a-1393-4bb0-b14b-bbf20d20b5c9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_aacbf121-907e-4597-9bf9-f028ecf72db6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_e7b17adb-7f88-402f-b686-7e78c592e9b8_verboseLabel_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses and currency exchange [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_label_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_documentation_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:href="bsx-20220630.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:to="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_f7fb0b6b-90f6-49ab-9d67-bbfd23d156ce_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_16c4cd62-4b9e-420f-8beb-65ae40e235c1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_7f98792a-9cfc-459f-95c9-c56fd7cda4ff_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028NotesMember_f4b5a1f8-05ba-4ac7-b939-a80b008c759b_verboseLabel_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_label_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_documentation_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028NotesMember" xlink:to="lab_bsx_March2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_c181175d-c999-41be-96a6-b611bb4220ab_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InterventionalCardiologyTherapiesMember_8f02cc39-ee90-46f5-88f3-237eeec5ad6a_terseLabel_en-US" xlink:label="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Cardiology Therapies</link:label>
    <link:label id="lab_bsx_InterventionalCardiologyTherapiesMember_label_en-US" xlink:label="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Cardiology Therapies [Member]</link:label>
    <link:label id="lab_bsx_InterventionalCardiologyTherapiesMember_documentation_en-US" xlink:label="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Cardiology Therapies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember" xlink:href="bsx-20220630.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InterventionalCardiologyTherapiesMember" xlink:to="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d67873a1-e488-49bb-ab8c-908b4525d462_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_e8d174a2-3b5d-44c0-ac0c-a4f0c82e8e95_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_64284736-40c7-49e2-bba7-bc85e30afa37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_a1ed64e6-66df-439b-862f-97e570bb01fa_terseLabel_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_label_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_documentation_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:href="bsx-20220630.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:to="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_b8e17cda-c26f-473f-b9eb-7f9c85445668_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_936d76dd-b70c-4d1a-8bbf-2464c6c77cd5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_5b8ab6f9-06df-4660-ba16-e4ec6fd11ee5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NumberOfBusinesses_59034b1f-7601-47ea-8400-9521514a6cef_terseLabel_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_bsx_NumberOfBusinesses_label_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_bsx_NumberOfBusinesses_documentation_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinesses" xlink:href="bsx-20220630.xsd#bsx_NumberOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NumberOfBusinesses" xlink:to="lab_bsx_NumberOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_52df1eca-2e32-4a71-bb8d-e3ee76507fc5_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementliabilitiesMember" xlink:to="lab_bsx_LicensingarrangementliabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_88debbc0-8274-4a8c-b3ab-17e5cb7cf880_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_1598ab5e-2d1e-4d03-b6d6-567e90b41308_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_68de712b-221b-41f4-8a16-1fdc169fca65_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InventoryStepUpAmortization_c2ede53a-faf2-4d5b-a78b-03c30fd5d624_terseLabel_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step-up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_label_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_documentation_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step up amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization" xlink:href="bsx-20220630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InventoryStepUpAmortization" xlink:to="lab_bsx_InventoryStepUpAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_80c6a115-a550-426a-a838-4bbeca592349_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_c1e34719-14fe-4619-81e9-82ddbb88b723_negatedTerseLabel_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_label_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_documentation_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:href="bsx-20220630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:to="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b1507cf8-cbda-4bfd-817c-477de77d8f31_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_fe6ff32b-9376-4daa-94fc-fcb1608acc84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_c9b88861-c660-40dd-b215-37959c1c8134_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_28451862-43f7-4d89-ba75-d42715cc9289_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d6275c47-d299-4711-a238-f7ed46597475_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_826de639-5878-4df4-8ffa-1f15b9332724_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_label_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:href="bsx-20220630.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:to="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_01fd2a7b-77b1-4a0b-a052-e09a712ebefc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_2e72dc96-f484-4b6a-a85e-0cbdaf2f70ad_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_c15de00a-f270-46bb-b3dd-f0043f0dfa71_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_0279ee4d-7086-4e34-8f35-d5e321d4fdfe_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_531fe13c-fbf5-4af7-afde-973a534bf327_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_05ea406b-f375-4bf0-a834-35dc8310aacf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_4ab13a46-3314-4eeb-9238-ca53816c77ad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b59965c2-a0c9-48e7-9e4e-1fdd9f87f925_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_56d62594-f377-435d-938e-8ac14f5951ac_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_b1725ab7-3c62-47ec-a51d-475f81cc909a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Par value)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IndemnificationAsset_a44f3418-de32-43fe-b64d-eb0ede9082e4_terseLabel_en-US" xlink:label="lab_bsx_IndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification asset</link:label>
    <link:label id="lab_bsx_IndemnificationAsset_label_en-US" xlink:label="lab_bsx_IndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification asset</link:label>
    <link:label id="lab_bsx_IndemnificationAsset_documentation_en-US" xlink:label="lab_bsx_IndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IndemnificationAsset" xlink:href="bsx-20220630.xsd#bsx_IndemnificationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IndemnificationAsset" xlink:to="lab_bsx_IndemnificationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_940fec94-6c67-40d7-8371-c990c4c893bc_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_7763a955-85ac-4866-a736-3669edd26a07_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantDomain_f4119c1a-9373-4e9c-888f-4b35c51969db_terseLabel_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_label_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_documentation_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain" xlink:href="bsx-20220630.xsd#bsx_CovenantDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantDomain" xlink:to="lab_bsx_CovenantDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_d0928c0a-19a7-4a87-b8ae-1e95ed6dee52_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_1c9e1be6-bbd2-4705-be55-8768fed88d97_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalCardiologyReportingUnitMember_e1655c99-06b7-4a29-ae35-4fa945d4eef6_terseLabel_en-US" xlink:label="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiology [Member]</link:label>
    <link:label id="lab_bsx_GlobalCardiologyReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Cardiology Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCardiologyReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Cardiology Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember" xlink:href="bsx-20220630.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalCardiologyReportingUnitMember" xlink:to="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3dc58f2d-e4d9-497a-b97c-d78044f8169e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61ede65f-5420-4960-a592-0ca06e4714c6_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_3cf90f9b-5b58-4081-9968-4f5e0d9c0d28_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_2e04b865-b2d5-47f7-84c5-11e28c1e207e_terseLabel_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</link:label>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_label_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</link:label>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_documentation_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:href="bsx-20220630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:to="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_ccfefe28-9cbe-4294-9dad-a78d0c4711a7_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_576b7e3f-e527-45b9-9f5d-7503d890837f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_6321447f-e4ee-4e61-8621-dd5460e9e800_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_05649319-80f4-44d1-b10f-ea01325fa9f8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_83c64b8d-30ed-414b-84b2-544c11006be4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration recorded in purchase accounting</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_1cf8ffb7-e6ae-4868-aef9-0712e2162a0d_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_label_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfield Vena Cava Filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:href="bsx-20220630.xsd#bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:to="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_a50ed57b-9e27-4bec-ab9c-87ca5e2767fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_33c43306-9a39-439e-beef-75f3c108c82f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_fbc3c9fd-91a7-4fbd-a306-592e4b6aeb5f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Outstanding [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5dd0efcc-7a2b-4c92-b70b-9cf0f3ba9139_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9c3b529e-0425-4de0-aa40-27ef60bef4e7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_40b693a1-8105-4448-8f25-986e786febdb_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_06438450-6a71-4d44-abbd-8da650de3709_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_e441cf51-0091-4055-b07c-585b32c0d5af_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_003f6e97-a2c5-4ce0-a076-a5099994d996_terseLabel_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_label_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_documentation_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:to="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_e621748e-284e-4ba3-a4b4-b48aa547e21d_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_3ef5fdf7-698e-479a-bc50-a111497864b1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_12ea22e1-7ab8-49cb-844e-95d75d4e1076_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_056e7088-2701-4f03-8dce-4f7d7832b8b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_07dcaa54-0758-4afa-a085-12968bc9e96b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_813c72ef-3320-4c86-beb6-143f96898447_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0721eca1-56f1-4fad-98a6-1e0884a0d076_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_27e63928-7cd2-48bb-9998-0db19d2f1e1e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_2447d45c-0efc-4564-8d23-c71e0bc9d81a_terseLabel_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_label_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_documentation_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:href="bsx-20220630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:to="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_af9644b5-c75f-4148-b6b3-951871d71886_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_498e5814-27b1-4fce-b4f7-092f7e72f5b8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f21698d6-e6d0-46bc-8e64-27de5bafbe60_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_f9346f29-0ef3-47b6-a10f-137243e90b1f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_979e190f-10f2-466e-b844-910757ba264c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_84f50bcd-3d16-4105-aee6-8abb1fc65a8c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b9d2187e-65af-4c28-b9c2-5efc50a8c1aa_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_e8ae66f7-a47f-4011-91c6-53d6adffc952_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_c15fc163-699c-4102-a7d4-d3038e13c8fb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4ae791c6-aa1d-49b8-a2b8-de8efbf86eb7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_36e454e6-bd82-4ece-8038-c44616d53e6f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_ae780e34-bfa4-412e-b3cc-37166f4beb17_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9cc52324-89c8-4fdc-b92f-b69cba0e696c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_cde7dcd4-97f3-4b78-ba74-05b8e82734d3_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_label_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:href="bsx-20220630.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:to="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_24b1f55c-524d-45c2-a54f-4d5a690b484b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_28b1cfa7-bb89-4a06-a6ee-d31c561828fb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_f60652e7-a5b5-4cb3-9151-211151da13d1_terseLabel_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_documentation_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:href="bsx-20220630.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:to="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7adf319e-c2f5-4d78-890b-38dcf63db2b8_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2030NotesMember_73e28d91-0b5f-43b6-ad92-8007e73361e9_terseLabel_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_label_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_documentation_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember" xlink:href="bsx-20220630.xsd#bsx_June2030NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2030NotesMember" xlink:to="lab_bsx_June2030NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ac428a5-b5bb-451f-9e1f-7383f6d023d2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2e935272-d9be-433c-a5bd-b7eca6bdf304_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_b461b8ea-a514-4b2f-9ba3-4cf67e74ef7d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_42737da6-0b17-434b-b11b-14e830391b34_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_c22ca6ae-e2a2-4465-8c2c-fc38b72a17d4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_da06bf4b-e890-4335-94e7-7e551639b2e1_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_38034feb-642f-4347-ad90-2136f4a094c0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_b2fffb04-7b68-44c5-9d85-9057223fa9ae_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_d5c1aa45-1354-423d-b2e6-a9b051017f79_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b255e541-1f33-43c4-a5f7-b6b4328ad53a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_e5685daf-b770-4a46-b7e8-12b371d3bf57_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_label_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:href="bsx-20220630.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:to="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_a79f5643-45e6-4213-9a12-d041525f4740_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_d0fcffd9-fa39-4374-a066-6617fa46dcff_terseLabel_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20220630.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_116aa53e-7b70-423d-9c05-62f6cfd87a2b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_316a12a2-168d-49c1-aecc-db0c279c3fc7_terseLabel_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_label_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_documentation_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets" xlink:href="bsx-20220630.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherOtherLongtermAssets" xlink:to="lab_bsx_OtherOtherLongtermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_97bb25a6-2b25-488a-b014-c782a54921d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_1993770e-1ab9-4686-adc3-4d6720535f06_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0b7b40ba-e047-43cd-8219-d9c09758563e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9689118c-ec1b-4c03-b42d-4ffff37f9888_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6b78ad4d-e0af-4eac-8a6e-a14b8598ec5a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,693,192,785 shares as of June 30, 2022 and 1,688,810,052 shares as of December 31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_255089f3-6c50-4f70-a5de-fbcc2f56e066_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_913feb54-e631-4d5c-97e2-2e39a2144133_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_ecc59de7-0cee-47c0-982f-8d1991f8ae8d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_f475f717-5717-46eb-a69d-ee88c0dd5266_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_1695d27b-e34f-44f5-88f6-3ce590151c05_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d2a4d31a-9188-46f9-a0f9-236998d41a1c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_11b96b5f-fb5e-4110-a8e2-2ec3128a9390_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_92704301-6736-4abf-a786-1d992808c5ce_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a4d93070-9af5-48cf-929c-cf70ce613744_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_October2023NotesMember_f813304c-22d5-408c-bd62-bbd708fb89e1_terseLabel_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_label_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_documentation_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember" xlink:href="bsx-20220630.xsd#bsx_October2023NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_October2023NotesMember" xlink:to="lab_bsx_October2023NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_5ec7c56d-4370-4891-8f5f-cfcb4c859f6e_negatedTerseLabel_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_label_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_documentation_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights" xlink:href="bsx-20220630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentsForRoyaltyRights" xlink:to="lab_bsx_PaymentsForRoyaltyRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_f4127096-3032-4805-a64f-19f2b9fe095e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_a03142f4-ce6f-44bb-9eb1-53a88bf0b7f2_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND STRATEGIC INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_5a404f1d-ed16-483f-a510-76182d0ac86a_terseLabel_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:href="bsx-20220630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:to="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_c74667ce-3ac4-4c47-ab69-b1eceac554bb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_19182818-e54e-446d-9fa7-808c3144ec17_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_0de1ae34-51ba-42b8-9c12-c1bb74141b49_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_9e67cee8-c0cc-4df6-9a03-e40ef250eb71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_df749232-2d4e-4f73-806f-47507ca867cd_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:href="bsx-20220630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_c07d70e7-7c31-4ea2-ab8b-9b30526e4d7b_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:href="bsx-20220630.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:to="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_be2c3781-f49c-468a-9aa6-06891c960aa1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_fdaba6e3-13a8-4a25-891d-3838dfb9cd8a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_44be81b5-b70f-478c-81b5-7718bcd5f68b_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_d749da38-c7d3-4e77-a1b0-8345f04afb59_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_e1ea65b8-5ac1-48b0-b972-46a0d860264b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_690f3c5b-599b-4b58-96b2-db207a5b076f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_66062b22-b452-4a7b-84c7-c296edf23649_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_a1bae2fc-0fd1-43d9-a6f8-3386a2bf47f3_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_60057576-23de-4c14-9525-fb4da4c70fa3_terseLabel_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:href="bsx-20220630.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0fab323d-5748-4986-b378-091a4efe2622_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7e21a5d4-8d27-4152-9f12-1ed3e25c5a9a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_5e40875f-0c60-4033-8437-99f4ed924800_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_d7f8d251-fa35-428f-9907-9ff5d7bb0c9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ec8bba7f-6cdb-496c-a6a2-b3f47cb24fef_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_2d6811ef-f01c-47b3-92da-b2a4c844102d_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8de24cf9-f921-48b7-b0fd-e9cb49766ade_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aeabbf94-fdf5-4a5b-9f14-fe5d26a65dbd_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_c17848ee-a1f8-4bd2-89dd-a488eda7ffa0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligation</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsMember" xlink:to="lab_us-gaap_CapitalLeaseObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_96167ece-9505-41f0-81ea-867ffb200f06_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_5fca58a0-1076-4ace-89aa-1493f2e8ca8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on preferred stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_60933595-23b9-43bc-83d7-b81a11305c00_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_fc3e2844-79d2-471e-994a-b832a638957f_terseLabel_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_label_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_documentation_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:href="bsx-20220630.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:to="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_f6a67758-2e85-4189-8bf1-5801fa5755a8_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_49ab130e-fc77-489f-a203-2549cc81106f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_88c68961-7606-487a-8a3b-0b72cf236ee9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf034561-6b39-4594-b311-01c28ad6e436_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b4283515-369e-48a4-a7e3-845e7ec0a376_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DiscountRateFairValueInput_32bab7d5-010c-4f7b-a475-ccf04c896a15_terseLabel_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_label_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_documentation_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput" xlink:href="bsx-20220630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DiscountRateFairValueInput" xlink:to="lab_bsx_DiscountRateFairValueInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_e029e196-48af-40a4-8753-1d98d1096fd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4efc4a8c-a660-4127-be75-190ee6bdfba0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4606d4a2-db9b-4e97-873d-b95fdc9b5236_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6e2ef603-9f97-46c3-b33b-5465211365de_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_30a04bcb-5eb5-44d5-90fc-e629958a8511_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_12bb31ac-0cb0-435a-9778-d4fa48486871_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_20fe3b97-90b4-4141-ba65-c223575729ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EntityAbstract_8257e8d4-0919-4ccb-88c2-165a4fcd492e_terseLabel_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_label_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_documentation_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract" xlink:href="bsx-20220630.xsd#bsx_EntityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EntityAbstract" xlink:to="lab_bsx_EntityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_5987c477-6164-4eac-bac0-ab026644e00d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3128012-39ca-4556-beb8-44a97e460006_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_df052263-cf93-40db-8ae6-a27c1febdf20_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_ff7a2b03-6b59-4ab6-a496-e3ba20588d56_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_83f44aee-f32b-45c7-a763-148d52cc0fe1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0d853d6e-dd30-45b0-b5a5-92d0b9d080fe_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_4fcdd0b8-f025-4ad7-9421-84533dabac62_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6eef7b39-33ef-410e-8ba1-f7a1eed20bd7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_48c6f0eb-b431-4501-9a5f-2a6b8327c86a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_789c3421-6446-4547-b77d-a36a13a6291f_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_09573c02-7955-4f6a-a557-8600433cb585_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_1ef17513-7f6f-42f5-8ee2-f481679135e1_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_a3f5b6ea-240d-4a2f-85ee-9315722aa67c_terseLabel_en-US" xlink:label="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - early redemption of combined aggregate principal SN</link:label>
    <link:label id="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_label_en-US" xlink:label="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - early redemption of combined aggregate principal SN [Member]</link:label>
    <link:label id="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_documentation_en-US" xlink:label="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - early redemption of combined aggregate principal SN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:href="bsx-20220630.xsd#bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:to="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_995d6ba8-b2a7-4f44-8f50-8b069679b291_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_eaad57f4-505f-47ba-a81b-55720971796c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_53182bd2-d1e4-4046-ab84-57fc5ac8d989_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_f01a2d28-8f48-4453-9240-a84d1e1f024c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BaylisMedicalMember_52abcb10-cf25-4ef0-b8aa-8022f9bc8471_terseLabel_en-US" xlink:label="lab_bsx_BaylisMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baylis Medical</link:label>
    <link:label id="lab_bsx_BaylisMedicalMember_label_en-US" xlink:label="lab_bsx_BaylisMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baylis Medical [Member]</link:label>
    <link:label id="lab_bsx_BaylisMedicalMember_documentation_en-US" xlink:label="lab_bsx_BaylisMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baylis Medical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember" xlink:href="bsx-20220630.xsd#bsx_BaylisMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BaylisMedicalMember" xlink:to="lab_bsx_BaylisMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_020e205a-3b72-4b8e-9162-37573beffc53_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CanadaSettledClaims_f633ef4f-8b83-4fb1-a146-4e5c2eafab02_terseLabel_en-US" xlink:label="lab_bsx_CanadaSettledClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, settled claims</link:label>
    <link:label id="lab_bsx_CanadaSettledClaims_label_en-US" xlink:label="lab_bsx_CanadaSettledClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, settled claims</link:label>
    <link:label id="lab_bsx_CanadaSettledClaims_documentation_en-US" xlink:label="lab_bsx_CanadaSettledClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, settled claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CanadaSettledClaims" xlink:href="bsx-20220630.xsd#bsx_CanadaSettledClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CanadaSettledClaims" xlink:to="lab_bsx_CanadaSettledClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_69de64c0-e79d-42f5-a7b1-bb10e3d29266_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_071a3c10-0131-489e-b424-e83a7ffdb763_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_aaf9ac9e-997f-4806-8286-c16395f42520_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b3f9aaa4-22eb-46c9-b4cf-6d82cffa54ad_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_279c9ecc-e512-4959-8a08-18efc72dba11_terseLabel_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_label_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_documentation_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:href="bsx-20220630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:to="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f3f8b99-c507-4180-bb18-357d0d346518_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2a357280-606d-4960-93bf-e98bcd8c9b13_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment and internal use software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_c0c61b21-25e3-48df-b0e9-1b86543b4068_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_80a37115-c5db-4c8c-81af-fcd91e4e3d9e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_30095504-c3da-429f-95c6-3724d373640b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_5320a3ad-5bae-4c24-b9c5-84eb9995bd16_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_ac83c8ae-8919-45b2-a602-46504f5a397c_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_f84e6950-01bb-45db-b60d-3c4e600cb397_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_2cb2285e-a3c6-443b-b94c-2973f9cce3ab_negatedTerseLabel_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_label_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_documentation_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:href="bsx-20220630.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:to="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4a84f030-a414-48b6-a035-228ae83c61cc_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_e44306b4-34e4-4ab0-9688-04a6849b2a34_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e15fd3ec-b761-4d26-b32a-1c856ecac610_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_5834e00a-2a1c-47cd-95ba-8708362db909_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_42ba243b-2665-416e-9fd7-39ba1606cca6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_435d1640-c663-4b85-bbe4-7859491e8f07_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7e481bea-f59f-46d4-abb3-8674939185d1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_0560ede8-85a5-456b-bdd0-97d887836e4d_terseLabel_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20220630.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_c4a1549d-19f9-496f-be2e-8ce07bcc5e5b_terseLabel_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred and prepaid income taxes</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:href="bsx-20220630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:to="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_73643fa3-7314-4259-901e-6bd7c4f611c7_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b541d2f9-1ebd-43a4-b3c4-167b72f85571_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_2e51a023-23e0-4f7d-9e8a-f7eee1d238f7_terseLabel_en-US" xlink:label="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Foreign Currency Fluctuations on Net Sales</link:label>
    <link:label id="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_label_en-US" xlink:label="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Foreign Currency Fluctuations on Net Sales</link:label>
    <link:label id="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_documentation_en-US" xlink:label="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Foreign Currency Fluctuations on Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:href="bsx-20220630.xsd#bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:to="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_7384d7ca-8144-40df-b1bc-912106418cc1_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_ae996620-cf9c-41ae-a82b-86dbfc1641d9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d9fa0bf0-81af-48f8-8cca-3e823599d48d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1d827741-5567-4ad2-b089-34e4434b67ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6bbad169-6b62-486b-af21-d6ae3bc10dbc_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and restricted cash equivalents included in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_de78f2ae-31df-4f06-b9d0-4f849886c5fb_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_76e8e4aa-3e7f-4ccf-b364-454a2a5bdf1f_terseLabel_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember" xlink:href="bsx-20220630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BSXReportableSegmentsMember" xlink:to="lab_bsx_BSXReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_a2cedbeb-9051-482e-b7ca-db4cde21574f_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_5bf6f36d-6ba4-40a0-9f9f-2d3fe6aacebc_terseLabel_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_label_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_documentation_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm" xlink:href="bsx-20220630.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DebtInstrumentExtensionOptionTerm" xlink:to="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2b17de60-b1a6-400f-831b-2f2429591758_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_17f4e3e1-0042-4337-8dfd-492828c9a791_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_9e46d131-d59e-46e0-93bc-79b1e1e7111a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term borrowings and debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_cc7c4f21-baf6-45f8-a5ea-37827339b1ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_bde2a904-1783-412c-b450-2868b40f2587_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2035NotesMember_dacceb4e-ca3a-46a1-9c69-cdcd3fe9a1d9_terseLabel_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_label_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_documentation_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember" xlink:href="bsx-20220630.xsd#bsx_November2035NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2035NotesMember" xlink:to="lab_bsx_November2035NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LumenisMember_7a523b63-1795-422c-a0c4-126a57ac96eb_terseLabel_en-US" xlink:label="lab_bsx_LumenisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis</link:label>
    <link:label id="lab_bsx_LumenisMember_label_en-US" xlink:label="lab_bsx_LumenisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis [Member]</link:label>
    <link:label id="lab_bsx_LumenisMember_documentation_en-US" xlink:label="lab_bsx_LumenisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisMember" xlink:href="bsx-20220630.xsd#bsx_LumenisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LumenisMember" xlink:to="lab_bsx_LumenisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e4f54f04-77d6-407c-85e0-c39678335992_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_fd0f53cd-4375-4d4b-9c59-e70a0bc72172_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d7722195-5628-48f5-8f5f-2e028c39090c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Other Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6d0c6ca9-b6b7-4ed2-9672-fe7f7f8e4e88_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f935316c-097d-42fc-8031-7888dc50e4fe_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_95458117-19c4-4f02-981c-17580c88c24a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_9d83cb3a-ed85-4390-bff5-676ef83d7846_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_9e056d85-66e2-4a38-ae0c-b1bb8c9c9455_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_aaf09906-c1e0-45a8-a204-69c29bc7e214_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_dbf85026-a002-4854-9d5b-489e47f26674_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_094738f4-2b0a-44d5-a846-7eb2f14a0810_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_5e19244b-4ba4-4202-8575-8fff3d2cc817_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_2531bbe0-445d-42ae-a74f-5b02dc9bd76a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_64a88498-5a88-4660-b5d3-ec0bba43084a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AllBusinessAcquisitionsMember_a317df1c-ff9c-4541-855d-3964d850dd5e_terseLabel_en-US" xlink:label="lab_bsx_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions</link:label>
    <link:label id="lab_bsx_AllBusinessAcquisitionsMember_label_en-US" xlink:label="lab_bsx_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_AllBusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_bsx_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllBusinessAcquisitionsMember" xlink:href="bsx-20220630.xsd#bsx_AllBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AllBusinessAcquisitionsMember" xlink:to="lab_bsx_AllBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b90f4490-0b80-490e-95b8-1cb57720e5a5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_680a8d61-d09f-4616-92fe-13b3fb81d0b1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_9d459839-b26d-42dc-9b16-d4659da905f1_terseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:href="bsx-20220630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_ff422e9d-023b-4092-90ef-3a02e013d7cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_265683a9-6e48-429d-869f-87ae88936044_terseLabel_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20220630.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_57ff7403-3c62-40cd-9622-2f0b8ec7ce87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_24ac27a8-8a8d-48b9-bbc9-5437c9ba007b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_6754243e-e343-4070-8485-f23a3dd4858c_terseLabel_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:href="bsx-20220630.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_75168c20-de2d-4a54-85c6-c83a2be67fef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_a2e66202-2cb4-48c8-a1fb-d5c483ec6430_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) on investments and notes receivable</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_50e7c121-19d8-4f3e-9dea-148dc6d9580b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_e7a055aa-3fed-4331-acdb-3fef85951127_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average interest rate of de-recognized receivables</link:label>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_label_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable with Imputed Interest, Effective Yield (Interest Rate)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:to="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_8905af0d-5927-4e46-bc19-33a5ca9e95ef_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_79ef9fcb-553e-4b54-81b1-6d88452f6424_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f322f440-978d-43c9-bc9d-1d12c3fba3b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_725e2a05-d839-4103-96fa-c84b1015f766_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_4d04782b-9808-497e-b8e9-05c6286c7159_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_ba125556-9722-442e-83ca-1ff3d2f5c1e1_verboseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:href="bsx-20220630.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_679e5c23-469f-44cb-bcac-b7d84dcef98a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementAxis_726668d3-efa1-4b4c-a528-f8e1dcaa1ff0_terseLabel_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_label_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_documentation_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis" xlink:href="bsx-20220630.xsd#bsx_StatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementAxis" xlink:to="lab_bsx_StatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_a91944d8-9edb-4e32-95d4-bc36da0015b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Indemnification Assets, Amount as of Acquisition Date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Indemnification Assets, Amount as of Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:to="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_6d5a46f9-fbd8-4c4b-bf06-5104c851bef1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_38e8c940-958e-44c2-bd8f-bdaecf979ed5_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_beee02a8-46c6-49ba-8144-8486a133e98d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_79b0ce63-1c76-4535-aff6-2463b6bf0d40_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_cfb6fb54-ce3b-4ab9-87ed-a7037b7daff7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_71d14579-1754-4a4d-9e74-231880834f40_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract (less than)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50bcc4f4-5ffe-4350-b831-79647a25f0c6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_126734f9-c580-4a6d-9936-41c1b737bc48_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7724fb57-ff37-490e-a00d-4c1a6c46b1cb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3a2ea911-b0cc-43d0-9a9e-731f266f6994_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2dfcf35f-da4d-46e9-bc6d-7207e8594e58_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0930c325-1d6e-413d-aa70-eb14ac59bef9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ad9042ba-71c4-4bcc-8775-10d3ac21a6e9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_375bb8d8-3e81-443a-9419-2bcce96349e0_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsasset_c4417b72-c325-4825-b1ab-542ab0bedfa9_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_label_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsasset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsasset" xlink:to="lab_bsx_Licensingarrangementsasset" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_1b4d0db8-c48a-48f9-814b-e102b3cedb20_terseLabel_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_label_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_documentation_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:href="bsx-20220630.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:to="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a213452e-ce7f-4b29-aa93-fdd2ed5628bb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f2f1a3b9-cf5e-4155-b3c4-a271623b7227_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_904c6390-5cbf-452e-9a7c-d24b348339a0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_195259a2-caca-4940-9519-50978b48b555_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_92b5cfb1-efea-45d3-b9c9-476c79ff531a_verboseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_16f0d71e-9f89-4295-8c69-f7ce3ea07246_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiacRhythmManagementMember_440280b6-ba27-45a4-9aaf-0e8e56ff989c_terseLabel_en-US" xlink:label="lab_bsx_CardiacRhythmManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm Management [Member]</link:label>
    <link:label id="lab_bsx_CardiacRhythmManagementMember_label_en-US" xlink:label="lab_bsx_CardiacRhythmManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm Management [Member]</link:label>
    <link:label id="lab_bsx_CardiacRhythmManagementMember_documentation_en-US" xlink:label="lab_bsx_CardiacRhythmManagementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm Management</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember" xlink:href="bsx-20220630.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiacRhythmManagementMember" xlink:to="lab_bsx_CardiacRhythmManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dec68627-5c4d-48da-bfb3-8151524fb970_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_208cd1c2-5deb-426c-8894-4b7dd8e2d7a0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_434f55ec-da13-4499-86a2-4772ec0d2405_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_bde23672-9b9b-4a4f-a22d-ee9cb60e396c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_cb54a22b-048a-4bf9-afc8-f818dca13037_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_930ceb45-abe6-48c4-9dfe-9bf3dad5ab6b_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_457c1a7c-23c1-46cd-81aa-ab482546e30a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_5d8b89ec-9cfa-490b-8839-7b61762de71b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_fb5e1a23-8687-4bca-ba0c-7a50d89ddde9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9655a682-cd7a-40c3-9537-0578698f01ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7029995c-087d-41dc-934d-eb04454bd66c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_510da3f2-455f-4fda-ae75-136032555a5f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_35c8a2f2-de76-40d4-a942-8b2bfd1bea67_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:href="bsx-20220630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ab33f778-af5e-4079-bd47-02d9a25cdd14_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0b8ce602-df8f-41d1-9a75-d8676d7337aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_9a2962da-0d36-405e-9702-a1e9c2650ff1_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_21dd774f-bcf6-4ba1-b50a-b3ffcad76e48_terseLabel_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_f706ab6f-33c5-4474-b37c-e69b6f1a6d5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_3edf9f22-7de6-472d-9ac1-8a91b8768e20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_29094c4a-d935-4826-9d01-605062c3f3b4_terseLabel_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_label_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_documentation_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity in Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:href="bsx-20220630.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:to="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d0e8d4be-69aa-4408-9751-e6e56b3f68ac_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement alternative investments(1)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_9708e092-b22a-46ca-b8ed-837861d23ddc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_160e6473-81af-4552-a296-89df9e8f4686_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2049NotesMember_d96a52a0-5be4-4341-a08e-bf8007f2dcf8_terseLabel_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_label_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_documentation_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2049NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2049NotesMember" xlink:to="lab_bsx_March2049NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2039NotesMember_551fe989-004b-44dd-8086-80ddcd15757f_terseLabel_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_label_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_documentation_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2039NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2039NotesMember" xlink:to="lab_bsx_March2039NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028SeniorNotesMember_5b20eb45-e764-4e7b-88d9-01b5d9e60550_terseLabel_en-US" xlink:label="lab_bsx_March2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Senior Notes</link:label>
    <link:label id="lab_bsx_March2028SeniorNotesMember_label_en-US" xlink:label="lab_bsx_March2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Senior Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028SeniorNotesMember_documentation_en-US" xlink:label="lab_bsx_March2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028SeniorNotesMember" xlink:href="bsx-20220630.xsd#bsx_March2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028SeniorNotesMember" xlink:to="lab_bsx_March2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a00bc136-8fc6-4cfe-bc60-15643208bfe0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_5cce6a59-b546-4945-823a-88ac4dd25ae2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockStock" xlink:to="lab_us-gaap_DividendsPreferredStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0b286c56-34fc-4dcf-8507-5de0b0b78bae_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9029d872-cca6-431c-a40c-743db9d7f5b1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_088d8693-3d27-4ea5-a368-ddbb60c4771c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6499a79b-74d7-4f02-ba05-95caad66e8af_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_cabedf4a-38c7-4735-bacd-b896e9a62f0e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_f28f842a-34f2-4401-a46b-da9257ccf79e_negatedTerseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_label_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:to="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsMember_d416ed99-8493-4636-81d1-bc9f446bda80_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_label_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember" xlink:href="bsx-20220630.xsd#bsx_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsMember" xlink:to="lab_bsx_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_1a9d75f1-2fab-443e-8dfe-05b54eb23b1c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d4eb47a6-255f-4916-9be2-8961e1892f09_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_907f3e65-0956-4f20-b616-1d384f3214d4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6da3e5ce-71d9-4b38-9620-4d25eb17af5c_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_601785ae-5519-4c5b-9d0a-6c12494b737b_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_ea66adaa-43cd-404f-a340-3f0b9c846eef_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_label_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:href="bsx-20220630.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:to="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_a328e273-f44f-4220-a181-cfa897d84b06_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_f087926f-5eaf-4857-b568-309e7878b9f2_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_d2da0fd9-f4c9-4bb2-b499-cae53fa24bc6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_2ea00e55-4de4-498d-aca5-6c968ff344c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_fea98878-8e83-4205-b609-ab1b08398aca_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_label_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:to="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_60b52498-59d5-487f-ab54-e7195982c706_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:href="bsx-20220630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c1feadc5-5c61-4a58-b85f-2f7b70fb5012_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4b414caa-ebfa-4a82-8c82-42afef5248fb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a5ba054e-7391-41c6-a872-c640aa6778d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_25c8ca2c-b817-4c2c-a319-0026c0824195_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_e1fdbb47-9dcc-4aba-9954-c3286872190f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d0062209-ba10-45ce-b104-97b066579b05_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss)&#160;before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_81f31bcd-8c7b-4366-9277-752689175582_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_5cae90eb-6bfc-4671-b773-6b2ffb729609_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_14c3ff2c-2490-42af-b47e-dd9bdd10f935_terseLabel_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20220630.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_f17039a3-8e49-48cf-9902-e0f0faf088b4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_067cf1f2-5831-420f-a42d-7f87a6286e80_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_289a5bec-3a81-4d75-a872-acbffffca5a5_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_ba3eff53-7369-4a47-a514-38a8ae4c3861_terseLabel_en-US" xlink:label="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from contracts with customers, disaggregated - performance measurement</link:label>
    <link:label id="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_label_en-US" xlink:label="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from contracts with customers, disaggregated - performance measurement</link:label>
    <link:label id="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_documentation_en-US" xlink:label="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from contracts with customers, disaggregated - performance measurement - measures used by CODM to make business decisions, excludes impact of foreign currency fluctuations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:href="bsx-20220630.xsd#bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:to="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efb38bd5-17d5-46ec-a486-618050e3d56b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd275483-8e7b-4bfb-85cb-c6141f109ce6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_46380de0-4fcb-45dc-95c4-57cb2bc5b340_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:href="bsx-20220630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_5afd8fc2-0315-4ce0-8d11-43d3976ab1a8_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_99e12f05-c80e-4fc9-b2da-478d473d06d7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_cc2f82d0-b3bb-4549-9925-5bc39215cf8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_f8e86606-38b5-4590-9540-a8b0d4b2838a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a313c2f6-1bbe-4c31-be77-e57cf6820d8b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2022NotesMember_e98aedef-dae8-4617-be15-97f757cca433_terseLabel_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_label_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_documentation_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember" xlink:href="bsx-20220630.xsd#bsx_May2022NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2022NotesMember" xlink:to="lab_bsx_May2022NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c95ed9cb-407d-40d0-a85b-a152d86474d4_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_5afccd36-2751-4a9b-89a7-a5b728a1750a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_a4ae190a-007b-4669-b33b-3a032467039a_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementassetsMember" xlink:to="lab_bsx_LicensingarrangementassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_a49016b8-e3f7-42e9-9732-499b088eb6d9_terseLabel_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_label_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:href="bsx-20220630.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:to="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ce69a1f5-3de4-4036-8d2d-17af71823b92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4acb870f-b4a4-40ae-a0a1-cf0ad4c156aa_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bffac204-d67d-42de-aff7-787b99ad62d5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_24171313-8adb-4d0c-9623-fd00cec68632_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_80273dcb-7ce4-434b-9166-4244fd795a16_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9df83bd9-21c2-4229-8dfc-dcb5cb4b2b3f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_f6b07a68-2801-42c6-86ad-e17d70bc4597_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d5d8990f-8de9-473e-b0cc-c47f1eb1f853_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_9ed9f960-2b58-49fb-873d-9586d3ff35f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_f0ff4cd7-5194-4e47-8903-50fc5be03fae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_e798b85b-4867-4f62-b844-d2541e9a550f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_25cf3908-06c6-4389-8d24-d8e33b96d3bf_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Beginning Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6d32b323-b7d9-4eae-b213-51fe1679db8a_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Ending Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_ea51e46f-f5cf-4655-9341-658f6bb4e712_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_c2b7814d-176a-4a96-90d6-5733abfc97da_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_December2027NotesMember_208de9be-4279-48c1-bc72-384c7ba0073e_terseLabel_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_label_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_documentation_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember" xlink:href="bsx-20220630.xsd#bsx_December2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_December2027NotesMember" xlink:to="lab_bsx_December2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_ba66b8b9-77f7-4541-926e-e3d7954c2f6f_terseLabel_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of facilities</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_label_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of facilities</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_documentation_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities" xlink:href="bsx-20220630.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DivestitureAgreementTransferOfFacilities" xlink:to="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_2f368f74-cca1-46fd-8626-582f275d5a03_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_a52ea83f-d5a3-46e6-8af5-c5098643f0a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b649cdca-1fd8-436c-aaf6-3f70ccbf7eb4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_e88f7f1e-5924-4b65-9564-c35ba75ddcc9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7d16440c-9d06-47ed-8a35-fa03fcef07fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_745551af-f0e2-40e2-97ce-5e29604ccfb8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_a8185265-3ca4-4bbd-b0fd-7a2385af8615_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ba6f4b71-3f9f-48dd-847d-34ceb9885191_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3bd5714c-044d-468b-bc2d-c91d5acf239a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8a3486e-52b8-49b7-8255-e53462755d1b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fc406603-22a2-4c14-8ab8-0f6f49bb32f5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; assuming dilution</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_9d640b56-95b7-4776-a942-ef7d94cc98fc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_d136064d-031e-4e7e-979f-1ea219c3c080_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_302da0e8-eb57-45ed-9ea1-74d1b20defe6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_305ca686-fddf-4c9f-be0f-f43b69e5fb21_terseLabel_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_label_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_documentation_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh" xlink:href="bsx-20220630.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CertifiedClassActionsInAustraliaMesh" xlink:to="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_e0e6f3ca-f81a-46b9-a06e-6b0f573341c5_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2026NotesMember_ca480949-046c-43ca-b30d-8c1f5bbd713d_terseLabel_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_label_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_documentation_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2026NotesMember" xlink:to="lab_bsx_March2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_68ff7a1e-e2a8-439a-b828-daae99e730e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_c49631ea-d363-49bc-a96b-cdd2551566b9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_312ee757-12a4-40e6-b2e0-cdf14d6fc0f7_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_28f91a23-7c53-4faf-ad26-604c935f45b2_terseLabel_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen denominated factoring arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:href="bsx-20220630.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialChargesMember_1da4ea9f-2b35-44a2-8c87-6a1964e7c5b0_terseLabel_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_label_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_documentation_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember" xlink:href="bsx-20220630.xsd#bsx_SpecialChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialChargesMember" xlink:to="lab_bsx_SpecialChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_92fd94a5-1201-4997-a9f0-e0463dc85e30_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_9bbef587-8541-4189-ab35-3da4bf6e8231_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_50ea9fd8-e98a-485a-9bd4-eaea96ded4d7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_457e5ebc-6c8e-4438-973a-28fed7b8e517_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 263,289,848 shares as of June 30, 2022 and December 31, 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f8ead94a-afce-44a8-9578-5ca1e331ad6d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_16307e7d-b67c-4e5e-b016-cffe50b0302a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_179f24b5-4b81-4475-86fc-8ead26332c40_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_c4ccb433-fef5-46f6-8532-95c8b6c21d1d_terseLabel_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Text Block]</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:href="bsx-20220630.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:to="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_b088dbb0-ee9f-4258-b08d-46e9e407ec54_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2025NotesMember_d41eef33-fb48-4f86-98f7-b6138da232a6_terseLabel_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_label_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_documentation_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember" xlink:href="bsx-20220630.xsd#bsx_June2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2025NotesMember" xlink:to="lab_bsx_June2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_86aaf419-eb30-4a23-9d7f-12e7c01fc61b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_2bff21cf-3cb0-48d1-8e40-5a32af0370a8_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total countries</link:label>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_label_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_documentation_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries" xlink:href="bsx-20220630.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketstotalnumberofcountries" xlink:to="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_7b12eaf8-01ed-4370-a16b-c9ebd3322e1e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_9d7149cf-e441-4515-b7a4-f9688eaa478f_terseLabel_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_label_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_documentation_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims asserted related to mesh products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:href="bsx-20220630.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:to="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c5faea86-7c86-4a1e-a3ec-ac5cedd62236_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_b642c896-37b0-4ebe-b81c-384cd4f30a95_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring net charges (credits)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7c838505-ebbf-467d-b066-43a30032ea14_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2024NotesMember_84905ff9-fd9d-4daa-bb60-98b90bc4b95f_terseLabel_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_label_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_documentation_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2024NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2024NotesMember" xlink:to="lab_bsx_March2024NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4881446b-23f6-4382-a9ba-a3526220a81b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_fc1d45a3-fae8-472c-9b51-dc9fa57ea6bc_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal reserves, current</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6e050607-26c9-485c-94d5-9a168840120a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_47f89832-3a97-4120-a262-6d2364df0917_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_fa700a73-7ade-4268-90b6-b3f08484e64b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_f9093c8a-020a-4e21-8c65-d63b14ee5a9a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fabe5b41-62ad-48ff-8dbf-515270c1af75_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_aaf2e315-d488-4e42-b593-76d3b959883c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_bc7d5358-170b-49c9-a22a-0f9f16e71845_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2b956c59-2c89-4acf-9c64-2f0de7b775f5_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b6d07b18-b522-4ca7-943f-acd6986329e5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_a08d022d-d88c-46ad-88f6-67da835a199c_terseLabel_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_label_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_documentation_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding" xlink:href="bsx-20220630.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumCommercialPaperOutstanding" xlink:to="lab_bsx_MaximumCommercialPaperOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_52ff906b-b212-49be-b653-0b7ba6bfab2b_terseLabel_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_label_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_documentation_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:href="bsx-20220630.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:to="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2031NotesMember_330185b0-4515-4956-9a74-50dac0d5feba_terseLabel_en-US" xlink:label="lab_bsx_March2031NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2031 Notes</link:label>
    <link:label id="lab_bsx_March2031NotesMember_label_en-US" xlink:label="lab_bsx_March2031NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2031 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2031NotesMember_documentation_en-US" xlink:label="lab_bsx_March2031NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2031 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2031NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2031NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2031NotesMember" xlink:to="lab_bsx_March2031NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_999197fb-db18-4844-bc94-86ec673f6914_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of certain businesses and assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cb3cd6dd-449a-4cf0-a394-20a0eccf009d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_73adaf9b-a236-47e7-92ad-09914a67ca33_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_5be4b83b-f23e-4133-afc6-2fbbe20ce1f3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MITechCoLtdMember_35d96fee-ca8d-4ab0-8439-9422f5bd5546_terseLabel_en-US" xlink:label="lab_bsx_MITechCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">M.I. Tech Co., Ltd</link:label>
    <link:label id="lab_bsx_MITechCoLtdMember_label_en-US" xlink:label="lab_bsx_MITechCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">M.I. Tech Co., Ltd [Member]</link:label>
    <link:label id="lab_bsx_MITechCoLtdMember_documentation_en-US" xlink:label="lab_bsx_MITechCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">M.I. Tech Co., Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MITechCoLtdMember" xlink:href="bsx-20220630.xsd#bsx_MITechCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MITechCoLtdMember" xlink:to="lab_bsx_MITechCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_1439435b-9fb8-49c8-b507-4702f2f35f14_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0db11dd0-ae3d-4625-b0eb-996418996fd0_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ce25797d-1708-47ef-87ad-01484dfc3535_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_6f06453a-ed7e-433b-8740-f9dc4481e464_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_7a2daf8f-0428-4ee3-bfc4-df85d1953c13_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_83ef0415-5825-4e7e-96e2-53798d9084e5_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c764db42-65fd-45fa-b2f0-ff215f4fd744_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ElectrophysiologyEPMember_55c1e4ed-9600-45cb-9a34-e54bc63ecb98_terseLabel_en-US" xlink:label="lab_bsx_ElectrophysiologyEPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrophysiology [Member]</link:label>
    <link:label id="lab_bsx_ElectrophysiologyEPMember_label_en-US" xlink:label="lab_bsx_ElectrophysiologyEPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrophysiology (EP) [Member]</link:label>
    <link:label id="lab_bsx_ElectrophysiologyEPMember_documentation_en-US" xlink:label="lab_bsx_ElectrophysiologyEPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrophysiology (EP)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember" xlink:href="bsx-20220630.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ElectrophysiologyEPMember" xlink:to="lab_bsx_ElectrophysiologyEPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_2bd69c39-a590-43ba-b30e-7b67df3596d0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_d6e16aa4-e9d0-4001-835b-9ffc2c8882c0_terseLabel_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_label_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_documentation_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember" xlink:href="bsx-20220630.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LatinAmericaandCanadaMember" xlink:to="lab_bsx_LatinAmericaandCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_b1a92013-d92e-4290-9c89-7ebe896db1b9_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockCash" xlink:to="lab_us-gaap_DividendsPreferredStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d5f22980-9290-4727-bdae-40be6251b056_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_35445812-e3fd-45a0-953f-2575c1bcb05d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_81e4f938-014a-48e8-8446-83abfe78c969_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementDomain_34e50304-c41b-4805-b0e4-a9f6d584d7bf_terseLabel_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_label_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_documentation_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain" xlink:href="bsx-20220630.xsd#bsx_StatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementDomain" xlink:to="lab_bsx_StatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_d5553497-8695-45a7-b0d1-d40560aa5534_terseLabel_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_label_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_documentation_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss" xlink:href="bsx-20220630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Netcurrencyexchangegainloss" xlink:to="lab_bsx_Netcurrencyexchangegainloss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_50745a38-b163-4821-a972-07659afa7828_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e6c6589e-948e-4a9b-a79d-49b098991c56_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_fa60bc17-b026-4a2f-8986-339b01b36f99_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a24e2e3c-c603-48e8-8d3b-7e67a57f68a3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f825e0f7-11e1-4fad-948e-44668cabe6ba_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_3c5b210a-780b-4c19-81ec-fe9ccf487a33_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_5c5e7fd8-7a25-41aa-a9c2-b9c09c9701eb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_c6754778-4f78-4a18-83c7-b9e5a6e5acc7_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_cd866d22-a8e7-43f1-8f03-4b0adbd433d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0ea6e495-f99e-4378-bbff-7e5fb58eb38e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_5dd704e2-53f2-4be1-b501-b79c76215eea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_2a0cbc93-0088-4c80-8430-5c5ad4371219_terseLabel_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_label_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of term loan and revolving credit facility agreement compliance with debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:href="bsx-20220630.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:to="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_864d4981-a00a-4b5c-9c91-b23d2f3d34ee_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_97d8ea4c-cfe5-4dd6-a660-e754052f197f_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for legal matters that are probable and estimable</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_abf55d85-2862-4fff-93bc-dd9c8787d800_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_83cc3517-fa6e-473b-82f4-8a2965d357f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_9c9033d1-0778-4ca3-8b70-dfc931e95a66_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_cea2cd0a-1c43-4103-ac03-39e275e995d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_36734e05-cbc3-424d-849d-c6a8de351b19_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_e19c4647-4724-4ae6-9058-965c93a63599_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumLeverageRatio_dad76168-8c98-496b-bb31-2cae01f4e07e_terseLabel_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_label_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_documentation_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio permitted by revolving credit facility agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio" xlink:href="bsx-20220630.xsd#bsx_MaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumLeverageRatio" xlink:to="lab_bsx_MaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a32449da-edcb-496e-a147-699a0c975efb_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_d092b036-0f52-4097-9d51-37db49e05fd3_terseLabel_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:href="bsx-20220630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:to="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_2c60dec7-1043-4e76-902b-7a62e48c3ae4_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_c02aaf19-d155-4817-a8a4-6bcf9c3ee398_terseLabel_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_label_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility [Member]</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_documentation_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:href="bsx-20220630.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:to="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cc7fa622-dfeb-419e-96b9-91f3e771cfeb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate from continuing operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_3304351b-be04-4904-837d-7727aa9d7926_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_69b8bad6-d9d6-47f2-b091-c87a6849656e_terseLabel_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_label_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_documentation_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember" xlink:href="bsx-20220630.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenueBasedPaymentsMember" xlink:to="lab_bsx_RevenueBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_6c146eca-727b-4462-9882-4418eea09857_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d3b74fb4-88f3-432b-92de-c640a52445f7_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_71051d02-8a87-4ba7-80ef-ed29f8dc872d_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_2d4022d9-1383-4810-bb85-bba98bea34c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_50a1edf8-6b57-4788-b7c1-412e18abaa16_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_65fa009e-f8d4-4845-bd99-7615c3515386_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_25fb85d8-a08b-4bcb-838e-f81499f09c10_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4960d47b-dfd9-4c2a-8d41-135e37644b43_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_652f2fea-68e9-43ca-b4e2-d783f2024216_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ceed295f-4276-47ec-9b40-9013f5eade65_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eda2a3ca-2d6c-456e-81e1-dae9acfd3edc_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_2c4a9e61-68de-4df7-948e-9d21f1488af8_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:label id="lab_us-gaap_SharesIssued_78b61df4-2f48-47bb-87d7-3e715c4b9dda_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_aa086f05-9c2c-469a-9226-8107a171896d_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_aadcc8ab-b9f4-42cd-8819-cfc7ac16e028_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_56c655d0-83b6-4972-8195-784d8930f5e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_0130776e-a79c-46dd-9300-39592c425448_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0ebb5ec3-37c0-49bc-b322-42e08b92f07a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_881cc22f-0590-4810-a0e7-e48532f5fa90_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_603302df-ce92-45ae-a9d2-77e3a94d7631_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_707b5c43-2559-484a-8cf3-ec338b1bdafe_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_28103b4f-df4f-4a1c-9745-0fb86b003975_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_ac63522c-8fd0-4a36-aeef-a1075d31e681_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7dfde240-38d4-4251-bac9-9d36d7942008_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_a31a94a1-de67-44fa-ab7d-698f9d26f172_terseLabel_en-US" xlink:label="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cases in final stages of resolution, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_label_en-US" xlink:label="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cases in final stages of resolution, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cases in final stages of resolution, related to Greenfield Vena Cava Filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:href="bsx-20220630.xsd#bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:to="lab_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_63d67d82-1ac1-4218-ab0e-1ed9c857ec74_verboseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c3bb6ac-24e7-461a-8a5c-88e8e0c69d7a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assuming dilution</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f1e5cad4-1bfc-429f-bca4-d0300b529379_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_75e9bc48-11ac-4373-babd-7931f7b7ca42_terseLabel_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_label_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_documentation_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:href="bsx-20220630.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:to="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7dfc1ba-5faf-4da8-811b-32c3cf311d6b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c5bd319c-44a0-4aae-a6d9-ac8a008e4f2d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_61237359-168d-4ee2-bd81-7574e45b3aa1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_3631edcf-066c-44f4-b80a-a186679228bb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2b273d7b-900f-4ce8-b238-51f4bf489753_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_7bf90eea-55e0-4ee3-b79e-4d7b88dcc91f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_defb5e7d-1b4d-4662-a28d-6e51f5c6fad2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_6e9f290b-65fa-4071-88a1-71a0a43624a0_terseLabel_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:href="bsx-20220630.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:to="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_7588c7b5-ccd1-4945-b9c6-6f9ceb360aef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CurrentRequirementMember_9dea73ab-9c99-41d3-adc5-1fb03d67f3ca_terseLabel_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_label_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_documentation_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember" xlink:href="bsx-20220630.xsd#bsx_CurrentRequirementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CurrentRequirementMember" xlink:to="lab_bsx_CurrentRequirementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_88e5d9e9-3763-4e36-8e40-9868a220dc0f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsliability_0fb07873-c2ba-4f6d-8694-9f372de19c2f_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_label_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsliability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsliability" xlink:to="lab_bsx_Licensingarrangementsliability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9953faf9-fd64-4545-9c92-a85574e303ff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AccruedRebatesCurrent_cbda0f5f-034e-4bd0-9c00-1321e5da15dd_terseLabel_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_label_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_documentation_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent" xlink:href="bsx-20220630.xsd#bsx_AccruedRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AccruedRebatesCurrent" xlink:to="lab_bsx_AccruedRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_9eec3fc0-cb5a-457e-a7fe-1a18d1249b0b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6b1848cb-4fed-43f3-8977-e6bad9ccd9d4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_9ccecb86-897c-404e-abcd-1d6616da6c53_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e9c4bc79-e6f2-423f-890c-8f66e119a1e5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e567979f-e230-4b85-a2d3-d3704fe5cceb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_69aa7c7c-7d4d-4a30-b51b-a1e703618059_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_7b648de2-21a9-4b16-9cf8-69772adc1622_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_9507db9c-f5e7-4f42-b7a6-4b9ac1393e17_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherNet_618fbd28-36fd-4069-a13a-4dfb5624b2cb_terseLabel_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_label_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_documentation_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet" xlink:href="bsx-20220630.xsd#bsx_OtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherNet" xlink:to="lab_bsx_OtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f1880bca-9554-43b6-806d-f6713ea51029_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2029NotesMember_fafe73a4-3540-4883-9b12-34762ce10926_terseLabel_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_label_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_documentation_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2029NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2029NotesMember" xlink:to="lab_bsx_March2029NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_10b76f8e-d5ab-458b-b09e-1cd532a5c838_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingParValuePerShare_b5aa9687-0651-409c-a31b-0ac3ad318c3b_terseLabel_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:label id="lab_dei_EntityListingParValuePerShare_label_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingParValuePerShare" xlink:to="lab_dei_EntityListingParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_46c76be6-6669-4962-a4c5-7a89409135d9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_171f1511-5c12-4e16-8214-ffa131024c04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_19e658e2-3391-4da6-a6e2-4ac7399e05b9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_031129a4-deae-466e-9217-3ad9eed9d84c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_5571c2c1-e237-4c24-8647-9752784cfa47_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_38556e60-f1e0-434d-a4f3-19df8c5e6a55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_57a49ca2-812b-47b1-8684-befd744769d7_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_a99376e8-1b3a-4058-9960-bb118b6242a3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c95ab0f5-11bf-4eea-9073-276930a13d33_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_b0f396e3-1497-4579-9c9b-4976ce55f812_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_de5cfdd3-b517-42d5-b5c6-3ac67c85daf6_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_44320b9a-48a5-456c-ae76-328903b8a8d4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_69b3602c-ea50-45dc-8e6c-5f9ae989bcc3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_4bc04317-f484-46d2-9bc7-89c17cf741c2_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20220630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0eb5de94-84de-442c-9d2e-f11616bd9afb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_671e7eca-e6f2-4d04-8f1e-1a1dd8f1b7c9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_02ffa741-a6e5-4e28-aede-cf1224b51b3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_1709c18d-a7de-49a6-bc99-800a719a510a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_facef7de-610f-4bdd-9356-bb01a7130a6c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7dac65bd-12db-48c4-8aff-bb81b39f4655_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_62181995-b395-4452-81b5-2e874cb3361b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_57011897-8106-4915-8b58-4e3edba14e8b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_d13ba23f-b169-46d9-ac29-bfe06986c327_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1a0cbee7-e98d-42e3-a4ae-9f25b5a527d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_ef72a66d-887e-4308-95a7-17b5beb8402c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_aec45101-631d-4ddc-8280-667002f413c8_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_4a019118-bb75-4e2a-bc03-429b0c59449b_terseLabel_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice</link:label>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_label_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc. [Member]</link:label>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_documentation_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember" xlink:href="bsx-20220630.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PreventiceSolutionsIncMember" xlink:to="lab_bsx_PreventiceSolutionsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_c3aa2a87-a519-4a8c-b1b9-6883a1fb3cf7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_2a16310b-6ae6-4806-b1cf-60e318a73bdf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_label_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeRemainingMaturity1" xlink:to="lab_us-gaap_DerivativeRemainingMaturity1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_a1c3345f-c25b-4bed-bffc-51c823a0d9ba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2040NotesMember_998b7b70-dcf2-46cd-8f23-d3b87a3ca7e7_terseLabel_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_label_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_documentation_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember" xlink:href="bsx-20220630.xsd#bsx_January2040NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2040NotesMember" xlink:to="lab_bsx_January2040NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_1b682a11-8ac6-4a05-b1fa-4b32da1f40fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_9543193d-1b8f-4b32-b91b-aab84ed652d5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_85bebdc8-90d6-42a5-8071-568fde61fcba_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d71c9cbb-e2a8-4c0f-9c66-293783448ddd_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_68c70403-33ab-40ed-8161-1150cc347bb8_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_a239de0a-3e3b-4162-b047-f0d5e1cb3fee_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0525154b-dba0-4807-9063-3e96a4af4d8e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_b9d32bb0-4e0d-4655-902a-f2c8764b918b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_e3620a89-7341-4757-853d-7d6ecd6a5a71_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_c7891cf3-7e4a-4c60-9de9-9ee19101ad25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_c7225621-5f37-4f5c-b01a-f440f276821f_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_2e80dbfd-f145-4a9f-abf4-28bc023bbf51_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_b51179d8-2aa1-4195-97ce-6b30e11b6a10_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2025NotesMember_e35b3a3f-faab-42f6-94cd-b1d099afd194_terseLabel_en-US" xlink:label="lab_bsx_March2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2025 Notes</link:label>
    <link:label id="lab_bsx_March2025NotesMember_label_en-US" xlink:label="lab_bsx_March2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2025NotesMember_documentation_en-US" xlink:label="lab_bsx_March2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2025NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2025NotesMember" xlink:to="lab_bsx_March2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2025NotesMember_33a57e9a-3cc2-4844-8f93-1959358b516f_terseLabel_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_label_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_documentation_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember" xlink:href="bsx-20220630.xsd#bsx_May2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2025NotesMember" xlink:to="lab_bsx_May2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_8b0c1a23-687f-4389-b6be-d86b66473192_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_674da26c-e586-43dc-83ab-7046570fca2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_1e3f7857-7cf4-4d6c-bfb4-35cb519eac39_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_450837ec-2f72-4e2b-84a0-3a2e550ad569_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_33fd5af2-4cc4-4b1d-b0fc-5ebad5164021_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2034NotesMember_c65f466c-d7c0-4cc9-a4be-0a76ae04e810_terseLabel_en-US" xlink:label="lab_bsx_March2034NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2034 Notes</link:label>
    <link:label id="lab_bsx_March2034NotesMember_label_en-US" xlink:label="lab_bsx_March2034NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2034 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2034NotesMember_documentation_en-US" xlink:label="lab_bsx_March2034NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2034 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2034NotesMember" xlink:href="bsx-20220630.xsd#bsx_March2034NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2034NotesMember" xlink:to="lab_bsx_March2034NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_672047fa-3008-4f38-bf23-14af2c24101f_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_label_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:href="bsx-20220630.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:to="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>bsx-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:202f2156-2eff-48c6-8020-e675b6a04e60,g:66d98efe-f6bb-4852-90b5-5e203e0b5e35-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20220630.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract_0a5e34c7-59dd-4deb-a354-8cb2c1ae47b3" xlink:href="bsx-20220630.xsd#bsx_EntityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_e6a64cea-8e19-4882-8d14-40916b5c7a53" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_EntityAbstract_0a5e34c7-59dd-4deb-a354-8cb2c1ae47b3" xlink:to="loc_dei_EntitiesTable_e6a64cea-8e19-4882-8d14-40916b5c7a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_418358bb-e1e0-4466-aeb9-3adea07b2b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_e6a64cea-8e19-4882-8d14-40916b5c7a53" xlink:to="loc_us-gaap_StatementClassOfStockAxis_418358bb-e1e0-4466-aeb9-3adea07b2b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_418358bb-e1e0-4466-aeb9-3adea07b2b60" xlink:to="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_146db0ed-022b-4033-95d4-466304ea0bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:to="loc_us-gaap_CommonStockMember_146db0ed-022b-4033-95d4-466304ea0bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_02dbf16b-0010-467e-a6ec-b9cd0e7c0441" xlink:href="bsx-20220630.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:to="loc_bsx_SeniorNotedue2027Member_02dbf16b-0010-467e-a6ec-b9cd0e7c0441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_4838c029-bae7-409e-94a4-160b3e5f1e7b" xlink:href="bsx-20220630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8f2b84a4-5b5d-4e40-81b3-ea25bb8ab0b1" xlink:to="loc_bsx_A550MCPSSeriesAMember_4838c029-bae7-409e-94a4-160b3e5f1e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_e6a64cea-8e19-4882-8d14-40916b5c7a53" xlink:to="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d5e0c651-6804-4d36-a3dc-9984e5a6f7f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentType_d5e0c651-6804-4d36-a3dc-9984e5a6f7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9bdee5f3-c1a8-4cec-9a4a-65f746b03e14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentQuarterlyReport_9bdee5f3-c1a8-4cec-9a4a-65f746b03e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_81e7d436-278c-462e-964e-3e3519b5ea64" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentPeriodEndDate_81e7d436-278c-462e-964e-3e3519b5ea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_37a8e593-b47f-4f34-ab19-7e3981fa9a18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentTransitionReport_37a8e593-b47f-4f34-ab19-7e3981fa9a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7dfd4fdc-a935-496a-bf3a-228c5ff4cf3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityFileNumber_7dfd4fdc-a935-496a-bf3a-228c5ff4cf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8f429674-f8c4-438e-bf9f-33970037958e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityRegistrantName_8f429674-f8c4-438e-bf9f-33970037958e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8e8f52c8-3681-4f3e-a094-98b4768245f2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8e8f52c8-3681-4f3e-a094-98b4768245f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f6cc1ecb-74a2-4a1c-a0b0-1b934b5c959e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityTaxIdentificationNumber_f6cc1ecb-74a2-4a1c-a0b0-1b934b5c959e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a4b6f633-b5d3-42a7-8eb2-2b3c4deefb5e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressAddressLine1_a4b6f633-b5d3-42a7-8eb2-2b3c4deefb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_be388b45-341c-4ace-83d3-c22ca0b44ba9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressCityOrTown_be388b45-341c-4ace-83d3-c22ca0b44ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_922983d7-11a4-477d-88d7-8117a0e1c824" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressStateOrProvince_922983d7-11a4-477d-88d7-8117a0e1c824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c0c8874c-0fa4-42cf-9d44-db0fb1afc896" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityAddressPostalZipCode_c0c8874c-0fa4-42cf-9d44-db0fb1afc896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ac1e37ce-7ffe-4284-9595-f2d8ee4a727e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_CityAreaCode_ac1e37ce-7ffe-4284-9595-f2d8ee4a727e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a5488d2a-88cf-465a-adf6-dca033bb9947" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_LocalPhoneNumber_a5488d2a-88cf-465a-adf6-dca033bb9947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a60e0880-da90-4edf-ba9b-24c266f7a2cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_Security12bTitle_a60e0880-da90-4edf-ba9b-24c266f7a2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_891d5f56-dcf5-43e5-8b4c-d268774594e4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_TradingSymbol_891d5f56-dcf5-43e5-8b4c-d268774594e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_23050701-34f9-47f3-b24f-e873d9897b1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_SecurityExchangeName_23050701-34f9-47f3-b24f-e873d9897b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b0b0d7b0-2297-425a-a974-ec658cb220e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityCurrentReportingStatus_b0b0d7b0-2297-425a-a974-ec658cb220e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e6e5dfd2-7b58-4c78-8ca6-465833b65bf9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityInteractiveDataCurrent_e6e5dfd2-7b58-4c78-8ca6-465833b65bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a31cadaf-eeff-458c-a11d-7969ff839616" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityFilerCategory_a31cadaf-eeff-458c-a11d-7969ff839616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_fdf55d69-25bb-4aef-8140-e885be4d5db5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntitySmallBusiness_fdf55d69-25bb-4aef-8140-e885be4d5db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d4235403-2365-4947-9c7f-3d49849d5d2c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityEmergingGrowthCompany_d4235403-2365-4947-9c7f-3d49849d5d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_868e9e42-18c3-4cca-810c-d98df3cb4f37" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityShellCompany_868e9e42-18c3-4cca-810c-d98df3cb4f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_128e28ac-08ee-4413-85e9-d21eac4c7bfc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingParValuePerShare"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityListingParValuePerShare_128e28ac-08ee-4413-85e9-d21eac4c7bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_28ab9a85-dbeb-46e6-89cc-5268c9feab08" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_28ab9a85-dbeb-46e6-89cc-5268c9feab08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8e21d623-445d-49e0-9dc8-4c3909eb4036" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_EntityCentralIndexKey_8e21d623-445d-49e0-9dc8-4c3909eb4036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_caac9f29-22e7-402a-a282-c400a5f0b74e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_CurrentFiscalYearEndDate_caac9f29-22e7-402a-a282-c400a5f0b74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b759f7f2-59d4-48a4-a2a6-0c63c179ce4a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentFiscalYearFocus_b759f7f2-59d4-48a4-a2a6-0c63c179ce4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_45da61b3-f808-423c-ac51-f5f8e2c5e221" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_45da61b3-f808-423c-ac51-f5f8e2c5e221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9d2f2974-3fb1-4ee3-ac9c-cd1cbcac6af8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_002a387d-62ef-4631-bbbe-a4e2d581e5cf" xlink:to="loc_dei_AmendmentFlag_9d2f2974-3fb1-4ee3-ac9c-cd1cbcac6af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_2650ca76-ee68-4909-9d60-f05b08ff993a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c8c86595-54a0-4b80-a199-d7948aae29a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2650ca76-ee68-4909-9d60-f05b08ff993a" xlink:to="loc_us-gaap_StatementTable_c8c86595-54a0-4b80-a199-d7948aae29a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f925c4ee-68b4-42fe-936f-cf6d00323682" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c8c86595-54a0-4b80-a199-d7948aae29a3" xlink:to="loc_srt_StatementScenarioAxis_f925c4ee-68b4-42fe-936f-cf6d00323682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3891edd5-5fb7-4560-8aa2-279f70ef7585" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f925c4ee-68b4-42fe-936f-cf6d00323682" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3891edd5-5fb7-4560-8aa2-279f70ef7585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c8c86595-54a0-4b80-a199-d7948aae29a3" xlink:to="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b0e4338-b8dd-498f-bb31-fbd514836c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b0e4338-b8dd-498f-bb31-fbd514836c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bdd48bfc-8216-4886-b46a-584f0bdb16df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bdd48bfc-8216-4886-b46a-584f0bdb16df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_376485b0-ea1d-40fe-8206-5f9508f53b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_GrossProfit_376485b0-ea1d-40fe-8206-5f9508f53b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8205f0ac-2305-457e-a0f7-48d734d26ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8205f0ac-2305-457e-a0f7-48d734d26ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9a130b24-aaaa-42e6-bfba-e5bb36ce0d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9a130b24-aaaa-42e6-bfba-e5bb36ce0d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_03719fbc-7e04-4721-aba7-d0604725d241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_RoyaltyExpense_03719fbc-7e04-4721-aba7-d0604725d241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e67da025-d2f4-4bc5-8e0f-d26477905adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e67da025-d2f4-4bc5-8e0f-d26477905adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c841180d-da40-4348-bc3c-ccb9869f7e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c841180d-da40-4348-bc3c-ccb9869f7e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d557c0a-2a00-4960-aeaf-aa049de41505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d557c0a-2a00-4960-aeaf-aa049de41505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_034b5cd2-e96f-4894-8c1e-b2c2470ff9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_RestructuringCharges_034b5cd2-e96f-4894-8c1e-b2c2470ff9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_d37e3546-2bf8-4e1d-a4a9-2df21e235b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_LitigationSettlementExpense_d37e3546-2bf8-4e1d-a4a9-2df21e235b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_636a5db3-78eb-415d-9aaa-efc142353a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_636a5db3-78eb-415d-9aaa-efc142353a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9e374da2-f6a5-4896-82fb-582a43814faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7174a408-e71e-44af-80ab-62611307dd73" xlink:to="loc_us-gaap_OperatingExpenses_9e374da2-f6a5-4896-82fb-582a43814faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ddbfa705-18e4-42b6-947f-80307606c126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_OperatingIncomeLoss_ddbfa705-18e4-42b6-947f-80307606c126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3879538e-5af2-4f8b-8008-9319b932b4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:to="loc_us-gaap_InterestExpense_3879538e-5af2-4f8b-8008-9319b932b4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1e788205-2b30-45c0-8a82-c2c7387ef95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_b2db93db-5094-4503-bcca-366040ab7650" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1e788205-2b30-45c0-8a82-c2c7387ef95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98766e36-92e3-4136-9dee-a344e6270308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98766e36-92e3-4136-9dee-a344e6270308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_84f30efe-0188-4210-afd2-6b5ae34e1623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_84f30efe-0188-4210-afd2-6b5ae34e1623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_856a6043-2372-417c-a4cb-0ada52584bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_ProfitLoss_856a6043-2372-417c-a4cb-0ada52584bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_740c1848-e382-43e0-933f-c3c2813212a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_DividendsPreferredStockStock_740c1848-e382-43e0-933f-c3c2813212a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_535e6f66-eee6-44d5-b079-0706b1047c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_535e6f66-eee6-44d5-b079-0706b1047c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e03272a3-81d7-4ae5-8c63-355e20e5dac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_EarningsPerShareBasic_e03272a3-81d7-4ae5-8c63-355e20e5dac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5fd334ce-f38d-47fa-9ee9-b5b9bc524739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5fd334ce-f38d-47fa-9ee9-b5b9bc524739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5d6e27bc-4e70-477a-88ae-96a1499f812d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e1b323f-892b-49ed-a5e6-e3a3e8b64162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e1b323f-892b-49ed-a5e6-e3a3e8b64162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3be7d8fd-2f39-4b17-9229-16570abd4e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de9fcb34-2717-42ff-bd6a-73af32805888" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3be7d8fd-2f39-4b17-9229-16570abd4e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_771a8757-4c70-483c-8738-87b97982d961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_952cac60-6fdd-4bb0-9694-6ec821c1a396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_771a8757-4c70-483c-8738-87b97982d961" xlink:to="loc_us-gaap_StatementTable_952cac60-6fdd-4bb0-9694-6ec821c1a396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4b3a2424-1837-4d35-a57b-b48969acd419" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_952cac60-6fdd-4bb0-9694-6ec821c1a396" xlink:to="loc_srt_StatementScenarioAxis_4b3a2424-1837-4d35-a57b-b48969acd419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b750f066-0227-4c9c-b00a-dcb5fc067c06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_4b3a2424-1837-4d35-a57b-b48969acd419" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b750f066-0227-4c9c-b00a-dcb5fc067c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_952cac60-6fdd-4bb0-9694-6ec821c1a396" xlink:to="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_faa8521c-ade9-4f09-930c-cb6fa2b001d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:to="loc_us-gaap_ProfitLoss_faa8521c-ade9-4f09-930c-cb6fa2b001d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aec3f50-1e67-4abf-95ef-b253ef58a07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aec3f50-1e67-4abf-95ef-b253ef58a07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2b64e1b8-029e-4e18-a36c-473d86b16388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2b64e1b8-029e-4e18-a36c-473d86b16388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9d549c66-a7d3-437b-a468-740b4e1e3101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9d549c66-a7d3-437b-a468-740b4e1e3101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fb5a27a5-c887-4406-a93b-cf02b6c871f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_81472b2d-31a3-421f-9ecc-c0b558db2cad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fb5a27a5-c887-4406-a93b-cf02b6c871f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1a71cdd-e3e3-4264-bbcf-6b1994af1c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9180519f-0f34-4893-8682-b6a18e1317f1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1a71cdd-e3e3-4264-bbcf-6b1994af1c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4a0bc431-9370-4326-86d9-0f71d1f01f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4a0bc431-9370-4326-86d9-0f71d1f01f24" xlink:to="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_acb9daf5-bede-4c06-8b86-0045890fbf9e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:to="loc_srt_StatementScenarioAxis_acb9daf5-bede-4c06-8b86-0045890fbf9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5fd5713e-c130-4fb8-b7b8-a65f49d90ede" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_acb9daf5-bede-4c06-8b86-0045890fbf9e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5fd5713e-c130-4fb8-b7b8-a65f49d90ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_36f0a764-618a-4358-9cea-72ee118b5dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:to="loc_us-gaap_StatementClassOfStockAxis_36f0a764-618a-4358-9cea-72ee118b5dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9884c12a-4597-4f07-b74e-189fd658b0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36f0a764-618a-4358-9cea-72ee118b5dd8" xlink:to="loc_us-gaap_ClassOfStockDomain_9884c12a-4597-4f07-b74e-189fd658b0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7adc694a-997d-441d-9473-a31db467c738" xlink:to="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:to="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9e7a3bf-9962-4fb0-af00-034522d23667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9e7a3bf-9962-4fb0-af00-034522d23667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_3598b6f5-d513-4ad6-9546-82c53e3653f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_3598b6f5-d513-4ad6-9546-82c53e3653f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4cf672f6-9c6e-4435-be66-26442de69985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_InventoryNet_4cf672f6-9c6e-4435-be66-26442de69985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_0f960ce5-9166-4c1c-9b12-c856710c910f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_PrepaidTaxes_0f960ce5-9166-4c1c-9b12-c856710c910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_98852570-df46-4c5f-9cde-eb4c4e1620b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_98852570-df46-4c5f-9cde-eb4c4e1620b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_04c74bb0-3e14-488b-a001-850370455502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8d16dff-8d79-4309-bb16-99e8a030dcf7" xlink:to="loc_us-gaap_AssetsCurrent_04c74bb0-3e14-488b-a001-850370455502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_11ba1f77-2221-48fc-8cc8-b0e9f1a8d126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_11ba1f77-2221-48fc-8cc8-b0e9f1a8d126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_79b18ce9-6065-44ac-b34e-91fba89d9a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_Goodwill_79b18ce9-6065-44ac-b34e-91fba89d9a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67c0f339-c0c1-4d2f-b7d3-a35760ccc7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67c0f339-c0c1-4d2f-b7d3-a35760ccc7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7a949add-ec05-4d24-be3b-cce523c78b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7a949add-ec05-4d24-be3b-cce523c78b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5ecac811-13d8-4987-9a00-39bc1de9c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5ecac811-13d8-4987-9a00-39bc1de9c65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6d849615-b15b-40d0-9b00-1e1784184a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_fccfb8d1-79f7-4df7-ae96-ca8f85451763" xlink:to="loc_us-gaap_Assets_6d849615-b15b-40d0-9b00-1e1784184a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1fe9d31d-91c5-4df6-a695-e1d28416129f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2b14e9f5-20fb-428a-bf87-7900eb51a480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_DebtCurrent_2b14e9f5-20fb-428a-bf87-7900eb51a480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a82bc68e-61de-4148-bd6e-60d41406be97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_AccountsPayableCurrent_a82bc68e-61de-4148-bd6e-60d41406be97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4140201a-d9f5-4901-bd9e-e62251dd2e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4140201a-d9f5-4901-bd9e-e62251dd2e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_dd8d7be4-3e89-4868-9744-e2372968848c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_dd8d7be4-3e89-4868-9744-e2372968848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d66f1145-3b92-4e11-953b-fc109381916f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8acefe77-ab86-43c4-b145-f2ffa6a035c3" xlink:to="loc_us-gaap_LiabilitiesCurrent_d66f1145-3b92-4e11-953b-fc109381916f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b62cfb57-20f8-4d74-a893-c7296ee9dfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b62cfb57-20f8-4d74-a893-c7296ee9dfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b1a58f1f-1af5-4c71-ae77-920e2f3509c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b1a58f1f-1af5-4c71-ae77-920e2f3509c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_181eb274-322d-47d0-a030-cbe1f9f8e652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_181eb274-322d-47d0-a030-cbe1f9f8e652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a6c2f99b-c2ae-4773-b07d-cdfcbe93e54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a6c2f99b-c2ae-4773-b07d-cdfcbe93e54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3d24392a-bfd9-4e13-a976-dc84c0f4521a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_PreferredStockValue_3d24392a-bfd9-4e13-a976-dc84c0f4521a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a15af368-a6f6-43a2-8999-8b1f158f6671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_CommonStockValue_a15af368-a6f6-43a2-8999-8b1f158f6671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f11b0eca-dc16-412b-84da-b408cf9d9e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_TreasuryStockValue_f11b0eca-dc16-412b-84da-b408cf9d9e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_039152de-61ee-4ea4-8002-81b669537bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_039152de-61ee-4ea4-8002-81b669537bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01651cfc-57d7-4c78-abb8-7e499f758216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01651cfc-57d7-4c78-abb8-7e499f758216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_39381923-fedf-4438-8fa7-90266cb6b620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_39381923-fedf-4438-8fa7-90266cb6b620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59fc985b-701d-440d-a45e-26609489e24b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_220e1244-6330-4199-ab91-bef504a3a432" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59fc985b-701d-440d-a45e-26609489e24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c5d3822-35c5-4cfe-b8ee-040097ad3971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3220923c-7736-4d76-951e-d70958d0e276" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c5d3822-35c5-4cfe-b8ee-040097ad3971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:href="bsx-20220630.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e7c1a87a-620a-4b0e-bf4a-610d76051525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e7c1a87a-620a-4b0e-bf4a-610d76051525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_326f1f44-c17d-41c7-a6cc-ed9b51b47bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_326f1f44-c17d-41c7-a6cc-ed9b51b47bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_fec3920d-78a9-4e62-ba45-df212b878971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:to="loc_us-gaap_PreferredStockSharesIssued_fec3920d-78a9-4e62-ba45-df212b878971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_72863b9f-433f-45a9-80d2-4681df7f840d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_72863b9f-433f-45a9-80d2-4681df7f840d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7ff68af7-432e-4f37-a18b-03be2a7484ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7ff68af7-432e-4f37-a18b-03be2a7484ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_aaa87b75-2214-4214-a194-fd44e3279430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:to="loc_us-gaap_CommonStockSharesIssued_aaa87b75-2214-4214-a194-fd44e3279430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_bb35fdb1-c78c-43f6-88e4-539bbae7be5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_6f488211-00a0-4e99-9f11-b61543c2ac5b" xlink:to="loc_us-gaap_TreasuryStockShares_bb35fdb1-c78c-43f6-88e4-539bbae7be5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d4c0dd09-2c7a-4edd-b169-9e4ae6396087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_888872f6-c10c-46bb-8cd3-d3d6900366c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d4c0dd09-2c7a-4edd-b169-9e4ae6396087" xlink:to="loc_us-gaap_StatementTable_888872f6-c10c-46bb-8cd3-d3d6900366c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4c16b912-915a-4be8-8e71-285119e306e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_888872f6-c10c-46bb-8cd3-d3d6900366c1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4c16b912-915a-4be8-8e71-285119e306e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4c16b912-915a-4be8-8e71-285119e306e8" xlink:to="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_c6273c39-6418-488d-b63e-5187fb240fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_PreferredStockMember_c6273c39-6418-488d-b63e-5187fb240fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8002b958-bcf7-4a91-a215-a79b37ff4ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_CommonStockMember_8002b958-bcf7-4a91-a215-a79b37ff4ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_3b24deb8-a8fe-46c8-bd46-01647a2cf527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_TreasuryStockMember_3b24deb8-a8fe-46c8-bd46-01647a2cf527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_96d3f3b8-5135-411f-829a-ffb304fcabc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_96d3f3b8-5135-411f-829a-ffb304fcabc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7b070ccc-4a30-4e91-b406-e890bbb1eb44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_RetainedEarningsMember_7b070ccc-4a30-4e91-b406-e890bbb1eb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_667507aa-c2a7-4690-b4a1-95d188b4536b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_124a0e6b-3491-4494-a5c5-addf445b1262" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_667507aa-c2a7-4690-b4a1-95d188b4536b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_888872f6-c10c-46bb-8cd3-d3d6900366c1" xlink:to="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_1517a114-419e-4033-8f52-21a7af022e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_SharesIssued_1517a114-419e-4033-8f52-21a7af022e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_45593228-b5f3-4dd8-96cf-b488b4e0204c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_45593228-b5f3-4dd8-96cf-b488b4e0204c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d7cf3626-0da0-4904-b29a-e52f9e5bf571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d7cf3626-0da0-4904-b29a-e52f9e5bf571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_c846704d-7bef-4b5f-9b30-3117bce1a599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_c846704d-7bef-4b5f-9b30-3117bce1a599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_166143df-5c23-40d2-9e46-c514f250e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_166143df-5c23-40d2-9e46-c514f250e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_293627b3-a254-476c-a852-fce15468e44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_CommonStockSharesIssued_293627b3-a254-476c-a852-fce15468e44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_f410ea0f-9463-4a77-9f38-857d27b493dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_f410ea0f-9463-4a77-9f38-857d27b493dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ad2bca87-272c-4219-8ed9-9397257e2174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e102c038-08d0-4730-8205-94152c5d3066" xlink:to="loc_us-gaap_SharesIssued_ad2bca87-272c-4219-8ed9-9397257e2174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32f166cd-f9db-4a63-96cb-d539b645cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32f166cd-f9db-4a63-96cb-d539b645cd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b6ec389f-0bdf-49c7-ac88-add6e81edadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_ProfitLoss_b6ec389f-0bdf-49c7-ac88-add6e81edadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_42f263da-b033-4267-97ab-b9986ddf6d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_DividendsPreferredStockCash_42f263da-b033-4267-97ab-b9986ddf6d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc6ebb85-ff45-4509-b3ac-a61a825f9330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2666eb4a-ead4-4149-8cd7-1ff6ba179cf3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc6ebb85-ff45-4509-b3ac-a61a825f9330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_af3af76c-b074-451f-8acc-ca3139a6a022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6dbdf00d-15d5-4803-9715-391ec1e721b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_af3af76c-b074-451f-8acc-ca3139a6a022" xlink:to="loc_us-gaap_StatementTable_6dbdf00d-15d5-4803-9715-391ec1e721b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_138d9c37-d254-44a2-808d-3d84125a95dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6dbdf00d-15d5-4803-9715-391ec1e721b2" xlink:to="loc_srt_StatementScenarioAxis_138d9c37-d254-44a2-808d-3d84125a95dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9fd4612c-a53b-4f1b-b385-b2ef7460eae3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_138d9c37-d254-44a2-808d-3d84125a95dd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9fd4612c-a53b-4f1b-b385-b2ef7460eae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6dbdf00d-15d5-4803-9715-391ec1e721b2" xlink:to="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a4fa62ca-a507-4155-9409-62e19a4a2595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_ProfitLoss_a4fa62ca-a507-4155-9409-62e19a4a2595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6c0677a6-e009-48b3-89ef-dc5b3289bbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6c0677a6-e009-48b3-89ef-dc5b3289bbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_75d7c280-416f-4bec-acd7-4868803738c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_75d7c280-416f-4bec-acd7-4868803738c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_64942931-f399-441b-91a2-624cf5fe602b" xlink:href="bsx-20220630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_64942931-f399-441b-91a2-624cf5fe602b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4eea6812-667e-40fa-823c-40aea0c2e18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_ShareBasedCompensation_4eea6812-667e-40fa-823c-40aea0c2e18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7092778c-84b9-487b-800e-b299dfa3a488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_7092778c-84b9-487b-800e-b299dfa3a488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_56632b2b-14f6-4bec-becc-465a5fbfdf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_GainLossOnInvestments_56632b2b-14f6-4bec-becc-465a5fbfdf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f8a51616-2d44-4227-baa4-8fa3b33a38f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f8a51616-2d44-4227-baa4-8fa3b33a38f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_653aad5f-f621-4175-b3f6-6ba499eed16e" xlink:href="bsx-20220630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_bsx_InventoryStepUpAmortization_653aad5f-f621-4175-b3f6-6ba499eed16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1e1c91e5-febb-4133-a7bf-0bd5f2334b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1e1c91e5-febb-4133-a7bf-0bd5f2334b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_e9971997-2733-4ec7-9f4a-19e2b3798315" xlink:href="bsx-20220630.xsd#bsx_OtherNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_bsx_OtherNet_e9971997-2733-4ec7-9f4a-19e2b3798315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_59ed0315-e287-4cbd-93e3-205de204ef53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_59ed0315-e287-4cbd-93e3-205de204ef53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2c383a96-dec7-4ca3-997c-ad3cf744b417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2c383a96-dec7-4ca3-997c-ad3cf744b417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_94ebb28c-ddc6-470e-b63b-64c42b92eef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_94ebb28c-ddc6-470e-b63b-64c42b92eef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e2da3f4b-d84c-49dc-be50-af65e62034e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e2da3f4b-d84c-49dc-be50-af65e62034e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73a4dd16-b80d-4c24-bb36-add57d1b567f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1f03a8d-b47e-4453-aa98-71011b7abf98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73a4dd16-b80d-4c24-bb36-add57d1b567f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_710688f0-52a7-4e70-a791-1d6646dcb225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_710688f0-52a7-4e70-a791-1d6646dcb225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_5ac3d8f7-3aeb-46fb-907c-f88096d70187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_5ac3d8f7-3aeb-46fb-907c-f88096d70187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ef70a2c7-0916-43fb-aa2b-a4ec8e776f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ef70a2c7-0916-43fb-aa2b-a4ec8e776f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129b1fea-dc7e-4c63-810a-732351db0003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129b1fea-dc7e-4c63-810a-732351db0003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f37f772f-7796-4eee-ab9d-e1db6e7f782b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f37f772f-7796-4eee-ab9d-e1db6e7f782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ae330340-bffc-47e9-94fb-345f96bf7170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ae330340-bffc-47e9-94fb-345f96bf7170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_6c8388ce-0a44-40f7-aa94-8651774371ab" xlink:href="bsx-20220630.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_6c8388ce-0a44-40f7-aa94-8651774371ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8d9f7152-8e47-4782-b200-d04010b1a8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b706b76-0059-48bb-b61e-e29ecf8128bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8d9f7152-8e47-4782-b200-d04010b1a8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b274f1f8-6070-4857-843f-3ea1ce39073d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b274f1f8-6070-4857-843f-3ea1ce39073d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_7c27199a-448c-4d79-b345-690a754d8551" xlink:href="bsx-20220630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_bsx_PaymentsForRoyaltyRights_7c27199a-448c-4d79-b345-690a754d8551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_dadda752-9b2d-43a2-879e-fa7f6c445b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_dadda752-9b2d-43a2-879e-fa7f6c445b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_882ca6f4-874f-4e8a-b78e-f40a40adeae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_882ca6f4-874f-4e8a-b78e-f40a40adeae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_a67ccbe7-1cc8-461a-8b12-8df0133d16f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_a67ccbe7-1cc8-461a-8b12-8df0133d16f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d411ac1d-6c7f-4290-a6b7-72b4124c92bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d411ac1d-6c7f-4290-a6b7-72b4124c92bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_c50a00a6-7cbc-4cc0-bc77-3135582f625c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_PaymentsOfDividends_c50a00a6-7cbc-4cc0-bc77-3135582f625c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_f28bd74a-0e0a-4c64-ace4-d46ba4ab6234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_f28bd74a-0e0a-4c64-ace4-d46ba4ab6234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_de360e9d-5b8b-4d37-9090-503a425f0e67" xlink:href="bsx-20220630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_de360e9d-5b8b-4d37-9090-503a425f0e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_c1d144fa-20f1-4b55-9d77-a2c81b465755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_ProceedsFromStockPlans_c1d144fa-20f1-4b55-9d77-a2c81b465755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73d5ba59-07de-4f32-b937-306d3c672e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a442725-e87d-4f56-ba09-658be7884a14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73d5ba59-07de-4f32-b937-306d3c672e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc07ae76-ba5b-4e9a-b23f-c1a4524911a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc07ae76-ba5b-4e9a-b23f-c1a4524911a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f11c0294-ef12-4e97-8d2d-a86c05425323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f11c0294-ef12-4e97-8d2d-a86c05425323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87803ae6-89f1-4813-a39a-f1c7f09d39f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87803ae6-89f1-4813-a39a-f1c7f09d39f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d076c3d-3a86-4921-8381-2205a7549ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d076c3d-3a86-4921-8381-2205a7549ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb31d32-2cb8-48b4-adfe-cedd7b3e64f2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7a9d1986-984c-4f8d-a952-a605b826491d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:to="loc_us-gaap_ShareBasedCompensation_7a9d1986-984c-4f8d-a952-a605b826491d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_2e6c8582-e356-4f86-8a48-14cb3f516b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_2e6c8582-e356-4f86-8a48-14cb3f516b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_6ca5ae5c-f4ec-40ab-9bf8-3f30c461c0d1" xlink:href="bsx-20220630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_32cdc5d7-f975-4d71-99df-145222233013" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_6ca5ae5c-f4ec-40ab-9bf8-3f30c461c0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20220630.xsd#ConsolidatedStatementsofCashFlowsSupplementalDisclosure"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_d823975f-c3a2-4395-b5d5-1734a1537d57" xlink:href="bsx-20220630.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_30ba55fa-03b9-4948-b2b5-b349d25849f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_d823975f-c3a2-4395-b5d5-1734a1537d57" xlink:to="loc_us-gaap_StatementTable_30ba55fa-03b9-4948-b2b5-b349d25849f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_b1b3411f-6c59-4a17-a694-c90dd66cb836" xlink:href="bsx-20220630.xsd#bsx_StatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_30ba55fa-03b9-4948-b2b5-b349d25849f7" xlink:to="loc_bsx_StatementAxis_b1b3411f-6c59-4a17-a694-c90dd66cb836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_1d4a1242-9995-4466-9714-041e201bb000" xlink:href="bsx-20220630.xsd#bsx_StatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementAxis_b1b3411f-6c59-4a17-a694-c90dd66cb836" xlink:to="loc_bsx_StatementDomain_1d4a1242-9995-4466-9714-041e201bb000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_30ba55fa-03b9-4948-b2b5-b349d25849f7" xlink:to="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ebf06d5-0dcc-4b1c-bd96-0383330e54a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ebf06d5-0dcc-4b1c-bd96-0383330e54a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ce55c340-04cf-4d76-8fdf-eb26047f78e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ce55c340-04cf-4d76-8fdf-eb26047f78e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_d237b813-c07f-4e4c-babc-a140b49e8ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_d237b813-c07f-4e4c-babc-a140b49e8ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45f6ceb7-13aa-4235-b158-558988fef059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3045d21-d854-496f-ba8e-0baee4f8f68c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45f6ceb7-13aa-4235-b158-558988fef059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bsx-20220630.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95b4b9f-00a6-47e6-bf42-c2cfd5c22c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4b5cb5bb-9bbd-4766-9200-d653501492a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b95b4b9f-00a6-47e6-bf42-c2cfd5c22c98" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4b5cb5bb-9bbd-4766-9200-d653501492a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="simple" xlink:href="bsx-20220630.xsd#BasisofPresentationBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_61936975-bda0-46bd-a126-a032680ff5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_e4a6ce71-8893-4c30-b7ec-919f628d774f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_61936975-bda0-46bd-a126-a032680ff5c5" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_e4a6ce71-8893-4c30-b7ec-919f628d774f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#BasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6941a8c-920b-4b5d-8a09-28360d0ba34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_322fada7-9636-44f8-bf9a-a0080ca75109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6941a8c-920b-4b5d-8a09-28360d0ba34f" xlink:to="loc_us-gaap_NumberOfReportableSegments_322fada7-9636-44f8-bf9a-a0080ca75109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20220630.xsd#AcquisitionsDivestituresandStrategicInvestments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_fa921199-8008-44d4-8ad5-50cae9a8ddb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b43bbc13-bf6a-48cf-86f2-42177a8d4450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fa921199-8008-44d4-8ad5-50cae9a8ddb6" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b43bbc13-bf6a-48cf-86f2-42177a8d4450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#AcquisitionsDivestituresandStrategicInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_dce2ecca-7353-49ef-a23c-44040701a4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_dce2ecca-7353-49ef-a23c-44040701a4a4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab7d380d-9831-41d6-b283-7036665a14a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab7d380d-9831-41d6-b283-7036665a14a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab7d380d-9831-41d6-b283-7036665a14a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_77cd83c1-f2f6-4681-a2bc-180b3bc8e285" xlink:href="bsx-20220630.xsd#bsx_BaylisMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:to="loc_bsx_BaylisMedicalMember_77cd83c1-f2f6-4681-a2bc-180b3bc8e285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_9ec2ff55-4ca5-4803-927d-a911e95ff9fc" xlink:href="bsx-20220630.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b14cbe4-bff8-4b9c-b0b6-0b70e7965bbc" xlink:to="loc_bsx_PreventiceSolutionsIncMember_9ec2ff55-4ca5-4803-927d-a911e95ff9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_20bbd248-7e84-4bb7-a78f-01574ee00abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_20bbd248-7e84-4bb7-a78f-01574ee00abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ab0285df-aca8-416c-bf4b-9e833ed347ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_20bbd248-7e84-4bb7-a78f-01574ee00abd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ab0285df-aca8-416c-bf4b-9e833ed347ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_930b96f7-24ff-4046-8bfe-384d1432d1a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_srt_OwnershipAxis_930b96f7-24ff-4046-8bfe-384d1432d1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c7b201f1-ed74-4bd6-b044-bfab72e99a3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_930b96f7-24ff-4046-8bfe-384d1432d1a1" xlink:to="loc_srt_OwnershipDomain_c7b201f1-ed74-4bd6-b044-bfab72e99a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0302483a-e55d-49b5-83f6-467b03a3c66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0302483a-e55d-49b5-83f6-467b03a3c66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5032bdb1-da47-4c1b-94d4-0fd8c029d423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0302483a-e55d-49b5-83f6-467b03a3c66f" xlink:to="loc_us-gaap_ClassOfStockDomain_5032bdb1-da47-4c1b-94d4-0fd8c029d423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_847abe2d-8590-4450-8ac0-c5c9882c419a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_d22d25f4-4da0-42b2-9c31-24e1701de4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_d22d25f4-4da0-42b2-9c31-24e1701de4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7f0d2349-ca27-401e-a5bf-64e22714ebf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7f0d2349-ca27-401e-a5bf-64e22714ebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2d8aafa2-3a50-43d6-91b0-6e1d7a849971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2d8aafa2-3a50-43d6-91b0-6e1d7a849971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9705d0f1-8739-4255-bce2-415d09ca1f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9705d0f1-8739-4255-bce2-415d09ca1f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_8dde68cc-155c-409f-81f1-65fb98c1fdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_8dde68cc-155c-409f-81f1-65fb98c1fdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_1996d1d8-2b20-4727-bb53-1b165372dd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15b102f6-3852-4cea-b2c9-2c45b4f6aa1b" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_1996d1d8-2b20-4727-bb53-1b165372dd4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#AcquisitionsandDivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_29d75577-e956-4474-a826-10b956578136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_29d75577-e956-4474-a826-10b956578136" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_670c8f4f-997a-4ca0-bbd0-f2875269f8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_670c8f4f-997a-4ca0-bbd0-f2875269f8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_670c8f4f-997a-4ca0-bbd0-f2875269f8e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_979df8e7-c19a-4350-b6e1-93ced2bbef0f" xlink:href="bsx-20220630.xsd#bsx_BaylisMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_BaylisMedicalMember_979df8e7-c19a-4350-b6e1-93ced2bbef0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_11c0cc70-7c70-404c-94d6-3690f0d84c8a" xlink:href="bsx-20220630.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_PreventiceSolutionsIncMember_11c0cc70-7c70-404c-94d6-3690f0d84c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisMember_90c500f8-821b-4e7e-b6be-ff681be67c2a" xlink:href="bsx-20220630.xsd#bsx_LumenisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_LumenisMember_90c500f8-821b-4e7e-b6be-ff681be67c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MITechCoLtdMember_25498e60-7ab6-43ef-a3da-13330c3f4c30" xlink:href="bsx-20220630.xsd#bsx_MITechCoLtdMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9d966e9-5e81-4a74-baf1-3219e9aef058" xlink:to="loc_bsx_MITechCoLtdMember_25498e60-7ab6-43ef-a3da-13330c3f4c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f07bdbd0-a900-40cf-9c19-6064e8667eb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_srt_RangeAxis_f07bdbd0-a900-40cf-9c19-6064e8667eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f07bdbd0-a900-40cf-9c19-6064e8667eb7" xlink:to="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1f74a3ec-1bf8-48b5-82f8-6945da687f6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:to="loc_srt_MinimumMember_1f74a3ec-1bf8-48b5-82f8-6945da687f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0053b578-88ca-447f-b063-aebf472ae464" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:to="loc_srt_MaximumMember_0053b578-88ca-447f-b063-aebf472ae464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_036726e7-e544-4209-9e03-b776e970647e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_91614b01-bae2-4724-bf7c-948a03f075ac" xlink:to="loc_srt_WeightedAverageMember_036726e7-e544-4209-9e03-b776e970647e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0d3ef1e-bb0a-44db-8c7d-2a7cfca55249" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_75672f24-42bc-4e89-9b50-f0d6a5302e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_75672f24-42bc-4e89-9b50-f0d6a5302e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a8ff94f0-47a3-44fc-987c-6ee26d6d08a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863b4e19-adc0-4559-b013-db6dc1ba05fa" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a8ff94f0-47a3-44fc-987c-6ee26d6d08a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8ec0c376-50c4-46cd-bc43-609099588cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8ec0c376-50c4-46cd-bc43-609099588cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8ec0c376-50c4-46cd-bc43-609099588cdf" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d7af4ce7-907a-4a40-9b48-427d64b5a6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d7af4ce7-907a-4a40-9b48-427d64b5a6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9e58d14e-0694-4b65-8f47-01f4a4c7794a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3736ddc-bdf7-4ca4-8e1c-1b152bae7ba9" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9e58d14e-0694-4b65-8f47-01f4a4c7794a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b42f871a-8971-42b2-ac29-2382eca3da42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b42f871a-8971-42b2-ac29-2382eca3da42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b14e3af-046e-4f1e-9307-a30f38e6fab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b42f871a-8971-42b2-ac29-2382eca3da42" xlink:to="loc_us-gaap_SegmentDomain_1b14e3af-046e-4f1e-9307-a30f38e6fab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f6d71d6d-0e48-4f21-9cf9-50fd38974156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f6d71d6d-0e48-4f21-9cf9-50fd38974156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_230cf4f8-c14d-4da4-8ab5-c9cfc4a1c039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f6d71d6d-0e48-4f21-9cf9-50fd38974156" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_230cf4f8-c14d-4da4-8ab5-c9cfc4a1c039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_189463bf-1f7c-49e1-8679-9300d1c70cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_230cf4f8-c14d-4da4-8ab5-c9cfc4a1c039" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_189463bf-1f7c-49e1-8679-9300d1c70cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd818675-4cb6-423c-9b40-7eebf292c405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd818675-4cb6-423c-9b40-7eebf292c405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2449b65-cab5-4332-95a2-78ad41d53a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd818675-4cb6-423c-9b40-7eebf292c405" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2449b65-cab5-4332-95a2-78ad41d53a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_ecf1a14c-6a53-4ba9-85d3-f2f1da0aca70" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2449b65-cab5-4332-95a2-78ad41d53a86" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_ecf1a14c-6a53-4ba9-85d3-f2f1da0aca70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6d5f9c81-f889-44b8-aeb9-7c66d7f85298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6d5f9c81-f889-44b8-aeb9-7c66d7f85298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_de36c655-1add-42b3-bc93-db81a909f1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6d5f9c81-f889-44b8-aeb9-7c66d7f85298" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_de36c655-1add-42b3-bc93-db81a909f1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_23bcc849-cf2f-4427-99f3-5bba9dad6819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_de36c655-1add-42b3-bc93-db81a909f1b5" xlink:to="loc_us-gaap_SubsequentEventMember_23bcc849-cf2f-4427-99f3-5bba9dad6819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c6135cde-8cbb-4c40-ac31-adb3abd4b276" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_b3d647e6-20ac-4d9d-ad2a-ccd29a95ed37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_b3d647e6-20ac-4d9d-ad2a-ccd29a95ed37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinessesDivested_560307c7-479d-4741-b98b-89793fbe0e5e" xlink:href="bsx-20220630.xsd#bsx_NumberOfBusinessesDivested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_NumberOfBusinessesDivested_560307c7-479d-4741-b98b-89793fbe0e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_989ec04f-128a-4da4-9008-e13b19be3186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_989ec04f-128a-4da4-9008-e13b19be3186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_e7268b18-8f4a-4e84-b1bf-12f3f8b605e8" xlink:href="bsx-20220630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_e7268b18-8f4a-4e84-b1bf-12f3f8b605e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_20080df4-e7fe-4bc0-8a08-6d68a1bf5b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_20080df4-e7fe-4bc0-8a08-6d68a1bf5b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d34a46f6-25e3-46b4-9925-4a234cc90d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d34a46f6-25e3-46b4-9925-4a234cc90d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5fa313f9-6361-476f-bbf8-5cc6bfdcc6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5fa313f9-6361-476f-bbf8-5cc6bfdcc6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_18e748e4-c6df-41af-b131-822ba6f56548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_18e748e4-c6df-41af-b131-822ba6f56548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6dc22ea9-7c6f-4fe8-823d-76d9cda19870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6dc22ea9-7c6f-4fe8-823d-76d9cda19870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_64da5295-59d2-4b1e-9b9e-d7d9a8bd5214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_64da5295-59d2-4b1e-9b9e-d7d9a8bd5214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4401d709-a86d-473c-ba5d-fb8d16dd8f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4401d709-a86d-473c-ba5d-fb8d16dd8f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4cc27850-6829-4378-b1c9-0cc43951d86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_Goodwill_4cc27850-6829-4378-b1c9-0cc43951d86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a469aa73-0eb4-41fe-bcde-3a7d7a1c0fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a469aa73-0eb4-41fe-bcde-3a7d7a1c0fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0a4b4837-5dd5-478e-9800-2259ec48ae65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0a4b4837-5dd5-478e-9800-2259ec48ae65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_fe58765c-851e-454b-9273-3c387e763582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_fe58765c-851e-454b-9273-3c387e763582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_456de02c-ddeb-4d93-a967-89a17004c22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_456de02c-ddeb-4d93-a967-89a17004c22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7db54e2b-dbaa-47f6-a2ba-cdf435cb0933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7db54e2b-dbaa-47f6-a2ba-cdf435cb0933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_58629517-6fe8-40e3-a8bb-bcff0a509bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_58629517-6fe8-40e3-a8bb-bcff0a509bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_884cc636-8a55-4660-9bd9-f7534a318e9e" xlink:href="bsx-20220630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_DiscountRateFairValueInput_884cc636-8a55-4660-9bd9-f7534a318e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4555f593-d9f0-406c-af77-6cdd5b26550f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4555f593-d9f0-406c-af77-6cdd5b26550f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities_07497a47-0899-46e0-af31-125e628a0afc" xlink:href="bsx-20220630.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_DivestitureAgreementTransferOfFacilities_07497a47-0899-46e0-af31-125e628a0afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_a86de83d-3073-4ea2-8be6-c2fc6c212b8f" xlink:href="bsx-20220630.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_a86de83d-3073-4ea2-8be6-c2fc6c212b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f0c23799-fc4d-4e6f-adc3-eee61c9e770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f0c23799-fc4d-4e6f-adc3-eee61c9e770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_d66fd05e-b280-4afd-81b9-b069dd97184b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_d66fd05e-b280-4afd-81b9-b069dd97184b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cf1b4840-81e7-4227-990e-8a301dad8e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cf1b4840-81e7-4227-990e-8a301dad8e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_190f37a4-bc78-44cf-9376-6626af002ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4e2a7a5-7ef8-49e6-ac35-e1c71e41fba0" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_190f37a4-bc78-44cf-9376-6626af002ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#ContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_99f3d7de-63ef-457e-811a-f183d62708c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_99f3d7de-63ef-457e-811a-f183d62708c0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9b762bfd-811b-471b-a05a-b2c459e5997d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_srt_RangeAxis_9b762bfd-811b-471b-a05a-b2c459e5997d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9b762bfd-811b-471b-a05a-b2c459e5997d" xlink:to="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f4561d08-37f3-4972-9f3d-63b8ad6cff0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:to="loc_srt_MinimumMember_f4561d08-37f3-4972-9f3d-63b8ad6cff0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_56fb195d-524b-42c3-9214-5d17c7b609fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:to="loc_srt_MaximumMember_56fb195d-524b-42c3-9214-5d17c7b609fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_a8882a5c-6778-4fd8-899e-1227d6e7ac00" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2f9a3bc0-3d23-48a7-8c9e-0d8da917a187" xlink:to="loc_srt_WeightedAverageMember_a8882a5c-6778-4fd8-899e-1227d6e7ac00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_c274035e-ed93-4be5-a9e9-b2a15fda21b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_ValuationTechniqueAxis_c274035e-ed93-4be5-a9e9-b2a15fda21b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_d14cbdcb-e4f5-47b8-b167-43c64e841947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c274035e-ed93-4be5-a9e9-b2a15fda21b4" xlink:to="loc_us-gaap_ValuationTechniqueDomain_d14cbdcb-e4f5-47b8-b167-43c64e841947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_51edab90-bd58-49a5-8360-ed06416e53ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_d14cbdcb-e4f5-47b8-b167-43c64e841947" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_51edab90-bd58-49a5-8360-ed06416e53ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9dd80e40-9bae-46ed-94e0-778881b8d237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9dd80e40-9bae-46ed-94e0-778881b8d237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ab2b0f7-46a5-4de3-9856-26e30bb1c513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9dd80e40-9bae-46ed-94e0-778881b8d237" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ab2b0f7-46a5-4de3-9856-26e30bb1c513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllBusinessAcquisitionsMember_13c916d1-0cea-4ca8-a5b8-4dd796a62a85" xlink:href="bsx-20220630.xsd#bsx_AllBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ab2b0f7-46a5-4de3-9856-26e30bb1c513" xlink:to="loc_bsx_AllBusinessAcquisitionsMember_13c916d1-0cea-4ca8-a5b8-4dd796a62a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_4a7148a6-c010-4639-a559-70dcb787616d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_4a7148a6-c010-4639-a559-70dcb787616d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4a7148a6-c010-4639-a559-70dcb787616d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_414bfc9f-497e-4d39-82c6-d105d4197a70" xlink:href="bsx-20220630.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_414bfc9f-497e-4d39-82c6-d105d4197a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_a8daed79-1f1c-4106-aca1-120d5f4431e1" xlink:href="bsx-20220630.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9b053154-55c9-4efe-8a5b-a06a46a43380" xlink:to="loc_bsx_RevenueBasedPaymentsMember_a8daed79-1f1c-4106-aca1-120d5f4431e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2e9a14e5-6352-4240-8965-c36b9ec87eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2e9a14e5-6352-4240-8965-c36b9ec87eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7e799e59-67fe-4a09-8a5d-81c2c92a8a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e9a14e5-6352-4240-8965-c36b9ec87eb3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7e799e59-67fe-4a09-8a5d-81c2c92a8a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_773bc235-4b5b-4a90-8b5b-79be63bf8e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7e799e59-67fe-4a09-8a5d-81c2c92a8a66" xlink:to="loc_us-gaap_SubsequentEventMember_773bc235-4b5b-4a90-8b5b-79be63bf8e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_edca5ad4-ab81-4d6b-bd79-ab29274aa383" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2b901711-7d01-4bce-bbd6-b166ff815133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2b901711-7d01-4bce-bbd6-b166ff815133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5f7add71-593d-4950-8b13-f68c8ddf9782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5f7add71-593d-4950-8b13-f68c8ddf9782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f200dd58-5453-43cc-8efd-37646d90cf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f200dd58-5453-43cc-8efd-37646d90cf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_949db7d3-9eac-4de9-ae87-e522a3ff7328" xlink:href="bsx-20220630.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_bsx_PaymentOfContingentConsideration_949db7d3-9eac-4de9-ae87-e522a3ff7328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9d97ffe5-5757-49ac-b097-bccdcf702213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_d227e9d1-5664-49a8-93e7-e863501eef9b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9d97ffe5-5757-49ac-b097-bccdcf702213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b6eda605-466d-4258-a68a-0777952334a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b6eda605-466d-4258-a68a-0777952334a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_2677fbe8-7291-4db6-8e55-817fdf6d31c5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5ca2537c-c922-4f92-9eb1-e50ce0eaae6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5ca2537c-c922-4f92-9eb1-e50ce0eaae6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_2216c5e9-3df7-45c7-83fe-eda0bf3511d3" xlink:href="bsx-20220630.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_2216c5e9-3df7-45c7-83fe-eda0bf3511d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_7aa11ce4-b50a-4592-8c8e-18152e8f9de3" xlink:href="bsx-20220630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b949bbc4-f3cc-40d5-aec1-a27f6ab9822d" xlink:to="loc_bsx_DiscountRateFairValueInput_7aa11ce4-b50a-4592-8c8e-18152e8f9de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f9f73e4c-10df-48b0-b45b-5ee7c6c99ca2" xlink:href="bsx-20220630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0292796d-f80d-4dd5-bab5-503609d3a186" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f9f73e4c-10df-48b0-b45b-5ee7c6c99ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#StrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_39576bf6-cb6f-4114-a39c-74a2d3619c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_39576bf6-cb6f-4114-a39c-74a2d3619c37" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f5039486-34eb-4dc9-b77c-b5df41fc9bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f5039486-34eb-4dc9-b77c-b5df41fc9bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ea52d40f-df2c-4f53-a859-dd3a7b33c39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f5039486-34eb-4dc9-b77c-b5df41fc9bce" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ea52d40f-df2c-4f53-a859-dd3a7b33c39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_acae0f23-6ccc-4869-bc73-78163589c9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ea52d40f-df2c-4f53-a859-dd3a7b33c39d" xlink:to="loc_us-gaap_SubsequentEventMember_acae0f23-6ccc-4869-bc73-78163589c9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_31075f16-3884-44f6-832f-119bb10f4ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_31075f16-3884-44f6-832f-119bb10f4ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b490ca05-7333-4db9-b854-cf6cde336769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_31075f16-3884-44f6-832f-119bb10f4ae1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b490ca05-7333-4db9-b854-cf6cde336769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_8c787805-8336-4f36-a41f-546666faff84" xlink:href="bsx-20220630.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b490ca05-7333-4db9-b854-cf6cde336769" xlink:to="loc_bsx_PreventiceSolutionsIncMember_8c787805-8336-4f36-a41f-546666faff84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1c3daad9-c9f0-4525-820e-4e7dc02861b1" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b58f5869-e315-4224-b980-9abc96098a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquityMethodInvestments_b58f5869-e315-4224-b980-9abc96098a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d3eaf57a-d250-4aa3-b08d-52f795fe7197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d3eaf57a-d250-4aa3-b08d-52f795fe7197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ee40551a-7774-431a-9ddc-826d9b617cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ee40551a-7774-431a-9ddc-826d9b617cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6796a9f2-d5a2-42e5-8c34-ad80da0a586d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6796a9f2-d5a2-42e5-8c34-ad80da0a586d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_dc42cb27-2d28-494c-86f4-2cdd3a65f46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_Investments_dc42cb27-2d28-494c-86f4-2cdd3a65f46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_035c854c-3c6e-42ef-8251-87050350cc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_035c854c-3c6e-42ef-8251-87050350cc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1c236f32-b357-451b-b112-ced1c1b8b175" xlink:href="bsx-20220630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1c236f32-b357-451b-b112-ced1c1b8b175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_80474eab-a4b7-43c4-bc99-52654f2c25ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_c42ee098-3657-4d27-873b-4308aaf31e78" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_80474eab-a4b7-43c4-bc99-52654f2c25ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20220630.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43157e84-0958-4796-a26e-13873d1fcdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_db528255-06e2-4fb5-a552-c4ba2f4f1659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43157e84-0958-4796-a26e-13873d1fcdb1" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_db528255-06e2-4fb5-a552-c4ba2f4f1659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#GoodwillandOtherIntangibleAssetsGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fad3d876-cf78-4a89-8500-0ec1aab1e202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_f3b5b97c-26c7-4248-b741-2378ad86105b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fad3d876-cf78-4a89-8500-0ec1aab1e202" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_f3b5b97c-26c7-4248-b741-2378ad86105b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_a80dc58b-3730-4890-988c-54d5c991bad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fad3d876-cf78-4a89-8500-0ec1aab1e202" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_a80dc58b-3730-4890-988c-54d5c991bad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_23d14fd6-3404-4c7a-af82-a0c383c5d2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_23d14fd6-3404-4c7a-af82-a0c383c5d2c9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb63ed08-daae-489f-831b-af128c187d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb63ed08-daae-489f-831b-af128c187d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb63ed08-daae-489f-831b-af128c187d50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00aab881-8938-4a60-aecd-b61aab4b2347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00aab881-8938-4a60-aecd-b61aab4b2347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_2f5d20f5-39ec-40a8-9de1-a49e72a6f261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:to="loc_us-gaap_PatentsMember_2f5d20f5-39ec-40a8-9de1-a49e72a6f261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a930fca7-5d9b-4f84-9e75-414a6f507584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e44537e-7438-4dae-98e8-921b48b77524" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a930fca7-5d9b-4f84-9e75-414a6f507584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dcfda880-5a96-4b9a-b962-0f3b50fb81b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dcfda880-5a96-4b9a-b962-0f3b50fb81b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dcfda880-5a96-4b9a-b962-0f3b50fb81b7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_b2df8654-99df-4b25-a066-44896309c8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:to="loc_us-gaap_GoodwillMember_b2df8654-99df-4b25-a066-44896309c8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d3ef402b-ade0-4219-8a64-20675381ed77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d3ef402b-ade0-4219-8a64-20675381ed77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f8336dd7-c669-413c-a44c-053f17148fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_47eeefde-3671-4c63-af0c-42aef19907b5" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f8336dd7-c669-413c-a44c-053f17148fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a75a733a-2ec8-4cb9-af22-174078e15a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a75a733a-2ec8-4cb9-af22-174078e15a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a75a733a-2ec8-4cb9-af22-174078e15a05" xlink:to="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_fd44832f-b68e-47b8-9a08-a0e561ea388f" xlink:href="bsx-20220630.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:to="loc_bsx_MedsurgMember_fd44832f-b68e-47b8-9a08-a0e561ea388f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_cc664006-3d04-4016-80ce-0f09166bf344" xlink:href="bsx-20220630.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cda62a7c-7197-4b4a-b099-cf8926e01958" xlink:to="loc_bsx_CardiovascularMember_cc664006-3d04-4016-80ce-0f09166bf344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:href="bsx-20220630.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_833616dc-6474-43af-bf63-55643edc8fae" xlink:to="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_322d86c4-df3f-468c-9c91-e884062ff8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_322d86c4-df3f-468c-9c91-e884062ff8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2697b3c1-59c6-4b9e-8059-c8ace9731f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2697b3c1-59c6-4b9e-8059-c8ace9731f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_76323445-fcf5-49f1-9e3f-f971341fd30c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_GoodwillGross_76323445-fcf5-49f1-9e3f-f971341fd30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_078c4d46-820c-478a-b5f9-782359b65dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_078c4d46-820c-478a-b5f9-782359b65dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae387bb1-59c9-41c2-9998-0abc01fb83bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ae387bb1-59c9-41c2-9998-0abc01fb83bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2227b169-d950-487e-9561-c5a33f11aeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2227b169-d950-487e-9561-c5a33f11aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e1f935fc-cd7c-4c28-b43b-04851466e485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:to="loc_us-gaap_Goodwill_e1f935fc-cd7c-4c28-b43b-04851466e485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7ca311d9-487e-4814-aa1d-96a2f6413e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7ca311d9-487e-4814-aa1d-96a2f6413e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_418ea8a6-cde4-4e74-823c-54509c267a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_418ea8a6-cde4-4e74-823c-54509c267a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7cb2cdd1-a14c-4513-8905-b9ba21187130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_40e8fb4d-e304-473d-a70a-477ec748148a" xlink:to="loc_us-gaap_Goodwill_7cb2cdd1-a14c-4513-8905-b9ba21187130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_0ad798e9-a024-4f5f-9c68-90a490ee75cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_e25fe118-318f-4d19-afd1-59c89c579be9" xlink:to="loc_us-gaap_NumberOfReportableSegments_0ad798e9-a024-4f5f-9c68-90a490ee75cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20220630.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b21aeaff-f336-400e-ad81-1d269e4060c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2fe55938-04b3-438a-a873-aa79519a8fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b21aeaff-f336-400e-ad81-1d269e4060c3" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_2fe55938-04b3-438a-a873-aa79519a8fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_f1eb02cb-b277-47c4-8b86-1867308a3ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2fe55938-04b3-438a-a873-aa79519a8fae" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_f1eb02cb-b277-47c4-8b86-1867308a3ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="bsx-20220630.xsd#FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ee33ee59-d7f1-4196-94fd-d4378d6f614c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_984d915f-08e4-4c0b-ab79-c9320aed68c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ee33ee59-d7f1-4196-94fd-d4378d6f614c" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_984d915f-08e4-4c0b-ab79-c9320aed68c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_58c2e732-6497-4bb3-98f9-3634039dc964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_10bf22a1-e40d-4873-8a5a-48ca05aeb3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_58c2e732-6497-4bb3-98f9-3634039dc964" xlink:to="loc_us-gaap_DerivativeTable_10bf22a1-e40d-4873-8a5a-48ca05aeb3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d14b2556-bfed-454a-a5f3-b532d1c2adc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_10bf22a1-e40d-4873-8a5a-48ca05aeb3de" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d14b2556-bfed-454a-a5f3-b532d1c2adc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4607ab05-5597-4837-a945-baa824ea602f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d14b2556-bfed-454a-a5f3-b532d1c2adc2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4607ab05-5597-4837-a945-baa824ea602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_10bf22a1-e40d-4873-8a5a-48ca05aeb3de" xlink:to="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_f50df68b-7f7e-47b0-a5b6-524a50884931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_f50df68b-7f7e-47b0-a5b6-524a50884931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e46416ea-4241-4289-8125-1a8a38f1fcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e46416ea-4241-4289-8125-1a8a38f1fcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_aa317fee-4acd-4eb2-a652-b0261adad1cb" xlink:href="bsx-20220630.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_aa317fee-4acd-4eb2-a652-b0261adad1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_22798faf-28dd-42db-9917-236f2f2bb42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_22798faf-28dd-42db-9917-236f2f2bb42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_ce92cc75-260d-43e2-9ba2-063502166192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e4ccb975-f25b-4ed0-b4dd-4ccaa72fa8f5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_ce92cc75-260d-43e2-9ba2-063502166192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_af9b4221-f4eb-4f7c-bd6e-3007f2273466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_58c2e732-6497-4bb3-98f9-3634039dc964" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_af9b4221-f4eb-4f7c-bd6e-3007f2273466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_af9b4221-f4eb-4f7c-bd6e-3007f2273466" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fd978629-06a2-40de-adf6-fe94103d5275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fd978629-06a2-40de-adf6-fe94103d5275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_eae58c7d-670e-4dbd-b0d8-28ba30f0f0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fd978629-06a2-40de-adf6-fe94103d5275" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_eae58c7d-670e-4dbd-b0d8-28ba30f0f0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c3179b4-9bdb-45bf-ad21-331b2804002e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e86f31e2-ed06-4dd4-8c68-01cb00b8dcca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c3179b4-9bdb-45bf-ad21-331b2804002e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_659e5500-18af-4f83-9c1a-d902dbc5bf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0cd5f9d4-fc05-48dd-b3af-063c9851db73" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_659e5500-18af-4f83-9c1a-d902dbc5bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_50e243de-1d7e-4d70-9235-f4aa64537229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_659e5500-18af-4f83-9c1a-d902dbc5bf96" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_50e243de-1d7e-4d70-9235-f4aa64537229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f80e99ef-43ca-4840-a4df-24d9e408197d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f80e99ef-43ca-4840-a4df-24d9e408197d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_91f346af-ec98-4cdc-87fb-d6432a5ed305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_91f346af-ec98-4cdc-87fb-d6432a5ed305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_91f346af-ec98-4cdc-87fb-d6432a5ed305" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2250acbf-d33b-417e-8a5c-3c4029d44d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:to="loc_us-gaap_CashFlowHedgingMember_2250acbf-d33b-417e-8a5c-3c4029d44d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9d76a661-f2c0-45bf-acfe-4652f87df536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4386614f-a1ea-4458-90b2-eebda9b67304" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9d76a661-f2c0-45bf-acfe-4652f87df536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_40088d6d-63e8-4988-b006-2c6963c80019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_HedgingDesignationAxis_40088d6d-63e8-4988-b006-2c6963c80019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_40088d6d-63e8-4988-b006-2c6963c80019" xlink:to="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9859460e-06a2-4c60-a7a6-37e5eb788413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9859460e-06a2-4c60-a7a6-37e5eb788413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a85e79de-d58d-4857-91c8-4c7161b8fa54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2d04f498-2593-46d8-bc1d-ce865d4818bb" xlink:to="loc_us-gaap_NondesignatedMember_a85e79de-d58d-4857-91c8-4c7161b8fa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_38df7f68-338c-4a17-b315-6da05eeecbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_38df7f68-338c-4a17-b315-6da05eeecbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38df7f68-338c-4a17-b315-6da05eeecbb5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_c6205103-b6a7-4377-9ba3-8f866eddfcae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_c6205103-b6a7-4377-9ba3-8f866eddfcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0d9e31fe-abdb-4dc8-8aef-f6e3f7334765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0d9e31fe-abdb-4dc8-8aef-f6e3f7334765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_9cc251e4-e93c-4780-b5a1-4a690cbb7ea0" xlink:href="bsx-20220630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_9cc251e4-e93c-4780-b5a1-4a690cbb7ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_476b8e59-8095-4d95-8ee7-c7fe08032e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_InterestRateContractMember_476b8e59-8095-4d95-8ee7-c7fe08032e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e444fed3-bbe7-4a12-a83e-d2d080150dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ffabbe1-a473-4927-81ce-591f3a6b1b7f" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e444fed3-bbe7-4a12-a83e-d2d080150dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c659c154-06e6-4ff2-8d41-90b31dc37219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c659c154-06e6-4ff2-8d41-90b31dc37219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c659c154-06e6-4ff2-8d41-90b31dc37219" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_527cbbd9-acec-4bb9-b95f-2296d87190b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_527cbbd9-acec-4bb9-b95f-2296d87190b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_90219db0-e61b-47cf-8304-ec23b46e5403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_90219db0-e61b-47cf-8304-ec23b46e5403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a270649a-7677-43ae-aab7-52a43317fd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a270649a-7677-43ae-aab7-52a43317fd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f01dcdcf-f02e-479a-bffb-e22495a9bb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_465c2533-9bef-44f6-99a7-27d9919036e9" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f01dcdcf-f02e-479a-bffb-e22495a9bb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2b51af03-5d59-4353-b171-825169d9a315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2b51af03-5d59-4353-b171-825169d9a315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2b51af03-5d59-4353-b171-825169d9a315" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9093369f-0bf4-4468-be4f-676802756932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:to="loc_us-gaap_CostOfSalesMember_9093369f-0bf4-4468-be4f-676802756932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_95c293df-1cbb-47b4-aa0e-f9ce15f1aaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:to="loc_us-gaap_InterestExpenseMember_95c293df-1cbb-47b4-aa0e-f9ce15f1aaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b49a55ec-4ca2-460f-9e15-e20f13dfe257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2d1d484c-0521-44d9-88e4-9f8061165fde" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b49a55ec-4ca2-460f-9e15-e20f13dfe257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_95a7c94e-e3ce-47ae-a895-2f5deeca1023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_95a7c94e-e3ce-47ae-a895-2f5deeca1023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7e38988d-bb65-4754-b4c4-327273ea4eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95a7c94e-e3ce-47ae-a895-2f5deeca1023" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7e38988d-bb65-4754-b4c4-327273ea4eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_5e3b09b9-61cf-45a3-abf3-34e3087c92bd" xlink:href="bsx-20220630.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e38988d-bb65-4754-b4c4-327273ea4eb6" xlink:to="loc_bsx_December2027NotesMember_5e3b09b9-61cf-45a3-abf3-34e3087c92bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_494016f2-8cdb-4efc-8c18-1bcff594d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_26d787c1-5c99-4ed4-8f87-7bb738fb2bf0" xlink:to="loc_us-gaap_EquityComponentDomain_494016f2-8cdb-4efc-8c18-1bcff594d47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_474da03a-6d0d-43de-81b2-41805d38b51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_494016f2-8cdb-4efc-8c18-1bcff594d47d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_474da03a-6d0d-43de-81b2-41805d38b51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6f745d95-bbe1-42f2-9bc3-ec9aabf66083" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_00f88642-fca5-4f3f-aca4-c39af5750f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_LongTermDebt_00f88642-fca5-4f3f-aca4-c39af5750f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b037bd5b-0543-4036-a5ba-aceaa99f37f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b037bd5b-0543-4036-a5ba-aceaa99f37f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_e2ecdb05-c6a8-4e3f-8e5b-1dddb691787d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeTermOfContract_e2ecdb05-c6a8-4e3f-8e5b-1dddb691787d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_b71d45e3-1123-483e-a420-30aef0d34d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_b71d45e3-1123-483e-a420-30aef0d34d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_0e6ca2c9-90fc-4dd0-a714-b4e5a2a5fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_0e6ca2c9-90fc-4dd0-a714-b4e5a2a5fba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_843843b1-44d6-4e26-92c3-8fe84238bbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeNotionalAmount_843843b1-44d6-4e26-92c3-8fe84238bbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_871f0b3e-2a01-467f-b08f-ce518571c484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_871f0b3e-2a01-467f-b08f-ce518571c484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_dd8dd4ac-c500-46ce-a95a-5133f4f02259" xlink:href="bsx-20220630.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_dd8dd4ac-c500-46ce-a95a-5133f4f02259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_87dd1149-c0ae-40e6-83eb-26ffea295ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_87dd1149-c0ae-40e6-83eb-26ffea295ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c33a28a3-49eb-4cf6-89e8-1ef693e8c6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c33a28a3-49eb-4cf6-89e8-1ef693e8c6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_0e820a9f-ebfa-4b4f-9c2c-e7fab8706f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_0e820a9f-ebfa-4b4f-9c2c-e7fab8706f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_56650400-8204-4ad8-8f0e-d31872e12ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_56650400-8204-4ad8-8f0e-d31872e12ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_95e0a329-af32-4342-a3f9-98b06b035c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_95e0a329-af32-4342-a3f9-98b06b035c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3523be97-a05a-4823-841e-286747e422bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3523be97-a05a-4823-841e-286747e422bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_3f6daf23-0166-4e7b-a136-78fb1fe4be09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_3f6daf23-0166-4e7b-a136-78fb1fe4be09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2f85e4dc-f37c-4786-88d4-b48567f8d60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2f85e4dc-f37c-4786-88d4-b48567f8d60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9aba3fa6-ecee-4704-a6fe-9f1c3922dc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9aba3fa6-ecee-4704-a6fe-9f1c3922dc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0672bd6-6097-4d93-9f02-3d4b80041402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0672bd6-6097-4d93-9f02-3d4b80041402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_52beee63-d606-4065-be4a-d618e88168e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_52beee63-d606-4065-be4a-d618e88168e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1b44f74b-8382-49b6-b5ac-4585d7e73747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_InterestExpense_1b44f74b-8382-49b6-b5ac-4585d7e73747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_72359c66-4325-4f70-8f99-541d53629553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_72359c66-4325-4f70-8f99-541d53629553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_63189602-cd7e-4ded-bd1f-ae1d7d77163f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_63189602-cd7e-4ded-bd1f-ae1d7d77163f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_1a42252e-8f5d-474b-bcd3-ffc0c2ab3755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_1a42252e-8f5d-474b-bcd3-ffc0c2ab3755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_0368e32b-0a80-43fc-8014-ed227cc96590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_0368e32b-0a80-43fc-8014-ed227cc96590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5a395d82-87cf-44e7-9790-c5177ca0a0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5a395d82-87cf-44e7-9790-c5177ca0a0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_63a571ac-6fd7-4c14-9dd7-0b43eaec57ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_63a571ac-6fd7-4c14-9dd7-0b43eaec57ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_142f1a1a-a12b-4894-b1c5-c06d5ac3ae15" xlink:href="bsx-20220630.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_142f1a1a-a12b-4894-b1c5-c06d5ac3ae15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fbdb9c50-0d42-440b-9ecc-8562d9f5570f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fbdb9c50-0d42-440b-9ecc-8562d9f5570f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_409e1734-086a-4a02-9ca0-9946d217bcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_409e1734-086a-4a02-9ca0-9946d217bcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_5d5ee7ab-b667-4e46-9af3-d9b150a33263" xlink:href="bsx-20220630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_bsx_Netcurrencyexchangegainloss_5d5ee7ab-b667-4e46-9af3-d9b150a33263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_61b0d26d-6eec-4dfc-b1b2-f7a75b927dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_61b0d26d-6eec-4dfc-b1b2-f7a75b927dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_bb66e748-c0d3-498a-929f-f3d941ac9fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_bb66e748-c0d3-498a-929f-f3d941ac9fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c01ff0c6-a471-44f3-83b0-ee535438b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c01ff0c6-a471-44f3-83b0-ee535438b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b20043b9-a543-4d39-ae5c-7d2ab093e75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b20043b9-a543-4d39-ae5c-7d2ab093e75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_db99b908-6be9-4d8c-92cb-804871dd3e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_db99b908-6be9-4d8c-92cb-804871dd3e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42558274-ff7e-46fb-a019-e551a8775cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1e2838ae-1ad5-48c7-bafa-5a279dbb9a13" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42558274-ff7e-46fb-a019-e551a8775cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f80e99ef-43ca-4840-a4df-24d9e408197d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_359edc71-d6e3-42eb-9592-9a01529dc85e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_srt_RangeAxis_359edc71-d6e3-42eb-9592-9a01529dc85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_359edc71-d6e3-42eb-9592-9a01529dc85e" xlink:to="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_b0f76f9c-add5-485f-bc83-654563bc712e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:to="loc_srt_WeightedAverageMember_b0f76f9c-add5-485f-bc83-654563bc712e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cfecc3e4-ea5d-48d5-981d-c1c903e93eee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:to="loc_srt_MinimumMember_cfecc3e4-ea5d-48d5-981d-c1c903e93eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d9386ad8-6750-47d8-96de-cda02e75d3ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_44f6099d-bb9b-4b34-b6f4-c388851266d6" xlink:to="loc_srt_MaximumMember_d9386ad8-6750-47d8-96de-cda02e75d3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_746c134e-c121-4854-88bd-cafdd16a2b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_746c134e-c121-4854-88bd-cafdd16a2b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_466741c4-ce10-4145-8fdd-6eb4e7346c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_746c134e-c121-4854-88bd-cafdd16a2b0e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_466741c4-ce10-4145-8fdd-6eb4e7346c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6c497352-3b9a-4b4d-af8f-8680a1189228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_466741c4-ce10-4145-8fdd-6eb4e7346c49" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6c497352-3b9a-4b4d-af8f-8680a1189228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b68518b0-8bd6-4897-87ed-66e9710cb62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b68518b0-8bd6-4897-87ed-66e9710cb62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b68518b0-8bd6-4897-87ed-66e9710cb62b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1faad1ba-d15f-48dd-8ac2-3916efb88a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1faad1ba-d15f-48dd-8ac2-3916efb88a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1d66f379-325b-427e-a795-aaef19a2db91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1d66f379-325b-427e-a795-aaef19a2db91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d5d341ad-e98e-4bb6-b847-5bc9eebc6351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6ca6dc-463b-4b44-b19c-ce200efd4545" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d5d341ad-e98e-4bb6-b847-5bc9eebc6351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6ef4a1d9-5ed3-4be4-a5a3-e4b87b9b650c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_51dbea48-0c6b-48af-a6da-57e2954ef722" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:to="loc_bsx_LicensingarrangementassetsMember_51dbea48-0c6b-48af-a6da-57e2954ef722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_732919b6-c8c7-4a3c-8eb8-94c6f475bbe2" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ca66c8c-1c1a-492e-8f0b-5d22fbea6ee3" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_732919b6-c8c7-4a3c-8eb8-94c6f475bbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f3aca658-b8a6-4f71-85c7-4ac121d9048f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_8f16fba1-7ab9-4d99-ad7e-66d73e5985b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_8f16fba1-7ab9-4d99-ad7e-66d73e5985b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cf23d1d2-65d7-4a28-9eb6-5ecb47f7c900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cf23d1d2-65d7-4a28-9eb6-5ecb47f7c900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d6a9fef1-405f-4f61-832b-e1a795199ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_DerivativeAssets_d6a9fef1-405f-4f61-832b-e1a795199ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_1a1cf4d1-7c23-4f37-98a1-6568ebbd256b" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_Licensingarrangementsasset_1a1cf4d1-7c23-4f37-98a1-6568ebbd256b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_fdbc61de-b4af-46e3-b658-54e5f3a54ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_fdbc61de-b4af-46e3-b658-54e5f3a54ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_c285a24a-6d93-4f9b-9b80-008f4f5decc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_DerivativeLiabilities_c285a24a-6d93-4f9b-9b80-008f4f5decc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b3ce075f-f9c6-41a6-9b31-377b967f183a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b3ce075f-f9c6-41a6-9b31-377b967f183a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_a7c80f6d-f62f-4409-bb15-de18d7f4ab5b" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_Licensingarrangementsliability_a7c80f6d-f62f-4409-bb15-de18d7f4ab5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_38a1a0f9-5021-47a6-a19b-a66bf76345b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_PaymentsForRoyalties_38a1a0f9-5021-47a6-a19b-a66bf76345b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8db7cdab-371e-4a1b-a851-9ef11418edfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8db7cdab-371e-4a1b-a851-9ef11418edfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_7b0913ea-b027-4ac2-94db-2d0d877f6637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_Cash_7b0913ea-b027-4ac2-94db-2d0d877f6637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_0233c58b-79c7-4ed4-9cec-0059b9dd1b1a" xlink:href="bsx-20220630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_DiscountRateFairValueInput_0233c58b-79c7-4ed4-9cec-0059b9dd1b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_e6ec5cd8-ba39-4ded-bd95-78706529b0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_e6ec5cd8-ba39-4ded-bd95-78706529b0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_5d387ec9-3500-45e6-908b-dd8cbd2e3051" xlink:href="bsx-20220630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_5d387ec9-3500-45e6-908b-dd8cbd2e3051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_9c713528-1cc3-485d-9a2f-842c1b97877c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_9c713528-1cc3-485d-9a2f-842c1b97877c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_3428dcf4-fe88-45b8-9512-5b715e1d876c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97c5836b-3645-45c5-b050-d1c674e193e6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_3428dcf4-fe88-45b8-9512-5b715e1d876c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20220630.xsd#ContractualObligationsandCommitments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e6f96112-8d28-48ea-8c48-d6d55a98dd27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_4a87722c-31c0-4a1d-a125-971d681245a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6f96112-8d28-48ea-8c48-d6d55a98dd27" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_4a87722c-31c0-4a1d-a125-971d681245a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_502b110c-7e40-4959-800b-38a4c1d371af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_502b110c-7e40-4959-800b-38a4c1d371af" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ea9101cb-1508-4bef-80cc-6799828b5678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bb5c9515-f3dc-4f2f-b50e-86f72048fdc3" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ea9101cb-1508-4bef-80cc-6799828b5678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_64992191-90d5-4106-ab2b-feccd6571fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ea9101cb-1508-4bef-80cc-6799828b5678" xlink:to="loc_us-gaap_CommercialPaperMember_64992191-90d5-4106-ab2b-feccd6571fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1bf24019-4317-4533-a26b-f16e8d941a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:to="loc_us-gaap_DebtInstrumentAxis_1bf24019-4317-4533-a26b-f16e8d941a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_28454c50-3eeb-4447-ba27-cdd9188e7bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1bf24019-4317-4533-a26b-f16e8d941a01" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_28454c50-3eeb-4447-ba27-cdd9188e7bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_d10df047-fdda-45f8-bd7f-9113ffc9315f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b3ab6e21-65a6-43ef-acff-fb4ca38b7b9f" xlink:to="loc_us-gaap_ShortTermDebtLineItems_d10df047-fdda-45f8-bd7f-9113ffc9315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_427fe555-c8cd-4297-aa7e-53dcfff60068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d10df047-fdda-45f8-bd7f-9113ffc9315f" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_427fe555-c8cd-4297-aa7e-53dcfff60068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9ef02583-6322-4ebf-9dc9-2310017ac32f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_502b110c-7e40-4959-800b-38a4c1d371af" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9ef02583-6322-4ebf-9dc9-2310017ac32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_20ac989b-3d17-47c3-9e95-0c4ac81485a9" xlink:href="bsx-20220630.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_502b110c-7e40-4959-800b-38a4c1d371af" xlink:to="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_20ac989b-3d17-47c3-9e95-0c4ac81485a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_0efd63c8-74ba-404b-8196-1ce58866b5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_502b110c-7e40-4959-800b-38a4c1d371af" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_0efd63c8-74ba-404b-8196-1ce58866b5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c44101c2-7b4d-4b2b-8f2b-0b9085a89e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c44101c2-7b4d-4b2b-8f2b-0b9085a89e9b" xlink:to="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c5784bbe-b378-4806-aef8-eed6eb866e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_DebtInstrumentAxis_c5784bbe-b378-4806-aef8-eed6eb866e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5784bbe-b378-4806-aef8-eed6eb866e6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member_07c11144-df10-45b4-a664-194057412ef8" xlink:href="bsx-20220630.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_RevolvingCreditFacility2021Member_07c11144-df10-45b4-a664-194057412ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_0b64ca7a-3692-464c-b400-ca56a93f6d5d" xlink:href="bsx-20220630.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_0b64ca7a-3692-464c-b400-ca56a93f6d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_e8eb97ec-06fa-4b33-94ca-32f92e039829" xlink:href="bsx-20220630.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_e8eb97ec-06fa-4b33-94ca-32f92e039829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_2a2ed82b-9988-433e-9b1d-0fe5ee1a4c47" xlink:href="bsx-20220630.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_babd6f7a-5ea8-4026-b82a-783627079f72" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_2a2ed82b-9988-433e-9b1d-0fe5ee1a4c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ab12ad4-e2d1-4df0-b11e-968a202f99d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ab12ad4-e2d1-4df0-b11e-968a202f99d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ab12ad4-e2d1-4df0-b11e-968a202f99d1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_20dab163-dc67-48a6-9ed6-feabdd503d0f" xlink:href="bsx-20220630.xsd#bsx_May2022NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_May2022NotesMember_20dab163-dc67-48a6-9ed6-feabdd503d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_33034baf-1acd-46a9-a0df-c9c2ca7ebd1f" xlink:href="bsx-20220630.xsd#bsx_October2023NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_October2023NotesMember_33034baf-1acd-46a9-a0df-c9c2ca7ebd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_d7e7ab94-fa4b-4f5b-99b0-82b956945dac" xlink:href="bsx-20220630.xsd#bsx_March2024NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2024NotesMember_d7e7ab94-fa4b-4f5b-99b0-82b956945dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_3ec344f6-330b-4319-8b0b-69e1550ecac1" xlink:href="bsx-20220630.xsd#bsx_May2025NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_May2025NotesMember_3ec344f6-330b-4319-8b0b-69e1550ecac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_e3526741-c1d0-4d33-892f-eb8bd53c7714" xlink:href="bsx-20220630.xsd#bsx_June2025NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_June2025NotesMember_e3526741-c1d0-4d33-892f-eb8bd53c7714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_bfae3c78-c7ca-49b2-b784-c585656e7f6d" xlink:href="bsx-20220630.xsd#bsx_March2026NotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2026NotesMember_bfae3c78-c7ca-49b2-b784-c585656e7f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_0b4902e0-32be-4f04-8461-de269a915cac" xlink:href="bsx-20220630.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_December2027NotesMember_0b4902e0-32be-4f04-8461-de269a915cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_3222fc6d-9b97-412f-b774-d2c2a0729829" xlink:href="bsx-20220630.xsd#bsx_March2028NotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2028NotesMember_3222fc6d-9b97-412f-b774-d2c2a0729829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_b1e42f79-6483-4b74-9a7f-81f18a71c734" xlink:href="bsx-20220630.xsd#bsx_March2029NotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2029NotesMember_b1e42f79-6483-4b74-9a7f-81f18a71c734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_c35784c8-aee5-40d4-8753-2727f50a2ace" xlink:href="bsx-20220630.xsd#bsx_June2030NotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_June2030NotesMember_c35784c8-aee5-40d4-8753-2727f50a2ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_4f5be227-1f7c-42e6-b3c2-2c765d0f2e6f" xlink:href="bsx-20220630.xsd#bsx_November2035NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_November2035NotesMember_4f5be227-1f7c-42e6-b3c2-2c765d0f2e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_0302b811-5800-4194-b40a-44a702f1c3c6" xlink:href="bsx-20220630.xsd#bsx_March2039NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2039NotesMember_0302b811-5800-4194-b40a-44a702f1c3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_59b4a131-f53c-4b55-934f-3bb116b9ade9" xlink:href="bsx-20220630.xsd#bsx_January2040NotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_January2040NotesMember_59b4a131-f53c-4b55-934f-3bb116b9ade9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_5d4c0621-a724-41d6-bb96-585070f09288" xlink:href="bsx-20220630.xsd#bsx_March2049NotesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2049NotesMember_5d4c0621-a724-41d6-bb96-585070f09288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_a7bf6515-57e5-4090-8ddf-8d9dbad4bebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_SeniorNotesMember_a7bf6515-57e5-4090-8ddf-8d9dbad4bebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b0ca76d5-d5d7-4757-9f58-8470ebe4668f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_InterestRateSwapMember_b0ca76d5-d5d7-4757-9f58-8470ebe4668f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_0c1975d7-c253-47c7-a50a-fd55b55806bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_0c1975d7-c253-47c7-a50a-fd55b55806bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9e9e6006-882f-400a-8e49-02ded408caa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_us-gaap_LineOfCreditMember_9e9e6006-882f-400a-8e49-02ded408caa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2025NotesMember_b5182086-d840-4ac9-8d2d-bdca96a740ec" xlink:href="bsx-20220630.xsd#bsx_March2025NotesMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2025NotesMember_b5182086-d840-4ac9-8d2d-bdca96a740ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028SeniorNotesMember_aff0244e-4bdc-438e-b1a9-47be44d96635" xlink:href="bsx-20220630.xsd#bsx_March2028SeniorNotesMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2028SeniorNotesMember_aff0244e-4bdc-438e-b1a9-47be44d96635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2031NotesMember_5c06019f-e3c1-4f2b-bdb1-8873738add18" xlink:href="bsx-20220630.xsd#bsx_March2031NotesMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2031NotesMember_5c06019f-e3c1-4f2b-bdb1-8873738add18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2034NotesMember_ba8350ee-260a-4649-aac6-08982e97f691" xlink:href="bsx-20220630.xsd#bsx_March2034NotesMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_March2034NotesMember_ba8350ee-260a-4649-aac6-08982e97f691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingAggregatePrincipalAmountMember_1da82900-3a4d-4348-9d48-a4b77860ad12" xlink:href="bsx-20220630.xsd#bsx_TheOfferingAggregatePrincipalAmountMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_TheOfferingAggregatePrincipalAmountMember_1da82900-3a4d-4348-9d48-a4b77860ad12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_870765e9-42b7-47cc-b77a-69bfc007f9a1" xlink:href="bsx-20220630.xsd#bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98f40dc2-2cef-4c9a-9f45-b39ddbead872" xlink:to="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_870765e9-42b7-47cc-b77a-69bfc007f9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_af97f9e8-5cd8-4470-afdd-390f12454e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_af97f9e8-5cd8-4470-afdd-390f12454e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_423e5659-c72b-4c3a-a486-4b5b0899eb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_af97f9e8-5cd8-4470-afdd-390f12454e31" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_423e5659-c72b-4c3a-a486-4b5b0899eb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_6032ab7f-380d-438e-9750-60eff9ea422b" xlink:href="bsx-20220630.xsd#bsx_The2018FacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_423e5659-c72b-4c3a-a486-4b5b0899eb7a" xlink:to="loc_bsx_The2018FacilityDomain_6032ab7f-380d-438e-9750-60eff9ea422b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1d2170ed-9910-495c-8e1c-ab1f9084480a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_CreditFacilityAxis_1d2170ed-9910-495c-8e1c-ab1f9084480a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cccc2e7c-a821-4a86-bc47-4a2aa9ccfc25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1d2170ed-9910-495c-8e1c-ab1f9084480a" xlink:to="loc_us-gaap_CreditFacilityDomain_cccc2e7c-a821-4a86-bc47-4a2aa9ccfc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5e95926a-c2b4-4a16-920b-cfa3b51c0070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cccc2e7c-a821-4a86-bc47-4a2aa9ccfc25" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5e95926a-c2b4-4a16-920b-cfa3b51c0070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_b83a8035-1524-4a5e-abe0-4ab760630acb" xlink:href="bsx-20220630.xsd#bsx_CovenantAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_bsx_CovenantAxis_b83a8035-1524-4a5e-abe0-4ab760630acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:href="bsx-20220630.xsd#bsx_CovenantDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantAxis_b83a8035-1524-4a5e-abe0-4ab760630acb" xlink:to="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_eb502928-b431-4389-90e8-8d4a8d5aee09" xlink:href="bsx-20220630.xsd#bsx_CurrentRequirementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_CurrentRequirementMember_eb502928-b431-4389-90e8-8d4a8d5aee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_621f8277-0817-457c-878d-54993ee0dee6" xlink:href="bsx-20220630.xsd#bsx_ActualCovenantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_ActualCovenantMember_621f8277-0817-457c-878d-54993ee0dee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_e2ab5531-64c1-45a4-9842-bc4502a2a823" xlink:href="bsx-20220630.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_e2ab5531-64c1-45a4-9842-bc4502a2a823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_ef0d45e8-075e-445f-b9a0-43d2816f1ced" xlink:href="bsx-20220630.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_ef0d45e8-075e-445f-b9a0-43d2816f1ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_0b391dd9-9647-408d-add2-f0cfaefe3e22" xlink:href="bsx-20220630.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_0b391dd9-9647-408d-add2-f0cfaefe3e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_374d63c3-46e4-417f-a274-dd133526ca4f" xlink:href="bsx-20220630.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_374d63c3-46e4-417f-a274-dd133526ca4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_50b3a7ea-8124-4fca-a6e1-d966ef429761" xlink:href="bsx-20220630.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_50b3a7ea-8124-4fca-a6e1-d966ef429761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_736b8cc9-3348-4aff-90fd-dcf95332463c" xlink:href="bsx-20220630.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_b8c72460-e982-465c-9902-ca3006e8fb11" xlink:to="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_736b8cc9-3348-4aff-90fd-dcf95332463c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1066abae-e2f1-475e-826e-8f54ba6f53e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1066abae-e2f1-475e-826e-8f54ba6f53e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1066abae-e2f1-475e-826e-8f54ba6f53e4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d99251f0-0f81-4ea2-99f8-ba8486c3678a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:to="loc_us-gaap_CommercialPaperMember_d99251f0-0f81-4ea2-99f8-ba8486c3678a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_4a93c5ab-3db8-46f4-b54f-30ac1338bd6e" xlink:href="bsx-20220630.xsd#bsx_May2022NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_84937cb7-610f-49ff-bf3f-3bf0d209b910" xlink:to="loc_bsx_May2022NotesMember_4a93c5ab-3db8-46f4-b54f-30ac1338bd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a5d88009-d81c-4b98-b89d-2226122fc31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a5d88009-d81c-4b98-b89d-2226122fc31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5d88009-d81c-4b98-b89d-2226122fc31f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_3e84ccc5-3e1d-4f55-95fe-82a43492dc79" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:to="loc_bsx_LicensingarrangementassetsMember_3e84ccc5-3e1d-4f55-95fe-82a43492dc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_ee18b9df-f4f4-477e-9e78-50c2165575ec" xlink:href="bsx-20220630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_15e8059c-98f9-4a4c-88d0-7179c34274d7" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_ee18b9df-f4f4-477e-9e78-50c2165575ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d13845dd-bbc3-4c75-91d6-ca693520bdae" xlink:to="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_e3dd1aad-3082-40e0-8590-076c510d7cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_e3dd1aad-3082-40e0-8590-076c510d7cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3ba40b8f-675b-4c08-8f52-24888575f55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtCurrent_3ba40b8f-675b-4c08-8f52-24888575f55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0a32fcda-592a-42ac-a709-414e86c5ea36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LongTermDebt_0a32fcda-592a-42ac-a709-414e86c5ea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_064bf55c-f44a-46bf-984b-f9f80bb21cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_064bf55c-f44a-46bf-984b-f9f80bb21cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_188e4d10-cb2f-49e0-803a-a84db741260d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_188e4d10-cb2f-49e0-803a-a84db741260d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1fe728ac-ea6f-406a-b311-7fc9d98faeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1fe728ac-ea6f-406a-b311-7fc9d98faeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_982a54eb-5b31-41dc-9081-2263a6a41cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_982a54eb-5b31-41dc-9081-2263a6a41cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm_5aaf2096-ac3e-4e69-b4d2-162fbce940d0" xlink:href="bsx-20220630.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_DebtInstrumentExtensionOptionTerm_5aaf2096-ac3e-4e69-b4d2-162fbce940d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_4a0f8df3-0173-4b8d-be2a-69aa0d8ecb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_4a0f8df3-0173-4b8d-be2a-69aa0d8ecb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_3925b501-de34-4627-ba9f-b56c87ffdbd1" xlink:href="bsx-20220630.xsd#bsx_MaximumLeverageRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_MaximumLeverageRatio_3925b501-de34-4627-ba9f-b56c87ffdbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_e276cbf0-6102-450b-a6fa-1cb915e25a88" xlink:href="bsx-20220630.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_e276cbf0-6102-450b-a6fa-1cb915e25a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_e188075f-90fe-4d0e-8a9c-ad9deaf7b3d8" xlink:href="bsx-20220630.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_e188075f-90fe-4d0e-8a9c-ad9deaf7b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_966c5d94-c128-4b7e-ba5d-a2c98310e1ca" xlink:href="bsx-20220630.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_966c5d94-c128-4b7e-ba5d-a2c98310e1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_89e1276e-7d67-45ea-aa36-2cd4b71e6246" xlink:href="bsx-20220630.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_89e1276e-7d67-45ea-aa36-2cd4b71e6246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_1aed30f3-a1bd-4951-b6d6-efbc2db43c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_1aed30f3-a1bd-4951-b6d6-efbc2db43c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_c366bd53-9b3f-42f3-9f41-72e0268ee837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_c366bd53-9b3f-42f3-9f41-72e0268ee837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_a440dcdf-57df-4bd0-8cab-1cd897b5d1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_a440dcdf-57df-4bd0-8cab-1cd897b5d1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration_9425993b-3b3d-41a8-82d2-8381dbb83da1" xlink:href="bsx-20220630.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_QualifiedAcquisitionConsideration_9425993b-3b3d-41a8-82d2-8381dbb83da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding_18be069a-142a-4a23-8a32-011b728384ab" xlink:href="bsx-20220630.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_bsx_MaximumCommercialPaperOutstanding_18be069a-142a-4a23-8a32-011b728384ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f4ed7bd4-771c-465b-a082-a26662bcb77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f4ed7bd4-771c-465b-a082-a26662bcb77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_b11df23c-2889-4d03-bf52-485056f608fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_b11df23c-2889-4d03-bf52-485056f608fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_641e33de-52d5-4b34-be07-947cc22d22da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_CommercialPaper_641e33de-52d5-4b34-be07-947cc22d22da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ed42d9ff-93d6-4372-8dce-358a1e737300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ShortTermBorrowings_ed42d9ff-93d6-4372-8dce-358a1e737300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_de0b7098-2178-43f0-abf8-54d28a90404e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_de0b7098-2178-43f0-abf8-54d28a90404e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_576d211b-ac0b-4af6-9c04-7fe352b16680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_576d211b-ac0b-4af6-9c04-7fe352b16680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_c382cefb-5817-42b2-9402-ad9b56bee1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_PaymentsForRoyalties_c382cefb-5817-42b2-9402-ad9b56bee1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_9317fb6a-661c-455a-91e8-cf109b68c658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96379d86-3820-4f7e-abca-996595fc468b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_9317fb6a-661c-455a-91e8-cf109b68c658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20220630.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_c46f7a15-b370-470e-99be-4aecd6546b84" xlink:href="bsx-20220630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_5f3960af-d364-4e46-b674-8834dfaa2a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_c46f7a15-b370-470e-99be-4aecd6546b84" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_5f3960af-d364-4e46-b674-8834dfaa2a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:href="bsx-20220630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_097ec747-41d1-4c5c-9459-3ae630a83dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_097ec747-41d1-4c5c-9459-3ae630a83dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_678be075-d4a7-4b28-b184-d2e6375e87e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_678be075-d4a7-4b28-b184-d2e6375e87e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_e9077d14-cd16-40fa-8a52-f2278c318246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_e9077d14-cd16-40fa-8a52-f2278c318246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4eda28ec-8862-4f19-9141-2e3ffcbffdda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4eda28ec-8862-4f19-9141-2e3ffcbffdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_c5d84f9c-91d5-41eb-9300-8ba166077177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_c5d84f9c-91d5-41eb-9300-8ba166077177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_438c0d23-0947-4eeb-987f-ef1c0f774e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_438c0d23-0947-4eeb-987f-ef1c0f774e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7fa4c4ad-8070-46dc-97b4-880d7dc70cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7fa4c4ad-8070-46dc-97b4-880d7dc70cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_1c34c0dd-c468-4587-b5a8-30d33f5c9da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_4a86574c-a437-4e29-b443-9b8e84d03648" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_1c34c0dd-c468-4587-b5a8-30d33f5c9da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:href="bsx-20220630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3a373eb4-d8cc-4ced-919d-1ea3650759f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3a373eb4-d8cc-4ced-919d-1ea3650759f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74d4939b-5ad0-4312-bcf9-a557253bd8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3a373eb4-d8cc-4ced-919d-1ea3650759f2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74d4939b-5ad0-4312-bcf9-a557253bd8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_753e0074-6b55-46fb-9b5e-e87b28db1934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_753e0074-6b55-46fb-9b5e-e87b28db1934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5dd2d980-665b-4284-8312-e2be222c357f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_753e0074-6b55-46fb-9b5e-e87b28db1934" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5dd2d980-665b-4284-8312-e2be222c357f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:href="bsx-20220630.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_80d4af14-6382-4335-8e6a-dca347f7f9dd" xlink:to="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cfc71445-fd97-4599-8e6a-b57522025036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cfc71445-fd97-4599-8e6a-b57522025036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6c9aa703-66f3-4eac-8de2-a0a8b018fc79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6c9aa703-66f3-4eac-8de2-a0a8b018fc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_c7537a11-eefb-408f-a895-258c23d52b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_c7537a11-eefb-408f-a895-258c23d52b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_14f7ae0c-596c-4c7e-be88-246261775621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_14f7ae0c-596c-4c7e-be88-246261775621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_11c1a814-f189-4d1d-bacf-14e54eb3b037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_Depreciation_11c1a814-f189-4d1d-bacf-14e54eb3b037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cbd0e13b-6bd4-4bd1-bff6-3a96b4c85d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_dcc89a29-00ea-4f34-b4c5-ce932121086f" xlink:to="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cbd0e13b-6bd4-4bd1-bff6-3a96b4c85d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_2ba62c01-08d7-41ae-b6d4-39751e46e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_2ba62c01-08d7-41ae-b6d4-39751e46e8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_a242bde6-b75e-4507-b33f-858a04a68be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_2ba62c01-08d7-41ae-b6d4-39751e46e8f4" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_a242bde6-b75e-4507-b33f-858a04a68be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c0dda90b-160b-43f6-9c26-f07af7add0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_2ba62c01-08d7-41ae-b6d4-39751e46e8f4" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c0dda90b-160b-43f6-9c26-f07af7add0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_e64cdc24-6585-47f2-9de1-97b5545f7fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_2ba62c01-08d7-41ae-b6d4-39751e46e8f4" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_e64cdc24-6585-47f2-9de1-97b5545f7fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_dc92b186-8ab3-41f5-9a09-435d6ed0fba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_dc92b186-8ab3-41f5-9a09-435d6ed0fba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_4d236e77-a288-4d24-ad18-7db0cf67cf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_dc92b186-8ab3-41f5-9a09-435d6ed0fba0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_4d236e77-a288-4d24-ad18-7db0cf67cf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_7c5d5b49-bea2-4675-9e36-ea0a00f4eb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_dc92b186-8ab3-41f5-9a09-435d6ed0fba0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_7c5d5b49-bea2-4675-9e36-ea0a00f4eb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_de0f6b54-6c23-48b0-b677-053c6fa3e41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_dc92b186-8ab3-41f5-9a09-435d6ed0fba0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_de0f6b54-6c23-48b0-b677-053c6fa3e41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_5ac357da-166d-4853-86ce-726bfa0c0708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_dc92b186-8ab3-41f5-9a09-435d6ed0fba0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_5ac357da-166d-4853-86ce-726bfa0c0708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_0afbd097-e760-410c-9839-e13362cdcd84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_InventoryNetAbstract_0afbd097-e760-410c-9839-e13362cdcd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2ca27538-c1c6-4825-8276-4404599888ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0afbd097-e760-410c-9839-e13362cdcd84" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2ca27538-c1c6-4825-8276-4404599888ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9f84f773-e273-48a1-8b44-1a41a5ffe4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0afbd097-e760-410c-9839-e13362cdcd84" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9f84f773-e273-48a1-8b44-1a41a5ffe4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_bf775d0e-5d26-4eda-a04f-8390035f07e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0afbd097-e760-410c-9839-e13362cdcd84" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_bf775d0e-5d26-4eda-a04f-8390035f07e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b8e91182-877a-4e72-ae4e-87082e86da66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0afbd097-e760-410c-9839-e13362cdcd84" xlink:to="loc_us-gaap_InventoryNet_b8e91182-877a-4e72-ae4e-87082e86da66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract_a1d51bee-a444-43e0-92ca-ca71d42488d9" xlink:href="bsx-20220630.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_bsx_OtherCurrentAssetsAbstract_a1d51bee-a444-43e0-92ca-ca71d42488d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8717b2c8-67c9-4c83-83dc-d74b8bf14f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_a1d51bee-a444-43e0-92ca-ca71d42488d9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8717b2c8-67c9-4c83-83dc-d74b8bf14f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_cf4b3e8e-bc72-46e6-b4d3-d576bce51873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_a1d51bee-a444-43e0-92ca-ca71d42488d9" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_cf4b3e8e-bc72-46e6-b4d3-d576bce51873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_08eb2950-94af-41be-87d1-87bf42b8d522" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_a1d51bee-a444-43e0-92ca-ca71d42488d9" xlink:to="loc_bsx_Licensingarrangements_08eb2950-94af-41be-87d1-87bf42b8d522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_b8686ab8-a67a-4943-b9c3-2015e67c5e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_a1d51bee-a444-43e0-92ca-ca71d42488d9" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_b8686ab8-a67a-4943-b9c3-2015e67c5e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_2f9a6d94-e793-4412-b9e3-ef4b81d7819b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_a1d51bee-a444-43e0-92ca-ca71d42488d9" xlink:to="loc_us-gaap_OtherAssetsCurrent_2f9a6d94-e793-4412-b9e3-ef4b81d7819b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_c8d3142f-7d08-498f-848d-22fa52f305ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:to="loc_us-gaap_Land_c8d3142f-7d08-498f-848d-22fa52f305ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_828b53ba-95f6-4be5-9307-f6e9c4d85a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_828b53ba-95f6-4be5-9307-f6e9c4d85a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_845a45ba-437c-4a3f-8eb9-64a78d5f42e7" xlink:href="bsx-20220630.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_845a45ba-437c-4a3f-8eb9-64a78d5f42e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_64066ad9-4a91-47ed-9a9f-11d3279cc786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:to="loc_us-gaap_ConstructionInProgressGross_64066ad9-4a91-47ed-9a9f-11d3279cc786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f5856fd4-c3d1-4bf2-80f0-ff2492b89390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f5856fd4-c3d1-4bf2-80f0-ff2492b89390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b62fcdeb-86d3-444f-a611-90c7db892408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b62fcdeb-86d3-444f-a611-90c7db892408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_89652b15-661a-430a-9982-41baff0430b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_11848c14-f7c4-4ed9-90c4-6ae257418ca3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_89652b15-661a-430a-9982-41baff0430b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_2242c1dc-de3b-4e08-97be-c51565b54b6d" xlink:href="bsx-20220630.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_2242c1dc-de3b-4e08-97be-c51565b54b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_38a6d7dc-e2aa-474f-85e5-f0122d391b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_2242c1dc-de3b-4e08-97be-c51565b54b6d" xlink:to="loc_us-gaap_Depreciation_38a6d7dc-e2aa-474f-85e5-f0122d391b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_de4236fe-8064-439d-bc36-4ecf6e69e8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_de4236fe-8064-439d-bc36-4ecf6e69e8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_24731324-58db-4b92-a7f9-2d463f4fb53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_24731324-58db-4b92-a7f9-2d463f4fb53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_83a72257-c114-4bed-a6bb-91e85ba5b604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_us-gaap_DerivativeAssets_83a72257-c114-4bed-a6bb-91e85ba5b604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_77687f37-b985-4216-8345-50da4d3c12cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_us-gaap_Investments_77687f37-b985-4216-8345-50da4d3c12cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_98836c1b-8d5e-4651-af04-1e495327026d" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_bsx_Licensingarrangementsasset_98836c1b-8d5e-4651-af04-1e495327026d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IndemnificationAsset_1c379a39-88c9-4462-b4f8-90709c4dbd17" xlink:href="bsx-20220630.xsd#bsx_IndemnificationAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_bsx_IndemnificationAsset_1c379a39-88c9-4462-b4f8-90709c4dbd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_98ff1465-bfd4-4735-a7c3-eb5344d35a35" xlink:href="bsx-20220630.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_bsx_OtherOtherLongtermAssets_98ff1465-bfd4-4735-a7c3-eb5344d35a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b9d13afe-558b-4738-bfba-7746a3293a14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_c33bab5b-25a4-40fb-9dee-cb9451012a6f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b9d13afe-558b-4738-bfba-7746a3293a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_2cfbf458-6fb2-434b-8b52-011a2066597d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:to="loc_us-gaap_LitigationReserveCurrent_2cfbf458-6fb2-434b-8b52-011a2066597d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a4e9cce4-1342-4a08-aeee-3020e7f3bdba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a4e9cce4-1342-4a08-aeee-3020e7f3bdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_d812601c-f477-4cef-8ef1-2269805aaaa5" xlink:href="bsx-20220630.xsd#bsx_AccruedRebatesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:to="loc_bsx_AccruedRebatesCurrent_d812601c-f477-4cef-8ef1-2269805aaaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_5869ed97-6446-44c3-8dde-fdd6a25c4bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_5869ed97-6446-44c3-8dde-fdd6a25c4bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fbc68c83-d9df-4b41-af39-4a35ac0dae22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fbc68c83-d9df-4b41-af39-4a35ac0dae22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ac638bbc-5e43-4c20-be1e-0eadcb95d8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bf4c89b1-4c93-4298-8d8a-a24646bbd2fb" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ac638bbc-5e43-4c20-be1e-0eadcb95d8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_0c4eb352-48c4-495d-bbdc-b31567159910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_0c4eb352-48c4-495d-bbdc-b31567159910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_fd55018e-ceb0-4bfb-8c3e-75f11a35238a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_0c4eb352-48c4-495d-bbdc-b31567159910" xlink:to="loc_us-gaap_DeferredRevenueCurrent_fd55018e-ceb0-4bfb-8c3e-75f11a35238a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_30707fec-c5a2-4920-aacf-2cede7675a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_0c4eb352-48c4-495d-bbdc-b31567159910" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_30707fec-c5a2-4920-aacf-2cede7675a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_c2b87b2a-bc8b-46a0-a60c-272fb4c18278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_0c4eb352-48c4-495d-bbdc-b31567159910" xlink:to="loc_us-gaap_TaxesPayableCurrent_c2b87b2a-bc8b-46a0-a60c-272fb4c18278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_7d300a6a-a779-4107-a77e-9299107b39e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_0c4eb352-48c4-495d-bbdc-b31567159910" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_7d300a6a-a779-4107-a77e-9299107b39e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bf6d8a12-4ebb-47e1-ab81-bc47cf077ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_0c4eb352-48c4-495d-bbdc-b31567159910" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bf6d8a12-4ebb-47e1-ab81-bc47cf077ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_84f545ea-4af5-4844-b899-f187b9b5c830" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_d3541f36-30b9-48a6-9dc5-f17b0c090b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_d3541f36-30b9-48a6-9dc5-f17b0c090b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_e7a39e06-7ede-451f-a949-5ccc827167c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_e7a39e06-7ede-451f-a949-5ccc827167c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f966e802-c7bd-406f-a327-c929ca688763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f966e802-c7bd-406f-a327-c929ca688763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_3f526088-3651-40ac-a4a5-4ffcb95e9f2c" xlink:href="bsx-20220630.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_bsx_Licensingarrangementsliability_3f526088-3651-40ac-a4a5-4ffcb95e9f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7b63924d-ccd9-4c49-814b-eeab05fd2a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7b63924d-ccd9-4c49-814b-eeab05fd2a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_cee29e1b-1d8c-4013-8be5-7095338b0316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_us-gaap_DeferredRevenue_cee29e1b-1d8c-4013-8be5-7095338b0316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_fb6abd4b-b772-4657-816f-bca54edc764c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_fb6abd4b-b772-4657-816f-bca54edc764c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_26ec0abd-6a46-4fe6-8af4-a047f6f74324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7971efb7-fcae-4f82-9a5c-69199348818f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_26ec0abd-6a46-4fe6-8af4-a047f6f74324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20220630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fb5b3461-f1b0-44f7-a508-2892665d373b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d61fca38-75ee-43f8-80a7-c7dd0be4d5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb5b3461-f1b0-44f7-a508-2892665d373b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d61fca38-75ee-43f8-80a7-c7dd0be4d5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_af6400b1-11be-4eb4-956c-034a31f1c5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d6543cab-3b7b-4819-b520-6f9b07f8934f" xlink:href="bsx-20220630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af6400b1-11be-4eb4-956c-034a31f1c5cb" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d6543cab-3b7b-4819-b520-6f9b07f8934f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_70548cf0-087e-4bc7-b741-db3a5e5c8bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d6543cab-3b7b-4819-b520-6f9b07f8934f" xlink:to="loc_us-gaap_VariableRateAxis_70548cf0-087e-4bc7-b741-db3a5e5c8bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b6213e50-45d5-459d-a69a-20f954c5b06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_70548cf0-087e-4bc7-b741-db3a5e5c8bd4" xlink:to="loc_us-gaap_VariableRateDomain_b6213e50-45d5-459d-a69a-20f954c5b06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_862c22b4-247d-4fe7-8820-385d64d9a69b" xlink:href="bsx-20220630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d6543cab-3b7b-4819-b520-6f9b07f8934f" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_862c22b4-247d-4fe7-8820-385d64d9a69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_b2fb75fe-1afe-495c-9e54-ee4b99346b9d" xlink:href="bsx-20220630.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af6400b1-11be-4eb4-956c-034a31f1c5cb" xlink:to="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_b2fb75fe-1afe-495c-9e54-ee4b99346b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_10917962-1683-4196-8cfa-73c76626f9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_fe8c37d8-7186-43ff-83b9-873f56ecded1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10917962-1683-4196-8cfa-73c76626f9c5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_fe8c37d8-7186-43ff-83b9-873f56ecded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_940a6872-1ca5-4f79-af79-d9985acc0320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_fe8c37d8-7186-43ff-83b9-873f56ecded1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_940a6872-1ca5-4f79-af79-d9985acc0320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_bf0259e7-1acb-4ef3-b489-b3bcc3b7f40b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_fe8c37d8-7186-43ff-83b9-873f56ecded1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_bf0259e7-1acb-4ef3-b489-b3bcc3b7f40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b5454505-4dc4-46d1-b722-0b6fd9b6b4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_fe8c37d8-7186-43ff-83b9-873f56ecded1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b5454505-4dc4-46d1-b722-0b6fd9b6b4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_ba3fb42a-8397-4d3d-8fde-30fea29a3a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10917962-1683-4196-8cfa-73c76626f9c5" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_ba3fb42a-8397-4d3d-8fde-30fea29a3a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20220630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09376f84-87af-4747-ba87-16ae94817922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ac55d469-8fa0-4985-abb1-355399589558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09376f84-87af-4747-ba87-16ae94817922" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ac55d469-8fa0-4985-abb1-355399589558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="simple" xlink:href="bsx-20220630.xsd#CommitmentsandContingenciesCommitmentsandContingenciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_07e61385-074a-44dd-9d6b-e74763180696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_0f18270a-25e7-4119-87d4-deace1bb9f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_07e61385-074a-44dd-9d6b-e74763180696" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_0f18270a-25e7-4119-87d4-deace1bb9f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e96c7d1-32c7-4795-8c1c-235c5b2f10aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e96c7d1-32c7-4795-8c1c-235c5b2f10aa" xlink:to="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf2edd36-8621-493e-86f2-c84e88e1b2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f1d8b36-54ae-4eb9-ac90-cf7bc8044db2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf2edd36-8621-493e-86f2-c84e88e1b2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8b70fa59-cf2a-4406-b280-32f5994e9d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:to="loc_us-gaap_LitigationStatusAxis_8b70fa59-cf2a-4406-b280-32f5994e9d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9f2c1034-1289-4733-93ab-d6c819310b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_8b70fa59-cf2a-4406-b280-32f5994e9d10" xlink:to="loc_us-gaap_LitigationStatusDomain_9f2c1034-1289-4733-93ab-d6c819310b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b6d03ca9-cdb1-49c2-bf72-75d77622406b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_9f2c1034-1289-4733-93ab-d6c819310b7a" xlink:to="loc_us-gaap_SettledLitigationMember_b6d03ca9-cdb1-49c2-bf72-75d77622406b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4491e126-a0b2-4653-b9fa-72ce5e823868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4491e126-a0b2-4653-b9fa-72ce5e823868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1ff365c5-965a-4ea3-8ead-2074fb2f5646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4491e126-a0b2-4653-b9fa-72ce5e823868" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1ff365c5-965a-4ea3-8ead-2074fb2f5646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_577910a0-c26e-467c-9cec-b75e48093373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1ff365c5-965a-4ea3-8ead-2074fb2f5646" xlink:to="loc_us-gaap_SubsequentEventMember_577910a0-c26e-467c-9cec-b75e48093373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6c12ac72-b85a-4bc2-834e-d6323d60fcb8" xlink:to="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_61cc77d0-1954-4306-96e8-531827255556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_61cc77d0-1954-4306-96e8-531827255556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_77a469e7-2b9e-4a5e-a3f8-fd884ab4b3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_77a469e7-2b9e-4a5e-a3f8-fd884ab4b3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_da03ecb6-9553-439d-9fe7-d97bb62b0bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_LitigationSettlementExpense_da03ecb6-9553-439d-9fe7-d97bb62b0bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_aaf30735-1af0-4a6e-a9ec-ea0260c2bd13" xlink:href="bsx-20220630.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_aaf30735-1af0-4a6e-a9ec-ea0260c2bd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_cc4efa24-35a7-44ef-bfc9-fd2e1997f8de" xlink:href="bsx-20220630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_cc4efa24-35a7-44ef-bfc9-fd2e1997f8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_efbd9c37-083d-4a16-a396-3c9c607770ec" xlink:href="bsx-20220630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_efbd9c37-083d-4a16-a396-3c9c607770ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_3f4f9c41-7549-4a52-ac3c-e5136c870bf8" xlink:href="bsx-20220630.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_3f4f9c41-7549-4a52-ac3c-e5136c870bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh_56641a0a-bf68-4e48-b8f6-504617497aa1" xlink:href="bsx-20220630.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_CertifiedClassActionsInAustraliaMesh_56641a0a-bf68-4e48-b8f6-504617497aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_3738e48d-3359-4bb2-b842-db8980b296b8" xlink:href="bsx-20220630.xsd#bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_3738e48d-3359-4bb2-b842-db8980b296b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_e4873e8d-c097-4a0d-adba-19f03c8b01c2" xlink:href="bsx-20220630.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_e4873e8d-c097-4a0d-adba-19f03c8b01c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_bb931bf8-4295-4252-a685-5a72f7fe1442" xlink:href="bsx-20220630.xsd#bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter_bb931bf8-4295-4252-a685-5a72f7fe1442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CanadaSettledClaims_5f412a15-4696-417c-a0ed-4f5dcb663a7f" xlink:href="bsx-20220630.xsd#bsx_CanadaSettledClaims"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_bsx_CanadaSettledClaims_5f412a15-4696-417c-a0ed-4f5dcb663a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16a66cdb-9003-4601-a344-c23ab03b3256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15bcc33b-8122-4b2d-856f-dea02ca6f588" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16a66cdb-9003-4601-a344-c23ab03b3256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20220630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_fad15f52-fae2-4fcc-b83e-3ea67419c0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_95159dc3-31ad-4c98-ad63-652ebc6a1c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fad15f52-fae2-4fcc-b83e-3ea67419c0b6" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_95159dc3-31ad-4c98-ad63-652ebc6a1c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7312d19b-edb7-485d-b4cf-87a94c9a3622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract_6f7daf05-5860-4f72-bfdf-441aa01cc926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7312d19b-edb7-485d-b4cf-87a94c9a3622" xlink:to="loc_us-gaap_ClassOfStockDisclosuresAbstract_6f7daf05-5860-4f72-bfdf-441aa01cc926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract_6f7daf05-5860-4f72-bfdf-441aa01cc926" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a6383baa-2619-447f-8397-334eb0fe38ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a6383baa-2619-447f-8397-334eb0fe38ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a6383baa-2619-447f-8397-334eb0fe38ac" xlink:to="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_ec7a5a51-55e2-4716-8ec1-5a2163071640" xlink:href="bsx-20220630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:to="loc_bsx_A550MCPSSeriesAMember_ec7a5a51-55e2-4716-8ec1-5a2163071640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4e1653d3-a6a8-4152-817a-4631f1396838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:to="loc_us-gaap_CommonStockMember_4e1653d3-a6a8-4152-817a-4631f1396838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_d14e41d6-91a0-4481-a228-59d4d30cd71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9dadb392-f909-4736-b042-a0b680e42e6c" xlink:to="loc_us-gaap_PreferredStockMember_d14e41d6-91a0-4481-a228-59d4d30cd71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_080c8125-42ac-446c-921b-f53e5a292633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6fe4f6d0-4ac5-4c5a-954d-31fe99041e1e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_080c8125-42ac-446c-921b-f53e5a292633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_622c6448-b0bb-4a0b-a9ae-2c198a3d53a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_080c8125-42ac-446c-921b-f53e5a292633" xlink:to="loc_us-gaap_SubsequentEventMember_622c6448-b0bb-4a0b-a9ae-2c198a3d53a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44c81dbc-1b09-4eb3-9f9d-171172408cc6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:to="loc_srt_RangeAxis_44c81dbc-1b09-4eb3-9f9d-171172408cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_44c81dbc-1b09-4eb3-9f9d-171172408cc6" xlink:to="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_582628b7-7fb0-4e72-8d69-d73b82bcd5a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:to="loc_srt_MinimumMember_582628b7-7fb0-4e72-8d69-d73b82bcd5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_abafcf34-7ea6-4c1f-b7a8-109b968d379b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_707f14d9-afcf-4c9e-8415-a8375accf73b" xlink:to="loc_srt_MaximumMember_abafcf34-7ea6-4c1f-b7a8-109b968d379b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e88de8d0-785a-474d-a480-ab6569cfee13" xlink:to="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b441d4e5-dc55-43c4-ba99-cbafe199983b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b441d4e5-dc55-43c4-ba99-cbafe199983b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_cd4ac4ac-38d1-464a-9d85-8492de53acb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockSharesIssued_cd4ac4ac-38d1-464a-9d85-8492de53acb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_09309003-6f98-4dc8-809f-e330c9cf5de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_09309003-6f98-4dc8-809f-e330c9cf5de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_6b99d31a-6146-47cc-8b34-21fe742b2cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_6b99d31a-6146-47cc-8b34-21fe742b2cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_eeeca20e-65c6-4a83-8f8e-2daadf2d83ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_eeeca20e-65c6-4a83-8f8e-2daadf2d83ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_f66e7e48-7cec-442c-97d2-bc98bd27c6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_f66e7e48-7cec-442c-97d2-bc98bd27c6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_3f52a3da-41b5-41d9-84ae-8727c431d7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_3f52a3da-41b5-41d9-84ae-8727c431d7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_69415f38-ff92-4fa1-a162-9f8bbdb51487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PaymentsOfDividends_69415f38-ff92-4fa1-a162-9f8bbdb51487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_f5e18934-ebde-4ae1-aca4-07b1be936278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_f5e18934-ebde-4ae1-aca4-07b1be936278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_89927cfb-daba-49ac-82fb-3ffff171046c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_89927cfb-daba-49ac-82fb-3ffff171046c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8e788d4d-e496-4a7a-be35-9a0c48de6356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c08842dc-53b8-4bc6-95bc-e1e90e0afb26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8e788d4d-e496-4a7a-be35-9a0c48de6356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20220630.xsd#WeightedAverageSharesOutstanding"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_020e90be-cc53-41bb-8ee5-915b8579aaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7a6b2c8d-6be7-437a-9770-c4574d1c6e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_020e90be-cc53-41bb-8ee5-915b8579aaf6" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7a6b2c8d-6be7-437a-9770-c4574d1c6e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e4e8495e-f5b8-4199-9a29-443773e204dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_f0a83523-8706-49f1-a615-55f734685155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e4e8495e-f5b8-4199-9a29-443773e204dd" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_f0a83523-8706-49f1-a615-55f734685155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e9234005-4165-4474-aac4-28d2286b8a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e4e8495e-f5b8-4199-9a29-443773e204dd" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e9234005-4165-4474-aac4-28d2286b8a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bd1b1f17-ea8a-4024-8e31-8423b8fd4809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea6cf02e-348d-465b-aba0-51306226f596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bd1b1f17-ea8a-4024-8e31-8423b8fd4809" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea6cf02e-348d-465b-aba0-51306226f596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea0c7e33-5d7d-41d5-b7c3-66125128a16d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea6cf02e-348d-465b-aba0-51306226f596" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea0c7e33-5d7d-41d5-b7c3-66125128a16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea0c7e33-5d7d-41d5-b7c3-66125128a16d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b08dbbd5-5064-4f0b-9ea1-701f0b723d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b08dbbd5-5064-4f0b-9ea1-701f0b723d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_8ceda80b-cb28-44fd-87e5-5bc055fe105e" xlink:href="bsx-20220630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3ab9f19c-442c-4b6a-891e-bfb46aac9cc8" xlink:to="loc_bsx_A550MCPSSeriesAMember_8ceda80b-cb28-44fd-87e5-5bc055fe105e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea6cf02e-348d-465b-aba0-51306226f596" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a48050a4-4b2b-4c5e-a66a-b4f286dfc3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a48050a4-4b2b-4c5e-a66a-b4f286dfc3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44011a7d-75e6-4cd2-8bcb-01a4b131a477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44011a7d-75e6-4cd2-8bcb-01a4b131a477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b9c005bf-f48f-449e-b72c-8d8fa5890edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b9c005bf-f48f-449e-b72c-8d8fa5890edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c0ba35b6-68cf-4712-ba4e-19cb895b3cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c0ba35b6-68cf-4712-ba4e-19cb895b3cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_73c03bc9-549d-41ab-90bb-6a039065e852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_73c03bc9-549d-41ab-90bb-6a039065e852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0c0203d2-5065-4ff9-a34a-aad679c442b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a07d4fee-2c21-423d-aee8-708db3336c2d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0c0203d2-5065-4ff9-a34a-aad679c442b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20220630.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3e51cda8-f6e6-4f54-be29-44716d44b423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c37b124c-2f9b-44c4-a8fa-72ca06510b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3e51cda8-f6e6-4f54-be29-44716d44b423" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c37b124c-2f9b-44c4-a8fa-72ca06510b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_68a82d8e-86dc-4b12-b1e5-761b153bdd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b0467ea8-4247-4986-870e-8aa2c6140808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_68a82d8e-86dc-4b12-b1e5-761b153bdd8e" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b0467ea8-4247-4986-870e-8aa2c6140808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cf92af65-1763-4d4b-a57e-cfedc9f63dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinesses_32518700-bf7c-41bc-b344-ea91618605a4" xlink:href="bsx-20220630.xsd#bsx_NumberOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf92af65-1763-4d4b-a57e-cfedc9f63dac" xlink:to="loc_bsx_NumberOfBusinesses_32518700-bf7c-41bc-b344-ea91618605a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_60d56068-f935-49d7-b1f7-def85cbd9595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf92af65-1763-4d4b-a57e-cfedc9f63dac" xlink:to="loc_us-gaap_NumberOfReportableSegments_60d56068-f935-49d7-b1f7-def85cbd9595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf92af65-1763-4d4b-a57e-cfedc9f63dac" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_79142888-cc75-40c6-9087-bd3625e69e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_79142888-cc75-40c6-9087-bd3625e69e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_79142888-cc75-40c6-9087-bd3625e69e92" xlink:to="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_7b44d937-7b63-4e56-a3e1-769ca91ae61f" xlink:href="bsx-20220630.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_MedsurgMember_7b44d937-7b63-4e56-a3e1-769ca91ae61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_a4265164-b1dc-4a46-81ee-d24d183dc5bb" xlink:href="bsx-20220630.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_CardiovascularMember_a4265164-b1dc-4a46-81ee-d24d183dc5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_00b3eb24-8cfd-4192-bb63-5797bd606a84" xlink:href="bsx-20220630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_BSXReportableSegmentsMember_00b3eb24-8cfd-4192-bb63-5797bd606a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_9c554439-ff8e-463f-a51e-607632b26bb3" xlink:href="bsx-20220630.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_9c554439-ff8e-463f-a51e-607632b26bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_29aab033-0c76-499e-9bbc-c3163092e5e6" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_29aab033-0c76-499e-9bbc-c3163092e5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_d238354c-dc9c-4fe8-8c3e-a5df5c2a0a56" xlink:href="bsx-20220630.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_d238354c-dc9c-4fe8-8c3e-a5df5c2a0a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_95176a22-66c3-47cf-91fe-0579ae100914" xlink:href="bsx-20220630.xsd#bsx_SpecialChargesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c07d2802-88ba-4b60-80a9-a3d70d91606f" xlink:to="loc_bsx_SpecialChargesMember_95176a22-66c3-47cf-91fe-0579ae100914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:to="loc_srt_ProductOrServiceAxis_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_97a4ffa6-b88e-47bd-a3eb-58f95ccf6c73" xlink:to="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_91485c70-9cc2-4c79-ac5c-d12d430e4d9f" xlink:href="bsx-20220630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_91485c70-9cc2-4c79-ac5c-d12d430e4d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_e0e14c50-2556-42b5-9c37-a6072aaaec19" xlink:href="bsx-20220630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_e0e14c50-2556-42b5-9c37-a6072aaaec19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_eb2695ab-59dd-4b0a-bf8d-d4f5be98081f" xlink:href="bsx-20220630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_eb2695ab-59dd-4b0a-bf8d-d4f5be98081f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember_6ac53463-d2df-48a6-80c6-9187ae862206" xlink:href="bsx-20220630.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_InterventionalCardiologyTherapiesMember_6ac53463-d2df-48a6-80c6-9187ae862206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember_8c783f15-3094-470a-a488-b91c3cb3bb7a" xlink:href="bsx-20220630.xsd#bsx_WatchmanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_WatchmanMember_8c783f15-3094-470a-a488-b91c3cb3bb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember_3a2220b2-8a05-476a-9475-0b29e012ee1f" xlink:href="bsx-20220630.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_CardiacRhythmManagementMember_3a2220b2-8a05-476a-9475-0b29e012ee1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember_feef869b-4491-48c0-96a2-003e158189a6" xlink:href="bsx-20220630.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_ElectrophysiologyEPMember_feef869b-4491-48c0-96a2-003e158189a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember_d2e818a6-98ae-4909-bbca-5a47a2deef27" xlink:href="bsx-20220630.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalCardiologyReportingUnitMember_d2e818a6-98ae-4909-bbca-5a47a2deef27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_11f355bf-73f4-4737-8def-69b6f8e3cb3c" xlink:href="bsx-20220630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_11f355bf-73f4-4737-8def-69b6f8e3cb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_c4e7d16e-edb5-427d-8d05-0c1a581ebdf1" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5787ad9c-ae3a-43ae-8397-8477a88ec143" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_c4e7d16e-edb5-427d-8d05-0c1a581ebdf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_028cadd3-9ff5-4cf1-8649-b73fe295ffc6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:to="loc_srt_StatementGeographicalAxis_028cadd3-9ff5-4cf1-8649-b73fe295ffc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_028cadd3-9ff5-4cf1-8649-b73fe295ffc6" xlink:to="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f05e19bc-4df8-4d0a-abe8-14daf8232c95" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:to="loc_country_US_f05e19bc-4df8-4d0a-abe8-14daf8232c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d634d940-498d-4bbe-be61-51dc3f3d148e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_47e471b7-b72e-4e18-9201-3dfc26e4ec0c" xlink:to="loc_us-gaap_NonUsMember_d634d940-498d-4bbe-be61-51dc3f3d148e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_936af580-6d39-4249-a5e0-057982ff2684" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_2d22cd4b-43f5-45c0-ab5d-613fb60e94a3" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_2d22cd4b-43f5-45c0-ab5d-613fb60e94a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_639f6fda-0d55-4577-a128-0f28afabd7c2" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_a6cef591-9ea7-4424-b911-f6646e86128f" xlink:href="bsx-20220630.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_a6cef591-9ea7-4424-b911-f6646e86128f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4726e1e7-a7f3-4ca9-81ca-aa206b764113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4726e1e7-a7f3-4ca9-81ca-aa206b764113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_17956952-d954-4912-b31f-0ef5a6fa2a40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_OperatingIncomeLoss_17956952-d954-4912-b31f-0ef5a6fa2a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3cec154e-a727-4a1f-a3a3-937ecff81382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3cec154e-a727-4a1f-a3a3-937ecff81382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be2db2f5-5ed6-4a26-bf97-103cdb1a09ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_e64113f9-8bd1-4065-b05c-94f7ebc33d7e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be2db2f5-5ed6-4a26-bf97-103cdb1a09ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_1468186e-f1da-4288-b6ef-59c384c91487" xlink:href="bsx-20220630.xsd#bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_1468186e-f1da-4288-b6ef-59c384c91487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_ad2ae7bf-628f-46e0-ac10-02660152fc53" xlink:href="bsx-20220630.xsd#bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_ad2ae7bf-628f-46e0-ac10-02660152fc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_d023af37-d09a-435b-a32a-ec9b3b0a7fc6" xlink:href="bsx-20220630.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_d023af37-d09a-435b-a32a-ec9b3b0a7fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_94c0fade-2713-4b33-9a46-fb1a30af5b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_9bb30324-d2aa-4be2-bcb9-5425cdb2da75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_94c0fade-2713-4b33-9a46-fb1a30af5b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20220630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e24a7b5-b106-4894-8498-1748673604d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a30e75f4-d357-4929-92ff-23d4aa25b376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e24a7b5-b106-4894-8498-1748673604d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a30e75f4-d357-4929-92ff-23d4aa25b376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9182b5ec-7e9b-496d-aafe-2bb756c79122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_96edc346-dc66-40b3-90c9-c88246d33c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9182b5ec-7e9b-496d-aafe-2bb756c79122" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_96edc346-dc66-40b3-90c9-c88246d33c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_947565d8-8aad-460c-9e55-1dc2970a7a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_96edc346-dc66-40b3-90c9-c88246d33c5c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_947565d8-8aad-460c-9e55-1dc2970a7a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ce966558-84b2-4018-a4d8-3308e288c9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_4beee999-e512-49c7-851d-f3f3532df4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ce966558-84b2-4018-a4d8-3308e288c9a5" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_4beee999-e512-49c7-851d-f3f3532df4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_4beee999-e512-49c7-851d-f3f3532df4e3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_aad0ff04-12d2-488e-a154-fae15a0b08b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_aad0ff04-12d2-488e-a154-fae15a0b08b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aad0ff04-12d2-488e-a154-fae15a0b08b2" xlink:to="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_12dfab96-e4d9-4e63-91ad-1c388185f303" xlink:href="bsx-20220630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:to="loc_bsx_BSXReportableSegmentsMember_12dfab96-e4d9-4e63-91ad-1c388185f303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_828ea25d-b955-4e9b-83f9-dc49f5b16686" xlink:href="bsx-20220630.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:to="loc_bsx_MedsurgMember_828ea25d-b955-4e9b-83f9-dc49f5b16686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_2ba97176-130a-41c7-b58f-4c05db36d130" xlink:href="bsx-20220630.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_96b1913c-0453-4bc8-acc4-a5b16bf2762f" xlink:to="loc_bsx_CardiovascularMember_2ba97176-130a-41c7-b58f-4c05db36d130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e0ec29be-b656-4efe-946a-c8d01a8da57d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:to="loc_srt_ProductOrServiceAxis_e0ec29be-b656-4efe-946a-c8d01a8da57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e0ec29be-b656-4efe-946a-c8d01a8da57d" xlink:to="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_bd6d7c28-9271-4f6b-8078-b60be7ab2d0c" xlink:href="bsx-20220630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_bd6d7c28-9271-4f6b-8078-b60be7ab2d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_85ca67e4-04bd-4360-b74c-bc26376debbc" xlink:href="bsx-20220630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_85ca67e4-04bd-4360-b74c-bc26376debbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_54be635e-4874-4b25-8ee7-ff3080af97e2" xlink:href="bsx-20220630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_54be635e-4874-4b25-8ee7-ff3080af97e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember_9258011a-801a-42f9-bda7-89c47695ad22" xlink:href="bsx-20220630.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_InterventionalCardiologyTherapiesMember_9258011a-801a-42f9-bda7-89c47695ad22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember_3f3c2c00-ba93-4676-8714-a5b8a1d8fde0" xlink:href="bsx-20220630.xsd#bsx_WatchmanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_WatchmanMember_3f3c2c00-ba93-4676-8714-a5b8a1d8fde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember_cf6a50bb-96fa-491e-8bd5-a1f8805235cb" xlink:href="bsx-20220630.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_CardiacRhythmManagementMember_cf6a50bb-96fa-491e-8bd5-a1f8805235cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember_c5500310-2fb7-4cf1-9cec-a2bcd1fa6605" xlink:href="bsx-20220630.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_ElectrophysiologyEPMember_c5500310-2fb7-4cf1-9cec-a2bcd1fa6605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember_8566c779-7a9c-467f-a811-02fec629e86d" xlink:href="bsx-20220630.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalCardiologyReportingUnitMember_8566c779-7a9c-467f-a811-02fec629e86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_148395b6-4bc5-4768-8266-a90bc95f936d" xlink:href="bsx-20220630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_148395b6-4bc5-4768-8266-a90bc95f936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_5b733443-6f92-40fe-b8f2-b91ecd4d1e89" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0af0feb3-2ebd-4578-b80e-1f31f05c40b6" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_5b733443-6f92-40fe-b8f2-b91ecd4d1e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:to="loc_srt_StatementGeographicalAxis_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5b6f3086-6ebd-487b-bfd0-1807ef1dacc9" xlink:to="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d542f975-61b7-437e-b37e-314a53d21a10" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_country_US_d542f975-61b7-437e-b37e-314a53d21a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_144fade5-65c8-479f-b224-18509f2dfecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_us-gaap_NonUsMember_144fade5-65c8-479f-b224-18509f2dfecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_86d69cf7-676a-493d-ae35-74fde42f8632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_us-gaap_EMEAMember_86d69cf7-676a-493d-ae35-74fde42f8632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_d6f49acc-4880-4404-b6c9-9d2908b2dda7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_srt_AsiaPacificMember_d6f49acc-4880-4404-b6c9-9d2908b2dda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_9e7a2cea-b14c-46b8-99a7-7b243cc1ec87" xlink:href="bsx-20220630.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_bsx_LatinAmericaandCanadaMember_9e7a2cea-b14c-46b8-99a7-7b243cc1ec87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_1c9d3fc5-af1b-452d-8804-38f809101863" xlink:href="bsx-20220630.xsd#bsx_EmergingMarketsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1a3cc40a-d8d6-4eea-98f4-51206ec72bfb" xlink:to="loc_bsx_EmergingMarketsMember_1c9d3fc5-af1b-452d-8804-38f809101863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4ef9057-a696-4e1d-991f-424bf8d026ad" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23e3a2ae-2b7b-47d2-a5b2-7b302ad8f2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23e3a2ae-2b7b-47d2-a5b2-7b302ad8f2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries_accb7e0d-e86a-4041-84f2-c82e9d922e3d" xlink:href="bsx-20220630.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:to="loc_bsx_EmergingMarketstotalnumberofcountries_accb7e0d-e86a-4041-84f2-c82e9d922e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ba272f1-1a96-4056-a65a-95614e7743d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95b2fde9-7cf1-43e5-bcc9-8740c4b471eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ba272f1-1a96-4056-a65a-95614e7743d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_99d99701-83af-487b-90b7-841ac95ca385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_4beee999-e512-49c7-851d-f3f3532df4e3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_99d99701-83af-487b-90b7-841ac95ca385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ce106202-ebfd-4ecc-8dec-b230fbc2e059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_99d99701-83af-487b-90b7-841ac95ca385" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ce106202-ebfd-4ecc-8dec-b230fbc2e059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_970cd30e-bf3b-49b7-acdb-9e2941885318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_4beee999-e512-49c7-851d-f3f3532df4e3" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_970cd30e-bf3b-49b7-acdb-9e2941885318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_743fd073-d2af-4eef-8f85-917a472b9eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_970cd30e-bf3b-49b7-acdb-9e2941885318" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_743fd073-d2af-4eef-8f85-917a472b9eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20220630.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_41d666c3-b42a-48c9-b83f-5d89a54ab48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a97d7dd6-c74e-4c48-9600-144371a07519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_41d666c3-b42a-48c9-b83f-5d89a54ab48b" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a97d7dd6-c74e-4c48-9600-144371a07519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="simple" xlink:href="bsx-20220630.xsd#ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20220630.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_76ce749c-df8e-4fce-9237-2c577913dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b8c61f00-5aba-499d-9730-068761cb8287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_76ce749c-df8e-4fce-9237-2c577913dbcf" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b8c61f00-5aba-499d-9730-068761cb8287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20220630.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_53ff32e5-d775-4a54-a388-d7b630376445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_53ff32e5-d775-4a54-a388-d7b630376445" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_32c13c08-2899-4c97-89a9-7c8cf382a51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_32c13c08-2899-4c97-89a9-7c8cf382a51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fdcbc34e-8512-4dae-8eeb-7f77aa71ef52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_32c13c08-2899-4c97-89a9-7c8cf382a51d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fdcbc34e-8512-4dae-8eeb-7f77aa71ef52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_3e6ae473-f139-47e9-90aa-f5d7e746ed72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fdcbc34e-8512-4dae-8eeb-7f77aa71ef52" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_3e6ae473-f139-47e9-90aa-f5d7e746ed72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab9d096f-791d-42c1-962e-4d8ed5432b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab9d096f-791d-42c1-962e-4d8ed5432b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5e3d8a2-d5d3-45e3-8f32-7c6a27e46a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab9d096f-791d-42c1-962e-4d8ed5432b7a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5e3d8a2-d5d3-45e3-8f32-7c6a27e46a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_a7527621-7710-4652-bb1f-f4dcc3f7567d" xlink:href="bsx-20220630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5e3d8a2-d5d3-45e3-8f32-7c6a27e46a6e" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_a7527621-7710-4652-bb1f-f4dcc3f7567d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_014fd157-4bb2-4c89-bd22-14fe02f2e244" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78ed280d-acd3-48b7-b22e-2c2b66b1a7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78ed280d-acd3-48b7-b22e-2c2b66b1a7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_59d4cc17-2df5-42ee-9b6f-5a1d62134fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_59d4cc17-2df5-42ee-9b6f-5a1d62134fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dea35748-623a-4a4e-8942-4e43ccf0510c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dea35748-623a-4a4e-8942-4e43ccf0510c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e7b663e7-48ba-470e-813e-a760b8ac248a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e7b663e7-48ba-470e-813e-a760b8ac248a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_04d3d080-e589-4781-a9e7-fac39bbec331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_04d3d080-e589-4781-a9e7-fac39bbec331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_fc3a5a41-df2c-4635-9787-16ebf9c3fe71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_fc3a5a41-df2c-4635-9787-16ebf9c3fe71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d7911639-041b-4802-b13a-243732a96abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d7911639-041b-4802-b13a-243732a96abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d97f41c7-bba8-43e9-80fb-61e25a797fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d97f41c7-bba8-43e9-80fb-61e25a797fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c22e70ab-4c83-4581-b007-533b13174bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c22e70ab-4c83-4581-b007-533b13174bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_aede8f75-e4b3-46b8-82cc-45238ea52c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_aede8f75-e4b3-46b8-82cc-45238ea52c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ce612c33-8889-4e2e-ab4d-a0c393f7dc18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ce612c33-8889-4e2e-ab4d-a0c393f7dc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_029f520f-40a9-4373-adcb-21a7e33fab10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_029f520f-40a9-4373-adcb-21a7e33fab10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1bf68234-18d4-43ac-ae9f-7fec1f3db6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1bf68234-18d4-43ac-ae9f-7fec1f3db6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_65d35c78-c012-4fdb-90b3-beadbd92b065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_65d35c78-c012-4fdb-90b3-beadbd92b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_05601045-3cac-44d0-b9d2-a4ae574004d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_05601045-3cac-44d0-b9d2-a4ae574004d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820f12b3-1ba1-4e21-aa5e-b0b2f4347fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_611170ed-2a19-41e0-b3dd-3e2050c78b4d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820f12b3-1ba1-4e21-aa5e-b0b2f4347fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20220630.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_3d4f7835-0139-4460-b8d0-e3db9aa672bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_5884bd62-ce0c-40f4-9b23-b68d024b10e1" xlink:href="bsx-20220630.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_3d4f7835-0139-4460-b8d0-e3db9aa672bc" xlink:to="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_5884bd62-ce0c-40f4-9b23-b68d024b10e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20220630.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_869f49bd-9350-446e-934d-f7171ba0cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_87c3c4f3-76f4-41a3-b1cb-c1d3255ddfc0" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_869f49bd-9350-446e-934d-f7171ba0cbf9" xlink:to="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_87c3c4f3-76f4-41a3-b1cb-c1d3255ddfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_386ea422-46f2-4fdd-914b-332a49610cde" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_869f49bd-9350-446e-934d-f7171ba0cbf9" xlink:to="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_386ea422-46f2-4fdd-914b-332a49610cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_4a22a76c-b88f-4741-ac70-2aff3abc6f24" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_869f49bd-9350-446e-934d-f7171ba0cbf9" xlink:to="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_4a22a76c-b88f-4741-ac70-2aff3abc6f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_24d7c383-c045-4324-8db5-fa90314b9558" xlink:href="bsx-20220630.xsd#bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_869f49bd-9350-446e-934d-f7171ba0cbf9" xlink:to="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_24d7c383-c045-4324-8db5-fa90314b9558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853357496928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Document - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431,614,313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853357726240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,244<span></span>
</td>
<td class="nump">$ 3,077<span></span>
</td>
<td class="nump">$ 6,270<span></span>
</td>
<td class="nump">$ 5,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">945<span></span>
</td>
<td class="nump">1,966<span></span>
</td>
<td class="nump">1,839<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,233<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">4,304<span></span>
</td>
<td class="nump">3,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,165<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">2,225<span></span>
</td>
<td class="nump">2,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expenses</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">654<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">402<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="nump">36<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring net charges (credits)</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits)</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on disposal of businesses and assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">1,870<span></span>
</td>
<td class="nump">3,415<span></span>
</td>
<td class="nump">3,358<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="nump">889<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="num">(343)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">85<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="nump">527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Preferred stock dividends</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) available to common stockholders</a></td>
<td class="nump">$ 246<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 342<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss)&#160;per common share &#8212; basic</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss)&#160;per common share &#8212; assuming dilution</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">1,429.7<span></span>
</td>
<td class="nump">1,421.3<span></span>
</td>
<td class="nump">1,428.8<span></span>
</td>
<td class="nump">1,420.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Assuming dilution</a></td>
<td class="nump">1,437.8<span></span>
</td>
<td class="nump">1,432.5<span></span>
</td>
<td class="nump">1,438.1<span></span>
</td>
<td class="nump">1,431.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853357450880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="nump">134<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">211<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="nump">$ 471<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
<td class="nump">$ 540<span></span>
</td>
<td class="nump">$ 558<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853356009904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 1,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,917<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,752<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">874<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,083<span></span>
</td>
<td class="nump">6,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,246<span></span>
</td>
<td class="nump">2,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">12,883<span></span>
</td>
<td class="nump">11,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,349<span></span>
</td>
<td class="nump">6,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">4,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,569<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">32,189<span></span>
</td>
<td class="nump">32,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">732<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,197<span></span>
</td>
<td class="nump">2,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">784<span></span>
</td>
<td class="nump">783<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,883<span></span>
</td>
<td class="nump">4,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,802<span></span>
</td>
<td class="nump">8,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,988<span></span>
</td>
<td class="nump">2,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of June 30, 2022 and December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,693,192,785 shares as of June 30, 2022 and 1,688,810,052 shares as of December 31, 2021</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 263,289,848 shares as of June 30, 2022 and December 31, 2021</a></td>
<td class="num">(2,251)<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">20,103<span></span>
</td>
<td class="nump">19,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,050)<span></span>
</td>
<td class="num">(1,392)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">17,251<span></span>
</td>
<td class="nump">16,622<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 32,189<span></span>
</td>
<td class="nump">$ 32,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355608096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract', window );"><strong>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,693,192,785<span></span>
</td>
<td class="nump">1,688,810,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853356193040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,911,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
<td class="nump">$ 19,732<span></span>
</td>
<td class="num">$ (2,378)<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,094,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Jun. 30, 2021</a></td>
<td class="nump">$ 15,942<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,817<span></span>
</td>
<td class="num">(1,878)<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividends, Preferred Stock, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,683,861,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,750<span></span>
</td>
<td class="num">(2,050)<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Jun. 30, 2021</a></td>
<td class="nump">15,942<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,817<span></span>
</td>
<td class="num">(1,878)<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividends, Preferred Stock, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,685,006,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,688,810,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,688,810,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity at Dec. 31, 2021</a></td>
<td class="nump">$ 16,622<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,986<span></span>
</td>
<td class="num">(1,392)<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,382,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Jun. 30, 2022</a></td>
<td class="nump">17,251<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">20,103<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividends, Preferred Stock, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,692,828,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">20,043<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Jun. 30, 2022</a></td>
<td class="nump">17,251<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
<td class="nump">$ 20,103<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividends, Preferred Stock, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">$ 211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,693,192,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121321822&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121323062&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853357599664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash provided by (used for) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 370<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">558<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit', window );">Deferred and prepaid income taxes</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Goodwill and other intangible asset impairment charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net loss (gain) on investments and notes receivable</a></td>
<td class="nump">36<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="nump">48<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_InventoryStepUpAmortization', window );">Inventory step-up amortization</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherNet', window );">Other, net</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(180)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(244)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="num">(449)<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash provided by (used for) operating activities</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment and internal use software</a></td>
<td class="num">(226)<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(1,471)<span></span>
</td>
<td class="num">(706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Payments for Hedge, Investing Activities</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from disposal of certain businesses and assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies', window );">Proceeds from (payments for) investments and acquisitions of certain technologies</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash provided by (used for) investing activities</a></td>
<td class="num">(1,603)<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration previously established in purchase accounting</a></td>
<td class="num">(283)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentsForRoyaltyRights', window );">Payments for royalty rights</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Payments on short-term borrowings</a></td>
<td class="num">(250)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Net increase (decrease) in commercial paper</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on long-term borrowings and debt extinguishment costs</a></td>
<td class="num">(3,184)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from long-term borrowings, net of debt issuance costs</a></td>
<td class="nump">3,270<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid on preferred stock</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Paymenttonetsharesettleemployeeequityawards', window );">Cash used to net share settle employee equity awards</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided by (used for) financing activities</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="num">(1,710)<span></span>
</td>
<td class="nump">903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</a></td>
<td class="nump">2,168<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</a></td>
<td class="nump">458<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair value of contingent consideration recorded in purchase accounting</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (43)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash flow impact of deferred income tax expense (benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_InventoryStepUpAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory step up amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_InventoryStepUpAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Noncashimpactoftransferredroyaltyrights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Noncashimpactoftransferredroyaltyrights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentsForRoyaltyRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentsForRoyaltyRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Paymenttonetsharesettleemployeeequityawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment to net share settle employee equity awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Paymenttonetsharesettleemployeeequityawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from (payments for) investments and acquisitions of certain technologies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355628752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Supplemental Disclosure) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 1,925<span></span>
</td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 458<span></span>
</td>
<td class="nump">$ 2,168<span></span>
</td>
<td class="nump">$ 2,898<span></span>
</td>
<td class="nump">$ 1,995<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853359119632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853361869360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Strategic Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND STRATEGIC INVESTMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed one acquisition in the first six months of 2022, and one acquisition and one divestiture in the first six months of 2021. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2022, we announced our entry into a definitive agreement with Synergy Innovation Co, Ltd, to purchase its majority stake of M.I. Tech Co., Ltd., (M.I. Tech), a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. The agreement, whereby we will purchase approximately 64 percent of the outstanding shares of M.I. Tech, consists of a purchase price of KRW 291.2 billion or approximately $230 million, subject to closing adjustments. The acquisition is expected to close during the second half of 2022, subject to customary closing conditions. The M.I. Tech stent portfolio complements our existing Endoscopy portfolio which will give physicians more treatment options to meet specific patient needs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which has developed the radiofrequency (RF) NRG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and VersaCross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which expands our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment of $1.471 billion, net of cash acquired, subject to closing adjustments. We are integrating the Baylis Medical business into our Cardiology division.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price was comprised of the amounts presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 805).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the acquisition of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $925 million and up to an additional $300 million in a potential commercial milestone payment. We had been an investor in Preventice since 2015 and held an equity stake of approximately 22 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $195 million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first quarter of 2021. The transaction price for the remaining stake consisted of an upfront cash payment of $706 million, net of cash acquired, and an additional revenue-based milestone payment of $216 million made during the second quarter of 2022. The Preventice business is being managed by our Cardiology division. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of Preventice as a business combination, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022 we recorded certain measurement period adjustments related to our prior year acquisition of the surgical business of Lumenis, LTD. (Lumenis). We recorded an accrued income tax liability within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other non-current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets of $177 million related to uncertain tax positions assumed in connection with the acquisition. We were indemnified by the sellers for the majority of such tax obligations and recognized a corresponding indemnification asset of $172 million at the acquisition date within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Subsequent to the acquisition date, interest and penalties accrued on the tax liability are being recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and corresponding adjustments to the indemnification asset are being recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations. The outcome of these matters is subject to uncertainty and ultimately, the amount of tax due and the related indemnification reimbursement we receive will be dependent on the outcome of tax return examinations by relevant authorities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details regarding our indemnification asset.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $800 million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of five facilities and approximately 280 employees globally. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter and first six months of 2021, we recognized a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain on disposal of businesses and assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the transaction of $2 million and $9 million, respectively, within our accompanying unaudited consolidated statements of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability during the first six months of 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">486</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was $544 million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$107 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$112 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to research and development (R&amp;D), regulatory and commercialization-based milestones and revenue-based payments are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of June&#160;30, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Publicly-held securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span>As of June&#160;30, 2022, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $233 million, which represents amortizable intangible assets, in-process research and development (IPR&amp;D), goodwill and deferred tax liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358300912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,078)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,955</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,838)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,476)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,783</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in our balance of goodwill and amortizable intangible assets is primarily related to our acquisition of Baylis Medical completed in the first quarter of 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,241</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Asset Impairments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the first six months of 2022 or 2021. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. Following the reorganization of our operational structure in the first quarter of 2022, we identified the following reporting units for purposes of our annual goodwill impairment test: Interventional Cardiology, Rhythm Management, Peripheral Interventions, Endoscopy, Urology and Pelvic Health and Neuromodulation. Based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 350), we aggregated the Interventional Cardiology Therapies and Watchman components of our Cardiology operating segment into a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">single Interventional Cardiology reporting unit, and aggregated the Cardiac Rhythm Management and Electrophysiology components into a single Rhythm Management reporting unit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, we performed our annual goodwill impairment test utilizing both the qualitative and quantitative approach described in FASB ASC Topic 350. The qualitative approach was used for testing reporting units where fair value has historically exceeded carrying value by greater than 100 percent, and all other reporting units were tested using the quantitative approach. For those tested using the qualitative approach, after assessing the totality of events, it was determined that it was not more likely than not that the fair value of the reporting units was less than their carrying value, and it was not deemed necessary to proceed to the quantitative test. For all reporting units tested using the quantitative approach, we determined that the fair value of each reporting unit exceeded their carrying value and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $7 million in the second quarter and first six months of 2022, and $45 million in the second quarter and first six months of 2021. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. During the second quarter of 2021, we determined it was more likely than not that one of our indefinite-lived intangible assets was impaired based on our qualitative assessment of impairment indicators. We tested the intangible asset for recoverability and recorded an impairment charge associated with incremental time and cost to complete the associated in-process research and development (IPR&amp;D) project.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853359062256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, British pound sterling, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of June&#160;30, 2022 and December&#160;31, 2021, we designated as a net investment hedge a portion of our &#8364;900 million in aggregate principal amount of 0.625% euro-denominated senior notes issued in November 2019 and due in 2027 (2027 Notes). For these nonderivative instruments, we defer recognition of the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency remeasurement gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of June&#160;30, 2022 or December&#160;31, 2021. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $9 million loss as of June&#160;30, 2022</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a $24 million loss as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of June&#160;30, 2022 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature between one and three years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.117%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">966</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">760</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">966</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">767</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $36 million invested in money market funds and time deposits as of June&#160;30, 2022 and $1.632 billion as of December&#160;31, 2021, we held $240 million in interest-bearing and non-interest-bearing bank accounts as of June&#160;30, 2022 and $293 million as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We maintain a financial asset and associated liability for our licensing arrangements measured at fair value in our accompanying unaudited consolidated balance sheets in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2022 include the following significant unobservable inputs:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$182 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$215 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">281</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $8.517 billion as of June&#160;30, 2022 and $10.196 billion as of December&#160;31, 2021. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853359143760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</a></td>
<td class="text">The debt maturity schedule for our long-term debt obligations is presented below: <div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.875%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,802</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December 31, 2021, respectively.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below. In addition, in the first quarter of 2022, we repaid $250 million of 3.375% May 2022 Senior Notes classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated balance sheets as of December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the 2021 Revolving Credit Facility as of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022 or December&#160;31, 2021; however, outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility.</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of 3.75 times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for the recently completed qualified acquisitions due to the funding using cash on hand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreement, through maturity, of any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2022, we had $311 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $1.455 billion in the aggregate. As of June&#160;30, 2022, we had $1.080 billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the 2021 Revolving Credit Facility. We had $155 million of commercial paper outstanding as of June&#160;30, 2022 and none as of December&#160;31, 2021. </span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 days</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 days</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $8.878 billion as of June&#160;30, 2022 and $9.121 billion as of December&#160;31, 2021. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, American Medical Systems Europe B.V. (AMS Europe), an indirect, wholly owned subsidiary of Boston Scientific, completed a registered public offering (the Offering) of &#8364;3.000 billion in aggregate principal amount of euro-dominated senior notes comprised of &#8364;1.000 billion of 0.750% Senior Notes due 2025, &#8364;750 million of 1.375% Senior Notes due 2028, &#8364;750 million of 1.625% Senior Notes due 2031 and &#8364;500 million of 1.875% Senior Notes due 2034 (collectively, the Eurobonds). Boston Scientific has fully and unconditionally guaranteed all of AMS Europe's obligations under the Eurobonds, and no other subsidiary of Boston Scientific will guarantee these obligations. AMS Europe is a &#8220;finance subsidiary&#8221; as defined in Rule 13-01(a)(4)(vi) of Regulation S-X. The financial condition, results of operations and cash flows of AMS Europe are consolidated in the financial statements of Boston Scientific. The Offering resulted in cash proceeds of $3.270 billion, net of investor discounts and issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $3.275&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. We recorded associated debt extinguishment charges of $194 million in the first quarter of 2022 presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $128 million as of June&#160;30, 2022 and $134 million as of December&#160;31, 2021, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of June&#160;30, 2022 and December&#160;31, 2021 we had not recognized a related liability for any outstanding letters of credit within our accompanying unaudited consolidated balance sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355623808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET INFORMATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions within our accompanying unaudited consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.861%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 326), we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic and geopolitical conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other entities, and, in southern Europe, relative to those in other countries. More recently, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,610</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">874</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $80 million&#160;for the second quarter of 2022, $83 million for the second quarter of 2021, $156 million for the first six months of 2022, and $166 million for the first six months of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">784</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">783</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our 2019 acquisition of BTG plc. (BTG), we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom employees. During the second quarter of 2022, we transferred the benefit obligation and associated assets of the pension plan to third party insurers, and as a result, were relieved from primary responsibility of the benefit obligation and the related plan assets. The transaction did not have a material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853361811024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our reported tax rates for the second quarter and first six months of 2022, as compared to the same periods in 2021, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include acquisition/divestiture-related charges and receipts, charges and receipts on investment portfolio net losses (gains), litigation-related net charges, as well as certain discrete tax items primarily related to changes in tax laws, unrecognized tax benefits, changes in valuation allowance and foreign return-to-provision adjustments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we had $411 million of gross unrecognized tax benefits, of which a net $333 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2021, we had $255 million of gross unrecognized tax benefits, of which a net $177 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $55 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853359143760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity. For additional information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $514 million as of June&#160;30, 2022 and $548 million as of December&#160;31, 2021 and includes certain estimated costs of settlement, damages and defense primarily related to product liability cases or claims related to our transvaginal surgical mesh products. A portion of this accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $132 million as of June&#160;30, 2022 and $188 million as of December&#160;31, 2021. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We recorded litigation-related net charges of $42 million during the second quarter and first six months of 2022, $298 million during the second quarter of 2021 and $302 million during the first six months of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against four then-asserted patents, which resulted in the court staying the case until 2020. All IPRs concluded and confirmed the validity of certain claims of each challenged patent. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in February 2023. The Company has also asserted patents against Cook in Germany and the United Kingdom. In January 2022, the D&#252;sseldorf Regional Court, Patent Litigation Chamber ruled that Cook&#8217;s Instinct Endoscopic Clip technology infringes the Company&#8217;s patent, EP 3 023 061. The D&#252;sseldorf Court granted an ex parte preliminary injunction giving the Company the right to enjoin Cook (Cook Medical EUDC GmbH, Germany, Cook </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutschland GmbH, Germany and Cook Medical Europe Ltd., Ireland) from offering and selling Instinct Endoscopic Clips in Germany.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, in the United States, approximately 55,000 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. Outside the United States, approximately 2,700 cases or claims have been asserted, predominantly in Canada, the United Kingdom, Ireland and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately 53,000 cases and claims in the United States, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 53,000 cases and claims, approximately 52,000 have met the conditions of the settlement and are final. In Canada, we have settled approximately 300 claims. In Australia, the Company has reached a settlement, subject to court approval, that resolves the approximately 2,300 claims asserted in the consolidated class action filed against the Company in the first quarter of 2021. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the company is facing fewer than 90 cases and claims in the United Kingdom and Canada.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In February 2021, the Multi-District Litigation (MDL) established in February 2012 by the United States Federal Courts was closed after all pending cases were dismissed or remanded to courts of primary jurisdiction.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle, and expect that more cases will go to trial through 2023. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in 127 filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and actively selling in the fourth quarter of 2018. The plaintiffs assert they are entitled to monetary damages related to alleged injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of approximately 325 claims, none of which have been filed. As of June&#160;30, 2022, we have entered into master settlement agreements with certain plaintiffs' counsel to resolve approximately 225 cases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#8217;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. Subsequently, on March 30, 2022, the Federal Prosecutor&#8217;s office issued a non-binding recommendation that is contrary to the Attorney General&#8217;s recommendation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full Commission is considering both of these recommendations but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#8217;s decision.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam. The Company is cooperating with government agencies while investigating these allegations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments were due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents. Labcoat sought monetary damages related to an earn-out provision. On March 25, 2022, the parties agreed to a confidential settlement which resolves the dispute. The settlement did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro Corp. (Nevro) in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro's Senza&#8482; Spinal Cord Stimulation (SCS) System. The company sought lost profits, a reasonable royalty and a permanent injunction. At a trial held in October and November 2021 regarding six of Boston Scientific's originally asserted patent claims, a jury granted Boston Scientific a monetary award, finding that each asserted claim was valid, that four of the six claims were infringed by Nevro, and that two of the claims were willfully infringed by Nevro. On July 29, 2022, the parties reached a confidential settlement agreement, pursuant to which the Company agreed to make a payment to Nevro of $85 million to resolve all pending litigation between the parties, including this matter and the 18-cv-664 and 21-cv-258 matters described below. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation were infringed by Nevro&#8217;s Senza&#8482; I and Senza&#8482; II SCS Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our SCS systems infringed five Nevro patents. Nevro sought lost profits, a reasonable royalty and a permanent injunction. On July 29, 2022, the parties agreed to a confidential settlement, described above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, Nevro filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#8217;s spinal cord stimulation systems. Nevro sought lost profits, a reasonable royalty and a permanent injunction. On July 29, 2022, the parties agreed to a confidential settlement, described above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358865488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of June&#160;30, 2022, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared, and we paid, a cash dividend of $1.375 per MCPS share to holders of our MCPS as of May 15, 2022, representing a dividend period from March 2022 through May 2022. On July 25, 2022 the Committee declared a cash dividend of $1.375 per MCPS share to holders of our MCPS as of August 15, 2022, representing a dividend period from June through August 2022. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheet as of June&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358216112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Weighted Average Number Of Shares Outstanding [Text Block]</a></td>
<td class="text"><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,437.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,432.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,438.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,431.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the second quarter and first six months of 2022 and 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented within our accompanying unaudited consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued less than one million shares of our common stock in the second quarter of 2022, approximately four million shares in the first six months of 2022, approximately one million shares in the second quarter of 2021, and approximately five million shares in the first six months of 2021, following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first six months of 2022 or 2021. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of June&#160;30, 2022, we had the full amount remaining available under the authorization.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358216112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. There was no impact to the reporting units identified for purposes of our annual goodwill impairment testing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and evaluate our reportable segments based on their respective net sales, operating income, excluding intersegment profits, and operating income as a percentage of net sales, all excluding the impact of foreign currency. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations and are included in the reconciliation below. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for net sales by reportable segment presented in accordance with U.S. GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages). We have revised prior periods to conform to the current year presentation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,526</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,758</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">474</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Prior to the divestiture, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.</span></div></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853451099488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes within our accompanying unaudited consolidated statements of operations. In the first quarter of 2022, we reorganized our business structure into five operating segments and on March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction. The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We have revised prior periods to conform to current year presentation:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">906</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">877</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,933</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,277</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,602</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,402</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,483</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">769</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,760</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,868</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,893</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,564</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,711</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,559</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note K- Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for information on our reportable segments.</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">359</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">817</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, which currently includes the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $501 million as of June&#160;30, 2022 and $484 million as of December&#160;31, 2021. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiology business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our Cardiology business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $35 million in the second quarter and $76 million in the first six months of 2022 that was included in the above contract liability balance as of December&#160;31, 2021. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on variable consideration, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853451099488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income (Loss) Note [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">134</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from Accumulated other comprehensive income (loss), net of tax.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358216112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NewAccountingPronouncementsPolicyTextBlock', window );">New Accounting Pronouncements, Policy</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first six months of 2022, we implemented the following standards, which did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We adopted Update No. 2021-05 in the first quarter of 2022 on a prospective basis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASC Update No. 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods. Update No. 2022-01 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the corresponding period. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASC Update No. 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments- Credit Losses (Topic 326: Troubled Debt Restructurings and Vintage Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-02 makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13. Update No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Update No. 2022-02 should be applied prospectively, with the option of modified retrospective adoption for the recognition and measurement of troubled debt restructurings. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2016-13. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASC Update No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance and the amendments in this update should be applied prospectively. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NewAccountingPronouncementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New Accounting Pronouncements, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NewAccountingPronouncementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853470578512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853451099488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853451099488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Commitments and Contingencies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs, Policy [Policy Text Block]</a></td>
<td class="text">FASB ASC Topic 450, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span>Our accrual for legal matters that are probable and estimable was<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358524576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock', window );">ASC Update No. 2020-10 Codification Improvements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such </span></div>classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We adopted Update No. 2021-05 in the first quarter of 2022 on a prospective basis.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock', window );">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASC Update No. 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods. Update No. 2022-01 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the corresponding period. We do not expect the adoption to have a material impact on our financial position or results of operations.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock', window );">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASC Update No. 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments- Credit Losses (Topic 326: Troubled Debt Restructurings and Vintage Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-02 makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13. Update No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Update No. 2022-02 should be applied prospectively, with the option of modified retrospective adoption for the recognition and measurement of troubled debt restructurings. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2016-13. We do not expect the adoption to have a material impact on our financial position or results of operations.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock', window );">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASC Update No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance and the amendments in this update should be applied prospectively. We do not expect the adoption to have a material impact on our financial position or results of operations.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-10 Codification Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355546720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Strategic Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability during the first six months of 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">486</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$107 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$112 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Investment [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Publicly-held securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text">The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 805).</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text">The final purchase price was comprised of the following components:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358859200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,078)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,955</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,838)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,476)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,783</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,241</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355415792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock', window );">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.117%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</a></td>
<td class="text">The following are the balances of our derivative and nonderivative assets and liabilities:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">966</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">760</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">966</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">767</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2022 include the following significant unobservable inputs:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$182 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$215 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">281</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853356821520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments [Table Text Block]</a></td>
<td class="text">The debt maturity schedule for our long-term debt obligations is presented below: <div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.875%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,802</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December 31, 2021, respectively.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below. In addition, in the first quarter of 2022, we repaid $250 million of 3.375% May 2022 Senior Notes classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated balance sheets as of December 31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock', window );">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility.</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt [Table Text Block]</a></td>
<td class="text">We had $155 million of commercial paper outstanding as of June&#160;30, 2022 and none as of December&#160;31, 2021. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 days</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 days</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of term loan and revolving credit facility agreement compliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355457104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade accounts receivable, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.861%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Disclosure [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,610</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">874</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">784</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">783</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other long-term liabilities [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our 2019 acquisition of BTG plc. (BTG), we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom employees. During the second quarter of 2022, we transferred the benefit obligation and associated assets of the pension plan to third party insurers, and as a result, were relieved from primary responsibility of the benefit obligation and the related plan assets. The transaction did not have a material impact on our financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358829408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems', window );"><strong>Schedule of Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock', window );">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853356177216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,437.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,432.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,438.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,431.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358933088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages). We have revised prior periods to conform to the current year presentation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,526</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,758</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">474</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Prior to the divestiture, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.</span></div></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358841568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We have revised prior periods to conform to current year presentation:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">906</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">877</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,933</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,277</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,602</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,402</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,483</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">769</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,760</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,868</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,893</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,564</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,711</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,559</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note K- Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for information on our reportable segments.</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">359</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">817</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, which currently includes the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853358871008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">134</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from Accumulated other comprehensive income (loss), net of tax.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853361892048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>reportablesegments</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853348996208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures (Details)<br> &#8361; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 15, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 15, 2022 </div>
<div>KRW (&#8361;)</div>
</th>
<th class="th">
<div>Feb. 14, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of Businesses Acquired | business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NumberOfBusinessesDivested', window );">Number Of Businesses Divested | business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,471<span></span>
</td>
<td class="nump">$ 706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DivestitureAgreementTransferOfFacilities', window );">Transfer of facilities | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DivestitureAgreementTransferOfGlobalEmployees', window );">Divestiture, agreement, transfer of global employees | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical | Weighted Average [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical | Weighted Average [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice | Weighted Average [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice | Weighted Average [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisMember', window );">Lumenis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate', window );">Business Combination, Indemnification Assets, Amount as of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_MITechCoLtdMember', window );">M.I. Tech Co., Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">&#8361; 291,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="nump">64.00%<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DivestitureAgreementTransferOfFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture, agreement, transfer of facilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DivestitureAgreementTransferOfFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DivestitureAgreementTransferOfGlobalEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture, agreement, transfer of global employees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DivestitureAgreementTransferOfGlobalEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NumberOfBusinessesDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Businesses Divested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NumberOfBusinessesDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_LumenisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_MITechCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_MITechCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853349753888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair value of contingent consideration recorded in purchase accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="num">$ (85)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="num">$ (91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllBusinessAcquisitionsMember', window );">All Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration liability, probability of payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationLiabilityProbabilityOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_AllBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_AllBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355912064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Strategic Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 212<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Measurement alternative investments(1)</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Notes receivable</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">$ 412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</a></td>
<td class="nump">$ 233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853354844688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>reportablesegments</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 14,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(8,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,476)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">12,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">4,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(88)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">8,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, Gross</a></td>
<td class="nump">22,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">12,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(7,078)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,078)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,754)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(398)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">1,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (1,368)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,368)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,325)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_IntangibleAssetsandGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_IntangibleAssetsandGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853341324128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>units </div>
<div>derivative_instrument</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>units </div>
<div>derivative_instrument</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>EUR (&#8364;) </div>
<div>units </div>
<div>derivative_instrument</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>derivative_instrument</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">$ 363,000,000<span></span>
</td>
<td class="nump">$ 146,000,000<span></span>
</td>
<td class="nump">$ 363,000,000<span></span>
</td>
<td class="nump">$ 146,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,000,000<span></span>
</td>
<td class="nump">$ 206,000,000<span></span>
</td>
<td class="nump">$ 165,000,000<span></span>
</td>
<td class="nump">$ 36,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">7,917,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,917,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,378,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">165,000,000<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">121,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">1,011,000,000<span></span>
</td>
<td class="nump">945,000,000<span></span>
</td>
<td class="nump">1,966,000,000<span></span>
</td>
<td class="nump">1,839,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">64,000,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="nump">343,000,000<span></span>
</td>
<td class="nump">168,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other Operating Income (Expense), Net</a></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">46,000,000<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liability, Fair Value, Gross Liability</a></td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">252,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">88,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">219,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">103,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">8,517,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,517,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 935,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 935,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,021,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember', window );">Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (72,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember', window );">Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">$ 182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,632,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">760,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">760,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,282,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">219,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,838,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,632,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,642,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">219,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">434,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">767,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">498,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">938,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">938,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,049,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">$ 926,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 926,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,011,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ForwardCurrencyContractsTimetoMaturity', window );">Forward Currency Contracts, Time to Maturity | units</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">$ 246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">252,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="num">(34,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(63,000,000)<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="nump">35,000,000<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="nump">56,000,000<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Netcurrencyexchangegainloss', window );">Net currency exchange gain (loss)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">3,029,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,029,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,892,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</a></td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative, Term of Contract (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeRemainingMaturity1', window );">Derivative, Remaining Maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 251,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="num">$ (3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of Interest Rate Derivatives Held | derivative_instrument</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 3,527,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,527,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,996,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">213,000,000<span></span>
</td>
<td class="num">(15,000,000)<span></span>
</td>
<td class="nump">259,000,000<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="num">(48,000,000)<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="num">(58,000,000)<span></span>
</td>
<td class="num">(35,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">165,000,000<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">121,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(41,000,000)<span></span>
</td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(71,000,000)<span></span>
</td>
<td class="num">(16,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">16,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(32,000,000)<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(55,000,000)<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet', window );">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">365,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">34,000,000<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">39,000,000<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">997,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 997,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">62,000,000<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="num">(14,000,000)<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="num">(19,000,000)<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">48,000,000<span></span>
</td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="nump">27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ForwardCurrencyContractsTimetoMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forward Currency Contracts, Time to Maturity in Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ForwardCurrencyContractsTimetoMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Netcurrencyexchangegainloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Netcurrencyexchangegainloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Noncashimpactoftransferredroyaltyrights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Noncashimpactoftransferredroyaltyrights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeRemainingMaturity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeRemainingMaturity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853339436320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 10, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>Rate</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,971,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,065,000,000.000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Capital Lease Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,802,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,804,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ExclusionFromEbitdaForRestructuringCharges', window );">Exclusion from EBITDA for Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationAndDebtExclusionFromEbitda', window );">Litigation and Debt Exclusion from EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,455,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Legal payments remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,080,000,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_QualifiedAcquisitionConsideration', window );">Qualified Acquisition Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 194,000,000<span></span>
</td>
<td class="num">(194,000,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from long-term borrowings, net of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,270,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember', window );">Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember', window );">Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumCommercialPaperOutstanding', window );">Maximum Commercial Paper Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,595,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Short-term Debt, Weighted Average Interest Rate, at Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=bsx_May2022NotesMember', window );">May 2022 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_CurrentRequirementMember', window );">Current Requirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_ActualCovenantMember', window );">Actual, Covenant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember', window );">Requirement, as of December 31, 2021 and through remaining term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember', window );">Requirement, four succeeding quarters following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fifth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, sixth quarter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, seventh quarter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember', window );">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain', window );">the 2018 Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 2,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember', window );">October 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember', window );">March 2024 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember', window );">May 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember', window );">June 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember', window );">March 2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">935,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,021,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember', window );">March 2028 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember', window );">March 2029 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember', window );">June 2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember', window );">November 2035 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember', window );">March 2039 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember', window );">January 2040 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember', window );">March 2049 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,878,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,121,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Finance Lease Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2025NotesMember', window );">March 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,039,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028SeniorNotesMember', window );">March 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2031NotesMember', window );">March 2031 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2034NotesMember', window );">March 2034 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingAggregatePrincipalAmountMember', window );">the Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember', window );">the Offering - early redemption of combined aggregate principal SN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member', window );">2021 Revolving Credit Facility | Line of Credit | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DebtInstrumentExtensionOptionTerm', window );">Debt Instrument, Extension Option, Term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember', window );">Euro Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember', window );">Yen Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember', window );">Renminbi Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DebtInstrumentExtensionOptionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Option, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DebtInstrumentExtensionOptionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExclusionFromEbitdaForRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion from EBITDA for Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExclusionFromEbitdaForRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal payments remaining to be excluded from calculation of consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationAndDebtExclusionFromEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationAndDebtExclusionFromEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumCommercialPaperOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Commercial Paper Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumCommercialPaperOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio permitted by revolving credit facility agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_QualifiedAcquisitionConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Qualified Acquisition Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_QualifiedAcquisitionConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=bsx_May2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=bsx_May2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_CurrentRequirementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_CurrentRequirementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_ActualCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_ActualCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2031NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2031NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2034NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2034NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingAggregatePrincipalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingAggregatePrincipalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853351510000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="nump">$ 1,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted Cash Equivalents in Other long-term assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">458<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">2,168<span></span>
</td>
<td class="nump">$ 1,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Trade accounts receivable, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Allowance for doubtful accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charges to expenses</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Utilization of allowances</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherCurrentAssetsAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangements', window );">Licensing arrangements</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other Assets, Miscellaneous, Current</a></td>
<td class="nump">362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">1,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EquipmentFurnitureAndFixturesGross', window );">Equipment, furniture and fixtures</a></td>
<td class="nump">3,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Capital in progress</a></td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">5,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="nump">3,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract', window );"><strong>Supplemental Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IndemnificationAsset', window );">Indemnification asset</a></td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherOtherLongtermAssets', window );">Other, Other Long-term Assets</a></td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets, Noncurrent</a></td>
<td class="nump">1,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal reserves, current</a></td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related liabilities</a></td>
<td class="nump">754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AccruedRebatesCurrent', window );">Accrued Rebates, Current</a></td>
<td class="nump">335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business Combination, Contingent Consideration, Liability, Current</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">2,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued Royalties, Current</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes Payable, Current</a></td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other Sundry Liabilities, Current</a></td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 1,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AccruedRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AccruedRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EquipmentFurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equipment, furniture and fixtures Gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EquipmentFurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_IndemnificationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_IndemnificationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherOtherLongtermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, Other Long-term Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherOtherLongtermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853360129840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate from continuing operations</a></td>
<td class="nump">24.70%<span></span>
</td>
<td class="num">(24.90%)<span></span>
</td>
<td class="nump">26.10%<span></span>
</td>
<td class="num">(11.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">$ 411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853354921920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>claims </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>claims </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for legal matters that are probable and estimable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada', window );">Product liability cases or claims related to mesh product - Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom', window );">Product liability cases or claims related to mesh product - United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CertifiedClassActionsInAustraliaMesh', window );">Certified class actions in Australia, Mesh | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter', window );">Product liability cases related to Greenfield Vena Cava Filter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter', window );">Product liability claims, not filed, related to Greenfield Vena Cava Filter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter', window );">Cases in final stages of resolution, related to Greenfield Vena Cava Filter | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CanadaSettledClaims', window );">Canada, settled claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party | $</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct', window );">Total Product liability cases and claims settled related to Mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CanadaSettledClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Canada, settled claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CanadaSettledClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cases in final stages of resolution, related to Greenfield Vena Cava Filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CertifiedClassActionsInAustraliaMesh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Certified class actions in Australia, Mesh</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CertifiedClassActionsInAustraliaMesh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases related to Greenfield Vena Cava Filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability claims, not filed, related to Greenfield Vena Cava Filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims asserted related to mesh products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Productliabilitycasesorclaimsrelatedtomeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - Canada</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - United Kingdom</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Product liability cases and claims settled related to Mesh product</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355356208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 25, 2022</div></th>
<th class="th"><div>May 27, 2020</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred Stock, Liquidation Preference, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Preferred Stock, Dividends Per Share, Declared</a></td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853347619536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">1,429,700<span></span>
</td>
<td class="nump">1,421,300<span></span>
</td>
<td class="nump">1,428,800<span></span>
</td>
<td class="nump">1,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">8,100<span></span>
</td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">1,437,800<span></span>
</td>
<td class="nump">1,432,500<span></span>
</td>
<td class="nump">1,438,100<span></span>
</td>
<td class="nump">1,431,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">4,000,000,000<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853351253040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>reportablesegments </div>
<div>business</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NumberOfBusinesses', window );">Number Of Businesses | business</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="num">$ (204)<span></span>
</td>
<td class="num">$ (180)<span></span>
</td>
<td class="num">$ (402)<span></span>
</td>
<td class="num">$ (365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="nump">889<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales', window );">Impact of Foreign Currency Fluctuations on Net Sales</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,244<span></span>
</td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
<td class="nump">5,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,933<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">1,277<span></span>
</td>
<td class="nump">2,559<span></span>
</td>
<td class="nump">2,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology and Pelvic Health [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">397<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="nump">758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology and Pelvic Health [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology and Pelvic Health [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">740<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">2,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement', window );">Revenues from contracts with customers, disaggregated - performance measurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement', window );">Revenues from contracts with customers, disaggregated - performance measurement</a></td>
<td class="nump">$ 1,278<span></span>
</td>
<td class="nump">$ 1,185<span></span>
</td>
<td class="nump">$ 2,442<span></span>
</td>
<td class="nump">$ 2,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">31.20%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">31.50%<span></span>
</td>
<td class="nump">33.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,248<span></span>
</td>
<td class="nump">$ 1,195<span></span>
</td>
<td class="nump">$ 2,402<span></span>
</td>
<td class="nump">$ 2,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">844<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="nump">1,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">543<span></span>
</td>
<td class="nump">529<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement', window );">Revenues from contracts with customers, disaggregated - performance measurement</a></td>
<td class="nump">$ 2,066<span></span>
</td>
<td class="nump">$ 1,865<span></span>
</td>
<td class="nump">$ 3,967<span></span>
</td>
<td class="nump">$ 3,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">26.30%<span></span>
</td>
<td class="nump">28.40%<span></span>
</td>
<td class="nump">25.70%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,996<span></span>
</td>
<td class="nump">$ 1,883<span></span>
</td>
<td class="nump">$ 3,868<span></span>
</td>
<td class="nump">$ 3,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
<td class="nump">1,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">906<span></span>
</td>
<td class="nump">877<span></span>
</td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement', window );">Revenues from contracts with customers, disaggregated - performance measurement</a></td>
<td class="nump">3,344<span></span>
</td>
<td class="nump">3,050<span></span>
</td>
<td class="nump">6,410<span></span>
</td>
<td class="nump">5,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,244<span></span>
</td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
<td class="nump">5,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,933<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember', window );">Total allocated to reportable segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">1,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember', window );">Corporate expenses and currency exchange [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">(123)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember', window );">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">$ (192)<span></span>
</td>
<td class="num">$ (331)<span></span>
</td>
<td class="num">$ (308)<span></span>
</td>
<td class="num">$ (445)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impact of Foreign Currency Fluctuations on Net Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NumberOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Businesses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NumberOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeAllocatedToReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Allocated to Reportable Segments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeAllocatedToReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeUnallocatedToSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Unallocated to Segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeUnallocatedToSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues from contracts with customers, disaggregated - performance measurement - measures used by CODM to make business decisions, excludes impact of foreign currency fluctuations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Segmentoperatingincomeaspercentageofnetsales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment operating income as percentage of net sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Segmentoperatingincomeaspercentageofnetsales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_WatchmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_WatchmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853338817776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 3,244<span></span>
</td>
<td class="nump">$ 3,077<span></span>
</td>
<td class="nump">$ 6,270<span></span>
</td>
<td class="nump">$ 5,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EmergingMarketstotalnumberofcountries', window );">Emerging Markets total countries | units</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,244<span></span>
</td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">$ 6,270<span></span>
</td>
<td class="nump">5,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,933<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,933<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">1,277<span></span>
</td>
<td class="nump">2,559<span></span>
</td>
<td class="nump">2,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">1,277<span></span>
</td>
<td class="nump">2,559<span></span>
</td>
<td class="nump">2,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember', window );">Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="nump">817<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="nump">817<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology and Pelvic Health [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">397<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">397<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology and Pelvic Health [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology and Pelvic Health [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">740<span></span>
</td>
<td class="nump">699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">740<span></span>
</td>
<td class="nump">699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">2,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">2,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">3,244<span></span>
</td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
<td class="nump">5,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,244<span></span>
</td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
<td class="nump">5,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,933<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,933<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | APAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | Latin America and Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
<td class="nump">2,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
<td class="nump">2,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">844<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="nump">1,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">844<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="nump">1,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,996<span></span>
</td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">3,868<span></span>
</td>
<td class="nump">3,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,996<span></span>
</td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">3,868<span></span>
</td>
<td class="nump">3,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
<td class="nump">1,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
<td class="nump">1,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">906<span></span>
</td>
<td class="nump">877<span></span>
</td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 906<span></span>
</td>
<td class="nump">$ 877<span></span>
</td>
<td class="nump">$ 1,760<span></span>
</td>
<td class="nump">$ 1,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EmergingMarketstotalnumberofcountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Markets total number of countries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EmergingMarketstotalnumberofcountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_WatchmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_WatchmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139853355515616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (47)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</a></td>
<td class="num">$ (127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>bsx-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20220630"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bsx-20220630.xsd" xlink:type="simple"/>
    <context id="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3470063d13da4b78885156191cea35c6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i92528d124d4e47d4a4ecea47db134aa8_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia14da29940934c628d805300ec2c17c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d88de9252574e38a75e71a25f421c17_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c57ac41bacb4c959c5a7c938d5fe29b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic39344112e4b495b9d151b1e92eaac82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic195e04f558f4180bdfa85d54ab847eb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1083b51b32f84f9ca03bffc92e5faa00_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idc86164a6a43461a9651ec61b88f32e6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id535101847a6481a96023d3bc410b6bd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifd0efc03c9fd497083ef2469237d078f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2696e3eb89444f7e9d4aa930e613f0b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ideceab173cc44867a7c0a083004446ae_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifee4f63199724a10854016dabc453a58_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id049216887f0461ebc0924dd96909b7f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic8f7a0da6f194f4f924ff1168b96527d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id45c80183e4a4f64b08b6a4853ef9f4c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i815c23c139b84522831b294d59dd7d1e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if1accaba913b4d1fbcb2c28cac07c0b0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie90c9ee4716140dd8fae0ab1d0950fed_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9391520b32e640fe97bcc36c1e5962f2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i22ff7c22212045f6b95c0a15cfeed14a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibf5905737675481fb710c2ba0f468446_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fd9a0d26fab4332b61d8fad802ce5c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if15cc720f87a460abc0eb4e4e59fe876_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8d680683b1e14d29be1a910573f28e70_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic5f97f1273c1442381613e9edae599b9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7c84bc9bc635449b990165995bfde9a2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6cd771fc7d304e65a737b060eb018b8f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3466963199fd4fa3ade9bfff3a977e9f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i84240be430054940bd414a4c7f52641a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if25f858a6d47415ba74ad94fa706aa56_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6833d10fdee44d23b00e6ef571848119_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b6ff8621f654a959cb451ed414f77d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e2b757294d44982a169d202719a992a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia346d18d384c42c7a6e99a584fdc97ce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9a9e610d324a45d1a062c68adfb90b1f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i74f91cea543f4d33980254e8da67f9f5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic48e2fdfe8f64c8b8bae824c8b0d223a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9be8a81ffb4f47a6b727c3d0e0043401_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i04889bdcfd104454b1ef3794d7f8830a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if43d66985bfd4da1b42f8e3e134778a6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib2c7ff30c0e34b678886a170580868c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44a04e2556f74b76bb8d693c12f82912_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a98c3dc779644d6b41945be1f5e75ed_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i62ebba7d42bf4a138a7fea99714df893_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id47b2514859f4f27848ade4cccce2be8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7ffda331fdc249b9afd399366fe2269a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i43c66b638de3480c9eb8a388b49f2860_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7781cde9f4be4c6f8a6068f01de92fb5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9303b7f6c9604c1a9623997b119bcbcd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib4588728b1b54b1598ce091e28f075b5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i530a24628ff94bd8b6ecf768eb616100_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f2c362bdaec4d7c93ae599a3400d63c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i23a6e58ba7314b24a600982bbb84d5a8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icbd1a4c6e5ac4665bd79ed3e6e017085_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i685d9eb49f444cc59ed839c5b206c9d5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icbe2dc1f9b004e68839d9b76d40729f1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i53edfe4ecc4f46be8baf73fc46188f98_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifb6d5756a23e440086572a008869074f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i34144dea661c452383c3d71bbf39f3ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee11fc6752204977a88f533ae4110495_I20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MITechCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-15</instant>
        </period>
    </context>
    <context id="i901ac63f75eb49639a4b506d76c7ec85_D20220615-20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MITechCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="i5d7ad645f9b848e1960b6c1e9e613c6d_D20220214-20220214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-14</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic6d6608abc97401680adb8a26144b089_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie6ac896dcc134060bdfc576d15c1f097_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i28d9b36d9b8943b68833ea0d071ed7d7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1d861b96bd57474b92fcd29da39816fd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8031cd75b7814af29c4289dc1effe3ab_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib50cd8c4907244fa92f0e05706dcb767_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i4462bc60133842ae953e65f20c772978_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifabaa3915ef144c09350675944f975ab_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie6400d3c1fc24ca7bc85488919500c81_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9b875ad2ff61444eb8f91d7e24664368_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i75537fd4e06e411da653741c44074044_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if74b152ba6674c9da5871cb3bbed2af5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia306834040fd4493904c3d80050dfd07_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0038b38441f64cd1b1acadca2f9bdaf0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4e1b80835cd3429dbe3445e36fc51f36_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id81e42a730db41b38addf624d55f0162_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="ib0f0a63946614b93a706e459effcd822_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1a007c4c42ba48c5af6af1adc620a5fe_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9f07b1cab36340b2ac0e5013fe615164_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i49748441876b428ca5de05c44d5f8499_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i989b56a183c946599da9be6a40044f0d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i424661b18ce84471819c51a4428349f4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7a66fba061d3493aadeb2bf2117d4954_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i375d15b254054889b41fe012dea6ffd6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie03013c27a6841b7b47d775cd8a4af8f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id1d47dac14094180bc21b9214c11f723_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i468740812f144020bed248757e33716f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i02c663df999f43dba49c3e3fbdf4fd2a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if5061cce88844571861e47c227eaa358_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d1877eb16ab4005bd5a1107e8dbe1aa_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf43344805b748ac8599d034b8fce38c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2155113815f245cb9e7caf23337d1848_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7a865e40488d4b68a9fc599365b502d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87fc7373cbc44f879acb93c09335f462_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i77cb4812b8444881a8d1c6f3fe5f74ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89b5c735c1eb4e9d95ed6be4cff64301_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i719d462654114eafa29963ace1f8a603_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91b81d90dcbd47d4994136811e97c5d2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1e8c43d7f5314418961e8542ec180403_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d7a66e4fc364008a329768490327166_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie1c1d0d7e6944bec9f3db53ad92fa034_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7bb3e27fa63747a6b668bebab370867c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibe82f860e15b483eaa3f27e40e7892cb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib8474860170d474cbdbaf74e8fca9837_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i54cc7fcec9c242049c00578499ae8d13_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i997580c2ac9449cd9e09cac79cf4ac38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1344f19ab092477889926fa8d06bba45_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if739a2c2f671402cb916170e3525437c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idb9d19a6bc3646338057525a9924ed42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id543b8483478491ab47eae96f17a2688_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i18555e5fe782424da673f442fb298b06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c2e1aa2b5844bed9e3e6cae8d1958cd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id86e5cefc372494fb57cf5b9fb285236_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i721e9eac5b5c48a6aed4014b232cb438_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4b807c0a08b94dddbe4f5e93f8fa811f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie84824453888409a909a24869be1cb1e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i19171c2bd8484559af6db37d1aef1e11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47f84dd2e1f24639a171ca54b2bba99a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i082a9a99169e4067bb5133812e745527_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i761665691f614dc391144cd928de4ff7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6605492210c74a4d9c31d30486122af1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9915524281c147b9b413b8c968c0375a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7f1313d335714e77935281b63801f86d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i94e1669b9c2046b8aca9b105f46ecef9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idc5d2dfee4ee42909a9a420320563b9f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i894ed00d9114436795ac77d2513cb0d7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4ad80cea173e459d9cffda4c1fb19c1d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i213187d28dcc430e8a47b7ba1ff645fe_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if85f496eaa364904b720459ed2c8ae50_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie06eeef8c3a2458a80d5fbb8e8971e2f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i283c9b3d2d864286a042216f0f64a9d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f79da42a51e4c689131977628edf127_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id9a8a481fded45df857975789968d39d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec2075fa6d454b41ae2afcc3adfef0cc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i70cc74c177124666847f665ef6dcce62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie23236f5602843f6a6cbba70fbcd25a3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i522dd4a58a4841a5963ab9f73b804c01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e040f387ddc4ec38df96824cb9d67e4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifd0b6009b67642718139f8490ac1a838_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i395049b051f7434bbf8dc1b8a8366602_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i20de2ae88de4431b9b32645d028faae9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i903aa99cb11d474c86e447953994f505_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1390af8c345c4263bf87707c4ef576e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id85c78ca58b04142a6350664eedf1e72_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1ab5d2a58a3649bfb781ee50c6b74f2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4db18d7065c43ef83b29c8496790e86_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i98c61e122e2347a5aa71be7a5df24cec_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5b623df0e8c34375b46c759975f64119_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id5f68cddd5ad42158036f7073b369a6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i809d63415d1e4ec79fe179aeb9672c1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d6c530f66c44fcbb0d73cdbba129592_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa3999e4bde44be99a76ff42c4163037_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27f146899c2744beaee1eff239630ac4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5055ee5be0c54a1498e064e638e3fc43_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iad29e7417ab84660bbf5561c20e93d02_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icf9c2c8c325e4eafb24af39665b6c948_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifb3b1e53f8964f6589f2176f191c0f08_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i21815a7af6e34709a5951ddbb9f495fc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4ce1e2f30ce34162a65a41a860c47fb7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic1ff32150be744fab5239abe91331844_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i50e7fbf9ea5d43a2b38aa9bad667e187_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6bce25b2bb6a42e1a1077eeec7d3b9bc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80e70f9bdc9a4a9f829773dd8d40f1a2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idd5038c2fb0e4b95b80671df1615c58e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73db81a84992414f90cb1a67fc97fb24_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i10527d633af14853a3d6a28a3b84ea28_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e95c9c3ca2647bebeb689903f4662b6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibf8c1c7c026a4812bc680c9687955ea5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i771f92b343bb4886afe00f44b7d62b4d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie85ee741df5d4ac693e71a7c46cb1f5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ee2942cb1e94674ab49ef190a069073_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i48210b087009430d87d3ee09bbd7480b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id937d257d4a3403f8db692c5b41aa9ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8fcf8358875242f7af0e421a76768692_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id6669b1014a64e8189357320d104615a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2b9b62e05a72418aa23a2c8539d02f68_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5293e3f0677c486fa8ef0b0311b62005_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9fa9924b99f54b9bba102c4cbf10aca9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ea96d4ea7d04a2daa8f980b999df830_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i05aa77d5eb404436ad25e54997dd9780_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a0674ef27014518a6dd75ea87e28933_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id715136c1f6f43e190b1b7cb7b6a75e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib286dd30c58f4a679933177bb048f7b4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ice55734ff9694ebb8bba28051710baa2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd222b4f248248c38837a4b7e751501d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if7b3863114dd40908e490c5e045b081d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacacfc94ceb24a648193a04798d1e6dc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id86681f9c3b6492daaf4162fa8970450_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie950b3741f1d4e158b9ee15c4b4ed9a2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i68de0d9b3a8e49ceafd696fc5709bd12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4b1f8f175024c6bbb7edb59c01d0d1c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i416ba9b4dd0d46c889e4493851b6db3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ae315c0e1554dacaae58b7af1c8736f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i784b8e2bd7b74fe1b05c54c5962c8c64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie68f0f5b7ac54919bae4f7f9efc554d2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iff06f923ba6c43cc86c4783c3efd3131_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08584e30dcf848aba71c8d5f57625e6f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib4aea0c204194bf984d537214fddfde2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24581130201d4bb6bb06505b8f5af435_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i138c7c7c86e847c989a9ffb258cc207b_I20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-10</instant>
        </period>
    </context>
    <context id="i1c00dff781d2413cbbf1f18bed5d6e0f_D20210510-20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-10</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="ia309b17ea78345ba80fb7b052728c043_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69088951be3f4fdeba3d3644b3c3b6f5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i449d136159f049a5985130241fa62d0c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i29b4c437272d480aa75455fc20ccedd2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7e3ac65cbf784533b5620e4ff1832c2c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0ca81ce52f414e53a0e5cc4d51005e69_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1f6851db735d4b949b672cef2153d2d0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7d1ff42f2c334bd38528daf462dad7f6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iea70986a88704b33aeb401629439ceee_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i950105374ecc4d5681ba3458a73eadc0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie27b0338c0a34e858b0b2dccd5137bb4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i327d423409a741438941c3983d47e655_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib0a8923e44054f43b4d6eed3d687f722_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39de90268a7a4225b6941c9ff3a19fab_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingAggregatePrincipalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2038d40094f64de1965e4f053aeab53d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ieb6722339b944352b0b56bcac0aadaaf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i649407080a3b4a2a8dbe0062791430e0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if742f92ece7547768b16200d191f5b16_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic314a6b5f97d44198af151b25dbf609c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02f1129cfb5e4c6bb359d217903f8368_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i95b3c6ed9730476381312a30a5c8bcbd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6e345c3e41bc48a8bc324b8f8375b600_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iab7bfd166b4841ad94b29f8f0775f55f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i646d9a6e9da946f785beb189d5511265_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f2e5182166b4e258ce14bd1c6bc2462_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia2579a67e9154ae9bdb34bfdbaff7852_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i32519afb04824cab904e19b493da014d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00ae8b0ca7d84dedb85b5fdbfbb37484_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i877957e5afdf40429ed18f3f84b993f7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaac3357a9aaa450e8357d06a28faf82a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0e48a7919ffd4f7981e1a7533395f383_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if145ba28e56b4a3e8ebaaade117334db_D20220805-20220805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-05</startDate>
            <endDate>2022-08-05</endDate>
        </period>
    </context>
    <context id="i762a71d1a5314a20b775461852e10332_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="i6b6b779abd6047358a4ff3e1753f9f78_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="ia45237c280a543b788d2d06d99616c10_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5bacdd63be81431e93233ee3874cc618_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4b8a09505de24098ace745ffd92c8c9b_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i07e0936bffa54f1fa93786399e12f047_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i48f9725f39b04b94a04843a31af9469d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if7da2c1103ea4f908aac0cd8da683037_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie962472004ed49bb91bf3bb5bc90460e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie3ea4cb7460f44638f76c93ae1fe62a6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i48c6b2ef29f5412b953d8ca8ea8e10f2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib6276dfcd8f548909ad2b95aec63305f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5f6c85fe355c406693e3fc90a6900617_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf7fdde677424e58ac261d8de70f896f_I20201214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-14</instant>
        </period>
    </context>
    <context id="icb3f873e631440948432841109248bb6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ida343bc176194f5883adbf14b2db3add_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaed936efbefb4d6883a1c81638adf58d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b181944f869422eaf28616562fd7a82_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i35b65bf8163846418605a1c7c4224987_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibe6a468432bf4452ae37008655365bb9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i525a2094c6934a6485d6adda3f6a9b3a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7cfee3824c314f15a3cc0a778059755c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i029f075c73314285a73d6046fc56ace1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic71339696da74c3c8be300118987e2a8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i51540ac012634339a60c076ab917ca1b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i06aeb53ebd2a4b1e99e14da58b780ce5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4ff0c73d214b4802aa383f6e6d6fb43a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i01387391808f459ca10145d370775508_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0a26c50603134586aeac79e838ea999a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibbab2482ba9049fa8035d7fda68e3e46_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6ff4cf4706044822b1d8fdff41caeeef_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifab3d8ec398548efb4eb940722d1321b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i24181bede48642979bf2659f8d3aca26_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i097b7bc5ad3e49d090a6fd4a3a2eac38_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i99a609ec70434875bcd818a22223603c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iad37ab5761724dd0bbe10d6aae7e351f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2acd2e07b1e341d4826054cff9f227ae_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib74ccd408f0b4969918ea713b800279e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib08dfea82b704fd2833f1be5b210aca1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i62067935217749dda69756e659e18d90_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia9aaa5a5ca5f4e1f9301c01ec21b59e4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ife3a11266e3d4321956fbc6d063b8a10_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie1bf87505d2e4df7a780b78429497619_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie096244a71f845ca9eb0386aa8bcb3df_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5b76bd80819b4615aeb5e962c486399a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5ad59d435c194a23bb052a2504b3a319_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i415f872bf2c24ddfb98d985defe44440_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i56bd4269832542bbba47c90663ce137a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i47af1619791b4510b83d7d9ec10d1f42_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i11f711ef34d649a2b44fa21f66871d34_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie14c2530827644ac893d5a38b3b01e88_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9768fb32a294fe1a98e46c54fb002fc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2cd92fc770d74050ae6bc234223e19d9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie89fa19fb7d0473489935cee03e984eb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i67775ec6a0934c30bf8aad1e7f6a0b6e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icd09fe7de65f43ac93174dff385f04f6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1bb15f66e0dd4ad0898c5b50246fc5c7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icc56c808748d4532afd8021abe0fbcba_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c8f3f10502c4f71ba2b31433a377b1e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i36124ada3c8c43858ecb9286e86c2606_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1fcfa3282cb148bbb748113d9528f7d4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i761eb0a00d5444d5bf6bd2da5be27e90_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia7433a0c7505464f961708a119d005b0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8cdfe346e87b4744ae0e10651fe6a828_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iabb00784efe74f8eba9e037108ad5aed_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2165365374154b58bb3c0a37d075e600_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic9984e82eade4f2da3d2886469fb33b5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i81be0345e72e40c38e9b1ec204739080_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifddfedd7174745d6aa132760e4e7d5f7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i99797b8a0ac14a2683275123479db9e2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if17b5b0c3eef43dbb88f6d84614f82fc_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i66ff310abb0c46ea842c1b5f2e101e06_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iec55fa860e274f43bd665e1c527396ce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i97f0fc8326c54d22b47c92fcf1404dac_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9bcbe244161b44d08e2fb019d7190d8f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i77e17753aeed403cb6eb068b78c4172e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i162fa62a834d4024853d19c92f7d6803_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibefe540c865646ed9b0550380e6694dd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5c88d81fbc054204b7dcb69d35b1ef8b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id67f6d5f8c204080bdcf3a8e11fae3eb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iee0862174ab84b5880a7a5c5cf80931d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia1d0fb3e4bf949b28e24977c79ce55f1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib647bd82c32d48dcab841641a70e3f4e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if0d47bcaff1842cb93b282563df9bd3d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f4d52a894b84bd585ff1aaee9ca68ed_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i717d79b707704b4a980799d216fbe641_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4179fffe78ef47a98f15ff8bc5762603_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0850efa38229479ea51013e0c6bd5ea4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i82bb612d582148409a856cd8d6ce1da9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i68f1e5b68bbf468ba366d5f07ad381b3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0a332d62f2234fb896c3d81a7d7067ae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i59461725015b4ab0a58f6b01f477955e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i042f5fcfd216400fb83d5b60c989ea25_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8e9c75133f8543928b4807ac698a3f26_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia26a0d345a5a449683f9b0d89f1bb0a2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idb908941b01946c392c481a9232193d7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i270e1d01244f4fd1b70234c80e9c0a94_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0abd801e946448e39c75bab8c1af730a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia9bd5d80ec5b456092ac8652192da3ec_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4e48cde1c09741fbbba8a76eba96c309_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i027ec43cabba41aaaaef1e9bb6739bbb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i54b6db5791ed44ccb0478df69ce8783d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifded57350dbc45cd90ffe08f24872546_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1cfbf4ba247a4bd986d605da59f36b2a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9cf55369f4514daa8887c854a382c1e1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i99703b37b0ba48548c020a30c6b767e1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b2e0b3398bd4e9089a8388936799f46_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0b6f04a66de74745848be0c25b2101eb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8c9374eeb03f4c75a38fbf4295d7ffce_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1cc10c58865a4ff49ce0aa5218fd4974_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9bdb29df4e854a19ae8ac360d53a3ea3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4da71fc4bd38481295e9d4de2b991770_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3c8a6d03a20a4949b1bf505a8eedd6e7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ief4415458b8949d9b372a41950b1d1c3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i68d0be2afe1f471a8619be6368d23738_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5ece9f53176241d1bddc8b97e5dcef4e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3e38e69dadc14904ae3f0b4e977669e6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic077b66564b344bebb50e1be764ab9f0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i376c6e7abe2e42cabecb0d501e815677_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2643d6f56a40465881ef187eb4469dcd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib8750752709c49678ab5476ee86964b1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5d74776bb9b34e2cb0202a6760a54d00_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e873293fe6f418abbda4c5513c16be8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icd5db3e942a74cbbaecb06454183c1eb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia531b4492dd040f3a0690a15663e829e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic8df47fefeb74301add15e147b70ea9e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i641e5a7630d44a29abf0929b9ecbef09_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6269d280022f444da4365044dfebd1d0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2cb6cd854f654144ad897e7e04aeb62b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0a9d62ca9859478bbe137b00bb8bb81c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2e27a21a2c6948ca8b4f0ed8a4c7ef45_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic6a9247c0e4f45168242ed303b39c984_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0bf11f4ecaa9458bab1012646612725f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0e5f14f850024bdebc7d74e786cc46f5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95d03048f54a432b95f83d107f210120_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia045a31057fb468287b2baf2b245589a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i11d9db0e99274141bc4e13555d17f9cb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icb18f5e6c0e247a1b6a690cad0c427ef_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b165acafefe40209f5b6aabf02a3eba_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i58a24ee4843a4c589a865ad63ca56d2a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1af6c9e0567f4219812341c9ab0f8940_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i983f6a62e8b44a20bd0879dcc23a0b33_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iad62834ae44945f2a01034ea56d06a2e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ica8940d222b9412497da6820d116c5db_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id893e6f844384001b614fa60554e39a0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic2e80e247a6c4d63b59a373ccd6a4547_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3d23ca3116f74ae08667619cf99610b1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i31a87cc275df4c02827aeae66b3db474_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifc114ba40df543a494974546b8688cda_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i996ce945e0ea47dc9b384cfd1a7cbb4d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3ee4a0405fcc46768dd9df2f2ee25d9a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i576cdae0729b4f15904cf440be39a5dc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iad2ffb4bccd6473cbf1edf6b51561e8b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i16fa28ceec55463fb802e656bce05d72_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i50b995e2611d498b87e589132f982b29_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icfb96738c2284048800a1132782bf2bb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8dcfd0caac50408a9d88c51b81a20b7c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id80b1eedfabd457080936ffd53512c5f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id6c5221cbb284081a999df868d95ab10_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5c19828588024500887d5d62d92864cd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icea6a8cb2f274f1cae8b176f73989975_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iac6b29cb0bd643ea830c23024f6f122c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i40c0a9db1c8e4014b2df4e46dd5de46d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if71761ebafaa4d329453f22bab510d1a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i353a9c38bf404c4b8bc5520b92a5b9c8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i251b6cd8103d489a9a3ad606f5d9de1e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie11f0a8ff4d240c69c1c5b12228bb893_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic50fcbfa6940498f8cf9056629ab9c88_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1ad83b783c274c09bcf887c0897c360a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ica1a058ee7ff4842a9dd996eaadeab8f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4d14bc6cd205427587873034553c97bf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i15c7a5b47c514f479f5321f0ab2663f4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib077df6e7685413397c816d1f7399061_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6c63c604879341609359afebf06b84fb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4e4f0985ad1740deba3b810eecdeeafe_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i58d6871b5efa47e089e55373103fc46a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i56409fbd56bf4a44914cd2c8465f7903_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i33a20447358346669ee315fe67d484ef_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i44122c777f7d4e659c894fab8bfe0463_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0b571919e0954c0998434728e8377c58_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8d01db59981d45bab53856f63a5438ae_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i88b175c8d6f949ae9aa8ce0c709a1945_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i804e2fb842734bbbb84a1af373c0f50b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i82c70b969bbd496a8d242a26de3a03b1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i10cf842a669546239f5adb70a68f5d12_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i96c8adaf4f394f7bbe3dbe88b56bf82f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie8ad17ca3dd24c48ad06fb834dcfe750_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie9cd2c0e0d24475aa93ac3069d5a1401_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7fb7facade49428fb1d9af329e51a7cc_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i981f627a420a466797e7c582e56d78d7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i637a3831852e44fc9d35643a000aa777_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b5433550a40439c899d6f89ee694767_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i41aab6c00bda4f86820878b7c6774c9e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie16d4e79dbaa470fbcb924d46c0c79ad_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ide5536294b9c422399ae5dc27f304dc9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3ccea46e8c094031bc29d50afc2fb0a7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d9437b6a921439292845559c4c462b2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i402fc673d13248f590527d5a9df8dd9c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0185ce7757d248cfb6fbd1ea52edba1c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id46a54a0a24f40f988a953734d9ef437_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80e3da031c9b4d6e944876c1bf4edd3c_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="reportablesegments">
        <measure>bsx:reportablesegments</measure>
    </unit>
    <unit id="business">
        <measure>bsx:business</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="krw">
        <measure>iso4217:KRW</measure>
    </unit>
    <unit id="units">
        <measure>bsx:units</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="derivative_instrument">
        <measure>bsx:derivative_instrument</measure>
    </unit>
    <unit id="claims">
        <measure>bsx:claims</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY18zLTEtMS0xLTk5NzA2_90db6a9c-601d-4460-8be2-1819ff862a90">0000885725</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY180LTEtMS0xLTk5NzA2_5bae4dcb-af62-4358-83eb-ddbf9d996dbe">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY181LTEtMS0xLTk5NzA2_1b75a1ec-7a57-47bd-9e93-4c2d0f354c4e">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY182LTEtMS0xLTk5NzA2_7a1417aa-51f1-4f7a-a315-c6b8a93a5911">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80L2ZyYWc6NzlkNzA0MjM2NTU1NGQ4Yzg4NGY4MGViYjk2MTA1YzkvdGFibGU6NTk5Yzc4NGNiZGEyNDNjZDhhZGFlNzRlNGUwOTM3MWMvdGFibGVyYW5nZTo1OTljNzg0Y2JkYTI0M2NkOGFkYWU3NGU0ZTA5MzcxY183LTEtMS0xLTk5NzA2_cb1874c5-510a-490c-b98a-7777999a62f3">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA0_105299fa-842a-42b6-8d65-166633997dcd">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MjYyOWE4YmRiMGM2NDQ3M2E5YjZiYTczYjQwMzljZDUvdGFibGVyYW5nZToyNjI5YThiZGIwYzY0NDczYTliNmJhNzNiNDAzOWNkNV8wLTAtMS0xLTk5NzA2_0016e561-7a1c-472e-a829-99675cb9f9dd">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8xMjA_0f57a8d9-3ea8-4a4e-bf81-941cdbbdd97c">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6ZGUyZDVmMWJmYzkyNDkxNmJjMDJkMTU3Yzk4MTIxZTcvdGFibGVyYW5nZTpkZTJkNWYxYmZjOTI0OTE2YmMwMmQxNTdjOTgxMjFlN18wLTAtMS0xLTk5NzA2_51c9aede-5474-43e9-9428-7db11fa56fca">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA1_6cfb5d0f-7faf-4652-8b26-682c32706cb6">1-11083</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDEy_cd0dc1fb-e833-4430-b1ce-3a9ac03f8d55">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6NjY3ZTQ3MGYxN2ZmNGU0OGFhNmExZmU2N2NiZWQ0ODkvdGFibGVyYW5nZTo2NjdlNDcwZjE3ZmY0ZTQ4YWE2YTFmZTY3Y2JlZDQ4OV8wLTAtMS0xLTk5NzA2_b0ebba4c-13d2-42f6-805d-e9a199adb7a5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6NjY3ZTQ3MGYxN2ZmNGU0OGFhNmExZmU2N2NiZWQ0ODkvdGFibGVyYW5nZTo2NjdlNDcwZjE3ZmY0ZTQ4YWE2YTFmZTY3Y2JlZDQ4OV8wLTItMS0xLTk5NzA2_f8033f40-9871-4f67-83db-14ddbd44764c">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDEz_b7f8b46b-a5e5-40cd-b7e5-b0be678a821c">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDAx_2f0e3d7e-6237-4d55-a7c8-b4dc91c6441e">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA2_13f884d8-6093-4d64-b43e-7267469957ee">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA5_fb63f353-ee42-4cb4-be1a-bcb186826b01">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA3_9b279eb7-916e-47f9-82fd-6156682b6bf2">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDAy_2377b80c-fa2e-4446-8302-23d7e495ea7a">683-4000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8xLTAtMS0xLTk5NzA2_8f150117-3a45-4f8f-a222-1ed1b7f2b3b6">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8xLTItMS0xLTk5NzA2_ee82689d-530d-4cac-bf2b-6afca9aeaff5">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5a4d4632267243f5a8d9c5e607d6592c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8xLTQtMS0xLTk5NzA2_42b9e375-dcd0-4b77-92ef-02537449235e">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8yLTAtMS0xLTk5NzA2_fd3a8dd1-a9a4-4ebb-aa5f-dd63b496a495">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8yLTItMS0xLTk5NzA2_a099dc3b-61e9-4f2f-98d4-08df98cc9b61">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4e64c3d6424b491d90dedc4da9bae8c9_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8yLTQtMS0xLTk5NzA2_88e4682a-897e-45fa-b448-bc1be5c2e164">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8zLTAtMS0xLTk5NzA2_964db46f-2279-446c-9936-8fdf4b58830f">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8zLTItMS0xLTk5NzA2_f1d6c87f-2adb-4bf4-9770-3fb3de988569">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6M2U5OTEyM2Q5ZWMyNGU4YzliMWFhMGRkNTg3MWMxODEvdGFibGVyYW5nZTozZTk5MTIzZDllYzI0ZThjOWIxYWEwZGQ1ODcxYzE4MV8zLTQtMS0xLTk5NzA2_18d123aa-b589-456e-9770-e564b34299e6">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDEw_c919c16b-c24c-45c5-8d87-d3308d89bc60">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDA4_ae541b7e-3a2e-4f74-8382-6b6cae7161c6">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MzhhYTYwM2Y4MWIwNDZmNDg3MzMyMDMwZTJmOWMxZTAvdGFibGVyYW5nZTozOGFhNjAzZjgxYjA0NmY0ODczMzIwMzBlMmY5YzFlMF8wLTAtMS0xLTk5NzA2_cc5f2174-7197-404e-904a-a4c4727051b8">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MzhhYTYwM2Y4MWIwNDZmNDg3MzMyMDMwZTJmOWMxZTAvdGFibGVyYW5nZTozOGFhNjAzZjgxYjA0NmY0ODczMzIwMzBlMmY5YzFlMF8xLTMtMS0xLTk5NzA2_b9150b03-03db-4a89-a69e-bf0c701f3f1a">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGFibGU6MzhhYTYwM2Y4MWIwNDZmNDg3MzMyMDMwZTJmOWMxZTAvdGFibGVyYW5nZTozOGFhNjAzZjgxYjA0NmY0ODczMzIwMzBlMmY5YzFlMF8yLTMtMS0xLTk5NzA2_a0e0d460-05ac-422a-81a6-46e930ac5c10">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8yMDAz_272f03fe-a151-4ea1-a8cc-0fd091da350b">false</dei:EntityShellCompany>
    <dei:EntityListingParValuePerShare
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8xOTYy_4dc5dfc9-d277-4183-9707-aaa6d0d8ab1e"
      unitRef="usdPerShare">0.01</dei:EntityListingParValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i92528d124d4e47d4a4ecea47db134aa8_I20220729"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xL2ZyYWc6YjdhNTNhOThkMGMzNDMzYjk1NWY4YzczYmY5NjhkNzUvdGV4dHJlZ2lvbjpiN2E1M2E5OGQwYzM0MzNiOTU1ZjhjNzNiZjk2OGQ3NV8xOTk5_44fa4ec9-2d83-41f0-8aff-ff9bb1222367"
      unitRef="shares">1431614313</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy0xLTEtMS05OTcwNg_3064f86c-696f-48bf-9ee1-03c338e62f2c"
      unitRef="usd">3244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy0zLTEtMS05OTcwNg_f1b03ede-2b5e-4cda-89c9-42f1cbca0db6"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy01LTEtMS05OTcwNg_3bec9cc5-62a5-43c1-a7ec-1dec59500293"
      unitRef="usd">6270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMy03LTEtMS05OTcwNg_00e172d6-241f-45c6-8438-d0ae36b9227f"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC0xLTEtMS05OTcwNg_0d4c780c-3bc3-4fe1-b734-9e809bb7e1e1"
      unitRef="usd">1011000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC0zLTEtMS05OTcwNg_f2a0f215-3c2c-4c1a-ad09-492f8f9e43e5"
      unitRef="usd">945000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC01LTEtMS05OTcwNg_ac75fdc2-8532-4da2-8d35-a2b2ee97afb5"
      unitRef="usd">1966000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNC03LTEtMS05OTcwNg_29db05ca-58e9-42a2-ac6b-b2f8a2c2edbe"
      unitRef="usd">1839000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS0xLTEtMS05OTcwNg_54f02f1f-27a4-4358-8e44-dbeeb99d7490"
      unitRef="usd">2233000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS0zLTEtMS05OTcwNg_3cd14e24-babb-4d51-a178-e41f9b5bb4b2"
      unitRef="usd">2132000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS01LTEtMS05OTcwNg_3ac5f2d0-07db-4057-8ffe-40fd5f791c9d"
      unitRef="usd">4304000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfNS03LTEtMS05OTcwNg_9ae832c8-be91-4b99-9884-99a925f9a73f"
      unitRef="usd">3990000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC0xLTEtMS05OTcwNg_cae93069-548c-41fd-8f39-9bf93cdb3a0b"
      unitRef="usd">1165000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC0zLTEtMS05OTcwNg_20192c51-81c7-414c-a7c0-9588ef84d840"
      unitRef="usd">1121000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC01LTEtMS05OTcwNg_911da315-1b81-409d-a115-1161ba72141e"
      unitRef="usd">2225000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOC03LTEtMS05OTcwNg_34b5a4ab-781c-4c2f-ab6e-7c3db890aa32"
      unitRef="usd">2139000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS0xLTEtMS05OTcwNg_ca2bdbee-faaf-4ab6-8b19-4996ac3b66d7"
      unitRef="usd">335000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS0zLTEtMS05OTcwNg_230d226b-455c-4866-ab43-e65f92d9e1d5"
      unitRef="usd">298000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS01LTEtMS05OTcwNg_a66fd62a-8345-4368-80eb-d6ce7fa15f3a"
      unitRef="usd">654000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfOS03LTEtMS05OTcwNg_bc4b69fb-6001-4d03-9f2d-1cd48e93fcc3"
      unitRef="usd">574000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:RoyaltyExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtMS0xLTEtOTk3MDY_aa146415-a7d1-46b0-a10f-2306b69ebd04"
      unitRef="usd">11000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtMy0xLTEtOTk3MDY_64fde8f4-be5a-4f32-9401-bcf627d7101b"
      unitRef="usd">12000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtNS0xLTEtOTk3MDY_9670db1a-6973-4ebb-95e4-a1a12fca07d0"
      unitRef="usd">23000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTAtNy0xLTEtOTk3MDY_b4faa2ef-2b4a-4ceb-b212-86c716b61ca4"
      unitRef="usd">24000000</us-gaap:RoyaltyExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtMS0xLTEtOTk3MDY_cfb24182-02be-4723-bdb9-3cd5631ff339"
      unitRef="usd">204000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtMy0xLTEtOTk3MDY_e6de3861-027f-45d1-bf2e-64ea91a676ad"
      unitRef="usd">180000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtNS0xLTEtOTk3MDY_36060347-fe1f-4625-98eb-441e29aa27a0"
      unitRef="usd">402000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTEtNy0xLTEtOTk3MDY_d2f4c921-279c-4a2f-a482-aeb8cf8c51df"
      unitRef="usd">365000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtMS0xLTEtOTk3MDY_81858954-451b-4d7b-9e35-00dac7c04e89"
      unitRef="usd">7000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtMy0xLTEtOTk3MDY_e7e69599-45ef-4ba9-bf27-1f466def7b11"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtNS0xLTEtOTk3MDY_128bb775-0427-43af-8b57-581f91cac18c"
      unitRef="usd">7000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTMtNy0xLTEtOTk3MDY_61977263-342d-445d-b6ad-6eb27e05c8d7"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtMS0xLTEtOTk3MDY_24ecc462-8639-4ebe-a6ee-a15a2a079dbf"
      unitRef="usd">36000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtMy0xLTEtOTk3MDY_69f261b3-64eb-45bc-9aa0-9f3a5be37a27"
      unitRef="usd">-85000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtNS0xLTEtOTk3MDY_c340f5b7-db1f-4427-a17a-adec8016a84e"
      unitRef="usd">48000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTQtNy0xLTEtOTk3MDY_5bd604ef-3ad1-4186-ac35-2a64d7b594cc"
      unitRef="usd">-91000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:RestructuringCharges
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtMS0xLTEtOTk3MDY_40fc4422-0d7b-44dd-bbb4-7e2b14534c6b"
      unitRef="usd">11000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtMy0xLTEtOTk3MDY_48064561-e2da-4e3f-8cee-6f774edf4179"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtNS0xLTEtOTk3MDY_a0cb3111-93a5-4329-9f61-be47c1cdd5b3"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTUtNy0xLTEtOTk3MDY_d222df37-831f-4304-9a80-8d0bcf129cef"
      unitRef="usd">8000000</us-gaap:RestructuringCharges>
    <us-gaap:LitigationSettlementExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtMS0xLTEtOTk3MDY_bd6cf8c7-efe9-48d6-971d-6faa048d0f40"
      unitRef="usd">42000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtMy0xLTEtOTk3MDY_5c2e2723-5cef-42c5-be76-d157f8c204fd"
      unitRef="usd">298000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtNS0xLTEtOTk3MDY_2908a82e-3a0d-47cd-849f-4d8e64233bdd"
      unitRef="usd">42000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTYtNy0xLTEtOTk3MDY_59970653-dfc6-47d7-ae00-772cc3e0fc82"
      unitRef="usd">302000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctMS0xLTEtOTk3MDY_e04c36bc-491d-4b1c-8c7b-30f239b0f9fe"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctMy0xLTEtOTk3MDY_8ac6baa7-e9bb-4594-89a1-0c76e5ef8f2c"
      unitRef="usd">2000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctNS0xLTEtOTk3MDY_bb89823d-bc1a-42d5-8e75-42453519f31d"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTctNy0xLTEtOTk3MDY_116f2c94-f3a1-41ae-956a-865167667e70"
      unitRef="usd">9000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OperatingExpenses
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtMS0xLTEtOTk3MDY_417a1931-5c01-4f09-9eee-81cd293f470d"
      unitRef="usd">1810000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtMy0xLTEtOTk3MDY_26ad99cb-3eef-4b4a-9697-6f9b1a87ab2f"
      unitRef="usd">1870000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtNS0xLTEtOTk3MDY_0e4accdc-386c-4d20-b279-fd04c4b36289"
      unitRef="usd">3415000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTgtNy0xLTEtOTk3MDY_3a450427-7b0c-4a72-88aa-7599fd8f9a3b"
      unitRef="usd">3358000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktMS0xLTEtOTk3MDY_85b7cc32-2cb9-4404-8114-de2bbff9fc4c"
      unitRef="usd">423000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktMy0xLTEtOTk3MDY_753d0a6d-4486-4ec2-b68d-63e79962b6cc"
      unitRef="usd">262000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktNS0xLTEtOTk3MDY_6eeb09f7-3816-41a1-8123-07a0e9a4ceef"
      unitRef="usd">889000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMTktNy0xLTEtOTk3MDY_26c49af3-1111-4e50-a3cd-8539dc2d9927"
      unitRef="usd">632000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItMS0xLTEtOTk3MDY_3f6015a6-fddc-4632-9f3c-19fab42df367"
      unitRef="usd">64000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItMy0xLTEtOTk3MDY_1c2a0ad3-35e8-4a50-b8e5-89f3a3b61bc1"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItNS0xLTEtOTk3MDY_4a15e538-1614-4221-a582-bd5ec3eb5c2a"
      unitRef="usd">343000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjItNy0xLTEtOTk3MDY_cae00af4-fcd8-4b2f-b99b-59f0fa28ef93"
      unitRef="usd">168000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtMS0xLTEtOTk3MDY_76b39457-1468-4797-bb6f-b45a82fe5bc8"
      unitRef="usd">-14000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtMy0xLTEtOTk3MDY_5de2cbf4-1ef2-4089-a03a-dfeccd3c7cfc"
      unitRef="usd">-26000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtNS0xLTEtOTk3MDY_ec4f2a45-c98d-416b-ac13-f00887590c5d"
      unitRef="usd">-46000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjMtNy0xLTEtOTk3MDY_35d4e560-df48-4eba-acef-a1c1c4bd7824"
      unitRef="usd">11000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtMS0xLTEtOTk3MDY_768f52fd-7f94-4194-b5f4-e32589d22ee7"
      unitRef="usd">345000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtMy0xLTEtOTk3MDY_9460b936-1070-48d1-b7d9-566ae63603cf"
      unitRef="usd">149000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtNS0xLTEtOTk3MDY_496c6316-080b-4011-b2e1-40de635f7156"
      unitRef="usd">501000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjQtNy0xLTEtOTk3MDY_18f83db7-6cf9-41c9-b097-4b90cd91d774"
      unitRef="usd">474000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtMS0xLTEtOTk3MDY_f0d95b43-2ee8-4012-aea0-7ece51e0843a"
      unitRef="usd">85000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtMy0xLTEtOTk3MDY_5c7aacf2-a62b-48de-8452-473af63e2c85"
      unitRef="usd">-37000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtNS0xLTEtOTk3MDY_9ec83d5d-cd7e-4bbc-99b8-25c6464fd2e8"
      unitRef="usd">131000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjUtNy0xLTEtOTk3MDY_3c3eb097-c92b-487f-8e31-feb4f5c7d669"
      unitRef="usd">-53000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtMS0xLTEtOTk3MDY_aa2eb9e2-e8ba-402d-87d6-4e57d28fd56f"
      unitRef="usd">260000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtMy0xLTEtOTk3MDY_ea96b581-071c-464d-a25a-d95cf6c4e241"
      unitRef="usd">186000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtNS0xLTEtOTk3MDY_2a34eec2-b845-4ec9-ab36-0b3b1e0a15cf"
      unitRef="usd">370000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjYtNy0xLTEtOTk3MDY_a663faa1-7294-4ac7-a53c-e04bee28dc1f"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockStock
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctMS0xLTEtOTk3MDY_9ab27cea-10a7-4047-9ced-5035b690661b"
      unitRef="usd">14000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctMy0xLTEtOTk3MDY_75075f28-55cb-4a60-a8dd-bc38dbb088e6"
      unitRef="usd">14000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctNS0xLTEtOTk3MDY_e10d3034-32f2-4082-a4a0-9e301573eddb"
      unitRef="usd">28000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjctNy0xLTEtOTk3MDY_ee9a07e6-8665-48a5-af1f-0e70bbbb26dd"
      unitRef="usd">28000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtMS0xLTEtOTk3MDY_3bb33874-b23b-4159-bf29-dbe01b003dba"
      unitRef="usd">246000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtMy0xLTEtOTk3MDY_336e59b5-f4fb-4efb-88e7-1a47361bfb31"
      unitRef="usd">172000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtNS0xLTEtOTk3MDY_bbc6ba4e-9183-4d43-8f11-096087432939"
      unitRef="usd">342000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMjgtNy0xLTEtOTk3MDY_b7f128e4-51b1-48bd-a600-a995f131208d"
      unitRef="usd">500000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtMS0xLTEtOTk3MDY_5ee60d7f-a318-4a38-8d7c-b485878f42f1"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtMy0xLTEtOTk3MDY_cc905311-cef2-4863-ae77-ea10e96474c1"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtNS0xLTEtOTk3MDY_7b7f4296-a731-497a-8956-6185276c4162"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzAtNy0xLTEtOTk3MDY_af1a24c7-d734-4b0d-942b-c9ce6ffe1d34"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtMS0xLTEtOTk3MDY_af25de8d-1b51-4539-80d3-312499792d49"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtMy0xLTEtOTk3MDY_cce39595-ae60-4553-83e9-f21db2bc3142"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtNS0xLTEtOTk3MDY_57f9afba-48b2-488a-b5c8-b9edc2524a4f"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzEtNy0xLTEtOTk3MDY_133599bf-7d9a-4a2c-9658-4f35330fe75d"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtMS0xLTEtOTk3MDY_a6ad48f8-d6f1-4a1b-ad36-69918414db24"
      unitRef="shares">1429700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtMy0xLTEtOTk3MDY_5cf196fb-19dc-40e9-8cc2-ac1d47c790c1"
      unitRef="shares">1421300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtNS0xLTEtOTk3MDY_dcc848d2-e7d7-4b75-82a8-d28fdaefea27"
      unitRef="shares">1428800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzQtNy0xLTEtOTk3MDY_4e5af27f-3b69-4f7a-9410-cebfe6a09cc1"
      unitRef="shares">1420000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtMS0xLTEtOTk3MDY_9dde85db-439d-47b6-8186-ed898e8ccd40"
      unitRef="shares">1437800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtMy0xLTEtOTk3MDY_01284266-9ec6-4eb4-803b-fd9d6dacc564"
      unitRef="shares">1432500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtNS0xLTEtOTk3MDY_e36fcda7-379a-4ffc-80e0-b77786217625"
      unitRef="shares">1438100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xOS9mcmFnOjZiMjU0YjAzMTBjOTRlMmE4OGYzOTJmOTU3YjAzYjM2L3RhYmxlOjcyZjgyMGRkMzkxNDRmZjZiYmRkNDNlZGZmNDk0NmIyL3RhYmxlcmFuZ2U6NzJmODIwZGQzOTE0NGZmNmJiZGQ0M2VkZmY0OTQ2YjJfMzUtNy0xLTEtOTk3MDY_4286218b-0099-4ea1-ba30-5fd11ea6b6ec"
      unitRef="shares">1431700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi0xLTEtMS05OTcwNg_aa2eb9e2-e8ba-402d-87d6-4e57d28fd56f"
      unitRef="usd">260000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi0zLTEtMS05OTcwNg_ea96b581-071c-464d-a25a-d95cf6c4e241"
      unitRef="usd">186000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi01LTEtMS05OTcwNg_2a34eec2-b845-4ec9-ab36-0b3b1e0a15cf"
      unitRef="usd">370000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfMi03LTEtMS05OTcwNg_a663faa1-7294-4ac7-a53c-e04bee28dc1f"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC0xLTEtMS05OTcwNg_a92cf1e2-967f-4243-b8f0-43a3edb012b7"
      unitRef="usd">77000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC0zLTEtMS05OTcwNg_b0e7c677-9f3b-4a26-a3c6-90ccd50bdfba"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC01LTEtMS05OTcwNg_39b5031c-9ba6-4e7b-9482-da9a8ba23f29"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNC03LTEtMS05OTcwNg_b1ccbf69-20bb-4bd4-bb53-5ba00be93e2f"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS0xLTEtMS05OTcwNg_6853966d-7fa8-4be6-bbaa-2b5c9700cfcf"
      unitRef="usd">134000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS0zLTEtMS05OTcwNg_306982a9-6a73-4873-83a3-08dfc40cca9f"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS01LTEtMS05OTcwNg_7ef5633e-f901-4deb-b224-6b2e1b6e37cf"
      unitRef="usd">157000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNS03LTEtMS05OTcwNg_11edfa7c-f582-4055-bed4-2979dabc98a2"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy0xLTEtMS05OTcwNg_6d07c133-5027-4891-8f18-d3bf848def10"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy0zLTEtMS05OTcwNg_48815552-ee76-4dab-878c-0876160d21c9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy01LTEtMS05OTcwNg_d928b1c2-80cb-42ee-adc8-d86c9fff015f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfNy03LTEtMS05OTcwNg_f6e75e07-e8bf-437e-87d1-21d6366cd381"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC0xLTEtMS05OTcwNg_dda9c008-9995-48be-bc5f-25848b5f33fa"
      unitRef="usd">211000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC0zLTEtMS05OTcwNg_7cde796a-48fd-472f-840d-3e151d0d7d3a"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC01LTEtMS05OTcwNg_5fbfe208-7c05-43cb-85af-efb2f023061d"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOC03LTEtMS05OTcwNg_81bcc1cc-9a72-4652-86ad-9bcd5e90c375"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS0xLTEtMS05OTcwNg_e806cb77-8069-4620-a191-d2e2179664d9"
      unitRef="usd">471000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS0zLTEtMS05OTcwNg_c651057f-8315-46a2-a2e0-6d6450677643"
      unitRef="usd">170000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS01LTEtMS05OTcwNg_f6906af6-c2ee-4aae-a27a-2c6a9bc2897d"
      unitRef="usd">540000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yMi9mcmFnOjE0NGU5MzUyMjQ4OTQ5MjliZjUxYjIxYzU4M2UxMTgyL3RhYmxlOjk2NDdmZjU1OWJjNzQ2MjU5YTkxZDEyMjZkMTJlYTE0L3RhYmxlcmFuZ2U6OTY0N2ZmNTU5YmM3NDYyNTlhOTFkMTIyNmQxMmVhMTRfOS03LTEtMS05OTcwNg_c70b61d1-be2d-473a-a306-58ed5f572c14"
      unitRef="usd">558000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNC0xLTEtMS05OTcwNg_cbcd390e-d40b-4452-8871-55975e5de404"
      unitRef="usd">276000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNC0zLTEtMS05OTcwNg_9a271f24-b0ac-450c-8c9f-1a7e17413122"
      unitRef="usd">1925000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNS0xLTEtMS05OTcwNg_93ba2f4b-5e59-4e9f-bebf-fe33dce4cb42"
      unitRef="usd">1917000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNS0zLTEtMS05OTcwNg_35742f6c-fc76-485e-9ddc-3d00c359fbb9"
      unitRef="usd">1778000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNi0xLTEtMS05OTcwNg_34b67d7d-db15-4899-8f9e-a9ededa7537f"
      unitRef="usd">1752000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNi0zLTEtMS05OTcwNg_a5385f3f-497b-45f7-8156-78b8af0b6961"
      unitRef="usd">1610000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNy0xLTEtMS05OTcwNg_2302098d-dcfe-4647-8a4d-cfd2a13f61c5"
      unitRef="usd">264000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfNy0zLTEtMS05OTcwNg_a5776c32-7e46-4400-93b8-ea1754f499be"
      unitRef="usd">205000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfOS0xLTEtMS05OTcwNg_c686c2bb-a9d6-46b9-8f51-ad800ac5f611"
      unitRef="usd">874000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfOS0zLTEtMS05OTcwNg_77cf7f00-c9ef-46d3-916e-ed4f329e6fd6"
      unitRef="usd">799000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTAtMS0xLTEtOTk3MDY_1889e51c-2aa4-4b35-b9bc-b3b0c3c61dbf"
      unitRef="usd">5083000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTAtMy0xLTEtOTk3MDY_17aad0a1-c84b-41a8-bc19-df036e31e825"
      unitRef="usd">6317000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTEtMS0xLTEtOTk3MDY_bfa3dd0e-4fbb-4731-93e6-2358afcdb8f5"
      unitRef="usd">2246000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTEtMy0xLTEtOTk3MDY_532cc894-6f1c-4bf6-be0e-c2f3fe2bb599"
      unitRef="usd">2252000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTItMS0xLTEtOTk3MDY_917ef038-7d97-4c9d-9193-f0dfa8dc095e"
      unitRef="usd">12883000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTItMy0xLTEtOTk3MDY_ea071e4c-b7cc-4999-90a7-4146ba728022"
      unitRef="usd">11988000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTMtMS0xLTEtOTk3MDY_29bec04a-41cd-418a-99af-e199b96453e2"
      unitRef="usd">6349000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTMtMy0xLTEtOTk3MDY_c5bc5e29-8406-4937-b70b-5ae4f0b8081e"
      unitRef="usd">6121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTQtMS0xLTEtOTk3MDY_3d6a8740-fe38-45fc-82ac-f2d22f37ad4e"
      unitRef="usd">4059000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTQtMy0xLTEtOTk3MDY_4c1969bf-0b0a-4207-8de1-6fd6fb060f1a"
      unitRef="usd">4142000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTUtMS0xLTEtOTk3MDY_090a39ae-2f9f-41b5-b8f5-38a6b2c0fe95"
      unitRef="usd">1569000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTUtMy0xLTEtOTk3MDY_b8703b0a-a73d-4a92-8621-27aa1c98caf0"
      unitRef="usd">1410000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTYtMS0xLTEtOTk3MDY_edd9ad9e-b034-42ce-8acd-5262c06785ca"
      unitRef="usd">32189000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMTYtMy0xLTEtOTk3MDY_24e3ccbc-b410-4a42-b230-fba439160d31"
      unitRef="usd">32229000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjAtMS0xLTEtOTk3MDY_398bda20-c4b9-4c5c-97d6-086bd38cd320"
      unitRef="usd">170000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjAtMy0xLTEtOTk3MDY_28b8a4b7-dcda-4bf6-bafd-83de4eb1a638"
      unitRef="usd">261000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjEtMS0xLTEtOTk3MDY_1b2b0f70-728d-49e5-bbb2-177bba865637"
      unitRef="usd">732000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjEtMy0xLTEtOTk3MDY_94d455e8-511f-42b7-b5ae-1fc383e00ac1"
      unitRef="usd">794000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjItMS0xLTEtOTk3MDY_d689f569-9a34-473e-a0e5-758099790257"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjItMy0xLTEtOTk3MDY_63074078-38b4-4b6c-8529-b481964a704e"
      unitRef="usd">2436000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjMtMS0xLTEtOTk3MDY_c4b77f3e-21ac-4a7d-b42b-0489db688bf9"
      unitRef="usd">784000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjMtMy0xLTEtOTk3MDY_3f1440b6-fd9b-4818-a1d2-68f9340dfa3c"
      unitRef="usd">783000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjQtMS0xLTEtOTk3MDY_9bf1183a-68ae-4974-8225-c3b6253cf1c6"
      unitRef="usd">3883000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjQtMy0xLTEtOTk3MDY_34929bcb-2659-413d-85d6-ad5f1e729373"
      unitRef="usd">4274000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjUtMS0xLTEtOTk3MDY_3bc095a1-4ea6-4dee-afab-5b85429ef84b"
      unitRef="usd">8802000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjUtMy0xLTEtOTk3MDY_b1e5b2d1-465a-43d7-bd14-927ad3d2440f"
      unitRef="usd">8804000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjYtMS0xLTEtOTk3MDY_2defd55a-a866-4124-940f-a03967871992"
      unitRef="usd">265000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjYtMy0xLTEtOTk3MDY_7703edd0-7e4b-4a26-a43b-ac86bb67758e"
      unitRef="usd">310000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjctMS0xLTEtOTk3MDY_f03d0901-eef1-4a9e-a076-5989161018d4"
      unitRef="usd">1988000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjctMy0xLTEtOTk3MDY_bf5108a7-3066-4097-8dcc-879b5dfdbe2b"
      unitRef="usd">2220000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjktMS0xLTEtOTk3MDY_38be2476-9a2d-45c0-b1c0-9db18634e6b4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMjktMy0xLTEtOTk3MDY_02d2d15d-df08-438e-a840-636564403cc0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF8yMQ_08dad1b0-d991-45cc-9a9c-c5b4d5102f26"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF8yMQ_f63486e4-5bb7-484e-9b39-b26a7b15d193"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF80Nw_58e96556-36f0-4ebc-ba19-c28129963a10"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF80Nw_be7def8b-e617-47aa-a1ab-afda30a5458a"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF82Ng_4601f0ce-c727-4c8c-b700-734b414ba74a"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoxZDY0MzNlOWE2OTA0YmIwOTVjNGQ1NmRmYzJlZTY4ZF82Ng_882e0b3d-5107-4905-a1aa-7c2717a9631c"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMS0xLTEtOTk3MDY_d15c8a2f-dd0d-4fba-9d4c-cc6f15b617ea"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzItMy0xLTEtOTk3MDY_14c63bd7-a0af-4d75-9e04-d80c3172f4d1"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl8xOA_66dddde7-27bc-401b-a0c6-d79dcd2b41dc"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl8xOA_867f75c3-aebe-404e-a0a5-1c6937a39fe7"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl80NA_6d4a57fd-6390-43f5-a00f-27e3166a2991"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl80NA_76b08837-c502-41ee-9b5f-056c32450463"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl8yMTk5MDIzMjU1NzAx_fe600fad-389e-4956-b2fc-9d6599acb8aa"
      unitRef="shares">1693192785</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjowYjVhNTIzZTRjYWQ0Nzk0YmI5N2Q5MGJjODBiZDNkZl85OA_39b7f132-95e6-4b5b-a589-f4c16a0a8ef3"
      unitRef="shares">1688810052</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMS0xLTEtOTk3MDY_0c0155f4-1190-4bf7-ae4e-deb8cc576700"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzMtMy0xLTEtOTk3MDY_0979d476-20c0-4ab9-8103-058fce9b5be2"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoyMWMzNjE0ODk4N2E0MDNjOTZjYmRkMTkxODg5MjljMF8zMA_2fadc4dd-771a-4f13-b2c7-27ecf4d4ba08"
      unitRef="shares">263289848</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMC0xLTEtOTk3MDYvdGV4dHJlZ2lvbjoyMWMzNjE0ODk4N2E0MDNjOTZjYmRkMTkxODg5MjljMF8zMA_d35abd52-f450-4cae-83c8-9299f2cd146f"
      unitRef="shares">263289848</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMS0xLTEtOTk3MDY_d339349c-77a9-4f51-bf84-c7aba6578242"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzQtMy0xLTEtOTk3MDY_c3727aef-fee1-45b0-aed2-6fae5c9ede2d"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzUtMS0xLTEtOTk3MDY_29bb394b-a952-4398-8159-f51da0d05e66"
      unitRef="usd">20103000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzUtMy0xLTEtOTk3MDY_e4c741ed-b35d-4eb2-8878-935057c567b2"
      unitRef="usd">19986000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzYtMS0xLTEtOTk3MDY_2f86aad2-f844-4d8f-9137-d49ca62e332c"
      unitRef="usd">-1050000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzYtMy0xLTEtOTk3MDY_cbf766ae-e7e8-416f-9809-fd5e5b39e9db"
      unitRef="usd">-1392000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzctMS0xLTEtOTk3MDY_56c1df11-8fc0-4199-a357-72bf0803bb59"
      unitRef="usd">433000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzctMy0xLTEtOTk3MDY_da65c186-a08e-4f80-bbf7-c57dd047ba6c"
      unitRef="usd">263000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzgtMS0xLTEtOTk3MDY_0e0e4ff3-b3c8-4a99-8f8c-6b296083c193"
      unitRef="usd">17251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzgtMy0xLTEtOTk3MDY_343da57e-80a3-411f-bfec-7a5473aae498"
      unitRef="usd">16622000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzktMS0xLTEtOTk3MDY_2cf48776-a8fd-4cce-85b6-3fbde9bde637"
      unitRef="usd">32189000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yNS9mcmFnOjIzOGZmYmQ4MDI4NjRiNzg4ZTgzODQ1OTJhMTM3ZjQxL3RhYmxlOjVlMzMyOGIyMTViMDRmM2RhNTE4OTJmYzYwMzVmYmZkL3RhYmxlcmFuZ2U6NWUzMzI4YjIxNWIwNGYzZGE1MTg5MmZjNjAzNWZiZmRfMzktMy0xLTEtOTk3MDY_14c42f90-0944-4b9e-b2c2-1d9a8a0214eb"
      unitRef="usd">32229000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i8d88de9252574e38a75e71a25f421c17_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy0xLTEtMS05OTcwNg_8b0c87d0-3608-4227-82d3-99694ff693ad"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i4c57ac41bacb4c959c5a7c938d5fe29b_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy0zLTEtMS05OTcwNg_f04a2e27-12de-4eac-bfb3-46240d322c4d"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ic39344112e4b495b9d151b1e92eaac82_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy01LTEtMS05OTcwNg_fc2700e6-07d0-406c-b19f-05fbb6967aa8"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMy03LTEtMS05OTcwNg_7cc90b09-4a65-40ef-b999-229c370dc9c1"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS0xLTEtMS05OTcwNg_4b36496a-44ff-4f9d-9a44-1c6e81ca0f34"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS0zLTEtMS05OTcwNg_704a0741-9c73-4541-b462-9fda55a8f399"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS01LTEtMS05OTcwNg_b3dcfaeb-93f1-48be-8c61-ac7447a6a3b2"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNS03LTEtMS05OTcwNg_2f2a5fe7-25a2-4642-8437-681528d94a72"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="idc86164a6a43461a9651ec61b88f32e6_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy0xLTEtMS05OTcwNg_88ff7246-2d89-4ee4-a25a-d9ab12408f4c"
      unitRef="shares">1692828987</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="id535101847a6481a96023d3bc410b6bd_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy0zLTEtMS05OTcwNg_1b27f0dd-e0ae-4cdb-97c4-3ef8621bac5b"
      unitRef="shares">1683861226</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ifd0efc03c9fd497083ef2469237d078f_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy01LTEtMS05OTcwNg_d2395c1c-e69d-4523-a44f-1eb73bc6e7c6"
      unitRef="shares">1688810052</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i2696e3eb89444f7e9d4aa930e613f0b7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNy03LTEtMS05OTcwNg_318127f7-d5a1-4c8b-92b0-8042ebe2e315"
      unitRef="shares">1679911918</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS0xLTEtMS05OTcwNg_c232da99-0bd3-4bb5-9f31-b10862551858"
      unitRef="shares">363798</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS0zLTEtMS05OTcwNg_7f4bd71d-fea1-471e-ab50-7d6cc5845dfa"
      unitRef="shares">1145382</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="ideceab173cc44867a7c0a083004446ae_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS01LTEtMS05OTcwNg_72d05e75-7ae8-4d49-8671-1a2bc4f0c574"
      unitRef="shares">4382733</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfOS03LTEtMS05OTcwNg_6747ba5a-a3e1-406c-a36b-eafca54200de"
      unitRef="shares">5094690</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtMS0xLTEtOTk3MDY_fd8ea75e-f9d4-4bc7-bdc4-b9ef457ba622"
      unitRef="shares">1693192785</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtMy0xLTEtOTk3MDY_3259945b-c704-4955-9e61-e19f5e56f718"
      unitRef="shares">1685006608</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtNS0xLTEtOTk3MDY_5e15a39c-ce2a-4a4e-9929-53b5b636bfc5"
      unitRef="shares">1693192785</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTAtNy0xLTEtOTk3MDY_4ec5bc50-9737-4950-92d6-7901559845cb"
      unitRef="shares">1685006608</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8d88de9252574e38a75e71a25f421c17_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtMS0xLTEtOTk3MDY_9f2adde8-9ff0-4f0b-a881-00ad3bf6bf33"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c57ac41bacb4c959c5a7c938d5fe29b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtMy0xLTEtOTk3MDY_f727fa70-bc11-437a-adef-dd9a6184a38b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic39344112e4b495b9d151b1e92eaac82_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtNS0xLTEtOTk3MDY_17db9218-76a2-41db-aea2-41466d1bc173"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTMtNy0xLTEtOTk3MDY_e2c3c9e6-aaab-4c0b-87f4-c9fe685a4cfa"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="id049216887f0461ebc0924dd96909b7f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtMS0xLTEtOTk3MDY_14f2a2be-7fed-4dc2-a535-51d5bb2933c9"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="ic8f7a0da6f194f4f924ff1168b96527d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtMy0xLTEtOTk3MDY_815a770d-64a2-4f16-b785-6c052e102f17"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="id45c80183e4a4f64b08b6a4853ef9f4c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtNS0xLTEtMTA1Nzk5_ef4f1387-5bdf-4ef1-97bd-3611cfa6235f"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i815c23c139b84522831b294d59dd7d1e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTQtNy0xLTEtOTk3MDY_f0185a3e-0406-405e-b034-0aacc438659d"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtMS0xLTEtOTk3MDY_e0af17b7-9e89-4f7b-baca-d4a5f6d94a26"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtMy0xLTEtOTk3MDY_00d325aa-0f24-4637-86b1-52ec8e647ff3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic195e04f558f4180bdfa85d54ab847eb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtNS0xLTEtOTk3MDY_91190ee6-5abc-45de-a30e-30000c41d4b5"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1083b51b32f84f9ca03bffc92e5faa00_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTUtNy0xLTEtOTk3MDY_313cacc9-1b9a-459d-a4cf-8cb44f7a4f0f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc86164a6a43461a9651ec61b88f32e6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctMS0xLTEtOTk3MDY_48ce829b-b719-4c75-9e84-7287aeb5e8f5"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id535101847a6481a96023d3bc410b6bd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctMy0xLTEtOTk3MDY_ad9972de-f62d-4a79-a91a-b6cddca3cb9b"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd0efc03c9fd497083ef2469237d078f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctNS0xLTEtOTk3MDY_1ead39ac-c32f-4ed6-8f81-907a55c38348"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2696e3eb89444f7e9d4aa930e613f0b7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTctNy0xLTEtOTk3MDY_e79303ab-f707-497c-9ec2-832882992317"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtMS0xLTEtOTk3MDY_7ad82480-3996-436f-8929-3bca8c14c855"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtMy0xLTEtOTk3MDY_b33b7b97-5973-491a-89a8-e51a196dc4a2"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="ideceab173cc44867a7c0a083004446ae_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtNS0xLTEtMTA1ODQ1_bcd73ad2-ef00-41fd-87c6-76c75412d790"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTgtNy0xLTEtOTk3MDY_d3316cb3-4804-4384-89c0-f76abf1580ad"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ie17e9ec8b7b7473a8c7efffce63634fa_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktMS0xLTEtOTk3MDY_ec72f37a-4eda-432b-8ff3-4a12584cc438"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i90b87b82e7b14880b7736422b5e98553_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktMy0xLTEtOTk3MDY_18afd878-82bd-4d61-bbac-788845bb4164"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ideceab173cc44867a7c0a083004446ae_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktNS0xLTEtMTA1ODQ1_818790fe-217e-49b0-a65b-117541db6658"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i28167b52c6124d9ebdd63c1dfb296872_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMTktNy0xLTEtMTA1ODU1_bfd9ec51-5ec9-4e99-bbf5-9721e7a051e5"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1accaba913b4d1fbcb2c28cac07c0b0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtMS0xLTEtOTk3MDY_f008b5ee-3941-4173-a7aa-9ddd565961b7"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie90c9ee4716140dd8fae0ab1d0950fed_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtMy0xLTEtOTk3MDY_25a6b397-b275-43e4-b14d-38df03713e07"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1accaba913b4d1fbcb2c28cac07c0b0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtNS0xLTEtOTk3MDY_3308a368-316b-4ea2-84dd-6eecd1901592"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie90c9ee4716140dd8fae0ab1d0950fed_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjAtNy0xLTEtOTk3MDY_697fe73c-8d68-4f40-bb1e-d87656a0d0b1"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9391520b32e640fe97bcc36c1e5962f2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItMS0xLTEtOTk3MDY_fdd8f7bc-211e-4b7f-b9b4-31acd87bfe92"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22ff7c22212045f6b95c0a15cfeed14a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItMy0xLTEtOTk3MDY_4b59cd75-8494-46f8-ae0b-0935652c119c"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf5905737675481fb710c2ba0f468446_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItNS0xLTEtOTk3MDY_b6641bf0-f060-4be9-8995-3a5265ea69d6"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fd9a0d26fab4332b61d8fad802ce5c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjItNy0xLTEtOTk3MDY_f75b5806-31fb-4aa6-b1be-9d0693372a2f"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if15cc720f87a460abc0eb4e4e59fe876_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtMS0xLTEtOTk3MDY_feda8cc2-8148-41bd-a1ae-41f4b5b07829"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8d680683b1e14d29be1a910573f28e70_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtMy0xLTEtOTk3MDY_54f773ea-59b5-4f4c-beb5-03fe87f07b1f"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic5f97f1273c1442381613e9edae599b9_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtNS0xLTEtOTk3MDY_cec58fae-186c-4be8-8fac-a76e17eaa2fb"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7c84bc9bc635449b990165995bfde9a2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjMtNy0xLTEtOTk3MDY_93b4700d-e19d-4295-a349-287eb666b6e8"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cd771fc7d304e65a737b060eb018b8f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtMS0xLTEtOTk3MDY_8df8385c-ab69-4bd9-8b45-284328ef2d04"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3466963199fd4fa3ade9bfff3a977e9f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtMy0xLTEtOTk3MDY_32fb438d-17f3-4f35-a1f9-c491ee6d5915"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cd771fc7d304e65a737b060eb018b8f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtNS0xLTEtOTk3MDY_f7a4b670-aef8-4f78-8a01-2f7a1e819fd8"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3466963199fd4fa3ade9bfff3a977e9f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjQtNy0xLTEtOTk3MDY_a856cdfd-adbc-49c0-959d-4bcc7f3e9151"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84240be430054940bd414a4c7f52641a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtMS0xLTEtOTk3MDY_9e94aa6c-88ec-4918-9187-0bad0e422b25"
      unitRef="usd">20043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if25f858a6d47415ba74ad94fa706aa56_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtMy0xLTEtOTk3MDY_09bc2509-da74-4b7e-b23e-a6b35dc3dd30"
      unitRef="usd">19750000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6833d10fdee44d23b00e6ef571848119_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtNS0xLTEtOTk3MDY_7228f45e-1432-49b8-91c4-dce1a361fe12"
      unitRef="usd">19986000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b6ff8621f654a959cb451ed414f77d0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjYtNy0xLTEtOTk3MDY_b726a02f-d140-4aa1-a830-87ec648d0b6c"
      unitRef="usd">19732000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i1e2b757294d44982a169d202719a992a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktMS0xLTEtOTk3MDY_59b6d5c3-acb6-4306-9ade-49a0ec55ac27"
      unitRef="usd">60000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ia346d18d384c42c7a6e99a584fdc97ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktMy0xLTEtOTk3MDY_4b281db0-3f7e-4c0a-858a-d504135fe0c4"
      unitRef="usd">66000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i9a9e610d324a45d1a062c68adfb90b1f_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktNS0xLTEtOTk3MDY_9e162d5c-7df7-415f-abab-70f51bcff9a0"
      unitRef="usd">117000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i74f91cea543f4d33980254e8da67f9f5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMjktNy0xLTEtOTk3MDY_05f62bca-8d7d-4b9c-a756-6145f7fa9567"
      unitRef="usd">85000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic48e2fdfe8f64c8b8bae824c8b0d223a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtMS0xLTEtOTk3MDY_a6f474ea-f43e-4326-9c31-93d939c27ca7"
      unitRef="usd">20103000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9be8a81ffb4f47a6b727c3d0e0043401_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtMy0xLTEtOTk3MDY_afa6f3b4-e01a-4a98-b436-61355591b194"
      unitRef="usd">19817000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic48e2fdfe8f64c8b8bae824c8b0d223a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtNS0xLTEtOTk3MDY_88447205-32ff-48bb-8989-febefac281c6"
      unitRef="usd">20103000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9be8a81ffb4f47a6b727c3d0e0043401_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzAtNy0xLTEtOTk3MDY_4ba89a64-c6fb-4b0e-ba00-6a7c6bded4fb"
      unitRef="usd">19817000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04889bdcfd104454b1ef3794d7f8830a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItMS0xLTEtOTk3MDY_fa2f5202-d8d2-43a0-bad9-1342a5ec23cd"
      unitRef="usd">-1296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if43d66985bfd4da1b42f8e3e134778a6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItMy0xLTEtOTk3MDY_153b7e6c-3879-4418-9f24-a10a452b4d61"
      unitRef="usd">-2050000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2c7ff30c0e34b678886a170580868c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItNS0xLTEtOTk3MDY_e45bc252-6994-40aa-b2f4-a146aab4b1b6"
      unitRef="usd">-1392000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44a04e2556f74b76bb8d693c12f82912_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzItNy0xLTEtOTk3MDY_30a9ff1c-9052-4372-a474-d5ee28c92a44"
      unitRef="usd">-2378000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i6a98c3dc779644d6b41945be1f5e75ed_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtMS0xLTEtOTk3MDY_b269cf1c-bb66-476a-b497-4da870b5dbab"
      unitRef="usd">260000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i62ebba7d42bf4a138a7fea99714df893_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtMy0xLTEtOTk3MDY_026cd79e-3715-4972-80dc-57d027e64e2e"
      unitRef="usd">186000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id47b2514859f4f27848ade4cccce2be8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtNS0xLTEtOTk3MDY_f91ba87b-922e-490f-b8e4-a780a313df9d"
      unitRef="usd">370000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7ffda331fdc249b9afd399366fe2269a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzMtNy0xLTEtOTk3MDY_50c95ae3-1641-4118-9672-534afca4e178"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i6a98c3dc779644d6b41945be1f5e75ed_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtMS0xLTEtOTk3MDY_3b3fc547-5b79-47eb-a0a3-1801dc6a8173"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i62ebba7d42bf4a138a7fea99714df893_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtMy0xLTEtOTk3MDY_4b7793cd-1b11-478e-935b-ae97a47a54cb"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="id47b2514859f4f27848ade4cccce2be8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtNS0xLTEtOTk3MDY_35559636-4bb9-4eeb-9f61-aea899e793ed"
      unitRef="usd">-28000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i7ffda331fdc249b9afd399366fe2269a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzQtNy0xLTEtOTk3MDY_c6ae439d-9650-4bd2-9507-b2b8f10cf410"
      unitRef="usd">-28000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i43c66b638de3480c9eb8a388b49f2860_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtMS0xLTEtOTk3MDY_ddd3c692-59b7-4a7a-ad38-251ef3702c57"
      unitRef="usd">-1050000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7781cde9f4be4c6f8a6068f01de92fb5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtMy0xLTEtOTk3MDY_c07868a8-9e11-44cd-9733-6f69c6f4ee60"
      unitRef="usd">-1878000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i43c66b638de3480c9eb8a388b49f2860_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtNS0xLTEtOTk3MDY_6126de1f-3412-464c-96a5-884293192271"
      unitRef="usd">-1050000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7781cde9f4be4c6f8a6068f01de92fb5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzUtNy0xLTEtOTk3MDY_5d20fb92-994d-429e-892b-3844baf732d7"
      unitRef="usd">-1878000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9303b7f6c9604c1a9623997b119bcbcd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctMS0xLTEtOTk3MDY_5a4144ed-f6da-4f2a-a569-9e1acc171ad6"
      unitRef="usd">222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib4588728b1b54b1598ce091e28f075b5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctMy0xLTEtOTk3MDY_17a79b28-e808-4981-8db6-6da3be1de954"
      unitRef="usd">254000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i530a24628ff94bd8b6ecf768eb616100_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctNS0xLTEtOTk3MDY_1bfc2bf3-a9ad-4dc5-bf1d-42c37503f81d"
      unitRef="usd">263000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f2c362bdaec4d7c93ae599a3400d63c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzctNy0xLTEtOTk3MDY_7634d2c1-72e7-4d0d-b887-90b66954b7b9"
      unitRef="usd">207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i23a6e58ba7314b24a600982bbb84d5a8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtMS0xLTEtOTk3MDY_4f680fd0-7f96-4803-a135-08eb3435669c"
      unitRef="usd">211000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icbd1a4c6e5ac4665bd79ed3e6e017085_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtMy0xLTEtOTk3MDY_173a4a5a-bc9f-40a6-8bc5-d3dc7346202e"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i685d9eb49f444cc59ed839c5b206c9d5_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtNS0xLTEtOTk3MDY_204b9326-16e8-4f46-8940-3cc75a548857"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icbe2dc1f9b004e68839d9b76d40729f1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzgtNy0xLTEtOTk3MDY_7488de78-6796-447d-9b46-c6e685282e94"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53edfe4ecc4f46be8baf73fc46188f98_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktMS0xLTEtOTk3MDY_e6a80ac0-d3f2-4c64-b1ed-f797a0491261"
      unitRef="usd">433000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb6d5756a23e440086572a008869074f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktMy0xLTEtOTk3MDY_d82b3137-7067-439d-a747-7186b21fad9c"
      unitRef="usd">237000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53edfe4ecc4f46be8baf73fc46188f98_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktNS0xLTEtOTk3MDY_213ec8f2-7f41-4d5e-aaa3-9618376110ab"
      unitRef="usd">433000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb6d5756a23e440086572a008869074f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfMzktNy0xLTEtOTk3MDY_09e99bdc-4fc4-46f1-b86c-2ac853cf0f62"
      unitRef="usd">237000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtMS0xLTEtOTk3MDY_d80fa2f2-16c5-4078-bad6-58d08568fdde"
      unitRef="usd">17251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtMy0xLTEtOTk3MDY_35516750-d453-431a-9b22-6d8a8dfa9659"
      unitRef="usd">15942000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtNS0xLTEtOTk3MDY_6120819b-02fd-46ec-9766-b6525ef05eac"
      unitRef="usd">17251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8yOC9mcmFnOmNmMTUxZDM3OTk3NzRkZjliMDY4OThkYWNjMzYxZjM4L3RhYmxlOjQ4NGMzMzY5MDg0MDQ3NDRiMDkyNWI0Mjc4NTA0ZWI3L3RhYmxlcmFuZ2U6NDg0YzMzNjkwODQwNDc0NGIwOTI1YjQyNzg1MDRlYjdfNDAtNy0xLTEtOTk3MDY_e82dc396-2cae-4de5-8469-a73d4b2f6237"
      unitRef="usd">15942000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMi0xLTEtMS05OTcwNg_303487f8-b86e-4f84-a954-640b49d446ce"
      unitRef="usd">370000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMi0zLTEtMS05OTcwNg_8a5f2f89-632d-4a41-a8e6-2be15236bd58"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNC0xLTEtMS05OTcwNg_04f18f5d-4e9f-4443-8610-e6df7da404ef"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNC0zLTEtMS05OTcwNg_c705ff58-5368-41cd-b41f-696003a0eca2"
      unitRef="usd">9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNS0xLTEtMS05OTcwNg_70440e32-b509-4c58-bff2-99cee82cdcab"
      unitRef="usd">558000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNS0zLTEtMS05OTcwNg_dd265ac8-35dd-4190-8185-71b1808046e6"
      unitRef="usd">531000000</us-gaap:DepreciationDepletionAndAmortization>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNi0xLTEtMS05OTcwNg_190e94ca-3ff0-48e1-b939-a88de4be682b"
      unitRef="usd">-93000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNi0zLTEtMS05OTcwNg_c49a5fd2-6176-4668-8676-8209208aba66"
      unitRef="usd">-88000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNy0xLTEtMS05OTcwNg_bf29c9a9-1264-47b9-82d3-ea030502f923"
      unitRef="usd">107000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNy0zLTEtMS05OTcwNg_feadc28a-c920-4378-b39c-b7cd1250773a"
      unitRef="usd">94000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOC0xLTEtMS05OTcwNg_6a6d038e-f55f-4bf4-aecd-9c4d21dd7c35"
      unitRef="usd">7000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOC0zLTEtMS05OTcwNg_4c422bbf-0243-4f6c-8c9e-c769fa149058"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:GainLossOnInvestments
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOS0xLTEtMS05OTcwNg_e7adf0aa-94a7-4c40-839e-cd35b832f78f"
      unitRef="usd">-36000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfOS0zLTEtMS05OTcwNg_cdc6f2a7-334f-49aa-8123-ec9761412784"
      unitRef="usd">22000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTAtMS0xLTEtOTk3MDY_15ad8c78-213a-44c7-b1e4-1d6c93cef73e"
      unitRef="usd">48000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTAtMy0xLTEtOTk3MDY_199b553a-5108-47b1-b687-2285543ed057"
      unitRef="usd">-91000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:InventoryStepUpAmortization
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTEtMS0xLTEtOTk3MDY_92174bae-b5fa-42bf-827b-ae6a738ca10d"
      unitRef="usd">25000000</bsx:InventoryStepUpAmortization>
    <bsx:InventoryStepUpAmortization
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTEtMy0xLTEtOTk3MDY_544e600d-02e8-41fa-a9c7-aa3eaa0e4bda"
      unitRef="usd">8000000</bsx:InventoryStepUpAmortization>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTMtMS0xLTEtOTk3MDY_cf537eb8-e0f4-4b50-9d6c-1561a511d00a"
      unitRef="usd">-194000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTMtMy0xLTEtOTk3MDY_dd0201a1-fb80-4bec-b3bb-22971129a464"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <bsx:OtherNet
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTQtMS0xLTEtOTk3MDY_34be411e-a3f7-43e4-a6bf-fb426a2a40ba"
      unitRef="usd">31000000</bsx:OtherNet>
    <bsx:OtherNet
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTQtMy0xLTEtOTk3MDY_955657a5-3f1e-4bae-ac4d-14e745c2ea90"
      unitRef="usd">35000000</bsx:OtherNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTYtMS0xLTEtOTk3MDY_bab4c919-6992-4a4f-a7db-9840027a4529"
      unitRef="usd">162000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTYtMy0xLTEtOTk3MDY_4c60abaa-6fd5-447f-8f3e-4e722eb04318"
      unitRef="usd">145000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTctMS0xLTEtOTk3MDY_452944f9-4752-42a9-88f6-98d32e52a5b0"
      unitRef="usd">180000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTctMy0xLTEtOTk3MDY_6d79d408-f1f8-4162-a5a0-3cb702fe4f6d"
      unitRef="usd">100000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTgtMS0xLTEtOTk3MDY_ffec70b5-3c9f-4d35-b246-198f4c347abe"
      unitRef="usd">244000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTgtMy0xLTEtOTk3MDY_16e26d4f-3824-4d56-9164-8eaabbd23838"
      unitRef="usd">200000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTktMS0xLTEtOTk3MDY_2f717716-9184-4c97-91c8-0826ee92e369"
      unitRef="usd">-449000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMTktMy0xLTEtOTk3MDY_7b831c50-521f-421f-8228-5f766c6a834f"
      unitRef="usd">340000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjEtMS0xLTEtOTk3MDY_7cc28fd8-7939-4694-a967-a407c28ea16e"
      unitRef="usd">249000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjEtMy0xLTEtOTk3MDY_b91f6fb0-27a7-46e1-978e-a1342ae0c4b0"
      unitRef="usd">927000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjQtMS0xLTEtOTk3MDY_28ab59f8-181c-438f-8446-1cf379ebd06f"
      unitRef="usd">226000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjQtMy0xLTEtOTk3MDY_41670ebe-15d8-41c7-9546-9d134346f7af"
      unitRef="usd">181000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjUtMS0xLTEtOTk3MDY_14f4a0db-bd18-45d9-aeef-75c5c7dbdb6e"
      unitRef="usd">9000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjUtMy0xLTEtOTk3MDY_cccd0dac-9624-4d11-b112-f70d6cc9b8d2"
      unitRef="usd">7000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjYtMS0xLTEtOTk3MDY_3b7b455a-14c6-4ab8-bc56-ab7e4f241c6d"
      unitRef="usd">1471000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjYtMy0xLTEtOTk3MDY_210212dc-f029-4198-8b3f-0b72da118416"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMS0xLTEtMTEzNjY0_b3684c80-cdb3-41b5-88a2-95f75dcfbe61"
      unitRef="usd">14000000</bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies>
    <bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMy0xLTEtMTEzNjY0_d7a4f106-cde4-4e7c-8576-f983ba632fb6"
      unitRef="usd">-92000000</bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMS0xLTEtOTk3MDY_44075010-0e6a-4ae8-917d-110cbb0b3633"
      unitRef="usd">5000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjctMy0xLTEtOTk3MDY_cd77572d-0e31-4e57-b64b-7f1995482035"
      unitRef="usd">801000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjgtMS0xLTEtOTk3MDY_1164df4c-a071-42dd-b63d-09c4114ecbb8"
      unitRef="usd">-36000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjgtMy0xLTEtOTk3MDY_eb382acd-2eab-47cc-9fb4-be46fc12ff70"
      unitRef="usd">-43000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjktMS0xLTEtOTk3MDY_4310ad94-1781-43b0-bb17-27fc178548a7"
      unitRef="usd">56000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMjktMy0xLTEtOTk3MDY_9c382391-105c-42cf-a12b-b64d31e2b96b"
      unitRef="usd">15000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzEtMS0xLTEtOTk3MDY_7e6c9573-8cc5-49b9-bee5-af00726b27bd"
      unitRef="usd">-1603000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzEtMy0xLTEtOTk3MDY_eb052721-e0cf-450f-b5c1-aa71d45951bd"
      unitRef="usd">71000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzQtMS0xLTEtOTk3MDY_d641e84e-6b4c-4dd6-8aba-c9f4d1928467"
      unitRef="usd">283000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzQtMy0xLTEtOTk3MDY_3cf1e980-0ee8-4b94-91be-cba2abc13109"
      unitRef="usd">14000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <bsx:PaymentsForRoyaltyRights
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzUtMS0xLTEtOTk3MDY_d9eac270-6ae9-4406-a4b8-74ff350976c5"
      unitRef="usd">39000000</bsx:PaymentsForRoyaltyRights>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzUtMy0xLTEtOTk3MDY_39b8f5d1-d681-4cc9-81cc-a5a9cf5fce16"
      unitRef="usd">42000000</bsx:PaymentsForRoyaltyRights>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzYtMS0xLTEtOTk3MDY_a5b287d8-a0d4-4ee4-ab41-37edfa89f17c"
      unitRef="usd">250000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzYtMy0xLTEtOTk3MDY_6ae41c2a-533d-4c42-a8b5-8b7d5a0895e3"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzgtMS0xLTEtOTk3MDY_01f52342-ccf2-4a3b-81e8-581b9e4f37c7"
      unitRef="usd">154000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfMzgtMy0xLTEtOTk3MDY_99310b56-11a4-43fa-87e7-d92f403c39d3"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDEtMS0xLTEtOTk3MDY_02881c23-818b-4560-a42a-52a6f69c5043"
      unitRef="usd">3184000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDEtMy0xLTEtOTk3MDY_4e08cdb4-fd58-4154-981f-dc38b1c1ecb4"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDItMS0xLTEtOTk3MDY_f7ea552d-e4b0-4c76-8c17-33e94c5ee754"
      unitRef="usd">3270000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDItMy0xLTEtOTk3MDY_a7dbe8fd-413d-4624-ab21-0cb8d838446a"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDMtMS0xLTEtOTk3MDY_274995c9-13fb-4944-87d5-9e40967acf87"
      unitRef="usd">28000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDMtMy0xLTEtOTk3MDY_f45dd8c3-50d6-49e5-b5d7-4be683a1b4eb"
      unitRef="usd">28000000</us-gaap:PaymentsOfDividends>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDYtMS0xLTEtOTk3MDY_52ec9f1e-e2e0-4ab3-8d67-90d2c3c8fcfa"
      unitRef="usd">47000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDYtMy0xLTEtOTk3MDY_4ff6ebf6-7891-4fe9-98d2-766153b308dc"
      unitRef="usd">47000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <us-gaap:ProceedsFromStockPlans
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDctMS0xLTEtOTk3MDY_7416000b-fedc-40cb-bb91-46f681a075c1"
      unitRef="usd">58000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDctMy0xLTEtOTk3MDY_5225b534-1860-4473-bed8-3c88b96d8254"
      unitRef="usd">38000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDgtMS0xLTEtOTk3MDY_6c13cd59-6ad4-42ba-8471-f27baf46dbda"
      unitRef="usd">-350000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNDgtMy0xLTEtOTk3MDY_3e4b6b67-e147-46a6-9399-b6775c991bfb"
      unitRef="usd">-93000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTAtMS0xLTEtOTk3MDY_799b69bc-4135-4241-ab53-de7da4af9c4e"
      unitRef="usd">-6000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTAtMy0xLTEtOTk3MDY_23b7d75a-ab94-4ddf-aeaa-5d3726ae92fe"
      unitRef="usd">-2000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTItMS0xLTEtOTk3MDY_393a53d0-f925-435a-b426-f12d83907530"
      unitRef="usd">-1710000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTItMy0xLTEtOTk3MDY_5b900032-088f-4e5f-8253-899d9dff9862"
      unitRef="usd">903000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTMtMS0xLTEtOTk3MDY_b9703027-1acb-4129-972f-3af6b516241b"
      unitRef="usd">2168000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTMtMy0xLTEtOTk3MDY_bba3a935-128e-4966-89b3-da61f887ff2d"
      unitRef="usd">1995000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTQtMS0xLTEtOTk3MDY_f9ae6eea-07ac-4530-9872-2ecbc223af30"
      unitRef="usd">458000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjRkNDRiZDEwYjAxMzQwNzQ4Y2UyZGE3NjA5MjE3YTU3L3RhYmxlcmFuZ2U6NGQ0NGJkMTBiMDEzNDA3NDhjZTJkYTc2MDkyMTdhNTdfNTQtMy0xLTEtOTk3MDY_c71f1537-96a5-4780-9857-8a15db0af9b1"
      unitRef="usd">2898000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ShareBasedCompensation
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfMy0xLTEtMS05OTcwNg_0c29de98-f1b8-4e24-a8cb-6720c7481eaf"
      unitRef="usd">107000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfMy0zLTEtMS05OTcwNg_fc13ea05-155a-4198-bf11-fc409ddd09e8"
      unitRef="usd">94000000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNC0xLTEtMS05OTcwNg_2fd445cf-2b52-4b34-8e54-b8189e709d73"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNC0zLTEtMS05OTcwNg_1224e16e-011d-4c2c-82b0-a87265441cc8"
      unitRef="usd">221000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNS0xLTEtMS05OTcwNg_b1780d2c-36d2-40a1-aaac-8de39ec01355"
      unitRef="usd">-36000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOjM0YTVjMmQ2OWU1ODQxZmNhMjIyMmIzYmIwODIyN2Y4L3RhYmxlcmFuZ2U6MzRhNWMyZDY5ZTU4NDFmY2EyMjIyYjNiYjA4MjI3ZjhfNS0zLTEtMS05OTcwNg_b200f513-a63c-4ad2-990d-4c1f5807fe82"
      unitRef="usd">-43000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMi0xLTEtMS05OTcwNg_cbcd390e-d40b-4452-8871-55975e5de404"
      unitRef="usd">276000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMi0zLTEtMS05OTcwNg_d50eb00c-d5d3-43fb-971e-b44df21e7fb7"
      unitRef="usd">2675000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMy0xLTEtMS05OTcwNg_50faef4d-b4c7-4fe1-a463-dde0cd43820c"
      unitRef="usd">132000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfMy0zLTEtMS05OTcwNg_ea05493c-7708-4cfd-9743-fff7a3631bc0"
      unitRef="usd">167000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNC0xLTEtMS05OTcwNg_c00bb88d-aa28-4fa3-be6b-67d9391b33b3"
      unitRef="usd">50000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNC0zLTEtMS05OTcwNg_d6839788-2aa3-4592-9db3-175d6f618e00"
      unitRef="usd">57000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNS0xLTEtMS05OTcwNg_c45459da-4f6d-4a56-a880-fc068977e99d"
      unitRef="usd">458000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNS0xLTEtMS05OTcwNg_eda1495c-888d-412b-a3e3-6fdfb999ec65"
      unitRef="usd">458000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zMS9mcmFnOjY2NGExNmYzMzM4ODQ0NGY4MTY3MzBjZThjNTllODI0L3RhYmxlOmNkZTgxZGYwMmFlMjQ0NDNhOTgyOTFhYmI4YTY1ZjY3L3RhYmxlcmFuZ2U6Y2RlODFkZjAyYWUyNDQ0M2E5ODI5MWFiYjhhNjVmNjdfNS0zLTEtMS05OTcwNg_66bb076b-8029-4741-a16f-d604d3820ca0"
      unitRef="usd">2898000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zNy9mcmFnOjE4ZjA2MjMyNzBkOTRmZmRiYjY0YmY2NzdmMjFlMWQzL3RleHRyZWdpb246MThmMDYyMzI3MGQ5NGZmZGJiNjRiZjY3N2YyMWUxZDNfMTkzMg_9527003a-2137-4490-b33a-846f7fde122e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE A &#x2013; BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zNy9mcmFnOjE4ZjA2MjMyNzBkOTRmZmRiYjY0YmY2NzdmMjFlMWQzL3RleHRyZWdpb246MThmMDYyMzI3MGQ5NGZmZGJiNjRiZjY3N2YyMWUxZDNfMTAzMA_981bdca8-b775-4672-9b72-735470fa455a"
      unitRef="reportablesegments">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8zNy9mcmFnOjE4ZjA2MjMyNzBkOTRmZmRiYjY0YmY2NzdmMjFlMWQzL3RleHRyZWdpb246MThmMDYyMzI3MGQ5NGZmZGJiNjRiZjY3N2YyMWUxZDNfMTkzNw_a62182b8-12a5-4387-b4b7-37d08c85d6a0">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc2MQ_ccc1229c-4e71-485e-b7fc-2115e947924a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE B &#x2013; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed one acquisition in the first six months of 2022, and one acquisition and one divestiture in the first six months of 2021. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 15, 2022, we announced our entry into a definitive agreement with Synergy Innovation Co, Ltd, to purchase its majority stake of M.I. Tech Co., Ltd., (M.I. Tech), a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. The agreement, whereby we will purchase approximately 64 percent of the outstanding shares of M.I. Tech, consists of a purchase price of KRW 291.2 billion or approximately $230 million, subject to closing adjustments. The acquisition is expected to close during the second half of 2022, subject to customary closing conditions. The M.I. Tech stent portfolio complements our existing Endoscopy portfolio which will give physicians more treatment options to meet specific patient needs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2022 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which has developed the radiofrequency (RF) NRG&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and VersaCross&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which expands our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment of $1.471 billion, net of cash acquired, subject to closing adjustments. We are integrating the Baylis Medical business into our Cardiology division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price was comprised of the amounts presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(FASB ASC Topic 805).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the acquisition of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $925 million and up to an additional $300 million in a potential commercial milestone payment. We had been an investor in Preventice since 2015 and held an equity stake of approximately 22 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $195 million gain recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the first quarter of 2021. The transaction price for the remaining stake consisted of an upfront cash payment of $706 million, net of cash acquired, and an additional revenue-based milestone payment of $216 million made during the second quarter of 2022. The Preventice business is being managed by our Cardiology division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisition of Preventice as a business combination, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2022 we recorded certain measurement period adjustments related to our prior year acquisition of the surgical business of Lumenis, LTD. (Lumenis). We recorded an accrued income tax liability within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other non-current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets of $177 million related to uncertain tax positions assumed in connection with the acquisition. We were indemnified by the sellers for the majority of such tax obligations and recognized a corresponding indemnification asset of $172 million at the acquisition date within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets. Subsequent to the acquisition date, interest and penalties accrued on the tax liability are being recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and corresponding adjustments to the indemnification asset are being recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations. The outcome of these matters is subject to uncertainty and ultimately, the amount of tax due and the related indemnification reimbursement we receive will be dependent on the outcome of tax return examinations by relevant authorities. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Supplemental Balance Sheet Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details regarding our indemnification asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $800 million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of five facilities and approximately 280 employees globally. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter and first six months of 2021, we recognized a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gain on disposal of businesses and assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; associated with the transaction of $2 million and $9 million, respectively, within our accompanying unaudited consolidated statements of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability during the first six months of 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was $544 million. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$107 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$112 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected contingent payment amounts related to research and development (R&amp;amp;D), regulatory and commercialization-based milestones and revenue-based payments are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of June&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Publicly-held securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. &lt;/span&gt;As of June&#160;30, 2022, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $233 million, which represents amortizable intangible assets, in-process research and development (IPR&amp;amp;D), goodwill and deferred tax liabilities.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTM3_74d2accf-8bb0-435c-b2cc-5773cd7ba305"
      unitRef="business">1</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTcw_7e5dc777-5308-438e-a7e9-4d43cc028af1"
      unitRef="business">1</us-gaap:NumberOfBusinessesAcquired>
    <bsx:NumberOfBusinessesDivested
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTg5_44235c84-756a-4133-b0cd-2115dd922d79"
      unitRef="business">1</bsx:NumberOfBusinessesDivested>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="iee11fc6752204977a88f533ae4110495_I20220615"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI3MDc5Mg_81ac4711-3e69-4957-875d-9ecfe0daff1d"
      unitRef="number">0.64</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i901ac63f75eb49639a4b506d76c7ec85_D20220615-20220615"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzcwNw_02fe78f4-b1e5-4858-a45c-0a485eacb06f"
      unitRef="krw">291200000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i901ac63f75eb49639a4b506d76c7ec85_D20220615-20220615"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzY4OA_a7b845d9-e1a9-4ca9-9a5d-d0fd73bee032"
      unitRef="usd">230000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5d7ad645f9b848e1960b6c1e9e613c6d_D20220214-20220214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfOTQ1_ff9b3d45-f814-42d0-8f37-5f573feef011"
      unitRef="usd">1471000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc0Ng_5f6df518-967f-45bc-878f-197476cc88d6">The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(FASB ASC Topic 805).&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjI2NjhhNmMyZGY4MTRhOWI5MTU4OGMyOTMyN2I3Y2IyL3RhYmxlcmFuZ2U6MjY2OGE2YzJkZjgxNGE5YjkxNTg4YzI5MzI3YjdjYjJfMS0xLTEtMS05OTcwNg_7bb0dc99-3259-410f-ae0f-83bd0c65354c"
      unitRef="usd">1471000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjI2NjhhNmMyZGY4MTRhOWI5MTU4OGMyOTMyN2I3Y2IyL3RhYmxlcmFuZ2U6MjY2OGE2YzJkZjgxNGE5YjkxNTg4YzI5MzI3YjdjYjJfNC0xLTEtMS05OTcwNg_12de2054-d9c1-4226-be96-9caaa69a18c4"
      unitRef="usd">1471000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjczNg_117e5383-b66f-4314-aec6-f40067daf201">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfMS0xLTEtMS05OTcwNg_04c7a467-02fc-458a-9b28-a592336bc18b"
      unitRef="usd">989000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfMi0xLTEtMS05OTcwNg_df3fef75-f6da-4219-bf11-a731bdcdeece"
      unitRef="usd">657000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfNC0xLTEtMS05OTcwNg_bcc4ed15-ddf2-4eea-a526-6fc623daa929"
      unitRef="usd">113000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfNi0xLTEtMS05OTcwNg_c9650ea7-3046-454d-bd2d-dfbb92899e5e"
      unitRef="usd">280000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfNy0xLTEtMS05OTcwNg_e53ab9da-bf35-4786-a263-62f1e650ed43"
      unitRef="usd">8000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE0OGUyN2QzZTY4MDQzNmFiZTNmOTYyZGE2OTczMjQ4L3RhYmxlcmFuZ2U6YTQ4ZTI3ZDNlNjgwNDM2YWJlM2Y5NjJkYTY5NzMyNDhfOC0xLTEtMS05OTcwNg_880bce74-25b2-4134-b0ed-c68201178458"
      unitRef="usd">1471000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i67f543c68ade48a08bbeaab1d2e779d6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcxNg_f19edbfd-a482-44b9-852c-7f0ff87fff6b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the preliminary purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic6d6608abc97401680adb8a26144b089_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfMy0xLTEtMS05OTcwNg_78b3dc47-cdcd-445b-89d2-525970a5c04c"
      unitRef="usd">622000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie6ac896dcc134060bdfc576d15c1f097_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfMy0zLTEtMS05OTcwNg_55478902-fd96-43ae-955c-e4e86c9cc3d3">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i28d9b36d9b8943b68833ea0d071ed7d7_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfMy01LTEtMS05OTcwNg_a72675bb-260b-4902-a80a-219fa3de2494"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1d861b96bd57474b92fcd29da39816fd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfNC0xLTEtMS05OTcwNg_4bc2a8a3-41ef-4924-a38f-cea7550f3c30"
      unitRef="usd">36000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8031cd75b7814af29c4289dc1effe3ab_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfNC0zLTEtMS05OTcwNg_ecc7566e-bc94-49ff-9872-2c916cf81093">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="ib50cd8c4907244fa92f0e05706dcb767_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfNC01LTEtMS05OTcwNg_d5a8b488-8b8b-482a-a267-dfe19063c6a5"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i614b63b3d4bf4d00bb4d9b76f683fdde_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjhiNGFhN2QyMGZlYjRiYWU4MTUwMjkwODY4N2RiYTFkL3RhYmxlcmFuZ2U6OGI0YWE3ZDIwZmViNGJhZTgxNTAyOTA4Njg3ZGJhMWRfOC0xLTEtMS05OTcwNg_24b64a54-0beb-474c-bba5-13a361b5fa43"
      unitRef="usd">657000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjM3OQ_5b09e2f8-ab72-4b6e-b43f-f68088fb7a95"
      unitRef="usd">925000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest
      contextRef="i4462bc60133842ae953e65f20c772978_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjQwNg_05bac815-6ff9-4701-b2da-6a24d90e814a"
      unitRef="usd">300000000</bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i4462bc60133842ae953e65f20c772978_I20210301"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjU0NQ_0c655db5-1cfe-4c11-bfc2-8794b481ef4c"
      unitRef="number">0.22</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjc2Mw_591c99ce-cd4d-4109-b6eb-7289fd634910"
      unitRef="usd">195000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1d1dc4e5612b47998a7eac0ae56df091_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjkwMA_607eb4d8-5e56-4e7b-8306-292ceebe25fc"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4462bc60133842ae953e65f20c772978_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzkzNg_7bc5460b-520b-4851-a958-3cbb03d1da47"
      unitRef="usd">216000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc1OQ_cfd06565-8f97-49c6-ab63-0c4d5681af76">The final purchase price was comprised of the following components:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfMS0xLTEtMS05OTcwNg_de2124a9-c47e-4ff9-8fdf-935490feee46"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfMi0xLTEtMS05OTcwNg_b0434498-a618-48ac-a53a-0c368e0c4e62"
      unitRef="usd">221000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfMy0xLTEtMS05OTcwNg_e7fefc31-3a0c-4197-8df9-0f6bea83288d"
      unitRef="usd">269000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjZjZDBhMDcyZTY4NDQ1ZWI5ZDM3YjJmOTgwYmFiOTMyL3RhYmxlcmFuZ2U6NmNkMGEwNzJlNjg0NDVlYjlkMzdiMmY5ODBiYWI5MzJfNC0xLTEtMS05OTcwNg_f5c9e954-320a-48f8-9d01-dd7ab417cb84"
      unitRef="usd">1197000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcwMQ_f15bc4b5-488c-4390-8d32-6b9cba3ff121">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfMS0xLTEtMS05OTcwNg_f910ca97-3db6-49d7-8453-c189d106bc15"
      unitRef="usd">926000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfMi0xLTEtMS05OTcwNg_70a1246a-6004-4171-b762-bf381aaa4b00"
      unitRef="usd">237000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfNC0xLTEtMS05OTcwNg_3fc0a5cd-52e8-4821-a274-c2e511afe826"
      unitRef="usd">65000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfNi0xLTEtMS05OTcwNg_11cbf3b7-bff1-414e-9e91-b65d605a37c2"
      unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjViMTFkZDBlNzdlNDRmZjliNTg5YTM4ZGMyNDFjZDM1L3RhYmxlcmFuZ2U6NWIxMWRkMGU3N2U0NGZmOWI1ODlhMzhkYzI0MWNkMzVfOC0xLTEtMS05OTcwNg_104cd2b4-52ba-4dff-96be-f8d0d8e58738"
      unitRef="usd">1197000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i640602fcdd24438fbdd194bd759369ae_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc1NA_520affe8-219c-4726-a0aa-c50bbef3aad8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie6400d3c1fc24ca7bc85488919500c81_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfMi0xLTEtMS05OTcwNg_1c4bb8fc-f928-4a05-885b-51c65de80563"
      unitRef="usd">215000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9b875ad2ff61444eb8f91d7e24664368_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfMi0zLTEtMy05OTcwNg_443efc24-6ec9-4370-8812-8430afa1f195">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i75537fd4e06e411da653741c44074044_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfMi03LTEtMy05OTcwNg_aa75d98a-ba5f-48b2-af6d-bda37f38e643"
      unitRef="number">0.10</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if74b152ba6674c9da5871cb3bbed2af5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNC0xLTEtMS05OTcwNg_33f41435-df31-496b-91fb-bc3c64ac2066"
      unitRef="usd">22000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia306834040fd4493904c3d80050dfd07_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNC0zLTEtMS05OTcwNg_c5e0495b-1604-4a7d-a5c7-a0fe7f97ef00">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i0038b38441f64cd1b1acadca2f9bdaf0_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNC03LTEtMS05OTcwNg_e417efd4-c448-4998-bb7d-e5ad3f7bc84e"
      unitRef="number">0.10</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ifabaa3915ef144c09350675944f975ab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjJlNmI3MTcwMmMzYzQwNzM4ZTg0OWMxMzMyODk0YTdhL3RhYmxlcmFuZ2U6MmU2YjcxNzAyYzNjNDA3MzhlODQ5YzEzMzI4OTRhN2FfNy0xLTEtMS05OTcwNg_061b2418-325c-4c70-b192-41a51c5c0dbe"
      unitRef="usd">237000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i4e1b80835cd3429dbe3445e36fc51f36_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMTA5OTUxMTYzOTA3Ng_8537caad-e2e7-4a22-a360-6fee619716ca"
      unitRef="usd">177000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
      contextRef="id81e42a730db41b38addf624d55f0162_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2OTk0OQ_61670e2d-77fa-44da-82b2-8e7291fe7020"
      unitRef="usd">172000000</us-gaap:BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDA0MA_9d27ca91-b166-4e36-85fc-b9575b13d0b7"
      unitRef="usd">800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <bsx:DivestitureAgreementTransferOfFacilities
      contextRef="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDE3Mg_5ab65dc8-e193-4c78-955c-07486418d564"
      unitRef="units">5</bsx:DivestitureAgreementTransferOfFacilities>
    <bsx:DivestitureAgreementTransferOfGlobalEmployees
      contextRef="i2a3b72b6b857416bab03ae570f6bd1c3_I20210301"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDIwNA_2f2e0f56-7618-4fde-9aa1-892e44c9c8bc"
      unitRef="units">280</bsx:DivestitureAgreementTransferOfGlobalEmployees>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib0f0a63946614b93a706e459effcd822_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2MzczMg_62f77cd6-a440-41cd-a018-d4c4bd5bff1a"
      unitRef="usd">2000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i1a007c4c42ba48c5af6af1adc620a5fe_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfMjE5OTAyMzI2Mzc0MA_a7fa327d-44ac-4090-a46c-7595b6ed60f5"
      unitRef="usd">9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcxNA_0dfb25bf-6376-4704-8950-ba2a1b62e94c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability during the first six months of 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfMS0xLTEtMS05OTcwNg_bb6655cb-1006-4312-9652-2a9c6eb584d0"
      unitRef="usd">486000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfNC0xLTEtMS05OTcwNg_02065c57-9d51-435c-a02e-42a2d412f6bb"
      unitRef="usd">48000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfNS0xLTEtMS05OTcwNg_05b02ed0-8b9a-418c-a12e-00cbf136809b"
      unitRef="usd">314000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmZmMGMwOTAzMjVmYzRkODFhNGM3N2I2ODExZGQzNDMwL3RhYmxlcmFuZ2U6ZmYwYzA5MDMyNWZjNGQ4MWE0Yzc3YjY4MTFkZDM0MzBfNi0xLTEtMS05OTcwNg_19a79684-c0b4-4228-a1fb-e0d5e8c33617"
      unitRef="usd">219000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i9f07b1cab36340b2ac0e5013fe615164_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNDgwMg_7b727c37-f170-4267-930f-9e750923960f"
      unitRef="usd">544000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjc2NA_77dd0974-565e-458c-a981-014ae4fe961e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$107 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$112 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i49748441876b428ca5de05c44d5f8499_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS0xLTEtMS05OTcwNg_8cfd2f27-daf0-400b-8d42-f8e52d2e23cb"
      unitRef="usd">107000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i989b56a183c946599da9be6a40044f0d_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS00LTEtMS05OTcwNg_63984c3b-c460-4ab8-b31c-817629aa32ea"
      unitRef="number">0.01</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i424661b18ce84471819c51a4428349f4_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS02LTEtMS05OTcwNg_8944c4fd-e398-4592-babd-6e7700806165"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i7a66fba061d3493aadeb2bf2117d4954_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMS03LTEtMS05OTcwNg_542d4474-87ea-4090-83df-a793b4112fcc"
      unitRef="number">0.01</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i989b56a183c946599da9be6a40044f0d_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMi00LTEtMS05OTcwNg_cf12b4f1-66bd-4baf-9c2a-ded2f493e1ca"
      unitRef="number">0.80</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i424661b18ce84471819c51a4428349f4_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMi02LTEtMS05OTcwNg_2b29ba39-3eff-4e50-b41a-935ff09cb485"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i7a66fba061d3493aadeb2bf2117d4954_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfMi03LTEtMS05OTcwNg_70c9df4a-5a5b-45fe-ad79-1e1841c90c67"
      unitRef="number">0.90</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i375d15b254054889b41fe012dea6ffd6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC0xLTEtMS05OTcwNg_02dadfd3-4d84-49c1-bf7d-0926b396c4ee"
      unitRef="usd">112000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="ie03013c27a6841b7b47d775cd8a4af8f_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC00LTEtMS05OTcwNg_704ed1c1-b205-420a-9389-afae3f86af30"
      unitRef="rate">0.06</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="id1d47dac14094180bc21b9214c11f723_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC02LTEtMS05OTcwNg_11c2669e-5b15-4894-9f38-2480ef52aee6"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i468740812f144020bed248757e33716f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNC03LTEtMS05OTcwNg_b843a8a1-b3b9-4ba8-b731-e0be08fa5844"
      unitRef="rate">0.07</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i375d15b254054889b41fe012dea6ffd6_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNS00LTEtMS05OTcwNg_54778535-6c9d-42f4-bc52-a0b9c3530f3f"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i468740812f144020bed248757e33716f_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOjAyYjdjYWQ0NWYxNDRmOGY5MGNiYjUxNGE5YTM2YjFhL3RhYmxlcmFuZ2U6MDJiN2NhZDQ1ZjE0NGY4ZjkwY2JiNTE0YTlhMzZiMWFfNS03LTEtMS05OTcwNg_deaa6e64-3202-403d-a0fc-0ab8cfd1c761"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjcyMw_50d2e6e5-8635-4f5e-be5a-018c88d97248">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Publicly-held securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMi0xLTEtMS05OTcwNg_fb83292e-f641-48fe-aec3-5c2a5621c42f"
      unitRef="usd">212000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMi0zLTEtMS05OTcwNg_e4eb8148-fb9a-47a3-8982-5da006b92e0f"
      unitRef="usd">259000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMy0xLTEtMS05OTcwNg_de20eaa1-049a-46df-ab83-3d2fcc94c886"
      unitRef="usd">159000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfMy0zLTEtMS05OTcwNg_1501edf4-15ca-4b05-8b85-a8bbaf4ea293"
      unitRef="usd">142000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNC0xLTEtMS05OTcwNg_7bc290ca-318b-4567-b0f0-308835984718"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNC0zLTEtMS05OTcwNg_fd43a857-3567-45cc-8571-cdaf3fc7a75a"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNS0xLTEtMS05OTcwNg_69f8e4d1-1a4b-4a4c-8547-5263cc5d732b"
      unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNS0zLTEtMS05OTcwNg_6d6762b0-0859-4256-b207-f2aaee5608e2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:Investments
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNi0xLTEtMS05OTcwNg_3a011a3a-a671-42e4-b8e1-ba1067fe96ea"
      unitRef="usd">384000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RhYmxlOmE1MGIxNDRjMzY0ZDRmZmI5YjgyZDk5Njg0ZjkwYmQ3L3RhYmxlcmFuZ2U6YTUwYjE0NGMzNjRkNGZmYjliODJkOTk2ODRmOTBiZDdfNi0zLTEtMS05OTcwNg_644abf9f-2ea0-4988-98e3-ff852cf440fc"
      unitRef="usd">412000000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80My9mcmFnOjVhYmQyMWYwNjA0ZDQ2OGQ4ODE1M2E3MGJiMzE1NGJlL3RleHRyZWdpb246NWFiZDIxZjA2MDRkNDY4ZDg4MTUzYTcwYmIzMTU0YmVfNjU1OQ_2ddd848d-9ec0-4d33-9ad1-26a2d9c34565"
      unitRef="usd">233000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfODUw_7e5a2d1e-f236-4769-9526-7ac34c4fa291">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE C &#x2013; GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,955&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in our balance of goodwill and amortizable intangible assets is primarily related to our acquisition of Baylis Medical completed in the first quarter of 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,741&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and other changes in carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,241&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not record any goodwill impairment charges in the first six months of 2022 or 2021. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. Following the reorganization of our operational structure in the first quarter of 2022, we identified the following reporting units for purposes of our annual goodwill impairment test: Interventional Cardiology, Rhythm Management, Peripheral Interventions, Endoscopy, Urology and Pelvic Health and Neuromodulation. Based on the criteria prescribed in FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(FASB ASC Topic 350), we aggregated the Interventional Cardiology Therapies and Watchman components of our Cardiology operating segment into a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;single Interventional Cardiology reporting unit, and aggregated the Cardiac Rhythm Management and Electrophysiology components into a single Rhythm Management reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2022, we performed our annual goodwill impairment test utilizing both the qualitative and quantitative approach described in FASB ASC Topic 350. The qualitative approach was used for testing reporting units where fair value has historically exceeded carrying value by greater than 100 percent, and all other reporting units were tested using the quantitative approach. For those tested using the qualitative approach, after assessing the totality of events, it was determined that it was not more likely than not that the fair value of the reporting units was less than their carrying value, and it was not deemed necessary to proceed to the quantitative test. For all reporting units tested using the quantitative approach, we determined that the fair value of each reporting unit exceeded their carrying value and concluded that goodwill was not impaired or at risk of impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $7 million in the second quarter and first six months of 2022, and $45 million in the second quarter and first six months of 2021. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. During the second quarter of 2021, we determined it was more likely than not that one of our indefinite-lived intangible assets was impaired based on our qualitative assessment of impairment indicators. We tested the intangible asset for recoverability and recorded an impairment charge associated with incremental time and cost to complete the associated in-process research and development (IPR&amp;amp;D) project.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfODQ0_8fca9949-c02e-4047-9988-f8d474d358a6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,955&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i02c663df999f43dba49c3e3fbdf4fd2a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi0xLTEtMS05OTcwNg_fb8bd4f8-51ea-4459-822b-75c8d284c487"
      unitRef="usd">12515000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i02c663df999f43dba49c3e3fbdf4fd2a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi0zLTEtMS05OTcwNg_c314712d-822b-4ad7-a0e0-63bc4cd94daf"
      unitRef="usd">7078000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if5061cce88844571861e47c227eaa358_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi01LTEtMS05OTcwNg_1b5777f9-b486-41bd-9a88-626fc5855072"
      unitRef="usd">11957000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if5061cce88844571861e47c227eaa358_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMi03LTEtMS05OTcwNg_67ba86e2-09dc-4d36-812b-9621c7501ce1"
      unitRef="usd">6754000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7d1877eb16ab4005bd5a1107e8dbe1aa_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy0xLTEtMS05OTcwNg_89155cd9-ea8c-4bd3-872a-56bec37fa6f6"
      unitRef="usd">487000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7d1877eb16ab4005bd5a1107e8dbe1aa_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy0zLTEtMS05OTcwNg_8db80e99-00e7-4cb3-ae7c-a33b9a51fde3"
      unitRef="usd">392000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idf43344805b748ac8599d034b8fce38c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy01LTEtMS05OTcwNg_d374d78c-e41c-4c9e-9805-169bee24a140"
      unitRef="usd">494000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idf43344805b748ac8599d034b8fce38c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMy03LTEtMS05OTcwNg_92302779-81e1-4cac-a904-a7776779eaf8"
      unitRef="usd">398000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2155113815f245cb9e7caf23337d1848_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC0xLTEtMS05OTcwNg_d1eef8d2-10e0-40d5-af16-96d1b3249769"
      unitRef="usd">1953000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2155113815f245cb9e7caf23337d1848_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC0zLTEtMS05OTcwNg_f9abfd9c-2dee-4c78-b956-3bc6c3e80f21"
      unitRef="usd">1368000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7a865e40488d4b68a9fc599365b502d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC01LTEtMS05OTcwNg_a4b109b2-c7ea-429f-b1d3-abdf656fe430"
      unitRef="usd">1900000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7a865e40488d4b68a9fc599365b502d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNC03LTEtMS05OTcwNg_98f9c663-2a7f-4602-8e98-319842637453"
      unitRef="usd">1325000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS0xLTEtMS05OTcwNg_2c4077da-6d6b-4c62-adef-d7e0f2ac591a"
      unitRef="usd">14955000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS0zLTEtMS05OTcwNg_33149de0-22a4-4c54-ac86-4bf693c98863"
      unitRef="usd">8838000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS01LTEtMS05OTcwNg_1d876f09-0f20-456c-9c1a-ae1c08045bc4"
      unitRef="usd">14351000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNS03LTEtMS05OTcwNg_5f24b9d0-b246-4ee9-88ff-74dbd33a6d2c"
      unitRef="usd">8476000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:GoodwillGross
      contextRef="i87fc7373cbc44f879acb93c09335f462_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy0xLTEtMS05OTcwNg_8a7370e9-aa48-437c-b314-77c7087d8926"
      unitRef="usd">22783000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i87fc7373cbc44f879acb93c09335f462_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy0zLTEtMS05OTcwNg_fedd8310-2182-4fb8-85cc-e148555f00cf"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="i77cb4812b8444881a8d1c6f3fe5f74ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy01LTEtMS05OTcwNg_6a770bae-e09a-42ab-84b8-af2dc813b271"
      unitRef="usd">21888000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i77cb4812b8444881a8d1c6f3fe5f74ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfNy03LTEtMS05OTcwNg_eecebd24-02b5-49bd-8a45-1d54c74900f2"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i89b5c735c1eb4e9d95ed6be4cff64301_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfOS0xLTEtMS05OTcwNg_e6ca9f83-a325-4dd5-aa2f-e06cf9db3c07"
      unitRef="usd">112000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i719d462654114eafa29963ace1f8a603_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfOS01LTEtMS05OTcwNg_9e862f46-722d-4600-b8ae-922724b77a5a"
      unitRef="usd">126000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i91b81d90dcbd47d4994136811e97c5d2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTAtMS0xLTEtOTk3MDY_92c3a5bc-130e-49ba-b693-ff3d62afab53"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1e8c43d7f5314418961e8542ec180403_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTAtNS0xLTEtOTk3MDY_a861e8d6-c6c5-4ca7-b875-9acbea7f7e07"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTEtMS0xLTEtOTk3MDY_69757fed-6968-4c66-8bd2-300e30179a4d"
      unitRef="usd">232000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjBkZjZmM2I4MjNmMDRhOTk4MDQ2MDdkZDcxMTQwMTI1L3RhYmxlcmFuZ2U6MGRmNmYzYjgyM2YwNGE5OTgwNDYwN2RkNzExNDAxMjVfMTEtNS0xLTEtOTk3MDY_ac3edd7b-869f-4450-951f-8ae2706d0295"
      unitRef="usd">246000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfODcz_6ab1c7d8-7183-43c6-9152-7d7351a7bdff">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,741&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and other changes in carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,241&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i0d7a66e4fc364008a329768490327166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfMS0xLTEtMS05OTcwNg_56b9b690-8855-45c8-a2f9-253350c29321"
      unitRef="usd">4246000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie1c1d0d7e6944bec9f3db53ad92fa034_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfMS0zLTEtMS05OTcwNg_7ac24066-2214-4c39-acbb-6657205a8e18"
      unitRef="usd">7741000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfMS03LTEtMS05OTcwNg_9c9526ab-6aaa-4be9-9e4c-d35a75f21359"
      unitRef="usd">11988000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNC0xLTEtMS05OTcwNg_906fb927-54b2-47af-9637-c39f359e0991"
      unitRef="usd">-5000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNC0zLTEtMS05OTcwNg_8d002feb-407e-4281-8baa-484a0d18c13f"
      unitRef="usd">-88000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNC03LTEtMS05OTcwNg_43401246-07ba-4384-9968-42722333d3cd"
      unitRef="usd">-93000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNS0xLTEtMS05OTcwNg_515c1685-ab82-4d70-9516-dfffe2f5d795"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNS0zLTEtMS05OTcwNg_ce14d0e8-d597-4b78-b159-e132cb4cb86d"
      unitRef="usd">989000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNS03LTEtMS05OTcwNg_032604f5-5069-42d2-8894-f55ce86b43e3"
      unitRef="usd">989000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i7bb3e27fa63747a6b668bebab370867c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNy0xLTEtMS05OTcwNg_f813930c-7f57-4ab3-9587-aeb4c545be8e"
      unitRef="usd">4241000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibe82f860e15b483eaa3f27e40e7892cb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNy0zLTEtMS05OTcwNg_878bfc4e-e7ff-41c2-9de1-b68af321cbc9"
      unitRef="usd">8642000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RhYmxlOjVkY2JhMzcyMzA1ZDRmOGU4ZWI0ZmQ5Nzg5NDAzNTQ3L3RhYmxlcmFuZ2U6NWRjYmEzNzIzMDVkNGY4ZThlYjRmZDk3ODk0MDM1NDdfNy03LTEtMS05OTcwNg_9c3107ca-eddf-46f2-8bc8-12a435d6252f"
      unitRef="usd">12883000000</us-gaap:Goodwill>
    <us-gaap:NumberOfReportableSegments
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfNDYx_981bdca8-b775-4672-9b72-735470fa455a"
      unitRef="reportablesegments">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfMjE5OTAyMzI3MTgzNQ_81858954-451b-4d7b-9e35-00dac7c04e89"
      unitRef="usd">7000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV80OS9mcmFnOjJlNTkyYmFjYmIwZTRlZjhhNWIzYWUxN2JhMzY5YmE1L3RleHRyZWdpb246MmU1OTJiYWNiYjBlNGVmOGE1YjNhZTE3YmEzNjliYTVfMjE5OTAyMzI1ODcwNw_99b02b6d-957f-4dbc-8921-6daee6fd6a28"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNDE_45f7fc27-4f97-4e21-a49d-ada75366f409">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE D &#x2013; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Currency Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, British pound sterling, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of June&#160;30, 2022 and December&#160;31, 2021, we designated as a net investment hedge a portion of our &#x20ac;900 million in aggregate principal amount of 0.625% euro-denominated senior notes issued in November 2019 and due in 2027 (2027 Notes). For these nonderivative instruments, we defer recognition of the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;foreign currency remeasurement gains and losses within the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We reclassify these gains and losses to current period earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also use forward currency contracts that are not part of designated hedging relationships as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest Rate Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as cash flow hedges outstanding as of June&#160;30, 2022 or December&#160;31, 2021. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was a $9 million loss as of June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and a $24 million loss as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining time to maturity as of June&#160;30, 2022 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature between one and three years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note M &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;966&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;966&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $36 million invested in money market funds and time deposits as of June&#160;30, 2022 and $1.632 billion as of December&#160;31, 2021, we held $240 million in interest-bearing and non-interest-bearing bank accounts as of June&#160;30, 2022 and $293 million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#x2122; Drug. We maintain a financial asset and associated liability for our licensing arrangements measured at fair value in our accompanying unaudited consolidated balance sheets in accordance with FASB ASC Topic 825, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2022 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$182 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$215 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Non-Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our strategic investments and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of the fair values of our intangible assets including goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our outstanding debt obligations was $8.517 billion as of June&#160;30, 2022 and $10.196 billion as of December&#160;31, 2021. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMjUyOQ_189b6809-855f-462e-b3d5-01028fc81311"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMjU2NQ_3374ac14-22f3-4bea-8541-e0bd32616a89"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DerivativeTermOfContract
      contextRef="i54cc7fcec9c242049c00578499ae8d13_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMzQ1Nw_f812a465-556c-4a9d-b5fe-c46c5ec388c4">P1Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i997580c2ac9449cd9e09cac79cf4ac38_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNDIwOA_2237ebb6-653e-4fe8-85f0-10eb44a13f8c"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i1344f19ab092477889926fa8d06bba45_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNDIwOA_d20a46fb-9159-46d2-9916-dee25cf713b3"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="if739a2c2f671402cb916170e3525437c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTIxMg_5724e9b0-2541-45ae-9647-f346a3c2e078"
      unitRef="usd">-9000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="idb9d19a6bc3646338057525a9924ed42_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTIzNQ_223100ac-7448-46e9-bf93-d6095c3176d9"
      unitRef="usd">-24000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyOTM_f2258f90-be54-425f-b17d-07bd19151de0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id543b8483478491ab47eae96f17a2688_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMi00LTEtMS05OTcwNg_1b64129b-ca0b-4444-beac-c58e22bd2cb2"
      unitRef="usd">3527000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i18555e5fe782424da673f442fb298b06_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMi02LTEtMS05OTcwNg_94f00b8e-ac24-4140-817d-b9a001cebee9"
      unitRef="usd">3996000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6c2e1aa2b5844bed9e3e6cae8d1958cd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMy00LTEtMS05OTcwNg_89cabcb7-9a21-49f0-a77c-25d0263c8cea"
      unitRef="usd">365000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id86e5cefc372494fb57cf5b9fb285236_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfMy02LTEtMS05OTcwNg_28eb2133-2720-4df9-a666-57c5625918be"
      unitRef="usd">493000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i721e9eac5b5c48a6aed4014b232cb438_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNC00LTEtMS05OTcwNg_29e3eb5d-d4f1-4b6c-a0f3-54434fb93086"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4b807c0a08b94dddbe4f5e93f8fa811f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNC02LTEtMS05OTcwNg_74e92346-ce8b-44cd-a89a-fc7ad9a218f9"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie84824453888409a909a24869be1cb1e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNS00LTEtMS05OTcwNg_d20d840c-b88b-4bc7-903f-bfb32df7698a"
      unitRef="usd">3029000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i19171c2bd8484559af6db37d1aef1e11_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNS02LTEtMS05OTcwNg_16ad4128-5569-45c9-ba97-45300e12a001"
      unitRef="usd">3892000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNy00LTEtMS05OTcwNg_5f09fd95-0da7-4188-ad2b-c51e61b7d802"
      unitRef="usd">7917000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmZkMjk2YTNlZGRiZDQyNzM4ODEzZDJiNWZkYjA4MWE5L3RhYmxlcmFuZ2U6ZmQyOTZhM2VkZGJkNDI3Mzg4MTNkMmI1ZmRiMDgxYTlfNy02LTEtMS05OTcwNg_1bcb4812-5406-4837-bf21-eedd33a9201e"
      unitRef="usd">9378000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTQxMg_189b6809-855f-462e-b3d5-01028fc81311"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <bsx:ForwardCurrencyContractsTimetoMaturity
      contextRef="i47f84dd2e1f24639a171ca54b2bba99a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTU1MA_33e25010-0a71-4771-bb8b-8828b52b13fe"
      unitRef="units">60</bsx:ForwardCurrencyContractsTimetoMaturity>
    <us-gaap:DerivativeRemainingMaturity1
      contextRef="i54cc7fcec9c242049c00578499ae8d13_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNTY1MA_7a777750-5de9-4d46-97e8-6019c03fb767">P1Y</us-gaap:DerivativeRemainingMaturity1>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTc_e3eb2aa0-d666-4038-a3e1-84a788848c46">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0xLTEtMS05OTcwNg_6689dc11-0363-4d36-ba11-97b60b80a0d7"
      unitRef="usd">213000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0yLTEtMS05OTcwNg_2449addf-43a2-4710-8da6-76387ffca32e"
      unitRef="usd">-48000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0zLTEtMS05OTcwNg_7e0cc0ce-65ea-4698-ba53-d86c5480d40c"
      unitRef="usd">165000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS02LTEtMS05OTcwNg_61262d28-70f5-45e8-9805-783134a6ec2e"
      unitRef="usd">1011000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS04LTEtMS05OTcwNg_b093355c-5336-4450-ae40-669a37040cd6"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS05LTEtMS05OTcwNg_9b379f16-08d3-489c-85f3-9b0c8c66d933"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i082a9a99169e4067bb5133812e745527_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNS0xMC0xLTEtOTk3MDY_605d019c-b91e-4896-8420-4f4f00b897d3"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0xLTEtMS05OTcwNg_09048397-4983-4f66-9130-a6b02c399383"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0yLTEtMS05OTcwNg_6f4df3c1-809b-47ee-8da7-d53d15ec6200"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0zLTEtMS05OTcwNg_0dd4fbc1-fe16-47c6-a14e-1278d19d830b"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi02LTEtMS05OTcwNg_62ecff6b-bbc6-4ba2-998c-dad3797496b7"
      unitRef="usd">64000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi04LTEtMS05OTcwNg_25b6d96f-cf50-4b6d-bdc2-fd5f6d5274c9"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi05LTEtMS05OTcwNg_416e6064-9afd-41ff-a58e-1be2b2d5680c"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="if2ab54b06d4b4a3495078c973e1367d0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfNi0xMC0xLTEtOTk3MDY_01b5af1b-ab93-48a7-85cd-a07e611284ad"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0xLTEtMS05OTcwNg_e480da05-1e18-4089-af35-5e82bb7d71f2"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0yLTEtMS05OTcwNg_a9583ffd-3201-4fe9-9898-9e3a67d29f6a"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0zLTEtMS05OTcwNg_eb93b567-d0e3-4c7a-a097-8e2c473e83d5"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC02LTEtMS05OTcwNg_3c422c8e-661f-4fc7-b36c-a106cb93f82a"
      unitRef="usd">14000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC04LTEtMS05OTcwNg_b60805da-3912-48ef-8da2-ed2a432541d1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC05LTEtMS05OTcwNg_67d9a64d-1f15-40da-b5fe-198368b3ea3f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i6ea25c25832c4a119f226655eaaeae40_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfOC0xMC0xLTEtOTk3MDY_460f560a-dbef-4285-ac12-b7ed9c580393"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMS0xLTEtOTk3MDY_befbaa3d-5b93-4a03-84dc-5f944a68a6bb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMi0xLTEtOTk3MDY_696f4216-4191-4b5a-b602-f1accd514fa0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMy0xLTEtOTk3MDY_ef251b63-b925-459f-ac05-a616463c8498"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtNi0xLTEtOTk3MDY_62ecff6b-bbc6-4ba2-998c-dad3797496b7"
      unitRef="usd">64000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtOC0xLTEtOTk3MDY_51422984-59b9-45c7-8406-0cbe7e557934"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtOS0xLTEtOTk3MDY_252e3a29-5552-427c-8ed0-d5393cd0b7cb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="icbd6d2ceb68243b5b45ef5286e562405_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjQ5NmRjMjk1MDc2MDQ0MWJhZDU1MDY0MTFkNGVmODg5L3RhYmxlcmFuZ2U6NDk2ZGMyOTUwNzYwNDQxYmFkNTUwNjQxMWQ0ZWY4ODlfMTAtMTAtMS0xLTk5NzA2_aad9e35c-e9d2-4352-b743-7bdf0ae55864"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0xLTEtMS05OTcwNg_31d63fb0-7157-4e06-8756-4b899e278ccd"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0yLTEtMS05OTcwNg_b40359ff-ecb0-4f92-a3e5-7f4eb442c9b2"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0zLTEtMS05OTcwNg_7ff27aec-2100-41f7-aa44-2081ead7c59f"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS02LTEtMS05OTcwNg_b3ddad65-7013-4994-944b-ea286643915c"
      unitRef="usd">945000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS04LTEtMS05OTcwNg_3ed101cd-58dc-4868-bd7f-c3c96408ddd3"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS05LTEtMS05OTcwNg_f9509678-9409-4011-ac0a-41e0e0235080"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0604949c6c6940989f3127f2f0e05d8c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNS0xMC0xLTEtOTk3MDY_713edae8-f50e-450e-bda9-8e59042abb1f"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0xLTEtMS05OTcwNg_fa3f09fc-d91c-4926-8228-8e42e40f22c2"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0yLTEtMS05OTcwNg_3499100c-7779-4968-b15b-84cb45bb1c6b"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0zLTEtMS05OTcwNg_8fcdd897-d8b5-436a-ad3e-eb569cef6585"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi02LTEtMS05OTcwNg_0b5c8ff4-c73f-48be-95e0-bbbf9322e7c8"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi04LTEtMS05OTcwNg_f49eccd4-8b22-4fe9-a771-917010c4655f"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi05LTEtMS05OTcwNg_19ed0be9-97f4-4cbd-8e9c-aca8ab6173fc"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i99af8ec70cee429094469e58e2ef51ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfNi0xMC0xLTEtOTk3MDY_b28a87e1-9a29-4aca-8733-d6f75007b7cb"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0xLTEtMS05OTcwNg_438a4cf7-9399-42b7-836b-fddd14b0b534"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0yLTEtMS05OTcwNg_8e21d91a-7d31-4619-8ce7-91be783149be"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0zLTEtMS05OTcwNg_ab407ce7-1088-430e-91be-4d2d718be4ff"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC02LTEtMS05OTcwNg_0f15649e-e1da-4e76-9bd6-efc0b64a727d"
      unitRef="usd">26000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC04LTEtMS05OTcwNg_1f17aa48-709c-4219-9900-69f7d64302a2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC05LTEtMS05OTcwNg_d75c1d5f-7411-484e-b4bf-93d4f67c13d5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="if3c6692821a14d0887dfc3858d7f6e5e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfOC0xMC0xLTEtOTk3MDY_0469c637-7751-424f-958c-9e289f6d468c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMS0xLTEtOTk3MDY_05c74cb1-b14d-4987-b158-c85525540636"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMi0xLTEtOTk3MDY_5d9aa093-7a6c-4b5d-84bb-c0aa1b1f1800"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMy0xLTEtOTk3MDY_6b978d63-a570-4ab5-b8d8-7615af611cf7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtNi0xLTEtOTk3MDY_0b5c8ff4-c73f-48be-95e0-bbbf9322e7c8"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtOC0xLTEtOTk3MDY_18e771eb-578d-4ccd-83e5-dbdbef574434"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtOS0xLTEtOTk3MDY_18df53a4-f113-4be2-baa7-dd9ac50bf0c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ia0ec6364247d438dbc568187f7fe14bc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjVjMmJjNzJjNTcwOTRlMjNiNDIyMmQxMDA0NTdkZDQxL3RhYmxlcmFuZ2U6NWMyYmM3MmM1NzA5NGUyM2I0MjIyZDEwMDQ1N2RkNDFfMTAtMTAtMS0xLTk5NzA2_c6bc806d-b42f-4f80-a1e0-d7b00dd60fa6"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0xLTEtMS0xMDQ5MDU_8d6d1ffe-ee5f-4a29-a7e0-05887202a5d0"
      unitRef="usd">259000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0yLTEtMS0xMDQ5MDU_136578d2-4837-4fd5-b44f-2263946e1b9b"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0zLTEtMS0xMDQ5MDU_e03b6ecc-9222-4f4b-a79c-3ff0a4421879"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS02LTEtMS0xMDQ5MDU_31dedd71-d3ba-4ca4-9d65-96305ea6f518"
      unitRef="usd">1966000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS04LTEtMS0xMDQ5MDU_2b8283b5-1a07-4d71-a6ab-94f5482a2c09"
      unitRef="usd">-71000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS05LTEtMS0xMDQ5MDU_64035633-1e14-4d71-ad51-17fb97710993"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id945c8be66cd4aa78bfc5fbe1da7bceb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNS0xMC0xLTEtMTA0OTA1_0c91ad41-0f45-49cc-88f1-f72c3ced1402"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0xLTEtMS0xMDQ5MDU_ae14ed42-33e0-468a-9cf5-561c19314d9f"
      unitRef="usd">49000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0yLTEtMS0xMDQ5MDU_c8fff9c6-1586-4250-a864-8d1da0d30cf5"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0zLTEtMS0xMDQ5MDU_43c1caa6-c1f9-422e-8b65-aca60cf16dad"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi02LTEtMS0xMDQ5MDU_3a0d204f-bcbc-4a27-8554-9dbd969f863e"
      unitRef="usd">343000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi04LTEtMS0xMDQ5MDU_d953a5e5-79c3-4b26-b4af-27a8fe4c3045"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi05LTEtMS0xMDQ5MDU_ada6a1d0-e236-4517-948d-a75c90118ede"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="id1a07899468f4505896f5a0cfc49dd81_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfNi0xMC0xLTEtMTA0OTA1_2505b45f-5b11-412f-a010-130d86b89dff"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0xLTEtMS0xMDQ5MDU_b6f59640-65cd-47cf-8be2-610b4d78a53f"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0yLTEtMS0xMDQ5MDU_125389db-ef5b-48e7-80fe-fa448cc283ee"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0zLTEtMS0xMDQ5MDU_4180f603-13bf-4214-acf4-345f0698527f"
      unitRef="usd">66000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC02LTEtMS0xMDQ5MDU_0e53826f-640b-4df4-9a65-e6dae7cfc820"
      unitRef="usd">46000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC04LTEtMS0xMDQ5MDU_d3b5e6b5-30d8-46e3-821c-20642d08af03"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC05LTEtMS0xMDQ5MDU_9ace64ea-aeaf-4d10-a59d-026b814d6e8c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="if767fb041c1142f3b83fc61bb44826b8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfOC0xMC0xLTEtMTA0OTA1_7ad6e31e-496f-4e45-8386-13ae6260e230"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMS0xLTEtMTA0OTA1_038d44d8-2e7e-43b6-8ef0-f9611af92a89"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMi0xLTEtMTA0OTA1_22368630-cea8-4b6b-897b-f72acb2035d3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMy0xLTEtMTA0OTA1_365e5246-008d-465f-b74c-42b002678919"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtNi0xLTEtMTA0OTA1_3a0d204f-bcbc-4a27-8554-9dbd969f863e"
      unitRef="usd">343000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtOC0xLTEtMTA0OTA1_d3f32690-666f-4607-bcf8-55048a1cfdb2"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtOS0xLTEtMTA0OTA1_8e4a021c-0a70-47cb-bb30-d090b258ae86"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i761665691f614dc391144cd928de4ff7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjIyZTNiODU5OTA2MjRjMTU5MGRkODNhY2E0YTA1Nzk0L3RhYmxlcmFuZ2U6MjJlM2I4NTk5MDYyNGMxNTkwZGQ4M2FjYTRhMDU3OTRfMTAtMTAtMS0xLTEwNDkwNQ_50206cda-2079-4248-a0ff-5a4f86bd1c80"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0xLTEtMS0xMDQ5MDA_a080582a-2d66-4c2b-8ed4-d69761c98278"
      unitRef="usd">156000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0yLTEtMS0xMDQ5MDA_9dd47c15-82f3-4c6a-b737-fbbb46d576b7"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0zLTEtMS0xMDQ5MDA_e4f2e3d4-8f30-442c-ac38-abf0954129a0"
      unitRef="usd">121000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS02LTEtMS0xMDQ5MDA_d97bd9b4-6d53-48cf-83cd-00af10556a78"
      unitRef="usd">1839000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS04LTEtMS0xMDQ5MDA_38e2387b-0ec7-4fbe-84a0-31ad95cb4b3b"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS05LTEtMS0xMDQ5MDA_a31bdd6d-00e6-466a-813d-4ad0a571db3a"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6b8efe53b6694842b66c792b86faa48b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNS0xMC0xLTEtMTA0OTAw_808e10bb-da39-4dbc-9120-051299e92ead"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0xLTEtMS0xMDQ5MDA_316aa748-ccd4-4cc0-921a-11c7121c0de9"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0yLTEtMS0xMDQ5MDA_d1bec0c1-6543-4790-9f6d-839e87a8b621"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0zLTEtMS0xMDQ5MDA_6c68e2ff-7de1-429f-b89c-460f28d85609"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi02LTEtMS0xMDQ5MDA_6c764caa-e86a-4a7a-83d9-999594110fa4"
      unitRef="usd">168000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi04LTEtMS0xMDQ5MDA_e9e26dfe-c4e8-4fc2-b084-72ad39f3fc84"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi05LTEtMS0xMDQ5MDA_a3fa3995-fa18-4070-badc-9125c9e08aec"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i6605492210c74a4d9c31d30486122af1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfNi0xMC0xLTEtMTA0OTAw_383a2d53-c2fe-49ea-adcc-3ed2c1e54756"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0xLTEtMS0xMDQ5MDA_8c7ad306-8f51-4dfb-8c01-3a34799ca845"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0yLTEtMS0xMDQ5MDA_5c950100-a8fd-4a0a-a761-1fc66ff5edb7"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0zLTEtMS0xMDQ5MDA_a40b4f42-6e6e-485c-a72d-1079095fdf33"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC02LTEtMS0xMDQ5MDA_a3bf6b77-9f6c-4653-8d63-16fdde81f853"
      unitRef="usd">-11000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC04LTEtMS0xMDQ5MDA_deb17fe5-0cc6-4ad9-83d0-f6e41ac6a9da"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC05LTEtMS0xMDQ5MDA_f04496d8-b9cc-4f0b-aec6-f817f941e3b0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i9915524281c147b9b413b8c968c0375a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfOC0xMC0xLTEtMTA0OTAw_01ac9df4-3d3b-40d2-a968-437816ea5927"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMS0xLTEtMTA0OTAw_9c657193-1146-45b7-b329-9e6018c05d98"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMi0xLTEtMTA0OTAw_31c9e57e-165a-4f06-9879-074fe65d740b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMy0xLTEtMTA0OTAw_06b7e516-331c-4bcc-8a50-7fc633f2cf8b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtNi0xLTEtMTA0OTAw_6c764caa-e86a-4a7a-83d9-999594110fa4"
      unitRef="usd">168000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtOC0xLTEtMTA0OTAw_a7a58875-5a8a-4cb9-85e4-55e057cd0ae7"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtOS0xLTEtMTA0OTAw_6fdcb0d4-4521-4e62-9b74-208de22eb173"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6df53d6807414d49b59d2d1869ce87b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjRkMDUxYWJkZDg1YjQzNzM4NzJlODYzOGRkMjI4YzcwL3RhYmxlcmFuZ2U6NGQwNTFhYmRkODViNDM3Mzg3MmU4NjM4ZGQyMjhjNzBfMTAtMTAtMS0xLTEwNDkwMA_b9943122-40cf-49cd-83dd-7805d1e1dc74"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i7f1313d335714e77935281b63801f86d_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_028d7c1a-3f75-4095-981d-f2e5d98e7f10"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i94e1669b9c2046b8aca9b105f46ecef9_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_5e6f940c-d456-472b-b475-11a42580ab6a"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="idc5d2dfee4ee42909a9a420320563b9f_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_ad8b0d20-c2cc-48c3-a948-dfc5df3a0418"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i894ed00d9114436795ac77d2513cb0d7_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfNzE3NA_f8b7287a-25b5-42c8-b78c-0275d0604dd8"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTg_eaf7b020-a5e5-4cf9-95e5-9ef437fceec3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i4ad80cea173e459d9cffda4c1fb19c1d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmI1ZTE0NjJlZmU4OTQ1NGZhM2RhNjhmYmQwZmY1ZTRmL3RhYmxlcmFuZ2U6YjVlMTQ2MmVmZTg5NDU0ZmEzZGE2OGZiZDBmZjVlNGZfMS02LTEtMS05OTcwNg_ae6edaeb-ade4-4075-bc76-8bd73d8b771c"
      unitRef="usd">251000000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet
      contextRef="i213187d28dcc430e8a47b7ba1ff645fe_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmI1ZTE0NjJlZmU4OTQ1NGZhM2RhNjhmYmQwZmY1ZTRmL3RhYmxlcmFuZ2U6YjVlMTQ2MmVmZTg5NDU0ZmEzZGE2OGZiZDBmZjVlNGZfMi02LTEtMS05OTcwNg_ab34f90a-a8b0-4586-ace4-db5c195310f8"
      unitRef="usd">10000000</bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="if85f496eaa364904b720459ed2c8ae50_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmI1ZTE0NjJlZmU4OTQ1NGZhM2RhNjhmYmQwZmY1ZTRmL3RhYmxlcmFuZ2U6YjVlMTQ2MmVmZTg5NDU0ZmEzZGE2OGZiZDBmZjVlNGZfMy02LTEtMS05OTcwNg_9a3f77f7-ed52-4eba-a996-14b6cdac2226"
      unitRef="usd">-3000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTk_6c55dec9-d1e1-44ef-8868-6a54c0ca5147">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi00LTEtMS05OTcwNg_95489d50-dfab-4939-a694-f2f961866831"
      unitRef="usd">-34000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi02LTEtMS05OTcwNg_f6bedcc0-335b-4e7f-9bc4-6a85fbaf614e"
      unitRef="usd">-1000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi04LTEtMS05OTcwNg_d57d1e9e-d63f-4b28-b058-f50f75f2dea4"
      unitRef="usd">-63000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMi0xMC0xLTEtOTk3MDY_d848ecf0-e66d-485d-bec6-b29e4ec9aa72"
      unitRef="usd">-2000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy00LTEtMS05OTcwNg_76cd347b-263f-4287-85b6-f4cdcafe2a2f"
      unitRef="usd">35000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy02LTEtMS05OTcwNg_d7c3da43-1b04-4d60-b8e1-40f5f488c766"
      unitRef="usd">-5000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy04LTEtMS05OTcwNg_36f6193e-3087-4d8f-a6a9-a816aa20cf33"
      unitRef="usd">56000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfMy0xMC0xLTEtOTk3MDY_8baf6b21-6505-4703-846c-5acb54b89872"
      unitRef="usd">-6000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i72863ff3028e49f7ac33a20eff409b5b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC00LTEtMS05OTcwNg_ce1570e9-b138-465b-b042-e90b2107b8ec"
      unitRef="usd">1000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="idd26b53e077741a7aec7343cabe4eef2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC02LTEtMS05OTcwNg_ca5f3701-5f1c-471b-85b6-da5e60cac427"
      unitRef="usd">-7000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i1ebe50809d1747fb98aaa58af27560fb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC04LTEtMS05OTcwNg_944235ea-84ba-40c4-aa97-e59c1c3fef0f"
      unitRef="usd">-7000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i5b137e80a00d4c648059cb6c66b70dab_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjBiMTY3ZDE5NDI3ODQ3ZmZiNmNmMDA3M2NmNWJjYTNhL3RhYmxlcmFuZ2U6MGIxNjdkMTk0Mjc4NDdmZmI2Y2YwMDczY2Y1YmNhM2FfNC0xMC0xLTEtOTk3MDY_87bdf913-b00b-466a-8458-b61b4a8aaf9c"
      unitRef="usd">-9000000</bsx:Netcurrencyexchangegainloss>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyNTM_e651f46c-93d4-40b6-9eaf-98e09abe338c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyODk_5be4fbad-1074-4ff0-8ac6-7c8b733eca19">The following are the balances of our derivative and nonderivative assets and liabilities:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;966&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ie06eeef8c3a2458a80d5fbb8e8971e2f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNC00LTEtMS05OTcwNg_47b26fa0-09b9-4655-b503-cb7e8d898aef"
      unitRef="usd">246000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i283c9b3d2d864286a042216f0f64a9d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNC02LTEtMS05OTcwNg_826fba67-6486-4ab9-944d-4a0bb7cf15ef"
      unitRef="usd">183000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i4f79da42a51e4c689131977628edf127_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNS00LTEtMS05OTcwNg_2f62d093-e94f-463e-9d6c-34930a49b408"
      unitRef="usd">252000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="id9a8a481fded45df857975789968d39d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNS02LTEtMS05OTcwNg_8a88b694-7ef9-4edd-a883-c23e53fa6591"
      unitRef="usd">169000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="iec2075fa6d454b41ae2afcc3adfef0cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNi00LTEtMS05OTcwNg_6de85c30-f19b-4202-889b-5c5ffff7c2d9"
      unitRef="usd">498000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i70cc74c177124666847f665ef6dcce62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfNi02LTEtMS05OTcwNg_fc39af01-6612-44f4-9e59-270dc37e2515"
      unitRef="usd">352000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ie23236f5602843f6a6cbba70fbcd25a3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfOC00LTEtMS05OTcwNg_da0ef93e-075d-4e2b-8350-b935d8b08cf1"
      unitRef="usd">40000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i522dd4a58a4841a5963ab9f73b804c01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfOC02LTEtMS05OTcwNg_e0e96ec3-c08d-4bc2-a95d-1d450d9ab781"
      unitRef="usd">42000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTAtNC0xLTEtOTk3MDY_d47cadf0-501e-4348-a8e2-e16cf2e00c99"
      unitRef="usd">538000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTAtNi0xLTEtOTk3MDY_3ba2de8f-0bd1-4257-807e-0994168aaae0"
      unitRef="usd">394000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i1e040f387ddc4ec38df96824cb9d67e4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTQtNC0xLTEtOTk3MDY_a1db5bfb-4c2d-44f4-99a6-81fd02f8960a"
      unitRef="usd">10000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ifd0b6009b67642718139f8490ac1a838_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTQtNi0xLTEtOTk3MDY_080f3a09-d166-4a21-a366-e2508fd9cbf3"
      unitRef="usd">32000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i395049b051f7434bbf8dc1b8a8366602_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTUtNC0xLTEtOTk3MDY_78df4b5d-163d-414e-a7bd-16e03d1ab251"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i20de2ae88de4431b9b32645d028faae9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTUtNi0xLTEtOTk3MDY_ae7cf0d9-6f75-4cc0-853b-8c27ef0c4a09"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i903aa99cb11d474c86e447953994f505_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTYtNC0xLTEtOTk3MDY_189eb092-11f4-48a5-8013-e3398ab33ee7"
      unitRef="usd">926000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i1390af8c345c4263bf87707c4ef576e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTYtNi0xLTEtOTk3MDY_034783f3-c72d-485e-806b-87263ab43188"
      unitRef="usd">1011000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="iec2075fa6d454b41ae2afcc3adfef0cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTgtNC0xLTEtOTk3MDY_ccd643b5-7ed3-429c-959b-726f6af5b7cf"
      unitRef="usd">938000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i70cc74c177124666847f665ef6dcce62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMTgtNi0xLTEtOTk3MDY_97113913-bb24-4b09-a58b-8472380e8160"
      unitRef="usd">1049000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="id85c78ca58b04142a6350664eedf1e72_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjAtNC0xLTEtOTk3MDY_e333996f-32c0-4e16-920c-f95a51a7f987"
      unitRef="usd">28000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i1ab5d2a58a3649bfb781ee50c6b74f2c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjAtNi0xLTEtOTk3MDY_9663620e-9ef6-428f-9beb-4e5dbd0dc5cc"
      unitRef="usd">22000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjEtNC0xLTEtOTk3MDY_a914d35e-ee57-4540-82e2-eed8bfd6027c"
      unitRef="usd">966000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmQ1MWZmOTNmNjMyYTRhZmNhMmI4MTU2ZmViNzJjNzZlL3RhYmxlcmFuZ2U6ZDUxZmY5M2Y2MzJhNGFmY2EyYjgxNTZmZWI3MmM3NmVfMjEtNi0xLTEtOTk3MDY_ce3cae9e-3ac9-4d71-9bd7-523b2fcb8715"
      unitRef="usd">1071000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LongTermDebt
      contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfOTAxNA_189b6809-855f-462e-b3d5-01028fc81311"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTMyOTg_799c373e-405b-4cb6-8795-227f73e0d689">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;966&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2022 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$182 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$215 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xLTEtMS05OTcwNg_77f72b14-bc04-46a0-9dcc-427af8434d7a"
      unitRef="usd">36000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0zLTEtMS05OTcwNg_09dfc005-22a1-4b66-9558-257a4d130284"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC01LTEtMS05OTcwNg_763eb908-4e19-4b49-a835-eeea9829b5e9"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC03LTEtMS05OTcwNg_a558cdd9-b5fb-47b5-a0c8-c8fe93153ff1"
      unitRef="usd">36000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC05LTEtMS05OTcwNg_268337e9-d0fb-41e4-a5ec-b5f2206b8696"
      unitRef="usd">1632000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xMS0xLTEtOTk3MDY_0cce398d-7d64-415d-95d6-55dcc38b3324"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xMy0xLTEtOTk3MDY_64598c40-9fed-418c-a86f-7a07d561b1b7"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNC0xNS0xLTEtOTk3MDY_c0e91a10-02a6-44d7-8cce-c135ce96df2e"
      unitRef="usd">1632000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xLTEtMS05OTcwNg_47c7051a-e677-400e-9aa1-5f6da60f3e48"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0zLTEtMS05OTcwNg_0ac45c0d-c14a-4543-a608-8772f18a6a8b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS01LTEtMS05OTcwNg_083590b7-5220-4846-b87a-8b51963a1e59"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS03LTEtMS05OTcwNg_98756ee6-f3da-431f-a0be-f46edbb45529"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS05LTEtMS05OTcwNg_1661a078-e4c7-46d4-b8c0-0ca61228c34e"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xMS0xLTEtOTk3MDY_295b1815-59ab-4249-9a7a-c935ea0a72ad"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xMy0xLTEtOTk3MDY_530c2af0-f08e-4b78-ab53-70cffed1fa3b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNS0xNS0xLTEtOTk3MDY_f14ee84c-e2dc-4e97-b89f-6da5c17ee477"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xLTEtMS05OTcwNg_6e2dc587-ca00-4ac3-b9b2-3506a8c3f73a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0zLTEtMS05OTcwNg_2f7330c5-4fd2-4497-817e-5e0a1f8e2342"
      unitRef="usd">538000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi01LTEtMS05OTcwNg_ee413e0d-db64-4ecf-8a2a-377a319f1814"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi03LTEtMS05OTcwNg_16f7378e-7f4e-46e1-90ca-757101f24b5c"
      unitRef="usd">538000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi05LTEtMS05OTcwNg_1d0c07c9-3233-4dd4-82df-b8b7df75aefb"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xMS0xLTEtOTk3MDY_bfd9528c-6343-4f20-9340-4a9b9f148d1c"
      unitRef="usd">394000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xMy0xLTEtOTk3MDY_00f4f5f6-7730-4403-b6e7-a24dfb5e83a1"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNi0xNS0xLTEtOTk3MDY_432de13e-252d-4981-a4b1-ab30f227dccf"
      unitRef="usd">394000000</us-gaap:DerivativeAssets>
    <bsx:Licensingarrangementsasset
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xLTEtMS05OTcwNg_b7a2a551-9157-400d-97d0-d325ec16c190"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0zLTEtMS05OTcwNg_de0dfc1c-bafd-4384-88f3-33ab0ec9553b"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy01LTEtMS05OTcwNg_34c7cec2-305f-418c-9e3f-0535d1e8400f"
      unitRef="usd">182000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy03LTEtMS05OTcwNg_d6c800e3-e951-4843-a60f-c4fb995934a9"
      unitRef="usd">182000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy05LTEtMS05OTcwNg_3ec3717d-f362-4752-bcfd-dd4d6231d167"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xMS0xLTEtOTk3MDY_57b6f2db-b2a5-4827-986f-eba36d27aec1"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xMy0xLTEtOTk3MDY_6075cfbb-616a-40ee-8fbf-01004717552e"
      unitRef="usd">246000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfNy0xNS0xLTEtOTk3MDY_18c7e494-82fc-4bdc-a7f1-de18c29c6923"
      unitRef="usd">246000000</bsx:Licensingarrangementsasset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xLTEtMS05OTcwNg_97008c09-678d-4e95-b2d5-0632fb20d553"
      unitRef="usd">40000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0zLTEtMS05OTcwNg_ff4bc4b6-83a6-4ed4-a2e8-5a76840cd2e2"
      unitRef="usd">538000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC01LTEtMS05OTcwNg_413901c6-389f-4c1a-b26a-005a39d85414"
      unitRef="usd">182000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC03LTEtMS05OTcwNg_750f2198-29a7-42cd-9fa8-8ad3d4bf788a"
      unitRef="usd">760000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC05LTEtMS05OTcwNg_caefb011-f0f1-426e-bdd1-b202adcb0162"
      unitRef="usd">1642000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xMS0xLTEtOTk3MDY_9aeed273-c85d-4c40-bab5-99fed9c3f558"
      unitRef="usd">394000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xMy0xLTEtOTk3MDY_9d7ccab1-bba1-4086-acb2-0e4d872b36cd"
      unitRef="usd">246000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfOC0xNS0xLTEtOTk3MDY_f4ca9fbb-29a1-467e-957a-b4b764bcd834"
      unitRef="usd">2282000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMS0xLTEtOTk3MDY_2c7466ad-079d-42b4-a7d2-0c85648f58eb"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMy0xLTEtOTk3MDY_8e315270-83a2-41c1-91c5-d4ea4e8f05f7"
      unitRef="usd">966000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtNS0xLTEtOTk3MDY_9eae475a-1eec-4aba-900b-2ce0edcb4a15"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtNy0xLTEtOTk3MDY_71171945-02e5-4abb-bac4-6132e7b6cab9"
      unitRef="usd">966000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtOS0xLTEtOTk3MDY_dbe302a5-a78d-4444-a347-24a79aad8587"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMTEtMS0xLTk5NzA2_93023bf8-68be-4de3-b8a1-e6d8918d246b"
      unitRef="usd">1071000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMTMtMS0xLTk5NzA2_90116f2e-cb3c-432e-aaab-5880bdd18e31"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTAtMTUtMS0xLTk5NzA2_73d69cc0-d922-4aef-a392-d882b895b8ed"
      unitRef="usd">1071000000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMS0xLTEtOTk3MDY_430cf038-d3fd-4ebc-a911-117e56091cc2"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMy0xLTEtOTk3MDY_ff10208c-d79b-43d3-9474-1b681263b485"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtNS0xLTEtOTk3MDY_18813898-a66c-4d9c-bfb0-feef41f6f907"
      unitRef="usd">219000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtNy0xLTEtOTk3MDY_0ab04501-4fd7-416b-847a-3d2c66650ba5"
      unitRef="usd">219000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtOS0xLTEtOTk3MDY_c91763ae-c7d6-460f-b3e0-9b3f4e9ce580"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMTEtMS0xLTk5NzA2_74a32824-95b8-4cb7-8d17-a717fb9d42ce"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMTMtMS0xLTk5NzA2_a4da112a-aff3-44bc-80b5-1dc8655e15a0"
      unitRef="usd">486000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTEtMTUtMS0xLTk5NzA2_2702f509-301b-45df-a975-76e427855cb0"
      unitRef="usd">486000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:Licensingarrangementsliability
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMS0xLTEtOTk3MDY_31c8b24c-01d5-4a2b-885b-2740c3033c1c"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMy0xLTEtOTk3MDY_440346f9-ed0b-459f-912b-e2cbca1d9453"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItNS0xLTEtOTk3MDY_e5fd7aea-95ca-47bf-86b0-ea70dd62ac39"
      unitRef="usd">215000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItNy0xLTEtOTk3MDY_3bea93bc-262d-4dd3-86a7-32dc4bdddcdf"
      unitRef="usd">215000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItOS0xLTEtOTk3MDY_01f7d87d-bde1-404c-8aa9-810f004c018a"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMTEtMS0xLTk5NzA2_27e66605-27de-4be1-a338-c738d1d68b9d"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMTMtMS0xLTk5NzA2_156d1144-af48-4eae-88a7-5e6de6e7fc62"
      unitRef="usd">281000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTItMTUtMS0xLTk5NzA2_c2f55b1d-e2eb-4333-aa9f-235111a7ebd7"
      unitRef="usd">281000000</bsx:Licensingarrangementsliability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMS0xLTEtOTk3MDY_3c2e35b6-5d09-408a-a0da-9c5656655b36"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i98c61e122e2347a5aa71be7a5df24cec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMy0xLTEtOTk3MDY_46c78cb8-d199-4420-82a8-ab8f818939f3"
      unitRef="usd">966000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtNS0xLTEtOTk3MDY_b430e6dd-2895-4e27-ad40-a450514f79bc"
      unitRef="usd">434000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib0d2c6aa9fb148d08124c2cfb24f74dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtNy0xLTEtOTk3MDY_00cb068b-567c-43c9-9223-b4aee4ea8604"
      unitRef="usd">1400000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtOS0xLTEtOTk3MDY_8e6c811a-7536-4518-bcf2-030b972cb60e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i809d63415d1e4ec79fe179aeb9672c1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMTEtMS0xLTk5NzA2_b954991e-f61d-4968-beb8-73087372fdbf"
      unitRef="usd">1071000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMTMtMS0xLTk5NzA2_62c556e3-e26b-407f-8cc2-5d8434b2b59e"
      unitRef="usd">767000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifa3999e4bde44be99a76ff42c4163037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjZjMWQ0ZTBkNWFkZDRjOTM5MTc5ZjI2MzNlYWU5NGVlL3RhYmxlcmFuZ2U6NmMxZDRlMGQ1YWRkNGM5MzkxNzlmMjYzM2VhZTk0ZWVfMTMtMTUtMS0xLTk5NzA2_0b35752e-5944-4f50-b908-6ea56f9af925"
      unitRef="usd">1838000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ie4db18d7065c43ef83b29c8496790e86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA3MTU_77f72b14-bc04-46a0-9dcc-427af8434d7a"
      unitRef="usd">36000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="id5f68cddd5ad42158036f7073b369a6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA3ODA_268337e9-d0fb-41e4-a5ec-b5f2206b8696"
      unitRef="usd">1632000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:Cash
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA4MDE_7170eb4a-1391-4e52-81ea-3cf3d76e57c0"
      unitRef="usd">240000000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTA4NzY_ef1d8767-1d07-4590-a806-60235ab797ab"
      unitRef="usd">293000000</us-gaap:Cash>
    <bsx:Licensingarrangementsasset
      contextRef="i27f146899c2744beaee1eff239630ac4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfMS0xLTEtMS05OTcwNg_7c81fd6a-a86a-4c1a-9dfe-63c3d9393098"
      unitRef="usd">182000000</bsx:Licensingarrangementsasset>
    <bsx:DiscountRateFairValueInput
      contextRef="i5055ee5be0c54a1498e064e638e3fc43_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfMS00LTEtMS05OTcwNg_42c2180a-605c-4c43-93e2-1f080299e256"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="iad29e7417ab84660bbf5561c20e93d02_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfMS03LTEtMS05OTcwNg_4dc8ce23-0e34-43c9-970d-56b572316b98"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsliability
      contextRef="i27f146899c2744beaee1eff239630ac4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC0xLTEtMS05OTcwNg_d62a1e35-3342-436a-8eb5-21e2ae500a6f"
      unitRef="usd">215000000</bsx:Licensingarrangementsliability>
    <bsx:DiscountRateFairValueInput
      contextRef="icf9c2c8c325e4eafb24af39665b6c948_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC00LTEtMS05OTcwNg_ea4e4be0-e2a3-4431-b429-39f84f64207d"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ifb3b1e53f8964f6589f2176f191c0f08_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC02LTEtMS05OTcwNg_70bf2a1c-9596-4763-9f66-a213a8966fc8"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i21815a7af6e34709a5951ddbb9f495fc_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOjM2N2U5ZTY0YjMzMzQzZDFiNjc3YzZiNmU0MzEzZmZhL3RhYmxlcmFuZ2U6MzY3ZTllNjRiMzMzNDNkMWI2NzdjNmI2ZTQzMTNmZmFfNC03LTEtMS05OTcwNg_e1c4c8d8-f88f-4598-9f7e-19ca449c1558"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsasset
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfMS0xLTEtMS05OTcwNg_1b56e603-c6b0-443e-a831-1e8c8578998c"
      unitRef="usd">246000000</bsx:Licensingarrangementsasset>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i4ce1e2f30ce34162a65a41a860c47fb7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfMi0xLTEtMS05OTcwNg_b277c847-d30f-4aa3-be57-ce1139b5dc32"
      unitRef="usd">72000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i4ce1e2f30ce34162a65a41a860c47fb7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfMy0xLTEtMS05OTcwNg_c9d7ba1d-28b4-497a-8a39-15d19392038a"
      unitRef="usd">9000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsasset
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmY2YWU0MTE4NmY3ODRhNDE5ZDBmNjM3NzgxODE4OTUzL3RhYmxlcmFuZ2U6ZjZhZTQxMTg2Zjc4NGE0MTlkMGY2Mzc3ODE4MTg5NTNfNC0xLTEtMS05OTcwNg_0e8d2ddf-0f8b-449e-8757-c2b1d3a8d7aa"
      unitRef="usd">182000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsliability
      contextRef="i0d6c530f66c44fcbb0d73cdbba129592_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfMS0xLTEtMS05OTcwNg_eaef6e46-a613-4706-b95c-ad67aab57444"
      unitRef="usd">281000000</bsx:Licensingarrangementsliability>
    <us-gaap:PaymentsForRoyalties
      contextRef="ic1ff32150be744fab5239abe91331844_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfMi0xLTEtMS05OTcwNg_03c7d9d0-bd30-4834-8811-0e6746fc4dea"
      unitRef="usd">75000000</us-gaap:PaymentsForRoyalties>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="ic1ff32150be744fab5239abe91331844_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfMy0xLTEtMS05OTcwNg_76710436-3a9e-4077-a3a9-a14b9007fb1a"
      unitRef="usd">9000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsliability
      contextRef="i5b623df0e8c34375b46c759975f64119_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RhYmxlOmNiYmFmNDc5MDJhYTQ0OTViYjdmZmUwNGI5ZGFhZjI2L3RhYmxlcmFuZ2U6Y2JiYWY0NzkwMmFhNDQ5NWJiN2ZmZTA0YjlkYWFmMjZfNC0xLTEtMS05OTcwNg_c4023d6b-6d15-4e4d-887b-1cc954f67a50"
      unitRef="usd">215000000</bsx:Licensingarrangementsliability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTI5MTA_0a9aad3e-bfec-4843-a752-36fed96dfe56"
      unitRef="usd">8517000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV81NS9mcmFnOmIwNDdlMWZjMzBiNDQ5YjNiY2U0N2M1YWQ3MmIzZWQ5L3RleHRyZWdpb246YjA0N2UxZmMzMGI0NDliM2JjZTQ3YzVhZDcyYjNlZDlfMTI5MjY_87364ff8-1601-4a0b-b720-6e6aac3457b5"
      unitRef="usd">10196000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfODA_45abc0ed-964c-4cf8-8e10-20a4810931e1"
      unitRef="usd">8971000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfOTY_14dbe076-3e3c-4f9c-a4d1-cf01a89f536e"
      unitRef="usd">9065000000.000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTM2_c1c213fc-c212-43ea-b2e0-3e6b7c498540"
      unitRef="usd">170000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTUy_a1b481cc-c304-4da7-bfac-447db88eddbf"
      unitRef="usd">261000000</us-gaap:DebtCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk2NA_f27dc17f-120b-4ba8-b791-f1e4427d1c5d">The debt maturity schedule for our long-term debt obligations is presented below: &lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.875%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,802&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and December 31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below. In addition, in the first quarter of 2022, we repaid $250 million of 3.375% May 2022 Senior Notes classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Debt Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 10, 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the 2021 Revolving Credit Facility as of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022 or December&#160;31, 2021; however, outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of 3.75 times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for the recently completed qualified acquisitions due to the funding using cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreement, through maturity, of any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2022, we had $311 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $1.455 billion in the aggregate. As of June&#160;30, 2022, we had $1.080 billion of the litigation exclusion remaining.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any inability to maintain compliance with this covenant could require us to seek to renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable&lt;/span&gt;&lt;span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper program is backed by the 2021 Revolving Credit Facility. We had $155 million of commercial paper outstanding as of June&#160;30, 2022 and none as of December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except maturity and yield)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper outstanding (at par)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum borrowing capacity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing capacity available &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 days&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0 days&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had senior notes outstanding of $8.878 billion as of June&#160;30, 2022 and $9.121 billion as of December&#160;31, 2021. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, American Medical Systems Europe B.V. (AMS Europe), an indirect, wholly owned subsidiary of Boston Scientific, completed a registered public offering (the Offering) of &#x20ac;3.000 billion in aggregate principal amount of euro-dominated senior notes comprised of &#x20ac;1.000 billion of 0.750% Senior Notes due 2025, &#x20ac;750 million of 1.375% Senior Notes due 2028, &#x20ac;750 million of 1.625% Senior Notes due 2031 and &#x20ac;500 million of 1.875% Senior Notes due 2034 (collectively, the Eurobonds). Boston Scientific has fully and unconditionally guaranteed all of AMS Europe's obligations under the Eurobonds, and no other subsidiary of Boston Scientific will guarantee these obligations. AMS Europe is a &#x201c;finance subsidiary&#x201d; as defined in Rule 13-01(a)(4)(vi) of Regulation S-X. The financial condition, results of operations and cash flows of AMS Europe are consolidated in the financial statements of Boston Scientific. The Offering resulted in cash proceeds of $3.270 billion, net of investor discounts and issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $3.275&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. We recorded associated debt extinguishment charges of $194 million in the first quarter of 2022 presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had outstanding letters of credit of $128 million as of June&#160;30, 2022 and $134 million as of December&#160;31, 2021, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of June&#160;30, 2022 and December&#160;31, 2021 we had not recognized a related liability for any outstanding letters of credit within our accompanying unaudited consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfODAxNQ_c78f5d1a-0c93-4c21-b020-88c566f140cc">The debt maturity schedule for our long-term debt obligations is presented below: &lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.875%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,802&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and December 31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below. In addition, in the first quarter of 2022, we repaid $250 million of 3.375% May 2022 Senior Notes classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Debt Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i50e7fbf9ea5d43a2b38aa9bad667e187_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMy02LTEtMS05OTcwNg_4c71dc9a-7fdf-44fc-93da-8862062c27f9"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6bce25b2bb6a42e1a1077eeec7d3b9bc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMy04LTEtMS05OTcwNg_8387e33f-0623-4a5b-b947-e17d96d5a535"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i50e7fbf9ea5d43a2b38aa9bad667e187_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMy0xMC0xLTEtOTk3MDY_956ec493-e05b-4e8e-9853-0eaef3cb3dd8"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i80e70f9bdc9a4a9f829773dd8d40f1a2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNC02LTEtMS05OTcwNg_7073eefe-8d47-4767-bf77-50a9673cefc3"
      unitRef="usd">504000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idd5038c2fb0e4b95b80671df1615c58e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNC04LTEtMS05OTcwNg_4b9dc93c-21c8-4d93-bad0-d0a93daadb6f"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i80e70f9bdc9a4a9f829773dd8d40f1a2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNC0xMC0xLTEtOTk3MDY_62673670-0a46-4939-8bb3-7a7f027d83da"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNS02LTEtMS05OTcwNg_df8b22fc-67fd-4bd1-9d86-3a44d2bcb119"
      unitRef="usd">1039000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i10527d633af14853a3d6a28a3b84ea28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNS04LTEtMS05OTcwNg_5156e240-b05b-4694-b67d-e383ee02378e"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNS0xMC0xLTEtOTk3MDY_8d9051f7-8c51-44de-a97b-6deee951f2a6"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7e95c9c3ca2647bebeb689903f4662b6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNi02LTEtMS05OTcwNg_d64a82db-af73-4ffb-b804-1e58ac951218"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibf8c1c7c026a4812bc680c9687955ea5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNi04LTEtMS05OTcwNg_0f98c707-9f03-4d44-a772-29e5c2067e99"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e95c9c3ca2647bebeb689903f4662b6_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNi0xMC0xLTEtOTk3MDY_4bb74ee7-cc3e-4645-90f9-19a1281c44ff"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i771f92b343bb4886afe00f44b7d62b4d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNy02LTEtMS05OTcwNg_1b8174cc-939e-499f-88fa-46395533e9bc"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie85ee741df5d4ac693e71a7c46cb1f5a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNy04LTEtMS05OTcwNg_20b5ca9d-d3f3-424b-bf3e-9c753c70cbf9"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i771f92b343bb4886afe00f44b7d62b4d_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfNy0xMC0xLTEtOTk3MDY_26dc06f0-7597-49f6-abcf-bb90643c979c"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0ee2942cb1e94674ab49ef190a069073_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOC02LTEtMS05OTcwNg_45916eee-d778-4917-9978-ca7a1bcd5fad"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i48210b087009430d87d3ee09bbd7480b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOC04LTEtMS05OTcwNg_0e3d4773-e6c4-4471-a1c6-ac39ede874fb"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0ee2942cb1e94674ab49ef190a069073_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOC0xMC0xLTEtOTk3MDY_13ade501-42ef-4f16-988a-a7e047be5dad"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOS02LTEtMS05OTcwNg_bdda24cf-ff01-40cb-9cea-66b76cc7fc68"
      unitRef="usd">935000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id937d257d4a3403f8db692c5b41aa9ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOS04LTEtMS05OTcwNg_6e216725-e74b-4428-be6b-7b830a6e1a73"
      unitRef="usd">1021000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8474860170d474cbdbaf74e8fca9837_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfOS0xMC0xLTEtOTk3MDY_620e7d26-9fbf-4313-98cb-58803221e2e8"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTAtNi0xLTEtOTk3MDY_25431cbf-bf55-4665-a9d3-c2a9054f4d97"
      unitRef="usd">779000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8fcf8358875242f7af0e421a76768692_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTAtOC0xLTEtOTk3MDY_9a71df1d-8468-4252-980a-5a8c7287cce5"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTAtMTAtMS0xLTk5NzA2_ad5e5a6a-bd83-40d3-acfc-eb2f93e29026"
      unitRef="number">0.01375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id6669b1014a64e8189357320d104615a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTEtNi0xLTEtOTk3MDY_e5d60142-d01f-4c1a-8b53-1c784e3e4157"
      unitRef="usd">344000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2b9b62e05a72418aa23a2c8539d02f68_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTEtOC0xLTEtOTk3MDY_e8cfafcf-b6ab-4519-9f80-2a8cde7e3e3c"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id6669b1014a64e8189357320d104615a_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTEtMTAtMS0xLTk5NzA2_ac162341-c4df-4893-8395-d90c899496d8"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5293e3f0677c486fa8ef0b0311b62005_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTItNi0xLTEtOTk3MDY_ffb3dc0e-11c5-481d-a94d-75c5515de0c3"
      unitRef="usd">272000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9fa9924b99f54b9bba102c4cbf10aca9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTItOC0xLTEtOTk3MDY_dcbad1bf-1a9c-4dca-9815-52c96da42b8a"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5293e3f0677c486fa8ef0b0311b62005_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTItMTAtMS0xLTk5NzA2_4120ba2d-efbc-4cb5-ae53-3d7b7d322348"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1ea96d4ea7d04a2daa8f980b999df830_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTMtNi0xLTEtOTk3MDY_cba071d1-58ed-49c5-a8cf-6a3236fc635f"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i05aa77d5eb404436ad25e54997dd9780_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTMtOC0xLTEtOTk3MDY_07798eba-5481-4497-b8d1-5b4d91a1c16f"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1ea96d4ea7d04a2daa8f980b999df830_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTMtMTAtMS0xLTk5NzA2_3a54d0f5-c186-4e2e-9a3b-f56a5ae2caec"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTQtNi0xLTEtOTk3MDY_bde8a3cc-a7cb-44c9-82f3-dcd2dbbc6bcc"
      unitRef="usd">779000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id715136c1f6f43e190b1b7cb7b6a75e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTQtOC0xLTEtOTk3MDY_25765343-26e1-4094-821a-23fdc56d9c79"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTQtMTAtMS0xLTk5NzA2_5b0e458c-8b62-4ef2-bd48-e2690cc0977f"
      unitRef="number">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTUtNi0xLTEtOTk3MDY_07318b7f-041f-4ac8-93d5-c3cf017dd222"
      unitRef="usd">520000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ice55734ff9694ebb8bba28051710baa2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTUtOC0xLTEtOTk3MDY_510bd8b9-9e0e-41dd-af11-f069ebd55a85"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTUtMTAtMS0xLTk5NzA2_adfbd7e6-16f6-46ea-a1d8-14bb334110ab"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifd222b4f248248c38837a4b7e751501d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTYtNi0xLTEtOTk3MDY_a223243f-fb8f-48e3-8a14-ff5444080c2a"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if7b3863114dd40908e490c5e045b081d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTYtOC0xLTEtOTk3MDY_1a5fce28-af84-422d-9454-d448b2f5c667"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifd222b4f248248c38837a4b7e751501d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTYtMTAtMS0xLTk5NzA2_e58817d8-9531-4ef6-8834-7bebb2c82e4c"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iacacfc94ceb24a648193a04798d1e6dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTctNi0xLTEtOTk3MDY_5120a23a-069c-4e7d-99f1-ff6b05ea1389"
      unitRef="usd">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id86681f9c3b6492daaf4162fa8970450_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTctOC0xLTEtOTk3MDY_9aa9592c-8d4e-4734-b7dd-1fc2852c0655"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iacacfc94ceb24a648193a04798d1e6dc_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTctMTAtMS0xLTk5NzA2_5ce34057-a4ac-4a9b-8894-5981a99d14c9"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie950b3741f1d4e158b9ee15c4b4ed9a2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTgtNi0xLTEtOTk3MDY_fd836938-3322-4074-9694-eb6a8aab828e"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i68de0d9b3a8e49ceafd696fc5709bd12_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTgtOC0xLTEtOTk3MDY_e13c4d38-2a37-4928-82e4-0629717d0b70"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie950b3741f1d4e158b9ee15c4b4ed9a2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTgtMTAtMS0xLTk5NzA2_5597dba5-8653-489c-8eba-9f6a9cfd5eca"
      unitRef="number">0.07375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia4b1f8f175024c6bbb7edb59c01d0d1c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTktNi0xLTEtOTk3MDY_84cf8eb4-bd94-44d9-8b17-fef90a0c5377"
      unitRef="usd">650000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i416ba9b4dd0d46c889e4493851b6db3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTktOC0xLTEtOTk3MDY_40b0f52f-d9d9-4d4c-b7d7-7896220d48cc"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia4b1f8f175024c6bbb7edb59c01d0d1c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMTktMTAtMS0xLTk5NzA2_3f61e570-85fa-4055-aa16-e8512257856b"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i8ae315c0e1554dacaae58b7af1c8736f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjAtNi0xLTEtOTk3MDY_4d333efe-2ae2-4fd5-9812-c292312882e4"
      unitRef="usd">-82000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i784b8e2bd7b74fe1b05c54c5962c8c64_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjAtOC0xLTEtOTk3MDY_f6b38ecb-893c-4036-b6d9-e4a0e16388bb"
      unitRef="usd">-76000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ie68f0f5b7ac54919bae4f7f9efc554d2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjEtNi0xLTEtOTk3MDY_74db69a8-feb3-442b-9dee-3db6af3ce70d"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iff06f923ba6c43cc86c4783c3efd3131_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjEtOC0xLTEtOTk3MDY_d6cb5a1a-c7b1-4804-9b3f-4d6353967c14"
      unitRef="usd">3000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i08584e30dcf848aba71c8d5f57625e6f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjItNi0xLTEtOTk3MDY_b02fe154-56a7-4216-8893-adbfc2b3c875"
      unitRef="usd">5000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib4aea0c204194bf984d537214fddfde2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjItOC0xLTEtOTk3MDY_6c978cb7-0f1a-4307-bd14-94a1f15748fd"
      unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjMtNi0xLTEtOTk3MDY_4f9e79fd-57a2-430f-8cd2-3dec6456338f"
      unitRef="usd">8802000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjEyMGM2MGI4YzQyMjQ3OGE4NjYwYTdhMDE3MGY3NWRiL3RhYmxlcmFuZ2U6MTIwYzYwYjhjNDIyNDc4YTg2NjBhN2EwMTcwZjc1ZGJfMjMtOC0xLTEtOTk3MDY_fcb1a89a-ca2e-4f05-9c8f-a87a8ca3d733"
      unitRef="usd">8804000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ShortTermBorrowings
      contextRef="i24581130201d4bb6bb06505b8f5af435_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTI0Mg_549c123c-9fd2-4e0c-b84f-de2867ec0d43"
      unitRef="usd">250000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i24581130201d4bb6bb06505b8f5af435_I20220630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTI0OA_b3f10527-87ff-4ba7-8653-7f34016cadc3"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i138c7c7c86e847c989a9ffb258cc207b_I20210510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTQyOQ_62102ba1-9235-4529-88bc-dfcce3c89a9d"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bsx:DebtInstrumentExtensionOptionTerm
      contextRef="i1c00dff781d2413cbbf1f18bed5d6e0f_D20210510-20210510"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk5Ng_8342e1ef-8535-4013-8eeb-0fb1efcb77bd">P1Y</bsx:DebtInstrumentExtensionOptionTerm>
    <us-gaap:LongTermDebt
      contextRef="ia309b17ea78345ba80fb7b052728c043_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTg3Mg_a63a34db-22e0-40a4-bf6b-69c9a8efe6a3"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i69088951be3f4fdeba3d3644b3c3b6f5_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMTg3Mg_ea76cdc4-cc12-4b89-bb8e-3c5afabadf5e"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfODAwNQ_f16b54c6-7ff0-45bc-b66d-0bbbcbec4672">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;</bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock>
    <bsx:MaximumLeverageRatio
      contextRef="i449d136159f049a5985130241fa62d0c_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOmJiYWFiNjlhZTNjZjRjODhhNjJhOWNlYTc0MGY3ZDE2L3RhYmxlcmFuZ2U6YmJhYWI2OWFlM2NmNGM4OGE2MmE5Y2VhNzQwZjdkMTZfMi0yLTEtMS05OTcwNg_60999985-f62e-4644-ac55-8928dd679792"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i29b4c437272d480aa75455fc20ccedd2_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOmJiYWFiNjlhZTNjZjRjODhhNjJhOWNlYTc0MGY3ZDE2L3RhYmxlcmFuZ2U6YmJhYWI2OWFlM2NmNGM4OGE2MmE5Y2VhNzQwZjdkMTZfMi00LTEtMS05OTcwNg_eb855d09-ac55-424e-8568-37f15b3e1ed9"
      unitRef="number">2.61</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i7e3ac65cbf784533b5620e4ff1832c2c_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjMyMg_b05bb4e6-8a88-46c1-9960-27faed15d084"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:QualifiedAcquisitionConsideration
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjUwMg_2c51eb0f-dd9f-4cbe-9572-e9cd8cd580dd"
      unitRef="usd">1000000000</bsx:QualifiedAcquisitionConsideration>
    <bsx:MaximumLeverageRatio
      contextRef="i0ca81ce52f414e53a0e5cc4d51005e69_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjY5NA_04c547aa-fd49-4c1a-8ee4-c750a1c90f32"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i1f6851db735d4b949b672cef2153d2d0_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjc5Mw_57c81886-bdaa-42b9-a472-acddba1600af"
      unitRef="number">4.50</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i7d1ff42f2c334bd38528daf462dad7f6_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjc5Nw_b65eac20-956b-4d29-87de-72ac87366545"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="iea70986a88704b33aeb401629439ceee_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjgwNA_bc64f23e-17a7-4d13-88a1-2a9262270390"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i950105374ecc4d5681ba3458a73eadc0_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjg2Mg_18bb03e2-e480-4769-88e3-2b1a4b012dde"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:ExclusionFromEbitdaForRestructuringCharges
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzI4OQ_814d1515-2765-4915-be53-94f0be3c0fa8"
      unitRef="usd">500000000</bsx:ExclusionFromEbitdaForRestructuringCharges>
    <bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzQyMw_06ab03d5-47b7-4291-b334-3331afefdb44"
      unitRef="usd">311000000</bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <bsx:LitigationAndDebtExclusionFromEbitda
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzc1NQ_fafaffcf-c16b-44c2-9a4c-45d62d6e55f9"
      unitRef="usd">1455000000</bsx:LitigationAndDebtExclusionFromEbitda>
    <bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMzc5Mw_3e7601e2-2e4d-45dd-b464-625031dc176d"
      unitRef="usd">1080000000.00</bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="ie27b0338c0a34e858b0b2dccd5137bb4_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk4Ng_fbd68a34-917b-4dba-aeee-4283f2e5a315">We had $155 million of commercial paper outstanding as of June&#160;30, 2022 and none as of December&#160;31, 2021. &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except maturity and yield)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper outstanding (at par)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum borrowing capacity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing capacity available &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 days&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0 days&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:CommercialPaper
      contextRef="i327d423409a741438941c3983d47e655_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNDc1OQ_b09fd8e8-a747-4850-a217-d50ad3eb20c4"
      unitRef="usd">155000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i327d423409a741438941c3983d47e655_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMi0xLTEtMS05OTcwNg_b09fd8e8-a747-4850-a217-d50ad3eb20c4"
      unitRef="usd">155000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMi0zLTEtMS05OTcwNg_65f6236b-e511-4173-bc11-08a09b9e20ba"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <bsx:MaximumCommercialPaperOutstanding
      contextRef="i327d423409a741438941c3983d47e655_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMy0xLTEtMS05OTcwNg_a696990a-b83e-455c-b045-2df1165f2d46"
      unitRef="usd">2750000000</bsx:MaximumCommercialPaperOutstanding>
    <bsx:MaximumCommercialPaperOutstanding
      contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfMy0zLTEtMS05OTcwNg_a74f5e49-f03b-4a11-ae6c-698eb36b0856"
      unitRef="usd">2750000000</bsx:MaximumCommercialPaperOutstanding>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i327d423409a741438941c3983d47e655_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNC0xLTEtMS05OTcwNg_9d3af117-ce08-4352-a8c2-98c7fb034c2d"
      unitRef="usd">2595000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNC0zLTEtMS05OTcwNg_c42d6ce6-ccf6-4b91-9dff-59607a1c1c18"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="i327d423409a741438941c3983d47e655_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNi0xLTEtMS05OTcwNg_5707db86-d364-400c-b082-b3f7565f7648"
      unitRef="number">0.0193</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="ib0a8923e44054f43b4d6eed3d687f722_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjNhYjIwMWFhOTlmYzRlNTg5YjUxYmE5Y2IxNDQzMWFjL3RhYmxlcmFuZ2U6M2FiMjAxYWE5OWZjNGU1ODliNTFiYTljYjE0NDMxYWNfNi0zLTEtMS05OTcwNg_ee27b589-0e8d-4f35-96d7-e1f9c3b86486"
      unitRef="number">0</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebt
      contextRef="i8ae315c0e1554dacaae58b7af1c8736f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNDg3Ng_1fef6ea6-d090-4c97-8210-7882477f7820"
      unitRef="usd">8878000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i784b8e2bd7b74fe1b05c54c5962c8c64_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNDg5Mg_5db52ce7-b951-456a-9bd5-6b58bf8db407"
      unitRef="usd">9121000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i39de90268a7a4225b6941c9ff3a19fab_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTQyMw_cdc1b066-2745-4cc7-aaad-95d7cf0ab634"
      unitRef="eur">3000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUwMA_853cb91d-0a6c-4d4b-812a-51632265fe97"
      unitRef="eur">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73db81a84992414f90cb1a67fc97fb24_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUwNg_4e741662-45ba-4a47-b6bf-b0a5cb7d6492"
      unitRef="rate">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUzMg_e4203ede-30d5-4092-b7c1-2c75375c51e6"
      unitRef="eur">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic2fc1b60c1e141bca6041f8cfdaacec3_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTUzOA_1aa38425-593d-4830-9bd2-1fdce116148a"
      unitRef="rate">0.01375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTU2NA_aa8a5d83-c28a-4ec6-b2b5-cc03d42a9cbd"
      unitRef="eur">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9a0674ef27014518a6dd75ea87e28933_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTU3MA_8ca65bb2-2e31-4f23-80a7-cc1ac098de31"
      unitRef="rate">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTU5OQ_631f12ad-803c-4d23-9925-b0944c11f7ae"
      unitRef="eur">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib286dd30c58f4a679933177bb048f7b4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNTYwNQ_55a616a2-a57f-455b-b7be-c484299afb80"
      unitRef="rate">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjE5OTAyMzI2MzYzMg_3967d841-4c5b-4396-8230-f49180be6334"
      unitRef="usd">3270000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2038d40094f64de1965e4f053aeab53d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNjMxMA_d100c873-686d-4a17-8758-d97cb104c289"
      unitRef="usd">3275000000</us-gaap:LongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ieb6722339b944352b0b56bcac0aadaaf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfMjE5OTAyMzI2MzU3NA_b478c2b4-f696-4c6c-80c4-f6142e5293de"
      unitRef="usd">194000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzk5MA_71c2faed-9af0-414b-bc82-cc9294e2d170">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i649407080a3b4a2a8dbe0062791430e0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi0xLTEtMS05OTcwNg_7c2e395b-0245-4be0-88e1-9c14b7d68e1e"
      unitRef="usd">147000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="if742f92ece7547768b16200d191f5b16_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi0zLTEtMS05OTcwNg_27af423f-da5c-4915-9d67-64834d5dcc24"
      unitRef="number">0.019</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ic314a6b5f97d44198af151b25dbf609c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi01LTEtMS05OTcwNg_7b1e57b5-4e07-4089-bc44-820369eb599d"
      unitRef="usd">141000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i02f1129cfb5e4c6bb359d217903f8368_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMi03LTEtMS05OTcwNg_10a4d975-e079-483a-8fa6-91881526ddd5"
      unitRef="number">0.021</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i95b3c6ed9730476381312a30a5c8bcbd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy0xLTEtMS05OTcwNg_27067bb8-2153-4817-851f-d059abde59f5"
      unitRef="usd">177000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i6e345c3e41bc48a8bc324b8f8375b600_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy0zLTEtMS05OTcwNg_0b8e7714-6027-49f6-b43e-60ef6dc321a9"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="iab7bfd166b4841ad94b29f8f0775f55f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy01LTEtMS05OTcwNg_aef7d875-be3e-4881-b12b-2111468b39db"
      unitRef="usd">223000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i646d9a6e9da946f785beb189d5511265_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfMy03LTEtMS05OTcwNg_fa3d7619-8b06-4f45-8781-7f27ac08b0e1"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i2f2e5182166b4e258ce14bd1c6bc2462_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC0xLTEtMS05OTcwNg_f5a70ccb-f95d-436f-aa14-163d6c2346fc"
      unitRef="usd">0</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="ia2579a67e9154ae9bdb34bfdbaff7852_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC0zLTEtMS05OTcwNg_3399c34f-c96e-4d52-975f-913154c76701"
      unitRef="number">0.031</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i32519afb04824cab904e19b493da014d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC01LTEtMS05OTcwNg_a049b9a7-84bf-4427-9cc9-5e7858abaa6b"
      unitRef="usd">0</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i00ae8b0ca7d84dedb85b5fdbfbb37484_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RhYmxlOjI5NjY2MjBhZjQwYTRjZDliNmY0ZDk1NWFjZmM0Nzg2L3RhYmxlcmFuZ2U6Mjk2NjYyMGFmNDBhNGNkOWI2ZjRkOTU1YWNmYzQ3ODZfNC03LTEtMS05OTcwNg_ce8d7f7f-84e7-4360-915d-08d495deaae1"
      unitRef="number">0.032</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzM1Nw_d55f1818-20e5-4b4e-aa99-4c81b4603b15"
      unitRef="usd">128000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV82MS9mcmFnOmRlNDE2MWUxNzVmZjRmOGRhNjc5ZjgwYWI1M2I3YmFhL3RleHRyZWdpb246ZGU0MTYxZTE3NWZmNGY4ZGE2NzlmODBhYjUzYjdiYWFfNzM3Mw_7e20ed39-a551-46b8-b1df-2c9aded65325"
      unitRef="usd">134000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE0NA_eb35c046-140d-475e-8fc2-1a4419b6d7eb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE F &#x2013; SUPPLEMENTAL BALANCE SHEET INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions within our accompanying unaudited consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 326), we record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic and geopolitical conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other entities, and, in southern Europe, relative to those in other countries. More recently, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,610&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;799&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $80 million&#160;for the second quarter of 2022, $83 million for the second quarter of 2021, $156 million for the first six months of 2022, and $166 million for the first six months of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indemnification asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;784&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of our 2019 acquisition of BTG plc. (BTG), we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom employees. During the second quarter of 2022, we transferred the benefit obligation and associated assets of the pension plan to third party insurers, and as a result, were relieved from primary responsibility of the benefit obligation and the related plan assets. The transaction did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE4NA_ac97f20d-42b2-4f98-a2d5-f79b87c51201">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMi0xLTEtMS05OTcwNg_01455f45-fbc6-4549-8e35-a19e4088e8e7"
      unitRef="usd">2034000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMi0zLTEtMS05OTcwNg_60ecc6d3-b650-450e-b503-c6ac831b57fd"
      unitRef="usd">1886000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMy0xLTEtMS05OTcwNg_58cf5b75-e07f-42b7-9c1a-9d2328757132"
      unitRef="usd">117000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfMy0zLTEtMS05OTcwNg_e74a1999-9e6f-4fef-9c78-2f8d1750dfb5"
      unitRef="usd">108000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfNC0xLTEtMS05OTcwNg_8393d8d5-e35a-47bb-8ad8-09fe7442fbd0"
      unitRef="usd">1917000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjEyZjQ4Njc5ZTI4ZjQ4M2U5MGViYTFmNjFlMmFhNTM5L3RhYmxlcmFuZ2U6MTJmNDg2NzllMjhmNDgzZTkwZWJhMWY2MWUyYWE1MzlfNC0zLTEtMS05OTcwNg_7927c2ea-8109-4d39-8a0f-ddeaa5756f6f"
      unitRef="usd">1778000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi0xLTEtMS05OTcwNg_b1a4621a-d8d6-4d6b-9c8a-cb8963a63c81"
      unitRef="usd">113000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi0zLTEtMS05OTcwNg_c91d2302-b2ef-4cfe-9d45-c72acf0538c0"
      unitRef="usd">101000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi01LTEtMS05OTcwNg_3ccc3b85-4261-484b-8229-e3af6b91e7b2"
      unitRef="usd">108000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMi03LTEtMS05OTcwNg_d1380692-e06c-44dd-aece-0148d1dc6275"
      unitRef="usd">105000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy0xLTEtMS05OTcwNg_93684002-ba48-4f60-83e8-16bde05eba06"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy0zLTEtMS05OTcwNg_86b4f81f-a077-44d0-b0c0-74c88e73cd4b"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy01LTEtMS05OTcwNg_2d2eb235-7dc4-4499-aa68-3b4f59c72435"
      unitRef="usd">20000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfMy03LTEtMS05OTcwNg_75dfef5d-fc19-40ff-b169-505ecf7d1dc7"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC0xLTEtMS05OTcwNg_8c60e388-ca5a-4ea5-8ca9-e312b4c1026c"
      unitRef="usd">5000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC0zLTEtMS05OTcwNg_c5fb8576-7a43-4aab-9179-a3dd3d6b8bf5"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC01LTEtMS05OTcwNg_563fca51-4984-4de7-99a5-cd571f475ccf"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNC03LTEtMS05OTcwNg_712da490-485a-493e-974a-f2cf689eb115"
      unitRef="usd">10000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS0xLTEtMS05OTcwNg_2ac81dab-d8e6-452d-a9c9-b153ed0985c7"
      unitRef="usd">117000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS0zLTEtMS05OTcwNg_d4bc9abb-4877-4d27-914d-7978eaee316c"
      unitRef="usd">107000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS01LTEtMS05OTcwNg_ad5d3dc9-3e26-4b0e-b7c6-018c8e1ba08e"
      unitRef="usd">117000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmM5YWExYjg2ZTA4MzQwNTU4MjFmMjEwMWFjYmMxYWIwL3RhYmxlcmFuZ2U6YzlhYTFiODZlMDgzNDA1NTgyMWYyMTAxYWNiYzFhYjBfNS03LTEtMS05OTcwNg_b3def719-dca0-48b0-adc5-020c20da57be"
      unitRef="usd">107000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjIwOQ_a4fdfc12-26fc-4c69-a995-27a9ef0b12d1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,610&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMi0xLTEtMS05OTcwNg_44dd6bfd-d6ed-4ba2-bcd2-6c112422950a"
      unitRef="usd">1082000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMi0zLTEtMS05OTcwNg_e61c88db-4df8-4a4a-8e5e-a741a2dfcbfe"
      unitRef="usd">1029000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMy0xLTEtMS05OTcwNg_c69cd4ea-719c-4534-b8ff-4af5727099bc"
      unitRef="usd">144000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfMy0zLTEtMS05OTcwNg_e42d7e88-fa4b-422c-a36c-480309fc3384"
      unitRef="usd">128000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNC0xLTEtMS05OTcwNg_84611782-c886-4a3d-a0b6-cbd793c100c4"
      unitRef="usd">526000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNC0zLTEtMS05OTcwNg_973c5adc-7487-4968-9da5-e374b76f6a83"
      unitRef="usd">452000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNS0xLTEtMS05OTcwNg_d2fb3c6a-989e-442a-9eaa-74bc828d7a30"
      unitRef="usd">1752000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjI2NTYzYWYwMWI0MzQyY2NhMTBkMTMzNjYzOWFlMmVkL3RhYmxlcmFuZ2U6MjY1NjNhZjAxYjQzNDJjY2ExMGQxMzM2NjM5YWUyZWRfNS0zLTEtMS05OTcwNg_f077b25a-df75-49b6-8e8f-7a35bfde3fac"
      unitRef="usd">1610000000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE0Mw_2fe23f6e-b1e0-4838-96eb-bcaf75c4e7d9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;799&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMi0xLTEtMS05OTcwNg_65b75a72-8108-4dce-bd2c-ef708b863bff"
      unitRef="usd">132000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMi0zLTEtMS05OTcwNg_91c14bb3-7336-4da4-8cb3-19697df3bc7c"
      unitRef="usd">188000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMy0xLTEtMS05OTcwNg_debe725e-c6b6-48ff-ad2d-411d3897e5df"
      unitRef="usd">286000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfMy0zLTEtMS05OTcwNg_b596803c-75ec-4620-9b30-2f1fed08d5d1"
      unitRef="usd">226000000</us-gaap:DerivativeAssetsCurrent>
    <bsx:Licensingarrangements
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNC0xLTEtMS05OTcwNg_d183636d-5dce-41f0-b660-8e59ddf50da8"
      unitRef="usd">94000000</bsx:Licensingarrangements>
    <bsx:Licensingarrangements
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNC0zLTEtMS05OTcwNg_9a36d7a2-eb82-4da2-aa86-ddb94dda9621"
      unitRef="usd">132000000</bsx:Licensingarrangements>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNS0xLTEtMS05OTcwNg_add8e8fe-7d55-429c-bdc7-1eea2a8a2d04"
      unitRef="usd">362000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNS0zLTEtMS05OTcwNg_dc104216-9f0d-4434-ad0a-0d64773bc65a"
      unitRef="usd">254000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNi0xLTEtMS05OTcwNg_49984658-4016-4ead-9f3d-978577572c79"
      unitRef="usd">874000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmUyYmQzM2YyMWM1YzRmNDQ5OGNmYWJiNzNlMGJmMjhjL3RhYmxlcmFuZ2U6ZTJiZDMzZjIxYzVjNGY0NDk4Y2ZhYmI3M2UwYmYyOGNfNi0zLTEtMS05OTcwNg_13773935-3e5e-4700-8e91-b0c6d93c6a95"
      unitRef="usd">799000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE5Ng_3516bb22-c4b0-4816-90bb-eae95f1e2a57">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMi0xLTEtMS05OTcwNg_6e89472f-c3fd-4478-a9f4-b131abf231c0"
      unitRef="usd">118000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMi0zLTEtMS05OTcwNg_a2bc75a8-55c8-43ca-bd64-11de93f3f470"
      unitRef="usd">109000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMy0xLTEtMS05OTcwNg_e4dd54be-d063-43ce-aee2-01f059d30092"
      unitRef="usd">1406000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfMy0zLTEtMS05OTcwNg_a4ca77e1-e548-4e6b-859c-159f2bf6a502"
      unitRef="usd">1335000000</us-gaap:BuildingsAndImprovementsGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNC0xLTEtMS05OTcwNg_cf84298d-352c-4ba3-8768-9701640c66b1"
      unitRef="usd">3453000000</bsx:EquipmentFurnitureAndFixturesGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNC0zLTEtMS05OTcwNg_b23e2609-0f18-4adc-8717-3b44d8a9ce2f"
      unitRef="usd">3475000000</bsx:EquipmentFurnitureAndFixturesGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNS0xLTEtMS05OTcwNg_98c51c7b-437c-4c2b-adf5-2c389aac5d0b"
      unitRef="usd">537000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNS0zLTEtMS05OTcwNg_1ca91181-a9b6-48e3-939c-b033d121d6c2"
      unitRef="usd">605000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNi0xLTEtMS05OTcwNg_3ccda21a-cab7-419d-989e-85146cfa588e"
      unitRef="usd">5514000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNi0zLTEtMS05OTcwNg_f986ff5d-a5d5-472a-a34d-790223a5575f"
      unitRef="usd">5525000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNy0xLTEtMS05OTcwNg_d115c039-4e3a-4c5e-8260-d368e7209937"
      unitRef="usd">3268000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfNy0zLTEtMS05OTcwNg_2fcfcb2f-1d15-4eb8-9d3d-cb1ffaa853e4"
      unitRef="usd">3273000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfOC0xLTEtMS05OTcwNg_b2763040-12fb-4e34-92b7-5108fb783d74"
      unitRef="usd">2246000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmRiMmRlZjEzMWRkYTQ0YzU5ZGMzMTUyMjJjOGI4MTUxL3RhYmxlcmFuZ2U6ZGIyZGVmMTMxZGRhNDRjNTlkYzMxNTIyMmM4YjgxNTFfOC0zLTEtMS05OTcwNg_6f438ab8-bf3b-4af5-af3a-fa7b5cc1cbb4"
      unitRef="usd">2252000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMTk3NQ_11b0c5b6-47fc-4f73-ab91-010c2931a5bb"
      unitRef="usd">80000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjAwNw_647c22df-a012-4d8e-8bb6-8961d2959fae"
      unitRef="usd">83000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE5OTAyMzI1ODg3Mw_29a846df-0858-4e67-bee4-99aae2f0d917"
      unitRef="usd">156000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE5OTAyMzI1ODg3OQ_00979875-d12e-4866-a63e-c144589fc164"
      unitRef="usd">166000000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE4Nw_02820310-fb61-4406-993b-60a58d00c7b6">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indemnification asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMi0xLTEtMS05OTcwNg_21dec8bc-27c9-42c7-9242-53a327b47ec7"
      unitRef="usd">50000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMi0zLTEtMS05OTcwNg_601761ec-c8d1-4c64-805f-44bc5c8c0743"
      unitRef="usd">55000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMy0xLTEtMS05OTcwNg_0ea18ba0-7618-4942-8e0b-475a23ed4eb9"
      unitRef="usd">400000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfMy0zLTEtMS05OTcwNg_e4b3ae14-2b8b-40d5-ae30-2db2a8051d8c"
      unitRef="usd">435000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssets
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNC0xLTEtMS05OTcwNg_32e4970f-3eca-4ca8-94db-31e042076a91"
      unitRef="usd">252000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNC0zLTEtMS05OTcwNg_1784d612-eda9-4a57-b251-09d6cb16734f"
      unitRef="usd">169000000</us-gaap:DerivativeAssets>
    <us-gaap:Investments
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNS0xLTEtMS05OTcwNg_3df2c74b-0a9c-48bf-a3e2-919ed16982e9"
      unitRef="usd">384000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNS0zLTEtMS05OTcwNg_e2418082-92b3-45b8-8330-d222a51fbbc4"
      unitRef="usd">412000000</us-gaap:Investments>
    <bsx:Licensingarrangementsasset
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNi0xLTEtMS05OTcwNg_14d4133a-9d66-4133-9304-2d4bcbaa7f37"
      unitRef="usd">88000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNi0zLTEtMS05OTcwNg_942ba794-90a7-4a79-ad3b-9a8ff7091b02"
      unitRef="usd">114000000</bsx:Licensingarrangementsasset>
    <bsx:IndemnificationAsset
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0xLTEtMS0xMDg5NjY_e5a51336-6c97-4ea7-b537-581d0119fadd"
      unitRef="usd">163000000</bsx:IndemnificationAsset>
    <bsx:IndemnificationAsset
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0zLTEtMS0xMDg5NjY_ceab2210-60a5-40b9-9dba-696809b88474"
      unitRef="usd">0</bsx:IndemnificationAsset>
    <bsx:OtherOtherLongtermAssets
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0xLTEtMS05OTcwNg_a877a975-41cb-44ba-901a-d26bb92fcefe"
      unitRef="usd">230000000</bsx:OtherOtherLongtermAssets>
    <bsx:OtherOtherLongtermAssets
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfNy0zLTEtMS05OTcwNg_e6e1de79-f9bd-49b1-918e-ba1adfbfe297"
      unitRef="usd">225000000</bsx:OtherOtherLongtermAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfOC0xLTEtMS05OTcwNg_a13f0459-8bad-4699-b04d-faf5f74966ab"
      unitRef="usd">1569000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjBhYWRlZTc1NjYzZDRjY2JiYzUyOTdiZDFjZDMxNzZkL3RhYmxlcmFuZ2U6MGFhZGVlNzU2NjNkNGNjYmJjNTI5N2JkMWNkMzE3NmRfOC0zLTEtMS05OTcwNg_7305cd31-b3e9-43c1-903b-6e0d2a1c2294"
      unitRef="usd">1410000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjIxMA_783c03f5-f14a-4ad9-83f8-5b362f12ed93">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserveCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMi0xLTEtMS05OTcwNg_71cd0a1b-cced-4b6b-991a-2700c57955af"
      unitRef="usd">359000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMi0zLTEtMS05OTcwNg_eee37110-228f-4d34-bd73-ca0629336f9c"
      unitRef="usd">264000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMy0xLTEtMS05OTcwNg_1cbe798a-49ac-47c1-a0e4-3b991ab3bdbe"
      unitRef="usd">754000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfMy0zLTEtMS05OTcwNg_cdf60232-d2e8-4fa1-bb14-f97e9dbf1b9b"
      unitRef="usd">848000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNC0xLTEtMS05OTcwNg_323bde46-ca03-48a0-8ae9-cd2bf0f54a26"
      unitRef="usd">335000000</bsx:AccruedRebatesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNC0zLTEtMS05OTcwNg_68a45ce8-0133-4fa5-9858-a932c830e098"
      unitRef="usd">350000000</bsx:AccruedRebatesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNS0xLTEtMS05OTcwNg_a20e6fa7-abd3-4c08-9c17-49d3c1b73a71"
      unitRef="usd">133000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNS0zLTEtMS05OTcwNg_422f1092-6053-4628-8f01-fcb346107c52"
      unitRef="usd">289000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNi0xLTEtMS05OTcwNg_b377156d-a5fa-495a-91a2-2c2dee341510"
      unitRef="usd">615000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNi0zLTEtMS05OTcwNg_0b33b435-caaf-4a55-9665-ca67f814591c"
      unitRef="usd">686000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNy0xLTEtMS05OTcwNg_5ba3cab2-6552-44cf-b195-c5566fc3de93"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmEyYjU4MzgyZGQ5ZTQyOWY5MWY0OGM3YTIyNzYxNzNjL3RhYmxlcmFuZ2U6YTJiNTgzODJkZDllNDI5ZjkxZjQ4YzdhMjI3NjE3M2NfNy0zLTEtMS05OTcwNg_4b46b5e4-60de-4328-93e3-d731a11b33d3"
      unitRef="usd">2436000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE4Mw_84b53d9d-4970-41ae-be06-e67a108bb2d2">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;784&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMi0xLTEtMS05OTcwNg_ff74d3ec-858b-4d37-ac8d-b802d09eb545"
      unitRef="usd">222000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMi0zLTEtMS05OTcwNg_3099ab37-c354-45fd-8334-3db9db5e1a99"
      unitRef="usd">208000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMy0xLTEtMS05OTcwNg_1ad8c6ce-af67-48db-ba6a-465c06f2acd6"
      unitRef="usd">112000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfMy0zLTEtMS05OTcwNg_88681a59-cee3-4ad1-ac4d-51f9fcc2ff14"
      unitRef="usd">138000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNC0xLTEtMS05OTcwNg_c496df90-c4a9-4ace-b367-e5432d17cdca"
      unitRef="usd">257000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNC0zLTEtMS05OTcwNg_46763595-2e1c-4dba-8eb9-92319d3c97bb"
      unitRef="usd">209000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNi0xLTEtMS05OTcwNg_01422a7c-ff1b-4562-8159-7eef41596002"
      unitRef="usd">193000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNi0zLTEtMS05OTcwNg_7dbd9519-714d-4bde-bcb3-0da54dd33a48"
      unitRef="usd">228000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNy0xLTEtMS05OTcwNg_1d386598-534f-463d-b3a2-b7675b7ef1ac"
      unitRef="usd">784000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOjQ3YTVlMjFjZTI5NDQxZGNhNGE2YzJiZjY2NjgzNTA5L3RhYmxlcmFuZ2U6NDdhNWUyMWNlMjk0NDFkY2E0YTZjMmJmNjY2ODM1MDlfNy0zLTEtMS05OTcwNg_67c04b4d-703f-4cef-a9c7-70ba33f5f12e"
      unitRef="usd">783000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RleHRyZWdpb246ZThiNTUyNzAzODQzNGMxM2FiZDZjZGI3NzdhZDM3MmFfMjE3Nw_a4958157-c64f-4611-aed1-2f20025d85dd">&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of our 2019 acquisition of BTG plc. (BTG), we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom employees. During the second quarter of 2022, we transferred the benefit obligation and associated assets of the pension plan to third party insurers, and as a result, were relieved from primary responsibility of the benefit obligation and the related plan assets. The transaction did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMi0xLTEtMS05OTcwNg_ecfd1bbc-183a-40e4-a4a4-ff2945862877"
      unitRef="usd">550000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMi0zLTEtMS05OTcwNg_b69ce687-c277-4277-89a4-c450ba8297c4"
      unitRef="usd">442000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMy0xLTEtMS05OTcwNg_6dc0b8fe-109e-4346-912b-80adac4d19d1"
      unitRef="usd">155000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfMy0zLTEtMS05OTcwNg_9faf17ca-5049-4854-9348-62eb6c7d06c8"
      unitRef="usd">284000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNC0xLTEtMS05OTcwNg_50197452-4018-48fe-9e59-b9bfb0ed76c1"
      unitRef="usd">86000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNC0zLTEtMS05OTcwNg_57118695-13cb-46af-a227-a58b0442adf3"
      unitRef="usd">197000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <bsx:Licensingarrangementsliability
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNS0xLTEtMS05OTcwNg_6d45a1a6-b7c8-4b6c-b90f-73a329e8125c"
      unitRef="usd">103000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNS0zLTEtMS05OTcwNg_ea27d997-732d-4bdd-a2e9-c3cff762883b"
      unitRef="usd">143000000</bsx:Licensingarrangementsliability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNi0xLTEtMS05OTcwNg_e2843b77-b58c-4072-99ca-aeb4b8806df9"
      unitRef="usd">357000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNi0zLTEtMS05OTcwNg_bcc86349-e135-4f25-9e92-2474cea214dd"
      unitRef="usd">389000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRevenue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNy0xLTEtMS05OTcwNg_c8dd4e80-bec8-4876-ba54-b8e9ddaa30ab"
      unitRef="usd">279000000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfNy0zLTEtMS05OTcwNg_fee0fa18-9689-4263-9c7a-9fa1f01d0c02"
      unitRef="usd">276000000</us-gaap:DeferredRevenue>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOC0xLTEtMS05OTcwNg_6ede37f6-ef8a-48a7-af20-639964034e16"
      unitRef="usd">458000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOC0zLTEtMS05OTcwNg_686ee307-9a82-451a-abde-d24cf462287d"
      unitRef="usd">489000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOS0xLTEtMS05OTcwNg_e788080b-cff2-4ff7-bc07-df18da88250a"
      unitRef="usd">1988000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV83Ni9mcmFnOmU4YjU1MjcwMzg0MzRjMTNhYmQ2Y2RiNzc3YWQzNzJhL3RhYmxlOmNjNGEyZmNlMTI0ZjQ3OWE4ZGM0YzA0YTJlZmVmN2QyL3RhYmxlcmFuZ2U6Y2M0YTJmY2UxMjRmNDc5YThkYzRjMDRhMmVmZWY3ZDJfOS0zLTEtMS05OTcwNg_f246f991-d9fa-4e25-84a6-50b4b30f3a49"
      unitRef="usd">2220000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfMTE5MQ_b13cbc8d-5949-422b-8e0d-82f1d0555738">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE G &#x2013; INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate from continuing operations is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in our reported tax rates for the second quarter and first six months of 2022, as compared to the same periods in 2021, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include acquisition/divestiture-related charges and receipts, charges and receipts on investment portfolio net losses (gains), litigation-related net charges, as well as certain discrete tax items primarily related to changes in tax laws, unrecognized tax benefits, changes in valuation allowance and foreign return-to-provision adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, we had $411 million of gross unrecognized tax benefits, of which a net $333 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2021, we had $255 million of gross unrecognized tax benefits, of which a net $177 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $55 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfMTE5OQ_05865a1f-abd2-424c-bc67-874456ababdb">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi0xLTEtMS05OTcwNg_5d0db1d4-dfe7-4c6c-9d25-37abf39fdb63"
      unitRef="number">0.247</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi0zLTEtMS05OTcwNg_232fb046-849f-428d-b9a8-a97346c75330"
      unitRef="number">-0.249</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi01LTEtMS05OTcwNg_123d7ad6-b3b6-4f98-a1c6-27417af39484"
      unitRef="number">0.261</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RhYmxlOmViYmRlNzQwNTY3MDQ4ZTA5M2E1NjI3MTlkYzY0YTIyL3RhYmxlcmFuZ2U6ZWJiZGU3NDA1NjcwNDhlMDkzYTU2MjcxOWRjNjRhMjJfMi03LTEtMS05OTcwNg_fea894bc-b61a-42b6-895e-27b76707c199"
      unitRef="number">-0.112</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNTYx_92a6dde3-5259-4ac0-aab1-988c3215aa62"
      unitRef="usd">411000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNjE1_d7ff37ad-382a-404b-a2a9-3595dfff5d58"
      unitRef="usd">333000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNjg4_a5de764e-d7b9-4597-934c-1bb17c7c2a9a"
      unitRef="usd">255000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfNzQy_4b86a720-f586-4d92-b805-6a1206cc56f2"
      unitRef="usd">177000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV84NS9mcmFnOjdjNGE2MjhhZDllNDRlMGM4NmUwNDhjNGUxZjE4N2JjL3RleHRyZWdpb246N2M0YTYyOGFkOWU0NGUwYzg2ZTA0OGM0ZTFmMTg3YmNfMTE4OA_2da0d015-16d9-4aff-b1c9-480e38ef3c89"
      unitRef="usd">55000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTIxNTM_741d8961-d109-4ef9-8dfb-be286da52507">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;NOTE H &#x2013; COMMITMENTS AND CONTINGENCIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity. For additional information, refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accrual for legal matters that are probable and estimable was $514 million as of June&#160;30, 2022 and $548 million as of December&#160;31, 2021 and includes certain estimated costs of settlement, damages and defense primarily related to product liability cases or claims related to our transvaginal surgical mesh products. A portion of this accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $132 million as of June&#160;30, 2022 and $188 million as of December&#160;31, 2021. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Supplemental Balance Sheet Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. We recorded litigation-related net charges of $42 million during the second quarter and first six months of 2022, $298 million during the second quarter of 2021 and $302 million during the first six months of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#x2019;s Instinct&#x2122; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against four then-asserted patents, which resulted in the court staying the case until 2020. All IPRs concluded and confirmed the validity of certain claims of each challenged patent. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in February 2023. The Company has also asserted patents against Cook in Germany and the United Kingdom. In January 2022, the D&#xfc;sseldorf Regional Court, Patent Litigation Chamber ruled that Cook&#x2019;s Instinct Endoscopic Clip technology infringes the Company&#x2019;s patent, EP 3 023 061. The D&#xfc;sseldorf Court granted an ex parte preliminary injunction giving the Company the right to enjoin Cook (Cook Medical EUDC GmbH, Germany, Cook &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deutschland GmbH, Germany and Cook Medical Europe Ltd., Ireland) from offering and selling Instinct Endoscopic Clips in Germany.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, in the United States, approximately 55,000 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. Outside the United States, approximately 2,700 cases or claims have been asserted, predominantly in Canada, the United Kingdom, Ireland and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately 53,000 cases and claims in the United States, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 53,000 cases and claims, approximately 52,000 have met the conditions of the settlement and are final. In Canada, we have settled approximately 300 claims. In Australia, the Company has reached a settlement, subject to court approval, that resolves the approximately 2,300 claims asserted in the consolidated class action filed against the Company in the first quarter of 2021. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the company is facing fewer than 90 cases and claims in the United Kingdom and Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#x2019;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In February 2021, the Multi-District Litigation (MDL) established in February 2012 by the United States Federal Courts was closed after all pending cases were dismissed or remanded to courts of primary jurisdiction.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. We continue to engage in discussions with plaintiffs&#x2019; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle, and expect that more cases will go to trial through 2023. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently named a defendant in 127 filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and actively selling in the fourth quarter of 2018. The plaintiffs assert they are entitled to monetary damages related to alleged injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of approximately 325 claims, none of which have been filed. As of June&#160;30, 2022, we have entered into master settlement agreements with certain plaintiffs' counsel to resolve approximately 225 cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Governmental Investigations and Qui Tam Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#x201c;technical note,&#x201d; announced that it was launching a formal administrative proceeding against Boston Scientific&#x2019;s Brazilian subsidiary, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#x2019;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. Subsequently, on March 30, 2022, the Federal Prosecutor&#x2019;s office issued a non-binding recommendation that is contrary to the Attorney General&#x2019;s recommendation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The full Commission is considering both of these recommendations but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam. The Company is cooperating with government agencies while investigating these allegations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Matters Concluded Since December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments were due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents. Labcoat sought monetary damages related to an earn-out provision. On March 25, 2022, the parties agreed to a confidential settlement which resolves the dispute. The settlement did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro Corp. (Nevro) in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro's Senza&#x2122; Spinal Cord Stimulation (SCS) System. The company sought lost profits, a reasonable royalty and a permanent injunction. At a trial held in October and November 2021 regarding six of Boston Scientific's originally asserted patent claims, a jury granted Boston Scientific a monetary award, finding that each asserted claim was valid, that four of the six claims were infringed by Nevro, and that two of the claims were willfully infringed by Nevro. On July 29, 2022, the parties reached a confidential settlement agreement, pursuant to which the Company agreed to make a payment to Nevro of $85 million to resolve all pending litigation between the parties, including this matter and the 18-cv-664 and 21-cv-258 matters described below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation were infringed by Nevro&#x2019;s Senza&#x2122; I and Senza&#x2122; II SCS Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our SCS systems infringed five Nevro patents. Nevro sought lost profits, a reasonable royalty and a permanent injunction. On July 29, 2022, the parties agreed to a confidential settlement, described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2021, Nevro filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#x2019;s spinal cord stimulation systems. Nevro sought lost profits, a reasonable royalty and a permanent injunction. On July 29, 2022, the parties agreed to a confidential settlement, described above.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTIxNjM_5ed0ce8d-4394-4f90-81ea-0de328137c8f">FASB ASC Topic 450, &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.&lt;/span&gt;Our accrual for legal matters that are probable and estimable was</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjU0NQ_c8588df4-3425-4929-8f1a-00fe08402442"
      unitRef="usd">514000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjU2MQ_29e246e5-3c04-42f9-a003-45d29d1f917e"
      unitRef="usd">548000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjkzNw_50faef4d-b4c7-4fe1-a463-dde0cd43820c"
      unitRef="usd">132000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjk1Mw_a6d674b5-0576-4095-8542-d50689a22785"
      unitRef="usd">188000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LitigationSettlementExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjE5OTAyMzI2Nzg0Mg_2908a82e-3a0d-47cd-849f-4d8e64233bdd"
      unitRef="usd">42000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMzA4OQ_5c2e2723-5cef-42c5-be76-d157f8c204fd"
      unitRef="usd">298000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMjE5OTAyMzI4MzMxNA_59970653-dfc6-47d7-ae00-772cc3e0fc82"
      unitRef="usd">302000000</us-gaap:LitigationSettlementExpense>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfNjkxOA_72b95e24-4b92-4160-9f92-208f2a9cd11f"
      unitRef="claims">55000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfNzE0Ng_c318fc2d-02ec-46fd-874d-56839831f2d6"
      unitRef="claims">2700</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i0e48a7919ffd4f7981e1a7533395f383_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfNzc1OQ_445d296d-1fb3-4bb7-b1f0-ec072e661512"
      unitRef="claims">53000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i0e48a7919ffd4f7981e1a7533395f383_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODE0OA_445d296d-1fb3-4bb7-b1f0-ec072e661512"
      unitRef="claims">53000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct
      contextRef="i0e48a7919ffd4f7981e1a7533395f383_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODE4Mw_7e4d344b-5094-4b76-a31c-15404afbee0b"
      unitRef="claims">52000</bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct>
    <bsx:CanadaSettledClaims
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODI4NA_f3ccd4cb-8c0b-4e53-b00e-8ff8d18f135c"
      unitRef="claims">300</bsx:CanadaSettledClaims>
    <bsx:CertifiedClassActionsInAustraliaMesh
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODQwNg_2f3a93b5-c61e-46d4-8193-032539ca2be3"
      unitRef="units">2300</bsx:CertifiedClassActionsInAustraliaMesh>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfODY5Mg_e55d4dff-39bc-42c5-b037-6c1e44b1a83e"
      unitRef="claims">90</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom>
    <bsx:ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTA3NzU_9f1b6e42-ff90-4af5-b578-663e9ea38352"
      unitRef="claims">127</bsx:ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter>
    <bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTEyNjQ_884a2969-d2ae-479f-9947-db32c81a281a"
      unitRef="claims">325</bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter>
    <bsx:CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTE0NzY_14126a2a-f43f-4231-b160-3b7657f07fe8"
      unitRef="units">225</bsx:CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if145ba28e56b4a3e8ebaaade117334db_D20220805-20220805"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85MS9mcmFnOmQwY2MxODJkMmI4MTRiYWZiNzBlYmU2NmE4ZmI0ZmExL3RleHRyZWdpb246ZDBjYzE4MmQyYjgxNGJhZmI3MGViZTY2YThmYjRmYTFfMTI2NDQzODM3NDc3Mjc_de2136ba-f83c-4277-bd19-a3e7fcb588f3"
      unitRef="usd">85000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfMTcwMg_853c94c4-350f-433e-ad6f-1e1693e691e9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE I &#x2013; STOCKHOLDERS' EQUITY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of June&#160;30, 2022, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2022, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared, and we paid, a cash dividend of $1.375 per MCPS share to holders of our MCPS as of May 15, 2022, representing a dividend period from March 2022 through May 2022. On July 25, 2022 the Committee declared a cash dividend of $1.375 per MCPS share to holders of our MCPS as of August 15, 2022, representing a dividend period from June through August 2022. We have presented cumulative, unpaid dividends within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheet as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNTI_fd84e8da-aa5e-44e7-b775-2c5199c323f3"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i762a71d1a5314a20b775461852e10332_I20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNDY4_b28a7dbb-c3c0-4d52-b277-362cf2ff9769"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i3470063d13da4b78885156191cea35c6_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNDgx_1c8f6e2e-2c2b-4c42-bcd8-6cdd4fecc943"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i762a71d1a5314a20b775461852e10332_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNTky_dcffd0ec-c6c9-4d9a-b973-57b12daf80da"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i6b6b779abd6047358a4ff3e1753f9f78_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfNjYz_b7e2354e-310f-46d9-a773-958adc0a9e31"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="ia45237c280a543b788d2d06d99616c10_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfODA0_a54fed95-edaa-43b8-86b0-94460f5a39a0"
      unitRef="usd">1006000000.000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="i5bacdd63be81431e93233ee3874cc618_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfMTAxNg_532b70c8-d4cc-4cc2-9c34-fa60fd7a8010"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PreferredStockDividendsPerShareDeclared
      contextRef="i4b8a09505de24098ace745ffd92c8c9b_D20220725-20220725"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV85Ny9mcmFnOjM0Mzk3NmZlOTVkZTQyYjg5YTBlNDUyOWI5MWMxZTk4L3RleHRyZWdpb246MzQzOTc2ZmU5NWRlNDJiODlhMGU0NTI5YjkxYzFlOThfMTIxMw_9d892080-bdac-4411-b71f-94941814d7c5"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareDeclared>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE5OTY_ad047533-b2aa-464b-9253-8647e0d78180">&lt;div style="margin-top:20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE J &#x2013; WEIGHTED AVERAGE SHARES OUTSTANDING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,437.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,432.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,438.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,431.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss)&#160;per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the second quarter and first six months of 2022 and 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was reduced by cumulative &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Preferred stock dividends&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as presented within our accompanying unaudited consolidated statements of operations, for purposes of calculating &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income available to common stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issued less than one million shares of our common stock in the second quarter of 2022, approximately four million shares in the first six months of 2022, approximately one million shares in the second quarter of 2021, and approximately five million shares in the first six months of 2021, following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first six months of 2022 or 2021. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of June&#160;30, 2022, we had the full amount remaining available under the authorization.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE5OTM_32f5b7b7-f34b-439e-b453-004c80446c2d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,437.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,432.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,438.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,431.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItMS0xLTEtOTk3MDY_a6ad48f8-d6f1-4a1b-ad36-69918414db24"
      unitRef="shares">1429700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItMy0xLTEtOTk3MDY_5cf196fb-19dc-40e9-8cc2-ac1d47c790c1"
      unitRef="shares">1421300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItNS0xLTEtOTk3MDY_dcc848d2-e7d7-4b75-82a8-d28fdaefea27"
      unitRef="shares">1428800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzItNy0xLTEtOTk3MDY_4e5af27f-3b69-4f7a-9410-cebfe6a09cc1"
      unitRef="shares">1420000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtMS0xLTEtOTk3MDY_4ea9cb73-2edf-4298-b8a3-4bfafb550177"
      unitRef="shares">8100000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtMy0xLTEtOTk3MDY_e15e94ea-1467-4072-a5a5-2827015792b5"
      unitRef="shares">11200000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtNS0xLTEtOTk3MDY_7b0d1bb9-9252-4ecd-ac32-a21793c17d42"
      unitRef="shares">9300000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzMtNy0xLTEtOTk3MDY_04451443-8e3d-4a9a-a5f7-18f6fc96b851"
      unitRef="shares">11700000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtMS0xLTEtOTk3MDY_9dde85db-439d-47b6-8186-ed898e8ccd40"
      unitRef="shares">1437800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtMy0xLTEtOTk3MDY_01284266-9ec6-4eb4-803b-fd9d6dacc564"
      unitRef="shares">1432500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtNS0xLTEtOTk3MDY_e36fcda7-379a-4ffc-80e0-b77786217625"
      unitRef="shares">1438100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo2ODI4ZTJmZjY1OGY0YjRhYWM3ZTkxM2VmODYxNGJiNC90YWJsZXJhbmdlOjY4MjhlMmZmNjU4ZjRiNGFhYzdlOTEzZWY4NjE0YmI0XzQtNy0xLTEtOTk3MDY_4286218b-0099-4ea1-ba30-5fd11ea6b6ec"
      unitRef="shares">1431700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE5ODg_29377cfd-6694-4988-bfaa-9148e260f84c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i07e0936bffa54f1fa93786399e12f047_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItMS0xLTEtOTk3MDY_62b3d332-5fea-460b-823e-8189eefe64a5"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i48f9725f39b04b94a04843a31af9469d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItMy0xLTEtOTk3MDY_8f44da49-38bb-4a12-800d-d96bd3bfcddf"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if7da2c1103ea4f908aac0cd8da683037_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItNS0xLTEtOTk3MDY_f5fd72af-a99f-4774-a47f-580b896b7457"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie962472004ed49bb91bf3bb5bc90460e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzItNy0xLTEtOTk3MDY_552616cb-30b0-406f-846d-f55fbd6e09e2"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie3ea4cb7460f44638f76c93ae1fe62a6_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtMS0xLTEtOTk3MDY_9c56bb08-cfed-4f4e-bc4f-992fc4b7cba1"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i48c6b2ef29f5412b953d8ca8ea8e10f2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtMy0xLTEtOTk3MDY_ff52a448-f10e-45de-b076-124ff4d49fdf"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib6276dfcd8f548909ad2b95aec63305f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtNS0xLTEtOTk3MDY_81aa0e54-9834-49b5-bd5d-07bd318a84fb"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5f6c85fe355c406693e3fc90a6900617_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90YWJsZTo3NmExYjljNTM5YzY0ZTkzYWFkM2QyOTdjYjY5Y2JhZi90YWJsZXJhbmdlOjc2YTFiOWM1MzljNjRlOTNhYWQzZDI5N2NiNjljYmFmXzMtNy0xLTEtOTk3MDY_cc0c7012-b851-4362-9628-df6cdbea72c6"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzIxOTkwMjMyNTg2Mjg_51b8ba55-fc44-4ede-a258-6f895a442d63"
      unitRef="shares">1000000000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzEwOTk1MTE2MzAxNDY_e335033c-61df-4bc2-9088-dcedbee2d838"
      unitRef="shares">4000000000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzEwOTk1MTE2MzA1MzY_b0a9b292-e094-497e-a9df-28a375c73e3a"
      unitRef="shares">1000000000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzEwOTk1MTE2MzA1ODQ_398f1c34-090c-49e1-ab53-b58b2a9eae9b"
      unitRef="shares">5000000000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="icf7fdde677424e58ac261d8de70f896f_I20201214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDAvZnJhZzo2ODQzMTkxMzM2OWI0MTNhYjM4YjAxMzAyZGJmYTg5MC90ZXh0cmVnaW9uOjY4NDMxOTEzMzY5YjQxM2FiMzhiMDEzMDJkYmZhODkwXzE4ODM_d26a71e5-009b-4a0a-b73d-2ca0f61955c1"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90ZXh0cmVnaW9uOjMzZTY0ZjhkZTY2ZDRhZjQ5YTRjOGM3NjNkMTc5MjA0XzE4NzM_3215095a-f5c1-4907-8d22-4cd15330ab1a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE K &#x2013; SEGMENT REPORTING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. There was no impact to the reporting units identified for purposes of our annual goodwill impairment testing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure and evaluate our reportable segments based on their respective net sales, operating income, excluding intersegment profits, and operating income as a percentage of net sales, all excluding the impact of foreign currency. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations and are included in the reconciliation below. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for net sales by reportable segment presented in accordance with U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages). We have revised prior periods to conform to the current year presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,233&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;474&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Prior to the divestiture, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income margin of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90ZXh0cmVnaW9uOjMzZTY0ZjhkZTY2ZDRhZjQ5YTRjOGM3NjNkMTc5MjA0XzI3OA_981bdca8-b775-4672-9b72-735470fa455a"
      unitRef="reportablesegments">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90ZXh0cmVnaW9uOjMzZTY0ZjhkZTY2ZDRhZjQ5YTRjOGM3NjNkMTc5MjA0XzE4NzE_57835c39-0bab-4a63-af4b-771e71a45fef">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages). We have revised prior periods to conform to the current year presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,233&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;474&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Prior to the divestiture, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income margin of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtMS0xLTEtOTk3MDY_852ca4bc-2930-4734-b0a9-89e375ce652c"
      unitRef="usd">1278000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtMy0xLTEtOTk3MDY_5d705bd1-dff0-4150-8046-609f2b81bec4"
      unitRef="usd">1185000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtNS0xLTEtOTk3MDY_eda7d4ad-e577-48f8-ad0f-65176f6774b2"
      unitRef="usd">2442000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzUtNy0xLTEtOTk3MDY_afdbbc18-8c6a-4cb4-ad78-eb2924997360"
      unitRef="usd">2233000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktMS0xLTEtOTk3MDY_af54c506-fbec-4b1e-ac06-f16c523b94c2"
      unitRef="usd">2066000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktMy0xLTEtOTk3MDY_f130b32d-656c-4f36-803b-b44a72309c7b"
      unitRef="usd">1865000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktNS0xLTEtOTk3MDY_9608e7e5-9311-499b-b504-848212c67af4"
      unitRef="usd">3967000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzktNy0xLTEtOTk3MDY_4a628de0-ad81-4c93-98fb-5d4f3a04fb65"
      unitRef="usd">3526000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="iaed936efbefb4d6883a1c81638adf58d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTEtMS0xLTk5NzA2_f5735ffc-ac77-4eb6-a7cb-459221cf8c43"
      unitRef="usd">3344000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i7b181944f869422eaf28616562fd7a82_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTMtMS0xLTk5NzA2_36a45c8f-842d-44d6-b035-4c98d7362f07"
      unitRef="usd">3050000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i35b65bf8163846418605a1c7c4224987_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTUtMS0xLTk5NzA2_b82349de-44dc-476f-b6f2-6180e6428f17"
      unitRef="usd">6410000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="ibe6a468432bf4452ae37008655365bb9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEwLTctMS0xLTk5NzA2_b47bfb98-1b90-4651-b87b-99d5d0769c3f"
      unitRef="usd">5758000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i525a2094c6934a6485d6adda3f6a9b3a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTEtMS0xLTk5NzA2_54d93221-dfee-4a5e-9eae-551991c33b66"
      unitRef="usd">0</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i7cfee3824c314f15a3cc0a778059755c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTMtMS0xLTk5NzA2_168ac8f7-f44a-47b9-bf79-d55aab95c8dd"
      unitRef="usd">0</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i029f075c73314285a73d6046fc56ace1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTUtMS0xLTk5NzA2_eb7192ac-825f-483c-b2ad-23a47a51b3a0"
      unitRef="usd">0</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="ic71339696da74c3c8be300118987e2a8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzExLTctMS0xLTk5NzA2_23837b06-3a32-4e05-89ee-20f4a3b1aa35"
      unitRef="usd">13000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTEtMS0xLTk5NzA2_9904c4cb-1aa6-4d34-bf83-a65f30633912"
      unitRef="usd">-100000000</bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales>
    <bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTMtMS0xLTk5NzA2_db5f5f33-58af-4509-beaf-9af4b3ce2e77"
      unitRef="usd">27000000</bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales>
    <bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTUtMS0xLTk5NzA2_12ef8b9d-2e92-479d-9c05-d18cfc47d871"
      unitRef="usd">-140000000</bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales>
    <bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzEzLTctMS0xLTk5NzA2_466a6b92-2f13-44c6-a41a-ffd184a8939f"
      unitRef="usd">58000000</bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTEtMS0xLTk5NzA2_ce9c8899-ef4a-4d6b-b547-b59dbecfb039"
      unitRef="usd">3244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTMtMS0xLTk5NzA2_d5cc3f5b-3917-41f8-bdcb-e9384651b15e"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTUtMS0xLTk5NzA2_cad737e2-f5d0-4ccb-84b3-2cc133b53d95"
      unitRef="usd">6270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZTpmYWViNDI4MGRmMTk0NWZkODJiN2E4MjQ5OWRlNTEyMS90YWJsZXJhbmdlOmZhZWI0MjgwZGYxOTQ1ZmQ4MmI3YTgyNDk5ZGU1MTIxXzE0LTctMS0xLTk5NzA2_ee16ceff-90f4-4631-89aa-cb58ef6307c8"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItMS0xLTEtOTk3MDY_3c65e80a-8904-405c-b8c4-9dc33b6f6429"
      unitRef="usd">398000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItMy0xLTEtOTk3MDY_3fdb1315-2304-4848-85a2-0f58c6f06df4"
      unitRef="usd">403000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItNS0xLTEtOTk3MDY_c30eaf3a-b102-43b4-81ee-40286335a8a4"
      unitRef="usd">769000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzItNy0xLTEtOTk3MDY_e15f2c2e-47e8-44a6-9bf8-da247648a835"
      unitRef="usd">748000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtMS0xLTEtOTk3MDY_fa61d55c-8c5e-46cc-a695-d56052aa01a0"
      unitRef="usd">543000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtMy0xLTEtOTk3MDY_4f23d573-694f-4416-b150-7294f698184d"
      unitRef="usd">529000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtNS0xLTEtOTk3MDY_4e70298c-4c32-4e83-8db3-a832ac7b5df7"
      unitRef="usd">1020000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzMtNy0xLTEtOTk3MDY_dcb0d83e-96f8-443a-be11-239935f95504"
      unitRef="usd">989000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="i51540ac012634339a60c076ab917ca1b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtMS0xLTEtOTk3MDY_1655f509-a3be-4ded-9035-2754a15517fc"
      unitRef="usd">941000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i06aeb53ebd2a4b1e99e14da58b780ce5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtMy0xLTEtOTk3MDY_e0d59f23-0a90-425a-80c2-143984d5c239"
      unitRef="usd">932000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4ff0c73d214b4802aa383f6e6d6fb43a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtNS0xLTEtOTk3MDY_ea01c355-7758-4df8-8122-bf0a90d7f5ad"
      unitRef="usd">1789000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i01387391808f459ca10145d370775508_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzQtNy0xLTEtOTk3MDY_334ecb21-ab66-4c73-ab03-43fa3e59e064"
      unitRef="usd">1736000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0a26c50603134586aeac79e838ea999a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtMS0xLTEtOTk3MDY_b8862eeb-c69b-4352-85d9-697b1b4dc050"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibbab2482ba9049fa8035d7fda68e3e46_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtMy0xLTEtOTk3MDY_6a9125e9-4d10-49b3-9958-9be775d70886"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6ff4cf4706044822b1d8fdff41caeeef_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtNS0xLTEtOTk3MDY_796e761f-3c5f-47bd-9eab-3c55e814add7"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifab3d8ec398548efb4eb940722d1321b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzUtNy0xLTEtOTk3MDY_d3410dff-9f2e-48fd-8eec-ce294564d351"
      unitRef="usd">4000000</us-gaap:OperatingIncomeLoss>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i24181bede48642979bf2659f8d3aca26_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctMS0xLTEtOTk3MDY_445fcd54-d598-4318-8c98-ea93524e343c"
      unitRef="usd">123000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i097b7bc5ad3e49d090a6fd4a3a2eac38_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctMy0xLTEtOTk3MDY_1b7fda40-f988-4602-8566-d2b878f45b4c"
      unitRef="usd">159000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i99a609ec70434875bcd818a22223603c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctNS0xLTEtOTk3MDY_349baa08-b6e6-4424-b70e-b43342c32aba"
      unitRef="usd">189000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="iad37ab5761724dd0bbe10d6aae7e351f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzctNy0xLTEtOTk3MDY_2eb1c6da-cc4a-4ea7-8943-403a6288a879"
      unitRef="usd">298000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i2acd2e07b1e341d4826054cff9f227ae_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtMS0xLTEtOTk3MDY_e7f209e8-7bf7-48c7-8c46-1bab01995124"
      unitRef="usd">192000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ib74ccd408f0b4969918ea713b800279e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtMy0xLTEtOTk3MDY_170807d9-9702-455f-9177-e71af716bdb0"
      unitRef="usd">331000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ib08dfea82b704fd2833f1be5b210aca1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtNS0xLTEtOTk3MDY_6447706a-053f-485d-8e1b-a0cee877244e"
      unitRef="usd">308000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i62067935217749dda69756e659e18d90_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzgtNy0xLTEtOTk3MDY_ff114074-8aa2-40cb-835f-2c059774e3ec"
      unitRef="usd">445000000</bsx:OperatingIncomeUnallocatedToSegment>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktMS0xLTEtOTk3MDY_20adc693-cc40-4fd4-8bd8-ad7e3111ffca"
      unitRef="usd">204000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktMy0xLTEtOTk3MDY_f9ed7cb4-76cb-492c-82df-e9df3198cea2"
      unitRef="usd">180000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktNS0xLTEtOTk3MDY_082d5c01-01fd-401c-bb24-91b6ac170c31"
      unitRef="usd">402000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzktNy0xLTEtOTk3MDY_b010d41a-a5e9-4ed9-ae8c-ee20cf265ddf"
      unitRef="usd">365000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTEtMS0xLTk5NzA2_21db0166-a8bb-4b7b-98e9-7ee6c110dde4"
      unitRef="usd">423000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTMtMS0xLTk5NzA2_4d103d36-351a-447c-954e-555f681d9177"
      unitRef="usd">262000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTUtMS0xLTk5NzA2_04e0d3c6-aedf-4fd5-9b42-d3d5abe33206"
      unitRef="usd">889000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEwLTctMS0xLTk5NzA2_2aa03a86-2644-4d33-963f-d992fc2925a5"
      unitRef="usd">632000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTEtMS0xLTk5NzA2_e425340d-3819-42bb-b497-341af0793e82"
      unitRef="usd">-78000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTMtMS0xLTk5NzA2_738250e9-7a6f-4210-8d9a-7fe1688a1120"
      unitRef="usd">-113000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTUtMS0xLTk5NzA2_efb9619a-23ef-4fdc-a1e7-d85cf46c5532"
      unitRef="usd">-388000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzExLTctMS0xLTk5NzA2_8f59bf07-35d7-45cf-b15a-71d3f3e6bef3"
      unitRef="usd">-157000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTEtMS0xLTk5NzA2_144dbcaf-b990-482d-8743-b4c1397bf382"
      unitRef="usd">345000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTMtMS0xLTk5NzA2_5ffd20ef-2a5b-4b39-b8fa-62d4be57b852"
      unitRef="usd">149000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTUtMS0xLTEwMTQzNQ_fca182b6-5f21-4051-9f98-084403303615"
      unitRef="usd">501000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToxNDI0YjUyZTVmYzY0NDdlYmIzNTlkMzljNTc5NTZlZC90YWJsZXJhbmdlOjE0MjRiNTJlNWZjNjQ0N2ViYjM1OWQzOWM1Nzk1NmVkXzEyLTctMS0xLTEwMTQzNQ_14b9b43c-7323-4fce-b686-3d3f8b5e4b3c"
      unitRef="usd">474000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItMS0xLTEtOTk3MDY_348a8a87-53e2-40cb-be0a-b515236ee973"
      unitRef="number">0.312</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItMy0xLTEtOTk3MDY_58c37614-19c5-4ed7-ac2d-0237f067b5f3"
      unitRef="number">0.340</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItNS0xLTEtMTAxNTMy_9adceee8-86d6-4c9c-808d-df9ff8131570"
      unitRef="number">0.315</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzItNy0xLTEtMTAxNTMy_28b942c9-6d76-4b14-a487-32d8808906cb"
      unitRef="number">0.335</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtMS0xLTEtOTk3MDY_8823ed3a-7e0b-42ba-a75a-b552eb667dfd"
      unitRef="number">0.263</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtMy0xLTEtOTk3MDY_9679077f-d43f-4b38-a0c8-532948c2d089"
      unitRef="number">0.284</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtNS0xLTEtMTAxNTMy_5b21a91f-ff2a-4234-8187-6afdfb0be12a"
      unitRef="number">0.257</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMDYvZnJhZzozM2U2NGY4ZGU2NmQ0YWY0OWE0YzhjNzYzZDE3OTIwNC90YWJsZToyNDRhMWM3ZDNmYmY0ZTZiYjcyMmRkZTdjMWNkMTBmYS90YWJsZXJhbmdlOjI0NGExYzdkM2ZiZjRlNmJiNzIyZGRlN2MxY2QxMGZhXzMtNy0xLTEtMTAxNTMy_2c26b29a-dfd9-4f49-8899-6a18d090dce1"
      unitRef="number">0.280</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzI2MTc_ee14508f-bca7-4f89-8b47-ab5df9aef459">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE L &#x2013; REVENUE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes within our accompanying unaudited consolidated statements of operations. In the first quarter of 2022, we reorganized our business structure into five operating segments and on March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction. The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We have revised prior periods to conform to current year presentation:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;844&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;404&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interventional Cardiology Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Watchman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,089&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;906&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;877&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,933&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,277&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,602&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;799&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,402&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;769&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Interventional Cardiology Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Watchman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,868&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,893&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,670&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,564&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,559&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Note K- Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for information on our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;817&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, which currently includes the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $501 million as of June&#160;30, 2022 and $484 million as of December&#160;31, 2021. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#x2122; Patient Management System within our Cardiology business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our Cardiology business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $35 million in the second quarter and $76 million in the first six months of 2022 that was included in the above contract liability balance as of December&#160;31, 2021. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information on variable consideration, refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.&lt;/span&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <bsx:NumberOfBusinesses
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzIwOQ_28c1fdae-0588-4711-89fe-00940d9d6e20"
      unitRef="business">5</bsx:NumberOfBusinesses>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzI2MTM_d4efd308-88b6-41ea-8559-13be89994059">The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We have revised prior periods to conform to current year presentation:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;844&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;404&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interventional Cardiology Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Watchman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,089&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;906&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;877&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,933&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,277&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,602&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;799&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,402&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;769&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Interventional Cardiology Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Watchman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,868&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,893&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,670&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,564&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,559&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Note K- Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for information on our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;817&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, which currently includes the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9aaa5a5ca5f4e1f9301c01ec21b59e4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtMS0xLTEtOTk3MDY_6a56db24-32b9-43cd-83e9-aa279b600b27"
      unitRef="usd">338000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife3a11266e3d4321956fbc6d063b8a10_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtMy0xLTEtOTk3MDY_d6cf63f3-816b-4313-8d3d-272afd51824c"
      unitRef="usd">221000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1bf87505d2e4df7a780b78429497619_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtNS0xLTEtOTk3MDY_3f6c6b73-cbd6-484f-93ca-84572adff279"
      unitRef="usd">560000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie096244a71f845ca9eb0386aa8bcb3df_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtNy0xLTEtOTk3MDY_b3ba71d4-0f0e-474a-b71a-5b08a79436f1"
      unitRef="usd">316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b76bd80819b4615aeb5e962c486399a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtOS0xLTEtOTk3MDY_bd19fd15-7d6d-4772-9a98-72ed39cc181b"
      unitRef="usd">235000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ad59d435c194a23bb052a2504b3a319_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzMtMTEtMS0xLTk5NzA2_b3630799-2e78-45af-9b99-8718c8343cce"
      unitRef="usd">551000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i415f872bf2c24ddfb98d985defe44440_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtMS0xLTEtOTk3MDY_0128ee9c-b5b7-4883-9317-f550c9d1c46f"
      unitRef="usd">320000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56bd4269832542bbba47c90663ce137a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtMy0xLTEtOTk3MDY_36fbb44c-03b7-491f-9bb1-e1000e41fdfb"
      unitRef="usd">130000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47af1619791b4510b83d7d9ec10d1f42_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtNS0xLTEtOTk3MDY_fffc2274-11f1-4b6a-b744-cc948f5e25df"
      unitRef="usd">450000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11f711ef34d649a2b44fa21f66871d34_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtNy0xLTEtOTk3MDY_bbcc940d-a4ef-4e84-823a-2df0bf5e7802"
      unitRef="usd">285000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie14c2530827644ac893d5a38b3b01e88_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtOS0xLTEtOTk3MDY_a9ae0e66-c6b5-4d39-b467-9640261b5793"
      unitRef="usd">112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9768fb32a294fe1a98e46c54fb002fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzQtMTEtMS0xLTk5NzA2_7d0cfdfa-b7fd-427f-8740-6adb7f31eae2"
      unitRef="usd">397000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cd92fc770d74050ae6bc234223e19d9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtMS0xLTEtOTk3MDY_b26aab10-8b28-43e9-88d1-7aaf46758bc0"
      unitRef="usd">186000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie89fa19fb7d0473489935cee03e984eb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtMy0xLTEtOTk3MDY_f9f5818b-f3bd-4bf3-96ab-44bb400e887b"
      unitRef="usd">53000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67775ec6a0934c30bf8aad1e7f6a0b6e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtNS0xLTEtOTk3MDY_76edc111-4165-4d9b-bcfe-7e435a3d8908"
      unitRef="usd">239000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd09fe7de65f43ac93174dff385f04f6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtNy0xLTEtOTk3MDY_44ce2e5d-b3e7-4504-85cc-36ddf5449b70"
      unitRef="usd">194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bb15f66e0dd4ad0898c5b50246fc5c7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtOS0xLTEtOTk3MDY_af72aeb6-d08f-42d4-be97-d9acc328134d"
      unitRef="usd">53000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc56c808748d4532afd8021abe0fbcba_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzUtMTEtMS0xLTk5NzA2_709f3970-332a-449a-827a-dae150fbe629"
      unitRef="usd">247000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c8f3f10502c4f71ba2b31433a377b1e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtMS0xLTEtOTk3MDY_c6b59b94-3788-4a26-8a13-172a640ea2df"
      unitRef="usd">844000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36124ada3c8c43858ecb9286e86c2606_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtMy0xLTEtOTk3MDY_a24fab8e-fb1f-441e-8339-39db7ebfd325"
      unitRef="usd">404000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb3f873e631440948432841109248bb6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtNS0xLTEtOTk3MDY_df10db0f-ef07-438a-9982-1b334d6def6b"
      unitRef="usd">1248000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fcfa3282cb148bbb748113d9528f7d4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtNy0xLTEtOTk3MDY_db7b590c-eabc-4340-8be3-84d683eb2fdd"
      unitRef="usd">794000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i761eb0a00d5444d5bf6bd2da5be27e90_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtOS0xLTEtOTk3MDY_6c6d5d82-6c46-4838-9c1a-c562af03c63c"
      unitRef="usd">400000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdb49aa706f1405abfb446540f80eb2c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzYtMTEtMS0xLTk5NzA2_1018c68b-69e4-425d-a150-439e936ef7ff"
      unitRef="usd">1195000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7433a0c7505464f961708a119d005b0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctMS0xLTEtOTk3MDY_ddc6e296-7318-4afd-89eb-e364ab547d92"
      unitRef="usd">192000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cdfe346e87b4744ae0e10651fe6a828_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctMy0xLTEtOTk3MDY_66e5744f-70b9-43b1-a1bf-97c2ff72c4df"
      unitRef="usd">382000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabb00784efe74f8eba9e037108ad5aed_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctNS0xLTEtOTk3MDY_a5a647c9-b9d4-4d0b-8148-bd339ff94291"
      unitRef="usd">574000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2165365374154b58bb3c0a37d075e600_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctNy0xLTEtOTk3MDY_e5296d59-38ea-47c8-b79c-b15a1f775de5"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9984e82eade4f2da3d2886469fb33b5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctOS0xLTEtOTk3MDY_54ab7928-7843-481c-bec3-8293d5af1f1c"
      unitRef="usd">369000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81be0345e72e40c38e9b1ec204739080_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzctMTEtMS0xLTk5NzA2_6b7fe090-80b4-4a0c-aa03-9e3195829331"
      unitRef="usd">574000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifddfedd7174745d6aa132760e4e7d5f7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtMS0xLTEtOTk3MDY_e99565c2-f4ae-4a54-9976-74fa93e02b72"
      unitRef="usd">225000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99797b8a0ac14a2683275123479db9e2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtMy0xLTEtOTk3MDY_81ffaba7-4567-43c3-adf2-d15a57bf673b"
      unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if17b5b0c3eef43dbb88f6d84614f82fc_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtNS0xLTEtOTk3MDY_7b7777c3-0a5f-4ea8-87c2-180279f4603c"
      unitRef="usd">250000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66ff310abb0c46ea842c1b5f2e101e06_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtNy0xLTEtOTk3MDY_3620117f-2e20-4412-bc9b-f120769260af"
      unitRef="usd">192000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec55fa860e274f43bd665e1c527396ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtOS0xLTEtOTk3MDY_818f7732-f83a-4f87-aa77-bc981312392a"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97f0fc8326c54d22b47c92fcf1404dac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzgtMTEtMS0xLTk5NzA2_ed10f03d-51a9-4e6d-bc67-4907c2cdebcb"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bcbe244161b44d08e2fb019d7190d8f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktMS0xLTEtOTk3MDY_c9cb7807-f43b-414d-b931-570243107e4e"
      unitRef="usd">342000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77e17753aeed403cb6eb068b78c4172e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktMy0xLTEtOTk3MDY_030c4baf-89ed-4842-8670-6f1130de226e"
      unitRef="usd">199000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i162fa62a834d4024853d19c92f7d6803_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktNS0xLTEtOTk3MDY_2de9059a-fb68-4126-9314-2068c9742d95"
      unitRef="usd">541000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibefe540c865646ed9b0550380e6694dd_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktNy0xLTEtOTk3MDY_c1eda30b-f97a-4d53-a1f1-d246cf1b35c4"
      unitRef="usd">314000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c88d81fbc054204b7dcb69d35b1ef8b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktOS0xLTEtOTk3MDY_b69cdaff-57bf-4672-b7e9-78056bcdca89"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id67f6d5f8c204080bdcf3a8e11fae3eb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzktMTEtMS0xLTk5NzA2_a20029de-18f5-409b-a725-3b08d7beef25"
      unitRef="usd">524000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee0862174ab84b5880a7a5c5cf80931d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTEtMS0xLTk5NzA2_8fe6feb0-c08b-4cdd-9ffb-797a98eda551"
      unitRef="usd">73000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1d0fb3e4bf949b28e24977c79ce55f1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTMtMS0xLTk5NzA2_cf88eec0-9e1e-4d9f-87f2-09165cd87296"
      unitRef="usd">79000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib647bd82c32d48dcab841641a70e3f4e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTUtMS0xLTk5NzA2_af371bc9-7991-4d9d-93b5-c4280e4d311d"
      unitRef="usd">152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0d47bcaff1842cb93b282563df9bd3d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTctMS0xLTk5NzA2_1325efbb-6670-42e7-b962-9e184837d4fa"
      unitRef="usd">34000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f4d52a894b84bd585ff1aaee9ca68ed_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTktMS0xLTk5NzA2_6cb16e49-fee8-4af1-8af1-9df7db1539ad"
      unitRef="usd">62000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i717d79b707704b4a980799d216fbe641_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEwLTExLTEtMS05OTcwNg_34ffb493-0a12-4cb4-a3f5-8ee8f50338c2"
      unitRef="usd">95000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4179fffe78ef47a98f15ff8bc5762603_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTEtMS0xLTk5NzA2_9af0ed03-e18e-41ce-8259-773fe3f0c9d9"
      unitRef="usd">832000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0850efa38229479ea51013e0c6bd5ea4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTMtMS0xLTk5NzA2_7083dca1-a321-45d1-a9cc-77d39203c4ea"
      unitRef="usd">685000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82bb612d582148409a856cd8d6ce1da9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTUtMS0xLTk5NzA2_06bc1ca7-e964-4a94-98f3-634ec76d49bc"
      unitRef="usd">1517000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68f1e5b68bbf468ba366d5f07ad381b3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTctMS0xLTk5NzA2_12531966-b01b-4d6c-ad98-9b3658dc233b"
      unitRef="usd">746000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a332d62f2234fb896c3d81a7d7067ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTktMS0xLTk5NzA2_9326db45-c216-47da-bf45-aff37f8f931a"
      unitRef="usd">664000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59461725015b4ab0a58f6b01f477955e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzExLTExLTEtMS05OTcwNg_eeae9d57-7b59-4094-a3a4-b9c3762451f1"
      unitRef="usd">1410000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i042f5fcfd216400fb83d5b60c989ea25_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTEtMS0xLTk5NzA2_890b2085-facb-4406-bfff-1375c1a5760c"
      unitRef="usd">257000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e9c75133f8543928b4807ac698a3f26_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTMtMS0xLTk5NzA2_aad3c2d8-86d6-45dc-877a-28ec4a174694"
      unitRef="usd">221000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia26a0d345a5a449683f9b0d89f1bb0a2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTUtMS0xLTk5NzA2_c540339c-7685-4626-ad44-6179980560c8"
      unitRef="usd">478000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb908941b01946c392c481a9232193d7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTctMS0xLTk5NzA2_074e3bef-19b1-49d2-afc1-326e963a5e0c"
      unitRef="usd">260000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i270e1d01244f4fd1b70234c80e9c0a94_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTktMS0xLTk5NzA2_b0db61ef-357e-4ecc-8b59-1481ec27d74b"
      unitRef="usd">213000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0abd801e946448e39c75bab8c1af730a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEyLTExLTEtMS05OTcwNg_0db30992-c61e-45bf-b9c0-408108e7f5e5"
      unitRef="usd">473000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9bd5d80ec5b456092ac8652192da3ec_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTEtMS0xLTk5NzA2_9b22cf30-2da6-437d-8cb8-405be169cd5c"
      unitRef="usd">1089000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e48cde1c09741fbbba8a76eba96c309_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTMtMS0xLTk5NzA2_03f769b3-47da-4345-a8ff-11775e556e86"
      unitRef="usd">906000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b6ddc930db74e29aa55086082f11459_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTUtMS0xLTk5NzA2_7f883539-ce1c-4e00-9b48-a3f37c336405"
      unitRef="usd">1996000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i027ec43cabba41aaaaef1e9bb6739bbb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTctMS0xLTk5NzA2_93c60f2d-4468-4901-bd63-2fd1aa7db9db"
      unitRef="usd">1005000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54b6db5791ed44ccb0478df69ce8783d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTktMS0xLTk5NzA2_5479f024-9e65-4f58-a6eb-5d9241a0d6ed"
      unitRef="usd">877000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida343bc176194f5883adbf14b2db3add_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzEzLTExLTEtMS05OTcwNg_f9adb63b-32cc-4945-888e-92f4bab9d150"
      unitRef="usd">1883000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifded57350dbc45cd90ffe08f24872546_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTEtMS0xLTk5NzA2_bc6c4a95-e211-465e-ae00-6ef2b356e2e8"
      unitRef="usd">1933000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1cfbf4ba247a4bd986d605da59f36b2a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTMtMS0xLTk5NzA2_26a55461-a581-4d0e-9419-1fccb3062a83"
      unitRef="usd">1311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTUtMS0xLTk5NzA2_4ab8d7f6-79dc-4f36-94db-cb12b549c105"
      unitRef="usd">3244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9cf55369f4514daa8887c854a382c1e1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTctMS0xLTk5NzA2_b835d235-fc6e-4ea2-8394-35caf4d6ad03"
      unitRef="usd">1800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99703b37b0ba48548c020a30c6b767e1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTktMS0xLTk5NzA2_664acec5-d7d1-45de-9732-675fbef79804"
      unitRef="usd">1277000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZToyZTQ2NTZmYjYyYzM0ZGQ4YWY0MTJlZmIyMTk1ZGU3NS90YWJsZXJhbmdlOjJlNDY1NmZiNjJjMzRkZDhhZjQxMmVmYjIxOTVkZTc1XzE1LTExLTEtMS05OTcwNg_efdd5f43-e93a-41e5-9bd6-c5346d5dc6a0"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b2e0b3398bd4e9089a8388936799f46_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtMS0xLTEtMTAxMTQ5_b279ecb2-603e-4646-8cb1-ecfc57d5a4de"
      unitRef="usd">650000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b6f04a66de74745848be0c25b2101eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtMy0xLTEtMTAxMTQ5_a6832ee0-6268-4771-8fb0-e0abec912527"
      unitRef="usd">441000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c9374eeb03f4c75a38fbf4295d7ffce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtNS0xLTEtMTAxMTQ5_ef51314a-d14b-438f-a2f6-c9c7ca9698ba"
      unitRef="usd">1091000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1cc10c58865a4ff49ce0aa5218fd4974_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtNy0xLTEtMTAxMTQ5_86dfe72d-580a-47bf-a3a2-5deb8f9b6dbe"
      unitRef="usd">596000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bdb29df4e854a19ae8ac360d53a3ea3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtOS0xLTEtMTAxMTQ5_7791c4c0-ed93-43a6-87d0-0fdb1f2ef1c9"
      unitRef="usd">454000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4da71fc4bd38481295e9d4de2b991770_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzMtMTEtMS0xLTEwMTE0OQ_ea16d1a1-ce20-43e9-889b-966ccd3b2173"
      unitRef="usd">1050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c8a6d03a20a4949b1bf505a8eedd6e7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtMS0xLTEtMTAxMTQ5_5a205b03-c0e3-4cdf-987f-90592fea2ad9"
      unitRef="usd">606000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief4415458b8949d9b372a41950b1d1c3_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtMy0xLTEtMTAxMTQ5_7d9db31c-7148-4a4a-a35d-966ccd4fca49"
      unitRef="usd">257000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68d0be2afe1f471a8619be6368d23738_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtNS0xLTEtMTAxMTQ5_46602c08-1224-4199-8f1e-c5da63e356a0"
      unitRef="usd">863000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ece9f53176241d1bddc8b97e5dcef4e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtNy0xLTEtMTAxMTQ5_ce87a051-4df8-4d2c-a0d0-95e0e75a7b41"
      unitRef="usd">542000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e38e69dadc14904ae3f0b4e977669e6_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtOS0xLTEtMTAxMTQ5_908e9315-568b-4fc9-86c0-59be32ea5472"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic077b66564b344bebb50e1be764ab9f0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzQtMTEtMS0xLTEwMTE0OQ_dbbf8402-fa85-44c3-ab66-14a5a533f898"
      unitRef="usd">758000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i376c6e7abe2e42cabecb0d501e815677_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtMS0xLTEtMTAxMTQ5_14f87661-eb3a-4946-8d89-e629d35636bb"
      unitRef="usd">346000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2643d6f56a40465881ef187eb4469dcd_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtMy0xLTEtMTAxMTQ5_faf4db86-569b-4f93-84c7-49ef467fd752"
      unitRef="usd">101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8750752709c49678ab5476ee86964b1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtNS0xLTEtMTAxMTQ5_b90598f3-ccaf-4573-9953-296541067690"
      unitRef="usd">448000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d74776bb9b34e2cb0202a6760a54d00_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtNy0xLTEtMTAxMTQ5_96ded638-ebdd-48c9-961c-6b3e18787534"
      unitRef="usd">345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e873293fe6f418abbda4c5513c16be8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtOS0xLTEtMTAxMTQ5_7c5f4bce-184f-47f4-8e6a-ccdd064a773c"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd5db3e942a74cbbaecb06454183c1eb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzUtMTEtMS0xLTEwMTE0OQ_377af248-65fe-4c58-883b-bfb70dbdddd0"
      unitRef="usd">444000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia531b4492dd040f3a0690a15663e829e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMS0xLTEtMTAxNjk5_f98cc6ff-c43d-414e-865f-0ad203dcd776"
      unitRef="usd">1602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8df47fefeb74301add15e147b70ea9e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMy0xLTEtMTAxNzIw_4c650c8a-0169-432c-b23a-b77c3b8247f5"
      unitRef="usd">799000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i083b08f9d5514d52bfc0541e8374858c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNS0xLTEtMTAxOTY3_5e5de6d3-d957-4b31-89a0-e8a3bf44f18d"
      unitRef="usd">2402000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i641e5a7630d44a29abf0929b9ecbef09_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNy0xLTEtMTAxNjc2_923505c9-1588-4998-8a5c-f291a7ccd86f"
      unitRef="usd">1483000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6269d280022f444da4365044dfebd1d0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtOS0xLTEtMTAxNzI3_584301ec-823f-4512-90cd-323b218a001f"
      unitRef="usd">769000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ae9ea5e27aa4dfb8658b995535f617d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMTEtMS0xLTEwMTk2NA_a3934b9a-e7c9-4fc1-b85b-0b6fa2a3225c"
      unitRef="usd">2252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cb6cd854f654144ad897e7e04aeb62b_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMS0xLTEtMTAxMTQ5_02e086fa-2155-43a6-a1fb-f045238ffb3b"
      unitRef="usd">378000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a9d62ca9859478bbe137b00bb8bb81c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMy0xLTEtMTAxMTQ5_29d80dcc-72ba-4f14-bef9-9e4d03e8b499"
      unitRef="usd">740000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e27a21a2c6948ca8b4f0ed8a4c7ef45_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNS0xLTEtMTAxMTQ5_425d92d8-89e3-4066-8f51-f31538497930"
      unitRef="usd">1118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6a9247c0e4f45168242ed303b39c984_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtNy0xLTEtMTAxMTQ5_6bfddac6-7878-4747-8199-df35db266781"
      unitRef="usd">400000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bf11f4ecaa9458bab1012646612725f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtOS0xLTEtMTAxMTQ5_e4fc41b5-e3c3-4506-91bb-095721f6c694"
      unitRef="usd">699000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e5f14f850024bdebc7d74e786cc46f5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzYtMTEtMS0xLTEwMTE0OQ_725e56fb-2436-49f6-9f82-f58915535ab4"
      unitRef="usd">1100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95d03048f54a432b95f83d107f210120_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctMS0xLTEtMTAxMTQ5_7df3bfc4-94c8-4e54-8586-4205a14dc371"
      unitRef="usd">428000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia045a31057fb468287b2baf2b245589a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctMy0xLTEtMTAxMTQ5_e25513e0-8951-466e-8ae5-9477b26db0a5"
      unitRef="usd">48000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11d9db0e99274141bc4e13555d17f9cb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctNS0xLTEtMTAxMTQ5_1f14c296-4886-4c69-9c98-f8c40383bf3c"
      unitRef="usd">476000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb18f5e6c0e247a1b6a690cad0c427ef_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctNy0xLTEtMTAxMTQ5_e3fe9fcf-ebe6-45e7-b9c0-f00dadf46249"
      unitRef="usd">341000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b165acafefe40209f5b6aabf02a3eba_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctOS0xLTEtMTAxMTQ5_e3260152-8b9e-4c09-911e-a40f70b9ad56"
      unitRef="usd">45000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58a24ee4843a4c589a865ad63ca56d2a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzctMTEtMS0xLTEwMTE0OQ_e8e6a226-31e2-4ac8-a9de-9f501e59afa4"
      unitRef="usd">386000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1af6c9e0567f4219812341c9ab0f8940_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtMS0xLTEtMTAxMTQ5_d5136167-c4a5-42f1-ae13-46c73e1c5c7c"
      unitRef="usd">667000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i983f6a62e8b44a20bd0879dcc23a0b33_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtMy0xLTEtMTAxMTQ5_ef831455-f612-4937-b954-57c29dd1b66a"
      unitRef="usd">394000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad62834ae44945f2a01034ea56d06a2e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtNS0xLTEtMTAxMTQ5_9abbf399-c3e7-48f2-81b0-4542f8de9ec1"
      unitRef="usd">1061000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica8940d222b9412497da6820d116c5db_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtNy0xLTEtMTAxMTQ5_f6a909b2-df3e-4f49-8c11-ba944650cb26"
      unitRef="usd">590000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id893e6f844384001b614fa60554e39a0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtOS0xLTEtMTAxMTQ5_567b764f-c930-43ae-9d73-d98cd13effb4"
      unitRef="usd">403000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2e80e247a6c4d63b59a373ccd6a4547_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzgtMTEtMS0xLTEwMTE0OQ_23f67407-decc-4947-8dfb-0a5fa098261a"
      unitRef="usd">993000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d23ca3116f74ae08667619cf99610b1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktMS0xLTEtMTAxMTQ5_8246cdc4-62e7-490f-8d86-0066422b6210"
      unitRef="usd">123000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31a87cc275df4c02827aeae66b3db474_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktMy0xLTEtMTAxMTQ5_324e30de-2d0d-4a4e-bd54-494ada31e512"
      unitRef="usd">147000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc114ba40df543a494974546b8688cda_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktNS0xLTEtMTAxMTQ5_540eed21-3cc6-4b69-9410-6bfe364928cf"
      unitRef="usd">270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i996ce945e0ea47dc9b384cfd1a7cbb4d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktNy0xLTEtMTAxMTQ5_d0652386-59a0-4610-8a02-259e431c9e51"
      unitRef="usd">64000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ee4a0405fcc46768dd9df2f2ee25d9a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktOS0xLTEtMTAxMTQ5_dd4972e9-66ac-402e-a7ec-854f497c2f33"
      unitRef="usd">115000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i576cdae0729b4f15904cf440be39a5dc_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzktMTEtMS0xLTEwMTE0OQ_2fe2e24c-e24e-40e8-bf38-7966276891ed"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad2ffb4bccd6473cbf1edf6b51561e8b_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTEtMS0xLTEwMTE0OQ_b84fa568-9622-4718-bdc0-e36ce3e4e754"
      unitRef="usd">1596000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16fa28ceec55463fb802e656bce05d72_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTMtMS0xLTEwMTE0OQ_3dbb51ab-70f0-4f1a-896a-6214e4622052"
      unitRef="usd">1329000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50b995e2611d498b87e589132f982b29_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTUtMS0xLTEwMTE0OQ_0a36678b-be07-4467-9696-21d0fdd6b629"
      unitRef="usd">2925000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfb96738c2284048800a1132782bf2bb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTctMS0xLTEwMTE0OQ_2c3c4aac-ee10-4b21-a134-3d123a188640"
      unitRef="usd">1395000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8dcfd0caac50408a9d88c51b81a20b7c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTktMS0xLTEwMTE0OQ_2a600ad1-5170-4fb5-9684-0d2f07ba7521"
      unitRef="usd">1263000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id80b1eedfabd457080936ffd53512c5f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEwLTExLTEtMS0xMDExNDk_4467702d-719e-443d-8917-9149efa6fde5"
      unitRef="usd">2658000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6c5221cbb284081a999df868d95ab10_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTEtMS0xLTEwMTE0OQ_6ab28e86-a0d0-45a0-ba50-ee9784ce64d8"
      unitRef="usd">513000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c19828588024500887d5d62d92864cd_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTMtMS0xLTEwMTE0OQ_50eb02ff-0d58-43e3-a7b8-31d2d08e5c07"
      unitRef="usd">430000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icea6a8cb2f274f1cae8b176f73989975_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTUtMS0xLTEwMTE0OQ_2e815571-52ca-4b4c-8f1f-f77a1128ae7f"
      unitRef="usd">944000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac6b29cb0bd643ea830c23024f6f122c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTctMS0xLTEwMTE0OQ_ce97125f-9423-43ab-b482-bbf01eeb2aed"
      unitRef="usd">498000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40c0a9db1c8e4014b2df4e46dd5de46d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTktMS0xLTEwMTE0OQ_ba47bb4a-41d2-4e64-a5da-98ff4e05fac4"
      unitRef="usd">407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if71761ebafaa4d329453f22bab510d1a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzExLTExLTEtMS0xMDExNDk_ba722a52-ee1e-4175-adc3-6d90ba20080e"
      unitRef="usd">906000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i353a9c38bf404c4b8bc5520b92a5b9c8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTEtMS0xLTEwMTY5MA_487c594e-fc95-49e4-a252-4e0ba1dd2788"
      unitRef="usd">2109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i251b6cd8103d489a9a3ad606f5d9de1e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTMtMS0xLTEwMTcxMw_cc96bc5c-2b90-4130-88b5-ceb02e90c53a"
      unitRef="usd">1760000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44a644c23fc447ebb147f98d2868a6d6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTUtMS0xLTEwMTk3MA_3882166a-f444-4ced-815a-ffb6b42ab170"
      unitRef="usd">3868000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie11f0a8ff4d240c69c1c5b12228bb893_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTctMS0xLTEwMTY2OA_6e028354-4e1d-4a56-9bb1-72d98424f013"
      unitRef="usd">1893000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic50fcbfa6940498f8cf9056629ab9c88_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTktMS0xLTEwMTcwNg_4716ff85-9fa2-4328-a742-a0ddce4b57cc"
      unitRef="usd">1670000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47be2b0f0da3485eb0c8840949681e1c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzEzLTExLTEtMS0xMDE5NTE_c75476db-ca18-4074-956d-51d5c4d96fd6"
      unitRef="usd">3564000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ad83b783c274c09bcf887c0897c360a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTEtMS0xLTEwMTg4NA_a6365e73-ad22-49d1-82b6-da43367e5733"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica1a058ee7ff4842a9dd996eaadeab8f_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTMtMS0xLTEwMTg4Nw_70a2d1ef-bea9-4399-afc9-eb0af9888e6b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i029f075c73314285a73d6046fc56ace1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTUtMS0xLTEwMTg5MA_b82e90c8-2257-428a-9633-2d1604b721c0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d14bc6cd205427587873034553c97bf_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTctMS0xLTEwMTg1MQ_12874974-242b-4a9d-a9ee-d8ceb91501a5"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15c7a5b47c514f479f5321f0ab2663f4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTktMS0xLTEwMTg2MA_cf7888e7-0f43-4c2d-b9d1-c88795bd97ba"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic71339696da74c3c8be300118987e2a8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE0LTExLTEtMS0xMDE4NzM_e0e42cd1-63a1-41df-a114-36943802ec31"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib077df6e7685413397c816d1f7399061_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTEtMS0xLTEwMTMwNg_77d4a1db-9659-47c5-acff-1a496144378a"
      unitRef="usd">3711000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c63c604879341609359afebf06b84fb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTMtMS0xLTEwMTMwNg_3182c3d7-a5be-44ed-9b96-4f83284c1dc1"
      unitRef="usd">2559000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTUtMS0xLTEwMTMwNg_c25c9035-12f4-4a0e-bbae-4ab18522c5f5"
      unitRef="usd">6270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e4f0985ad1740deba3b810eecdeeafe_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTctMS0xLTEwMTMwNg_5f69f77a-d855-47af-bbba-655540bc931f"
      unitRef="usd">3386000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58d6871b5efa47e089e55373103fc46a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTktMS0xLTEwMTMwNg_aaf9381d-cb36-4dc6-95c6-d6bd730ef23e"
      unitRef="usd">2443000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpmNGNhYzc5ODUxZjM0MDViYTlkM2U5ZWEzNTE4YWY5MS90YWJsZXJhbmdlOmY0Y2FjNzk4NTFmMzQwNWJhOWQzZTllYTM1MThhZjkxXzE4LTExLTEtMS0xMDEzMDY_a09cb318-e7ec-4c6c-9474-a6db909a0ce1"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56409fbd56bf4a44914cd2c8465f7903_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItMS0xLTEtOTk3MDY_975df327-b110-4359-bc88-efa1c0b6993f"
      unitRef="usd">1933000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33a20447358346669ee315fe67d484ef_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItMy0xLTEtOTk3MDY_a4e8101f-178c-443b-8eb5-969583cd6af2"
      unitRef="usd">1800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44122c777f7d4e659c894fab8bfe0463_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItNS0xLTEtOTk3MDY_6f87a953-1061-48cc-b0d2-dd95fb1f2905"
      unitRef="usd">3711000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b571919e0954c0998434728e8377c58_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzItNy0xLTEtOTk3MDY_881bb0c8-9117-41b2-89de-373670122508"
      unitRef="usd">3376000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d01db59981d45bab53856f63a5438ae_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtMS0xLTEtOTk3MDY_f653b016-64f2-4fa5-964b-d28bca6e37a6"
      unitRef="usd">660000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88b175c8d6f949ae9aa8ce0c709a1945_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtMy0xLTEtOTk3MDY_a4f1e18c-d6e2-4c4d-8244-cd8a4f66c0d9"
      unitRef="usd">662000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i804e2fb842734bbbb84a1af373c0f50b_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtNS0xLTEtOTk3MDY_49006b76-18ba-4602-a295-027c61112e96"
      unitRef="usd">1284000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82c70b969bbd496a8d242a26de3a03b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzMtNy0xLTEtOTk3MDY_ae59f29f-2092-4f1a-b60b-89d10bc3c688"
      unitRef="usd">1266000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10cf842a669546239f5adb70a68f5d12_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtMS0xLTEtOTk3MDY_14bdcb80-76d1-4908-a048-1ead3f17b50b"
      unitRef="usd">530000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96c8adaf4f394f7bbe3dbe88b56bf82f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtMy0xLTEtOTk3MDY_78e77be2-d763-48d4-a22e-6acc36a46f11"
      unitRef="usd">520000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8ad17ca3dd24c48ad06fb834dcfe750_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtNS0xLTEtOTk3MDY_c42181ac-6cce-449d-8e7e-cd7470f92f70"
      unitRef="usd">1047000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9cd2c0e0d24475aa93ac3069d5a1401_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzQtNy0xLTEtOTk3MDY_1a91ef44-febc-4e0d-8a6e-de477799ccc4"
      unitRef="usd">994000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fb7facade49428fb1d9af329e51a7cc_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtMS0xLTEtOTk3MDY_b32c9807-d48e-4dbe-b0af-3e5776992c6a"
      unitRef="usd">120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i981f627a420a466797e7c582e56d78d7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtMy0xLTEtOTk3MDY_65cf4db8-96bd-4f25-bb58-4a9def42a70c"
      unitRef="usd">95000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i637a3831852e44fc9d35643a000aa777_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtNS0xLTEtOTk3MDY_2e904e30-53ad-4406-8d19-15b9b93cfee4"
      unitRef="usd">228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b5433550a40439c899d6f89ee694767_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzUtNy0xLTEtOTk3MDY_cf5e18d8-7c82-47d3-88cd-a296a9597664"
      unitRef="usd">180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaed936efbefb4d6883a1c81638adf58d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtMS0xLTEtOTk3MDY_4c9b46fc-4b74-4ac0-8728-96d9a714ab92"
      unitRef="usd">3244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b181944f869422eaf28616562fd7a82_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtMy0xLTEtOTk3MDY_ed24c651-000f-44e5-8f3f-b04cdeb8e9dc"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35b65bf8163846418605a1c7c4224987_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtNS0xLTEtMTAxMjY5_77889dbc-06e8-47ff-91af-80273daae48b"
      unitRef="usd">6270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe6a468432bf4452ae37008655365bb9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzYtNy0xLTEtMTAxMjYy_821fecde-5c62-4ddf-b8e8-0c73eb112772"
      unitRef="usd">5816000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41aab6c00bda4f86820878b7c6774c9e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctMS0xLTEtOTk3MDY_b4c74bd1-4c60-4beb-9062-a5d361e8dd27"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie16d4e79dbaa470fbcb924d46c0c79ad_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctMy0xLTEtOTk3MDY_2728146d-a395-435f-acd6-0ea3702938a8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ad83b783c274c09bcf887c0897c360a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctNS0xLTEtOTk3MDY_a6365e73-ad22-49d1-82b6-da43367e5733"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d14bc6cd205427587873034553c97bf_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzctNy0xLTEtOTk3MDY_12874974-242b-4a9d-a9ee-d8ceb91501a5"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide5536294b9c422399ae5dc27f304dc9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtMS0xLTEtOTk3MDY_6e1c9673-362b-47fd-b3b6-a71e1b8e2040"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ccea46e8c094031bc29d50afc2fb0a7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtMy0xLTEtOTk3MDY_50023029-0bb3-4181-894c-5359ff6993c1"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica1a058ee7ff4842a9dd996eaadeab8f_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtNS0xLTEtOTk3MDY_70a2d1ef-bea9-4399-afc9-eb0af9888e6b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15c7a5b47c514f479f5321f0ab2663f4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzgtNy0xLTEtOTk3MDY_cf7888e7-0f43-4c2d-b9d1-c88795bd97ba"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i525a2094c6934a6485d6adda3f6a9b3a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktMS0xLTEtOTk3MDY_d88562e4-6709-489c-a3b0-9b4c17a27799"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cfee3824c314f15a3cc0a778059755c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktMy0xLTEtOTk3MDY_598a9a4a-9f59-43ff-92d0-df6dfa04491c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i029f075c73314285a73d6046fc56ace1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktNS0xLTEtOTk3MDY_ca5b20be-67e9-4a56-9882-8a25c6e50a1a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic71339696da74c3c8be300118987e2a8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzktNy0xLTEtOTk3MDY_e0e42cd1-63a1-41df-a114-36943802ec31"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTEtMS0xLTk5NzA2_4ab8d7f6-79dc-4f36-94db-cb12b549c105"
      unitRef="usd">3244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTMtMS0xLTk5NzA2_0bc6d3b7-e7a6-4259-b4b0-f47255190ed1"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTUtMS0xLTk5NzA2_88584c53-564d-46d3-9ffb-a39effcd993e"
      unitRef="usd">6270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTctMS0xLTk5NzA2_72e7e1ab-8155-40da-b334-b447453e36e1"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEwLTctMS0xLTk5NzA2_82a03f9e-d154-404f-a2a8-ebc216bd9622"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d9437b6a921439292845559c4c462b2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTEtMS0xLTk5NzA2_23f80323-d99e-4358-bd2a-4b1cc40d4282"
      unitRef="usd">427000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i402fc673d13248f590527d5a9df8dd9c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTMtMS0xLTk5NzA2_2c42deb1-6891-41f6-8bc8-9686bf693ad5"
      unitRef="usd">359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0185ce7757d248cfb6fbd1ea52edba1c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTUtMS0xLTk5NzA2_7f26942d-d447-4c29-b831-aa0385d560b4"
      unitRef="usd">817000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id46a54a0a24f40f988a953734d9ef437_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90YWJsZTpiMDA1MTJhODQ0Njg0YWJiODExMTg3NTdkYWE1M2JkNS90YWJsZXJhbmdlOmIwMDUxMmE4NDQ2ODRhYmI4MTExODc1N2RhYTUzYmQ1XzEyLTctMS0xLTk5NzA2_a0421694-ea31-4101-b860-b26fcc0d2262"
      unitRef="usd">676000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:EmergingMarketstotalnumberofcountries
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1Xzc3MQ_1a3f5f9a-bc32-47b1-8117-7b6d67c80a51"
      unitRef="units">20</bsx:EmergingMarketstotalnumberofcountries>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzE0MTA_7fac1dab-7ade-4514-8d44-cb291f71726a"
      unitRef="usd">501000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzE0MjY_44764f33-ba87-4866-8f17-4b0a0e3ac90d"
      unitRef="usd">484000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzE5ODE_1372ac46-e099-44cb-9459-0a2a337164d3"
      unitRef="usd">35000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTIvZnJhZzplN2IzZDViMmY4Mzk0NTdmYTA0N2UzNjQ4ODJhYTA4NS90ZXh0cmVnaW9uOmU3YjNkNWIyZjgzOTQ1N2ZhMDQ3ZTM2NDg4MmFhMDg1XzIwMDE_3cb3108e-3962-429b-b0fc-4e2a4c6b4d8b"
      unitRef="usd">76000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90ZXh0cmVnaW9uOjhkMWIxNzk4YjRlZjQxZTBhM2ZlNmJhOTg4YWU1ODI5XzMzMg_c2fef65a-1dc5-48c5-b1e1-1fe38eaf7409">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE M &#x2013; CHANGES IN OTHER COMPREHENSIVE INCOME&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;134&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from Accumulated other comprehensive income (loss), net of tax.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further detail on our net investment hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our cash flow hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90ZXh0cmVnaW9uOjhkMWIxNzk4YjRlZjQxZTBhM2ZlNmJhOTg4YWU1ODI5XzIxOTkwMjMyNTcxOTM_db78c2df-336b-4efe-b9b2-2a1f0f6122a9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;134&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from Accumulated other comprehensive income (loss), net of tax.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtMS0xLTEtOTk3MDY_0bb1acfe-d3df-4d47-a2ef-bcaa3d31b7bb"
      unitRef="usd">29000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtMy0xLTEtOTk3MDY_36c2a9e4-4b51-441b-bbd4-24336c3f07cc"
      unitRef="usd">229000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtNy0xLTEtOTk3MDY_de8bd72f-55b2-4f8a-8db1-8b13f94accf2"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i877957e5afdf40429ed18f3f84b993f7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzEtOS0xLTEtOTk3MDY_bf8abfb2-9547-4ca3-b679-dca39fbfd78f"
      unitRef="usd">222000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItMS0xLTEtOTk3MDY_75c1edc0-4461-44e4-8c6f-5bf0edbf66ad"
      unitRef="usd">79000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItMy0xLTEtOTk3MDY_118a5b42-c989-4dac-89ca-c4177d7f101e"
      unitRef="usd">165000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItNy0xLTEtOTk3MDY_1de0e276-cb57-4623-91bb-cdea49868b2d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzItOS0xLTEtOTk3MDY_b57e3221-47ee-41e0-a113-4733394728eb"
      unitRef="usd">245000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtMS0xLTEtOTk3MDY_44da265d-461a-493f-bc08-4247ae6978e6"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtMy0xLTEtOTk3MDY_2f941350-9f72-477e-95df-1b869334a57d"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtNy0xLTEtOTk3MDY_3cfb73e7-02dc-489f-96a7-28f741f54f63"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzMtOS0xLTEtOTk3MDY_ea134898-c61b-4888-8107-c80411c0c810"
      unitRef="usd">34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtMS0xLTEtOTk3MDY_095e8ba1-27ad-4f06-84bc-00da67b07cac"
      unitRef="usd">77000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtMy0xLTEtOTk3MDY_d17b1f46-bbc6-4efa-b10c-4b87df549262"
      unitRef="usd">134000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtNy0xLTEtOTk3MDY_24cf8d91-7323-4f79-a65c-121875869e17"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzQtOS0xLTEtOTk3MDY_c1a1e0d8-24dc-4cb1-b7fa-dc5d5f8f7644"
      unitRef="usd">211000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtMS0xLTEtOTk3MDY_6e262042-d8d4-4b03-932f-f4980ffd6f3e"
      unitRef="usd">106000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtMy0xLTEtOTk3MDY_9ec14e6d-f85e-47fa-973b-13d6cc889c16"
      unitRef="usd">363000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtNy0xLTEtOTk3MDY_b09aca56-96dd-41de-bbfe-6af4422bbbf6"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0NjA1Mzc0ZTU4ZWU0ZjAyYjZmMTg3YjIwZDk3ODYzYy90YWJsZXJhbmdlOjQ2MDUzNzRlNThlZTRmMDJiNmYxODdiMjBkOTc4NjNjXzUtOS0xLTEtOTk3MDY_c9d0f2c6-fbd2-4c31-ae01-67ce18de6542"
      unitRef="usd">433000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtMS0xLTEtOTk3MDY_5e3125b2-6f9c-41ea-b8f3-30bec1630be9"
      unitRef="usd">134000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtMy0xLTEtOTk3MDY_d444c5f0-bb35-4eab-8048-a24d98d4dc0b"
      unitRef="usd">165000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtNy0xLTEtOTk3MDY_29f4fc21-4608-42a1-9a10-f933266693c2"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaac3357a9aaa450e8357d06a28faf82a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzEtOS0xLTEtOTk3MDY_924c48dc-00f9-4dc1-ac28-c4cfb7601144"
      unitRef="usd">254000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItMS0xLTEtOTk3MDY_6d04dc1d-407c-4c1f-af06-842c1690959d"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItMy0xLTEtOTk3MDY_f2b05190-178a-4f38-8e10-8aff6ade7e4b"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItNy0xLTEtOTk3MDY_c7f74c17-ae54-4ccd-9d24-e6f9e56a6c16"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzItOS0xLTEtOTk3MDY_cceabe13-fb23-406c-84d0-defcf99dcce5"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtMS0xLTEtOTk3MDY_7c315c65-b698-4d17-b581-d93d87f5f34a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtMy0xLTEtOTk3MDY_bd6b3693-9b0c-4185-a86e-158c0fdd0508"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtNy0xLTEtOTk3MDY_b5166be0-5fba-4236-a900-7a6657cb363b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzMtOS0xLTEtOTk3MDY_c891ad3f-0a8e-4361-9caf-0b5760ce286b"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtMS0xLTEtOTk3MDY_b3d67db4-e970-445f-8e7f-49cc202f0dec"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtMy0xLTEtOTk3MDY_388c04c4-ccb4-40ec-b83e-79529afbd854"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtNy0xLTEtOTk3MDY_4d4ed03a-553c-4b5a-aa18-10704e396963"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i52d3ac1c619648f784185863bd23e0b2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzQtOS0xLTEtOTk3MDY_7a0b63df-ab96-4a3b-99e1-4b3054d8a4ee"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtMS0xLTEtOTk3MDY_3feef6c6-a18a-4f0c-8f19-50ad026557bf"
      unitRef="usd">136000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtMy0xLTEtOTk3MDY_e9a6ce90-7ae2-488c-a8cd-1565fd71680e"
      unitRef="usd">146000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtNy0xLTEtOTk3MDY_ae76afb5-d01d-451c-b665-b4d1d92ff9cd"
      unitRef="usd">46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyYzM2YzM3MjAzYjQ0ODQyYjQzMjE4NzlhNmM5MmU1ZS90YWJsZXJhbmdlOjJjMzZjMzcyMDNiNDQ4NDJiNDMyMTg3OWE2YzkyZTVlXzUtOS0xLTEtOTk3MDY_86c7db56-a2e6-41b9-8be2-d31ea2dd472d"
      unitRef="usd">237000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtMS0xLTEtMTAxMDU2_c99c8135-04db-4554-bdb5-5a4a92f934e9"
      unitRef="usd">93000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtMy0xLTEtMTAxMDU2_ab9b4375-f26f-47a2-beef-505a43e371d6"
      unitRef="usd">206000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtNy0xLTEtMTAxMDU2_fb847c71-4e66-40f2-883d-6a73a5f5b1dd"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia14da29940934c628d805300ec2c17c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzEtOS0xLTEtMTAxMDU2_3fe94ae0-80bc-4011-871e-4caf9e5feced"
      unitRef="usd">263000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItMS0xLTEtMTAxMDU2_31c5561d-50e1-4f8e-8e40-4fe7505a0a73"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItMy0xLTEtMTAxMDU2_11917c6a-2862-46b9-a2b9-ee2a6f127069"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItNy0xLTEtMTAxMDU2_99822c3a-4764-41e9-9433-9b780e863a68"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzItOS0xLTEtMTAxMDU2_ae2d9736-73fe-4be5-afee-e3012f12ad99"
      unitRef="usd">217000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtMS0xLTEtMTAxMDU2_17363baf-2fef-409e-ae5d-6e598a6aeb21"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtMy0xLTEtMTAxMDU2_8535ffec-bcfb-4f60-a995-467f74c89d73"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtNy0xLTEtMTAxMDU2_770ff1d3-8cf8-49d5-ad46-a8952c63e7a6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzMtOS0xLTEtMTAxMDU2_210dfd2f-f081-4c60-ac4e-e3961b78493a"
      unitRef="usd">47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtMS0xLTEtMTAxMDU2_1b9ded55-e7cc-4c1f-8b2f-c24037c0849b"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtMy0xLTEtMTAxMDU2_cf2e7430-de29-426e-8ade-27cbe1313331"
      unitRef="usd">157000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtNy0xLTEtMTAxMDU2_afdb9262-3240-48dd-8a46-0e363ee05d8a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzQtOS0xLTEtMTAxMDU2_c650c1d1-4c66-484a-acf2-d3aca0f4a1ab"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtMS0xLTEtMTAxMDU2_f90dbe1c-c5ee-46dc-a0e6-deeae26308e2"
      unitRef="usd">106000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtMy0xLTEtMTAxMDU2_40993b2e-1032-4d65-b324-6e9524b13271"
      unitRef="usd">363000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtNy0xLTEtMTAxMDU2_37c9c272-abd0-4640-8d4f-580510897461"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f7a3f89558f4cdf89f78dc544d9071b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZTo0MjU2YTNlOWY2NjE0YjU4YTJhYWRlNDY0NGYyNTdjZS90YWJsZXJhbmdlOjQyNTZhM2U5ZjY2MTRiNThhMmFhZGU0NjQ0ZjI1N2NlXzUtOS0xLTEtMTAxMDU2_4b0ebf1e-4ee2-4599-9ca5-978e015ce6ba"
      unitRef="usd">433000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtMS0xLTEtMTAxMDU5_5defe265-2e82-4f90-b1e8-ef4f19a8c29e"
      unitRef="usd">218000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtMy0xLTEtMTAxMDU5_88ebb95c-8462-47c0-bf27-5034c6b22bd2"
      unitRef="usd">36000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtNy0xLTEtMTAxMDU5_c87f485a-bc79-4ee8-b99e-962e09e3358f"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i34144dea661c452383c3d71bbf39f3ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzEtOS0xLTEtMTAxMDU5_b326d513-51aa-4d7c-8134-9b9e1aaa68c0"
      unitRef="usd">207000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItMS0xLTEtMTAxMDU5_9ea5edeb-38ff-452c-87fe-dd99741b098b"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItMy0xLTEtMTAxMDU5_7b8eb03d-3c80-469b-b34a-57f321b35fc6"
      unitRef="usd">121000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItNy0xLTEtMTAxMDU5_1726bd4d-cc36-424a-9454-d2aee6fa4493"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzItOS0xLTEtMTAxMDU5_34135d92-8067-4de3-9657-3a48130d745b"
      unitRef="usd">174000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtMS0xLTEtMTAxMDU5_ad35c2d9-6721-40e8-acfa-244fc16c0934"
      unitRef="usd">134000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtMy0xLTEtMTAxMDU5_b2868b22-eb45-4eae-85df-d15f666866a7"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtNy0xLTEtMTAxMDU5_04db5e0d-84ca-432f-95eb-68219688952f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzMtOS0xLTEtMTAxMDU5_f9cfe8e9-ef3e-43a2-a9cd-f2d66868476e"
      unitRef="usd">144000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtMS0xLTEtMTAxMDU5_c64053e2-ade2-451c-bcbc-d2877189e13d"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtMy0xLTEtMTAxMDU5_6f545ae3-c9d4-4f86-a2a8-6f62af165fe2"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtNy0xLTEtMTAxMDU5_8f3e396e-0ec4-4478-9b5b-d80c461ea68d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i728208e05f034f6d9bb48fe383dc1eae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzQtOS0xLTEtMTAxMDU5_35ec348f-7269-4ed3-82da-08b06020ecaf"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtMS0xLTEtMTAxMDU5_ba39ebf8-5b4e-4450-95ad-fb5eb33e8191"
      unitRef="usd">136000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtMy0xLTEtMTAxMDU5_e17acc49-806c-48f3-8b39-db14fd743806"
      unitRef="usd">146000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtNy0xLTEtMTAxMDU5_204d8575-3abe-4d2b-b875-cb8d8e8cd1ba"
      unitRef="usd">46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifee4f63199724a10854016dabc453a58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzUtOS0xLTEtMTAxMDU5_670ece4c-a909-402d-af53-8bd2e008142f"
      unitRef="usd">237000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i80e3da031c9b4d6e944876c1bf4edd3c_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMTgvZnJhZzo4ZDFiMTc5OGI0ZWY0MWUwYTNmZTZiYTk4OGFlNTgyOS90YWJsZToyNjljYzAyYTg2YjQ0YzU4OTU1YzliMzhhYzNhMTA3MC90YWJsZXJhbmdlOjI2OWNjMDJhODZiNDRjNTg5NTVjOWIzOGFjM2ExMDcwXzYtMC0xLTEtMTAxMDIxL3RleHRyZWdpb246MTgyMjBiYzYxM2FmNDBhM2I3NGQzODFiNGFhN2M2NDZfMTQ1_6653f643-85db-407e-9117-a6a2922fbb73"
      unitRef="usd">127000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <bsx:NewAccountingPronouncementsPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzMzODM_70ead8c3-327b-4c1d-8a8e-5c7123e469f4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE N &#x2013; NEW ACCOUNTING PRONOUNCEMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first six months of 2022, we implemented the following standards, which did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-05&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Lessors&#x2014;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We adopted Update No. 2021-05 in the first quarter of 2022 on a prospective basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Standards to be Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASC Update No. 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods. Update No. 2022-01 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2017-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the corresponding period. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASC Update No. 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments- Credit Losses (Topic 326: Troubled Debt Restructurings and Vintage Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-02 makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as well as amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13. Update No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Update No. 2022-02 should be applied prospectively, with the option of modified retrospective adoption for the recognition and measurement of troubled debt restructurings. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2016-13. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASC Update No. 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance and the amendments in this update should be applied prospectively. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</bsx:NewAccountingPronouncementsPolicyTextBlock>
    <bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzM0MTk_be77736a-f72a-490d-a627-0a2485abab59">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-05&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Lessors&#x2014;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases. Such &lt;/span&gt;&lt;/div&gt;classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We adopted Update No. 2021-05 in the first quarter of 2022 on a prospective basis.</bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock>
    <bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzMzODc_f4662545-a9af-42b0-8fc1-12a98bebfbd7">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASC Update No. 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods. Update No. 2022-01 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2017-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the corresponding period. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;</bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock>
    <bsx:ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzMzODg_7caee6fa-b060-4b39-b9a6-a6e6707994ff">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASC Update No. 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments- Credit Losses (Topic 326: Troubled Debt Restructurings and Vintage Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-02 makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as well as amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13. Update No. 2022-02 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Update No. 2022-02 should be applied prospectively, with the option of modified retrospective adoption for the recognition and measurement of troubled debt restructurings. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in Update No. 2016-13. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;</bsx:ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock>
    <bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzEwOTk1MTE2Mzc5NTM_5c9e73f7-9b30-41cc-9f42-3b20797cb6ba">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASC Update No. 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance and the amendments in this update should be applied prospectively. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;</bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock>
    <bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock
      contextRef="icce0d71a0541494fbaf94834bc475e99_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxZWM4NjI5YjlkZjQzMWQ5YmE5N2ZhZDJmNjc2OTkxL3NlYzo4MWVjODYyOWI5ZGY0MzFkOWJhOTdmYWQyZjY3Njk5MV8xMjQvZnJhZzpkNjc3ODliMmJiOGE0YTYyYTA5MzZjZTU0NTQxZGY0Mi90ZXh0cmVnaW9uOmQ2Nzc4OWIyYmI4YTRhNjJhMDkzNmNlNTQ1NDFkZjQyXzEwOTk1MTE2Mzc5NTc_836713e3-e826-4fbd-931c-8832b8a02925">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASC Update No. 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance and the amendments in this update should be applied prospectively. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;</bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>64
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M&M9,R6!XR9ME?3GB6DL6)L:"1,-:&AQ5!D=HHLINYSP(.;E,HULN3<9P#?O
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M_."P8$*PM+Q<$RSSK@#R^9(QL;]1WS"J;U;3_P!02P,$%     @ $(($559
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M*,UO:=JS(]2(MN7&;K?_+"EH1H:BB9]UTMG+CMY>!FR/ZC-,%9 SNE$9FC>
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M][;#'LFWVLC-OC$HV(BJ^<]>]@-QT@#ZP1O0?0/:;9 %&J3[!JESM%'FW/K
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MK'O2><'HW(46W&D<W.=KZ+!"FJP#-K*-1G;@;;"W/QGKZ=&QYJ>SPVAWD'X
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M<P8S:PW@]Z64YO#%WN#X3MK\_U!+ P04    "  0@@153(\.;^,"   ;"0
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M!*,DQA)BM)+JIXI "L36:(Y%@FY4(0ETNBKRG)HI3-&"B(@R47 X0Q?H8;5
MIR=GZ 21#-T22E7^Q=26RCF]A!U5CER7CGCO./*CR"[1P#E'GN-Y'?1Y/WT!
MD:*[ANYVT!?'K]Y%7QZ_NO.6;JN$U%GQZJQXQI[_7E:T]#B+4:0;\%R0+:8Z
M+UVZEJ9&QI0^%K:A-QI.[6U3O$.,._&"MZ!%AZ'AJ 5:]CJN3[4KD>,(9I8Z
MM@3P+5CAYT_NT/G2(\N@EF70*\L]",E)I$LUVBO$6V,-L51!1K2(U8RJS)\R
M :YV%.=J"F$AH%O-TH-A4ZF!UU*S S,>M\3LP Q'+2U[H_V@EGZMI?]?6O;K
M1EFVN9# TQ[E_(.( Z<E7 >D780=D+9LO8%]4+:@EBWXY\X\+X_&Y:MBYZ@A
M9[UYVV/+_GT<'&P_/VA5U?P0X[G#=NEU@,:3%FAY"'(GD]=DE.+8C8M%/QMN
M,=^03" *:T5S+D?*"B^OXK(C66[NFD<FU<UEFHEZO0#7 #6_9DSN._KZJM]#
MX5]02P,$%     @ $(($50Y7G 9_!@  T X  !@   !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6RE5^]OVS80_5<(%>A:P+4=)^V*-@G@I.F:#6W2.%T'#/M
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M!A3-@32B1L1Z$^14*^=D@5:E"=29.[U&<K08GA6* <J.F<%\E*F^^,Z9U3*
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M@]4ZHPM/7C[?NBMY*[-/VP\)_GM2C.('&QFE01R)1"Y?',V'3U^-Z7Z^X==
M/J369T&<+.+X,_USX[\X&A!!,I1>1B.X^',O+V48TD @XP\]YE$Q)3UH?S:C
MOV;>P<O"3>5E'/X6^-GZQ='%D?#ETLW#[&/\\(O4_$QH/"\.4_XM'M2]X_,C
MX>5I%F_TPZ!@$T3JK_M%R\%ZX&+0\8"C'W"8;C414WGE9N[+YTG\(!*Z&Z/1
M!V:5GP9Q042+<ILE^#; <]G+7Z2_"J*5F)-T@BR0J7 C7[QV@T3\ZH:Y%&^E
MF^:)Q$)DZ?,G&>:D)Y]X>OQ7:GRG8_RI>!M'V3H5UY$O_>KS3T!K0;!C"'[E
M[!WP'WG4%Z-!3S@#Q]DSWJ@0P(C'&W6,9W%Z%:1>&!.SJ?C?^2+-$NC,_[7Q
MK(8<MP])=O0TW;J>?'$$0TEE<B^/7O[];\/IX-D>@L<%P>-]H[_\Y?KJYYMW
M/XOYY=W-KS=W-]>W8O[N2KR>WWP4O\[??+H6;Z_GMY\^7K^]?G=WVT;]_O'?
MO;^[%E?B[W^[<(;#9^+KIA-7,@GN7;(T<1-!@CGK#>M4BZK])H7K^Y!1"IU.
M/L,')4'Z62R3>".\M1NM<$\0"?@>6%<$>T@2&7D[(;^H;T7B9EIC@RB3&"C3
ME[)U$N>KM1IOXT9P,$2)V";Q*G$WJ7A8!]X:3WEA[DO<+D6>2A$O8=(%!S1N
M%$?6E640N9$7N"&>++CK$Q]J#N'%D8=K(()\#H;SXIPHV[I)MA->(OU ,[G8
MB3#80 X0B>MY<INYBU#:]Y.$LA@C_QXGM9F#+*<)P$:0$1?WX)SY W-@Q\SC
MTNAIKYR(^'0W- 73IFZ37[:L]319$/E8'#_'/#5*2!B@6;G1<"<V<11D<4*C
MMO*HYF;9N&$:"[G9AC$><U/<*B*9*<Z3A!92:4FV=C-%*Q/*8JJ+$.MQMG5W
MS"QY=<'T>7GH(M1@T%"MLP\M('YH',PE5HA/:OR'. ]]L7:QFC&^31X"K/M"
M2HHQG@1OOM(_>M*>N2_F8;9FI8KB#%^!'YF1)"21'&%"OR<>I/!C?0,B%U2G
MFQ4=/(C,A10I-#Q8!IX+ZEV(&^2D]"V>P@B@$:J;J5@&J;[.$R*^1_)@M8WS
MQ%;=P#8^+&V:+W['PS070D8(8A,L,?2*90#)P;8"T&2O!PV>$#NX94?\9"1$
MD'$?I*Q\+$\:W9< ";Y>$J*DJ@1*H&Y44PX!@X$U]\6EL6OC(FS7\1[#M7J%
M+F_ @D_QY#8)X%4"K!#D W65&6 '9 LU4>H<!NXB"-D5]=C)>*2<VI?0 A/)
M=&.V#A+_3*T:;#M*7;4./>4BH%^E"2K:9,+"@MBA! &HD%4WT4J[XI-DRDS$
M84!J##HE+(Z6#M++/:E5,V7=6&N1P30S]S-+U;^'#M$LI!;+9:I-S2:<:=$6
MN=?A67K4LP0*83VXB5_R0=I!X1)W5>EDEG")M$*Z2<3Z0/- UFNQ!"A,:4EB
MN#9BE?W9XXO<%W=K4FKX3<0.K?[%O1U.7ZLI2"0UQF+V2%W-NE?D@UNC6!NU
MQ3:>DWD2]\0K&$L ^K>P9U^01T,87?7$/USH#!GK3D8]<;D.^!]0A;$6 ?,]
MSPE80/4BF!8L,=%Z02QN(7AP@%@$9P^O%FR9@*80R)VE9+[ *ZD*$R1L^24C
M?MG+>QDY<5<%6Y .GH+E$C&2;W!+QOLP-PK# 7'>.\3"$ADR79B5+"2/2 GI
M?UN"Q%$ $X+3V;/V,'YM*O5%W./,?$G.DDF IRP&8UL >3DI,!#*[2LQO[T4
M=_$V\,3%<")Z%CRI8I*3YMVGRKAI/O('!%^)8>V%6<:?^K=]O8CBGB$DF+#\
M2,/B"L(+!T'J=&8KFR\7[/^K3L6P!@+X$\6].#$8@^2VQPGI.W!9H2ZVL64>
M,6$4Z)7(Z2N;$@Z84ER#0L0^MC* ;UF ;Q;/%6+F9@%QCX9\=:A"8&6!W%9F
MFBP <HZFXV>SP0"93AC2-Z#!7:T2N2*9P0XC,HG0@C"#_M29_-048RJC .:!
M0$RJG*:Y8NA=?*_(=0;#&3/@Y[2^1/JY..'?[^B94X38.-&1=X]+9&9A500>
M8@1PPP])K@%;*8LJDBEMPQR'E!'3NFBA7][-&6$@:"D^WU_>"%8AS!/"7P;+
MG2:N,0R%>)X1C@]4QWYI>WJ&]QHZ\*JPZ % 5;@C8X#SR>$-R/'842C-\$<I
M%RT8QG:5I<<17./#6BK2M2_ \PCY<#B("04!/0V[%0:+/= I<C )UY0"@RI$
M0C$S(_>'?\/@CYRFMZ3*UATRH4; 193=E7"3T'QWE"JA"T$UB@4*^A=J:\(J
MNSKB<AUL4Z7,YFZ2&[GR3*YV"J=S:&=3LQ#UOE!O.=)'\ G_;VYO#5D<$I6R
MGEF,%-,7PBADP!@8@0 @'KQ"VEFPD8J33*%!#:5(E=AI6.M;C&O14/"-A0:T
M(X@)S0@I1'/$(:BZ@RZ4GI6S/O\LB\]T_E>/_TM*SY5O)0M+M!?>H]'ZRO=J
M-45%G5%^I/7J@J:5O-->51M_@F([5BSB!$D_T\_9"XM)(37"<?:M'-PLO\X*
M3KI=G;<C6-):0GW8>WXK&*OH<KDPU7R[+SY%.M<!;2X\MBP=I$+0U6RJ1S W
MW4H/*8]!W%AF/%"8"3UB((M'*5KV0%G:,OA"805C@EZ51Q2TJ+A D""DC)!X
M6)#;-6,P8%'D^6?L>&#^*@C6@TLM7BO&.L0L TZBX!TL=8V3)C*A<.:1%KM$
M#8NW"3QXYK5+2/RP57X$#L5Y1O[4Y]R@)8R#T$84[XL/"<5/" S_#G@904D)
M#0Y1/LZVY>-XS3@#\DQ!E'.N$IN ^B]IBA8PE']5(D$=!!L_%NY*7Z&]P9SB
MI^TWV)-7(FQA[@3#(ZH%W>OD/77A%G4H9:8>#W.<)+.O,K=6(@DA 29>\I.0
M'-S-4H$))6;9]21P//0BC&$A2?EXC\00*+%P6%7ZK@6E:6T+&S K2$':@X+V
M!96B>-&K<,,"7G7A<W;>%'.F)8;(PGD&9RGW.@?)*EBQHJ@':5B+,AFBL?K*
MYY0>BR&999]*-KZ5$9A@ B; 91#6\48SS5'"UNGHP@U=2^J,"Q/2>>V5=&W$
MLJ.&*=CJ^L Z>CPKP#!)NM6"V8#$L3-NN[7%MN\8G(8AQR"AZHY<J59F*PN,
MD!?NL$BR#3"RU\%:N*?B!/1K,M+3MBSL2B\XT=F65C0()B3>A>,NJQ(4QV+4
MFP#$T]_9;+KOT7=M2<EH.A'CV8B>JV#W9HYV,CQM'V(V.^>??5-7,=JH-W!F
M^'TQ<R"G#$)_9\+2>\LFCL5Y;S8DWF:]T?D%4_ XG8%:4BO7HG];<BV^VPJ#
M-1Q BU_F1P>E>$K3E*]C3:OCRS9E#@HKF X(%=/F$3P74'VX#] ?$&/V0=)B
MBAI\[I[1F-&!%+7G\R5)+),2Y1!="C<!JS"%>L+V@D&Y; >EWFL=_DHK+Y;$
M]AC*_L[K#J/B*E0(:JE [ZTE=BY7LY[Z:%7GAX#]CYS$0S=)N\7;8OOKLHP?
MG&.(2TR2R#5M2_,>%T5/5AX21L;&:SRFBML*S1PL&"W<$KI\&V]>A<Q D7E"
M8>&T+ZZ+-3-9S<=*FDN.&7%MHR'T'L;G"@]\-%B-BRP4O##$+VK=/A7D7MKD
MWE;(?5]6$\BKE<,J\!&831D.C, &L;@V$*,:;SXD\NS._2)^IL+7R1OB5]#_
MKV!HRP!>^UJAN]/*'>3'007=^";V"I#91@:MGO+1\P(+O2&\=D-(T$Q_0J.?
M"AJ=1SW1\Y\*/7_E#FOZ.[9W>\^\YAX/CX4I H4S'.'WR?CB%'^&B&V7>ML
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M)#MT [Y?QA" _H<F*-Y-_/+_ 5!+ P04    "  0@@15$Z0)!$\0  !0+@
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MN[4RU1;G^P"H$J)M++HD7BO16-&Y%4=,^:8N6%]0PR/]*4Q=FYH,[$MK9_J
MN%LN^EXLD2,?E.W\?PH:@ 2H7R'AXW,9&J@6PQP3K VV:[[*- ==G9?F-9DD
MDK'JSTI3#,W6>W%2GW_K-U+5%%,_5]B9@G?\]E4^Z;S*N4#ID@(F(XU*G]2U
M86A K88H=4[0IWO6#Q_IR2VO =72E#B5H0TY=#/?_'QY??]YVJ'C4P6Q-P*&
M/" 75OF2SXMD3GDZW2L$ RYR;ZB4-4,A@R(2,WL\W%HJ81YQ,")XI)J"-"9#
M L_?4A'G[%I#Y=*::N&-C)-!A1BGC.0EJJ7=!/6\KM'/2)-"/$2)([5.#<'
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M<YRF KR#M/.*H4:;\@I@#L[^4@E:2@#,8;_?!)C>=-OL-719.]<S3$M*8 7
MFV*7NY)KGSV/"E5&33U?1*ZB5Z4[?D/UW)(\<5)/_P\M&KPF]1F>'KHJC[S6
MYQ'_+TJ7&A\TG#4I:8[&XQK;QHYT@2.Q4;UA$&3<R088!Y,T#MUIB&E!]4[.
M?.6#>]15:AM?(&G4T8.^.TMC#"'L:*M3Z@?]#]=2"U-2GF8>*)6XURHDW)#W
M/DID-"1"-M&KYW< MP@*S^LBY-FI^_K@7 3@-[B,9C3 6I6E9I;SOR4W**B9
M)GR)CMGR@9LFGKL[M#U,GVW/DE+UHFXDB&8%X#&TPK]'*:B?Y<<RH3$'3V"P
MMW*A&FH>FJ#))/SP!B1)-C<X@9>Z&_&@G%PNXF,O,?QI@S]KS.\WSQ0(JE8Y
MI63*7;I<$Z>UFG)CE0_1>&+P+E+/&UQ3%UV0ZW*AHCF,3,HF2-LU@'B] ?'F
M)L*!&BUON*]5\S X8Y:7JG@=QB/ P8?7AWNN!-'EJ[.PX5?></,*>U16J9?:
M'VU_C[&+L&\DTZT#FC*\- A!'5$O-]X^=>R\UJDOC8C*6JLL/7Y&?HM>4R_;
M'!XA>E;2'HM#08(=UF/-V!CLZ)4&'6KK_=_+[<?R0>J,;3+HC"_&8>%WOJLE
M7!"@1"W*N4CEVHF>_V]K'4M)-R9#\5/-W4_MJ4BP36M TY02ZCR<="?GDSKG
MOF29PXMN'SIK+]MA(_*MUG&^UT-:\D.S537+=.)G310WOK+1J D)G72SLK27
MLWC#I-)Z:-88#@ F^8Z_*M(F$G([F*#M%5 $0(-*._2Q@OW2. IY=M>,//A#
M<(FS?IR!-*TD8M:4/"[<&A7R=,\GB#^J(O"/Q,\QK55=.' J^@P-LM0F6AK!
MT\H;/YALEA.>FQUSEMT,ZCIB"H?5E.V_*IKT9.)N#<2._/QS9<U*B<ON[UUQ
M-/UZ%WX@5$%%V'?ZE'H,30L![VDT';E9$W^7J"R0^2[18 !(->DTT*N$@A?:
M^4G6,Q.*(\H2-^';,=&"-P[/1N^'S?Z)2UJ$ 61E8-D5->2<\6F7G[CNG)PS
M*U;SB+4FWVK/Z/=P:]F* $J'=,78B;O.VT/%<#FW:\_DY3U\C;5CS[#/#A2V
M-9$O;YN\<-1P)(X26"9ZD>_KR(0S4Z0.?K!E'<0U0$9%UF2L7=0S,IX'+]"0
MH9H3(@NM_<8I_N9:'K^IL/6!G9",O<._Y2A^WE>?&,;OC2.ZC</Y^H#3U:#W
M/M:YS0'\H/^^"5KA-[?T%D!_>-+K'\GCH]'QT8-F/[M5BXA^[T[^;;M-*B(\
M]ZC*Q^$J]/D^UNL[']=6$@=V"T_78^M(G^\J OK;H1;/3HR+P(*GPX>BX/HY
M R7A87=P7OMR1X2&01</:$<,3>K\U9WGN;X6"6CP.Z%7QO"*=]:4ZSZAY@+9
MAO.EQ[3[C/U-/F,SO!Z[+,"X&8Q[WA=P?_*H,I[,@3O %@*;MFI<7W4BJRMD
M>%WEV#17H6F,[2%K 4D.69TO\YQ)-)N-1V_JB4 :VNXE]\JQZR3&^Q>C9GOZ
MXLU$^^[G.MYTA?.;EPI@']D*V,T/=V4%+\2NEC.U?6?CD]U=Q2#.)HAPN )"
MT_C Y1*H& ["#:\'<(X=+"C?^[*D3@@;N>R0TKBB;5T0T)T)9)"\Y)] +7'X
M%"]9<4(.WS-V';)R=,OF\6R(P&D]C=_!)<SM9*9B_ODRO;L4T[LK<6]62"F3
M,X"/>^C S:D/(8[NE'W0?%'=G-9 %R1I\[(S6+$,NZED;10&W_%)#?T1J26K
M7\DCE)&B^&AZ\RIV]72E1PG*9&DG#.&V;>#!";^>1)%4PSP"*:#DYNO0+!CK
M(G?U%)%T;ZM5F0!*QRN^5)V0*R\*OL_F@4[2B'^O_ T#L:78GA% @^E.GGV*
M^1\Z;?N"S".W.BUPOQ!OUD7SXM1/:I*U!S4M_'[\CAJ)X!HMG]\Q)@B_;0-Y
MK[8-0IX&A/S2[Q05+0Z!\4?G!*6!G^ES7PRZ?7S^=[1>S77]\W-Z)0A/!H-A
M^'2K"CR>Z=;"^AT()K/Y-L W'^![ONL8$7PS?0*2\:R5DJQOQCB/#29U'GL1
MQ/>'HV>+=EP]-V;B_!8!\GT.R)JMH[MN:GVHH70'#I8@"L_4C?T!_O[&H W)
MT1=H7<3)1'-NLG,>M/M./ Z)J UH1(>L!X,1<*_#"'3]AM;^5]Y/U\ !OA.2
M$U^\E0%=]K5LF!/$LW;B"HJGF-W$-7X5DUA0<^/*,&@64_\BR:U:&5ORJSG&
MYJ+?._F75\5FDJ0+_^XT%VDO>]W(!F,^OWOJ[GIK]+3QEB^JR(+?97:^S/@7
M?NM?Z]>EI_XMX<UR_ZXU^IL%G ,&FF,K8?@#8?W[R_Y+:5;\SO#,E*7)^>-2
M(:]96H#G<P,#A"]T0/T2^:?_!E!+ P04    "  0@@15(:P>",L)  !\%P
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M7@S0/M-!V#5J[L.H+ZX"=9H>P!WIUZS\#$ 1J##X^1 9]^B90DCND)!4#6%
MPF:,QY#F\)QIW5@08]:*8?(E^&2X&TGGI%FJT/ G*>\.QB=###0#FM'&([J.
M)A-Q3=GBJ!"6.55(LH:TE[3_UP?%2Y)#<TN8C";BM-8Y97<@A"X0A+O&QJB;
M]H>X)LE G.]4+VJ'^EB[T%07^IZ^>Y%TTT%"UQ'&+5EJ.IG -,A;.HKJ(!F)
M(4:Q07<0I72-!^(2?[RE&EP7E)5 .5,X;& \8OXEW7@XINLHX3DV3H?A/B#7
M]A:V(]T:C>#5N-_BT28 R@8Q77RO41E#<2-XNEB;_-Q:P/<J&@Q_6+S0SE=H
M;??4-&ATW8IFG*/A3V^)>@T9<FN6!S0D_#^Y_)"W@SY=!N(*# . X&;.Q=31
M2P#,P0>UW_(X[?=%"@(\P7!$(1I.N#KX*E F&:<BC>+G6(],B1#\"\SW11@&
MPLL-$@A923BWQ>\:*.*DCQP:<*H/H(GN*5)^.I^[&JXU8?\UB"XQP.2[6OE*
M) /2$ ]3<2TW?+8)%2 0,]=A,J$:.$*NCE,4*#7C^DL)D@#4,P04/C>S*(\]
MP<$H25 0)HU;PV@@AN- Y6@RXGN:#!]5LGV%O^+?>[50D$0>H'K7?!*,J5[%
M.!4]$Y\(H8L2'/;D/;2BS?/P&0]&V-1:'TW@2TSE8S3F8H4<>LS<OVI[&V"T
M>70M4;$Y1%DB;IK&CX,7@<PQK'DV $";D'[.[7Z"II/\D _[;B0 (4$(?X U
M'N$8.6JCEP[&(AT'JD[&XU"N<,J<\H%9^3JOVBDE[D<3U#YDIN<>3,]/;_^.
M>C_OB=?X%DY\2 Z,-C@9B)DR:H$F;W%Z6P:_6G;R3)SA7YH+VW5E\_:1&@C&
M9WI#08;/-JR&ZI&"($TA_F)XY/@G?,]H.BW*W&X4C3WO:]>>$)ZKHC 2IS_C
M&V!HZ1.F\E'.>TLU6V5M$0D#U4-3>3#4. S1($L3+":U<,)A$5L@23-/B;E&
M++(P6&-(I?>SM(0\UN$XT>IYQJYP%@M0L@G!NAZ_]6#?9)B(,IWQ@3%,8]OI
MA/HF5M#X1)%=;,_XI6UCZQJCV65;-L3TO:?>I1WNO1'%T+;D][X^C,?AY>CV
MZ?;5\C2\4=TM#^^E/TJ',Z@'H1?8VN^-!IU0YML?E2WY_>K,5I@0^>L*9V'E
M: '^7UB<=)H?I&#[POWD?U!+ P04    "  0@@15O@+5ZI$$  "O"@  &0
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M%^K.!5-&LB,2#ISJ1M@ 93I]@9H".6F*:"XX-()!%;QHK,1XD^KK("VAG/L
MF+/UF).0S%DVWD7+H&T#;5\)3[ 2^,(4#H5$C"SBW].'1.?:O_,X#A%PL*5S
MU1:,87?72B=#\"8%!)V7'I6_TW%\-!H(#&Q&S]X21J?4 :$.3$),2Z.D(8TO
M!OK)0?[M$EZY=R-2L+B,*5M;"F(];HSE"@,XQK2/18&VM.P[5Z3GVFU$< !!
M)#>R&R256 &OU:!IEEK^W>=YP9I+V?LRR-\+U8KN&Z!0Q4+GW.7<6 SMD [$
M1N]XL]-8<R_C]T84?[6=RVY,I[$<GI3S"(Y0)0IZO9NF&,Q*!2U(+2UBLHT8
M9%:5S"L2,3:O9[/9H#\B6=*C(FR85J$48KI?S'S'[@/R52]0S;-TU!?DP##;
MV_LFANG!P;<Q?.S.H3FW<^A&SS-%T)BNIF-5:GSRD1]<<"BKKN9CEU;6M,LJ
MEC!*=J,7AM+&]&]S)#U,F;@71) Q74;36&Z<T6(!VS#HY$)QUYTKZ:M0?W!'
M\X.G-.NG18SU"B$*V$;!^1I;@6R@*)UK S^H#@4WHI(+C#85V3@ONNJ/9%I?
M&1O9A('B @JN853@6+3=*M,'<2%4K&7DZ\5LQI=-B-WKQRH8/_>EFFPL$36C
M7\.J%&9?JWVW3ZQOU]O8:;>$/(IWJ]Q'M#L& BDNH3H='^PE9+OUJ#MXT\25
M9&$\%ISX6&&C9!L$\+XTQ@^'8&"]H\[_ 5!+ P04    "  0@@15ANV^6-47
M  !\0@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6S-7&MS&S>R_2LH
M)96UJFA*I"Q'CA]5>OBAC65Y0R?Y<.M^ &= $O9PP QF1'-__9[N!C S%*7(
MF]RJ6Y6*^<  C7Z</MT ]6+MJB]^84RMOBZ+TK_<6]3UZJ># Y\MS%+[H5N9
M$M_,7+74-=Y6\P._JHS.^:%E<3 ^/'QZL-2VW'OU@C_[6+UZX9JZL*7Y6"G?
M+)>ZVIR9PJU?[HWVX@>_V/FBI@\.7KU8Z;F9F/K7U<<*[P[2++E=FM);5ZK*
MS%[NG8Y^.GM"XWG ;]:L?>>UHIU,G?M";R[SEWN')) I3%;3#!K_W)AS4Q0T
M$<3X(\RYEY:D![NOX^QO>._8RU1[<^Z*WVU>+U[NG>RIW,QT4]2_N/4[$_9S
M3/-EKO#\?[66L<?C/94UOG;+\# D6-I2_M5?@QXZ#YP<WO' .#PP9KEE(9;R
M0M?ZU8O*K55%HS$;O>"M\M,0SI9DE$E=X5N+Y^I7YVZYM#6T7'NERUR=N[*V
MY=R4F37^Q4&-)6C@01:F.Y/IQG=,]U1=88*%5Z_+W.3]YP\@6I)O'.4[&]\[
MX3^;<JB.#@=J?#@>WS/?4=KO$<]W]-_L5UU8GQ7.-Y51_W,Z]74%I_G?75J0
M19[L7H0"Z2>_TIEYN8=(\::Z,7NO?OAN]/3P^3U;>)*V\.2^V5^=7U]=77ZZ
M>OWATT2=?KA0Y]<?/EU^>/OZP_GEZ\DN8>^?[L/UI]?JG?KANY/Q:/1<W3N[
M^K0P:FERF^D"OG]C,[S5U1> ARW5>F&SA5H;M=)5;3.[TK51UJM"5W-3;%1M
MLD7I"C??J+Q"+,*RI[ "8MLCA@:8HD9T(EP;S+ZJ #Q5O5$5Q94?A$D;3(:I
M:.IH0E@I-\J;K#(\KM ;3.KMO+0S"%K6JG*%(0$Q9]YD-4D.-%J1%_ ,N9W-
M3(5W5A-4#-5EJ6KLM*2X+U3FFLH;Y69JVGAHS],J8:K"ZJDM;+T9D 1-96OR
M(YHT@Z>9*K,T0:'M$I_"K;2'.]0F5WH.Q/2U:OQ03>S28E]QW!(;F.X<2IL@
MP69-33Y:F4+3@-HI[(CT4;I:?2G=NJ3/EKH$KLHN:WZ.O1%O:^ J[U+GN:4M
M#["1+]@B!E4D^4J7M(^PW);%;9D#F"IL&;:F3?EF^AEF8SF^UH38-R3<',9B
MZ)UN5,FO= $UU>06I*'"T:1S=V.J4J2,<1C6_74X&?+(*%=3UE7X/CD;N0EF
M'*HWE5ORSD@._C>(1U-%$6'$/QJK:KWDA.!*,58K!"2RY8WQM9UK^=[-L"7Z
MT!4W@(JX,4<*$.>G3ULQHY- V[1$9F!AQ T\Z%M7QH:+/(1'U F[59F)6;&;
MS-[80ARN@AN5$CJ9@<G*.1P5&X?&R;4+-2.YX+L&HY*?ZAQ/6<*Z6LQ&U@[?
M+30^T=AE;2J:0.<0%ALQB!=29JD0&C2M+MG15\X'=Q*A27G!0''#!ZZ"KT$3
M<+P-C(:WT0E9 <(SPAR(2C+F!P>/^;F%J'LQ'.-)*-U@4L1&*QP[GCR5X0G$
M%+Z&5B_QJ3IA2?'<TB'2*I.1>D_+DJ#H%[-R%>^6B( :'3[^68(GRUR58W9X
MFJT7ZLWIY$R=3L[5)[>RF7IRC+35ETTB)LNJAB(@8B1AA1==>5/7!0LY4+E>
M(B!@+V0DCX>AF=NPD["ES >J0=)%F  UL#G:I.@54Z0%0%@0GV; 5":G/2U@
M>U=Q?)NO,)4E[U*.%4\.QQ%=*[\R&>%IE(8""]),];20:";'7=*[H;JF.%A;
M6F9M>%8L29-Y$R31%,. R\KD4.5,%N():@9:W<Y-ZU$609[04"2O53JEEX0&
MK/@0&?(U1BX=9",\*S9=A3.2P=67S3(^[6;MDT/U.WD_F32IL#!S+<&U0_$+
M2FND6VS"UA'TM_6<< KF\#87AP:Z-V7CR;F@:#A]9?YH8C;J9B[HZ;V-@/ X
MXGV)?!N65X_"\OM1%>S\F6#XAI"I*6,LD BNL+F^*S"0D(LBP-A_N7==12UB
MC2#2!&D=D@P4X@!84.S"G> E_ENWT8GJ'M:P.3..OH8S J53>%(R;5*K""]A
MA'&Y =A!-'$8<13LU,(I2_A3O4 N[636J2DLDB_)#=5-B?S8G.P6>0V'=0,?
M:"-U:W&:%/0#\0U_Z8!AB+1(!]B+<[$(K='C M'1)&5$P 93"I"-5Q:J)-"&
M8H.:.)DQ3L.2VB_4##5:0FFV0# X]$*FP"R,='W4SY#"\+I&X(O1*G)L@BOQ
M(4@#<;RH[F[<4&MH[?OCT1-$*?R%=,,V10E@4@G CWQ__.1D:] %$'LYA=L>
MC7C@B <"8XHF-ZW5(\;<#[E""B6"(2R>J"RVWJ%;.T)"DZU<(G&=P:0MN'GI
M;_2<$S0*C#D#[M) Z6$N"CY%B88VQ<!$H!>422\+*KHWL#>55OBZ<LU<3/$'
MA@ Q*!K29GB<>O2OR9O]Z!O61X6P\\#T8%,9*X.,3YO>_@RP9&]TP>&%1ZZ%
MAQ%N,SAA.=;A]Z.C\9];;73RIU8;(MEVD_Z;E/0GS6HE.X,ZSG3!:7?"?8O+
MEC2PU^WF$QU\-]T(W(FJM*<G[99R$'L$"Q-)0WF55 YN7O'&9K8"9_#V*S(/
M%[]XFG8]4-^/GYT\8!(9+R[[_='ASG7O6 0:NY!!@;-LC*X\ISV #KBGGS4$
M Z69.RIOR+"APF7?OV$\+EPY?TPTD4CC5M0F'D@+ *FQ7WWC*H[8JB%<9]>(
M4TGR" \_5PNWIB\"Q"5 ]B$+NJ9NETTF020$HHGO@3O"^%W)M(2SNR1N;Y*4
M@GL/XZL=4 ,P%@D<8B *ER^WD!(@@.B%:O\*W05K;'/'/S!^A1Q($X12A>JW
M$%Z$V%QS2+0B^03#=.A]T#: E7*!PTYSZ6#(,P_GLU)(\PR1Z''V &&!P1A:
MIM3 "U!"M7J.PB-O>!1S&$F7\SG*(ZA_\$T6Z>:2,E:DMQ79YJBA^K4L*)UW
M 8UF"JPEP"9EL<A%6>2,(R!L)3)*&(U))O#,91(CG.5(Y>T^VSULFP%RE62X
M*<6(]@">*9224LU0?>1N18?)J6O\E]6.H&]\0M W.N80H=J&" \T4A"<-[9.
MY?^Y<U_46Z#^"C,MF0E)]8./KT*%_O[].1BAXRX*8I4(,'V_GRKJDI^;$&GB
M=A>C/<8T< C"3AJ4/F:$+O2:///1Z*?1\>/LYO'AX;.3PWVD(ZB!-D_LE2J<
M5)"&:(H[B:T:\HN*U442,:S_^-PC(J"G,JOQP9.3\7-J'#J?<0'USBQ=5M@5
ME\]I/F_,%T\&J\D$,TOD1;>*APW<!N7M1D@FBEW@?TFRV?)S4V:"+S0A96SF
M')R;D74J2=<]%?0U,P$>P9W*GHHNX2*(Z:%80@QW61*N?R1X]XBW&VI//[K\
M^,N^8J9/U(-=+'4Y@HN0S)^HGT6-!74]FU&_Y=&ODX^?KO>3(\R84"Q,^3BU
MB(*28Z87.#)YVS2@70!I-S&=\.;!;&U!6>10B#\$Y-HXA)20^A*99\F$PRA0
M 0:RKIT#W\$G1A,!79!GP!^B4!UE6]^-FBDSWH>[Y7W*'[3JC'XBNI']5L:T
M+<-..$$VCFBB5YUR'+MZ8Z9 D&I#VCGJ.^""R'WAG=K6?C]2,<E;]KU- ->T
MS9\A5.Z6G W^J<NXS%@0X.*'[\;'X^>8N\A=-8/WS(7+L#8&.\#D?*&91"$;
MLYUTO3O$NK%UCKCJ-F1C%/NN#M,,LL&!>OU1'2DH1!T^'8E2MJ45D\T148)/
MJ.NX<\N]QX(;5-6F$XIJ;F^B3T8%<TE.75]N*):?':,)5/JHAW6O?[TX5V^7
MTW>#J&@!.V 66$6V*$CMO>]OX^7KAMK,ZGV=#P?JDIA@F>^K&742'?6$8V?/
M2P5[IRI]Q]P(YE =O$_50<=:I[?I\6 G/ /65@B7KYQ%D%".CP>'AX??5GH\
MH.Q H4,=ASC>: **BG(K\4JQEM V;@QQ^6F*&VS<57/-K*G0*T0WI_JI,>7N
M)O<UC (Z\>?[' ]^Q#:W-W5[=FK"&\01<0=A2^H<4)#KP8Y@2];E#9Q2_QI8
M!M#^B.F)XLQ\[$X4DF.(9YN:]A^KPM0RX]R7NL.48GRH-CXWU>86CR!I&CE
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M+W MW-T9'QZ>! &DW4^N%RS0'MM2MLJK9O[8%-+P\K7<XXT+>Z(1]?W50:E
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M#<#W,^?J^(862']PXM5_ %!+ P04    "  0@@15".C(SC\%  "N"P  &0
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M%GA02\L&^+XPJ$"S8 ?M$WWR'U!+ P04    "  0@@15PVHMY',&   A$
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M!(PO#/;']H$7Z/XK</8/4$L#!!0    ( !""!%47J[(IF@<  -\2   9
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MFM,U&95=0-]GDH1I!G:#]N(]_AM02P,$%     @ $(($5>2M2ZJS!P  0!8
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M%9VQ"+9#)PRF,3*LX.= >3$9-_5U9WJ,:M@='-.-IE\K9(KO#];IKW.Z6^B
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M'(!N^E4SL:KR/2)5ECJ.'Q;4XE&[ -I?*&4W$W= ]Z>1_ 502P,$%     @
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MDZ,=@@?8]-L[?'2T.TH>2(T/TLZ(;:ZK)&?Y?+/1F\7GG%3EL4^*G? @<,*
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M4[CD*>@ HRZP3&M6@N=Y)N>%X13 R#32E1%ZI4K22P(?S/#6PLO;F;5R&&\
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ML78:^-WMK^Q%_EI*6\C!21VB(IVUJ\<3:PMPV/B0@U(7"P%5?[H5N./R="6
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M.S,F3.1Y%(',9U()B/K)DK@D&]O3'V8117[P4GHA)7T0^0%K5]W(M2QZSIQ
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MI7D"7V049Z7O?Y-#U6QD!^-2\K_0KQ58!A,]EJSHNMD.S88N98?BO.$@Q(G
M0H D$9S!JT-*(77!)=::OMFZG1)Y#'TI2J% 0ID@:/Q,Q2(6E+%;@C3**4\R
MRC(V,P'>%6C0LPGM=S8Z:)G[:"1Y00+Q$%&,?KS#O9.N@E<M4,*BI!+F1D%9
M\G\8IE3D.7I%$>\"_06GW4(RZS_PNCCV;1QQL&.X._'C(@Q]*R#-\R':A7[X
M_W$N2WG#)(G\MF'IN5<RZY)T4BG$BK=YE\%L]E.1Q0B2\.',T^(%[V*X/ KA
M2_ J3E)"3!/8_$B\*,A"@0"6)(($/40&GLLS'@O$]+\A7XPPY8FG:U1XXF;
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M>TH*V+-6X+WJ/L%0S[7CRY4P_DFZ(3:D)&\-JGH 6P4UE_V;/0Y]. ',9F<
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MNZ9$][O4&Z@:/[^90KL-_EC9WP]H%V#O]TKAT7 )QA]:^A]02P,$%     @
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MN^(V*\S5*OM7QZZ^N25'W63Y8OPBNX[FZM51\6J;J?2S.CK[VU_LR>#O76U
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MT7.0(4X&/E-K36WUSMTJ6Y"S79?/]2O/J[AJEYYWYC&.CYD-XXI$L$:8<S7
M^XW,WK=918M=^N);"HWOQ[2X!8H+V'3 [VN!EY*\8AZ1Q7\9)O\!4$L#!!0
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ME&90FJ5H99/F66"_+0M<)M<?DEVV/GJ2+<5+]M%_OCO^RGT.)^.E.4J+49I
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M:,0]LQV5E2A-H32-T@Q*LQ2M7%9YCCOPY[CN^_!UX?;"=S/NAP?7 4F+49I
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M=%374K2R6?.4<N1/*;ODZ:-Z%%:S)QI(M@L*5%"B-(72='MG&%304K2R(_,
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MQ2A-H#2)TA1*TRC-H#1+T<HEDP>QL\Y!+#*Z.LE-BH.<OGM5D?_(@FNCL[!
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MXL3=+/Y'QV7WVL._#=@VL>*L<7EV9%Q&EY8LIUA.LYPY<,UQ.0C<GVDQ:?2
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M\MT-RK^_SK+B\)O= I^S_!_[+^?5_P-02P,$%     @ $(($51(^8Y/Z#0
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M=Z3&EB.TG=Z8504<)X[,"\G(#[06B[.&ZF_%9*1,#C!ECT&[7,14S+YF>WZ
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MU0Y0(F.Y@TTD9A.)0XF,%0]X.7VO#LI[\7#O92;OD$])L[RU:[SGKVT9+&3
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M1/.E<R>22IP[[<. WA0/;[Y6VRE,L*2!92\CHZA)S1\;)"-%<@AI6#]4R+Z
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ML;)] S3M$-\8B.+TP1I:(!DIDD-(8R:%"MG74)D^$6[ZZ%X=J!;P])JQOI0
MYPQ6RP+)2)$<1.J^/!6RKY:R>B*K9_1 4RM'&ISIB9BO"\/A@R6T0#)2)(>0
M9H,[A?,3*><GLG%^[(>@7;3^"].,E<PX<[!R-DQ&RN0 T_/T-Q?$5,Q.NXN]
M]R2O1+EL7X%=.>U+5;J7T^Z^W;UF^Z9]N;3V_:W[;NH"W\_<=ZQ[B;8*W[W3
M^V-2+M.\<C+Q(%&CMV-Y)R^[UV1W?]3%NGU+\WU1U\6J_?@H$MG7;1+(WQ^*
MHG[]HP'L7E9^_7]02P,$%     @ $(($5:W;U>A[ P  NPT  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#4N>&ULK5?;;N,V%/P50MT6";"UKI9:US80VS*:
M @&,I.D^%'V@I2.;6(IT23K.]NM+4K*B)(K6V?6+35*<F<,SO(X/7'R66P"%
M'DO*Y,39*K4;N:[,ME!B.> [8/I+P46)E:Z*C2MW G!N025U \^+W1(3YDS'
MMFTEIF.^5Y0P6 DD]V6)Q9<94'Z8.+YS;+@EFZTR#>YTO,,;N -UOUL)77,;
MEIR4P"3A# DH)LZ5/UHFIK_M\!>!@VR5D1G)FO//IG*=3QS/! 04,F48L/Y[
M@#E0:HAT&/_6G$XC:8#M\I%]:<>NQ[+&$N:<?B*YVDZ<7QR40X'W5-WRP^]0
MCV=H^#).I?U%AZIO'#HHVTO%RQJL(R@)J_[Q8YV'%D#S= ."&A"\!$1O ,(:
M$)ZJ$-6 Z%2%80T8G@J(:T!L<U\ERV9Z@16>C@4_(&%Z:S93L'99M$XP869B
MW2FAOQ*-4]-KEO$2T)_X$22Z6(#"A,I+]#.ZOUN@BP^7Z ,B#-T02O4\D&-7
M:4V#=+.:?U;Q!V_PA^B&,[65*&4YY!WX13\^[L&[>JS-@(/C@&=!+^$?>S9
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M69P?;@D."<\:J/MKQN3+29:@VMHX_Q=02P,$%     @ $(($5?[8;:.R!
M;1H  !D   !X;"]W;W)K<VAE971S+W-H965T-#@N>&ULS5E=;]LV%/TKA-8-
M+>!&'Y9L)[,-.):$95A6(U[7AV(/C$1;7"31)2D[W:\?*2F*;3&:XQ)#\Q")
MU+F'E^=>?I@<[PA]8 E"'#QF:<XF1L+YYLHT692@#+(+LD&Y^+(B-(-<%.G:
M9!N*8%P:9:GI6-; S"#.C>FXK%O0Z9@4/,4Y6E# BBR#].LU2LEN8MC&4\4=
M7B=<5IC3\0:NT1+QCYL%%26S88EQAG*&20XH6DV,F7T5VJXT*!%_8K1C>^]
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MUP3!&%$)$-]7A/"G@FR@N6&:_@M02P,$%     @ $(($50&7"UP:%   !]L
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M(IV^UI1R1DS=N6Z*5(GH2P%5DN>U.V\"59:E[KP9HE41=[V*V-^L\*\ULDF
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M51/YD1^\<Z*,W??S0%GJO@7;#%AQK-FYU8#(3PDTY&"+!F =D@'K@ Q9AV3
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MHRS"F"99R!*4TN5-YQ9?^::9!Q2*7T/ZG!V\1OE0'AG[*S_P%C<=(^\1C6C
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MV'G8ZIQ^)Z0#<\4=O#>Z:X7:^\/@5<R"R^CC</P<@GAA_D\8]6XG2KC29=>
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M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-V;ENPD 4A>%707X
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MWC7J7?^GWBF?]S'=>VYK?/Y_4ITO]\;[XZ_+V\G!2[CB'."'],LW4$L#!!0
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M2P$"% ,4    "  0@@15!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !""!%7EL76 [@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M !""!%697)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ $(($5?WGI:LH!P  8"L  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M !""!%6#0E1,'@<  !4B   8              " @6L/  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    "  0@@15N K: I@#  #%#   &
M            @(&_%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ $(($50'8W;%F!@  OQH  !@              ("!C1H  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( !""!%560+\[Y0(  '@)
M   8              " @2DA  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    "  0@@15/VBW+\P+   [@0  &               @(%$)
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ $(($5>(*HQ;E
M"   GR8  !@              ("!1C   'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( !""!%5,CPYOXP(  !L)   8              "
M@6$Y  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  0@@15
M#E><!G\&  #0#@  &               @(%Z/   >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ $(($5<T3YQN-$   >S   !D
M     ("!+T,  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M"  0@@15 [:F@+P)  !P&0  &0              @('S4P  >&PO=V]R:W-H
M965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( !""!%6LUZSWZ1<  *=8   9
M              " @>9=  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L!
M A0#%     @ $(($51.D"01/$   4"X  !D              ("!!G8  'AL
M+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  0@@15(:P>",L)
M  !\%P  &0              @(&,A@  >&PO=V]R:W-H965T<R]S:&5E=#$T
M+GAM;%!+ 0(4 Q0    ( !""!%6^ M7JD00  *\*   9              "
M@8Z0  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ $(($
M58;MOEC5%P  ?$(  !D              ("!5I4  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    "  0@@15".C(SC\%  "N"P  &0
M        @(%BK0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( !""!%7#:BWD<P8  "$0   9              " @=BR  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ $(($51>KLBF:!P  WQ(
M !D              ("!@KD  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    "  0@@15)%0"/.T)   /%P  &0              @(%3P0
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( !""!%4B54FV
M#04  (0/   9              " @7?+  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ $(($5>2M2ZJS!P  0!8  !D
M ("!N]   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  0
M@@15X*]"20T#  #J!@  &0              @(&EV   >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( !""!%4:8TR_N@(  $ &   9
M          " @>G;  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#
M%     @ $(($5;W-Y%)N!   [PD  !D              ("!VMX  'AL+W=O
M<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  0@@15<757,'D&  !F
M%   &0              @(%_XP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM
M;%!+ 0(4 Q0    ( !""!%5^=HI 9@@  +<<   9              " @2_J
M  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ $(($599R
MQQLF!   [0D  !D              ("!S/(  'AL+W=O<FMS:&5E=',O<VAE
M970R."YX;6Q02P$"% ,4    "  0@@15AURP&F,,  !T,   &0
M    @($I]P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M !""!%4LEA"24 @  .86   9              " @<,# 0!X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ $(($563DYU/'!@  9Q,  !D
M             ("!2@P! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    "  0@@15^:!C=6L"  "$!0  &0              @(%($P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( !""!%7.F?2_ P0
M *X)   9              " @>H5 0!X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ $(($51I<^AAB!0  : P  !D              ("!
M)!H! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  0@@15
M0?5!7]H&  #G#@  &0              @(&]'P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( !""!%5/)5'D> 0  &$.   9
M      " @<XF 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ $(($5:CC]31  @  W 0  !D              ("!?2L! 'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  0@@15 ]B_M2(1  "A]0
M&0              @('T+0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( !""!%6@E4 G)@@  'A-   9              " @4T_ 0!X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ $(($59>7B1;Y
M P  <1   !D              ("!JD<! 'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    "  0@@15S3U(C+8(  #34P  &0
M@(':2P$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( !""
M!%6"4S<$7B8  *5$ @ 9              " @<=4 0!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ $(($5>/I\C%S&P  0K(! !D
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M=#0W+GAM;%!+ 0(4 Q0    ( !""!%7^V&VCL@0  &T:   9
M  " @4*U 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
M$(($50&7"UP:%   !]L  !D              ("!*[H! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    "  0@@15EVF4DC,8  !I,0$ &0
M            @(%\S@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( !""!%4%8Q)9RP<  )\]   9              " @>;F 0!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ $(($537S)$1N P
MK!8   T              ( !Z.X! 'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  0@@15EXJ[',     3 @  "P              @ &!\@$ 7W)E;',O+G)E
M;'-02P$"% ,4    "  0@@15K4F[&$@$   M(@  #P              @ %J
M\P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ $(($5:&7ZI3) 0  H!X
M !H              ( !W_<! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ $(($52BT:!/# 0  B1X  !,              ( !X/D!
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #L .P 4$   U/L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>478</ContextCount>
  <ElementCount>376</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>116</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure</Role>
      <ShortName>Consolidated Statements of Cash Flows (Supplemental Disclosure)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Acquisitions, Divestitures and Strategic Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments</Role>
      <ShortName>Acquisitions, Divestitures and Strategic Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Hedging Activities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</Role>
      <ShortName>Hedging Activities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Contractual Obligations and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</Role>
      <ShortName>Contractual Obligations and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2122107 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2128109 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2130110 - Disclosure - Weighted Average Shares Outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</Role>
      <ShortName>Weighted Average Shares Outstanding</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2133111 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2136112 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2139113 - Disclosure - Changes in Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</Role>
      <ShortName>Changes in Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2143114 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2213202 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies</Role>
      <ShortName>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2226203 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</Role>
      <ShortName>Commitments and Contingencies Commitments and Contingencies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2244205 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Acquisitions, Divestitures and Strategic Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables</Role>
      <ShortName>Acquisitions, Divestitures and Strategic Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</Role>
      <ShortName>Goodwill and Other Intangible Assets Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Contractual Obligations and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</Role>
      <ShortName>Contractual Obligations and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2323306 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - Weighted Average Shares Outstanding (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</Role>
      <ShortName>Weighted Average Shares Outstanding (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2334308 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReporting</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2337309 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Revenue</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2341310 - Disclosure - Changes in Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</Role>
      <ShortName>Changes in Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Acquisitions and Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails</Role>
      <ShortName>Acquisitions and Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContingentConsiderationDetails</Role>
      <ShortName>Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StrategicInvestmentsDetails</Role>
      <ShortName>Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Goodwill and Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - Contractual Obligations and Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails</Role>
      <ShortName>Contractual Obligations and Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424409 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2427410 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429411 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockholdersEquity</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2432412 - Disclosure - Weighted Average Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails</Role>
      <ShortName>Weighted Average Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2435413 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReportingTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2438414 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RevenueTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="bsx-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2442415 - Disclosure - Changes in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Changes in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bsx-20220630.htm">bsx-20220630.htm</File>
    <File>bsx-20220630.xsd</File>
    <File>bsx-20220630_cal.xml</File>
    <File>bsx-20220630_def.xml</File>
    <File>bsx-20220630_lab.xml</File>
    <File>bsx-20220630_pre.xml</File>
    <File>exhibit22-subsidiaryissuer.htm</File>
    <File>exhibit311-ceo302q22022.htm</File>
    <File>exhibit312-cfo302q22022.htm</File>
    <File>exhibit321-ceo906q22022.htm</File>
    <File>exhibit322-cfo906q22022.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1317">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>69
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20220630.htm": {
   "axisCustom": 1,
   "axisStandard": 29,
   "contextCount": 478,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 651,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 5
   },
   "keyCustom": 56,
   "keyStandard": 320,
   "memberCustom": 63,
   "memberStandard": 48,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Document",
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Acquisitions, Divestitures and Strategic Investments",
     "role": "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments",
     "shortName": "Acquisitions, Divestitures and Strategic Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Hedging Activities and Fair Value Measurements",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
     "shortName": "Hedging Activities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Contractual Obligations and Commitments",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitments",
     "shortName": "Contractual Obligations and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - Supplemental Balance Sheet Information",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122107 - Disclosure - Income Taxes",
     "role": "http://www.bostonscientific.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Commitments and Contingencies",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128109 - Disclosure - Stockholders' Equity",
     "role": "http://www.bostonscientific.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130110 - Disclosure - Weighted Average Shares Outstanding",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding",
     "shortName": "Weighted Average Shares Outstanding",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133111 - Disclosure - Segment Reporting",
     "role": "http://www.bostonscientific.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136112 - Disclosure - Revenue",
     "role": "http://www.bostonscientific.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139113 - Disclosure - Changes in Other Comprehensive Income",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome",
     "shortName": "Changes in Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143114 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)",
     "role": "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies",
     "shortName": "Basis of Presentation Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2213202 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "role": "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies",
     "shortName": "Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2226203 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies",
     "shortName": "Commitments and Contingencies Commitments and Contingencies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2244205 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Acquisitions, Divestitures and Strategic Investments (Tables)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
     "shortName": "Acquisitions, Divestitures and Strategic Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables",
     "shortName": "Goodwill and Other Intangible Assets Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables",
     "shortName": "Hedging Activities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Contractual Obligations and Commitments (Tables)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables",
     "shortName": "Contractual Obligations and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323306 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - Weighted Average Shares Outstanding (Tables)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables",
     "shortName": "Weighted Average Shares Outstanding (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334308 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337309 - Disclosure - Revenue (Tables)",
     "role": "http://www.bostonscientific.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341310 - Disclosure - Changes in Other Comprehensive Income (Tables)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables",
     "shortName": "Changes in Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Basis of Presentation (Details)",
     "role": "http://www.bostonscientific.com/role/BasisofPresentationDetails",
     "shortName": "Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Acquisitions and Divestitures (Details)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
     "shortName": "Acquisitions and Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia14da29940934c628d805300ec2c17c2_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Contingent Consideration (Details)",
     "role": "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
     "shortName": "Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bsx:PaymentOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
     "shortName": "Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Strategic Investments (Details)",
     "role": "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
     "shortName": "Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Goodwill and Other Intangible Assets (Details)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia14da29940934c628d805300ec2c17c2_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Hedging Activities and Fair Value Measurements (Details)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
     "shortName": "Hedging Activities and Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia14da29940934c628d805300ec2c17c2_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - Contractual Obligations and Commitments (Details)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
     "shortName": "Contractual Obligations and Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails",
     "shortName": "Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia14da29940934c628d805300ec2c17c2_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424409 - Disclosure - Income Taxes (Details)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427410 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia14da29940934c628d805300ec2c17c2_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429411 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.bostonscientific.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i762a71d1a5314a20b775461852e10332_I20200527",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432412 - Disclosure - Weighted Average Shares Outstanding (Details)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails",
     "shortName": "Weighted Average Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:NumberOfBusinesses",
      "reportCount": 1,
      "unitRef": "business",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435413 - Disclosure - Segment Reporting (Details)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingDetails",
     "shortName": "Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438414 - Disclosure - Revenue (Details)",
     "role": "http://www.bostonscientific.com/role/RevenueDetails",
     "shortName": "Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia14da29940934c628d805300ec2c17c2_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442415 - Disclosure - Changes in Other Comprehensive Income (Details)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
     "shortName": "Changes in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "ia7d03cf301fb419cb4981d6deb4bea85_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
     "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6bbd45b89d324f0e8ec5541faa0dc0e5_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "i6f7a3f89558f4cdf89f78dc544d9071b_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
     "shortName": "Consolidated Statements of Cash Flows (Supplemental Disclosure)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.bostonscientific.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20220630.htm",
      "contextRef": "icce0d71a0541494fbaf94834bc475e99_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 116,
   "tag": {
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2020-10 Codification Improvements",
        "label": "ASC Update No. 2020-10 Codification Improvements [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-10 Codification Improvements"
       }
      }
     },
     "localname": "ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method",
        "label": "ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method [Policy Text Block]",
        "terseLabel": "ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method"
       }
      }
     },
     "localname": "ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)",
        "label": "ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)"
       }
      }
     },
     "localname": "ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.",
        "label": "ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. [Policy Text Block]",
        "terseLabel": "ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions."
       }
      }
     },
     "localname": "ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AccruedRebatesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Rebates, Current",
        "label": "Accrued Rebates, Current",
        "terseLabel": "Accrued Rebates, Current"
       }
      }
     },
     "localname": "AccruedRebatesCurrent",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ActualCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actual Covenant.",
        "label": "Actual, Covenant [Member]",
        "terseLabel": "Actual, Covenant [Member]"
       }
      }
     },
     "localname": "ActualCovenantMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AllBusinessAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Business Acquisitions",
        "label": "All Business Acquisitions [Member]",
        "terseLabel": "All Business Acquisitions"
       }
      }
     },
     "localname": "AllBusinessAcquisitionsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BSXReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BSX Reportable Segments [Member]",
        "label": "BSX Reportable Segments [Member]",
        "terseLabel": "BSX Reportable Segments [Member]"
       }
      }
     },
     "localname": "BSXReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BaylisMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Baylis Medical",
        "label": "Baylis Medical [Member]",
        "terseLabel": "Baylis Medical"
       }
      }
     },
     "localname": "BaylisMedicalMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CanadaSettledClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canada, settled claims",
        "label": "Canada, settled claims",
        "terseLabel": "Canada, settled claims"
       }
      }
     },
     "localname": "CanadaSettledClaims",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CardiacRhythmManagementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiac Rhythm Management",
        "label": "Cardiac Rhythm Management [Member]",
        "terseLabel": "Cardiac Rhythm Management [Member]"
       }
      }
     },
     "localname": "CardiacRhythmManagementMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CardiovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiovascular [Member]",
        "label": "Cardiovascular [Member]",
        "terseLabel": "Cardiovascular [Member]"
       }
      }
     },
     "localname": "CardiovascularMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cases in final stages of resolution, related to Greenfield Vena Cava Filter",
        "label": "Cases in final stages of resolution, related to Greenfield Vena Cava Filter",
        "terseLabel": "Cases in final stages of resolution, related to Greenfield Vena Cava Filter"
       }
      }
     },
     "localname": "CasesInFinalStagesOfResolutionRelatedToGreenfieldVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "verboseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash flow impact of deferred income tax expense (benefit)",
        "label": "Cash flow impact of deferred income tax expense (benefit)",
        "terseLabel": "Deferred and prepaid income taxes"
       }
      }
     },
     "localname": "CashFlowImpactOfDeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CertifiedClassActionsInAustraliaMesh": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certified class actions in Australia, Mesh",
        "label": "Certified class actions in Australia, Mesh",
        "terseLabel": "Certified class actions in Australia, Mesh"
       }
      }
     },
     "localname": "CertifiedClassActionsInAustraliaMesh",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "label": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "terseLabel": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "xbrltype": "stringItemType"
    },
    "bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "label": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "terseLabel": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "xbrltype": "stringItemType"
    },
    "bsx_ContingentConsiderationLiabilityProbabilityOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration liability, probability of payment",
        "label": "contingent consideration liability, probability of payment",
        "terseLabel": "contingent consideration liability, probability of payment"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityProbabilityOfPayment",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_CorporateExpensesincludinghedgingactivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Expenses including hedging activities [Member]",
        "label": "Corporate Expenses including hedging activities [Member]",
        "verboseLabel": "Corporate expenses and currency exchange [Member]"
       }
      }
     },
     "localname": "CorporateExpensesincludinghedgingactivitiesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CovenantAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Axis]",
        "terseLabel": "Covenant [Axis]"
       }
      }
     },
     "localname": "CovenantAxis",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CovenantDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Domain]",
        "terseLabel": "Covenant [Domain]"
       }
      }
     },
     "localname": "CovenantDomain",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CurrentRequirementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Requirement.",
        "label": "Current Requirement [Member]",
        "terseLabel": "Current Requirement [Member]"
       }
      }
     },
     "localname": "CurrentRequirementMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DebtInstrumentExtensionOptionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Option, Term",
        "label": "Debt Instrument, Extension Option, Term",
        "terseLabel": "Debt Instrument, Extension Option, Term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionOptionTerm",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_December2027NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2027 Notes [Member]",
        "label": "December 2027 Notes [Member]",
        "terseLabel": "December 2027 Notes [Member]"
       }
      }
     },
     "localname": "December2027NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "label": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "label": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DiscountRateFairValueInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount Rate, Fair Value Input",
        "label": "Discount Rate, Fair Value Input",
        "terseLabel": "Discount Rate, Fair Value Input"
       }
      }
     },
     "localname": "DiscountRateFairValueInput",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_DivestitureAgreementTransferOfFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture, agreement, transfer of facilities",
        "label": "Divestiture, agreement, transfer of facilities",
        "terseLabel": "Transfer of facilities"
       }
      }
     },
     "localname": "DivestitureAgreementTransferOfFacilities",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_DivestitureAgreementTransferOfGlobalEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture, agreement, transfer of global employees",
        "label": "Divestiture, agreement, transfer of global employees",
        "terseLabel": "Divestiture, agreement, transfer of global employees"
       }
      }
     },
     "localname": "DivestitureAgreementTransferOfGlobalEmployees",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ElectrophysiologyEPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Electrophysiology (EP)",
        "label": "Electrophysiology (EP) [Member]",
        "terseLabel": "Electrophysiology [Member]"
       }
      }
     },
     "localname": "ElectrophysiologyEPMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets [Member]",
        "label": "Emerging Markets [Member]",
        "terseLabel": "Emerging Markets [Member]"
       }
      }
     },
     "localname": "EmergingMarketsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EmergingMarketstotalnumberofcountries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets total number of countries",
        "label": "Emerging Markets total number of countries",
        "terseLabel": "Emerging Markets total countries"
       }
      }
     },
     "localname": "EmergingMarketstotalnumberofcountries",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_EntityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity [Abstract]",
        "label": "Entity [Abstract]",
        "terseLabel": "Entity [Abstract]"
       }
      }
     },
     "localname": "EntityAbstract",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "xbrltype": "stringItemType"
    },
    "bsx_EquipmentFurnitureAndFixturesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment, furniture and fixtures Gross.",
        "label": "Equipment, furniture and fixtures Gross",
        "terseLabel": "Equipment, furniture and fixtures"
       }
      }
     },
     "localname": "EquipmentFurnitureAndFixturesGross",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_EuroDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Factoring Arrangements [Member]",
        "label": "Euro Denominated Factoring Arrangements [Member]",
        "terseLabel": "Euro Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "EuroDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ExclusionFromEbitdaForRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion from EBITDA for Restructuring Charges",
        "label": "Exclusion from EBITDA for Restructuring Charges",
        "terseLabel": "Exclusion from EBITDA for Restructuring Charges"
       }
      }
     },
     "localname": "ExclusionFromEbitdaForRestructuringCharges",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ForeigncurrencydenominatedindebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "foreign currency denominated in debt [Member]",
        "label": "foreign currency denominated in debt [Member]",
        "terseLabel": "foreign currency denominated in debt [Member]"
       }
      }
     },
     "localname": "ForeigncurrencydenominatedindebtMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForwardCurrencyContractsTimetoMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Contracts, Time to Maturity in Months",
        "label": "Forward Currency Contracts, Time to Maturity",
        "terseLabel": "Forward Currency Contracts, Time to Maturity"
       }
      }
     },
     "localname": "ForwardCurrencyContractsTimetoMaturity",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_GlobalCardiologyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Cardiology Reporting Unit [Member]",
        "label": "Global Cardiology Reporting Unit [Member]",
        "terseLabel": "Cardiology [Member]"
       }
      }
     },
     "localname": "GlobalCardiologyReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalEndoscopyEndoReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "label": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "terseLabel": "Endoscopy [Member]"
       }
      }
     },
     "localname": "GlobalEndoscopyEndoReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalNeuromodulationNmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "label": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "terseLabel": "Neuromodulation [Member]"
       }
      }
     },
     "localname": "GlobalNeuromodulationNmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalPeripheralInterventionsPiReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "label": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "terseLabel": "Peripheral Interventions [Member]"
       }
      }
     },
     "localname": "GlobalPeripheralInterventionsPiReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalUrologyandPelvicHealthReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "label": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "terseLabel": "Urology and Pelvic Health [Member]"
       }
      }
     },
     "localname": "GlobalUrologyandPelvicHealthReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of Foreign Currency Fluctuations on Net Sales",
        "label": "Impact of Foreign Currency Fluctuations on Net Sales",
        "terseLabel": "Impact of Foreign Currency Fluctuations on Net Sales"
       }
      }
     },
     "localname": "ImpactOfForeignCurrencyFluctuationsOnNetSales",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_IndemnificationAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification asset",
        "label": "Indemnification asset",
        "terseLabel": "Indemnification asset"
       }
      }
     },
     "localname": "IndemnificationAsset",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_IntangibleAssetsandGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Intangible Assets and Goodwill [Table]",
        "label": "Intangible Assets and Goodwill [Line Items]",
        "terseLabel": "Intangible Assets and Goodwill [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsandGoodwillLineItems",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_InterventionalCardiologyTherapiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Cardiology Therapies",
        "label": "Interventional Cardiology Therapies [Member]",
        "terseLabel": "Interventional Cardiology Therapies"
       }
      }
     },
     "localname": "InterventionalCardiologyTherapiesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_InventoryStepUpAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory step up amortization",
        "label": "Inventory step up amortization",
        "terseLabel": "Inventory step-up amortization"
       }
      }
     },
     "localname": "InventoryStepUpAmortization",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_January2040NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2040 Notes [Member]",
        "label": "January 2040 Notes [Member]",
        "terseLabel": "January 2040 Notes [Member]"
       }
      }
     },
     "localname": "January2040NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2025 Notes",
        "label": "June 2025 Notes [Member]",
        "terseLabel": "June 2025 Notes [Member]"
       }
      }
     },
     "localname": "June2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2030NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2030 Notes",
        "label": "June 2030 Notes [Member]",
        "terseLabel": "June 2030 Notes [Member]"
       }
      }
     },
     "localname": "June2030NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LatinAmericaandCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America and Canada [Member]",
        "label": "Latin America and Canada [Member]",
        "terseLabel": "Latin America and Canada [Member]"
       }
      }
     },
     "localname": "LatinAmericaandCanadaMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "label": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Legal payments remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingarrangementassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement assets [Member]",
        "label": "Licensing arrangement assets [Member]",
        "terseLabel": "Licensing arrangement assets [Member]"
       }
      }
     },
     "localname": "LicensingarrangementassetsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingarrangementliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement liabilities [Member]",
        "label": "Licensing arrangement liabilities [Member]",
        "terseLabel": "Licensing arrangement liabilities [Member]"
       }
      }
     },
     "localname": "LicensingarrangementliabilitiesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Licensingarrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements",
        "label": "Licensing arrangements",
        "terseLabel": "Licensing arrangements"
       }
      }
     },
     "localname": "Licensingarrangements",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsasset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, asset",
        "label": "Licensing arrangements, asset",
        "terseLabel": "Licensing arrangements, asset"
       }
      }
     },
     "localname": "Licensingarrangementsasset",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsliability": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, liability",
        "label": "Licensing arrangements, liability",
        "terseLabel": "Licensing arrangements, liability"
       }
      }
     },
     "localname": "Licensingarrangementsliability",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationAndDebtExclusionFromEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion of litigation payments and any debt Issued to fund tax deficiency payments",
        "label": "Litigation and Debt Exclusion from EBITDA",
        "terseLabel": "Litigation and Debt Exclusion from EBITDA"
       }
      }
     },
     "localname": "LitigationAndDebtExclusionFromEbitda",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LumenisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lumenis",
        "label": "Lumenis [Member]",
        "terseLabel": "Lumenis"
       }
      }
     },
     "localname": "LumenisMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MITechCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "M.I. Tech Co., Ltd",
        "label": "M.I. Tech Co., Ltd [Member]",
        "terseLabel": "M.I. Tech Co., Ltd"
       }
      }
     },
     "localname": "MITechCoLtdMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2024NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2024 Notes [Member]",
        "label": "March 2024 Notes [Member]",
        "terseLabel": "March 2024 Notes [Member]"
       }
      }
     },
     "localname": "March2024NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2025 Notes",
        "label": "March 2025 Notes [Member]",
        "terseLabel": "March 2025 Notes"
       }
      }
     },
     "localname": "March2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2026NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2026 Notes [Member]",
        "label": "March 2026 Notes [Member]",
        "terseLabel": "March 2026 Notes [Member]"
       }
      }
     },
     "localname": "March2026NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2028 Notes [Member]",
        "label": "March 2028 Notes [Member]",
        "verboseLabel": "March 2028 Notes [Member]"
       }
      }
     },
     "localname": "March2028NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2028 Senior Notes",
        "label": "March 2028 Senior Notes [Member]",
        "terseLabel": "March 2028 Senior Notes"
       }
      }
     },
     "localname": "March2028SeniorNotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2029NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2029 Notes [Member]",
        "label": "March 2029 Notes [Member]",
        "terseLabel": "March 2029 Notes [Member]"
       }
      }
     },
     "localname": "March2029NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2031NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2031 Notes",
        "label": "March 2031 Notes [Member]",
        "terseLabel": "March 2031 Notes"
       }
      }
     },
     "localname": "March2031NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2034NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2034 Notes",
        "label": "March 2034 Notes [Member]",
        "terseLabel": "March 2034 Notes"
       }
      }
     },
     "localname": "March2034NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2039NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2039 Notes [Member]",
        "label": "March 2039 Notes [Member]",
        "terseLabel": "March 2039 Notes [Member]"
       }
      }
     },
     "localname": "March2039NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2049NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2049 Notes [Member]",
        "label": "March 2049 Notes [Member]",
        "terseLabel": "March 2049 Notes [Member]"
       }
      }
     },
     "localname": "March2049NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MaximumCommercialPaperOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Commercial Paper Outstanding",
        "label": "Maximum Commercial Paper Outstanding",
        "terseLabel": "Maximum Commercial Paper Outstanding"
       }
      }
     },
     "localname": "MaximumCommercialPaperOutstanding",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_MaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum leverage ratio permitted by revolving credit facility agreement.",
        "label": "Maximum Leverage Ratio",
        "terseLabel": "Maximum Leverage Ratio"
       }
      }
     },
     "localname": "MaximumLeverageRatio",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_May2022NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2022 Notes [Member]",
        "label": "May 2022 Notes [Member]",
        "terseLabel": "May 2022 Notes [Member]"
       }
      }
     },
     "localname": "May2022NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2025 Notes [Member]",
        "label": "May 2025 Notes [Member]",
        "terseLabel": "May 2025 Notes [Member]"
       }
      }
     },
     "localname": "May2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MedsurgMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedSurg [Member]",
        "label": "MedSurg [Member]",
        "terseLabel": "MedSurg [Member]"
       }
      }
     },
     "localname": "MedsurgMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Netcurrencyexchangegainloss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net currency exchange gain (loss)",
        "label": "Net currency exchange gain (loss)",
        "terseLabel": "Net currency exchange gain (loss)"
       }
      }
     },
     "localname": "Netcurrencyexchangegainloss",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NewAccountingPronouncementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Accounting Pronouncements, Policy",
        "label": "New Accounting Pronouncements, Policy [Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_Noncashimpactoftransferredroyaltyrights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash impact of transferred royalty rights",
        "label": "Non-cash impact of transferred royalty rights",
        "terseLabel": "Non-cash impact of transferred royalty rights"
       }
      }
     },
     "localname": "Noncashimpactoftransferredroyaltyrights",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_November2035NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2035 Notes [Member]",
        "label": "November 2035 Notes [Member]",
        "terseLabel": "November 2035 Notes [Member]"
       }
      }
     },
     "localname": "November2035NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NumberOfBusinesses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Businesses",
        "label": "Number Of Businesses",
        "terseLabel": "Number Of Businesses"
       }
      }
     },
     "localname": "NumberOfBusinesses",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_NumberOfBusinessesDivested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Businesses Divested",
        "label": "Number Of Businesses Divested",
        "terseLabel": "Number Of Businesses Divested"
       }
      }
     },
     "localname": "NumberOfBusinessesDivested",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_October2023NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 Notes [Member]",
        "label": "October 2023 Notes [Member]",
        "terseLabel": "October 2023 Notes [Member]"
       }
      }
     },
     "localname": "October2023NotesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OperatingIncomeAllocatedToReportableSegments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Allocated to Reportable Segments",
        "label": "Operating Income Allocated to Reportable Segments",
        "terseLabel": "Operating Income Allocated to Reportable Segments"
       }
      }
     },
     "localname": "OperatingIncomeAllocatedToReportableSegments",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeUnallocatedToSegment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Unallocated to Segment",
        "label": "Operating Income Unallocated to Segment",
        "negatedTerseLabel": "Operating Income Unallocated to Segment"
       }
      }
     },
     "localname": "OperatingIncomeUnallocatedToSegment",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets [Abstract]",
        "label": "Other Current Assets [Abstract]",
        "terseLabel": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentAssetsAbstract",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, net",
        "label": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNet",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherOtherLongtermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, Other Long-term Assets",
        "label": "Other, Other Long-term Assets",
        "terseLabel": "Other, Other Long-term Assets"
       }
      }
     },
     "localname": "OtherOtherLongtermAssets",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of contingent consideration",
        "label": "Payment of contingent consideration",
        "negatedLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentsForRoyaltyRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for royalty rights",
        "label": "Payments for royalty rights",
        "negatedTerseLabel": "Payments for royalty rights"
       }
      }
     },
     "localname": "PaymentsForRoyaltyRights",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Paymenttonetsharesettleemployeeequityawards": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment to net share settle employee equity awards",
        "label": "Payment to net share settle employee equity awards",
        "negatedTerseLabel": "Cash used to net share settle employee equity awards"
       }
      }
     },
     "localname": "Paymenttonetsharesettleemployeeequityawards",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PreventiceSolutionsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preventice Solutions, Inc.",
        "label": "Preventice Solutions, Inc. [Member]",
        "terseLabel": "Preventice"
       }
      }
     },
     "localname": "PreventiceSolutionsIncMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from (payments for) investments and acquisitions of certain technologies",
        "label": "Proceeds from (payments for) investments and acquisitions of certain technologies",
        "negatedTerseLabel": "Proceeds from (payments for) investments and acquisitions of certain technologies"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases related to Greenfield Vena Cava Filter",
        "label": "Product liability cases related to Greenfield Vena Cava Filter",
        "terseLabel": "Product liability cases related to Greenfield Vena Cava Filter"
       }
      }
     },
     "localname": "ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability claims, not filed, related to Greenfield Vena Cava Filter",
        "label": "Product liability claims, not filed, related to Greenfield Vena Cava Filter",
        "terseLabel": "Product liability claims, not filed, related to Greenfield Vena Cava Filter"
       }
      }
     },
     "localname": "ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_Productliabilitycasesorclaimsrelatedtomeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims asserted related to mesh products",
        "label": "Product liability cases or claims related to mesh product",
        "terseLabel": "Product liability cases or claims related to mesh product"
       }
      }
     },
     "localname": "Productliabilitycasesorclaimsrelatedtomeshproduct",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - Canada",
        "label": "Product liability cases or claims related to mesh product - Canada",
        "terseLabel": "Product liability cases or claims related to mesh product - Canada"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductCanada",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - United Kingdom",
        "label": "Product liability cases or claims related to mesh product - United Kingdom",
        "terseLabel": "Product liability cases or claims related to mesh product - United Kingdom"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_QualifiedAcquisitionConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualified Acquisition Consideration",
        "label": "Qualified Acquisition Consideration",
        "terseLabel": "Qualified Acquisition Consideration"
       }
      }
     },
     "localname": "QualifiedAcquisitionConsideration",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RDRegulatoryandCommercializationbasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "label": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "terseLabel": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]"
       }
      }
     },
     "localname": "RDRegulatoryandCommercializationbasedMilestoneMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RenminbiDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renminbi Denominated Factoring Arrangements",
        "label": "Renminbi Denominated Factoring Arrangements [Member]",
        "terseLabel": "Renminbi Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "RenminbiDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of December 31, 2021 and through remaining term of facility",
        "label": "Requirement, as of December 31, 2021 and through remaining term of facility [Member]",
        "terseLabel": "Requirement, as of December 31, 2021 and through remaining term of facility"
       }
      }
     },
     "localname": "RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility",
        "label": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility [Member]",
        "terseLabel": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility"
       }
      }
     },
     "localname": "RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, four succeeding quarters following qualified acquisition",
        "label": "Requirement, four succeeding quarters following qualified acquisition [Member]",
        "terseLabel": "Requirement, four succeeding quarters following qualified acquisition"
       }
      }
     },
     "localname": "RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, seventh quarter following qualified acquisition",
        "label": "Requirement, seventh quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, seventh quarter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementSeventhQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, sixth quarter following qualified acquisition",
        "label": "Requirement, sixth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, sixth quarter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementSixthQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, fifth quarter following qualified acquisition [Member]",
        "label": "Requirement, fifth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fifth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfifthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.",
        "label": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "revenue-based payments [Member]",
        "label": "revenue-based payments [Member]",
        "terseLabel": "revenue-based payments [Member]"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from contracts with customers, disaggregated - performance measurement - measures used by CODM to make business decisions, excludes impact of foreign currency fluctuations",
        "label": "Revenues from contracts with customers, disaggregated - performance measurement",
        "terseLabel": "Revenues from contracts with customers, disaggregated - performance measurement"
       }
      }
     },
     "localname": "RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevolvingCreditFacility2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility 2021",
        "label": "Revolving Credit Facility 2021 [Member]",
        "terseLabel": "2021 Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacility2021Member",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "label": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Line Items]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Line Items]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationLineItems",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Table]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Table]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationTable",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_Segmentoperatingincomeaspercentageofnetsales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment operating income as percentage of net sales",
        "label": "Segment operating income as percentage of net sales",
        "terseLabel": "Segment operating income as percentage of net sales"
       }
      }
     },
     "localname": "Segmentoperatingincomeaspercentageofnetsales",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits",
        "label": "Special Charges [Member]",
        "terseLabel": "Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits"
       }
      }
     },
     "localname": "SpecialChargesMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialtyPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharmaceuticals [Member]",
        "label": "Specialty Pharmaceuticals [Member]",
        "terseLabel": "Specialty Pharmaceuticals [Member]"
       }
      }
     },
     "localname": "SpecialtyPharmaceuticalsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "statement [Axis]",
        "label": "statement [Axis]",
        "terseLabel": "statement [Axis]"
       }
      }
     },
     "localname": "StatementAxis",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for statement [Axis]",
        "label": "statement [Domain]",
        "terseLabel": "statement [Domain]"
       }
      }
     },
     "localname": "StatementDomain",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of term loan and revolving credit facility agreement compliance with debt covenants.",
        "label": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]",
        "terseLabel": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalBalanceSheetInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information [Abstract]",
        "terseLabel": "Supplemental Balance Sheet Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationAbstract",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalBalanceSheetInformationTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information (Textuals) [Abstract]",
        "verboseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_The2018FacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the 2018 Facility",
        "label": "the 2018 Facility [Domain]",
        "terseLabel": "the 2018 Facility [Member]"
       }
      }
     },
     "localname": "The2018FacilityDomain",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheOfferingAggregatePrincipalAmountMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the Offering - aggregate principal amount",
        "label": "the Offering - aggregate principal amount [Member]",
        "terseLabel": "the Offering"
       }
      }
     },
     "localname": "TheOfferingAggregatePrincipalAmountMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the Offering - early redemption of combined aggregate principal SN",
        "label": "the Offering - early redemption of combined aggregate principal SN [Member]",
        "terseLabel": "the Offering - early redemption of combined aggregate principal SN"
       }
      }
     },
     "localname": "TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalAllocatedToReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total allocated to reportable segments [Member]",
        "label": "Total allocated to reportable segments [Member]",
        "terseLabel": "Total allocated to reportable segments [Member]"
       }
      }
     },
     "localname": "TotalAllocatedToReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Product liability cases and claims settled related to Mesh product",
        "label": "Total Product liability cases and claims settled related to Mesh product",
        "terseLabel": "Total Product liability cases and claims settled related to Mesh product"
       }
      }
     },
     "localname": "TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_WatchmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Watchman",
        "label": "Watchman [Member]",
        "terseLabel": "Watchman"
       }
      }
     },
     "localname": "WatchmanMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_YenDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yen denominated factoring arrangements.",
        "label": "Yen Denominated Factoring Arrangements [Member]",
        "terseLabel": "Yen Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "YenDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20220630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "verboseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share",
        "terseLabel": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r319",
      "r358",
      "r418",
      "r421",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r605",
      "r648",
      "r651",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r319",
      "r358",
      "r418",
      "r421",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r605",
      "r648",
      "r651",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r213",
      "r394",
      "r398",
      "r606",
      "r647",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r213",
      "r394",
      "r398",
      "r606",
      "r647",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r319",
      "r358",
      "r406",
      "r418",
      "r421",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r605",
      "r648",
      "r651",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r319",
      "r358",
      "r406",
      "r418",
      "r421",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r605",
      "r648",
      "r651",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r157",
      "r162",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r214",
      "r215",
      "r394",
      "r399",
      "r650",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r214",
      "r215",
      "r394",
      "r399",
      "r650",
      "r661",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r157",
      "r162",
      "r291",
      "r419",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "verboseLabel": "Statement, Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r578",
      "r580",
      "r583",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r34",
      "r68",
      "r219",
      "r220",
      "r630"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Trade accounts receivable, net",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r54",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r219",
      "r220"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r30",
      "r614",
      "r632"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r59"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued Royalties, Current"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r52",
      "r275"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r83",
      "r88",
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r78",
      "r85",
      "r87",
      "r88",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r37",
      "r85",
      "r87",
      "r88",
      "r635",
      "r656",
      "r657"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r97",
      "r98",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r84",
      "r88",
      "r97",
      "r98",
      "r99",
      "r149",
      "r150",
      "r151",
      "r479",
      "r652",
      "r653",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r79",
      "r88",
      "r97",
      "r98",
      "r99",
      "r479",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r424",
      "r425",
      "r426",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r39",
      "r221",
      "r234"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedLabel": "Less: allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r132",
      "r258",
      "r266"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization expense",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r141",
      "r197",
      "r203",
      "r209",
      "r232",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r475",
      "r481",
      "r540",
      "r567",
      "r569",
      "r611",
      "r631"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r12",
      "r71",
      "r141",
      "r232",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r475",
      "r481",
      "r540",
      "r567",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r222",
      "r224",
      "r240",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Notes receivable"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r495",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r15",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r417",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r417",
      "r420",
      "r455",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1": {
     "auth_ref": [
      "r452",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination",
        "terseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r131",
      "r470"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration net expense (benefit)",
        "verboseLabel": "Contingent consideration net expense (benefit)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r463",
      "r464",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Business Combination, Contingent Consideration, Liability Ending Balance",
        "periodStartLabel": "Business Combination, Contingent Consideration, Liability Beginning Balance",
        "terseLabel": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r463",
      "r465"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r463",
      "r465"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "ACQUISITIONS AND STRATEGIC INVESTMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.",
        "label": "Business Combination, Indemnification Assets, Amount as of Acquisition Date",
        "terseLabel": "Business Combination, Indemnification Assets, Amount as of Acquisition Date"
       }
      }
     },
     "localname": "BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r457",
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease Obligations [Member]",
        "terseLabel": "Finance Lease Obligation"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r49",
      "r569",
      "r658",
      "r659"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r49",
      "r134"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r126",
      "r134",
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r126",
      "r547"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease)\u00a0in cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]",
        "terseLabel": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r138",
      "r141",
      "r166",
      "r167",
      "r168",
      "r170",
      "r172",
      "r181",
      "r182",
      "r183",
      "r232",
      "r305",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r356",
      "r357",
      "r361",
      "r365",
      "r540",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r25",
      "r612",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r64",
      "r290",
      "r619",
      "r639"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r299",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r149",
      "r150",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r33",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,693,192,785 shares as of June 30, 2022 and 1,688,810,052 shares as of December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r94",
      "r96",
      "r104",
      "r474",
      "r485",
      "r622",
      "r643"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r103",
      "r113",
      "r621",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income (Loss) Note [Text Block]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Capital in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r383",
      "r384",
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r107",
      "r606"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r618",
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current",
        "verboseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r137",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r333",
      "r340",
      "r341",
      "r343",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "CONTRACTUAL OBLIGATIONS AND COMMITMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r140",
      "r144",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r323",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r346",
      "r347",
      "r348",
      "r349",
      "r562",
      "r613",
      "r615",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r331",
      "r346",
      "r347",
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r61",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r62",
      "r140",
      "r144",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r323",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r346",
      "r347",
      "r348",
      "r349",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r62",
      "r140",
      "r144",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r323",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r342",
      "r346",
      "r347",
      "r348",
      "r349",
      "r373",
      "r376",
      "r377",
      "r378",
      "r559",
      "r560",
      "r562",
      "r563",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r329",
      "r344",
      "r346",
      "r347",
      "r561"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in Unrecognized Tax Benefits is Reasonably Possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r132",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r132",
      "r192"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r539"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r72",
      "r75",
      "r76",
      "r498",
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Asset, Fair Value, Gross Asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r72",
      "r75",
      "r76",
      "r498",
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative Liability, Fair Value, Gross Liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r75",
      "r496",
      "r499",
      "r508",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r493",
      "r496",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r493",
      "r496",
      "r508",
      "r514",
      "r515",
      "r518",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Assets, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Liabilities, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeRemainingMaturity1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Remaining Maturity",
        "terseLabel": "Derivative, Remaining Maturity"
       }
      }
     },
     "localname": "DerivativeRemainingMaturity1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r487",
      "r489",
      "r490",
      "r493",
      "r494",
      "r502",
      "r508",
      "r516",
      "r517",
      "r520",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative, Term of Contract (less than)"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r394",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r271",
      "r272",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r132",
      "r272",
      "r277"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r417",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r379",
      "r627"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "terseLabel": "Dividends, Preferred Stock, Cash"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r379",
      "r627"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "negatedTerseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r105",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r163",
      "r166",
      "r170",
      "r171",
      "r172",
      "r177",
      "r178",
      "r524",
      "r525",
      "r623",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r105",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r166",
      "r170",
      "r171",
      "r172",
      "r177",
      "r178",
      "r524",
      "r525",
      "r623",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 assuming dilution"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r173",
      "r175",
      "r176",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Weighted Average Number Of Shares Outstanding [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate from continuing operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r97",
      "r98",
      "r99",
      "r149",
      "r150",
      "r151",
      "r153",
      "r159",
      "r161",
      "r180",
      "r233",
      "r372",
      "r379",
      "r424",
      "r425",
      "r426",
      "r441",
      "r442",
      "r523",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r652",
      "r653",
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r50",
      "r198",
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Measurement alternative investments(1)"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r526",
      "r527",
      "r528",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r331",
      "r346",
      "r347",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r527",
      "r575",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r526",
      "r527",
      "r530",
      "r531",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r331",
      "r407",
      "r408",
      "r413",
      "r416",
      "r527",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r331",
      "r346",
      "r347",
      "r407",
      "r408",
      "r413",
      "r416",
      "r527",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r331",
      "r346",
      "r347",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r527",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r532",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Fair value of contingent consideration recorded in purchase accounting"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r331",
      "r346",
      "r347",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r575",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r534",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241",
      "r242",
      "r243",
      "r244",
      "r342",
      "r370",
      "r522",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r259",
      "r262",
      "r265",
      "r268",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r265",
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r259",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r541",
      "r543",
      "r545",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r75",
      "r407",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r496",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "terseLabel": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r110",
      "r132",
      "r223"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Net loss (gain) on investments and notes receivable"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r132",
      "r480"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on disposal of businesses and assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r132",
      "r350",
      "r351"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r248",
      "r249",
      "r569",
      "r610"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill Ending Balance",
        "periodStartLabel": "Goodwill Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r250",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, Gross"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r250",
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r252",
      "r253",
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Translation and Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r106",
      "r141",
      "r197",
      "r202",
      "r205",
      "r208",
      "r211",
      "r232",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r540"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r493",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r132",
      "r269"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r132",
      "r269"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Goodwill and other intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]",
        "verboseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r102",
      "r197",
      "r202",
      "r205",
      "r208",
      "r211",
      "r609",
      "r620",
      "r625",
      "r645"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss)\u00a0before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r417",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r278",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r435",
      "r439",
      "r440",
      "r443",
      "r445",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r160",
      "r161",
      "r195",
      "r433",
      "r444",
      "r446",
      "r646"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).",
        "label": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option",
        "terseLabel": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r261",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "verboseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r261",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r257",
      "r263"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r101",
      "r191",
      "r558",
      "r561",
      "r624"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "verboseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r75",
      "r407",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r41",
      "r245"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r69",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r43",
      "r245"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r42",
      "r245"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Investment [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r640"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r14",
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r38",
      "r141",
      "r232",
      "r540",
      "r569",
      "r616",
      "r637"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r60",
      "r141",
      "r232",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r476",
      "r481",
      "r482",
      "r540",
      "r567",
      "r568",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r56",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r56",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r64",
      "r290",
      "r297"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal reserves, current"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r64",
      "r290"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Estimated Litigation Liability, Noncurrent"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation Settlement, Amount Awarded to Other Party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation-related net charges (credits)",
        "verboseLabel": "Litigation-related net charges (credits)"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r29",
      "r330",
      "r345",
      "r346",
      "r347",
      "r615",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Capital Lease Obligations",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r62",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "verboseLabel": "Accrual for legal matters that are probable and estimable"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money Market Funds, at Carrying Value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash provided by (used for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r126",
      "r129",
      "r133"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r157",
      "r163",
      "r164",
      "r169",
      "r172",
      "r197",
      "r202",
      "r205",
      "r208",
      "r211"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of Businesses Acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of Interest Rate Derivatives Held"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r197",
      "r202",
      "r205",
      "r208",
      "r211"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "verboseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r59"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r70",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "totalLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other Assets, Miscellaneous, Current"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other Assets, Noncurrent",
        "verboseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r80",
      "r85",
      "r542",
      "r544",
      "r549"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r88",
      "r97",
      "r98",
      "r100",
      "r550",
      "r552",
      "r556"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r81",
      "r85"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "verboseLabel": "Net change in derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r81",
      "r85"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r81",
      "r85",
      "r497",
      "r503",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r85",
      "r89"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r85",
      "r89",
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r89",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r89",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r504",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r504",
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r85",
      "r89",
      "r90",
      "r91",
      "r548"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r93",
      "r96",
      "r97",
      "r98",
      "r100",
      "r103",
      "r372",
      "r550",
      "r555",
      "r556",
      "r621",
      "r642"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Total other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r83",
      "r85"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r83",
      "r85"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "terseLabel": "Net change in defined benefit pensions and other items",
        "totalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r85",
      "r89",
      "r91",
      "r414"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r16",
      "r17",
      "r59",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "totalLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "totalLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Other long-term liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other Operating Income (Expense), Net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r59",
      "r302"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other Sundry Liabilities, Current"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration previously established in purchase accounting"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r116",
      "r119"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedTerseLabel": "Payments for Royalties",
        "terseLabel": "Payments for Royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid on preferred stock",
        "terseLabel": "Payments of Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for acquisitions of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment and internal use software"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareCashPaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Preferred Stock, Dividends, Per Share, Cash Paid"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareDeclared": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends Per Share, Declared",
        "terseLabel": "Preferred Stock, Dividends Per Share, Declared"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r32",
      "r138",
      "r361",
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r138",
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Preferred Stock, Liquidation Preference, Value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r32",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r32",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of June 30, 2022 and December 31, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r47",
      "r48"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r9",
      "r11",
      "r246",
      "r247"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from disposal of certain businesses and assets"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r116",
      "r130"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Payments for Hedge, Investing Activities"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Net proceeds from issuance of preferred stock in connection with public offering",
        "verboseLabel": "Net proceeds from issuance of preferred stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Proceeds from long-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r121",
      "r123",
      "r135"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Net increase (decrease) in commercial paper"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "negatedTerseLabel": "Proceeds from Royalties Received",
        "terseLabel": "Proceeds from Royalties Received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r92",
      "r95",
      "r99",
      "r125",
      "r141",
      "r152",
      "r160",
      "r161",
      "r197",
      "r202",
      "r205",
      "r208",
      "r211",
      "r232",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r474",
      "r477",
      "r478",
      "r484",
      "r485",
      "r525",
      "r540",
      "r625"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r51",
      "r274"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r22",
      "r23",
      "r276",
      "r569",
      "r626",
      "r638"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r22",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, plant and equipment, net [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate": {
     "auth_ref": [
      "r560",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.",
        "label": "Receivable with Imputed Interest, Effective Yield (Interest Rate)",
        "verboseLabel": "Average interest rate of de-recognized receivables"
       }
      }
     },
     "localname": "ReceivableWithImputedInterestEffectiveYieldInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r88",
      "r97",
      "r98",
      "r100",
      "r550",
      "r554",
      "r556"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r88",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r202",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r201",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Payments on long-term borrowings and debt extinguishment costs"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Payments on short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r21",
      "r134",
      "r136"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted Cash and Cash Equivalents in Other current assets",
        "verboseLabel": "Restricted cash and restricted cash equivalents included in Other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r13",
      "r24",
      "r136",
      "r662",
      "r663",
      "r664"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash equivalents included in Other long-term assets",
        "verboseLabel": "Restricted Cash Equivalents in Other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r132",
      "r281",
      "r284",
      "r285"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "verboseLabel": "Restructuring net charges (credits)"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r36",
      "r379",
      "r427",
      "r569",
      "r636",
      "r655",
      "r657"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r149",
      "r150",
      "r151",
      "r153",
      "r159",
      "r161",
      "r233",
      "r424",
      "r425",
      "r426",
      "r441",
      "r442",
      "r523",
      "r652",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r188",
      "r189",
      "r201",
      "r206",
      "r207",
      "r213",
      "r214",
      "r217",
      "r393",
      "r394",
      "r606"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r397",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "verboseLabel": "Trade accounts receivable, net [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r88",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in Other Comprehensive Income [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "verboseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r62",
      "r144",
      "r346",
      "r348",
      "r373",
      "r376",
      "r377",
      "r378",
      "r559",
      "r560",
      "r563",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r496",
      "r508",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "verboseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r255",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r255",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r20",
      "r44",
      "r45",
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Disclosure [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r65",
      "r138",
      "r181",
      "r182",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r365",
      "r370",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Number of Shares [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r217",
      "r283",
      "r286",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r184",
      "r186",
      "r187",
      "r197",
      "r200",
      "r205",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (Shares Issued)",
        "periodStartLabel": "Shares, Issued"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r26",
      "r569",
      "r613",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Short-term Debt, Weighted Average Interest Rate, at Point in Time"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r217",
      "r255",
      "r279",
      "r283",
      "r286",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Statement, Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r138",
      "r141",
      "r166",
      "r167",
      "r168",
      "r170",
      "r172",
      "r181",
      "r182",
      "r183",
      "r232",
      "r305",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r356",
      "r357",
      "r361",
      "r365",
      "r372",
      "r540",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r67",
      "r97",
      "r98",
      "r99",
      "r149",
      "r150",
      "r151",
      "r153",
      "r159",
      "r161",
      "r180",
      "r233",
      "r372",
      "r379",
      "r424",
      "r425",
      "r426",
      "r441",
      "r442",
      "r523",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r652",
      "r653",
      "r654",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r180",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r422",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the number of shares issued.",
        "label": "Stock Issued During Period, Shares, Period Increase (Decrease)",
        "terseLabel": "Stock-based compensation (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r32",
      "r33",
      "r372",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r98",
      "r141",
      "r149",
      "r150",
      "r151",
      "r153",
      "r159",
      "r232",
      "r233",
      "r379",
      "r424",
      "r425",
      "r426",
      "r441",
      "r442",
      "r472",
      "r473",
      "r483",
      "r523",
      "r540",
      "r550",
      "r551",
      "r556",
      "r653",
      "r654",
      "r690"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodStartLabel": "Total stockholders' equity",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r139",
      "r357",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r379",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r372",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stock issuance (Par value)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r557",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r557",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r557",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "verboseLabel": "SUPPLEMENTAL BALANCE SHEET INFORMATION"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes Payable, Current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "verboseLabel": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r342",
      "r370",
      "r522",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r66",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r66",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r66",
      "r380",
      "r381"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 263,289,848 shares as of June 30, 2022 and December 31, 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r372",
      "r379",
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r430",
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r145",
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charges to expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Utilization of allowances"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow [Member]"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r172"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r165",
      "r172"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Assuming dilution"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r163",
      "r172"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3098-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121321822&loc=d3e3913-113898"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121323062&loc=d3e15009-113911"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r677": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r678": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r679": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r681": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r682": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r683": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r684": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r685": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r686": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r687": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r688": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r689": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e709-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0000885725-22-000023-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-22-000023-xbrl.zip
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M;M?%&SX\X;/'_WA?SXZ^>OA^UQ7E]M'?3W7#[XVW'^F_SQ=/__'^[>79IO_
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MGG:B=W'@^77^_L$;+__BUKWX%K, $S1#C2U#  'RK5-S;14:4R=H6'>A!.\
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M:XD;!)_0Q6P]LH\2,W&> 24^T(Z=\M:Q"RY'\*EY!:V%3'TA5NG$-51O-T.
M;ASMV)X N99KBLYRK@!6973_B;6)L ^4: 8E@P?:L5,!,HY$I"!CT4V4B$LV
M@U#!=ZH19Y";OGE*'XIYR$A40QF@L:I7LQ"I0\9U!O52T]>P+4:&+B75).IJ
M O9 J"Z#YH@:K<(,ZH4_79SQ65WPR<L$XLL^R5\LZCC_[#&O5B-S.([RVY1
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MN3O21?WKPYQTI+7D(M9@XA2$DJ#+Q3?SV:>:4.>L(]<(R/8TI&N#8"=Z0!3
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M]T%#K@&0;7:!9,H-E$MSP*'S+#3JX0@1M>[S9S![\??B]NCFI"!N;((N+:F
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M 6UIJ>70*&"&V73:G(4,[?U*2%7.C%6"A0+F*RN*+]E*)"0J\]\!OD5AFB7
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M*V,<55Q+ARG6F#M/-"3CG'!+K?\\H17T.%MDT(:T!1_M=48Y)BHP[8R FLO
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MY5XJ$P.=;%X>QOX=G&S">N< -K;M9>UR]VOM\E6[%M]W</FZ77M]3;8K:UG
M*.H[ BD!**0>*$@UT#3.%A:0(2/7-MY>S[;W\+%6.3?S+=?^A-8UNP2]CXKH
MS>G)?3*325_.:+.W<K-:OTXOFU=JZ<I,X/+/V_Y-:NE*S=W<M8AR&%^=#>*;
M!X/5S7"_(.TA:@VUB5R9"C%H4EG*E"20:JF YBJ5^X!60!1(0+?,<']+SKW#
MUNS#=G$KQP@[UUN@3T-*SYTHKD;W33FX6U?6?2:,!Q'&Q11A:!@GBW(((-,6
M4)QB]9#F@'*O"-26603O0!A3N]>/Y&$+O_!DI>0!USK@6N&ZS9!R"R1J:MU>
MN8-Q-AAYP>)R']6Y&GZKVW*UOY#V'=*[VA?IY5];\=7QM44W]JV7-(@OK4&I
M^75U-U4X3F9<2B&=+AX,4PA9WPV*E!&LY6[*$$">Z3^N]6MEW^_*^7X'Q[[=
MOEJ\Q;.X)$L/["@9_RU\G7^L%P>Q _-9&+\MGS3O/#UCO3*-T0I+B0=MIUU^
MP@('2(('&C$$J-<(:&DM@,%!A9PF46G\+<O/%"ZW6S<+RAUY_<LKL9'VR)N)
MU2;3YO%50J#$>V7@]*#HG0U+*9K$:5F9_<=C\?\U9J+7Y39[_/RLVQKQT-G
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MQ$"<J,@UW$"@$0P@6@D\DI W#M*UC9SC994Q.GOK/F/T01B]^!FCG ;G9:#
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MN92?Y.&'5!>W[>U:@].VODB-];_&>;[RYRN?6#S!=S(I=&*3HM4YU:U^>=[
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M8ASP**NPX)8BCA/]X>GS!IG^,OUE^KN)_A[HR<_T-Q_ZFSP$'I#&U K@!*&
M&NB HM@ JZSG(7CD"$WT1Z;S(3]-^IO1.?-*,]E=O9MZ,#CKQ,X5KM4^2VOC
M(2D!5XWLK^OBRI']O#V=VVEA>9?I_DYTOS.=<B]@YKQT !D6M5U&%)#0$4 0
MIDH)A1U5R^_KK%YJX$R *TZ \_9U9@*\)P%.>3L]44PQH#V'D0 9 9)X!0)&
MSF!C":)X^;V=F0 S :Z8MS,3X/T(<-+?R410.J1\R]*D[1ZI@6%6 J.\LYAA
MJFE8?G]G)L!,@"OF[\P$>$\"G"Q/20A3R@0@G(HLJ+$%BC,):"",$!B\8&[Y
M/9XS),"9!"'?-I=N?L9J/6/UW>6CID4B[XTJ#[^(G?']=-7:QL?R,N^ CNW5
M1W[D-Q\4O;/A8*B[J8<WIFQ=4(!W?L:"GK%:8?'7"ZE7UX6Y?^OL+?*D+V$2
MLQM5Q1'69YP7ATVJB5<4LSEBF/I9Q_A^(Y0JXZ#QG6?&V^6AU^_H86S(^?!%
M]ZP#7*_DKO3X?/3M3IKE^^G-%:Y=5/DE<#R@J%DB [0C''"ED*2(.H/IV@9Z
M3K%:GU52]0I%]&2<SS O2\9YA7 ^58HXQ%D-!B#E+*#0*R"MQ2#.MZ/""@53
MQ'3".5J?KI>8<;Y*.']H7I",\^K@?-)5[JR55#H,O' "4",8D%A'\9YJ$VH?
MO,9BA'.Y/IW)-.-\E7#^T+P4&><5POF$/*>>Z8!% ,1P!6@0&BB*(+#>!,\U
M5/9*GL/U654XRZ&HMT/IYN]"2V_%4K?=8UMVEEJ4=V&\%S5%5IFG9L=3'Z9+
M'SGG)7,&4*(<H,)P()'DP#NII(\FB*.PY"DB'JZ/5&\'/2/]$?P+&>D+0?J$
M1@(1EA1S#I2WJ1ZZH4!"8D!P*K*YMI;QD2>1X/7I;>J,]%5"^J(\#!GIBT#Z
M5"DDPH-U6@ B4C1*"#8BW4-@A!"28R0X9B.DRW64D;[22%^4CR$C?2%(G_0R
MX(1G:0"$2D69KA$PFD# @D-Q=KGAWHZ0CAZ^.SCK\*\_AREK:OS7M;YL_!5_
M7+WZAV>=G V&K7 QAMK&7Z;_Y[>(N=6[;V94HG[')#@QR5ZJ49;*,75[P_C0
M^,OPV$<^T6>N%;&<B*1,/ZK3'Z'5U5W;TNW8R/A!QW>'@_5BLQ-7R'!0=/1%
M>DH$>_SASLHB3^7BB2ME_<:!&+>&XG7!8HM/>X-6&>W4]VT];'WQ+[^VW/#X
MBO=^N'&TFE[ [[=H$YL:&>C&6R87Z.+9NQQS\O-@_/@S-;9D08F\C;A61KD0
MD1LY6RL1M,.!B[3O_PGCM:N;CK_%4)Y&-@:F[_5GH,/0]U_H]E=],5C[\Z=A
MZ+2Z8&+8)T?LQH$)86X#\ZN M[]T9=I2'/>35/W7[Z=(K&TTRVIGO5!L)8$<
M4?+7GWJ:%&YFC(E+%KU27S7VFXUZL;^UNU-O[K[>W2JV&GOO&GN;S=WX\69]
MN]C_\&I_=WMW<V]W9_\1R>Z6_=EJU/<;;W>W-YL[L>G-^$\M=FR_:+R.':N]
MV]OY]TY]?_>?G6*W'O_>*9Z];>SO_U$\^U#?_+"]&V_Z8V:"(,K9<FU\8[,R
M'VX<B+8^'?@75[^\=*W!:5M?O&AUR^Z4-[WLZ/Y1!/&8 A. )T1MV9K1U]^Q
MO0Y'^!Z[]L=O'G^]7GXUH0",OJ-L76)UX]=P'=WXW:\>B] Z1_=[[*^_8^3F
ME^;&5K&QF-[JL;_9F/JM,:BF+KW&VK.1IGV_0H'@48I$D>.+6KSN>%#L1$GD
M2D[Y^ZSK"P*?WR+4>V6'9K]U?LN!N>7BJ<CF9?G$%ZUA?)N]A4/@6:M;Q!>U
MHZHRF"IU>YU#Y0X5!BJ^ I)S<E8]ODUP_DJ-')H%=ZSJX.1E-9ME==\3*O<=
MD\H%FTSE/7LRA:ZO'X\G4+#JCG[[!12Z?M?OA=8P5:NJBLO]HM:Z<KDGM_<'
M5KO\<%$[>4\;S?>L=M)N'9Y\.#\XV3T_N/Q :_C#>:UY=/'=Y?X9U[==)UZ#
MXO-/ZI?O<>WD SN(;3G<WHG/.?Q<:_[=/FCNP$F7>Z-Y &/[._5FO+Y3(_78
MWGJS'=OX.MZS>U'OO#^O=?XYKC7W0JTU<K?7]B%K-.W7^M$GK;$WRF/@9<IW
M ;$#4KBTG\Y$&</+>(@TR&<5TY?+[F46JU+''[.,=&:Q^[+8Y02+>:VX81(!
M*) %E%,'-&8:.,5LX)9Z3%-TLN29Q3*+/6T6FWF1YLQB]V4Q-,%B6!/JO<7
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MZJKZ=-Z-IB>*@?*J=[W!L.^'K7Z9-^S5: [?M6/'LX?Z84+C8MJ]XZ"PB!#
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M/=!!&\",9!0K'R0U:QORN80YF&)U$3TS-2,C>O&(GDPB@SPSV$5$<Z8!)4X
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M!*73#AD(G%(HJ9(V*I7* LL,==&RQ@'S7VML-ZRB^WE'\RI:RE44HM$AN:>
M&2, E=0#98@"!G,M3%02D2)K&W =3B?>FOJ@.-7]XDN:W0(4^FQXW.M' G3%
MC6MPD%; 8";+#_YZ^95K;;#YK4VW\^SE-;GP-0GK7S\QZ15GC /" P34IW(
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MZ)R7*4SB4;#PM2SUVS/R8V:GJA&7DIVF@[@L8Y:FI(AT/A"0,1$G:"*B+,0
M+(*7E9VJ1JP:L6K$RL(+8^'IFE),!!>")<Q;ARQL(REA8,0$7WJF.<CT.P<G
ME86?6BW0BVV_;I.KOG2=W.L=WOX.E^K,Y"GGQ%_^[$L1:W_[Z)-@%%/@E ,!
MJO0%ERP%Q;PQ6?"D[CLGO@JH.014F#GJ !.2X=83KYDE$'0IRFF :&ZT2UXF
MDTM9/-VBDN4U%ZCRTW?X20K)*#.@G0)3^(ER$84/P*A7/MYW[GGEI_GX:<K
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M;.IM3K5S*24@/W2ZS-9P9W@S;!R<.-./>_SM;F\BZ:RRDN,^;.\JC:OZC4O
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M(4:$E9J&SHY",JHS(2AU*K5ICIW-;3[;8I+QQHY#YS.XG:,^.WN=LT%_[=N
M/;;&X F-43G)<JXU(H!]B 7=4<!I$,'2*VH=89*-:\S(WOW7(L[]0ND[:^
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M.PF[+3"K/=5^%P8*'* ]"#H7$QIBOQEG]X?@?JVA9NT;S*PWL[N3-G:^24O
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M \1M >).R7HU0*P&0$Q& 1AE*0XMK])< RQ0P9",!W5(3@BEU%)C-[;E=%N
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M^I#2AC'P#FM*,*/(H9V]<O0M_J6F6)#YN/9\G#EX:1P\F140C7^E.74 !<0
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M+U$1ZZ 1-GM0,\>OF.-S"<9#?27709)O[/#'/OZLM5.>, N\<I&_"4N9%)0
M85R .@ISR3=,EI=AXY_[VK3\L'HY_A@^VLBU4LY.,UP-V&_O/Z;[\]YXU?-]
MYY4WN7[IZMWB"[?T><^_&G[XQ35[YRU]]:K9+KFP/.F7,]W]TFP/*3&C&+N\
M877XE\NFZY\FOMV%%>\.HN*#.P\.[Y:')I9B<$SN4G7[8;B+;C_UCLN*78GD
MUE_U[F.,+)^NB.TRSI^ !%P\]#5738*Z;8)[KHK)7%>])Z7E?I<LO%%5-M/U
M.CMS[$T(WI837Y/8CX]=?"C[573:O=/F>:^(^LF^M1=G%ZVR 4VI/Q1C"D11
M:1!C NFQU%:3Q$Z],S:<TOMG42SW(WEMYTL[GN:*9KLX>OTND?B_=^<8D<7(
M<2M9^=Q[^*%DOZ\YS RA7JW4>M;DK[:^<,VTL5_'#9]>LMSE'_OQGS*I.#'&
MH,(O?F%5#65F/>R#&\J@^QK*+&MW;3?3#JR@N#M"MW-6["?.;;;[G>*-[K;C
M^_0> H#U2(0L+_BJV8\WL_-T HFX%>_32APQU;OA]EVU=*RIWV[YL^M!M(V+
M9#P7+Y+YG.DS2I]$FU]]VX=FOW@Q""EF"HU2:&3G%*FG610_D6A+(%$-=(/Z
M4?N/3N742F2>A?2Z[8KC3L3%X='XO3_B58IW43U8Q:(\1Q88@NB+Q L_%8D7
M,D1,@.B+ 8K^5+RY)V/F.5)H9.?<!J*S];,YZF6VATK'IUWOBT;\WFFO>--V
M$>]^OXC81N#+ D.,[J?7735TXV[GY=J1:R#6;YWNI>ZZZZZ\CRRL6X0Z2\@2
MS#?(-UCI#18N(*QSR>W#"@07>=4\N7US>IM"#JFBRG++%85*JD 0%@$'Z"%S
MTI8A>30,R:.GG-S^#%H0__VU<?;[U\,?\;]C>WET_*'5B.<<'KR[:IR]_]XX
MV(>'Q^[;R<'[[U/Q^7\:5Y_.&O&:#73X8Y\=OOWKJH'?P<;7=U<G!V\N&P?O
MT2'^\.WPX+=R>OMD]S'D. D& H&8 -1##J1@*657*N6QD-:ZG3TT/:YT+</;
M,]YL%-ZL%FZ>KH8R0\PB$#/9,-E02)@* 7@;<88&A8$FG@$1J#>48JL,GC7,
M;,$$H PSSQ5FMDNMV:[$PY6ASF3O9Q$"%MI;$!<1IAEM FA-:5Q5B;QVPD9(
MBHK-8P8^+1=QUM41IV9.O%NLT$ZO]&^>=SONPO9[R3AWV13=7,Q> +(9=D1;
M9#E2G,H@)$6224Z,P\1#@Q=6#=-F.@IO.QW7BT;D1]_]MVE][V/<41ET%P/=
MR5[6ACBG'8^Z'40$4*4H4)0:X#66G%.B$+,[>XI.FY-K5?:6 ;T9?#8'?#94
M8=SV>M.5P=9D[VWB'8+(.L"DLX!*+H%Q(@!+;!0Y4#KG2-0586UTQ0PVFP,V
M&^4$R^ZO1X/+9%OPH!A47$B0EA3$M4.I69".)JF/RXH)@Q+.&CR<W5\98)Z3
M-I,=7P^,Z$WV+Q<HZC/:2Q 8]("F'\9I!:1G"E*LC4%A9T_40YG)@YLW;7 S
M?I:#FQ<!6:5TD-X*&%^68@45I5QY)CWV@2'MGP9DG_4(YQ6A;7,J?R)H$J *
M%CB%HNFH, <28QG!EF)/8<#8XIV]Z0F3>1CLFFVM)3!I'ME<4R:=S$ @5*FX
M02P00D033"7_#F(&2&H-95$?LMPLP03+G+I-\C0/<%X]XTX&\66PSDDE@).&
M 4JX!MH1#[QA7%D?.)/L<:9,C:>B;MOHYF5V/]X\P%MGP'L[NQNO#)4FH]S0
M,"M#H, *$@"5Q@/%/ 3&F* (QEY8&75^7E-](D]L?@XZR>S9S9GQ%V'\R3AQ
MH,I;ZRB0!F- @U= "X& 0@(B:"EG+,S*9%Z[.K*5[+H%QGXV\Q_#GI.15J2\
M@R8RI1)1.$?;W@'IE07::JD-1U%:V^5U&LT\^HQ%:C;P'^@^GPQ6&BRU%#[*
MT-0"G$96!5(0 AP/@D$HJN[?-1&I,X.5Z"[&K7.]]ZT=(.*O[>L.$,#Y=N>L
MV2X;!CIO^GG"\C.Y1@[-;UIHGN30_#TZ1B"6<X4E1AI1!Z44+E@BF70B<,]R
M:'Y3=8OA!*$1<X 2J:D- BBBHFJ!C0"2< ."<PY1 PTKAP@]I@(PFP)/8JXO
M@4MS;+ZF7#H9FX_F'7(*:2 <08!RI("T/C(M,EY(@J@R?@G= 3*G;I- S;'Y
MU3/N9&Q>&PI%XE045QU0 GW)LX Z[ 22QM,0'EDT5>, V+8%YTMN>UFT_>WV
M_59BW3K#\B7-!U,7VE\J=!N$Z*/%D/%I,7R:BM('Q#A5'GCD-*!><*",X\ '
M"PVG6F#A=O9PCM)O+\?6U8Z8'9O?ZOFB*X.!R9@]"DAH32404%E <;0OE((0
M<!6$XU%MP1HO>[QHMC*>'1]G#EX:!T^&]9U@%CD6@* ( 2JI!X:: !1Q-'!A
M$7$L<W#FX*6%]#,;+\4=/QGJAY0KRXD 0K#(QYA&%F;2 N6Q5($[RJ6M(Q\O
M/!-B\X+^UZGYT13UD>^&_//(\0^;$.7.U]C\S($:CD7(DG\@^37T$?1YA'OA
M*)'.6,8EDB*(X!$U:VOL/8RQ9V'_:&'?.-Y/^OJXL&=64&L0,%'? U1)D4IN
M);"2,<P8C>O,ZRCL,^O6GW4SWRZ1;YOC?,N<TAHJ H3F%E##')#4&&"AULB@
M@"2$F6\SWSZNM7UFWN4P[]4X\W*CA'2< ,T$!%0;!HQT$@B.F X<(1M$W9DW
M!^?O,,_OFX+ZW)$O5\[7#*$.)]2+7#K_['ET_=I)[J.^+/8^FG#Q(^F%0-X
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M&CD(/";1SF=(@*@[.: %LPHB)+WS]6J8N?5,NJU"-=OZ#_2C3X4K<5QI0UD
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M/8V@,<!IH@!UQ@*%, 20(:R45]AKEUQD]=!G\DCVC1O)CO-(]GM@ED-&%8X
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MO/?9R=D[_ E_NFP<V!_Q7_3I[/"T@7]+R0EP,F3"J%2.0>""-H JHH#FBH*
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M>U(CH,B>0^X<,F?BS<29618M((L.7T]Y=JQ'3$"O0%0L)*"<&1 -0PR\@E%
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M9YN#EW"07C"<I/2<)^_ =U/,!^<LH4:86S=A+KST0+QT=IF7)!=&>XX1*)0
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MXR"]QC@R% U8PUP/VG<DY'ERQ@C#N#4%HL\<HG>-&A<C^"&@.QD[9M$S151
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M/"XV\;/'\%T#V 7##^?73L:IJ8I22BP052$B[@#)EC&-O&(ZD""U,Z& > U
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MO;@E.RA4F"BJ_L=$=?2LWRRA,<IP1SC=5%F$I@5L5'M8NP1C'QQ2"[[XB'5
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ML#Q 7.J9T+7E>JG2,X_C[1W97F4[\:I)SWFJ? 6H1!>#59WM-NJPV0G<63O
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M+$!3, EJV6QB.6/&S6V<GQ>U%U+EL^1\T N;T.\,3J(?D3=>#^[F=F+QR''
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MXKAI_-XV6A4PPSO;Z%3_L<U^K/X5P^'J#%M<E6L\&0/X?GN$KOV19Y0ZX23
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M$_4U0SP^J3\% /*P6G7B>:I)O]WO 8VWLC!<)N$,8[!*?:?A )LN I-O5A]
MC8'@Y&N]&&FQU.@ P_^W#\]0?WE]+V#1Q-'#_,\<APN4"TT(PQ23P)V3SF$I
ML' Z"9LX$[<]-/YX!$9X/EUXU>YTVJ=9ZSSKDX1F_-=?9U\^AQ-'N?SR_A/>
MV3_X\67_+=O]_.5X]_T!__+^+=W]V3S>>_/JZ.#;IY\'WT+CX/.[M+/_ >\<
M?A7<>$*91R8%BGC$'CG-$RP/U5)%CP-G&UMT1DN1"A#2',K6?*7PB^VU6.-"
M^#OM\M[V5\<2P8(JI%5*B#NK!MW:5&(<$^EM\+#+;':/-F":LP'/C#<KJWPS
M6W.I 221.0E(X7ZYM;[@RWQ4V/"W,=3[G4ZVE>LZ]+%SQ<?4W,-URO0+@*A/
MF6HCR=EF;4!WCV+L=8<&SY2*GU#J>9\RK!K@,@[.Y<;4_)7G-EO_=)U_;%UI
M'MS_><^%R37GAOX5_VXW_ZZ;!0R<BG?6-YJ-WMG5CL%36(5KGWFO58./X)&1
M!\JUSC,=^(YM\"U;\$WS*%K"M%?PGY91<^6--M:DY*C0WE.L!M%9( MR4W06
M;G8O#;9BM!,[]D?CN'^A>E_;$WBE=W;.OV;MZ/?/L[T_OTI84.HL088R@;B@
M!FGM/ K)^\A\WH( 2G;FB+_*#=5LYUS^ATYU&LG_+WG'JBOQ\>O 9K358;,-
M3%-US\#J\_6! UB%[>-CT)-@A (+M;YW:_,QY^ ,_;?,5>"__9T3B2]](]'7
M?./@M.'ZVQJ<+H!=UN_41Q]C@BY?#&YY*-:[H. [#3\AQQ[CD)+2)%!.F'<N
MD40TV*PBR(C3US<C.487 CT08=?],6$\O,WG*EU8Y;W:7,[VXR6K$?#K7X9^
MY[3="6 LKYD4[_[\+G8/OVK&:20Q(2VR%&/"D([1(9P<_-8[I1Q(<1LX[ S\
MCY$@#S=O:W!VU:T-QGJ1NR^J;M]]RQX^$-G(.X$]'K@9W2Q#C3&9R^=K#7!,
MJASQR/*43U@'JO1<A$_L2<SRVC[LV.,7M2R/^SE3[PR-#GS_P%7J^WSM$76!
M"S;@+N#2[%OU;I3G6N9!E$_S'_.$51DVCJAH%2RP<%;#>BJ7K36J/>;L[OW<
M9A0WXC43X9W]0P;>CI7,,AX<HC1B$&'+D4O2(6F\L3JF*"V;+]?)8*V-("ZR
MQ%.(SK+ ).>.Y?%BZ0I7!I>]FW_O "#2!\^1!X<5?!AMD',Z(N;!:[3.AB3B
MQE:K/2->/:E21_&Y<6ZX+<PGCB-O88L/+3J>]3M8?=-G6J>-T#L:Y6.,?7 8
MK\87'[$.G(9^[^J/3$:E'\ENI61B?<;^/.I<G$4>1N0ZT7Y'-H'-\=(V3^U9
M=^,?EQX)+!$TL8233W_E0Z9T;P\Y."0%3.=H4-Z;6H &YX__M"MS+]51)Q/5
M_VEH$L'FI\:9D#@CP3AK5+*!)JFD,>2KVMC:KP/<(-VO,\>U<D<V.^TE7>U"
M#?Z<P,* K!2V$H.7P90!^+OD')AD23 LN+72X0&OPF=BV,[4YPQ+0BDJ2*)<
M&*\U(5A[N',!H'?^2K%_7(=M.E*0CWE'KOSPE:$__UMUU#Z-?\?.BP<T4IZT
MKSSGB<&PO2 LY.OVWQ%^[LTAR]>X'N"TX:"(!=DEW/#D;#(<C#?GN1+1F-KU
M  \)$W2A_2]<CX_]XV/;.=M+6>/_T;:M[58XW[#+#O7V82?6,>77[>.39B,?
M$GT&QRB;":-'ZM:@W8>;>]5L^^]K9AOLO=D^W?WS:R+2">XE4BF!72? MW92
M!H2=<]Y%SZ6B&U4$ ^HDBVRG'U>4/[9KXV*:1>J3G]JSJ'VDD3!<1(/2N:S[
MH6  7?RWW\@G1>[L3LP PGH(.GAHC>14W^%O<BS.U,'!06;4N=E2)]/Y'.,]
MZ<:7HQ]^"XWN2=.>O6RTZ@>O/_3;Y:O/".O5>S-X>:CXC=E46&7=/RR(&G[Q
MT"S8K,V"B=S P6N,;AJBKGP9;Y(%7Q.,+?3):V^6;!*AG]+-FEM=]H92MCER
M'Q=XZZI5[L_.RAZ1.\"UQG!6 ;>HAWNVZ['M>WW;G*>?\FK6/<Z3U+Q.^VO/
MU5XUF6%3EF-Z.18M!IXGS?TI3-&JHTUU=F*CEX,5S>Q-V4$&6:/]!,=ID149
MI[6HH*Q@$YSY4E,X-X$P":9,PMQ88;3(B2J<)"MIP%=,::#C[MU0+/\8RN)?
M612?^MGMH%[I^/?L<S5VOS6/ONSO?H//P/<>P6?@NS[#O>Q[G.N5OL!U)^N5
M#HY_/X)KTKW/[YH[=!=\NAV^!S[=#CS7 ?W/T>[//T^_? O?=_:_I)T&/LNU
M2CL?L=C;]Z>[AU\E-O _+5"2N5Q)<HZL%P)I0W4(4AEE:,Y?F9&^4O6R-#UV
M,X&U!10UCGO.%%4T<(VM58(+D3S%L#+AJM:=!5!+!A2> %1T6HB S0!&G/*(
MM) :,96(<"R2&$S.2)#D-H"ZP1X9^?UPE7@]?E;OG7,4S#W;;.H+J^3!D^9^
MNUR22#9I7KZ: K*)W&OW;+/N%E/G$(SGU+U]]6'_S?:+'*X+,35:%^=@P_09
M.SI;[=9O KJ!+0HSDNS&DAB>VH'Y3;4;-\4ZA\6-W1N.&/,JUND8MMD<Y9>/
M5KG3R34=@[JHNF[I-&>V-UIUMD>^[/$-9OS\^<4J,NNE\"XIS05C3DB*(T^)
M:$8]75<C;O$ _+>=LYW#KPX+YWB42%NMP0CS!!DC,:(JV1@(J!/-KS7"8+O!
M-CH<'%B#U( $9*'+V6:#A+%S2%XD^Z3S K )L<BH'13!Q>:@-.+%><TEB%*C
M'>"?S>8@3F9SF4)SD*QL/<CL@ CK#PPJ,#-WP!<.XJ=U#6<,W;D2*Q>*"LU*
MZ,GR]^?H=K<O[O;U^"W>KJAA[?(MOWTZ!4FE7I#H<$(AF(2X=Q$9H2B*Q@?M
M@] XA(TMLHEG3&T;Y5O6-2]U6=K?62"!A+I]D)-<I'NQ)1<BE[(DPCNRW&2)
M&Y;%=*O&\3'\!E12\^Q"(%\,F;46?_CTJ(@&*'$@CG65Z)B@MKWO=T#D;T68
MC>Z<A(F]U<1'01.(;A3,XBB\YT& Q2^B-(4PYQ7# [&[_15S+[BR%J7 #8@A
ML3EADB.O!+;$&YP8K8<'7D68 U:<WN_!-G=[\02,F_9IZT(*&ZEW]*+J B<<
MU=F/W5IZCV9*)EA,\XD)25(+$IQB(G!GN'%241\3)8(%&G 1DWG%Q(N=TZ]"
M>4VTEL@%D!5.'7AE'-C*^A"<)1)CF[*8S$H.K\7DQ;SV42 I<9JH9Z"> M."
MZF 3ES38H)(L^SC_/NZ>?G521.LI!ETC'>(A9_FK$)&BMI[/)P47>1_IE?91
M1NQ\6QFMPD9+,,@4YHXQ&UTNZ**&,P. CV4KY]W*PU-@;N<E3Y1%1%3N'QUR
MJKNV8+A90R6E"C.#\U;.LA^&D+Q4CCU(#:^3',%L/6?TNSHZ1H Y*9CBL=;6
M4A-G&1?:*A9M\(60Y]]]"N8CT<YA%L%>Y!HCKF0NUXD,44<L=YC0$.+UCDZC
M>Y%]<[734Y]@W**NX'.LCNS?=9N%@;,S:BDT["IR*Z-P9")THA\T\JBSB&)^
MYTS?""R+?ARU^$C]89)T=Y!UV#W*%3M'P%=/.Z'PQO.1&\X\+KFIMO8;F_VZ
MQB5UVL?#4OZF[S?M>17^[<ZHSCWA%^?R4U=*@3R\R)>QK3,0AQ:JM\(?V<[A
M4'WT3_*>S>.WWK5=:V:1MZ/G?@>/_=8U>L&^:W?^BKF^RN?;;AV^'MQD*<:?
M23P_/_"]/[]J JI&$(&HD@)Q S\Y<,>0X0F[R#Q.5F]LB5E:9U2,W\B%@F/+
M?DDX+KV"1MW)XH^3V.K&2^W*ZA.\804UB';JUU5ZEZ]\TK2Y2NO:E,4C.U\;
MB&4(XRRQ^VM$O/OM5[&6UA!#%M;7%_#<2Z_'P#F0XB*NL\7USS-P7+"TH"<#
M2*IR><J&(0A,4(X88\2FF(+C^4"0S(@AC?6.&"BE:9$=(]-SM3G1B"2S8,V
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M%L8JDG3!-O\CDEJ/>J.N]-T_C#T?@$J$XJPFJG'?5LO.=.9W9R8>?NY:_P.
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M[],,F)ORYACQUO R/?#_WMH]2>#*+S8!;X+2%*5: +Y8 !F5T PE')L88^%
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MLR#M\D%/#N%EWX=_]$<]9/+ W^.?U2#X;1!\,1_#9IS'/%9(.P<([ER&E 9
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MKJJD+RO*XR#E8PN=*S1G ?Y'@!531)][N7\H>/?^M&ASUM>H$+GVMDN.]E)
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M&_X#)TA_0W$L>/R[Y\&P)V6YF_-;X31EM +V^DOJ9&JOR8,@X'Y$P1_/_E6
MUPWKT-=#^ 7CY%^>'#XO=$B6^K?MY;K;.2^++>OG%=9^+;R*#;W2E(6]<JHJ
MH#7Y6'9AIPEGY)YC!5;+CZW3/QOU=;G5A>I-683CNJL-M/*K4W!U9C[ U@@
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M=I[881-D<#&">JL<G!ODW\":^_3T^GHKO:D_\/$,'Z0L[:T2PVW-6WANN]\
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M/QUOG?Z&U]U%/2E\[>Y\,%($"P&(D#03$"(1%U4F+#%E15*6)3O9[#*X8&F
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M-FTI-%*7Q>/%C1-:!BV2<+>CKF_1%&OMA_N<JOMV)*JGZI%.%7[G!V%-9D$
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MQ$C'"<W2!)6IBJ77,] ;RI\JW52=:@%F<59J>4!JF6PC'P1-+@M'/*.<@/!
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MAA:0ER:"4#H;(Z2P)*"$(9 H)=:#*?TCA Y"*-2.BE)D;66FRDQSPTR4ZQ1
M!(?:$#"'_TN9)>N]T@+_?:1^_9699LE,8;*<(2B:>20 95:6Q:WT40G"<\0-
MU]';Z!MSC4X7.U=FJLST1,PD 94F+[5E*0*$X"EH$[.R(1EM:I_+.26?B2B@
M!&TSY4!L4I) EJ@1H<E-9+0<Y0V-*L6E%:.G,V8K]53J>2+JB4Z \(%IQ6PY
MLD:XZ#,#SZ/''Q^)>JI2-%,?]F1(,UO<5"4\$3R@P69!$F-,(I9G\ Z5(B9I
M48MP]RLWU5#K/(5:Y^^&ZSOK.^?YG<^K*/-J!6?S<.CV\&+#SEO4#:9J,6]Z
MU)&$:!_A%X&2(!X>^;W4&=_Y/;3!N5NK_WRJU7DV.G*.*4HM)(T^@ S1TIP3
M-9F#T5S"(U7!51UY9CHRF\KS\$$%<%:2Q!DCH&0BKL0U5,K<"ZD23Z8):8B%
MUI!GB_ G3CVN+%]9?H8LST+VQ1SFH!WX:$NQ+)7129N%\MQ5EE\\EI](J.'*
M2937C#AIRE QFH@%9@G+(7A!%7=&%)87;+H4NK)\9?DGI[/*\O?.V=:1BI+1
MR[)'Z </UK"H8O+@DS./U)RFLOPL67XB/:D,XXXZ*Z)M# 10>B/+1T^"9]Q+
ML(&5]"3Q@L-T5\/*\I7EGYS.*LO?E^5MR%(*93-(!M$Y8XS^?^R]>5-<.;+_
M_58JN#=^SYT(RZ,EM;DGB' W[AG/'7"[&T\/_L>1DE*F;!9?EK;QJW]2!;CM
M*K#97)P"3?1@H*A39U%^E)E*Y3<'"TW*(BN:DTA9I_Q-4GZJU"L%8XLV5M3L
MVIYKU"*8",+8C!6*0Y[G)VN:<K:!0J=\I_RMXZQ3_MJ4CUZ:9'R2"8'I'K+4
M$DV3)_+.=\HO(N6G%6<=8*9L1?%EHEU$(GJCA?.V)JH^!@F-\GJQJ^HZY3OE
M.^7/*8[6Q6!6V:GH(%0?0 4;G$GL_9%,NE-^\2@_VVF^EF(K&$'1H !%5L14
MG,C6@"NV9(>RY6QDYWPO81S:7TXJKOYZ@/P$^=\R_F/Y;_SE]!V?/9LWC)AQ
M/3IA[O+?TMY?/XW>B[UO\B&?QM?Q*.&SW,)W^_3H])L?3D]RO#,9L9,W_;"-
M>Z_'.Z>#SKZ;&223#SQ^^8?WXW*PV<;X0WG,ZY."LI-//GGYX>2EJ5%__)KQ
M#[6$<U^6#]6YKWWML.&AB_9*1_WZ:R;T<^WG>M_/U<N+G<\W2DR_N1_'?!9=
M?#$5?CG9G3'??3[396IZ'(-R:W\;?QBM\E]M[H^>[!0JHW\>[M#(R =?> C7
MO7W*3M^^64=A\>Y=6VX]MPO9S(#Y^A7?OUNG+C/"[D0-^(^'^_R[%J-=9-1\
MPQ6_"Z/@Q</?'G[W6W$^T^_5O7ZZ<_#_;?6;/<?='M>YV?U^=E!T4-S]FST+
MBJLV\KWJ31F<?"&'(;O[>??=T8WMHIY9:1C8.LS9]^'BZS"7OOZAK+1<NX.]
M29ID,B:&5(":Q@P&$T(TSL=8/^US4[UKZ#<74]YMK_U];7/C8[;/5EY\>/EF
M5:[R^S?6M]ZNZA?VY>]//JZM/VF+*W9U>C%E>T-NZ)_?K'U\"VOK/V^O?GS^
M?JV=X^_//[Y<W]K:6%]5J^MM<>7MA_]\/-W@\.1@=?TQG_-S^RII'RDG+9PT
M),"!:RV+E:!<L_7%(A1:6G;VNTOV?M_EBDMW@^G Z\";[@B87)6 SA7RX,$&
M"(EDUC9IAARE#KPA N]H"GCH@M%$4CC=FOYYKT2H20J2F"A'I:WV2\L UY:W
M[,#KP%MLX(4<C0>B)$V%["V:T#:]ZFB+KS73?(!W]VMIYD?#M6GWCZI51@&*
MHB )X <L4%<G<LP^8W3LW..D!6KL/.P\O.<\5#DKF6T(CL.B6B%F=AK0:A5J
M@>A/Y1=5;[PZ).1-.X#!E4I>%V&#1'8 $R//H!:V4 HUMMZZ'/':,[K1=^!U
MX-TKX,54DHZE K7=D"HB!<S&R6(-&D+3@3= X#V;]O&\CRI#YA"W1,,^'CH1
M?)%"UI)4U515CASQVMG][1UX'7CW"GA0T*N:(143("B.="D6**13C,I[.1_@
M]8CW!O-_GWKW/7G/W\MGSU\1*E<4*I%)2^8A11%"3"(ZEW,Q22L_V0LN%V?1
MXVY5\)UMQB_V^(->'XUPIXQ^H:T_QGGT#\*M@\TKB=&><0,&UZ[_^DNT.: K
MDJ,;B1 A)I6JE18#42F.?%^Q&!RQGL\NT5I^?#9)([(D]M]RJ2(&SU^DC;H2
M:BSLO[DSA!V')C%^]9*[>V_*5 &4!1M28$,N,1FO$52T,JFBLNFF/$13GLX]
M^1)+,BH+KR (0$"!QI83UP-J9DPO+6L[NVVUF_*=,647BDRDL9*JX!4&IV(B
M9_CWVG@3NBD/T)1G5L[ .:FS#$)I#8))S%%$522R+>@,&3O9@Q[<; ?P;LIW
MQI0M98K5&N6=!IZ'4RDYI.C)ELPS-O4$Z1!->7I6;KJ)*&WK\5QY5BXZ"Y1%
MBFA)DK?H$ZBE90NZF_+=-65&=B 7"Y:L($I ,E4FH.B]<Y%<-^4!FO+,6D>4
M@:)15E@7DF"'FF=EEZ6P[&$936C!:W:P58^5[[ I9^E]<LXZ2 8@44I6DDKD
M'6"*=4Y9_&[*EXN59Q/U):4:0&H>4,$*@&P$\G,5"M"B-::&&):6O0T#,N:K
M;B%;I$S\&AVR)>R6PRUL=_M*^?<S+OON@<AXEQUYY&B?0.=68)YDL5)14-;Y
MGG\?'HA>S.;?%=3 /J 2E%JWN=BV2)40!3D="\?YQJ6TM&S@I@K&!E0BT4WY
MU)2U U-<M0Y!@K,A**HJ>$H '#3DTDUYB*8\'>G7UNP]!<?A06SA030B0/9L
MU%3!^5J\Y?" 'V(WY;MKRBEX*_E!>QDS1.<#)@X+'5%PD4,&U4UY@*8\DW]/
M;?D[5"-RQBK >B-BM$;HZ"QP3.==E&T?W[6#@V[*PS5E6SQXS_Y7Y$B?-'O7
M;+'(SUZBA2)[I#](4YZ>E:,K5)P)[&"7(B#D**)36;ADB'TLQK6!YF#;;LIW
MUY0]!6]T-)5<!<5S<BH(V5IELG*)0C?E 9KR[%Z#;"ND3$(%X%G95Q"!'/(D
M78IT@-Z;O+0<8[?DNVO)N=C"Y(Z@T4-."5O6RP%[98%M^:1/1K?D85GR&>EW
MXSU6#4$X6TDPBX,(P221:O*R\%3-)MT\[)O:-]0+X2_6MVZ5RF^'>Z^O4_9^
M#<V<A5:'06M4 HB:AR[(:E!RE(C*.F<HZ-@[6BP8MS:^R-:W<W]58\C9U2HR
M& XF%) (## AL6AI2BX<+[;=/4[.EO,LK#;,L"6^.IDNX#2%4ME=IDK)@Y&*
M+U994N!YKB6<%YDZ?"X'G\\R&6L?G[Y_!=E9F0,*J5P48'0621L4R?ML4M#\
MA.W2LC\C_NGHZ>BY)?1(=NIEJ+'8)G]M=:I9<K!&P7@(-N3N%"T:ESY?+'FV
MOF%>6;*%7#&B1.L%)*-$B"@%!32I E05RM*R?@#=*>ID&@Z97)-V1,_ *0"H
M(Z8JHXZI=2PF_K:W8U@X,GWN,?'UOHK:6&ES%,J&("#&( +:+*J."GW.);C:
MPC4(LQNI.IDZF6Z+3-K%HH-D?XBG3R@(ACU__H;CMZ)*7W@>(GP^7ZWB<(W=
MHM!";<HB:--J2)064>8BC&Y=8 )*J1@^WO5PK:-G,.@Q2)'0DO:(S)L4G TI
M1FN-K4[YTIVB1>/2EVMO;_7:XU=HHH$449!GWPAJ5B(%FT33($"-1FN;6\"F
M;0_8YK0E9_+9_O;7!B='?#0^X$_+%W@B3YON%AMX&QJX-?H)]\KXN)'6^B;M
MX;OQ5Q0Q+U#*L* 4OOY^@)P<!R<6:BLWY>BTA.C)4]LXG)SN8B"#!.UTN9+4
M)#G 1*&5M<>M45'5)*H$JTVH-9FVM<??5!'Q,)RP&ZQDNJ_F+S$6IS/&8"/X
MD!(IXY.4*?'W0<TI9][-_\K+=1/SU[$$67(67B=D+TN!2%2CB 1%&@H)8N3X
M#[Y[']!N_HME_KI%7UJASBY"R,@CI4HJ 2%[JF#[DMFBL6&VOY>V)>H21(BM
MZZ9T3H1JE:A&61,@^LC/=%D]4*H[!YT.7];R.(P:?)8$S +E@@9-Q4B33,PQ
M=)V800)@VCEPJ9:"V0D??!,*!"]"Z_)7JK$E:>=\4$O+/%BZ^7?S_R(V2%6I
M"I018VO8BXDM73MP3FFO;>WF/T#SG]G)Q.S.H)(59#+/_U8Z$55*0D;KM:JN
M>7Y+R^[&MC)U\[\KYD^VMI8Q5DH-J5#*OG@@'US.X*KMZS.+QH8S]D8QQ\FZ
MFH0&XP3$RG2H08MJ0U1M*0X33**#!7$/;FC?U(*ND?R.!WF3C]N51,Y5@K-%
M&@D< 0."T2G:&DQ1TM>&,BU[OG-PW,JSRQV>8Y?$;HV(D#FD(0LBV,#\TM*B
M@I*-;R&-'E)#Q=X=]89-&258-$I:7Q.XH(-/.F'528/EV0N[*0_1E*>S$Z1;
M:PR2(L36N-PY$@')LF5[?IZN)(F63;E;\AVV9*6:G(RD&+4'Q<%J!E+&6EN4
MKS'W&H0A6O+,0H/B:#'KR+-P:%-Q=E&T++&H(8,T@2?LUC(%?&]9?H=-.2?%
MOC6Y+$F#1Y4<NB@S%IE!>^HYPT&:\LRD;"K%FJN@1&S*EKQ(,4M1I2Q8*CC=
MY+T,7+N]:#?EX9JR2<I9S-CV\H/4,E;+UMRVKFDTE+";\@!->3;];[23RFH1
M4FS-CR3/RDJ10)#5RQ2Q6-=$T[LEWUU+M@$U$$$ TUH1<FP<V+*+,QFM*[I;
M\A M^2S![]:"4&LGC"(M ',0& L))K-49"-6;/U%PY \[/N]:6&R2P'SZ-?-
MHX/-[=$J[N!KVJ:=@ZXU<FXR *O+D:1UOH)6,2C-CF:.F&0-$7J&?GBP>CV;
MH2]6&:><%QG0"M!5"21E!+CL#:ELL\]+R\Y=6R"X-U =KBG'8"K'_[H5H -J
MF8H,/I:<M4&93-?Z'J0ISR0#:C *K!75*?8ZHFG)  O"^JQC*2HYA^QUQ"&U
M3^VF?-.+;<7I8  )((*M&MEJ#5"+'R3[I+WAZ,+9^4S^GCVL5$V,(AOR D+5
M(J@D!5B>OD.A2%FU4B#INJK0';;TC,W++EKK%$%IB+Z@"UH6I5RVI7<]'Z0Q
MSPB$.8PR)MVJ_$E A2A"5DHDC "MMV?2;FG9QINJZNNF/$!3+B$:<C4 F, '
M8T]-044GK04R$7MSIR&:\DP&WSJ?O(,J<C2R[>TG$8MO+3!#+LKP,&XENB!G
M^\IU4[XSIIPYB#Y>4G<9BC/)1C3>Y%P<LH/FNRD/T)3/2.%K4YT'Z5O8DIL&
MKQ>AU"0DVHHR!NT4-EVA(1GS_:ZI?[)%^6!O]]WFT?YQOZ%>7']NQ4#1)J/A
M0*%ZP-:1QGFG8JXQ.B6[(.D (?5V-G4?-+A<,@BG6QX@RMIDPIV0TCG@J-#Q
M]+*TK/2U$=5+!@9LR@J#SUE[6RIDJ8/V2$C.)5,2>.BF/$13GLX"&,V!GBPD
M=)%%  *)5"PTOP,+@YJL:C+A<.U5N&[*PS7EFI6"A"!+M:T *$+T'#*X%%S@
M"++ODQFB*<]DYRU(HJ*5X)C/"4BMNAZ4%"Y5,@ZB#KDN+6M_[81>-^7AFC+[
MT9DB6)*$X$N.R03(M32%@91@3BV3NRE?SI2G9^4B76O*Z81MTC7 H9$(*+70
M-A(8E2-/RTO+[MKKZ=V2AVO)A@A0@K2U-=/P+I022]55$[5^;;TD=XB6/).:
M+X5]*4U1.(=9@-0DT#<9!MM6W'S6U1CVKU6OKK_#IFR]8R^:I-<Q054V2IZ2
M 61J:VRVY&[* S3ELU+SE31IR(*_$!LS!9&J"<)'YS03.BHJ;,S^VHVRAE==
M?]LI^6_7T%\]\W[/NWAAT6V!.+650O FI\K#N+IDE76*PISVUO?"O9M"UY/W
M_YI%5PI0T;H@HM-:@%>,KI*E(,/QHB$@;R==O&R\]M:@WN7O;O%!-1V>P/<@
M6PO.U!38BW76I4S2%J\['Q:/#ZO3?# E,? Q"2^K;/H *$)T*)Q60,#,D+:M
M SPPNG<![7SX,KJ139.-M%.*@]V0@J?6&M+H&H-..G8^+!X?7DSS0:)I;<"3
M2!S&"@#GV9.(3FA59"W%):=C4VF+^MJ9C,Z'N\6'7%-TWH2L=0 )(4B)BO'@
MF0Y5ISEM%^A\N$D^Y)G42#89$+,@4NP_)*T$*@/"%*4-JA <3#1$3.Q\Z'SX
M@@^AY%IDYL%C)<B L820K4I!M0W!?D[9T<Z'F^3#VQD^H&/L%R6L\BV^2);]
MAP!"%EVE3^BMGFP=U.ZFZIH['^X('TJ021&5BJF ]3+(:%RMQ1JK=)Z7R$CG
MPXWF)S^<YBA75YY\6%MY^ZJ%%%[J(KQJ7<C %,%!)$<9"B)5=+60;0&&LXLA
M0G9#6R(&O>[R"[_M79-6WAI]KKU\-97E>[$27%RV6JN<4HN%V,.),98:7"C1
M-O&D7FDY/%Q].&,YQ2$_0 I.H"RM_P%*D=!*CGZB#Y#)00E+RU;U'1!WV)AM
M5C'H8$.0&JR4(?ABB],E:@YW<^G&/$ACGEG[L)*2U+5R,&*# $-&H$]!&%5T
MD8%LEGYI&4POG+[#QIP)'8:<=-4>JLI((2GOJC<QQ.CGI'/<C?F2QCRS4*$I
M*&N]$E9G%) @BU!5%=5[5$H')%^7EB/TVND[;,R87=(Q)YF*8YYC,#)KP[-T
M=55IW0LNAVG,,ZL*F=UII6T5$;1IC4V22!"T2*E*190TMH)+B%W[YPX;,\@L
M,9:D<B"0"I(NM=6D%':VVS_=F =IS#-+  G!IP0\*;-?+8!C9(&VH(BA\O.4
MMF*>="GJ6XWOL#%7STZUHH05$8K1$:RI6B=,5LFB^JZF81KS;+X^H=<:K6X+
M_L0F[:W DHUP)<J$6LH@B?UL>0>5!@:2D_=?V0OQ!^[GPRW<NX?[(<Z^+9?9
M>&D-QFQ"JB A0PHI6ZMEBCS<4\RAUS,N&+\^?IG Y^,]?@7!9QN!1,W1"HC$
MSHBVS2UA>JE2M ^A+3<J.5OO?&I4MS'5#G&IL]="S(U-VJKD<@E*F@(A8D2#
MQ4E7;8F%)^+.IL5CT^?K$?G#ZOM7.4?'<TX6.D7)KI61(H1D16[+%!1EY@FJ
MU4IY-[LBT=G4V71+; ) !Y"UJ1G 4TH*?(VAZ. "NN(ZFQ:/39\OK[PU[#>9
M$+1R#D4%  &9B@C*\H\UN00:D_)R:=D\X&?>V=39-!0VD5)58DLT%@TRNYA5
MMDEIK4-*(9I>0[IX;/I\M6A#/WO\RI'4P;3FE:1:+TOK1.192'A=8@ -5:K6
M:^=!.*-W=F=39],ML2E;67.JZ")(B*&&7*.TSNF(+=T4.IL6CTV?+W[E]VNO
M7X%7KM9@1:RH!1@=!'K0K7ZT9()D?<Z-3>Z,]IR=39U-MQ73^40ZR2H+&@B6
MDF0@@8P075"D^MZ\!633%VMYEH_[*GL+WI4D,JH@0'H0T;HBK"HV0XFN%M>"
M.GM&Q]$.I[N\[^=L@/SVCHT/MPZ.1K]L(IMFIL/)N5UKX\]]1:S"$DSRP63M
M(<N8<@W!9QFBS\;).35?_QRQ=?R!BOA(>[N=KI>CJ_QRI?$UK#U^A<XX2]X(
M+*WS6BQ*!)V<* C&.$_6MPZP_^^_@E;ZAT7&ZZ7L>($*LNXKF-@90&D#D:\5
M FB,I<3H"+$0IE [F!8*3*M?@NG]*R]1%T55),+((6F, FN.@IU\K#&$0"YU
M,'4P#0Y,4L<JO<T\<2K0P:(WQ4EP-5O'ONB<1.0ZF&X(3)^O,;YNM5DI3*H<
M@M#:>L%/&$5TQ@BF%3_FY+7*LH.I@VEP8(*B(&67BY86M+?!!V^D 6M-CC[-
MJ5--!] E ?3Y0N)KM?K\E=+!-PDTH4$G >SX"HQ$HH1,*2HK%=JE9;70F?K.
MGKO%'L7^$-H$/EL%%7RLUNA6])"T<Z9"9\\@V?/Y0N%KS<Y/KKZ%7E[("D9
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M.4@J3JVQ^:J;VE$1!<"W7=51I&"40)0FV&*=3+"T'%3W%3L5.Q4OT!P.'%I
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MQ-686X<V%"E4(XQ,E)5K_\2SM^ L;-KNKA0S=01W!%\:P?>S(&E^>)W>X0@
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M!_@.M[RILI="T+0<5"_9:&(X1*,.A"K8%Z+&OL+P">; "  SS%\F4TP\ (Z
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M2KDV-Y!N(UF2XFFL%4NID!OR_JDF\KQZ]]X+0E"2=Z:-3J\A@.EKSY^J+8_
MCK.1XPU *UH"X!)BF0IH63<:(DSVA2^]=MS_(52.U$30P1F\WS9CSR>JZRB0
MQQ,Y&_@>:'&?S@3"$P04'_#[G@L/QB\(5,4!@KY?0(M/ !VH49$7'J:-Q^>9
M0]':<.Q[T0AAI^NI$X;)FU KICC>EE%;0A5C 5\8XRBF\(PZT(/5*^CJH^<[
M5HU=(1GBEX7"'+NP.J,9)M%A,@ "THGGXPMA 5MUB9+IR(KR^#X@5K7461L\
M(BY]CYA$!U+K@0?):/'(S6 &PW*F!(_&LP#^"#.51S\)0L4C@5D,!9$$RS!8
M-A^Y"-4)$H,"!*H#A@?HG! :K ^9^"P]K?(M)H:!)77(5:R($Y-#"0S,@G/0
M'L%AVT,:)-YHD^D -!2^J\+FL#9@X(R$/\L?,U""/.D)8Z3'G6!-(X!PP(4R
M@0+/2LWDXN-Q8LIIE#0%L\67M23 ?,/C/W@\"=X0V.37C7Q560'F56'#2#B2
M]Z;<#W'H8-H!QAO!A[@)=E:@"& )[/ E$65,",*/ YLFCZ/B/]2*4F@ R#'R
MO4=DH2DFB6 A"S14%6B=WPR8,0Z[71$&\^,B&TP3K+;AJ]S-)-$DL;_HN"]R
M5UP'0,3IB\15+,"M:TJS*&=E%C?;&#8_8FDB#SV?;@X/7FKY6&H@<B= ;\4#
M0'MA!2JO'FU9E400D)]![B 3%A*&-0;#+=[G9(3Y F<D/3!XI"Q@KQY%Y15[
M%07X+TSN%;WX%=YP+4'Z*[3@7;9>-!&OALCV#W:0<"\R TR<^R@T3D%JY^NF
MZR__NOU0-?KL*TQ:3( TIS#7S4'TNF2D/U LL[]+T?W%'W'7_H_D"@OKLF"N
M=$RAK(.#HTO&DL(.]B0=_$@%'XH$FU2$\(4WK*2:;QH3^2*A>_RG2SQK*24:
M[7('3 U9IX-<3ZHP CH#0""JB%/R$ML="C,= #X!9F=Z(YC*%:E8T.CD(]N+
M CEJ3&Q3P\V\<,[Q!#)Q.*2SD6/8@'PD$H&2;E@&2AP%&VR6BE)5I,QGR<$W
ME FN&''I*XFM:I@ZWH@2!Z735.*DH)(*Z0I*19 CJ*+L$/'!R)9[-CTC@^:[
M2]H(U2O\&8_#*IF:O*AVPIS]Q]@&R^A19/U.2QRFQ*YT;DKZXTHZSH8UHH7)
MB'D4[BY\"4TP@B;9QP?"L872=8X'H!U%-;"O:Z%?+41XX<.:VT@B'[,=<5!X
M(A<M.NESY2XN70S"I"_3',.6$V[,>QFM._3,*.7Z1^6D#*:V;Y-2P8&HW1<*
M/CD-+LB7Y3>P$!XN]+T/M Q.8:+Y[)Y,-(,X$<2%\] L=Q<H\33FEDQH6'3_
M99D9[T3I'>^)!5]@#*,(1($ E$(OWH+SK\++E01K)JB.H \^Y=@3<B0JY[0=
M(V2?/R:N2)"%Z'ST7$33E0PDMMUI%&)8 *RD@/LSM8UBRXKN!,0>^O8@"L6<
MI&66'!\Z,$D/A J\NT-5L"9QWHMX'P71= KB ?:D[2Z$*%9-+X3EIVH ^:.H
ML=^D@JO$()^;OB?B9<9Y>+["ZXY<)Y[(!#J$Q ?DWD?C$3\NS^X_RHIT@BH5
MT%]BL8?R!XM;F3C:RB(R]P6=[23V""F,0\YFD%Z(83,3!K*GE$+"3Q'S4JT[
M-SDBFGCMR40*4IH_\E%J?F!0QE6/P"B4Z9C[<ABP;P=)H$4 C7W*%2>="^P1
MTMT4<D:6P:!%4G@!%XX#L):8 -WC/X$U_0$&.,1/6!YX;X4EI,\(7K*R@*2H
MU9&=Z<!M(.8V(7T+;-U N)6D<$7\=\ ; 6X">?CL>^VN1B-67*4^B1)>^$0?
M/.KC4^Z3-$UQ4C*B!.#-MT=@&"H/?S(%JIRQ0((Y6\R,_$%*U5,&]LK"$>P.
MQ@%,%?/W*4PY7RV@<1_$DP4\)-P'&S"&Q!T51H7Q',ER8([[+J&9V(L2R/,8
M4]SWM+FG<7F2#()()3Y^BT]!?G&4*K#U',EB20+;=Y?D^6=E%]QEQO5!^K\H
MO/Z[AY H+L:5!)U"C$;+OZ<#I/HP+N(PR>?Y[B]7S1$!&OT2H*-A[#D6[L2X
M'H_CQ25IE&AR9IG-Z"A7B9A,'6\FQ+(K"__]H;!81-%0/^M8\C*FE)(<P1C'
M+WT0$U!V-/WD=$LZ2QG$%<XT<2%0*&\NG5+YVF M*+2=D5=8ZY#+V+D).A7Y
M7Y4,(YID.0*U3RC-IEB4B2%05U7BP6G!+Y+4-&RT0ZH 94TES#-;3++6-SH*
M$=AJI]V%0E#RP#5-&'Z3FF;3<]<8QK0=>?/-W)"5I8ISN>-#@>H*0*UB%)1V
M=JS.?I<<J]Y%%M8MVJ\!^;$R.DPB=1-WB ^(VHOY)V:,A GHK[AVZ)G"U,81
MZ"]:12#DR(=AU+ N;&P7RV'@.=@X9C_P7(#J4P<D@S2ET4N5,2Q4QB8HBA$:
MI.'"<H5T5@:FEPPH,X11LH_&$;P-=-P4LV/PU)2/.REY.#7BU9X&(]E2SF=2
M21>V)-,#;:FO$:ADCWVS3>]2GO(RX1^RT>F3-&4ZS/LHI.+"7#,K]CK^YOD#
M8%VZP;&EF^N*0O/\OP/V'E7WC9R-+U,W/D@/WD+N!^SP'_!2-Z*4"SP$+8^*
M*7:X1G[%+!TI4V2$VI;9TF *B$<E#H4_FJ%3#3GZ']_O[N%!HA(!6!H\S,B+
MO^9)#!</VZC7P;J#GU/VO8:%_H]PD]I*^-[F^X_LD[!L7L/)9[TD4G3Q;*6G
M8%XUJ>VWQ)X9HJA<)%RMA)W9Q8>;O_+)].WM)7P$/B?=QQ598 .7@F0K8E&?
M*F6Q*\F0W\BE2#GEZ/TWZM5_;C/J)79>^-)7W_N)NU_%_I,,92*1^O0G(<AU
M 92[0\&HY'..>;I6!^N\@!5Y 1U=_*,88SE.A/\XF#L]F7(7329H@3QE-[]D
MNFC^/.YAS03[Y%'=O!L7]72V:VWC:6*H4'9"&@2,I7. &-):JM%!:O%UL]9H
MM=A EN(F_41*UI>:'B[7N]WX\OHW&H@U[=17@G]^;72Z<9UO,IO;M5;LQJZD
M6"GC2#A(6DBGMK%C06-=QX*U#0N,E\ED65'M.%WN.,8Z9/U:)R9RXC]>\O0-
M6:M1EW59 &"3>XR",L/%&L]#!X\3J>Q,*D66K+"=EK&68WA$UY$/UHEO8V5.
M'S[H(G92Z&0ND)R!0L13(7QNI$P *\9%L9FJ_&F9(@.F%TV=V"Y5<U?..2FC
M*9%1.LZ"/,]9'-%"N(G@'PA&Y3M_"C.2IE-!*Z'_C]QV0.!O*H,69_(^+H'_
M!4CW8(O'H]<\YY3*'<F$%+6.*:L 5RSZ'D[;@2/#_&CLD">76A"D&=ODJ9Z
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M8LMWOP[\7]XE"_7$-]% DN65BP0S<?@T$&_B'][&$[%=8AAZZ.W\%S >O[!
M]$%Y^>VC;85C9+%:G=@L]A2K+ZO+-;JTP'3R6@MC_HV5E^LU8^6U=:_MU;J-
MCGYK2=[:J;6,WE9OW1"-*&3081>!G,S)Z&TS*5.XH?"+I.;NQ[X0[!/<-P[8
MC6L)B_TC<@5KUBNL46\8<Q,NU6K2"]_8(7S,W":R:+L,ON/8GAM4F/AI"M"
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MM79F#JV/=FB/*-E*^[ R*5@Z ^N INJN[FI-W!TR6+3SM6C 2E-8LV\AB O
M2GNQ7B[_"J.#E&Z5MG-":.5X 7:NO!AQVSTW?Y5A:+OI<*!5TU8GL)20MMI=
MI;FWO+35Z5<O2.R;R/>F C[[W:7F7S??+]DG8>'HF"4>;!.+4X_BCO<7GSY\
MN\2\=X=*ILL_FEX0/BWSO;2X7QM5APP%:-H>C+:-GB9NP6"7IK!FWT(05SNS
M7I#8'\0@9# \&'ID!^/S/41H]+67Y8 >+)U6<4#6;>F$MJ*A*4UAS;_%H&Z]
MMG-:AG9C/1U.J68@(?\9U[@*V,5 =H0YMV0K;8@>FL(7G:8^-7B0\Q?:LZKE
M0GDIK-FW6&GLVD'U9$1E!Z8O0D&(BGK2GI=?2IN?FL*:PIK"FL*:PJ=-X9/(
MMRH&E,IO$7%%#0*>W)92#OU-$PAL>1&6'XU'K#N([(L^!=F@*UK[55I&IZP]
M1O:P.L^0W'J+Z2VVU1;KE[9[IMY@!>(CO<%6ZK!&>?MDZ2U6($[26VS_74 U
M@Q=H'36#K]0A1K^K=8C>8GJ+'8HP]5JOJ7?8TYR8OX0</@K_M>R'=[_"/_'
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MQO9!KIWG?Z08UI83;W>>6+SB)2*Q3SD?N"C1-2.?"2.WGU@FI"R,_!*Z[:B
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M+8'B^<T+U?BQW+'F3?AZ#M4F8-OH$JJMDW> NZX7N>@NX0I#5]@#($@P!@$
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M$U(DO]W.NM+E%Y4'>9M5 5#9JV>/R^,;,E_.6XTB5R5<47%Q-W?-Z0FVZ_D
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M>$)19DP=A'[/UD"368[P#-.4T?G2&1_E.$2<6:%;(J140,-?5[#0^BV8GGZ
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MW><4*0/$8-\W=/A-6VO,8T5D.DZID</2@_+CE!J)Z-#/\,<$<:!]&@;"FEE
MJ5AOYJ*\\$#\'&E<4NVY,EM<66+%=)=VJBX"+M-5APY5.SR 4T22(6IUFBM6
MUGZ) __( W_6LO6%.:Y"=DM[$I@QP+1?:0$X\08+P >49I "W18)1I(B''-$
M1KPH!G N$IV&X5G'/=WS<^HV4]CNH$">=*^+BIXCOEZ*3G7/I[PWE0;YE/+$
M/+ EW#*,?/AE? &3A%CB7Y.W+D3J8##$A\A95@:+5,\+ T,J9H; 5FC=P@NT
M[4&+;I?)SLY2>USJ+3L,C\$1-*C621>:P!!QUA4#;;#R%Q$T>#KD%%_D\A'*
MU4YT,&[>(EQ63[^M,N4Y(<=6XV-ZRM!@%(N:T5RZ2=^7LB#X$UP3$['T^1]G
M)QNM0P\V<%^-L'E:5%6V.E5/<G0_1)<(!26*J&*&2]LPP!_#6QM4\D)580T3
MA07G&><Z&'7S)%6FPR&7P,"NQ92*9,*+\#F[5N7/7:(J[PCC"CGJ!<)O8(4-
M5J-T<Y-QI[#V!"$5($'PUR1WC!/$8!@:;OAP]^^T="23Q6(*-C1F70LG)O(^
M@QWOTZ)BP3,#JT(R@X2"TK(HR]/ #$*\/+8.\S7OLAD8%;C0!00:.2+F%5 B
M_;Q'QA'_RZE:UO49 D?3L67><G)C>B07<6:?HNWF+ZRRJ,0[H'H^%=T&21SA
MNA;^R@7@(!RW<9B/E$@: BEU: N-MYO$X W<K-X1SDI$U8594A!7D&ZDCAN#
MVI5,P1$]*$3V])Q)O*BWIO3B.7+@.$=N7(^GP8K>D:89[%D14:+V!CK<YK)5
M,X7=XMNF]*(KY)RN2.'(]&^)=XQV%4<L80*R@()/,+B2ZO4Q_(U%]W;V<<\1
M$6KH%+/1 MLTA\-=RI@EV=!FC#8L3@5 W0E9WU*$XN15FG3\SSAD2,'YQ((Q
MY:D:\QVU7M##S<T\"WTJ5G6-JSB5R"33"XP4>"IT&-+/>@_0 6 Q2#VJND=7
M+0R&<=RO4B-3VE*?#MPKAK,WVJ0HCI6/XCAEU@([<MQ/><+,#7SL\3D!SQJQ
M?:DFL9E&(B_@MF6^"<:&H* XFTU6I.GG*/@;O)GS1:;6:];TFT/&.;9EH5T.
MBA*8J;94']92+>.P3H^UM2BA'*:&L*Z"LP)%=HAZ&=QQ\-S@IL^[*2,,IVR_
MM.C@Z0 : 4YQ73S3^$.F6I=G^<&("RHIM$H[,'$8H&G'4[U7:-:/:%QN R%?
MG6D4XJVPX_"8XHX"')<2F2IX H2>% .@4;".\* /DEX^2C,F"8YM'R7.V3J/
MD5 6>;9T:UDO,$&_T92<,BU:Z31C8J>7C',GL#C/!Y<)OD837:QL=(?LO 1$
MC((L!QHDAXLTVT%;'-1\\?$.TP ,<V/HS,G!5CP:S!%&"^NZJ,R0OJ0[-B6>
M031?TE,^V0P=?(%VM7R:N0.MCZ3'/9+6'&0V<XVJLTG(P/!![-J?*7U[\K5<
M"!()U2![O[U7"1'A7P41YBW>;[0.QL^55:8,P]YCVR[S\JR%Z6H1IH859S%V
M4ADSP3_<Q4G8OPO _>&XQJ04.A'GN"'&NN59<"G[\4&@^=!#:3SXKJL%XLD$
M K6K1+D* 25=8&-C2NDDA<.JR*:B T&6'$,_@NQ&"4$Y!8SH8L<1&W[Z(.;<
ME41@Q)!#_S0(<Z9+H@B4JN*_\T-LC,#@R.+PT?6T["U,16B*!A>/HA;I%13I
MSQ6APF)X-X@&NNV8X/71<$!Z+O_.66F6;<QW<G1Q05A6AW\E\)7.W%"UV*RB
MV"RC"8F#A5(PO:'JYZ& -KA)\:UT98$K-SA,Q]T-A0*T7O757W6BRD4(:I#Z
M*5-"%?,2!;(OP^A#S#=#!<?,D/A]-0B7$QM^!L]*8HK5:Q1&5(YD.T>BDZ31
M$H41V7R9<^<UXC?;-7YS-<;RO/C-9;1AK5>?2J\>V[0WTL.IQ*3U+&,D)C<Y
M>>M+)V?4=*87VG3>M3Y"5W&IKQU(@CY*BU5KN,W'PTD:] (L1<7)U;F 89R.
M,9:5-B15*P5V7%]1Z#A)1$;T+'.3<\SJA#XFGK4A;G,&VM#'5V!@/<JI@QN.
MRW*T"S!2]6?+6:UD5DWRBN6!'(UR9 U_ AF25JH#!#3W,$;0*"@6]A%5;QAA
M44[ Y(R<X[&-]G32OY:.]9$.T4<,W<AZDB32VLJ!?A2!-JF@%TBEI!DH'B75
MJ4P?3H"0QE25K0$S9<,@Z3,MK-*8:VFFJF%)566M2?F)?_LK1]_S9*1KD7Y$
MD?[#3P*;?C0R:UBQ":(I3J6-4U;)6@68R1&VOY:$J57<4\G#>1D.1S3;'G$3
M4T*FX85^'E%S 0/U1' D7!'AU#(Q'X5"9Y^%-A,DP&@<G&V.@V@Z9"7&.@]^
ME$#\ C'N=32>Q] #RSX=Y*$)SD<"#Q+^&UW9+GE<%P]9V_^K*(37IDL1\\IH
MFE&- S4(:#<!Q,!:P^)/7(B.OY 02S7!,>RO:\-K/01B2BLQ2%<,[C\9&LV-
MX; M6_!#_# ZJX0=U4\-I*=HJ!,3$;'V(:,&@Z60X(@,KUI$UE1$,C@Q>KHB
M@E+ X-ZKJ "%_JXFPD@?*22_)91WILSI,7U<:-H;;'+.G0OP7(E!GZ W*"6]
M'B*:,>Q>B\Y:B ZY=9&Q<@=3;2E&XS">*&87 F'"$E;X%[;L(PZT#<+?8T$3
MUV[Y<U.UVBFS;Z2G]I(\R!QII X*;JX8Q"R4""9A8');X4&D1@M3P;70K9S0
MF32ABH;H2_5U7QO3T#GN,O\V!0]$YS@57M3Y\):BFTQSK0O(I,V9@5VY:D_8
M<36*P=%[(,@ZBJ$!#/H4U6^:X\G5<8/7*KZV9HB*1PF%Q0(IA .LZ.@P)FC_
M@ -:&QC0FI2*&,LYFG)?X/N(>MD-%+(#5\BY_1\23NG?JA]C(5YRR_6<"L!I
MC_9G=D6M9)]&2D$>=9Q* A5<5E+H&) :VFLIB5Z*-UO.XL54T&0XUB*RJB)B
M%)GM1WU?'GV=H4PLW[BM"5SOPIE[U@=<6O/DV'2(;'B?3;DP3>F)G_G>10+S
M3774+WYOW',2UV*W,$"M1RT/N"4G*S[I *%N@E0(9$GI&K%0@P'5$CHG.3>6
M!\NTZD0GCQN[$4RFS%%^LFL^D*7 O2<<<"W7M,.#L+2*BMTCBBD3ZX'.>DA"
M+VT4NJ$4^Z4;VUAAZ3(V[ITT9O?/X>2=,T\)MGP<V;F!HZ%VV-9"](5YI!0D
M8I7O,&Z8EK@H*/_)?3)\N81!0"<H2VPL+"O_KB2/E!+*9/-2:[L4ZSVGZRKT
M>.P>>?%Z=QU%K9C_D"H94!GH?3OK'AN,$M/LIARA*N.+K>Q8-\V14]"<L ZI
MXP^AZ"AZJGV5J=2N ^)K(D2E@#AVE1W!(ZE Z38.#$YE$*B0M9*4R'\\Z7AP
M2A)_9$C-[*4 C]A#XAF^>:HQZBZ?4! -J4$95R,7[&L'4=4';RQ. E6H\_MY
M^$HMAJLDAK,"16DOR4&B*-Z.8L,/4D@_( K/-1B1PE(WWO-[FB-PI*B3-$(3
M L+@]6%-$J;(P6NHS-XP9TVQ8[&MVK#H3AV\LKBKNR M:%#N)DVAIP[(\<;O
M0>][U^]]GQW^>8WU$]MU_<1JC&5MZB>>6D21\3K'WGNTE3_Z8:J\8R2I24UW
M>$W0&_IWW#2%7+D_P9A.D9B*T\%\NW#['<<)EB5[%YAYIG(#?-;;C\<7G7?+
M/Y*X]G1L6],&JA]$.B$,5PULC(!E]*.NG]S$;+K!?,8P?'QV?3:NQ]EX3.8V
M'4N5SJ7;]$NL-0P_4K<6R[Y7K_9ZK';1JT/#-BR&1,E(=KIVC+4>*;#0JW
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M0A<T8@$;YQ3.$;^ER/54X0FI6VY.K 59@/E<ZID@ZUVNN.33UD2QR<]T3[.
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M3U&.*.A+>)LB%S.J RJ6=W5BUZL2IF[-#E-O=N/^!/XSS$;AK_\/4$L#!!0
M   ( !""!%6&+YU/1!4  /'A   0    8G-X+3(P,C(P-C,P+GAS9.T]VW+C
MN([O\Q7:O.QLU7''MZ23U'2?<N?2D[-)G+73T[-/IVB)LKDMB6Z22NS]^@4I
MR99CB:(49\(]3M5<')L "0($ 1 $?_O[(@R<1\PXH=&G@\Z']H&#(Y=Z))I^
M.OCV<-4Z.?C[YU]^^>W?6JT_OXQNG OJQB&.A'/.,!+8<YZ(F#G?/<Q_.#ZC
MH?.=LA_D$;5:GQ70.9TO&9G.A--M=[O/?V5G\*W?[1P=M[K8]UO]$_>X==+N
MMEOX^./1Y!BU^_BX_;?IV?&Q=WJ"?=SRCR<3:';4;9VV)T>M(]QM]S!\PKTC
MA73!S[@[PR%R@+"(GRWXIX.9$/.SP\.GIZ</3[T/E$T/N^UVY_#/VYNQ:GJ0
MM@U(]&.C]6+"@JQ][U#^/$$<9\TG?+'1>D*YH!%W"4P/\8G[P:7AH:2Z?=QK
M9T 2)=%T0B(N4.2N.O$$:XGE'/-B&/CY4/XL^VFWVIU6MY/OR1,KL'PW1X?)
MCP<.$H*122SP%67A!?91' !('/V,40 T8 _$(<"2X1L-<C\+Q*98W*$0\SER
M<8T9^?R+XTA^D7!.F7"B+10^XA,U9,Z$!.M( GM 8,+A&^HBH<16MN<9C5M0
MAS@07/[56N/XL.#>P:'Y"&+>FB(T;S"*/&0RDO2;^J/)"7#G]/3T<"$ELG@<
MA;*EVK?DQU:G6Z_;,B$U[QO^:F5PNQC#>C76&T,&]\(Q%"Z\,HFH@E1_<\-A
M%"]DPTG( "3U1W4ZY-C],*6/ARZ-(\&62IPKED 12/:'$OXF_7N8*$0_^X:]
MKP'DQU;R<;-G%$54*!SRF_2[^9Q$/DV^@*^DV)QELC/"?J9DM_:,@@6J_G>&
MF,MH4+&:#^>,SC$3!//\?J,0S!CV/QW KM/*5.@_ S3Y  /)6FSAWY1_^?,A
M@.#@9DU(!BM%\-,!!RX$.)D:B^F>,UR7;@#AL TI-O]_)]]%05WR <2-@W\)
MZCWLUZ4>0$A$&A OH1_@=X=XGP[.*1C*F0%\X,C?OHVNJRT>-81-X*R7K)_U
M #^WP3:%?YS6VM9N.0IZ]<5OA\^!GJ&+.?:&T6?U^;G@I\!I$PW@,Y$QAMN<
M[$*P],ML=K5S'G$:$$_Z&F,@0MFBG/I#$!@U-/XM0K%'A+1%ZW+$'+6&7QW%
MKRXP:85$,6R-?/T#=ZCOK/$[OZYZ^(]WGOKG- 3"9CCBY!%?@Q<:XAO*^:[X
M6H9>SUNI1,QYN]&'DW3B_"J[V5<&?T&!-/G',XS%;M9J"48]&WOM=E_'QA2I
MDV!]7YB;LWR/&% UPX+ .'?&NTVL>O[UP5^IP[\-W/O*P[SV&POJ_IC1P,.,
M7_Z,B5CN?./4=:'G[E&[?6RN9//]_+N3]/2^8C?W.L1G5P%]VKUU5(!9S]OC
M=OMCC0T4T#L*_SM'B^=]',_G24@6!1>$NP'E,<,[9V])-WI>?VRW3YKQ.M^=
ML^YOGSC_!7$"'+C/$5&7JT4H-!SK=MJ=3N)JKF8<_E!8)(/R>/:;$05?W8-4
M PMJNR<UL>O8IT(B9NPK^?;7K)\]7V@76" 2[(*7&28=W_KM7M^4;[^F"/>)
M00,7;#JNL/$+<*2Y( +FB*,(]BH&6\B4N->1_%[M)76Y5A>]7H/V.RKXL\'*
M? ]_<_)].-")L^K%R77SSM\R!CR@25!?SS;K1,?K7ONHM[ULF_#:^37I;E\7
M-4Q,?J(::E\#C'HM?-S7+UW%P V.[J,V!@M>D&@*!$A;GGAI]+HATRJPZ1GV
ML:^"L1L,6R-T-C#N):^*-%M#1NE0Z;ETTE>QU@TNE:C!/6315TJ])Q($H%N&
M8H;9-5 230EL!P/.<7UKIA*?WGPY[6POJ0RETG\*J;/&ZB1HWSFVFN'L]V9V
M2DWL6@,%>+F]HYEP<]UH#RV3*@XT5*"F:+7*M-/IJX./^AS=1]WZ._:F8 L,
M7$$>B<PG@0FZ0H3]@8(8WV(DYZ^1RVB.6*MM.])??,[-%+>S1J[X*M$["K^3
M[V"/N%DXP<:<:!J?VU&OVKA=I]?=UM,E#*\I'_L9TC/F3[,]NBYZ_2;=[VV;
M7'69O'^[M#$/&F[7M?'K]^VCOCK2?A&3]W 'E]X\0ZZ(43"<!&2*LNC..0U#
MTBS>:X13OV\?=[:ML!Q:)X=7L32'^9UY&Q/=3 '7P*S7O1][VP:8(2/W4>F:
MS/L+ H&FJ/6J]J2O,DR:\70/=6P^UR*?D'<=^92%C1(/3%#J->QI9WN_W$@*
MV<CP<W*(WSF7G^9F^M4<L5:]=MN][7W2C(O[J%T-9KUI\-X<LU:W=CM]E='5
MB*%[J%J3C/\'M*B_!/.@6E79[7:V][OTJH$"W\_Y;J;XMA'H%5ROM[U-Y>=^
M']58;@X;JJL"#'JUU.^W3_5LV$/ED[-KE1F=GHLW"8+J4.F5TU%G>\/(&]R)
M 9[#]\X@.0N:GYH&LE_8FS: W3WN%F5B:-A<\>M>1JTU;&CL5%=BU"O6C_U.
MNQY?]U'3;M]TJI]=LX5!KU=/.ML[7M%%J+WF0N-4IS)$^L5RVN]LI8,67T[;
MPS7R'<NR7]@;/&*&IN!^(B!G& M9 DB6%ZO+I$I\VO73DS==GO,J0^FD.)T$
MJ9/#^LZPU50T<[ ,L6J]KAZP;\OC-6#>/CIC5?/=4$6:HM4JS%ZWW]E*>S#B
MXQ[JSS&>2I-KA&59K ;Z<@M>KQ][G8*]+$'AK'#L\?0WC*L78]%KNWZO(.;Z
MG!7[J-N>SV93<Z\$C5YW'?4[6QYO 5?V4%.-\"..XMI7T#,PO5XZ[FQO&2GD
M_DUQ,R6T":S7/1][VVYF"K^/&B<EO:&B>0:MUR\G_<Y69LIJYO=0JYS/4#3%
MG$0JP;V@>%?MV%@E0KTF.NUL;P I3H=$:1Y^40&P=Z:MY[BR0>-H]^YZUD:^
M^^UN00:9B1@8MMK/2'@5<QJF#1JBU>Z)8/<5Q,3->+E_.V;EE#<]V3#%J]UE
M^S(SNR$O]W /OL-/ U>5[ ;?YI[1"#ZZS6Y0Z5!I]]U^K[-M& $V9XW.V<3W
MSJ"7W'\R0:G?(?O=[21 +</^Y?>\WPXW2\HG?V^4G9=%Y].G-A1G)WSQ3Y@P
M%F-OA"=(8'X>,UG3\L!!$ZYRFS\=^"B0I;)ES7Q98*.P=22OH$YDC6S!I).N
M7B YFV-&J/>@2E\GSS*([*=)DM'WZ<!EV"/R;8%XH@I@R*%^932>?SI(6A*!
MPP,GJ9^=?!/2"+0D6U[#+Q+YNLC^<]I2U^8+@MF[1TLE![<XG&"6)S 9<D*?
M#J*:2"]F:6:S$3FK=U?./!HB$E43= /HHT$(7;I(GKVC"'E(3Y$6Q *2+A=N
M$,N7@:X8#2\G1'CHBK(1!EIB5\0,5C+LG6PJE4R)4-9!T5Q2/3QY-4&]P5,4
M9/(VPG+F9""7?L&*-@][DK3SM489^OF:APG-I?.S(^QV3IVRIM1_;F@T%9B%
M68F+DMDH!["4P*24>S1-;,1O$0H"^1P)]AYH&ALNI]4$MHX2^"NU][/!#]9#
M3T+A<LPI$1INUT)BZU3DZD,-I@RK'Q\8BK@/HNQ_#2@,XS*<!W2)-7JR)I8:
MRZ$&T202>(J9 <W0T2/,]2/^!ILQB>[DS8*LK(^\Y8J_@B*39>\%G> 1=@/$
MN7HP[$*I_#N\$)WN+8W$C -L^:SLNA]+C:$QC@AE=Q2$/\;==O>CWFXH;6Z!
MS9"(ZC>P?^ET"4;-/0X>B?L[1H&8K8[)OH$1K2>Q-AH+2+\AK@P91%/$F(PH
MJ!LR:O^J, ,KX2P@[A]Q)$7M2$I=!3V%32T@(9&I<\0\HL2JMCA6@%I XGB.
M70)K9'D/1G6(7!RK!Q J&%8%90-A6>7PP8+P4CHV&^U@V)XX\T@H5R=5@]Q4
M\# &:;U4#OX6,7?6;?<Z!HNGN*T%')!/4$5(SX#--M;,ORPT+_^5V;B/*$A<
M+0GLP@XJ?X -9O.+7,L;$F'913G1.\*^<QXW$M+NR=JZ,!/50@@+!/8RQ$R6
M6X%A_H"]5%"!@BB6PZ-^\@PET04NS*#?V!"_14O#3;FHI05,&AP=M6_/[\=C
M+.=SH*>AI+$%9*01'!6<*2IO6RIFU8"V^KVI3QIYE+MTOI0?:AM4U= 6\%9Z
MG)&@;#D6>/YM/@CE*/]7SU8MS LX^IK!K'M&O=@5 4$3$A"Q=!''G#+PJ4G(
M&0YD:$;0$//9/&DI^82]_P2.P5262_@+T;YYJ,-5HBC=; ,U6]K< D'^;QQ=
MX(B&)))S?@5CI](T&*R]S@KB:B"P@-RB0X:=Q^]WVXF=4>[+ +N"T?ELR1/O
M]_)>+R<:  ODXF&&N^W."8BOTD<7"JR,E)+&%I!1=4Z_?, +\26@[H]2X:V#
MXA4I%EDOQO&-=*$9136>M;6 <X/Q^;>Y7/=W-'G!:1WFYH/(2ZM$/M Y<4\Z
M1U=_I%_<@PWA UOH#5IB=HO%C'JFG'[-+NV0C-'%"$^E<@6C*RTBAYGD?VIV
MR4>_O5L28)GW@BLR#1KALD"R1OAG3)+RH6.R$+/_BA$3F%W1(*!/P$_X.U#'
M([E73JJ2+IICM&!"LA#%<8UPQK%M=ELVL-,:1)S:1L0]D^D[@KAX3 .%G%]'
MKIX8/8P%1-VI@-#0_Q)S$F'.-?&DHJ9O[-JD9^LT.X8GZA@><?C;E4=04TQ]
ML!$Y"C1TU4/RBCQ+.S193@L2QN$-3NX;CV1WI>05-WX=QLUCA@W,5QF)U.9*
MZ!>5.;P%"RR=_O4.?(^@_XTJ$GK&Z2 M30:X#N= SM"_H@R3:90D<KK+JT"Z
MF4D9VZ',A!AKUV5-++9&&<%+]G $YE;9*_(;#[T/TKDH/Y]JANV-CV; "1WZ
M/I:-+Q$+EB/LX7">A1'""6PHWF Z97@*]-Q#,Y?,43"^JU $+\1J@7JXHX]I
MM*UG<@92VMP"4FZO'[ [.Z<WPJNP\+8;6C#\-,I[DT5YSV64=Y1$=Q_H5X9Q
M!%Y"X/V!(W2.'M$5"<0FC45!X]KHWMBBN@1C52RKM-#S5F^L7;Z@94!@*7A2
MY^EEK["I!=*G4H9UB83K!I8>OIQC)I0??2Y3&.4#(<K9&<22G("@6\QGI=29
M ;_QV@"3,_-]\F^L5ISXZH$L$+T+/!'7D3P$D%]?+D22K#)4&^D#9N4'8P:0
MKZ09,B#SS*5^C<REOFU;:Z'5)_-PK@+ZE"]F?G&=W5AK9$B:HGQC?9]D,3XB
M+L^BF)ZGQ6TMX.EES.C+#C/K8+" X)+\D)6%!!;3)/TX]-.LDO(-HQ&R76\@
M#6(W\DZI/*\: <M6CW-=1_-8<X=  V(!1:E_[J;^N;>62 (J9E*11F,*;84
MLSF5CT!?+N92=<*N+D_&00QGR6$36KV*5J&3ZB.R@'S]!9_T?%F7D&B.X(T-
MO:+K#.5DE;2V,Q,B587RU$]P5:82"Q$ +Y*+65A5^T5/L&F6$UP+AZUAN2_C
M/^O&G;4@%BS0<1R&0/O0EZ;W#4710*9M/]+@46;VJ,G,LD!6ZT\6"@'_"N;[
M.Q$S:=!G&?#):R+5!_.OW*L=9_.989S%I"\PZ"R@;?7L1ZK)O^ (^T1CMM3%
M8ZFSGQW2FN5M%[6U8+VHD-QU= 7F1C"6YWQ\Z(\P3P]JFX?^7HSWS5/R$S>X
MQFE]S[K3^M5-*GUVW%8S"X8^PA&8P!/R,N^P+A8K"%^EZOC$%[.?2:J.GZ7J
M_,Q2=5"#Y)_:&"V8D&Q7U,OP\U86#/S9W:.*.$9Q8PO(N,,B<TSQPE5%UJ8
M&%"N29/1P=AJ#8]=\#SC %-_98G(:,,(NS22MEM6:$I_C[ NEC<.(R9U^)(J
M4TF5EJJ@J0["CLN/_1J;=M^Z3?L&%'#RSC$X$=(M*"B^I/'#38#M=,M52E/A
M/2,4><E%H\3)]E;WC6[7]XU*I^2E:-_ZP$V]?IUM;Q7G;(5M+9#IZP@F:$I@
M$(G&@)G_2JGW!".K5*AFL/;D]FPGVPQ"&;DV3N.I0F !/Y-[G_?0Y1PV Q0
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M*_-@%JZ2YI;&ALXK]&F!0(&G+M/-LBNBJXWB@818T%LD72FQ+)4B4_"WSLO
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M.Y%8\^,D=3KAC^8V8$';MXXD9^\>U7DCZ>V4E7ILG(/R"-'G7_X/4$L#!!0
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MPWHE/4^V?CNC.;EE-CH0SFNI&7I/SH[5H1XJ>):M(E?72F%$.3B7]Q#HCGF
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MC+7/DLV&A4Q^F\O<<R%$DKR/8[2M-<>^&9W9%QU4*<P:TI(N6=1\4LND% ;
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M,&3'P_;SU^N7"$O\VY_^/U!+ P04    "  0@@15UH\;#\ZA  #FY08 %
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ME:B#L$%#<HZ6&,4(K9<14F'TNB9G^8,=8]JZPW\J<5_*&MPM6P%O"8V^F]<
M^5 KS!!/T^FX'R^F\^RN-<G@A0?+4\Z LB:#"Z,@QE2 %@3O52@\:=5$@1T/
MY,5'9T]);/MC2J]%[=_$P)1:<#=&!MYX!0:3$SS1N^K;)'<^FV/*?;2QAS&?
M[S&EBC(()11P)VDBS5)#T+1(QWI)VX>4%=\HA^_%'U-N1>>CQY3;F/5@)U2;
M@/KVCBFWHFJCHZI=['PP$42K66'DD#,A"%QM[!<9"Y!3U"4Q8^F?ETK^UL>4
MW7._C7F?[ICRQT#A6L)/IXC3SOIWK/G01H>1FPSASOFC=J@\RXYKYI2A\,&H
MP@476I801)"]#3Z_\R-'7M!GR3-X\@5)@H4B&>,U(,_"*6ZX\&VNEW=_Y#@O
M@G@5!):42G290SVAKR.S$- ;2,$5IY7FUK1)BKN-XUG$)-NP?*]6Z>YF;7#\
M.$>SZ.]]#8H F5P*N&P]*,D\Q3G<@/?H I,LI]*F7L9*.(>G?!^.5M*]CX%;
M-.4+DUI0N_[GIW]=]+^$0<W,>#5]'<;C2PIX_S,,+K 7/-H@ZPF--[601ZQW
MFAD#)I46(@MI&E6BW0C>4ZEB+RKO[D]TSD,#L;Q*J18*G=0V=;77R[M1&$X^
M8D+"2Z'6;SA=F*0GM7?1% U9<PDJ9+)"K1+H1-(2I:&5N<WUCHTA'H-HVO#1
MI,#*%T(Q&E\2I)Y*Q5A!"Z5/IE:@(]\\(CG6PB@E,AKO-\NGW%H;-U$< _T[
M6[7!><R',9Z'?IZ52NFQX@U+J,DI(@0J\00^<@'):6,Y2YZS-J[O313'P/#.
M5FUP-++ LJP*M3@SO#7FGG=."VT9Y*(J1$TK5<H(&%6:53YIU<IY W!'I(?.
M.&A0<.\V&*:2G6VY2JQ=[)V+$!C1YS23EBFM=:.RS$='_>YV;5!DZL.X%G*;
M7M;D@"G)L+JLYXOT@![G,?!B+0A!U"A7V_^EY" R](4'LD&C^JL/H7K1D6-G
MYF[@VEUUQ+"T&+F$'@PSNA863A"E0EJM2@S.9Q],FZ/NIVM$TB'%.YFQ@1]W
MM_,)*>Q^\Y.ZV5VD])!8(LEE42#6+* @M247)24;VM0'V03=BY9!Y^9OX B^
M6=3"NBJ =P6U1P]6/M2LB%0[^V6A* BIV3ODM@J9K(NL3:KW>DPO6@X=F;J!
MFW?#\:P9,@NW1&,*R7$.7&97&S];\+51C/0Q\8P4FFILPO]*."^:^OT-W,#O
M6W11,]DI;[B&R'4$Q3*C2)353'YNG>).!=6&YJ?J5=?Y*<!6)FS22F?>TJD_
MVS>\692N^I;3RZNA2B&8I_D$K)44369;-PXY0K;,:Y<9"MO&F=\4X8L_!6Q"
M18/-_QLX[\:U+B1:J"@$"=$1,IEH+>)*0Q&E!$.1K4YM#H378SJ\+-KPN%XL
M^Y#00!YO,%Z=-@AZ, 6?FF@K-+D)%R 66JJL9PRCYD&Y-O>2;X!X4@'LQ<T]
M'W WPS8\__L0+NOYTA)5<"(FXQ ,N2"@>.V%F0U]RS)]PTQ$WRA'8"6>HV&^
M W,WV/ A5.,+S/?'W*M/%XP'R%6BRA-A,7L$-$)HGK/ 1@=[:R$=DQ0Z,'JK
M>U@K8.7LLHVH0*+SH)QQX*U2@+5XNC?.*=>FS?4:0$>CA"X,WF!3:!4B8PJO
MPY+1BWHCEI.?(R.4Q)F7CGMNVIP"'S'[>YJYP4;0N]'PY#..SZJ;,DM@.N]/
MP^!=O37X/@X6?4,GO6@$Q<S:5L_%5:=70:B7=%(5)U+T5%*;G<'-\!UKN- ]
M.0T\BGN[G#=L4[<Z(P_:%5Z A[K$)<LAU/?'"QI\D9KYU.9DZ1%@1RJ:+NDX
M@,=Q8W>4.XY1D'II^+6<>F90C]4A1>3%%X=&M\DV6(_I2#72$0EM;G"?]6>E
M"NKPKSK:)P+9"R:)XGV$) +66K:RMMK(D&B"HZA)HE9M%J$'0!VI0+JBH8''
M\L"(:<#(!7G-1M8^A+6:;8B>(BHLFJD@@Y)M)I#GM+]]$'UT1$*3W*:;O9[F
M>?<R"R6]J+MMV5<?6T+P--R<G$JL*"UXFUKR*\ \Q8%'-US=3V;<R] M;L-<
M]VA:7+C@.A1)L70PI<9J08#S-$@7>>'D!1ECVR2TWD5R-*SO9>(&P<?G6N#F
M8GQY Q&%TY%AJG=[.2'B(H)3F32IF$O%9X^F3=F@^UB.AO8]S=P@CGB5\\R4
M8? A]"G8603'-_398])S+7+=:<=:TRVHVK^:],FC,5Y+&W.;3<S'L1V-,#JF
MH4%$\1&G9!_,RR9>KU*Z.+L8U+OD%"KW4W_:8]QHGDH";6LCMV1I-HO1@<7:
M(L-J)WB;+(G'L1V-4#JFH<75AVM$&]4ZD[/M62&A8"[URI8#5X(%SX0Q*9IH
M1)MC\BV!'HV$6A+4(!*Y;X6=2I5I7Y)W.H)E/->2>AF"T@@T!N:5\RA4/%!0
M^U)*SS51WQ/0^029@SV7=)9.")"ZYL*E@A =K=M,,>9MR-(W"ID>0W:D.RF=
M$M) ,'?*L=$#D_$J@/>VRK<F32I;+R_P')6QR<HVP=6S*56X3[+H'L9\OJ4*
M0XH^U[.DB#6A*3%#P;\SP)C2SK,2B]\HG?S%ERK<BLY'2Q5N8]:#5:G;!-2W
M5ZIP*ZHV*E>WBYT/)@)=LK9<(B1>O:A"(5JTL>X ZJ)\]HPPOU3RMRY5V#WW
MVYBWP2;ZU3!?USX)[\O,)9D-59K"@C7D/7,70$GMP"<,8 4BYR[JG!NO_7<A
MO>")OUMS-]A9OXEGV>MO T3;S/[;'ZO<PW38):!CTNZ>K71C\18':_>1>>=4
MXH) :6]KMS5+LY1"X,Z7;+2+++29# ZE@34KP<$EL(VAGT>#S?M!;%>E;#=]
MR@$:;6X\R#O%;FUF*9><:8T7*B3C6)8Q2=093? 8UC;;?.B!G5>_%<88C+2B
M8<BJ7E+QX%*VP$LQ,7#K4VG<./U=5]5O[S9#>3N\;\F/H\'@Y]'XCS#./>1,
M)"8=,)=KQW3RP9Q@FE9TKD7=BV&FS6'0ED"?Q<W9;71ROUA&.V(:%-C]=!K&
M.'D[F5Q@[G'-;>"U=A.O[<*8E."*%B!XL*'0](6RS17ZFR@.KX"FE-UUC'>U
M=Y.8J).]?Z6UET)0/*>+!$5^ 'B32BUK[Z)")IAJDY#P4H]R#JJWPW/<I+/0
MW5&L;@G6RY:F9B,,L!Q8O7BH( I/$[D6Q:..13<ZY]D4X;>FM@YX:I!F-<,Y
MGX3?7(SKNS"#.9^<UT!.3AG+5 8;L8"*M81E).-(SFU,R(/V;>J+[0#V&U!9
M0_8:I&O=SS1\E<@F8\RO*4;[%:>G(W('C.%*Y@(Z"5G+[PCPJ PDS541FJ%3
M;>ZF;H+NN"75.3\-,KEN9!_>\B*%IYG41@E!:'(EK4D0''F1A62ME7&H5)M[
M &L ';=2NF"A55K6+^,PG-Z>%&=:G@&-9)A<D\MP.)E=L>T5Q1D&1C.A,K7^
M?KTN66HZF;:9AJ*\S&UNGNT ]KA%U9J]%ADT-\4?LH@I. O"BE0[\'IPF#UX
MZ:W0%@6W;2Y#KY]WGBP<EJ+00I$R%)\C\4+D4*@4(6OIHU$ZY4:%AUJ$P[O<
M5!N5_K1FK/:BP21=;7\::Z:J3Q9"<@Y"S@8=QQP:S2_7&%[\=N*.YFQ1$*'_
MI9]QF">WK\C5YD ])8HPLEZ3J7M82AB:BVR($+UW)N=BLFF3S?L J!=/?5<&
M?ZI&]RG1T*/34(K2H'1M+" #N46&!R=T\5*VN4GP7*\/=*J.SBEH$/7>22AQ
M]+]9-Z#$&7D))L8Z7 E99N,9D[1JMMJ<>R99MOL0OH<QGSK+]MX0YNY)5>]H
M.*O&,&N/F[B)GE-0S74 %9%\6;0<A-.<>R3_&1LG8JV"]4R2L;:B>YUR]C9[
M@T.H.YB63:TW -4T)VLEK"=.R]J?OE$KVQ],&%RHP-!$D,IS4,HK"/4&"?F^
M12D=N3!MBJ$<4!";YF@=2 _;F+R!#FY[O[_.O*Q>,L+*)#T8Q5UM-94A&HF@
MN;,E"L5*(U=B%9K#^Y(=$/5@W9,=K-P@-^7&5NL"4+UA'[UV$%/M<1!HF$%P
M&J'U45IR<K%1 M<]*,? ^7[V;?"JWSJ%64"2I+.,]:* *TB.3VTBEI4ACHRR
M0:2B19OMM!5@CH'T?6W<HGCWZFH;"W#>9%DD@=-<4@S+>0%74P5*B9*IDD),
M;3(7'X1U#%+HSNX-MICN5M98H+*1V=I-C":G>HT(ZS5WQ0R@\RS&R"FZ;G/2
ML!K/,<B@ TLWV#O:H"S& J@Q5C,;0JW<2(L6A<,$--2"TYG7[#0M&VT^;PSQ
M&%32AH^U:1('O=I1M]1_'HS^F+2XT;'BPP]PD>.Q(=VYOX&LYN )K/]5C'MZ
MT[U3S!DCC0O2K;V_L>(YG5_;P!0ESU* 2+&&(9%DF\E129BSC1*-*JT*H'9]
M;>,WG%:+?1B/ZME._O'R]TFM:?W^',>A%J-]E:;]+_.R&<LR')D7)D,-O90E
MYXQ>'PC!.["<<1YMB,6WV1;='NNS.%391BUW)[G&]#2(D6^<#P=5@A$IT)S.
M:-[ENN:>, K>!7(?5!#:M^ET\Y3'[:T96W\<OXVY6[0VZT_.1Y,P^&4\NCC_
M;32E[].LH/4%+=#ST8^&OY )*]CWP^6O]TQBQMI ?AQCM25+E. \%LA)1RF<
MCQ%;'=7O!/CH)74((IOTQR#W+_5GZ.CK <Y(&>979S77Z+_G.6I69YN$JT7)
M3,VZQ@2AGG?63D".22M=LR89CZ,[?F5U35&'83ZYS[VE[_CV[)R&^K[<Z_'Q
MT]>:[H@_XI#(F?8,^:;"2PY%>E\+4D3P/ B:<54JNJ!A(C[BI._PV*.526L*
M6B24U'3/'^^EPBK$8!PG&*:.GI4 KA:N4RQ@8(D69-?PWNH]/$>KF YI:' _
MHFJX/Z[!P/OR=C@-PY-^'."\M?7;X8(&'/2_8/[IZR(Q]I?1*/_1'PQZEGEA
MK4O@5*RKJ8VUG#/66VD^EUI#T[6)LO9!??1".QBE#6YD7+ML;X=?<#)O.]/3
MQD@1102N:F.!NMS2/S6C1P==8LF%M7&_5\(Y>@'M3T*#JQ,_7DSZ0YQ,:/*,
M_>%L[KSJ132M&VUDF;G;_VH\)LW/]]I>G]8OWP[)>[NH[\.:O[*LO'K)>\4%
MS0TW(+)2H(2P$$.M4T_BCU(&Z4J;)(D##?#HU?L<A7+_?7#[Q #UM1S2'U]^
MFN+Y[^>W0A.C90A9%RB&9*:XU1 EO; F!N4]8N;FL4WY1QYQM KJTK3W&?==
MK(V3.B\CS<P_?:T#O^A/3N<+?>T+VN/(D^>HH6",!%#2H&V<W7W114A)2WH;
ME_Y1:$>KF3;DK-CZW'G3NZIZ=OA8.WZB]Y;3/R!LO0*#J=Y_5 &X1Q&E]4YR
MO<'LL/R\HZ5U9Z.M8&[O7>O[EVI?I527J<E'3-C_,LMUUQXS(R" PM6.*3&#
MERB).YU1,(5%M\GRVP3=T>JD&44K=+3W[O-]D,O5KO;R%$DZ&;R!7 6N4I"U
MAFV"D&4J5JE("]Z!!'0#UC>HG%U)62&9O1/*[J.;S8K7QICM*O2\HC5-N 0Y
M)XH-;=TP,#*"44F)Z 5B.52AQ%7XOD$1[4W3"C7MO1.]?I;\$"[K%%G/65(:
M7V"^T0NEAR('652$[%0"Y7/=>= ,0C$:C6!2X:%FIDWP?H-JZYS&%>K;>ZM[
M<ROUK PJ4S@'T;%,TZY0$*,T->=/V\RC-K9-4:G-,1Z]RAK1M4)9>^]:KX$Z
MWSU=;1D9+3/1UN80>I:($&DJYDBNH<=4'!?TDT,J[ &LQYJ@UA4]+:[OA<O9
MKN3GT:*B&F$GW4\O/PS"<$K3:TU5/J^_TJ-7R3A7&.A9XC!:5B\><>#9&&5R
MBD(T2F#;&..SF:HZ8_QN@EL;NIK<"QTEQ#SYF4SV*0SP?5D/58<DLRL69, (
MRI0(GE'L49QCWF3+N&OC=FT!\OBEU8BP!LEM]]Z"Y4D,SFNK5+,M"T3VL%@6
M!,6TS->6X9*PAB#H7PJ30VM-<6V2W+9!>?SJ:D59@[MM2ZP_C\8W7XI9H+O"
M/CTN?.0%:U/ZZGLF(\%Q%L!*(37/D3'69D-T2Z#?C,A:$-<@7>XFQK]CKH?"
M]S$6:8NUHH"UGMX%1*S=@W/M_!D-TI^YNUF5#=;&=>B.7U%=4]0@L>XFQC?]
M&;SIQ9C6[^LIMA=02B85@UA* @J1/7A5ZDU#7;R)Q7+;IMC;!N"^*1%U05"'
MV7#U]/$FO!LSZ(V,K-DN&ZW-DQDO$UJMR2TD0W_&=#H<#48G]2TPR4GG$@(+
M-4N%D7<8@E?@C.;6*FEYV"3]NQLT1ZNI)R*L09K=Y@;KN>SI!= "'"H*96D^
MA2@8@\P4XRSRX&*;W@Z;8SQ:P36FJ\-\M4>0_MP?AF%:;1A%;X"P0@.ZVDNU
M: ,QU,N"VD6TSJG V\2(VV,]UCW2KNAIM]U 4^QCN9HK!M&+PJK"BP/#+"-;
M:0N.0EJ0&'A"Z9F5C<IL[P/[V<QGG>EB=:QX %([W%R=K?[7*_['T6483"\_
M]D].IY.>3:(FCP50RI$+F6VM)JPT&,^"U2H[K?DF#MB:SS]:171FU 93ST<\
M7R![7SZ=CL;3SS@^FR5YUG+RA$" CX)&*@,MM]8CE&"+2;5<3*-I92VDHQ5(
MMV2TV+"\$1#<!%DK".(X]6L%L?-:/]")%$PA%Y]F+U#H D3K"*:B$("%C $;
M;85O!O#H%=2"J 8;D[>$CL/^:#Q3>3 V)1HC\)3(ZS,\@(N<I)X+XU)F;DJ;
M,&PUGJ-72P<T--YNK)U]:.BXQ/=N-#RYGA05YR'Q#"99$K'P# )%GV!%5%RH
MY$5LUE]F(X1'+Z F5#6XB_OA2N97355Z2;/ 6#!@4R3'*R4&,5E+7$NMG2A&
MZ#9MBU> .7ZA[$E @^W!U=JE".T+CJ?UFOGMDMB](ES,5@5@R$(]RU,0$BK(
MJEZ:"]$(V=ZWV0#H\6NI(7$=WVY=R'XZ&N)T,FM5A]/I /'L?#"Z1,19E<Y0
MVP=.>AFE8>@SZ.@B!8+2@F<T3VHF@Q*Z,#1W<I0>BJXW>>31*J6EZ1O<AKV5
M&%4E6_.A:'[DF2M5 G%<>&U9K,%GFA^#2(Y'9;35S>KYK<!SM&KID(8N+[MN
M;X6>E5G'H#TPFY%&+P5$3V*6S&29C!78Z.+DYAB/7D6-Z&IQ&?>G4K 6_?KI
M:YJ5C/@8IOA^6-'7?VHRYI<PP-G%3S),/TTQS[+HAOGV#V[\9J\D9@/::C =
M:]7P %'( HD'I87R% :T\9(:#.;%GX0]-<$-=B+W C]OJGS_SM>B<M1-,\U-
MURN<)R:\ BQ<U-%:<%ED",XDILDWD*)1PYF#CO/%*_T9RZ+!]NE^;["SCOQ:
M-.!\=6@<EQ!D;>S!DRW,9^E+FU)WW_9D?#C2&NS)[@=>9F9-DADDO2"@/*G#
M2<>!0E==#SE]PC9WZCM4W/8V^W1Q?CYOH!H&5W56AV4T/IN7[+I*FA(I)YTM
M%&]U/0'F4 L4 J?UE/XG)>-MUI@- ;[X-Z\%$0TV)-=45;7!9^[IO?&SN^;%
MT3+CM8!@F(Y.&'*YVIQR;%+<=OM1_ASZX_\,@PO\==:';$;+/_K3T]^'HSC!
M\:R\S-OA^<6LW,R(0J;!O( U?7<Q'M-R3(CZDZO<F0\78UJ=:X*S0).<=@)0
M4KQ&=J*Y,BA'[)%TBJY=,=LL:ZU&] 3O78L79?0,^>\PD:;N-?Y&.,E<_5D1
M[5$A(PTG\QWH\3S79SS/]3$IZ( Z05$X*XL<P<?B0!;)DC+D4^9-$J@V?-QQ
MZ:>5G1O$J'=:=YL<<V$L ]>91DM^''C+-4C/,7&T@L?&[8N>NNW]7HOW[L9\
MZK;WD_'T&OZGA,- <>:L23.7+OLD+62A%2A5T[D8+>PR.\6%IO4];[2FTQ-N
MR(&^NRN%M1">25O[K>@<=6G6#I-F9X 6.'X?3LXQ]4L?\[+IW@:@MFEEOQGG
MZ^ <MH5]1U2-6MGY8"+P)=.Z(Q($+2,Y)SQ"E$Y#%%BL,@P#;A3C/4?RU[2K
M/R3WVYAW+>=/TW+RIL]46S_1ND1>\6VPW?2?7/.D0S:CW&2P=SI3<IZ5#9;E
M:+62G@7C!+GT*I?HC.'R\<Z4:Q[:?9M*R93.]#9F5V7M38$8' *+ 9'BD6)<
MFX2R[MM4+K;&[FR(O9J^#N/Q)<5@LP"N9S 69FC=9KDV3X@\0<S> )-.D@^/
M6H5V&\F/PGL>VU9;:&+5AG&W)#3H/WEO._41N FU3O4:.E.IU-"/HO1"H1]&
M89BJI0P:W1#8$NB+5T]+8AI4\UJ["U]C_@L*\8?37A;2QGKRD5A-(D9%4@^1
M%GVN6%0>78AM$J(V '=D>MF?@ 9WU?8[A%*ZF(31 I<A@!*2W$.N'6CMO',%
M"]-M+I<<P;'GGJO884AKOY,G:<!:ET"+:^THYI6C""/6UBG*4RSCE"]MR@@^
MGYV\/92PAS&?>B>O;CY?P9_%L)$33LX+F%0K701N(1BO('F6LS$I.FD>"=CN
M?>@SV9/;BIA1%P;J^ +[%9#%[L F4%;OP#W,V5/LJ.UIZ%5T[6&EQL11Z!^X
M4 *\]QJ4,J;N#BMR43D*QF.MG_=<"%NS"]:.KVV,<]@]KYN5H6Z4(YN$8?XT
M'=,H3OKI1BVIV:PSV6'':[?G=+C?U<% [^QVV1 %:A3"IJB"SX'EDGU*1M5=
M4<E[NSVRFWZ5-YY][1%P'3D3Q8!T6H!*6/.!DP>1E(ZJF!!XF_*1#Z':V^]+
MIY@O!C<JZ-VT^X^7-[[[3 S^.*CWS+(0M#P6<HN(-O)5([V:27(0"KEE/*/*
MC<YY=T![^+BB,Q7=\RM;D]5@V^P:<\UR.1GV_QOSVSR?8##/>]PLJQ53@'2C
M]PC]V<49YMF+?3T<6Q@%Y\I#"L*"8APAZ$AKC*IS"5<8&W4MZG@@1RG+PU/<
M8(/NYUFK[7>UU3:AO6Z^/?O)W=[<5^.:? CCZ?6+>:.1[9W1B>Q"*$& #)K>
M1YG)F^&1@4&>;:"8@WR;-ME[3<=U1'I^1@)HL+=XE99XXSU<9"CF]W>2#^^E
M*M[.5+P>D[=,YWIKU%E)KK[0%$0G),-S^K%/@1?9YD2PQ6B.2<I/37:#K<JK
M,2U>P%LKRHK!T2_\-AJ.;XVU_OW%J-+IL/^O"YS<>4M=SFA<2L"UKIF5OH#C
M-&:C2_0N\9)+F[;,!QG>,4K\V<BAP3VXZT#W[Z-!O:HWN7:Z[@;!UZ"Y]R;S
M[("<?EII;.UV'[4$'KG1THJ<59N(=2>X1Z3)]G0UN/FV370YVSYWRM*GB Q.
M>U8;!3)P(3%(.OE:=D]Q'YY\&^"0QTC/(O#?FIJG/G)ZP'JS;>00;9:U1V3M
MV4Y.!OG+43@)EDECC Y<A3;)$&L /=GA55,1C+HGHT%LO@K6/ ##Q6'!)@"W
M24+O1#6W(![V&*U30C<0R?YL/(EL3*RWYU#5IC$.5/0)(HL&6+0,K3<ZQC8!
M[!/)9<TAWM.J91L2.CZ0_3%<#OH4+N1^"H-?9WYCS]J4G4P<2EVVE7$<@H@4
M C@694P.A;NS\*P\E%WQT<_"U=W'^*/N+-?AF<.\HP]^J5O/"3^-!A>SI?'M
M,"UP>4RB%*W)_0K+2UC"UFOFG*/7I?B2-F#TH6<<$[6=V;+!E$Y 1F=XG;A5
M_\)REA(LQBR4 XM.T7BCA6!=H=E76X7(6&A4+OD!4-^$U]@5*0VVO== 6[PA
MFX!KZC4^".]I/,;.R-Q,)'LP<;CIY<JM9;2"Y0(A!9I0N:$)M:@('IV4F"6]
M0@>=8)[04WP:E6Q#0,=77]__,<3QY+1_/ANBERQZ4RP(50HHI@RX6!"D4YDK
M*3(/&YWF;G3=]=:CCWI!V<_0'1XZW0*RO(.[ 93.[[G? 7'XV^U[T+&*U#UL
MV>J%7D!*-@I6SW8PVSIKU1B7J>H\4_0KT/L@-SHU>3ZT/G!OO0VKVYBPP>)]
MM6J\'H1)[?A2:US/!L@DH_5(!D"M,R@?-3@Y"U%M9#+(9$QI>Z_E+J2CGL:[
M):1%?=$;>!;:W011TU#@/J:G\?\[(NWN+;EN+-Y@UEB!3#,I8HX<<JCM=Q,G
M#U-E!:QD5\OB9M6J*/*!-/"(<W\P"6QCZ*>[XA&&^>9-A#<X#?W!OO<YUGQH
MH\L;FPSASDV-X"++Q;#$:#'7PD26M'.6A5RD8.GV38TUG]_P6D90*((-FH+,
MNKGIT5!0*#4@3Y:CXB4&UN0=;7DMX[>+NL=ZO3;C59YI+\ILE*51"A9J&U6?
M(601(*4L?/":HM\V5W/78WH6>]Z[*>)>4XMN#-_QH<9]5/.7C%!I0U.Q3;4Y
M/ %25G&(WD5PWGI9(C+4C\U&#S_A",CMT(0-#Z=O9(S?ZI[]^;KXYW6E_EE3
MI[?#*=(D.WU[=>#S=QSD#^/^:/QY=./C>,\[CXFI ERX4&\"*?",.;*:C-Q'
ME-RUN35S@,$=@4"?JQ0ZKAZ\>GBK.L:_&H]K(XI9EN3'^M7[\OYB6G>$9[FZ
M^/?^R>F5!6:C7!J@AU88%[D#5U2H#7\51![K<(LL+AJFT6TP(1X"ZQ$H]UG2
MVN#2P8HQ?IKB^0T[KGL//^ XU8I\)]@3])Z1*ZT ;4%0,=4M%'KU3#8NT&!T
M-&WNS7:!_@C$^F1D-MBYVGT,'^G]NRI(_TN-OK-401F*WH5&22%\I"7!"PTJ
M"*E2+=? VF;8=C"(/^6Y-[4M.IPONB%_'BT@7KO?O^'T_:QTZ56 I4N07!8/
M1AI.?G@MN52+V>N43"R9_EW:U"W;!N41Z:P9.0WZFG?K8_2X0ZL<*D@F%U \
MT&BXY."$B,$4;;1J4]"UVW$<D1B?D. &'8XV'\U5?Y>>R4D(#!XLO4N@"I*O
M*V0&:[)/.7#O;-N-S"W ?I/"VXVJ#ANM[^\@7%V6Y3U#H;\67H/V6=1RR@@^
M>H1LLP\N9BUXF_K$7: _;OVU);-!7_<58[A?"B;<JYGQRVB4_^@/!BN+PI +
MTE.*\6R9K^U&Z\ZLK&5X=8827>8F9U<:G74T&M!QR_;@E+=H0K\$V*/H2%BG
M&1@G/"AI'7D0R0-+24FO>7:-4H66"(Y(+#L9M44C^!U5NU*MUY6 JG&,#\%*
M8$@1-AD#(::,((/--O#$2C[8#DH7 SHB[3T'RE=(>>\++5V.Z_WT%,?7Y>_G
M?Z/'@HK*20LZUY9EUI%3X1@#(;3'I%Q \_Q%O7)H?\J[D0Q6"+W%T<O.([SQ
MDUY![:S1"9PF=UGI>GU$T/LLDW06K9':'>PTIHL!_2GJ3BE?(>46AS8[C^L-
MSA,!/H>O-X>HM,G(1(*<,=8L)0G!&PO.!VX94TF(ME6*VXWM3X&W$L(*K>]]
M]-/&[YK_\FRA^GP:AE>!A<U1$Q\1<JSM4VPQM>) @)2+DCI%YF6;3.V##O//
M-^  \ECQ,NQ]?+6$?Z.T[%W0_\#:TIM&^ 7'X01_GV"Y&+SK%^QI9P3%QA9,
MW6A6#.E-=C%2N%$*"YKYF-I4#-X']1%)]6#DK5#>SB=1-3&K]@ =70RG'\/T
M>K-X5MJUYYQ*R4@#+M02'L8P\#%[*%9+%21WZ#=)&U[_A"/@OT,3KF!V[U,@
M@G8^FH3!+^/1Q?E5UMP,<#V^NJ!X[GQQ<G7K&(L\ ZV+)G\@^\)(DB9!*)84
MFBC B\)HS=KL;.Z*^ BT=%#25JAMYR.>^4MP=:/GU<D8YQVT%JG([\O/(2U]
M3F:5M_4&%W/>TRN!C$!*#EQH-,(%%C:JK[3I\XY %\W,NR)U>Z\K* ^#_&4P
MBF'PT]GY8'2)=7/44?#A9 ;)*+Q66!N?1[)'$B69)+B(KNPMA#L/_2;4L(^A
M5TAB[P.56_/9;Z/IRIFL9B*^&TTF[X?+7^\5EH2TI.*25";<ID#(20(B&IX\
M6LO:U%O<$? 1B.N0E*V06HL#C]J;XVQ8;[O.,\/FH>)9==A>3=Z7&Z9[0_Y;
M+QM3,M-8:U;2&AI*!L>CA\B,S]E;[AK50]\;^A')[[ TKA!B9P<2-W!=WPMX
M7_YS5)/'ENDZU_='4^%1.<4(+%I00ECPGB&%#Y+Q'+)#<;"+RAO@/4+)-21L
MA<[V/BUXE=+X8G;3;W2&G\-7O-FAG'M6)#F#$),E>]16]EY: \8($PIC F.;
M(.XA5$>DF<Z,OT(9AV_5D R7NF8GN!0CJ$2B#K4)8,A1AIA5%+9UU[P7U*IA
M']TTI>:YMVHPY *ZHNAMH#BU%@9F$&-F4(2S6AA?'+8]A7FIK1JV$L&&K1JV
M(>-I:NYO /#/5@T[$KI]\?T=V'@2V42?O3'H0:/CY/Y;6H9#(7(%]^@#%J;;
MWMUZ&:T:VJIE&Q(.T*K!6Y]I0!82]S18J6FP!CEY90FSB)'P;++?^$):-6QE
M_$=:-6QCN4.V:N \L90L UO_I9A*M2*< 6G(]V;9J>3"!HR^M%8-NU+;F2T[
M?EG?7= \5C4W%QM+FK%2;\MQ<G/0(HF-7*I2C.,1C4UB$U)O?>@QL;B[M3JN
MU//KV]H)\_7HW30OP BMO$-#&@K1T#R!!8+, ;B4DB595))L ^KN?? QT;>?
MU3JN6CZ[&CWS! JS,=>E/WA67_^Z6T&S/1AF%#IC+,:-;M%M5-#ZZK%''7OM
M;N .7]0K$ NQ;0*C\[KT-P <OB;]CA3<)7$/^W5<B_XF',\-5Y&L'4-MKFU%
MK9]NZ]+M I,$5H>-CDB?!XT/U*#OEL5MS-8Q>[^2I<XNSI9>5[$J2$S :YT4
MY6J)9$%?&:]T#L;98KKK(W#KT8=;4_<R_J@+RW48D\R A*\W@#"F9=26/#"7
M*#A2MM1#1@D!8Z'!!51FHQH)FU%X\]$OD,*=+=?Q6W@G%W<)2!HK#,6YJ)4"
M)9@'CTQ"M)8\/<MJ:=_.J%P)X>51NK\E&S1R>R +^\?+7\-_C<:S^O*S]22Q
M3"XWI[@ILJK"',G)LQE$L*FDH+50;2J*;0'RJ/WDUJ0UJ/3Y -1KH+^%LV6P
MN G<IJ<86P)^FC.-9@+87&B=L=?@U&-;V,[(J) \XY 3.<I:U^PG+B%'DQ./
M@>D2CE=LCYR(/%>M;4-: XW5O:GA:# ZN?PQ3%9 7K1NUK2Z%U$7]IAJG65:
MW:-F4%@V04LF[ET,ZDA9&\$[_&YA4Y)'K1GJ,#I:@IQ=KEP#+;A2O*KW4VR0
M]#85\C$=.9H&49AL,G.;=</<6CP/@#INR73%1I,6N@MC;S@5.TPLU2PZS1*)
MVZ0,,2D)AGGFO:9 ,K?):-P2Z#?AL+<DKT$U]$?@KG[M-H#<N.?WUJ"?JA-X
M0S%L)[S.F#S\A+<2>I16FIP3Q%QJX[N@P"&O.Y]<BQC0QM!FA^+9B._1_N+/
M6WO;$-A$<Q_&HT1KP4><('WRZ:MA?H-?<# ZKXF^"T\@VU!40@N>U5RPH.I5
M=>7(@[39J*B#":V6U@W@'=Y#:T[T/6%US=*!'7N/VF6N$)CQM:&ST;4/CR7&
M"^%,UGK59K_A63GVAY9-5XRT;+&]]$4_S6\6S"?AJ$1QEH?:0H_7.%60YRD\
M".D$IIH!H]J4UGL0UC?AN'='3(-V, LLRU=C S!-'?!;<)ZXR?;^=-T5PMZV
M;C%MW )%<Z!"&0HP91!4W8;UDED(DA7IT)00V]R(/0#QFW;6;LS[-B9NP/>M
M6@.SI?'ZEO<LX<=DR[/)P+ Z.H78\JEX<MY+EC1XQ76;>XF/ /LFEHHNR6G0
M\ND!> MQ;P*PZ0+R*,2G650Z)79ST>S!RF&GG@50(5DJJCA(O!8TJ9UP78@:
M$L%-JI9PEVWV7IY(-H\L24^KFFW(:*V6VCKYY]'X4Z")>#S_$\PT)5_6GZRK
MF+,,S+CSRLC:F;:F6"F/')RQOBZ[+/-D:ZN+]JK:9PB'#ZP[EL=#XCL8MPUV
M:.;%**Y=QS (PX2?3A&GKX;Y5<XSFL*@CF$PJGU R66X-?K)PR4'Y]YGR8[3
ML#2Y$_72BI"I[D,QL(BQ""_(R6C3]^$PX_LF?+MG*)4&;1:W GQC4VX3V(=S
M'#<'_E3'?\]/2P]-\8V%T-K[V )^%$KYNO6;ZEJHI!3@=1!@7<B*9RV#.T#X
M_-3Z??0$\6CENPW_'5_L_G2.J1\&T\L/IV%\%A)>3&M5@:6GA*GPP%6"FI(&
M*@8/3F<)112> PLIW&UFN_*Z\,-/>6)'M151HR96;N"/?KJ($_S7!;U4/]7B
M Y_IK\U+CV1=?'(<BG,>E(JNWON9=<NE&+(X+7R;"BUK 'T3'E\79#3H5;P"
MUK+@T ; VA[_K(/V1$=!71#XN"CVL'Z+ Z&U #-*DXS6P$/.]0Q$0DRU_GUT
M/'CF"X]MHM #R^*Q@Z*#JF(;H[=7P[*(AHPI.>4AT;I&0YW582T2=*0%+X=L
M'&^S3[L2SN&=CH[H>E@$.]AZK4?Q[S_<L<T[^G;V![.?U[%_Q/)=_>_O']]>
MV>F//_[X2QQ-IK0VIOZ\ 53Z"_GN/\R,]7KF8)W0SV\UQGB#T] ?3&YCFO3/
MS@>/]:]YY -_N 9\>R"+3[U%<7?0\>L4AQGS]]_U\]^^[Z>2HLC%%I&,,CIZ
MJU*QF%3&R*+&WB.?W7DQOC7/>W=5/)51K&.]R30QL;I3FS7$ZO1J)@WS60;>
M*";= 6R#DO1K'OEJ/*X7LF='_*]/ZY=OA_,*Y^_+NK\2)]-Q2-->%L*BSQRT
M,0J4#PZ\K/>OG9&:<<3B#U:VOOOA/8L"4)VJ>H.*]T^LD@:QX.:#7/;ON^R)
MZ!FWG(/-)#X54[V&F0U$;DPICFM^N*:-CX%].ID^(]GL+.S=.&]QT7K9P^U7
M#'6KK]KL'_WIZ>_#$;E#XR\U#)^U=YO4;I3#VGIIV9OR8CRFD?T8)OW)U7 ^
M7(S3:9C@I*>+)1_,DAV]I G":P8N<@G%N.1R+MXVZB;=:D1_"G[%C>_GH)X&
M-56:6OYJN+Q7!&.T=#K0JNY7RI3 8<D@+3FWV3-R;=MT?3K0 /]\9P[L_>RH
MK0[+QLR*[X;+"GHMRIY7/D>;)7@,B;Q']!#0U0I*0@19BI7"/1*M;O*</^5W
MIRARE[PTN+6\B__DL[>E($4>5MMJBP21>0LQI4P2)\GP9^HS'VI9NI*-,-:6
MB ZL\.1JYFAH1M :'+<E%Y,E3VUVD/?#_6= W"&O#3M4;(=^5H_O?7E_,:W9
M").9%_GW_LEI+QK,P;!9!^FZATLK6# N +/6>BVD5*'M?EDWXW@I:\]N*NI$
MP)U(H&5,O&B\.,S+&;R/DT6DD]_?"6+NA3RW(YXK,T=:8V-,"DKUR!2C>2)@
MXA"$+29$[X3(;>/B!J/ZIL3^;.3QI('OM0>F4Q!:V@3)"P&J>$'N8^3D-+*$
M#$- TT;1!_3 JO?\V&=_&(_BXLOW9>%J]\C]-$F3'RUGU]UULN!D0: )CL4B
M->=9;A#I[/+L)RCT]6S>C-$!:>NXU<@L=X["P(]ABE<&G1FF9T/@/*&"J&MQ
M1DUOFDL.@3NN!;KB\]UV@FNZR*][PI^2Z9*"CG=5NG6RKG(U/XS[H_&RV6^O
M> KR427@+)=::IY!5#J"1K3)).]ILM] 8H? >KQQX;-DNX&WL44^Z)JQS]-$
M,:>@0U808NU/E$V$F*VG;ZOQ50C2M=D#ZF@ 3]CDM^F^QE/P^]0M@6\W</'1
M&A%+IL"BMBRS]*_ =( H$JT=J+VW&_G&1]=JJCN^5W:@VL;N+5L6;0#C6#M0
M;47!NMY%.]BO(9VB^"!C8A05"$G+9:"H('D$EET.GEN:"SMN'/?D':BZ8'$;
MLS7M0%64-CPS!](6 N*M %]D!B.C"]FD4EAWL_$SZ4"UE?'7=J#:QG)-.U!I
M4R+W.H,6BO0HD@0ON *=N4TVDDNR6:.'E]2!:F<*=[;<03I0!>><"#J!L;;6
M3\D.G*=A<5'K>Z(-B6U4[>PE=J#:E=+]+=D@C*M1YMQ[J_T:^O^ZF"\=B5PU
M)G7=-//U,B9J"!X]+1V!ZY*#X+%-X9?5>+Y%I[A#A@ZBFV43H@UP-;T)N0[9
MTUR$[(*]1P6QA^D;',&NQ9>Y2C&G"*B*)G\TNIHI;6M^6VV)JKA7&[G@SUP2
MCUR"/*0BMK'X892PV)W'_#I,3G\>C/Y8>C@<<XB>T;RH74T%T^"D860-9A0W
MJ"6VR:;='./A]ZR[X?5QL71!2L-K.#>;V\_BVIP=PUE%^8"@#&;P"AF0 ^4<
MCX[<LC;SR!I W[)WT@5'#1I?KH)5OQSC\A7:!&!3/^51B$_CL'1"Z 8BV9^-
MANF0ZX$J>BDBJWD%AF9#E9$B<:<-"(.2Q<B3;IRR?&"Y/.+,/(U:MB&AXU)1
MKP:#59/MLJ:F3)Z;3/PE#+5!AH.@:7%6F>93$XP([DZ6]LH3^ <?\BR.SO<A
M9-3"F@W<CS5KYH^75W5+5+!<N6 @,<YH[)+6S-KQT#+RS:RSAC?*GGL4VK?L
MDG3+6X.K,NM&?ET+91. 39V31R$^C7/2,;6;"6=/7AJX*8\#]9%IR;4"K9,'
MA07!T=P)@9E <[22TK7I1O)$PGG$37EJW6Q#1\<.R\<W'_'D8E!_XS(,\^O1
MV1E-Y_TPZ/_W#&6LW9E_[0^P%OQ9'DHHKF))OM330G+?,EG#B60@<Z:SXMYN
M5O%REV<?WKWIF+[1 6W?H=<SPXM?<'B!LX;=BVSJZ_[+.6!=@7GA"11G!D(*
M'+A@61>E)$>^B2+6/N&H>._&CH<I43B;_@3ZP!5J,%(+4((B-^=KB5=IHL?D
M+,9&69@OMLII,_^U"XY:]+M;6[EO$V!_%C_=DL"-RUSN8OV#%C^U:'W--@-C
M:0)5@?DZB]:LM"22IR ^F#:7@E]&\=,VJMC&Z <K?FJMC$E(#2K2*JJ"KY6!
MZ"OK(]96- [506II/[_BIUO1M5'QTVUL?=CBIY^FM%+B23^]'7XASW?F'>U>
M^?2A3^NP[.G&H._4/'5<)O3:V9*C\DPXRYRSW'KE$TNN]![ZX*YNZ-SXZ'=7
MET.2$HC,.Y"F%E_)PH(CS8"2S(50R!&UC5[&!W'M._/\1 [:]/)7G)Z.\HW/
M[T7MBG;& Y)'3].L4!"]8^!#3-Z0'8)H4]-N#: GF'VZT\/=*:@+HS?8P9_#
M^E3OG\[NI-;R=J-ZXS3D_N"2WC(<G_6'U6&_OLHZ*^/4RQ)#T39 %II!]=<A
M,E?S;XOUNJ"E.+RA6G: ?(1Z:DU< [_G+O"?O_S6[R$JIC4/8*U5-'[ZRN><
MP F3?33<IM+& 5Z%YJAULK6Y&V3&OOI":_=,FO/.C-?HWF"<7G_7,_40TQ<!
MN7;/(2MH<$DJ"-FQVO"&)LXVIX>;(CPJJ32AI4'FTLWE,]. 4Z11BBQJ_ITB
M$9NB0*2<93"Z*+/1A9FM%7*L?LJNQFUP"+S:97K3+P7'.$SX(T[_0!R^#N/Q
M97]X,E_>7@WS[Q1<C ?U1_-/Z#&ID].$7B:#5:^%9CK-R2A,TY^QE!I5U.]J
M!$>EL">AM</=WH.5K^!)2%.D@"BKD36/$#D7D##SQ*.+W&Z2*G6<Q4H:"/19
M$GM?N*9!%;1/4SR_<7 S?\&6>-]>Y;)]P'&B\883[#FFK,(0(:@XRZI7M1>1
MIRC":%5$$CH<K+;WUNB/0JY/1N=]2>[=V7FE>>;GA#S)'$+VD'RA<%4+<C8%
MH_D>;4Y,.,,C;R*T]9@.5="FH6@Z,OA3EZ-Y[.2HD"/@E3,@%9)A<O(0K4T0
M=2Z*%W(0$K81SW,]M-^/[@W/X;<Q^T$/6C<!]N<Y_)8$;GSBNHOU#RH/#%ID
MQ0ID6O) %2TA..VAAKLV2IFD;[/?]#+.X=NH8ANC'^P</J2 K @))M7:FO6
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M-']\_PF#.[_B&!GD768.)N:#8,YX&I3DH(/0EFO'@S":2>&[IY#W&S[XT#W
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M3D0#E.)]#* #"YQDXXT*CIL4VO0"W0WG25'H *K:T,.C0H.I?6JIY^NXO8R
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MQ>N?RZ_A"US,;]VFY\/OKW\N;HFO!T!_6(XF?[VQJU.9];B8OJ"SD2HY14(
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MBTV>FDW!Q.1QN89!Z7N!P*QBQ&$@R"2SD'*;(9X/XWK)+*JHL?M\ZCUAO0S
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MN8B$6UMF;5-!0LFVDU91I;.F-K?)8>R*\#3HTT0?&S+C>N>WKIG'@98,A$A
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M1[2TI2D60G'>9&)99M8;%HWHLA5N>O;)*'!O@57N(K;8FP6]#2>*<H4=+?$
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M=$"R>>M^4&O'V(+[27F#JGJ(J'+\= \1AA!24P+.EFY2N)\X1SER4%"JP>;
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M32-V8#:XE$F6Z!Q*8X X,)8H&CG32F$$V>6\MM/+?I&DDB*V&I'_];<UT7[
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M(R!(DFPL>W)I%<%<(@R\T(H:Y3)O:L/6 !WK^KR/BK?8FCZB;A#T;8(5YXG
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M[X%7/%<MUI):Y<.H;^.9OW@P@6:)T46EI$2/,)>QQ5*+C&XA Z*IT8('KC&
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M4:&SP7B2@H),KLNI5K>W';8U=R6UC)O*M/)YV +A'RBB\=E//TJ?X0(7_A^
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MSB)& AG&(>19@B%"F82,1Q1FB*99@&BB(BL/UYM&4Z.FRBCPN+$*+!NSP*H
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M221H;'KP4K>EBO=A&&?)\MH#83?]>@=WX(G4"ZH]6O<ZH.2YB:^-Y)';^3J
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MCW)1RAE27(\%BR#C 8(H8QS2+$PA%7J>R"(:*%/FPWXCL9<64YLT:C5+L"J
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MD.(L$(S%:13$ME373X6ID>'6"M V VSL )4AX/MGIOS0JRAYSQ$[3:K#C\/
MM#OU(;"G[^&'8B2"'VI(G.:#\]#LF#%Z/GBT.>4\P]NSSIE/ZA<=,'FPYC%_
MRU?W5^MR53S(97,J[-MGJ6? M=P=)IME2K)8101F@9F3.%&0X)1"F45I@&0F
MP]BI_*:;^ G.1Y7VX ^M/FCTO]B>&_UFCIM6-K2.G3IVI7<;'[OHP7"H#S_[
M> 3<O8][+]S\]F%W4V'</NJ]X-GK@][O*>YNN7Y6,7_*%W=751G II.P 7ZS
M%HQD*B@1" 8QYJ:GN80LS#*89F&L4)22Q*Z*@Y6TJ9&;T0QLM0:UVJ>;5/>
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MC[:$8"]EVO:^,]*H+SE?KF6[4?E5X_PDDJ(@95#%66)./@3F?#&"<2(XCL.
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M!=44>?DU+V<$!4IRO?A.>9J9Z@D9Q'$60DY(P!'')&;<+JIR5,;T0B-;-2]
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MBK??ILM^5!NWQ;)7./<:*OM]>C_Z?RN7^5.UD5S'[YN2VCQ,% _3&*:$<+/
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M1NXL$%?N+#"#*"]*@WG&L,R"BOV>EC6V3WU?C.(*--I>@5I?4$1^^5U ^W%
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M2L1*K0PJ2K^DI@"98R.H5LM&IS28SL%&[=VIT%;UR"Z7'?C[L5-B5'OFIA2
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MPB[^"(.ZRG@F9&4_6B]V>D4;QD9[%@;0X&!7 7\##@J8H2NP0Z,58.3.W&I
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M#":? %22TH^/W$$)* "(EQ04<FML@RC[#>O5^GW3P6B2,5P5U&"(1,8AQHI
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M_%-C^<]U_LP5V%@/-N8#9Z)E 6-?'F"-#./;OE\4/YH>P[@/E)\WS%@'4_U
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M3,UO4X9EX;64"])B= 2YLV'=F@'6=JP;)]3A[\U,;_:LPQ=Y80/G2*5]#\>
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M#[-Y]=\V^DAARE)=P%PJ!%&28TAD)F%:,EVF),LY]:HGWR%K;*Y(HRJH=;T
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MRG&N-2Q5H7E!%,^)"F"PF#J.E.=>F]CDZ>P8N9ZZ+\P$C9W60ZDM!8VI=85
M&V7A[1!&?1G<F'7PL1V&?P<?3V^J[@/XJ(0>5<%!:;\/:%]_''J1<4;)@?6#
M=W)HVP*64I8)J@L,Z\SXLBJU+>_,'R45)<[20BFOH\).:6-;QZ\G^7HZ[ZCK
M6;W(#6HWQHT&8,\4>@9V88GRIS")GRM_5.+PZ?*GC#^8,7_RIH#TT]7C(YL_
M&UY2\\=/,S:]G,IOZL=L\L-XO*\BH^_GJLXNLSPWJ9@QUC:\LS%(5[,?:LIL
M7*(-)MV&U68L$5S0'"8)(1 )4O<13F A"F86V&6:I4YAA+UK.C8B6QL+;HP7
M8L-VK;W & PV%K_NV@TV1H.MU<":W<3\;@P/#J?N_W7I)M11O00]D_'_F>/O
MD;P\EO=@H'3 ]GTPJY*FWH]]'^PAWWSS/HCF?=#M^\ V[X/8O@]U UIIWP?1
MVOZ72)G40XQ(5UYVK_*'R_(> L87.>.#" Q;Z7R8S55U/[U>YVFV;7;7[C?!
M2")*4LB2A)F53B$@%=2L=+)<9CJ7.5+*9Z73*6UL#L):6=!JN^TQ';;2Z8;:
M;:43#<">/ZYG8.>]TG'").I*IUOBH"L=)^-?KW3<;HK1W.WY4HCYBDTNEU=L
M/G\VO_Q/-EFI.UI*HA@24&A50"0EA@SC!*JR0$F1Z926VB\YTTFNSPP9)C]S
MK6==?V6B[LU/CVQIV0TL']@2V CCI_F,U^YD':JU6%:/]F_G-(0[-BIN'!0=
MZ9ZYZ%6;N&>PUKBO_G G$.FQ5=PQR6_8->X$&-T-Y$[=',90O\UF\L]J,FFB
M%!G712%) 3.",XBTUI#F7$ IJ2 E,3R5.)7L/_CTL;DTK7*GPA4=<'/CBF T
M>N8$5R"\J>"@P5&G_$L)@T[M@\:]GL*'+SKG'&;_S&<OT*D-;WJGS(=4O3Y)
MLF>W)!<B+](2:H851*7M99UI! G+*"YD7I3:JT),/-7&1A+'CW$W<8)[ 84O
MH@AY;2EX;>J%_^E]Q/'W.4D:>E2'.78:>$ #3ZQB8M_#\584]=[@+"PFK(</
MSJ)*\#]EN_Q^]?N39$OU959O7.8?6#6OW<7/BBU6\WI7[7;V5 F2)8?^[4;;
M=('E\W<E5O/ZY._[BO^7$N:F=H%L7-'O;&(47RSGE; Z+[[.)I5XWNZO4T&3
M/)?F!:I#_P7+(>%E J46-$\5+<PRU_4X;APFC>WS9% !#2S@R^POP"(#D_P"
M6 ! C0#8@0#\4@,$#$*__NNQ:V8:-$"!+5)@#158SL .6,"B!7;A.KZY/]9W
M]/09X#@4'=$G='0O'?BC 2OLC'$<X^MQ&#D.A4=X:CFZ%S/.4>>XQKOC3'0D
MB@YV>#H2>P^<LHY,L_!B<9>V]=Y393L<V1R)&SZI[FL66=P)Q3(A$P93@7*(
MTB2'3)@_<JJRLE"4%K+PK1EW7-S8/+];V_6I#JWP+Q37 :K;SD \J'IV5>I0
M)'M45.L(MDK&K1EW&HOHI>,Z1 Y>0>ZT^8<*R3G<%5CRPO#>=-E&3>>XS)%*
M"BBX,#21(0D)HA(*S(A4>9%RMYC0@T\?&RNLE0L,RG@)G!L5!,/1\\QW1L*_
M&L4AB^,6GW@A8=A:$X>,VRLM<?"B<XM7MV<E=4C7G4JI0!B5MI$E@H@I#&E2
M$$AQ(6C.<%[X580](F=L$WBWBO)'LV":WE<VVJ')!:V_9*WZZ[C:X-K4+^%V
MF^P10.QYVN_BYXS4&86F#^+04W7IE[+>J*3T08./UY$^?+G_CO9G]K-Z7#U^
M4C_4G-VK;]91N)-,ECC%!!)!"404<\AYGL),,)6DVGSU2Z>(S&,"QD8.:QU!
MJR2HM73?Z3H(XND-T'.AZ7G*]X**^V[<N>@,M#?6HC1I4;)%!F;@2<T?JZ5-
M6.;/+L']D;:TND#KV& Z>-M@VSU=2N]NOG1>YU\B^WJZ-$.PSL7[IIYF<QL1
M9GNOK19W+,^06<TPJ*3@E@(59*GQFC"E+!&T+)1VJM]W2M#8J+#1=9,^NM$6
M-.JZ5]3N1+>;&V-BUC-'AL+E58#;!8O@>MR=#Q^L/+>+B;O5NIVN]_>&?IO,
M.)M<3^5L(69/S_:'S<-_GU9M&H5,:,:3',-$%QE$"2TAE87Q,$O)$55)H:53
MO5YWD>.CB;6^GCLB'B"?]I_B0]<S6S0*@RUXO]@??]VA#:MV?Y"Z.U_QH1W(
M'8L%L9?7Y8=6AQ_F^*#!/#,_PW9]-<\[ ]. ;"[+U6RQW#OTSP1.I!(E3!-[
MAJ5*N\N5<5@RG"E$1,Z44V_;DY+&1LRUHJ#6] *LHS>"HSA.X^RVO14%O9ZY
M^5S@_/-Y3H$2-X?GJ+1A\W9.&;V7JW/R!G\O[YLM1=X<QU]7]P_+A_]8L;F9
MG!]FD\GL3T-0YN^32E=*7@ISY:*RGZS+J;Q]F,]6]P_?E&W*;2ZSF=8WNLVJ
M7G]C19(QIE,*95H4$)&TA(PP!#$7FHI<J9PZI0#TK>C8B&O'U@N@:FO!/QIS
M@6[MM;]I# 9L:W&]?;]L; ;SUNBFP,),;S9;W-VI7E^0TW[M6(:]9\;M?\0#
M/.E>A][=_Q[+*S"0U_Z&D]_+T1]B6#J6![V*'VQ1,02(NTN10>0%-HK36HGE
M)I?EEOW\QI:JR4U>&9'KFL5U5)XHM5F\9%!JQ2%*;<]IS"FDJ<Y56:9"^S64
M<1<]-D]AHSE8LI_VN$4U56+%1G<PVRCOV5S.?3S<5C[]H-SWIO8&X'4"GU';
M'O[5R7EF?IOW?YV:]U49D1T=??R;TGGC%;=-G;OX81O7><.RU\K._PEG9%/O
M5+9<[]%OVC3F>8)L<"#D*D$04?,'R4L)RS(K&:.RI)E3[IJCO+&15Y,FNZ/O
MMFIU:$?,4XB[,55$''NFI_,@#,L8/@U,_#3@#IG#Y_:>!N!@PJ[#;2'[-S_4
M=*7>L8627]GSXTYL+::<<"8QE-3\@4J=09[0% I2,DP0Q05VCEPZ+F9LI#)O
M-(7<J@J>UKH&K7Z/(NNR;1$#KY[)8PBH?);Y,2 ;:)$>"IWG"OL4(IWKXZ,W
M#[BZ/67 R[7IR:L# YL,XS81R%BD""O!H'&PN.TTGD%*2&9^2HE2+*&D<&H1
MN/?DL;%@JYQ? /<^8-U,=Q8,?2_<7!'P#S]Z;>UY\4:;IPT;8/3:B+V(HKT+
M@GL#ZVIIBY#<R9R72'.SR"$ZARC/.*295%!@E+ B0ZC09O;9G$.WY<[VT5[3
M;R.@OY?/-MNIU@5_)K:DCW>?WQ:S,DV*5"89)(R4$'%60I(H#97,J";2^'*9
M].R='(+9 )05#S.W15X8$CVSE@7A5:4H\]?)2MJ=O*\V9&0V!9?+Y;SBJV5=
MHW0Y U_,E+?YTK/)Q%[V<6J&2RTB[D3M0Q6[#W+[^*%['K\RZT!_X]=7!/8R
M%F*V,O[,-R54]<,.7%VM;[T.O,LD,OZ;I##-26X/RA/(.2G,'XP2KEB./%L7
M=XH;V\QOM07SC;J>38B[T77C@WB8]<P1&[BVFFXJQEW:8YRZ*X*M;[QNIV'?
MW\V^4,1&PTZ Q>TKW"URV#;"3N;O=0UVNRN\F$7[TA<)2Y74!&)>V 170B O
M10I1FJF4,,Y8BOT*?N\\W6<V#%/6N]WUK/N S+9I_OZ%*UH <:%9DE %C9N%
M#"<C0\>24ECBM+"%38N<>&W.!\(W! %;U4X3Q$G$W'@V$(>>2=4-@J#"'7T2
MXN[S!R_)<8+J#ET2ORIQVX"R:4=Y5?=7V!SW9(4V;I0DD"6$F]63X)#DQ$[I
M%%&J$RI2KUKCH8J,;<*?+%"[TR[V8MU"%C0FG7<T%S*('F=V/0_-((=YO8U*
MU/K +I .5@VX4YG1U/YU@<RGTJ_3\\((]]UJ44V5[0SQR*MI[4G9<)?[:?7?
M2GZ4AM$K75GGM:D94L>*F;7&Y53N''*:?UL]JMW?W"&*$XE*#J4VBUTD,@:-
M<Y6:96^A\A(CQ%$>T-R])W6=J&'X/N^MM6#'W NP-1CL6MQ6=6EM;@J5[33"
M79M]L?M+/V+OZV5QX_VW'/MA/@MO.-[>GXR>1R/J%Z4O70?]X/0,^.OO4=_B
MPCY7MN:]_;\M)_J#352]O])4#%72_D/=_W'W%SM7FH5^IC.M&,1$F8]2+ACD
MMMF\+$FNS;N#LA3?/=4?V>]+-E^Z?9/.TLF'?5YKUN,>BU'R @C;N4)M=;T
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MP4PC8GP2SB$I90ES5::%0)Q*R7Q]DO/@Z]_%,!*L#_B.3>HSZU\:?==8>@8
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M-VY_TV#]#J>9\<D+"E-,)$1*99!+DL*R*)%"!<\9\TMY<A Z-F*R.C<EP"[
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MYYI12HJ9-@4HH.!N>0,IX,HR0'E9%D(K2(NHO!57Y$UMH7.L[F%NF:Z.,-<
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M<NG&I6OPQV*^W/[SC5C-5CL]/QOU,)_]]6).[TY5R3A4%H'28 &PHCG@VG#
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M5FN_T/9UDVX_O'U_YQ]Q?ZC3<]\YY99F/=NLQM^8N;&S=55:Z0_CM/8W*I)
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M/;PJ8688P8\:AEU)!F:S4AT&<V1IAH;R53J=SKMN0Z4L><O@!)>!RM1'4NY
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MWN N>+MWNW,8;;5N_&YVQK[1RGWEY^D3"G$-7Z;Q1B_M/2SBKF\8U$P>Q-Y
MMO.R*?Z;Q6E L':T7$/4.\Z8<\0B>!!+22)$DR(*@03.VY1"G7LD3U%UJ*5[
MX-D/Q4=!BA B$[AZM"?2QDRLSIQ(SHQ!UJ54=>8Y]*-O7 LX&&KN&K8*RFD_
M>-W1#G1'\D<P=MOWC&GR'F+U&(8O1> 08QF-I#""<)")YR(BF*FDAC(O*_4#
MJ&GX/L432.>S&Y-0;FKC]<6-KS95'U8:? I'OT0Y6J;R4ES(D9*HHBL]-R5S
MODZ NR.E#1O#79!T+]JMJ; &S@(?X*JK1_/!)%$F-#LK&)$L:1+0*R:&"JVU
M\DQ62EH_0M#(M3-54?#(_GN(2AI%UF96(VQK%74HMVY E@E0Z*0$%TF@01,:
M# 7CM$+_XF@8NT5:&\;L( #T -7^VABY-/BUOYA-5[]#FD8_^QU*'#XQ)B8K
M(B.99XRYM65HY$,DS-(@0K3 K7K&-WODT>V!X0#%+8:3XMC-'9=0\L_3")\6
ML_/.$+^;QRT?#B+/62DBH\</E@KBN"DW8!D#IW)V.?9 PU/O&+>FKAXL!I-K
M WL0$KXXA>OJF_('E]:4TQ 2EY88L!+E$PSQQF;<+I21 )3Z2IVWGR!JY#K-
M8WHY0ZFF791MUZ$/%(UFPI@C>ER'3,=2<1"( RL$)($R/"K.6O!P!E-^/U#M
MH8D18;5:KB?O_YKC<TZF9YU(G*#!Z6P(ESD3C%HUL2$#$58F)@5/S+,^$,(G
MWX /?G47.O=>/7(I[S$,TF'B;@4G6XA'$SAEF1%(IBR>$B)067P #!XX..=%
MKQG<NR%E3)-RH/H> L$>LFQ@%[JR>F]F?E5FJ)2>QYU J*!H3X4GH%0BT@5%
MK.C<>Q.H\")J7:E(YC&21J[&/J:?,XQ:&L#73?JW*T11P4,*C"1?YLY&AGMI
M.6JB.=G2G3+)6GU*[]'2R-VZPY1\M\S_,(DW@)D'UM=O5S<@F J,EC2#L(HC
M+U!Z $='<#VI(+/VGO7:JX9(_UU1-7)/VI'SS/LIIP&@[2*XJQ/LQ'GB*N/>
MWE5!\L")BX*AWP#,4)9 )EYG7]R#VN:RD'MBY8#SM;T4UQ0X2[.R+_/I?T%Z
MES;G\I!>K5:P7FV3=^G5/%UV+2L%NZO5^2FD;JU?LV\R35Q(1Z+GN E0!L2K
MD(F6P+EA$D*N4Q(T,"/-95"'AO3QU=T VG^9SJ=K^&WZM>/NW3Q!OO[..U3P
M_$N9*G5'#JL/?KF^-@(WSO'O2(,GZWWVG B/FYT4&)4Y%BC1P)+Q5CIG>N5"
M=@9_7;[&3;146PL-@:&%I7'9U?+&FM\VN$SO[_2NO-?I\G:CRVL9.$-5*K.,
MK!$.-T.E2(B BF+X;1<]RZ+.*7H-;L9-#-1;!F,KOB7P;Q?[K9WO 6'@+_RQ
MF"]OR:;\_58*\60^_><YK.Y8!)L2:!LC84J5QIPN$UMR>%KEX&QD.66HNQIJ
MLC=N=%I_>30#C0;6RW4)[G\L9F4*S.K:L;Q;GGO-)'-.)Y8LP: (=T2#'F,(
M2A 6F%;"\)1DG:3*7N2..R*E&I[KJ^XEW1KR\W2SS'S_JY,]'EJM4+X/$\>H
MBN<N&:6,(>!*_W)I)/&6:\)HP&\H8]G=/J??8U5\U$RHF(#8& (N3DF)+PD@
MGX+P =<)-[4S("^^*GX7)!U<%;^+PIKHP?98#:XV--HL,\'0LDR_]A2-=*(D
M<VL4URY;J'/D]7W4Q>^$@YYU\;NHI &_[OG*S>"2TQH<46 9D1Y79O#HJ K.
M'#A?&G35Z;_T0NOB=P+ SG7QNVBCP;IX9UQ" 1@2F4/A"(7"T<"($Q$2#P'I
MS\_X72^T+GXGQ3U3%[^+%%NNBR]30V,TE)CR05(92_T !CG:T4R3E='Z'FAX
MR77Q^\)B,+F.C(_?SC'X+/C> )M&16FVQ')6!C$;0& '(#EKRP)H$WD?0-QZ
M:'-G&0,A8'_)C:SRW]^5I-B;Q6_KM"6>*^DL:,2K#^C\BW(E5B1/6.G*'44N
M#9MZJ/W>@YO+WP^D^L,D.'*1\,<R.[KSE#(U(177R#M:S%1$GPEW-**IEF"U
M-A!ZC=GI51Y\]=H7=JMEGQAE?S&W@(U+B\8TDP&5&'PY1C*\U#J;LI-93P4R
MI7ROD\3^Z!C3D3Q 97>5OH?\1E;[[]/Y]/3\]-)[R49Z 9&P,L-.VE*DRO$S
M[:1*7EN3]7"W!FZ]>F35[Z.XQ1!2'#7'U9'NO]T@G5(E@C+HR]CH2RXPDX ;
M/?$0,HK#@]2]>JWT \#-5X^S-PP&@+VE.#H _@YEDB6D5_A ?R4(*K3A&N-<
M4%(2R:DC#J@@P1CTF@P:0]/K^+P7$!XD89S@82A '"[5!C*4OSQ>HO7ZXG?_
MOQ;+[F9"MV]&FM#U91C[!%HPGP*Z3281[DW,T2O%99W&E#L0^<(N,1Z2(Z^E
MNK91><W8'_[T,M2S6@0)Z,+Y%-&C4\JA-6:"I*!39,%3E>MTSMJ1T''3J-4
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M-[?%+DM;K)-:A$Q8.027#ABQVKABUFEBT= 8Z\SB&8R%9F&[#[2> N[1]-P
MP.^T>W[M9WX>X=,)P!K#\E<I==N/GUV/+\.-Z9:T2@G_[+Q<T7Y8+ANCDBQ#
M,92F]Z74MXP.PFB>$@,0,G<<M[(ZLW".PU^OI6&^"S^B0< TL(QV8O!F4H-+
MZ4K*(19+)87@Q"G/B;$^29:4\/8(CG%_@L?.5+:'O:<VDDI &/DJS*<S*+.
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MYTMF$Y!Y7J0RM/L26W7(34[@;(F0C9(B:,RRT2RI_>CM$/4=H._@1?)L*'0
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M+HTF&CU*UK1QP&C*'P:J/331 :Q>+U;K#^5S.,5K9]-+:7P!%HLB!HR#B*J
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MPH7:=:*..T^%F/?H@&,Q7J)+)K;) A^5C6&GT.P%(W@ZK?]Y('\1V3G!@B^
MD22OHBK@DTB MH3H+#/%M2GQ&H^'86!_R7<N$^G[SX/TJX,,;8RN,W^!I*!
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M1H56$L.J35^R <1U$AN-!8B' #>2=CH%W.IJW6YM>Z792BU 1K]I'IPA%%?
M&<<"Y\Z+ZV3'YHB[2UTGD!L+$@,@=Y!^>L+<+S^O/OVO&842R_3MYWO\@:>;
ME1H->1\N,G"U-8URWH*S2&(SZ"UG*1K1IL?H,/JFG9#8W0X\EB9[PN?--7>?
MO^WJ%L60_'("14%N77PU@Y^BX(1$&Y:L*/P]GG%\B,Q.K.2(.!EB*$=16A?-
M6*XX>3?_?KY>;63&M^:?EQ RCP$RUZ5&WAE<2+0;>&ZP1.<";W-5_@A1G>!M
M?# \!+L#]=*3V;O!BKAD)1M3I/4@A281"8L0K-<0 A;N@\C1MYF?\ A1G83
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M13&^JI4<L;K!%.-K\HFU"K%-%/(@22\_HAC'<HVCLP[ =[\\ED1YDH330:@
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MFA-#<3:0,Q$$9D?!@O>UL$)*!!]Y!E90(_*@DK*#=JSGO'7ZHY^1MZ]F(N_
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MO).<(4]A /R&O&OBR75CPVIT\4X-%_Q:,Z1_;A(V]EX?SB,G2XY@LZD=,#!
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MTN8&ZBG*)AXIV.3H?TQE3.Q+[JHDK[[(C/2RT=*)5T)[+R-(BIA \># B2S
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MHD.(R=93X9HZH[*$K*V)"34M5-D$;P\0-%T:72-<C2'XB0N'W\\2SE>$?%H
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M)+ROQ,F6%:.8,8%DHX+GH&QMRAA\ <ZS%-:G9%VC=DH/$S7M?49S@S26.CI
MUH.RNN"F:*=-R0J2K!/C8A'@6&%0BE!>D/\H?;.9\8_0-4T8=S1\C:B4#B#V
M*J7SL_/3FK9YLZL#?7Z*&Y7-\ZNSQ7(]^Y_-]Q]D_B0:45+&",[D&MBJ L%P
M7N5J,[$M5*-,S+$XF"90/!IL)U%T!P!_3+ GSALM(M=U@'IU-U@=T%Z[2?(8
M2F'TC7AD"SHTWZ#90/OI[.=S%3)Q/L*0J<A(;FTXO3Y,%$*)Q.N])<I(<J.8
MV]N(D#371D>MHLD# H@]7OTRI@SMF\'06A==G(C=ZKHD73!U+!*@""0N6Q.Z
M-$77A7$ALO0\JC8W0,]N@C75<([#%/Y8QZOGR+X+Y-RXA[CN<7@EER1E#%%'
M$!1VUT&KL5:EDURB5YH33^%NB^GQ;X#ND_4RIE(=<FX_GE8Z<+.&--7,J(0T
M!2D@,O4JS6>(2=:<U%0,&H^NM*D='*LC:K/#_A&AL$>ST^?HI0.H?2#WD30S
M__H>PPH_S;Y^6W\H?UU=9/R<"&4EET*!=IFL?/0"@BT>1%9&%E7J<70;:_88
M6=-> K2#UWBZZ !8=Y/'3IP,5E!  XGSVO /,X6ZD<3#T>D8=#2-YM?>I63:
M^X!V\#E(XAT@IN;2K]87*6;6&F>+M!!];>XCN $GE0;-<E!9)BY2&S?J!A'3
M'NVWP\F^<I[4^WXP&S%LC*-W3IK$([A<F^<9S2$4IH"C\EH*R\2@LX"'WS#M
M.?SX8!A1GA-?->_J.UMGSUH?I ?G:HJ[,@*B*A2C,LOJ77G,?,CE\JYG3WNT
MW08)!\MP8@QLI++Y\'XQ_TK//-MN@=Z5P@F^$.LM$GE0FIRF) ')6U)DX'20
M>@ .'GK^M*?+;; PBBP[<"=V2N<D^LQEH/!,:Q<K$X[8B0&L529(X67@;;S0
MG>1,<RYSA$CF8-EWD*[[*J7E.;WU>L#YW4:7L:CD?.2@4LT_%M[1?ND"!*&,
M(D\[B](F/'Z2M$' \F,#Z\@MO4?43A<GR^^)C:\;"6WKS:_RW%,A9K0#4V*=
MSJ?(+XM:$#!XH(W*:&_;=#%YB*+)VW:/J?J[J;QC:*&#_>_MV??3Q4_$3[C)
M4[@OK9.@T*>$Y-5+10P%YB @67C)!$.*"F..;8Z0GR1M\D;<#?$UKEXF=KRW
MHOJ$D7BY8B [+@SC"8JRMD[/KCFGA8,0QCNF _TWQ.O>^?#)FV$W@,8XDNS
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M\?VS"JR:M8=K$8&-(_[N@/1ST^4GG+Y:OP[+Y4_ZYG^'TW.2%4_)VLR >ZU
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MQ$J@&7=11 S*2M?FXN'  4Y+-W-P#[6373J V[V+ED_V^7P(Y%5+9!DB>=P
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M_<^^K>^CW'0KE\HKHQ.CQ)_6R8*>'*5"PGPN)DG@\)@9\_G88ML73WM%9Z3
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M5+]=(.9/>N+B] KF^1.>DZ+^BA2^GSTG&G(4.AG.I#$4O,MH2$CE&% ^)P&
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ME9MD>77RY^>3P@V*$!/3N7CZ4A/^B)X)G:%XJ61ZM:YLA>G_GBZ^_=?U$S<
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MC64Z7P!KF64)W%3"J6!K<41F(8A2KZA7)B$N+>2#KWM]+W=;F7^+Y6XK6W2
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MGTI["#1LROS8!_"'Q$0/Z<DPG?],(L\QW\C^FGX>>@I/8;"0Y!I$!%&S-<$
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M/UQPTH;AQ1RI%@G]4)FQM#JEVGXC\*S=[4PUYXRH:<-UG#<5,[3=BGFJP)Z
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MS?+K[D,X=0 3=Q^=_0:>Y=4>7^VV8SGNSM.3ZM?4E!^77?XO(5GO_ ] =%V
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MX0  $               @ 'X20, 8G-X+3(P,C(P-C,P+GAS9%!+ 0(4 Q0
M   ( !""!%70[#3S1R0  *5A 0 4              "  6I? P!B<W@M,C R
M,C V,S!?8V%L+GAM;%!+ 0(4 Q0    ( !""!%76CQL/SJ$  .;E!@ 4
M          "  >.# P!B<W@M,C R,C V,S!?9&5F+GAM;%!+ 0(4 Q0    (
M !""!%7P^6*1RBX! ,/K#  4              "  >,E! !B<W@M,C R,C V
M,S!?;&%B+GAM;%!+ 0(4 Q0    ( !""!%4KIY'7'\(  $>?"  4
M      "  =]4!0!B<W@M,C R,C V,S!?<')E+GAM;%!+ 0(4 Q0    ( !""
M!%6?J7_YRP(  /T*   >              "  3 7!@!E>&AI8FET,C(M<W5B
M<VED:6%R>6ES<W5E<BYH=&U02P$"% ,4    "  0@@156T%]FAD)  "D40
M&P              @ $W&@8 97AH:6)I=#,Q,2UC96\S,#)Q,C(P,C(N:'1M
M4$L! A0#%     @ $(($5;D-/LTD"0  AE$  !L              ( !B2,&
M &5X:&EB:70S,3(M8V9O,S R<3(R,#(R+FAT;5!+ 0(4 Q0    ( !""!%4D
M*22-"@8  !4K   ;              "  >8L!@!E>&AI8FET,S(Q+6-E;SDP
M-G$R,C R,BYH=&U02P$"% ,4    "  0@@15K<&%W!8&  "C*@  &P
M        @ $I,P8 97AH:6)I=#,R,BUC9F\Y,#9Q,C(P,C(N:'1M4$L%!@
0   +  L ] (  '@Y!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
